PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	PIERCEALL, WE; ANANTHASWAMY, HN				PIERCEALL, WE; ANANTHASWAMY, HN			TRANSFORMATION OF NIH3T3 CELLS BY TRANSFECTION WITH UV-IRRADIATED HUMAN C-HA-RAS-1 PROTOONCOGENE DNA	ONCOGENE			English	Article							EXPOSED BODY SITES; HUMAN-SKIN CANCERS; RAS GENE; N-RAS; XERODERMA PIGMENTOSUM; ACTIVATED ONCOGENES; AMPLIFICATION; MUTATIONS; TUMORS; CARCINOGENESIS	Our previous studies have shown that human skin cancers occurring on sun-exposed body sites frequently contain G --> T mutations at the second position of Ha-ras codon 12. In this study, we investigated whether the c-Ha-ras-1 proto-oncogene could be activated by in vitro UV-irradiation of pEC plasmid DNA, which contains the 6.6 kb BamHI fragment of the human c-Ha-ras-1 proto-onocogene oncogene. Focus formation and nude mouse tumorigenicity assays showed that UV-irradiated pEC DNA induced morphologic and tumorigenic transformation of NIH3T3 cells in multiple cycles of transfection, whereas unirradiated pEC DNA did not. DNAs from secondary cycle foci and tertiary cycle tumors were analyzed for mutations in Ha-ras codons 12 and 61 using the polymerase chain reaction and synthetic oligonucleotide probes. Eleven of 11 secondary cycle foci analyzed possessed a G --> T mutation at the second position of Ha-ras codon 12. However, the nude mouse tumors exhibited a G --> A mutation at position 1 of the Ha-ras codon 12. These results suggest that in vitro UV irradiation of the c-Ha-ras-1 proto-oncogene DNA can induce mutations that are similar to those found in human skin cancers that originated on sun-exposed body sites.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT IMMUNOL,BOX 178,1515 HOLCOMBE BLVD,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NCI NIH HHS [T32-CA-09598, R01-CA-46523] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA046523, T32CA009598] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANANTHASWAMY HN, 1988, J CELL BIOCHEM, V36, P137, DOI 10.1002/jcb.240360205; ANANTHASWAMY HN, 1988, CANCER RES, V48, P3341; ANANTHASWAMY HN, 1989, MOL CARCINOGEN, V2, P298, DOI 10.1002/mc.2940020510; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BLUM HF, 1959, CARCINOGENESIS ULTRA; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOS JL, 1989, CANCER RES, V49, P4682; COROMINAS M, 1989, P NATL ACAD SCI USA, V86, P6372, DOI 10.1073/pnas.86.16.6372; Epstein J H, 1978, Natl Cancer Inst Monogr, P13; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FORBES PD, 1981, J INVEST DERMATOL, V77, P139, DOI 10.1111/1523-1747.ep12479351; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HUSAIN Z, 1990, ARCH DERMATOL, V126, P324, DOI 10.1001/archderm.126.3.324; KEIJZER W, 1989, CANCER RES, V49, P1229; KRIPKE ML, 1977, CANCER RES, V37, P1395; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIPPKE JA, 1981, P NATL ACAD SCI-BIOL, V78, P3388, DOI 10.1073/pnas.78.6.3388; Maniatis T., 1982, MOL CLONING; MARSHALL CJ, 1984, NATURE, V310, P586, DOI 10.1038/310586a0; PADAU RA, 1985, MOL CELL BIOL, V5, P582; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; ROSENSTEIN BS, 1987, PHOTOCHEM PHOTOBIOL, V45, P775, DOI 10.1111/j.1751-1097.1987.tb07881.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Scotto J, 1978, Natl Cancer Inst Monogr, P169; SETLOW JANE K., 1966, CURR TOP RADIAT RES, V2, P195; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHUKLA VK, 1989, ONCOGENE RES, V5, P121; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STRICKLAND P T, 1985, Photochemistry and Photobiology, V41, p110S; SUAREZ HG, 1989, CANCER RES, V49, P1223; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Urbach F, 1969, LONG TERM FIELD MEAS; URBACH F, 1978, NATL CANCER I MONOGR, V50, P5; VANDERLUBBE JLM, 1988, ONCOGENE RES, V3, P9; VANDERSCHROEFF JG, 1990, J INVEST DERMATOL, V94, P423, DOI 10.1111/1523-1747.ep12874504; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114, DOI 10.1128/MCB.9.7.3114; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; VOUSDEN KH, 1986, P NATL ACAD SCI USA, V83, P1222, DOI 10.1073/pnas.83.5.1222; WHITE SI, 1988, J INVEST DERMATOL, V91, P407; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; 1988, NASA1988 OZ TRENDS P	46	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2085	2091						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945413				2022-12-28	WOS:A1991GX11900020
J	BONHAM, L; KWOK, J; CHISHOLM, O; SYMONDS, G				BONHAM, L; KWOK, J; CHISHOLM, O; SYMONDS, G			INDUCIBLE TRANSFORMATION OF FIBROBLASTS USING A METALLOTHIONEIN-V-MYC GENE CONSTRUCT	ONCOGENE			English	Note							MAMMARY-TUMOR VIRUS; LEUKEMIA-VIRUS; FUSION GENE; CELLS; INVITRO; ONCOGENE; GROWTH; IDENTIFICATION; TRANSFECTION; EXPRESSION	An inducible oncogene construct has been engineered by coupling the MC29 v-myc oncogene to the sheep metallothionein promoter. Transfection of this plasmid, which also contains the neomycin resistance gene, into Rat-1 cells, has resulted in the isolation of independent clones resistant to G418. Certain of these clones were found to exhibit inducible transformation in response to ZnSO4. Transformation was graded with increasing ZnSO4 levels and was reversible when ZnSO4 was removed from the media. By analyzing v-myc mRNA levels, the inducible alterations in cellular morphology and growth were found to be associated with increased v-myc expression. The metallothionein promoter exhibited negligible constitutive expression of v-myc and none of the clones isolated exhibited spontaneous transformation. Our results show that the use of a metallothionein promoter v-myc construct facilitates the study of inducible fibroblast transformation.			BONHAM, L (corresponding author), CHILDRENS MED RES FDN,POB 61,CAMPERDOWN,NSW 2050,AUSTRALIA.		Chisholm, Orin/L-4206-2016	Chisholm, Orin/0000-0002-9749-4160				ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; BIRCHENALLROBERTS MC, 1989, ONCOGENE, V4, P731; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Bishop JM, 1985, RNA TUMOR VIRUSES, P249; BONHAM L, 1987, J VIROL, V61, P3072, DOI 10.1128/JVI.61.10.3072-3081.1987; BRIGHTMAN BK, 1988, J IMMUNOL, V141, P2844; BRIGHTMAN BK, 1986, J VIROL, V60, P68, DOI 10.1128/JVI.60.1.68-81.1986; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; CHISHOLM O, 1988, NUCLEIC ACIDS RES, V16, P2352, DOI 10.1093/nar/16.5.2352; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; FREEMAN AE, 1973, P NATL ACAD SCI USA, V70, P2415, DOI 10.1073/pnas.70.8.2415; FRYKBERG L, 1987, ONCOGENE, V1, P415; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; JAKOBOVITS EB, 1984, CELL, V38, P757, DOI 10.1016/0092-8674(84)90271-X; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; OSTROWSKI MC, 1984, EMBO J, V3, P1891, DOI 10.1002/j.1460-2075.1984.tb02064.x; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PAPKOFF J, 1984, J VIROL, V52, P420, DOI 10.1128/JVI.52.2.420-430.1984; PETERSON MG, 1986, EUR J BIOCHEM, V160, P579, DOI 10.1111/j.1432-1033.1986.tb10077.x; Prehn R T, 1976, Adv Cancer Res, V23, P203, DOI 10.1016/S0065-230X(08)60547-3; REYNOLDS VL, 1987, ONCOGENE, V1, P323; STAPLETON P, 1991, ONCOGENE, V6, P807; SYMONDS G, 1989, ONCOGENE, V4, P285; TOWNES TM, 1985, MOL CELL BIOL, V5, P1977, DOI 10.1128/MCB.5.8.1977; WEINBERG RA, 1989, CANCER RES, V49, P3713; WURM FM, 1986, P NATL ACAD SCI USA, V83, P5414, DOI 10.1073/pnas.83.15.5414	27	12	12	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					1073	1077						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067845				2022-12-28	WOS:A1991GU62200026
J	BOEHM, T; SPILLANTINI, MG; SOFRONIEW, MV; SURANI, MA; RABBITTS, TH				BOEHM, T; SPILLANTINI, MG; SOFRONIEW, MV; SURANI, MA; RABBITTS, TH			DEVELOPMENTALLY REGULATED AND TISSUE SPECIFIC EXPRESSION OF MESSENGER-RNAS ENCODING THE 2 ALTERNATIVE FORMS OF THE LIM DOMAIN ONCOGENE RHOMBOTIN - EVIDENCE FOR THYMUS EXPRESSION	ONCOGENE			English	Article							T-CELL ONCOGENE; ALPHA-LOCUS; V(D)J RECOMBINATION; EARLY THYMOCYTES; GENE; PROTEIN; REARRANGEMENTS; LYMPHOCYTES; HOMEODOMAIN; MOTIF	The T-cell oncogene rhombotin was first identified as a gene near a chromosomal translocation breakpoint in a human T-cell tumour and represents the first example of an oncogene carrying the duplicated cysteine-rich regions (CRR or LIM domains). Transgenic expression of a reporter gene under the control of one of the rhombotin gene promoters subsequently showed high levels of expression in the developing brain. These disparate sites of transcriptional activity suggested that the gene may have been activated de novo specifically in the T cell tumour via the translocation. Here, we assess this possibility by analysing rhombotin gene expression in mouse development by in situ hybridization of whole embryos, Northern filter hybridization, and a sensitive semi-quantitative PCR method. The results show that the central nervous system is the major site of rhombotin mRNA production. Low level expression does, however, occur in other tissues including thymus. Furthermore, both promoters are active and differentially regulated during mouse embryogenesis in both brain and thymus. In subregions of the adult brain, different levels of rhombotin activity can be observed, with evidence for regional variation in promoter usage. A detailed analysis of mouse and human T-cell differentiation suggests that fluctuating promoter activities are related to a general T-cell differentiation process rather than to the differentiation of functionally distinct subsets of T-cells. These data suggest that the transforming activity of rhombotin in the T-cell with the chromosomal translocation was not due to de novo transcriptional activation, but rather to a quantitative or qualitative change in expression levels of this CRR-containing oncogene after chromosomal translocation.	AFRC,INST ANIM PHYSIOL & GENET RES,DEPT MOLEC EMBRYOL,CAMBRIDGE CB2 4AT,ENGLAND; UNIV CAMBRIDGE,DEPT ANAT,CAMBRIDGE CB2 3DY,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	BOEHM, T (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		; Rabbitts, Terence/D-6262-2016	Surani, Azim/0000-0002-8640-4318; Rabbitts, Terence/0000-0002-4982-2609				ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; BAER R, 1988, EMBO J, V7, P1661, DOI 10.1002/j.1460-2075.1988.tb02993.x; BOEHM T, 1990, EMBO J, V9, P857, DOI 10.1002/j.1460-2075.1990.tb08183.x; BOEHM T, 1990, ONCOGENE, V5, P1103; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1991, IN PRESS P NATL ACAD, V88; BONNEVILLE M, 1988, NATURE, V336, P479, DOI 10.1038/336479a0; BRENNER MB, 1987, NATURE, V325, P689, DOI 10.1038/325689a0; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHELLY J, 1990, NATURE, V344, P64, DOI 10.1038/344064a0; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GOEDERT M, 1987, EMBO J, V6, P3627, DOI 10.1002/j.1460-2075.1987.tb02694.x; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; LEFRANC MP, 1986, CELL, V45, P237, DOI 10.1016/0092-8674(86)90388-0; LINDSTEN T, 1987, J EXP MED, V166, P761, DOI 10.1084/jem.166.3.761; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MINOWADA J, 1982, CURRENT CONCEPTS HUM, P74; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; RABBITTS TH, 1990, NATURE, V346, P418, DOI 10.1038/346418a0; RUGH R, 1968, MOUSE ITS REPRODUCTI; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5	25	60	64	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					695	703						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052354				2022-12-28	WOS:A1991GT82500003
J	HIRST, MC; PORTEOUS, DJ				HIRST, MC; PORTEOUS, DJ			MOLECULAR-CLONING OF A REARRANGED HRAS1 ONCOGENE IN CHROMOSOME MEDIATED GENE-TRANSFER ASSOCIATED WITH ELEVATED TUMORIGENICITY	ONCOGENE			English	Note							DNA-SEQUENCE ANALYSIS; TELOMERIC DNA; HAMSTER-CELLS; TUMOR DNAS; APRT LOCUS; BCR GENE; TRANSLOCATION; FRAGMENTS; REPEAT; UNIQUE	We describe the molecular cloning of the rearranged HRASI oncogene found in association with the increased tumorigenic potential of the chromosome mediated gene transfectant E65.5. The rearrangement occurs immediately 3' to the c-Ha-ras coding region, removing the variable numbered tandem repeat (VNTR) but not altering the HRASI transcription unit. The novel 3' DNA sequence contains a short open reading frame but shows no homology to any previously cloned elements. Sequence analysis identifies a number of short DNA motifs consistent with the activity of an aberrant recombinogenic mechanism.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Hirst, Mark/0000-0003-3851-9740				ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BISHOP JM, 1986, TRENDS GENET, V1, P245; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEKLEIN A, 1986, NUCLEIC ACIDS RES, V14, P7071, DOI 10.1093/nar/14.17.7071; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GOSDEN JR, 1987, CYTOGENET CELL GENET, V45, P44, DOI 10.1159/000132429; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HEISTERKAMP N, 1985, NATURE, V317, P559, DOI 10.1038/317559b0; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HOPE TJ, 1986, SCIENCE, V231, P1141, DOI 10.1126/science.3003919; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Maniatis T., 1982, MOL CLONING; MORTEN JEN, 1987, ANTICANCER RES, V7, P573; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NALBANTOGLU J, 1988, J MOL BIOL, V200, P449, DOI 10.1016/0022-2836(88)90535-9; NALBANTOGLU J, 1987, MOL CELL BIOL, V7, P1445, DOI 10.1128/MCB.7.4.1445; PICOLLI SP, 1984, NATURE, V310, P327; PORTEOUS DJ, 1985, SOMAT CELL MOLEC GEN, V11, P445, DOI 10.1007/BF01534838; PORTEOUS DJ, 1986, INT J CANCER, V38, P603, DOI 10.1002/ijc.2910380422; PORTEOUS DJ, 1906, MOL CELL BIOL, V6, P2223; ROGERS J, 1985, NATURE, V317, P559, DOI 10.1038/317559a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHUANGYOUNG X, 1986, GENE ANAL TECH, V3, P90; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; VANDERFELTZ MJM, 1989, NUCLEIC ACIDS RES, V17, P1, DOI 10.1093/nar/17.1.1; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; VARMUS HE, 1984, ANNU REV GENET, V18, P553; VIERA J, 1982, GENE, V19, P259; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880	47	3	3	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					153	157						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992442				2022-12-28	WOS:A1991EY03900022
J	GARCIA, M; DEROCQ, D; PUJOL, P; ROCHEFORT, H				GARCIA, M; DEROCQ, D; PUJOL, P; ROCHEFORT, H			OVEREXPRESSION OF TRANSFECTED CATHEPSIN-D IN TRANSFORMED-CELLS INCREASES THEIR MALIGNANT PHENOTYPE AND METASTATIC POTENCY	ONCOGENE			English	Article							BREAST-CANCER CELLS; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; MURINE FIBROBLASTS; PROTEIN; SECRETION; ACID; CARCINOGENESIS; STIMULATION; ANTIBODIES	Cathepsin D, an aspartic lysosomal proteinase, is over-expressed by breast cancer cells and highly correlated with the occurrence of metastasis in patients. We used an adenovirus transformed rat cell line that does not secrete cathepsin D, to study the consequences of transfecting human cathepsin D cDNA. Overexpression of human cathepsin D in stable transfectant clones, results in higher initial growth rates in low serum conditions, overgrowth at high cell densities resulting in stellate aggregates, and greater anchorage-independent growth in soft agar. The metastatic activity (mostly in liver) of cathepsin D clones injected into athymic mice was significantly higher than that of control clones. These results show that over-expression of cathepsin D increases the transformed phenotype of malignant cells in vitro and their metastatic potency in vivo.	UNIV MONTPELLIER,FAC MED,INSERM,U148,UNITE HORMONES & CANC,60 RUE NAVACELLES,F-34090 MONTPELLIER,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier								AUGEREAU P, 1988, MOL ENDOCRINOL, V2, P186, DOI 10.1210/mend-2-2-186; Barrett A, 1977, PROTEINASES MAMMALIA, P209; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BRIOZZO P, 1988, CANCER RES, V48, P3688; CAPONY F, 1989, CANCER RES, V49, P3904; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; CONNER GE, 1989, BIOCHEMISTRY-US, V28, P3530, DOI 10.1021/bi00434a057; DENHARDT DT, 1987, ONCOGENE, V2, P55; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; FIDLER IJ, 1973, EUR J CANCER, V9, P223, DOI 10.1016/S0014-2964(73)80022-2; GARCIA M, 1985, CANCER RES, V45, P709; GOTTESMAN MM, 1978, P NATL ACAD SCI USA, V75, P2767, DOI 10.1073/pnas.75.6.2767; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; KANE SE, 1988, MOL CELL BIOL, V8, P3316, DOI 10.1128/MCB.8.8.3316; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KHOKHA R, 1989, SCIENCE, V243, P947, DOI 10.1126/science.2465572; LIOTTA LA, 1986, CANCER RES, V46, P1; MONTCOURRIER P, 1990, CANCER RES, V50, P6045; OHARE K, 1981, P NATL ACAD SCI-BIOL, V78, P1527, DOI 10.1073/pnas.78.3.1527; OSSOWSKI L, 1983, CELL, V35, P611, DOI 10.1016/0092-8674(83)90093-4; RECKLIES AD, 1980, CANCER RES, V40, P550; ROCHEFORT H, 1987, J CELL BIOCHEM, V35, P17, DOI 10.1002/jcb.240350103; SLOANE BF, 1984, CANCER METAST REV, V3, P249, DOI 10.1007/BF00048388; SPYRATOS F, 1989, LANCET, V2, P1115; SULLIVAN LM, 1986, CELL, V45, P905, DOI 10.1016/0092-8674(86)90565-9; TANDON AK, 1990, NEW ENGL J MED, V322, P297, DOI 10.1056/NEJM199002013220504; TANIGUCHI S, 1990, BIOCHEM BIOPH RES CO, V168, P520, DOI 10.1016/0006-291X(90)92352-Z; THORPE SM, 1989, CANCER RES, V49, P6008; UEDA H, 1985, CANCER RES, V45, P3332; VIGNON F, 1986, ENDOCRINOLOGY, V118, P1537, DOI 10.1210/endo-118-4-1537; WEINBERG RA, 1989, CANCER RES, V49, P3713; YAMASHITA T, 1980, INT J CANCER, V26, P435, DOI 10.1002/ijc.2910260408	33	181	188	0	5	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1809	1814						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284099				2022-12-28	WOS:A1990ET43600010
J	STURZBECHER, HW; MAIMETS, T; CHUMAKOV, P; BRAIN, R; ADDISON, C; SIMANIS, V; RUDGE, K; PHILP, R; GRIMALDI, M; COURT, W; JENKINS, JR				STURZBECHER, HW; MAIMETS, T; CHUMAKOV, P; BRAIN, R; ADDISON, C; SIMANIS, V; RUDGE, K; PHILP, R; GRIMALDI, M; COURT, W; JENKINS, JR			P53 INTERACTS WITH P34CDC2 IN MAMMALIAN-CELLS - IMPLICATIONS FOR CELL-CYCLE CONTROL AND ONCOGENESIS	ONCOGENE			English	Article									TARTU BIOCTR, TARTU, ESTONIA, USSR; SWISS INST EXPTL CANC RES, CH-1066 EPALINGES, SWITZERLAND; ACAD SCI USSR, INST MOLEC BIOL, MOSCOW V-71, USSR	Swiss Institute Experimental Cancer Research	STURZBECHER, HW (corresponding author), MARIE SKLODOWSKA CURIE MEM INST, CELL PROLIFERAT LAB, CHART, OXTED RH8 0TL, SURREY, ENGLAND.		Maimets, Toivo/E-9268-2017	Maimets, Toivo/0000-0001-6461-3365; Chumakov, Peter/0000-0002-8078-2908				ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; BRIZUELA L, 1989, P NATL ACAD SCI USA, V86, P4362, DOI 10.1073/pnas.86.12.4362; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; CRAWFORD L, 1982, J VIROL, V42, P612, DOI 10.1128/JVI.42.2.612-620.1982; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GIORDANO A, 1989, CELL, V58, P981, DOI 10.1016/0092-8674(89)90949-5; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HAYLES J, 1986, J CELL SCI, P155; JAY G, 1981, P NATL ACAD SCI-BIOL, V78, P2932, DOI 10.1073/pnas.78.5.2932; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; JENKINS JR, 1989, CANCER CELLS MOL DIA, P127; JENKINS JR, 1988, ONCOGENE HDB, P403; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1989, ONCOGENE, V4, P665; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NURSE P, 1981, NATURE, V292, P558, DOI 10.1038/292558a0; NURSE P, 1975, NATURE, V256, P547, DOI 10.1038/256547a0; NURSE P, 1985, TRENDS GENET, V1, P51, DOI 10.1016/0168-9525(85)90023-X; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; RIGAUDY P, 1989, NUCLEIC ACIDS RES, V17, P8375, DOI 10.1093/nar/17.20.8375; ROVINSKI B, 1988, ONCOGENE, V2, P445; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; STURZBECHER HW, 1988, ONCOGENE, V3, P405; STURZBECHER HW, 1987, ONCOGENE, V1, P201; STURZBECHER HW, 1988, CANCER CELL, V6, P159; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; THURIAUX P, 1978, MOL GEN GENET, V161, P215, DOI 10.1007/BF00274190; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365	58	194	194	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1990	5	6					795	801						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2141683				2022-12-28	WOS:A1990DP55300003
J	TSUJIMOTO, Y				TSUJIMOTO, Y			STRESS-RESISTANCE CONFERRED BY HIGH-LEVEL OF BCL-2-ALPHA-PROTEIN IN HUMAN B-LYMPHOBLASTOID CELL	ONCOGENE			English	Article											TSUJIMOTO, Y (corresponding author), WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104, USA.							ADACHI M, 1989, P NATL ACAD SCI USA, V86, P2771, DOI 10.1073/pnas.86.8.2771; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; FUKUHARA S, 1979, CANCER RES, V39, P3119; IIDA H, 1984, J CELL BIOL, V99, P1441, DOI 10.1083/jcb.99.4.1441; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; OFARRELL PH, 1976, J BIOL CHEM, V250, P4007; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; SETO M, 1988, EMBO J, V7, P125; SHIN DY, 1987, MOL CELL BIOL, V7, P244, DOI 10.1128/MCB.7.1.244; TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WEISS LM, 1985, NEW ENGL J MED, V5, P1185; WESTRA A, 1971, INT J RADIAT BIOL RE, V19, P467, DOI 10.1080/09553007114550601; YAHARA I, 1986, CELL STRUCT FUNCT, V11, P65, DOI 10.1247/csf.11.65; YATES J, 1984, P NATL ACAD SCI-BIOL, V81, P3806, DOI 10.1073/pnas.81.12.3806; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	20	248	256	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1331	1336						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554236				2022-12-28	WOS:A1989AX65900009
J	QUINLAN, MP				QUINLAN, MP			THE AD5 12S GROWTH-FACTOR INDUCES F9 CELL-PROLIFERATION AND DIFFERENTIATION	ONCOGENE			English	Note									COLD SPRING HARBOR LAB,COLD SPRING HARBOR,NY 11724	Cold Spring Harbor Laboratory								DETHE H, 1987, NATURE, V330, P667, DOI 10.1038/330667a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FOX NW, 1984, DEV BIOL, V103, P263, DOI 10.1016/0012-1606(84)90028-9; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; HARLAND R, 1988, TRENDS GENET, V4, P62, DOI 10.1016/0168-9525(88)90041-8; Hogan B. L. M, 1983, CANCER SURV, V2, P115; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KNOWLES BB, 1980, NATURE, V288, P615, DOI 10.1038/288615a0; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; MONTANO X, 1987, MOL CELL BIOL, V7, P1782, DOI 10.1128/MCB.7.5.1782; MORAN E, 1986, J VIROL, V57, P765, DOI 10.1128/JVI.57.3.765-775.1986; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; QUINLAN MP, 1988, MOL CELL BIOL, V8, P3191, DOI 10.1128/MCB.8.8.3191; QUINLAN MP, 1987, J VIROL, V61, P673, DOI 10.1128/JVI.61.3.673-682.1987; QUINLAN MP, 1987, P NATL ACAD SCI USA, V84, P3283, DOI 10.1073/pnas.84.10.3283; QUINLAN MP, 1986, CANCER CELL, V4, P327; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SOLTER D, 1979, DEV BIOL, V70, P515, DOI 10.1016/0012-1606(79)90043-5; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; TAUB M, 1984, METHODS SERUM FREE C, V2; TOGARI A, 1985, J NEUROSCI, V5, P307; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988	23	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1051	1055						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2569707				2022-12-28	WOS:A1989AJ29700017
J	ZHANG, X; SILVA, E; GERSHENSON, D; HUNG, MC				ZHANG, X; SILVA, E; GERSHENSON, D; HUNG, MC			AMPLIFICATION AND REARRANGEMENT OF C-ERB B-PROTO-ONCOGENES IN CANCER OF HUMAN FEMALE GENITAL-TRACT	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT PATHOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GYNECOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center			Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	NATIONAL CANCER INSTITUTE [R01CA045265] Funding Source: NIH RePORTER; NCI NIH HHS [CA 45265] Funding Source: Medline; NCRR NIH HHS [RR-5511] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BERGER MS, 1988, CANCER RES, V48, P1238; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUNG M-C, 1988, Cancer Bulletin (Houston), V40, P300; HUNG MC, 1986, BIOCHEM BIOPH RES CO, V141, P1109, DOI 10.1016/S0006-291X(86)80158-9; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; HUNG MC, 1986, UCLA S MOL CELLULAR, V40, P391; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; RAINES MA, 1985, P NATL ACAD SCI USA, V82, P2287, DOI 10.1073/pnas.82.8.2287; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEBBA K, 1985, P NATL ACAD SCI USA, V82, P6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STECK PA, 1988, CANCER RES, V48, P5433; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VARLEY JM, 1987, ONCOGENE, V1, P423; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816; ZHOU DJ, 1987, CANCER RES, V47, P6123	33	125	129	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					985	989						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2569708				2022-12-28	WOS:A1989AJ29700006
J	SITHANANDAM, G; DEAN, M; BRENNSCHEIDT, U; BECK, T; GAZDAR, A; MINNA, JD; BRAUCH, H; ZBAR, B; RAPP, UR				SITHANANDAM, G; DEAN, M; BRENNSCHEIDT, U; BECK, T; GAZDAR, A; MINNA, JD; BRAUCH, H; ZBAR, B; RAPP, UR			LOSS OF HETEROZYGOSITY AT THE C-RAF LOCUS IN SMALL CELL LUNG-CARCINOMA	ONCOGENE			English	Article									NCI, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA; NCI, PROGRAM RESOURCES INC, FREDERICK, MD 21701 USA; USN, NCI, BETHESDA, MD 20892 USA; NCI, IMMUNOL LAB, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Brauch, Hiltrud/0000-0001-7531-2736				ARIYOSHI Y, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P23; BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BERGER CL, 1981, J CLIN ENDOCR METAB, V53, P422, DOI 10.1210/jcem-53-2-422; BONNER T, 1984, SCIENCE, V223, P71, DOI 10.1126/science.6691137; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BRAUCH H, 1987, NEW ENGL J MED, V317, P1109, DOI 10.1056/NEJM198710293171803; CARNEY DN, 1988, SEMIN ONCOL, V15, P199; CARNEY DN, 1985, SEMIN ONCOL, V12, P289; CARRITT B, 1986, AM J HUM GENET, V38, P428; CHENEVIXTRENCH G, 1987, LEUKEMIA, V1, P82; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; FUJIMOTO E, 1987, NUCLEIC ACIDS RES, V15, P10078, DOI 10.1093/nar/15.23.10078; GAREAU JLP, 1988, NUCLEIC ACIDS RES, V16, P1223, DOI 10.1093/nar/16.3.1223; GAZDAR AF, 1987, P AN M AM SOC CLIN, V6, P16; GRAZIANO SL, 1987, CANCER RES, V47, P2148; HEIDECKER G, 1988, GENES SIGNAL TRANSDU, P339; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; MARK J, 1982, HEREDITAS, V96, P141, DOI 10.1111/j.1601-5223.1982.tb00044.x; MARK J, 1980, CANCER GENET CYTOGEN, V2, P231, DOI 10.1016/0165-4608(80)90030-8; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; PATHAK S, 1982, SCIENCE, V217, P939, DOI 10.1126/science.7112106; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1987, MODERN TRENDS HUMA 7, V31, P450; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WASYLYK C, 1989, IN PRESS MOL CELL BI; WHANGPENG J, 1982, CANCER GENET CYTOGEN, V6, P119, DOI 10.1016/0165-4608(82)90077-2; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; ZECH L, 1985, CANCER GENET CYTOGEN, V45, P6024	34	43	43	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					451	455						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2566144				2022-12-28	WOS:A1989U567700009
J	DARLING, D; TAVASSOLI, M; LINSKENS, MHK; FARZANEH, F				DARLING, D; TAVASSOLI, M; LINSKENS, MHK; FARZANEH, F			DMSO INDUCED MODULATION OF C-MYC STEADY-STATE RNA LEVELS IN A VARIETY OF DIFFERENT CELL-LINES	ONCOGENE			English	Article									UNIV LONDON KINGS COLL HOSP, SCH MED & DENT,DEPT OBSTET & GYNAECOL, MOLEC GENET UNIT,DENMARK HILL, LONDON SE5 8RX, ENGLAND; UNIV SUSSEX, SUSSEX CTR MED RES, BRIGHTON BN1 9QH, E SUSSEX, ENGLAND	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of Sussex			Farzaneh, Farzin/B-4902-2009	Farzaneh, Farzin/0000-0002-9275-2415				ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLOMHOFF HK, 1987, J CELL PHYSIOL, V131, P426, DOI 10.1002/jcp.1041310315; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CELANO P, 1988, J BIOL CHEM, V263, P5491; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DALLAFAVERA R, 1982, NATURE, V299, P61; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DOTTO GP, 1986, EMBO J, V5, P2853, DOI 10.1002/j.1460-2075.1986.tb04579.x; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; ELY CM, 1987, CANCER RES, V47, P4595; ERIKSON J, 1982, P NATL ACAD SCI-BIOL, V79, P5611, DOI 10.1073/pnas.79.18.5611; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; GALLAGHER R, 1979, BLOOD, V54, P713; GEY GO, 1952, CANCER RES, V12, P264; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROSSO L, 1981, BIOCHEM BIOPH RES CO, V119, P473; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KANEKO Y, 1987, BIOCHEM BIOPH RES CO, V145, P549, DOI 10.1016/0006-291X(87)91355-6; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KLEIN E, 1968, CANCER RES, V28, P1300; KNIGHT E, 1985, P NATL ACAD SCI USA, V82, P1151, DOI 10.1073/pnas.82.4.1151; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; LOMO J, 1987, EXP CELL RES, V172, P84, DOI 10.1016/0014-4827(87)90095-4; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAGUIRE RT, 1983, P NATL ACAD SCI-BIOL, V80, P1947, DOI 10.1073/pnas.80.7.1947; MCCARTHY DM, 1983, LEUKEMIA RES, V7, P51, DOI 10.1016/0145-2126(83)90057-7; MIYAURA C, 1981, BIOCHEM BIOPH RES CO, V102, P937, DOI 10.1016/0006-291X(81)91628-4; MOORE GE, 1966, JNCI-J NATL CANCER I, V36, P405; POLACK A, 1987, EMBO J, V6, P2959, DOI 10.1002/j.1460-2075.1987.tb02601.x; POLACK A, 1988, 4TH ANN M ONC ABSTR, P57; PULVERTAFT RJV, 1964, LANCET, V1, P238; QUINN LA, 1979, CANCER RES, V39, P4914; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; RYFFEL B, 1982, P NATL ACAD SCI-BIOL, V79, P7336, DOI 10.1073/pnas.79.23.7336; SCARRA GLB, 1986, CANCER RES, V46, P6327; SCHOFIELD PN, 1987, J CELL SCI, V88, P57; SHENONG GLC, 1987, P NATL ACAD SCI USA, V84, P199, DOI 10.1073/pnas.84.1.199; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SZABO G, 1988, EXP CELL RES, V175, P334, DOI 10.1016/0014-4827(88)90197-8; TAVASSOLI M, 1988, ONCOGENE, V2, P337; TONINI GP, 1987, CANCER RES, V47, P4544; VERSTEEG R, 1988, EMBO J, V7, P1023, DOI 10.1002/j.1460-2075.1988.tb02909.x; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; WERKMEISTER JA, 1982, J IMMUNOL, V129, P413; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; YARDEN A, 1986, SCIENCE, V234, P1419, DOI 10.1126/science.3097823	59	34	34	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1989	4	2					175	179						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648255				2022-12-28	WOS:A1989U567500008
J	ZHENG, XF; PODELL, S; SEFTON, BM; KAPLAN, PL				ZHENG, XF; PODELL, S; SEFTON, BM; KAPLAN, PL			THE SEQUENCE OF CHICKEN C-YES AND P61C-YES	ONCOGENE			English	Article									HARVARD UNIV,SCH MED,DANA FARBER CANC INST,D1030,44 BINNEY ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115; SALK INST BIOL STUDIES,LA JOLLA,CA 92037	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Salk Institute					NATIONAL CANCER INSTITUTE [P30CA014195, R01CA017289] Funding Source: NIH RePORTER; NCI NIH HHS [CA06515, CA17289, CA14195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HAMAGUCHI M, 1988, MOL CELL BIOL, V8, P3035, DOI 10.1128/MCB.8.8.3035; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAMPS MP, 1988, ONCOGENE, V2, P305; KAPLAN PL, 1987, J VIROL, V61, P1731, DOI 10.1128/JVI.61.5.1731-1734.1987; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KAWAI S, 1980, P NATL ACAD SCI-BIOL, V77, P6199, DOI 10.1073/pnas.77.10.6199; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; KORNBLUTH S, 1987, NATURE, V325, P171, DOI 10.1038/325171a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; Maniatis T., 1982, MOL CLONING; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; NEIL JC, 1981, VIROLOGY, V108, P98, DOI 10.1016/0042-6822(81)90530-4; NISHIZAWA M, 1986, MOL CELL BIOL, V6, P511, DOI 10.1128/MCB.6.2.511; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YOSHIDA M, 1980, NATURE, V287, P653, DOI 10.1038/287653a0; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	52	15	18	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					99	104						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2464785				2022-12-28	WOS:A1989U567400015
J	ISHIKAWA, F; SAKAI, R; OCHIAI, M; TAKAKU, F; SUGIMURA, T; NAGAO, M				ISHIKAWA, F; SAKAI, R; OCHIAI, M; TAKAKU, F; SUGIMURA, T; NAGAO, M			IDENTIFICATION OF A TRANSFORMING ACTIVITY SUPPRESSING SEQUENCE IN THE C-RAF ONCOGENE	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV CARCINOGENESIS,CHOU KU,TOKYO 104,JAPAN; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	National Cancer Center - Japan; University of Tokyo			Ishikawa, Fuyuki/AAU-4056-2021; Sakai, Ryuichi/R-7741-2017	Ishikawa, Fuyuki/0000-0002-5580-2305; Sakai, Ryuichi/0000-0001-6833-1103				BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FUKUI M, 1985, P NATL ACAD SCI USA, V82, P5954, DOI 10.1073/pnas.82.17.5954; FUKUI M, 1987, MOL CELL BIOL, V7, P1776, DOI 10.1128/MCB.7.5.1776; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; HEFFRON F, 1978, P NATL ACAD SCI USA, V75, P6012, DOI 10.1073/pnas.75.12.6012; ISHIKAWA F, 1987, ONCOGENE RES, V1, P243; ISHIKAWA F, 1986, JPN J CANCER RES, V77, P1183; ISHIKAWA F, 1986, P NATL ACAD SCI USA, V83, P3209, DOI 10.1073/pnas.83.10.3209; ISHIKAWA F, 1987, MOL CELL BIOL, V7, P1226, DOI 10.1128/MCB.7.3.1226; ISHIZAKA Y, 1988, ONCOGENE RES, V3, P193; IWAKA S, 1988, MOL CELL BIOL, V8, P2651; KING HWS, 1988, ONCOGENE, V2, P617; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MOLDERS H, 1985, EMBO J, V4, P693, DOI 10.1002/j.1460-2075.1985.tb03685.x; NAKATSU Y, 1986, COLD SPRING HARB SYM, V51, P1001, DOI 10.1101/SQB.1986.051.01.114; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PARKER RC, 1977, P NATL ACAD SCI USA, V74, P851, DOI 10.1073/pnas.74.3.851; PIWNICAWORMS H, 1986, MOL CELL BIOL, V6, P2033, DOI 10.1128/MCB.6.6.2033; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTZ AM, 1988, ONCOGENE, V2, P187; SHIMIZU K, 1985, P NATL ACAD SCI USA, V82, P5641, DOI 10.1073/pnas.82.17.5641; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; TAKAHASHI M, 1988, MOL CELL BIOL, V8, P1854; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6	33	30	31	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					653	658						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577866				2022-12-28	WOS:A1988R646000005
J	TULCHIN, N; ORNSTEIN, L; GUILLEM, J; OTOOLE, K; LAMBERT, ME; WEINSTEIN, IB				TULCHIN, N; ORNSTEIN, L; GUILLEM, J; OTOOLE, K; LAMBERT, ME; WEINSTEIN, IB			DISTRIBUTION OF THE C-MYC ONCOPROTEIN IN NORMAL AND NEOPLASTIC TISSUES OF THE RAT COLON	ONCOGENE			English	Article									COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA; SCRIPPS CLIN & RES FDN, LA JOLLA, CA 92037 USA	Columbia University; Scripps Research Institute	TULCHIN, N (corresponding author), CUNY MT SINAI SCH MED, DEPT PATHOL, 1 GUSTAVE L LEVY PL, NEW YORK, NY 10029 USA.				NCI NIH HHS [CA 021111] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA021111] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BUTNICK NZ, 1985, MOL CELL BIOL, V5, P3009, DOI 10.1128/MCB.5.11.3009; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DALLAFAVERA R, 1982, NATURE, V299, P61; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; ERIKSON J, 1982, P NATL ACAD SCI-BIOL, V79, P5611, DOI 10.1073/pnas.79.18.5611; ERISMAN MD, 1988, ONCOGENE, V2, P367; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GUILLEM JG, 1988, CANCER RES, V48, P3964; GUTIERREZ C, 1987, MOL CELL BIOL, V7, P4594, DOI 10.1128/MCB.7.12.4594; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HOLLIS GF, 1984, NATURE, V307, P752, DOI 10.1038/307752a0; JACK AS, 1986, BRIT J CANCER, V53, P713, DOI 10.1038/bjc.1986.123; JONES DJ, 1987, BRIT J CANCER, V56, P779, DOI 10.1038/bjc.1987.287; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; LIPKIN M, 1984, CANCER RES, V44, P4201; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MIYAMOTO C, 1985, P NATL ACAD SCI USA, V82, P7232, DOI 10.1073/pnas.82.21.7232; MORGAN JH, 1985, J NATL CANCER I, V75, P937, DOI 10.1093/jnci/75.5.937; NEPVEU A, 1987, ONCOGENE, V1, P243; ORNSTEIN L, 1986, J CELL BIOL, V103, pA428; REDDY BS, 1985, JNCI-J NATL CANCER I, V75, P791; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P2500, DOI 10.1073/pnas.80.9.2500; SCHUBACH W, 1984, NATURE, V307, P702, DOI 10.1038/307702a0; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SPECTOR DL, 1987, ONCOGENE, V1, P5; STERNBER.LA, 1970, J HISTOCHEM CYTOCHEM, V18, P315, DOI 10.1177/18.5.315; STEWART J, 1986, BRIT J CANCER, V53, P1, DOI 10.1038/bjc.1986.1; TULCHIN N, 1988, ENVIRON MOL MUTAGEN, V11, P107; VENNSTROM B, 1981, J VIROL, V39, P625; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P3642, DOI 10.1073/pnas.80.12.3642; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448; WESTAWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P843, DOI 10.1073/pnas.81.3.843	43	11	11	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					697	701						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577872				2022-12-28	WOS:A1988R646000012
J	GREEN, AR; SALVARIS, E; BEGLEY, CG				GREEN, AR; SALVARIS, E; BEGLEY, CG			ERYTHROID EXPRESSION OF THE HELIX-LOOP-HELIX GENE, SCL	ONCOGENE			English	Note							ERYTHROLEUKEMIA CELL-LINE; HUMAN-LEUKEMIA; MESSENGER-RNA; DNA-BINDING; ERYTHROPOIETIN; TRANSLOCATION; PROTEINS; DIFFERENTIATION; GLYCOPROTEINS; ONCOGENES	The SCL gene encodes a member of the 'helix-loop-helix' family of DNA binding regulatory proteins. It is transcriptionally activated in some cases of T-cell acute lymphoblastic leukaemia by a reciprocal translocation involving the T cell receptor delta-locus. In order to gain insight into the normal functions of SCL we have studied SCL mRNA levels in human and murine haemopoietic cell lines and normal tissues. We have observed high levels of SCL mRNA in all human and murine erythroid cell lines examined. Foetal and adult normal haemopoietic cell populations rich in erythroid precursors also expressed high levels of SCL mRNA. Our results suggest a previously unexpected role for SCL in the regulation of erythropoiesis.	ROYAL MELBOURNE HOSP,DEPT HAEMATOL,PARKVILLE,VIC 3050,AUSTRALIA	Royal Melbourne Hospital	GREEN, AR (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.			Green, Anthony/0000-0002-9795-0218				ANDRE C, 1989, ONCOGENE, V4, P1047; APLAN PD, IN PRESS MOL CELL BI; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BEGLEY CG, IN PRESS P NATL ACAD; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; BERNARD O, 1990, GENE CHROMOSOME CANC, V1, P194, DOI 10.1002/gcc.2870010303; BOEHM T, 1989, EUR J BIOCHEM, V185, P1, DOI 10.1111/j.1432-1033.1989.tb15074.x; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CONKIE D, 1975, EXP CELL RES, V93, P315, DOI 10.1016/0014-4827(75)90456-5; DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; GEWIRTZ AM, 1982, BLOOD, V60, P785; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; HARA K, 1988, EXP HEMATOL, V16, P256; HARRISON PR, 1978, EXP CELL RES, V115, P395, DOI 10.1016/0014-4827(78)90293-8; HASTHORPE S, 1981, CANCER RES, V41, P3985; HOFER E, 1981, CELL, V23, P585, DOI 10.1016/0092-8674(81)90154-9; KELSO A, 1984, J IMMUNOL, V132, P2932; KIRSCH IR, 1985, CANCER GENET CYTOGEN, V18, P159, DOI 10.1016/0165-4608(85)90066-4; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; MINOWADA J, 1981, J CANCER RES CLIN, V101, P91, DOI 10.1007/BF00405069; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NOWELL PC, 1988, FASEB J, V2, P3054, DOI 10.1096/fasebj.2.15.3056765; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; TABILIO A, 1984, EMBO J, V3, P453, DOI 10.1002/j.1460-2075.1984.tb01827.x; TAMBOURIN P, 1983, P NATL ACAD SCI-BIOL, V80, P6269, DOI 10.1073/pnas.80.20.6269; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485	34	119	120	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					475	479						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011404				2022-12-28	WOS:A1991FT34400020
J	LAMMIE, GA; FANTL, V; SMITH, R; SCHUURING, E; BROOKES, S; MICHALIDES, R; DICKSON, C; ARNOLD, A; PETERS, G				LAMMIE, GA; FANTL, V; SMITH, R; SCHUURING, E; BROOKES, S; MICHALIDES, R; DICKSON, C; ARNOLD, A; PETERS, G			D11S287, A PUTATIVE ONCOGENE ON CHROMOSOME-11Q13, IS AMPLIFIED AND EXPRESSED IN SQUAMOUS-CELL AND MAMMARY CARCINOMAS AND LINKED TO BCL-1	ONCOGENE			English	Article							HUMAN-BREAST-TUMORS; ENDOCRINE NEOPLASIA TYPE-1; FIBROBLAST GROWTH-FACTORS; PROTO-ONCOGENE; INT-2 GENE; PARATHYROID ADENOMA; MOLECULAR-CLONING; CO-AMPLIFICATION; MESSENGER-RNA; SARCOMA DNA	Approximately 15 to 20% of primary breast cancers and an even higher proportion of squamous cell carcinomas of the head and neck show amplification of DNA markers on band q13 of human chromosome 11. However, known genes within the amplified region, such as the FGF-related oncogenes INT-2 and HST-1, are very rarely expressed in these tumors. Here we show that another candidate oncogene, designated D11S287, implicated in the pathogenesis of parathyroid adenomas, is also amplified in breast cancers. Significantly, it is consistently co-amplified with INT-2 and HST-1 in 36 out of 202 primary tumors, including one case in which the amplified unit did not encompass the translocation breakpoint marker BCL-1. This implies that D11S287 is on the same side of the breakpoint as INT-2, and pulsed-field gel electrophoresis indicates that D11S287 is less than 250 kb from the BCL-1 marker. Since D11S287 RNA was present at elevated levels in a group of tumors and cell lines in which the 11q13 region is amplified, it may be the key oncogene on this amplified unit, and could also be activated by BCL-1 translocations.	ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND LABS,DOMINION HOUSE,59 BARTHOLOMEW CLOSE,LONDON EC1A 7BE,ENGLAND; NETHERLANDS CANC INST,1066 CX AMSTERDAM,NETHERLANDS; MASSACHUSETTS GEN HOSP,ENDOCRINE UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Cancer Research UK; University of London; Queen Mary University London; Netherlands Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School								ADELAIDE J, 1988, ONCOGENE, V2, P413; ADNANE J, 1989, ONCOGENE, V4, P1389; ALI IU, 1989, ONCOGENE, V4, P89; ARNOLD A, 1989, J CLIN ENDOCR METAB, V69, P496, DOI 10.1210/jcem-69-3-496; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALE AE, 1990, AM J HUMAN GENET S1, V47; BALE SJ, 1989, GENOMICS, V4, P320, DOI 10.1016/0888-7543(89)90336-4; BERENSON JR, 1989, ONCOGENE, V4, P1111; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BYSTROM C, 1990, P NATL ACAD SCI USA, V87, P1968, DOI 10.1073/pnas.87.5.1968; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; EHRICH E, 1987, GENE, V57, P229, DOI 10.1016/0378-1119(87)90126-0; ERIKSON J, 1984, P NATL ACAD SCI-BIOL, V81, P4144, DOI 10.1073/pnas.81.13.4144; FANTL V, 1989, CANCER CEL, V7, P283; FANTL V, 1990, EUR J CANCER, V26, P423, DOI 10.1016/0277-5379(90)90009-I; FRIEDMAN E, 1990, J CLIN ENDOCR METAB, V71, P293, DOI 10.1210/jcem-71-2-293; GOLDFARB M, 1991, ONCOGENE, V6, P65; GUERIN M, 1988, ONCOGENE RES, V3, P21; HATADA I, 1988, ONCOGENE, V3, P537; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HUEBNER K, 1988, ONCOGENE RES, V3, P263; KODURU PRK, 1989, ONCOGENE, V4, P929; LACROIX H, 1989, ONCOGENE, V4, P145; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LISCIA DS, 1989, ONCOGENE, V4, P1219; MACHOTKA SV, 1989, CLIN CHIM ACTA, V184, P207, DOI 10.1016/0009-8981(89)90053-3; Maniatis T., 1982, MOL CLONING; NGUYEN C, 1988, ONCOGENE, V3, P703; PARKES HC, 1990, BRIT J CANCER, V61, P39, DOI 10.1038/bjc.1990.9; PETERS G, 1989, P NATL ACAD SCI USA, V86, P5678, DOI 10.1073/pnas.86.15.5678; RABBITTS PH, 1988, ONCOGENE, V3, P99; ROSENBERG CL, 1991, ONCOGENE, V6, P449; SMITH R, 1988, EMBO J, V7, P1013, DOI 10.1002/j.1460-2075.1988.tb02908.x; SOMERS KD, 1990, ONCOGENE, V5, P915; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; THEILLET C, 1990, ONCOGENE, V5, P147; THEILLET C, 1989, ONCOGENE, V4, P915; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TSUTSUMI M, 1988, JPN J CANCER RES, V79, P428, DOI 10.1111/j.1349-7006.1988.tb01609.x; VARLEY JM, 1988, ONCOGENE, V3, P87; WADA A, 1988, BIOCHEM BIOPH RES CO, V157, P828, DOI 10.1016/S0006-291X(88)80324-3; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHOU DJ, 1988, ONCOGENE, V2, P279	52	475	484	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					439	444						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011398				2022-12-28	WOS:A1991FT34400013
J	CHALIFOUR, LE; GOMES, ML; WANG, NS; MESMASSON, AM				CHALIFOUR, LE; GOMES, ML; WANG, NS; MESMASSON, AM			POLYOMAVIRUS LARGE T-ANTIGEN EXPRESSION IN HEART OF TRANSGENIC MICE CAUSES CARDIOMYOPATHY	ONCOGENE			English	Article									SIR MORTIMER B DAVIS JEWISH HOSP, LADY DAVIS INST MED RES, BLOOMFIELD CTR RES AGING, MONTREAL H3T 1E2, QUEBEC, CANADA; MCGILL UNIV, DEPT MICROBIOL & IMMUNOL, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, DEPT PATHOL, MONTREAL H3A 2T5, QUEBEC, CANADA; INST CANC MONTREAL, MONTREAL H2L 4M1, QUEBEC, CANADA	Lady Davis Institute; McGill University; McGill University; McGill University; Universite de Montreal	CHALIFOUR, LE (corresponding author), NATL RES COUNCIL CANADA, BIOTECHNOL RES INST, 6100 ROYALMOUNT AVE, MONTREAL, QUEBEC, CANADA.			Mes-Masson, Anne-Marie/0000-0002-6498-266X				ASSELIN C, 1985, J VIROL, V56, P958, DOI 10.1128/JVI.56.3.958-968.1985; ASSELIN C, 1983, MOL CELL BIOL, V3, P1451, DOI 10.1128/MCB.3.8.1451; BAUTCH VL, 1987, CELL, V51, P529, DOI 10.1016/0092-8674(87)90122-X; BEHRINGER RR, 1988, P NATL ACAD SCI USA, V85, P2648, DOI 10.1073/pnas.85.8.2648; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V13, P2633; COMPERE SJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P129, DOI 10.1016/0304-419X(88)90008-X; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; CUZIN F, 1984, BIOCHIM BIOPHYS ACTA, V781, P193, DOI 10.1016/0167-4781(84)90084-8; DAWE CJ, 1987, AM J PATHOL, V127, P243; DEPAMPHILIS ML, 1988, BIOTECHNIQUES, V6, P662; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; EDDY BE, 1982, MOUSE BIOMEDICAL RES, V2, P293; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIELD LJ, 1988, SCIENCE, V239, P1029, DOI 10.1126/science.2964082; Flint S. J, 1981, DNA TUMOR VIRUSES; FREUND R, 1987, J VIROL, V61, P2232, DOI 10.1128/JVI.61.7.2232-2239.1987; GLAICHENHAUS N, 1985, ADV CANCER RES, V45, P291, DOI 10.1016/S0065-230X(08)60271-7; GRIEP AE, 1989, GENE DEV, V3, P1075, DOI 10.1101/gad.3.7.1075; GROSS L, 1970, ONCOGENIC VIRUSES, P651; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HULLAND TJ, 1978, TUMORS DOMESTIC ANIM; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAT PS, 1986, J VIROL, V59, P746, DOI 10.1128/JVI.59.3.746-750.1986; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEOPOLD P, 1986, BIOCHEM BIOPH RES CO, V141, P1162, DOI 10.1016/S0006-291X(86)80166-8; Maniatis T., 1982, MOL CLONING; MCALLISTER HA, 1987, PATHOLOGY HEART GREA, P343; MONK M, 1988, GENE DEV, V2, P921, DOI 10.1101/gad.2.8.921; MONK M, 1990, TRENDS GENET, V6, P110, DOI 10.1016/0168-9525(90)90124-O; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; MUELLER CR, 1984, MOL CELL BIOL, V4, P2594, DOI 10.1128/MCB.4.12.2594; MULLER WJ, 1983, J VIROL, V47, P586, DOI 10.1128/JVI.47.3.586-599.1983; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PETIT CA, 1983, VIROLOGY, V127, P74, DOI 10.1016/0042-6822(83)90372-0; PIPER HM, 1987, HEART CELL CULTURE, V1, P49; RASSOULZADEGAN M, 1983, P NATL ACAD SCI-BIOL, V80, P4354, DOI 10.1073/pnas.80.14.4354; RASSOULZADEGAN M, 1986, CELL, V46, P513, DOI 10.1016/0092-8674(86)90876-7; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; RASSOULZADEGAN M, 1987, ONCOGENE RES, V1, P1; ROCHFORD R, 1990, J VIROL, V64, P476, DOI 10.1128/JVI.64.2.476-485.1990; RUGH R, 1968, MOUSE ITS REPRODUCTI; SOLTER D, 1988, ANNU REV GENET, V22, P127; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TRASK RV, 1988, J BIOL CHEM, V263, P17142; WEISS R, 1984, MOL BIOL TUMOR VIRUS; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WIRAK DO, 1985, MOL CELL BIOL, V5, P2924, DOI 10.1128/MCB.5.11.2924; YEE SP, 1989, P NATL ACAD SCI USA, V86, P5873, DOI 10.1073/pnas.86.15.5873; YUTZEY KE, 1989, MOL CELL BIOL, V9, P1397, DOI 10.1128/MCB.9.4.1397	55	29	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1990	5	11					1719	1726						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176284				2022-12-28	WOS:A1990EL40100016
J	SHEPEL, LA; GORSKI, J				SHEPEL, LA; GORSKI, J			RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE RAT N-RAS AND RETINOBLASTOMA GENES - THEIR IDENTIFICATION AND CHARACTERIZATION	ONCOGENE			English	Article									UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008192, R37HD008192] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA018110] Funding Source: NIH RePORTER; NCI NIH HHS [CA18110] Funding Source: Medline; NICHD NIH HHS [HD08192] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CLIFTON KH, 1956, ANAT REC, V125, P65, DOI 10.1002/ar.1091250106; CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0; DEVARE SG, 1983, P NATL ACAD SCI-BIOL, V80, P731, DOI 10.1073/pnas.80.3.731; DURRIN LK, 1985, ENDOCRINOLOGY, V117, P2098, DOI 10.1210/endo-117-5-2098; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4843; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HANSEN MF, 1988, CELL, V53, P172, DOI 10.1016/0092-8674(88)90376-5; HOLTZMAN S, 1979, CANCER RES, V39, P779; KITYAMA H, 1989, CELL, V556, P77; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LINGHAM RB, 1988, MOL ENDOCRINOL, V2, P230, DOI 10.1210/mend-2-3-230; LLOYD RV, 1983, AM J PATHOL, V113, P198; LOOSEMITCHELL DS, 1988, MOL ENDOCRINOL, V2, P926; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MALKOVA J, 1977, NEOPLASMA, V24, P277; MARX JL, 1983, SCIENCE, V222, P602, DOI 10.1126/science.6635658; MIDDLETONPRICE H, 1988, ANN HUM GENET, V52, P189, DOI 10.1111/j.1469-1809.1988.tb01096.x; MURPHY LJ, 1987, ENDOCRINOLOGY, V120, P1882, DOI 10.1210/endo-120-5-1882; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SHEPEL L A, 1988, Biofactors, V1, P71; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPANDIDOS DA, 1984, ANTICANCER RES, V4, P269; STONE JP, 1979, CANCER RES, V39, P773; SUMI C, 1984, JNCI-J NATL CANCER I, V73, P1229; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TRAVERS MT, 1987, FEBS LETT, V211, P27, DOI 10.1016/0014-5793(87)81267-X; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VENNSTROM B, 1980, J VIROL, V36, P575; WICKLUND JA, 1982, ENDOCRINOLOGY, V111, P1140; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1708, DOI 10.1210/endo-109-5-1708; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1700, DOI 10.1210/endo-109-5-1700	45	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1675	1682						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	1980008				2022-12-28	WOS:A1990EL40100010
J	ZHAO, X; BATTEN, B; SINGH, B; ARLINGHAUS, RB				ZHAO, X; BATTEN, B; SINGH, B; ARLINGHAUS, RB			REQUIREMENT OF THE C-MOS PROTEIN-KINASE FOR MURINE MEIOTIC MATURATION	ONCOGENE			English	Note									UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030; OHIO STATE UNIV,DEPT ANAT,COLUMBUS,OH 43210	University of Texas System; UTMD Anderson Cancer Center; Ohio State University					NCI NIH HHS [CA16672, CA45125] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA045125] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; FREEMAN RS, 1989, P NATL ACAD SCI USA, V86, P5805, DOI 10.1073/pnas.86.15.5805; GALLICK GE, 1985, J GEN VIROL, V66, P945, DOI 10.1099/0022-1317-66-5-945; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GOLDMAN DS, 1988, ONCOGENE, V3, P159; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HERZOG NK, 1988, ONCOGENE, V3, P225; HOGAN B, 1986, MANIPULATING MOUSE E; KESHET E, 1988, ONCOGENE, V2, P235; LEE M, 1988, TRENDS GENET, V4, P287, DOI 10.1016/0168-9525(88)90171-0; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; OKEEFE SJ, 1989, P NATL ACAD SCI USA, V86, P7038, DOI 10.1073/pnas.86.18.7038; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; ROY LM, 1990, CELL, V61, P825, DOI 10.1016/0092-8674(90)90192-H; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SINGH B, 1986, VIROLOGY, V152, P502, DOI 10.1016/0042-6822(86)90156-X; SINGH B, 1988, ONCOGENE, V3, P79; SINGH B, 1986, J VIROL, V60, P1148, DOI 10.1128/JVI.60.3.1148-1152.1986; SINGH B, 1989, VIROLOGY, V173, P144, DOI 10.1016/0042-6822(89)90230-4; SINGH B, 1988, VIROLOGY, V164, P114, DOI 10.1016/0042-6822(88)90626-5; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; VANBEVEREN C, 1981, CELL, V27, P97, DOI 10.1016/0092-8674(81)90364-0; Zhao X., 1989, TECHNIQUES J METHODS, V1, P37	29	51	51	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1727	1730						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176285				2022-12-28	WOS:A1990EL40100017
J	HEIDARAN, MA; FLEMING, TP; BOTTARO, DP; BELL, GI; DIFIORE, PP; AARONSON, SA				HEIDARAN, MA; FLEMING, TP; BOTTARO, DP; BELL, GI; DIFIORE, PP; AARONSON, SA			TRANSFORMATION OF NIH3T3 FIBROBLASTS BY AN EXPRESSION VECTOR FOR THE HUMAN EPIDERMAL GROWTH-FACTOR PRECURSOR	ONCOGENE			English	Article									NCI,CELLULAR & MOLEC BIOL LAB,BLDG 37,ROOM 1E24,BETHESDA,MD 20892; UNIV CHICAGO,HOWARD HUGHES MED INST,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; University of Chicago			Bottaro, Donald P/AAF-3853-2020; Bottaro, Donald P/F-8550-2010; Di Fiore, Pier Paolo/K-2130-2012	Bottaro, Donald P/0000-0002-5057-5334; Bottaro, Donald P/0000-0002-5057-5334; Di Fiore, Pier Paolo/0000-0002-2252-0950				BECKMANN MP, 1988, SCIENCE, V241, P1346, DOI 10.1126/science.2842868; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DERYNCK R, 1987, CANCER RES, V47, P707; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIMARCO E, 1989, ONCOGENE, V4, P831; FINZI E, 1987, P NATL ACAD SCI USA, V84, P3733, DOI 10.1073/pnas.84.11.3733; FLEMING TP, 1989, P NATL ACAD SCI USA, V86, P8063, DOI 10.1073/pnas.86.20.8063; GAZIT A, 1984, CELL, V39, P89, DOI 10.1016/0092-8674(84)90194-6; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; MROCZKOWSKI B, 1988, P NATL ACAD SCI USA, V85, P126, DOI 10.1073/pnas.85.1.126; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; SAVAGE CR, 1972, J BIOL CHEM, V247, P7612; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308	28	33	33	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1265	1270						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392327				2022-12-28	WOS:A1990DX36100022
J	LOWE, PN; SYDENHAM, M; PAGE, MJ				LOWE, PN; SYDENHAM, M; PAGE, MJ			THE HA-RAS PROTEIN, P21, IS MODIFIED BY A DERIVATIVE OF MEVALONATE AND METHYL-ESTERIFIED WHEN EXPRESSED IN THE INSECT BACULOVIRUS SYSTEM	ONCOGENE			English	Article									WELLCOME BIOTECHNOL,DEPT MOLEC BIOL,BECKENHAM BR3 3BS,KENT,ENGLAND	GlaxoSmithKline	LOWE, PN (corresponding author), WELLCOME RES LABS,DEPT MOLEC SCI,LANGLEY COURT,S EDEN PK RD,BECKENHAM BR3 3BS,KENT,ENGLAND.							ANDEREGG RJ, 1988, J BIOL CHEM, V263, P18236; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHELSKY D, 1984, ANAL BIOCHEM, V141, P143, DOI 10.1016/0003-2697(84)90437-8; CHEN ZQ, 1985, J VIROL, V56, P607, DOI 10.1128/JVI.56.2.607-612.1985; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; DESCHENES RJ, 1989, J BIOL CHEM, V264, P11865; EDMOND J, 1974, J BIOL CHEM, V249, P66; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; LOWY DR, 1989, NATURE, V341, P384, DOI 10.1038/341384a0; PAGE MJ, 1989, J BIOL CHEM, V264, P19147; SCHAFER WR, 1989, SCIENCE, V245, P376; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x	16	25	25	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1045	1048						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2197592				2022-12-28	WOS:A1990DP41500013
J	BANKS, L; BARNETT, SC; CROOK, T				BANKS, L; BARNETT, SC; CROOK, T			HPV-16 E7 FUNCTIONS AT THE G1-PHASE TO S-PHASE TRANSITION IN THE CELL-CYCLE	ONCOGENE			English	Article									ST MARYS HOSP,SCH MED,LUDWIG INST CANC RES,LONDON W2 1PG,ENGLAND; LUDWIG INST CANC RES,LONDON W1 P8BT,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,IMPERIAL CANC RES FUND TUMOUR VIRUS GRP,CAMBRIDGE CB2 1QP,ENGLAND	Imperial College London; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; University of Cambridge	BANKS, L (corresponding author), INT CTR GENET ENGN & BIOTECHNOL,PADRICIANO 99,I-34012 TRIESTE,ITALY.							ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CROOK T, 1989, EMBO J, V8, P513, DOI 10.1002/j.1460-2075.1989.tb03405.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; GISSMANN L, 1983, P NATL ACAD SCI-BIOL, V80, P560, DOI 10.1073/pnas.80.2.560; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; NAKAJIMA T, 1987, MOL CELL BIOL, V7, P3846, DOI 10.1128/MCB.7.10.3846; OLTERSDORF T, 1987, J GEN VIROL, V68, P2933, DOI 10.1099/0022-1317-68-11-2933; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; QUINLAN MP, 1987, J VIROL, V61, P673, DOI 10.1128/JVI.61.3.673-682.1987; SATO H, 1989, VIROLOGY, V168, P195, DOI 10.1016/0042-6822(89)90423-6; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPENCE RP, 1988, CANCER RES, V48, P324; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; TAYLOR IW, 1980, J HISTOCHEM CYTOCHEM, V28, P1021, DOI 10.1177/28.9.6157714; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDENBRULE AJC, 1989, J MED VIROL, V29, P20, DOI 10.1002/jmv.1890290105; VOUSDEN KH, 1989, ONCOGENE, V4, P153; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; YEE C, 1985, AM J PATHOL, V119, P361; YOUNG LS, 1989, BRIT MED J, V298, P14, DOI 10.1136/bmj.298.6665.14; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887	30	35	35	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					833	837						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2359620				2022-12-28	WOS:A1990DP55300008
J	DELAPEYRIERE, O; ROSNET, O; BENHARROCH, D; RAYBAUD, F; MARCHETTO, S; PLANCHE, J; GALLAND, F; MATTEI, MG; COPELAND, NG; JENKINS, NA; COULIER, F; BIRNBAUM, D				DELAPEYRIERE, O; ROSNET, O; BENHARROCH, D; RAYBAUD, F; MARCHETTO, S; PLANCHE, J; GALLAND, F; MATTEI, MG; COPELAND, NG; JENKINS, NA; COULIER, F; BIRNBAUM, D			STRUCTURE, CHROMOSOME MAPPING AND EXPRESSION OF THE MURINE FGF-6-GENE	ONCOGENE			English	Article									INSERM, U119, 27 BDS LEI ROURE, F-13009 MARSEILLE, FRANCE; NCI, FREDERICK CANC RES FACIL, BRI BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21701 USA; HOP LA TIMONE, INSERM, U242, F-13385 MARSEILLE, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			Rosnet, Olivier/G-3536-2013; Coulier, François/G-6098-2015	Coulier, François/0000-0002-6288-7773; Birnbaum, Daniel/0000-0001-7920-9883; Rosnet, Olivier/0000-0002-3020-910X	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADELAIDE J, 1988, ONCOGENE, V2, P413; ALTABA AR, 1989, NATURE, V341, P33; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BENHARROCH D, 1990, IN PRESS ISR J MED S; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BROOKES S, 1989, ONCOGENE, V4, P429; BROOKES S, 1989, NUCLEIC ACIDS RES, V17, P4037, DOI 10.1093/nar/17.11.4037; BUCHBERG AM, 1988, ONCOGENE RES, V2, P149; BUCHBERG AM, 1989, GENETICS, V122, P153; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; CECI JD, 1990, GENOMICS, V6, P72, DOI 10.1016/0888-7543(90)90449-5; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DIMARIO J, 1989, SCIENCE, V244, P688, DOI 10.1126/science.2717945; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GARCIA M, 1986, EMBO J, V5, P127, DOI 10.1002/j.1460-2075.1986.tb04186.x; GOSPODAROWICZ D, 1987, J CELL PHYSIOL, P15; GREEN EL, 1981, GENETICS PROBABILITY, P1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KARDAMI E, 1985, P NATL ACAD SCI USA, V82, P8044, DOI 10.1073/pnas.82.23.8044; KIMELMAN D, 1988, SCIENCE, V242, P1053, DOI 10.1126/science.3194757; KINGSLEY DM, 1989, GENETICS, V123, P165; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LISCIA DS, 1989, ONCOGENE, V4, P1219; LOBB RR, 1988, EUR J CLIN INVEST, V18, P321, DOI 10.1111/j.1365-2362.1988.tb01020.x; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARICS I, 1989, ONCOGENE, V4, P335; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MCCOY MS, 1984, MOL CELL BIOL, V4, P1577, DOI 10.1128/MCB.4.8.1577; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; NOGUCHI T, 1988, CANCER DETECT PREV, V12, P383; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; PATERNO GD, 1989, DEVELOPMENT, V106, P79; PETERS G, 1989, P NATL ACAD SCI USA, V86, P5678, DOI 10.1073/pnas.86.15.5678; Rugh R., 1968, MOUSE ITS REPRODUCTI, P1; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH R, 1988, EMBO J, V7, P1013, DOI 10.1002/j.1460-2075.1988.tb02908.x; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; Theiler K., 1972, P1; THEILLET C, 1989, ONCOGENE, V4, P915; VELCICH A, 1989, ONCOGENE RES, V5, P31; WEINER HL, 1989, P NATL ACAD SCI USA, V86, P2683, DOI 10.1073/pnas.86.8.2683; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V157, P618, DOI 10.1016/S0006-291X(88)80295-X; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V155, P1324, DOI 10.1016/S0006-291X(88)81286-5; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	52	74	79	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1990	5	6					823	831						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2193291				2022-12-28	WOS:A1990DP55300007
J	CROUCH, DH; LANG, C; GILLESPIE, DAF				CROUCH, DH; LANG, C; GILLESPIE, DAF			THE LEUCINE ZIPPER DOMAIN OF AVIAN CMYC IS REQUIRED FOR TRANSFORMATION AND AUTOREGULATION	ONCOGENE			English	Article									BEATSON INST CANC RES,GARSCUBE ESTATE,SWITCHBACK RD,GLASGOW G61 1BD,SCOTLAND	Beatson Institute			Gillespie, David/R-4771-2019	Gillespie, David/0000-0002-6338-0544				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; Cleveland J L, 1988, Oncogene Res, V3, P357; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DANG CV, 1989, MOL CELL BIOL, V9, P2477, DOI 10.1128/MCB.9.6.2477; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; ENRIETTO PJ, 1989, VIROLOGY, V168, P256, DOI 10.1016/0042-6822(89)90265-1; FRYKBERG L, 1987, ONCOGENE, V1, P415; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HEANEY ML, 1986, J VIROL, V60, P167, DOI 10.1128/JVI.60.1.167-176.1986; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; MOORE JP, 1987, ONCOGENE RES, V2, P65; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PALMIERI S, 1983, EMBO J, V2, P2385, DOI 10.1002/j.1460-2075.1983.tb01750.x; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PATSCHINSKY T, 1986, J VIROL, V59, P341, DOI 10.1128/JVI.59.2.341-353.1986; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHUBACH W, 1984, NATURE, V307, P702, DOI 10.1038/307702a0; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; WALTHER N, 1986, VIROLOGY, V154, P219, DOI 10.1016/0042-6822(86)90444-7	37	54	54	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					683	689						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189105				2022-12-28	WOS:A1990DG37400008
J	KOIZUMI, S; FISHER, RJ; FUJIWARA, S; JORCYK, C; BHAT, NK; SETH, A; PAPAS, TS				KOIZUMI, S; FISHER, RJ; FUJIWARA, S; JORCYK, C; BHAT, NK; SETH, A; PAPAS, TS			ISOFORMS OF THE HUMAN ETS-1 PROTEIN - GENERATION BY ALTERNATIVE SPLICING AND DIFFERENTIAL PHOSPHORYLATION	ONCOGENE			English	Article									FREDERICK CANC RES FACIL,PROGRAM RESOURCES INC,NUCLEIC ACID & PROT SYNTH LAB,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KOIZUMI, S (corresponding author), NCI,MOLEC ONCOL LAB,FREDERICK,MD 21701, USA.		Fisher, Robert/B-1431-2009					BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BHAT NK, 1989, J IMMUNOL, V142, P672; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ELDER JH, 1977, J BIOL CHEM, V252, P6510; FUJIWARA S, 1988, ONCOGENE, V2, P99; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; FUJIWARA S, IN PRESS MOL CELL BI; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LEPRINCE D, 1988, J VIROL, V62, P3233, DOI 10.1128/JVI.62.9.3233-3241.1988; MATLASHEWSKI G, 1987, ONCOGENE RES, V1, P77; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1988, ONCOGENE RES, V3, P239; SACCHI N, 1988, LEUKEMIA, V2, P12; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SETH A, 1989, ONCOGENE RES, V5, P61; SHIMIZU K, 1983, NATURE, V304, P497, DOI 10.1038/304497a0; WANG LH, 1987, ONCOGENE RES, V1, P43; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294	29	132	133	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					675	681						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189104				2022-12-28	WOS:A1990DG37400007
J	HIRAI, SI; BOURACHOT, B; YANIV, M				HIRAI, SI; BOURACHOT, B; YANIV, M			BOTH JUN AND FOS CONTRIBUTE TO TRANSCRIPTION ACTIVATION BY THE HETERODIMER	ONCOGENE			English	Article											HIRAI, SI (corresponding author), INST PASTEUR,DEPT BIOL MOLEC,CNRS,UA 1149,UNITE VIRUS ONCOGENES,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.			Bourachot, Brigitte/0000-0001-7816-0539				ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BOHMANN D, 1987, SCIENCE, V228, P1380; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HIRAI S-I, 1989, New Biologist, V1, P181; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRYSZKE MH, 1987, NATURE, V328, P254, DOI 10.1038/328254a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MECHTA F, 1989, New Biologist, V1, P297; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; TURNER R, 1989, NATURE, V243, P1689; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WASYLYK B, 1988, CRC CR REV BIOCH MOL, V23, P77, DOI 10.3109/10409238809088317; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	35	105	106	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					39	46						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2108402				2022-12-28	WOS:A1990CM62000006
J	RUTHER, U; KOMITOWSKI, D; SCHUBERT, FR; WAGNER, EF				RUTHER, U; KOMITOWSKI, D; SCHUBERT, FR; WAGNER, EF			C-FOS EXPRESSION INDUCES BONE-TUMORS IN TRANSGENIC MICE	ONCOGENE			English	Article									GERMAN CANC RES CTR,INST EXPTL PATHOL,D-6900 HEIDELBERG,FED REP GER	Helmholtz Association; German Cancer Research Center (DKFZ)	RUTHER, U (corresponding author), EUROPEAN MOLEC BIOL LAB,POSTFACH 102209,MEYERHOFSTR 1,D-6900 HEIDELBERG,FED REP GER.		Schubert, Frank/C-1658-2010	Schubert, Frank/0000-0001-7567-8471; Wagner, Erwin F/0000-0001-7872-0196				ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Dahlin DC., 1986, BONE TUMORS; Finkel M. P., 1973, COLSTON PAP, V24, P353; FINKEL MP, 1966, SCIENCE, V151, P698, DOI 10.1126/science.151.3711.698; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HOGAN B, 1986, MANIPULATION MOUSE E; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MILLER AD, 1984, CELL, V36, P51; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PRICE CHG, 1972, BRIT J CANCER, V26, P2; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; RUTHER U, 1988, CELL, V53, P847, DOI 10.1016/S0092-8674(88)90289-9; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; TEITELMAN G, 1988, CELL, V52, P97, DOI 10.1016/0092-8674(88)90534-X; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VANBEVEREN C, 1984, VIROLOGY, V135, P229, DOI 10.1016/0042-6822(84)90133-8; VERMA IM, 1986, TRENDS GENET, V2, P93, DOI 10.1016/0168-9525(86)90191-5; WARD JM, 1976, CANCER RES, V36, P3985; WHITE MP, 1982, AM J MED, V72, P193	27	170	176	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1989	4	7					861	865						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE584	2547184				2022-12-28	WOS:A1989AE58400007
J	MOREAU, J; LEGUELLEC, R; LEIBOVICI, M; COUTURIER, A; PHILIPPE, M; MECHALI, M				MOREAU, J; LEGUELLEC, R; LEIBOVICI, M; COUTURIER, A; PHILIPPE, M; MECHALI, M			DETECTION OF PROTO-ONCOGENES IN THE GENOME OF THE AMPHIBIAN XENOPUS-LAEVIS	ONCOGENE			English	Article									UNIV RENNES 1, BIOL & GENET DEV LAB, CNRS, UA 256, F-35042 RENNES, FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	MOREAU, J (corresponding author), INST JACQUES MONOD, EQUIPE EMBRYOL MOLEC, 2 PL JUSSIEU, F-75251 PARIS 05, FRANCE.							ABRAMS HD, 1982, CELL, V29, P427, DOI 10.1016/0092-8674(82)90159-3; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BENDER W, 1987, CELL, V50, P519, DOI 10.1016/0092-8674(87)90023-7; BERGMANN DG, 1981, J VIROL, V40, P450, DOI 10.1128/JVI.40.2.450-455.1981; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BISHOP JM, 1985, TRENDS GENET, V1, P245, DOI 10.1016/0168-9525(85)90094-0; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BROACH J, 1985, DNA-J MOLEC CELL BIO, V4, P64; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; CHARDIN P, 1986, EMBO J, V5, P2203, DOI 10.1002/j.1460-2075.1986.tb04485.x; CHEN JH, 1985, MOL CELL BIOL, V5, P2993, DOI 10.1128/MCB.5.11.2993; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1984, CELL, V36, P259; Davidson E. H, 1987, GENE ACTIVITY EARLY; DAWID IB, 1965, J MOL BIOL, V12, P581, DOI 10.1016/S0022-2836(65)80313-8; DEFEO D, 1981, P NATL ACAD SCI-BIOL, V78, P3328, DOI 10.1073/pnas.78.6.3328; DEFEOJONES D, 1983, NATURE, V306, P707, DOI 10.1038/306707a0; DHAR R, 1984, NUCLEIC ACIDS RES, V12, P3611, DOI 10.1093/nar/12.8.3611; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DONNER L, 1982, J VIROL, V41, P489, DOI 10.1128/JVI.41.2.489-500.1982; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANCHINI G, 1981, NATURE, V290, P154, DOI 10.1038/290154a0; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GOODMAN M, 1975, NATURE, V253, P603, DOI 10.1038/253603a0; Gudernatsch JF, 1912, ARCH ENTWICKLUNG ORG, V35, P457, DOI 10.1007/BF02277051; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; Maniatis T., 1982, MOL CLONING; MARK GE, 1987, MOL CELL BIOL, V7, P2134, DOI 10.1128/MCB.7.6.2134; MOREAU J, 1981, P NATL ACAD SCI-BIOL, V78, P1341, DOI 10.1073/pnas.78.3.1341; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NECKAMEYER WS, 1984, J VIROL, V50, P914, DOI 10.1128/JVI.50.3.914-921.1984; NEUMANSILBERBERG FS, 1984, CELL, V37, P1027; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PAPAS TS, 1984, CANCER CELL, V2, P153; PERBAL B, 1982, J VIROL, V44, P586, DOI 10.1128/JVI.44.2.586-594.1982; REDDY EP, 1980, P NATL ACAD SCI-BIOL, V77, P5234, DOI 10.1073/pnas.77.9.5234; REYMOND CD, 1984, CELL, V39, P141, DOI 10.1016/0092-8674(84)90199-5; ROBBINS KC, 1981, P NATL ACAD SCI-BIOL, V78, P2918, DOI 10.1073/pnas.78.5.2918; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SHILO BZ, 1981, P NATL ACAD SCI-BIOL, V78, P6789, DOI 10.1073/pnas.78.11.6789; Smith T.F., 1981, ADV APPL MATH, V2, P482, DOI DOI 10.1016/0196-8858(81)90046-4; SOUSSI T, 1987, ONCOGENE, V1, P71; SPECTOR DH, 1978, P NATL ACAD SCI USA, V75, P4102, DOI 10.1073/pnas.75.9.4102; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; TAYLOR MV, 1986, EMBO J, V5, P3563, DOI 10.1002/j.1460-2075.1986.tb04683.x; VANBENEDEN RJ, 1986, P NATL ACAD SCI USA, V83, P3698; VARMUS HE, 1984, ANNU REV GENET, V18, P553; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; WANG JYJ, 1983, MOL CELL BIOL, V3, P773, DOI 10.1128/MCB.3.5.773; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WILHELMSEN KC, 1984, J VIROL, V49, P521, DOI 10.1128/JVI.49.2.521-529.1984; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X	68	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1989	4	4					443	449						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2654808				2022-12-28	WOS:A1989U567700008
J	SORRENTINO, V; NEBREDA, AR; ALONSO, T; SANTOS, E				SORRENTINO, V; NEBREDA, AR; ALONSO, T; SANTOS, E			PREPARATION, CHARACTERIZATION AND PROPERTIES OF MONOCLONAL-ANTIBODIES AGAINST INTACT H-RAS P21 PROTEINS	ONCOGENE			English	Article									NIAID,MOLEC MICROBIOL LAB,BDG 4,RM 312,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)			Nebreda, Angel Rodriguez/R-9594-2019; Sorrentino, Vincenzo/A-4793-2014	Sorrentino, Vincenzo/0000-0002-8573-8631				ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ALONSO T, 1988, P NATL ACAD SCI USA, V85, P4271, DOI 10.1073/pnas.85.12.4271; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECKNER SK, 1985, NATURE, V317, P71, DOI 10.1038/317071a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; CHANG EH, 1980, J VIROL, V35, P76, DOI 10.1128/JVI.35.1.76-92.1980; CHANG EH, 1982, NATURE, V297, P479, DOI 10.1038/297479a0; CZERNIAK B, 1987, CANCER, V60, P2432, DOI 10.1002/1097-0142(19871115)60:10<2432::AID-CNCR2820601014>3.0.CO;2-1; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FURTH ME, 1987, ONCOGENE, V1, P47; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GAY NJ, 1983, NATURE, V301, P262, DOI 10.1038/301262a0; HARBOE N, 1973, Scandinavian Journal of Immunology, V2, P161; LACAL JC, 1984, P NATL ACAD SCI-BIOL, V81, P5305, DOI 10.1073/pnas.81.17.5305; LACAL JC, 1986, EMBO J, V5, P679, DOI 10.1002/j.1460-2075.1986.tb04267.x; LACAL JC, 1986, P NATL ACAD SCI USA, V83, P5400, DOI 10.1073/pnas.83.15.5400; MCCORMICK F, 1985, SCIENCE, V230, P78, DOI 10.1126/science.3898366; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; NOWINSKI RC, 1979, VIROLOGY, V93, P111, DOI 10.1016/0042-6822(79)90280-0; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; PAPAGEORGE AG, 1986, MOL CELL BIOL, V6, P1843, DOI 10.1128/MCB.6.5.1843; PINCUS MR, 1983, P NATL ACAD SCI-BIOL, V80, P5253, DOI 10.1073/pnas.80.17.5253; POLLOCK RR, 1984, ANNU REV MICROBIOL, V38, P389; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; SANTOS E, 1988, J BIOL CHEM, V263, P9853; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SANTOS E, 1983, P NATL ACAD SCI-BIOL, V80, P4679, DOI 10.1073/pnas.80.15.4679; SANTOS E, 1985, BIOCHEMISTRY-US, V24, P3006, DOI 10.1021/bi00333a030; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SRINIVASAPPA J, 1986, J VIROL, V57, P397, DOI 10.1128/JVI.57.1.397-401.1986; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; ULSH LS, 1984, MOL CELL BIOL, V4, P1647, DOI 10.1128/MCB.4.8.1647; WARD JM, 1989, ONCOGENE, V4, P203; WARD JM, 1986, CARCINOGENESIS, V7, P645, DOI 10.1093/carcin/7.4.645; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4	42	8	9	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					215	221						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2467247				2022-12-28	WOS:A1989U567500013
J	HUEN, DS; GRAND, RJ; YOUNG, LS				HUEN, DS; GRAND, RJ; YOUNG, LS			A REGION OF THE EPSTEIN-BARR VIRUS NUCLEAR ANTIGEN LEADER PROTEIN AND ADENOVIRUS E1A ARE IDENTICAL	ONCOGENE			English	Article									UNIV BIRMINGHAM,SCH MED,DEPT CANC STUDIES,CANC RES CAMPAIGN LABS,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND	University of Birmingham			Young, Lawrence S/B-7213-2009; Huen, David/F-3676-2014	Young, Lawrence S/0000-0003-3919-4298; Huen, David/0000-0002-9900-2297				BODESCOT M, 1984, EMBO J, V3, P1913, DOI 10.1002/j.1460-2075.1984.tb02067.x; BORNKAMM GW, 1982, J VIROL, V43, P952, DOI 10.1128/JVI.43.3.952-968.1982; DAMBAUGH T, 1984, P NATL ACAD SCI-BIOL, V81, P7632, DOI 10.1073/pnas.81.23.7632; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; FIGGE J, 1988, NATURE, V334, P109, DOI 10.1038/334109a0; FINKE J, 1987, J VIROL, V61, P3870, DOI 10.1128/JVI.61.12.3870-3878.1987; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; RICKINSON AB, 1987, J VIROL, V61, P1310, DOI 10.1128/JVI.61.5.1310-1317.1987; SAMPLE J, 1986, P NATL ACAD SCI USA, V83, P5096, DOI 10.1073/pnas.83.14.5096; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X; YOUNG LS, 1987, J GEN VIROL, V68, P2853, DOI 10.1099/0022-1317-68-11-2853; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821	17	8	8	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					729	730						2	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577878				2022-12-28	WOS:A1988R646000018
J	HIRAKAWA, T; MARUYAMA, K; KOHL, NE; KODAMA, T; RULEY, HE				HIRAKAWA, T; MARUYAMA, K; KOHL, NE; KODAMA, T; RULEY, HE			MASSIVE ACCUMULATION OF NEUTRAL LIPIDS IN CELLS CONDITIONALLY TRANSFORMED BY AN ACTIVATED H-RAS ONCOGENE	ONCOGENE			English	Article							LOW-DENSITY LIPOPROTEIN; DIFFERENTIATION-DEPENDENT GENE; DEVELOPMENTAL PROGRAM; ADIPOCYTE DIFFERENTIATION; GLUCOCORTICOID REGULATION; PROTEIN GAP; BINDING; FIBROBLASTS; GROWTH; MICROINJECTION	Phenotypic consequences of ras oncogene expression were studied in cells conditionally transformed by T24 H-ras and a temperature-sensitive SV40 large T antigen (tsA58). Previous studies have demonstrated that transformation of REF52 cells by ras and SV40 large T antigen requires continuous T antigen expression. Thus, tsA58/T24 H-ras transformants ceased growing when transferred to a restrictive temperature for T antigen expression. Inhibition of cell growth was accompanied by massive accumulations of cholesterol esters, triglycerides and a third lipid species, identified as glycerol ethers on the basis of mobility on TLC. Cholesterol esters were derived from serum lipoproteins, and appeared to accumulate because LDL receptor expression and activity did not decline in growth arrested cells. Triglycerides and glycerol ethers were products of cell metabolism. The process lacked features characteristic of adipocyte differentiation, but may suggest mechanisms important in diseases, such as atherosclerosis, that involve abnormal accumulations of neutral lipids. Accumulating lipid species may also include metabolites induced by ras that accumulate in growth-arrested cells.	MIT,CTR CANC,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; AJINOMOTO CO INC,CENT RES LABS,KAWASAKI,KANAGAWA 210,JAPAN; DYNAX RES INST,PALO ALTO,CA 94304; MERCK SHARP & DOHME LTD,W POINT,PA 19486	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Ajinomoto Co Inc; Merck & Company					NATIONAL CANCER INSTITUTE [R01CA040602] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA40602] Funding Source: Medline; PHS HHS [14051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ALONSO T, 1988, P NATL ACAD SCI USA, V85, P4271, DOI 10.1073/pnas.85.12.4271; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHAPMAN AB, 1984, J BIOL CHEM, V259, P5548; CHAPMAN AB, 1985, J CELL BIOL, V101, P1227, DOI 10.1083/jcb.101.4.1227; DOTTO GP, 1985, NATURE, V318, P472; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Kates M., 1972, LAB TECH BIOCH MOL B, V3, P268, DOI [10.1016/S0075-7535(08)70544-8, DOI 10.1016/S0075-7535(08)70544-8]; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; KOHL NE, 1987, ONCOGENE, V2, P41; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LOGAN J, 1981, VIROLOGY, V115, P419, DOI 10.1016/0042-6822(81)90126-4; MARUYAMA K, 1987, ONCOGENE, V1, P361; McClure DB, 1982, COLD SPRING HARBOR C, V9, P345; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PREISS J, 1986, J BIOL CHEM, V261, P8587; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAGER R, 1982, P NATL ACAD SCI-BIOL, V79, P480, DOI 10.1073/pnas.79.2.480; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SEGE RD, 1986, MOL CELL BIOL, V6, P3268, DOI 10.1128/MCB.6.9.3268; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SUKUMAR S, 1988, SCIENCE, V240, P524, DOI 10.1126/science.3282307; WEBER KA, 1988, NATURE, V332, P553; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4	48	26	26	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					289	295						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000221				2022-12-28	WOS:A1991FZ13400015
J	SAITOH, A; KIMURA, M; TAKAHASHI, R; YOKOYAMA, M; NOMURA, T; IZAWA, M; SEKIYA, T; NISHIMURA, S; KATSUKI, M				SAITOH, A; KIMURA, M; TAKAHASHI, R; YOKOYAMA, M; NOMURA, T; IZAWA, M; SEKIYA, T; NISHIMURA, S; KATSUKI, M			MOST TUMORS IN TRANSGENIC MICE WITH HUMAN C-HA-RAS GENE CONTAINED SOMATICALLY ACTIVATED TRANSGENES	ONCOGENE			English	Article									TOKAI UNIV,SCH MED,DEPT DNA BIOL,ISEHARA,KANAGAWA 25911,JAPAN; CENT INST EXPTL ANIM,KAWASAKI,JAPAN; NATL CANC CTR,RES INST,DIV BIOL,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV ONCOL,TOKYO 104,JAPAN	Tokai University; National Cancer Center - Japan; National Cancer Center - Japan								ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; FASANO O, 1983, Journal of Molecular and Applied Genetics, V2, P173; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GUERRERO I, 1987, MUTAT RES, V185, P293, DOI 10.1016/0165-1110(87)90021-2; KANAI T, 1987, JPN J CANCER RES, V78, P1314; KATSUKI M, 1989, MOL BIOL MED, V6, P567; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; MARIYAMA M, 1989, JPN J CANCER RES, V80, P622, DOI 10.1111/j.1349-7006.1989.tb01687.x; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; REDDY EP, 1983, SCIENCE, V220, P1061, DOI 10.1126/science.6844927; REYNOLDS SH, 1986, P NATL ACAD SCI USA, V83, P33, DOI 10.1073/pnas.83.1.33; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SEKIYA T, 1985, JPN J CANCER RES, V76, P851; SEKIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P4771, DOI 10.1073/pnas.81.15.4771; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SLAMON DJ, 1984, P NATL ACAD SCI-BIOL, V81, P7141, DOI 10.1073/pnas.81.22.7141; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585	35	143	145	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1195	1200						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202951				2022-12-28	WOS:A1990DX36100012
J	HORAK, ID; CORCORAN, ML; THOMPSON, PA; WAHL, LM; BOLEN, JB				HORAK, ID; CORCORAN, ML; THOMPSON, PA; WAHL, LM; BOLEN, JB			EXPRESSION OF P60FYN IN HUMAN PLATELETS	ONCOGENE			English	Article									NCI,MED BRANCH,BETHESDA,MD 20892; NCI,USN,BETHESDA,MD 20892; NIDR,IMMUNOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	HORAK, ID (corresponding author), NCI,TUMOR VIRUS BIOL LAB,BLDG 41,ROOM D-907,900 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BOLEN JB, 1989, TRENDS BIOCHEM SCI, V14, P404, DOI 10.1016/0968-0004(89)90288-0; BOLEN JB, 1983, J BIOL CHEM, V258, P11686; COOPER JA, 1989, IN PRESS PEPTIDES PR; DESEAU V, 1987, J CELL BIOCHEM, V35, P113, DOI 10.1002/jcb.240350205; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FERRELL JE, 1988, MOL CELL BIOL, V8, P3603, DOI 10.1128/MCB.8.9.3603; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; HORAK ID, 1989, J VIROL, V63, P2343, DOI 10.1128/JVI.63.5.2343-2347.1989; Huang E. M., 1986, BIOCH PLATELETS, P1; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; OSHAUGHNESSY J, 1987, ONCOGENE RES, V2, P1; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1989, ONCOGENES, P121	20	78	79	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					597	602						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183161				2022-12-28	WOS:A1990DB85300021
J	KELLER, JR; RUSCETTI, SK; RUSCETTI, FW				KELLER, JR; RUSCETTI, SK; RUSCETTI, FW			INTRODUCTION OF V-ABL ONCOGENE INDUCES MONOCYTIC DIFFERENTIATION OF AN IL-3-DEPENDENT MYELOID PROGENITOR-CELL LINE	ONCOGENE			English	Article									NCI,GENET LAB,BETHESDA,MD 20892; NCI,FREDERICK CANC RES FACIL,DIV CANC TREATMENT,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KELLER, JR (corresponding author), NCI,FREDERICK CANC RES FACIL,BIOL CARCINOGENESIS DEV PROGRAM,FREDERICK,MD 21701, USA.		Keller, Jonathan R./O-6677-2018		OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CARACCIOLO D, 1989, SCIENCE, V245, P1107, DOI 10.1126/science.2672339; CHAMPLIN RE, 1985, BLOOD, V65, P1039; CONSCIENCE JF, 1986, EMBO J, V5, P317, DOI 10.1002/j.1460-2075.1986.tb04215.x; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GREENBERGER JS, 1983, FED PROC, V42, P2762; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443; IHLE JN, 1984, CURR TOP MICROBIOL I, V113, P85; METCALF D, 1984, HEMOPOIETIC COLONIES; NOWELL PC, 1960, SCIENCE, V132, P1497; OLIFF A, 1985, P NATL ACAD SCI USA, V81, P5464; PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0; PIERCE JH, 1984, P NATL ACAD SCI-BIOL, V81, P2374, DOI 10.1073/pnas.81.8.2374; RAPP UR, 1985, NATURE, V317, P434, DOI 10.1038/317434a0; RIGBY PN, 1977, J MOL BIOL, V113, P236; ROVERA G, 1987, ONCOGENE, V1, P29; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WANECK GL, 1986, CELL, V44, P337, DOI 10.1016/0092-8674(86)90768-3; WANG JYJ, 1983, MOL CELL BIOL, V3, P773, DOI 10.1128/MCB.3.5.773; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WHITLOCK CA, 1983, CELL, V32, P903, DOI 10.1016/0092-8674(83)90075-2; WITTE ON, 1978, P NATL ACAD SCI USA, V75, P2488, DOI 10.1073/pnas.75.5.2488; WOLGEMUTH DJ, 1985, MOL CELL BIOL, V5, P1791; WONG PMC, 1987, EXP HEMATOL, V15, P280	31	18	18	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					549	555						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2158039				2022-12-28	WOS:A1990DB85300014
J	SUKEGAWA, J; AKATSUKA, T; SUGAWARA, I; MORI, S; YAMAMOTO, T; TOYOSHIMA, K				SUKEGAWA, J; AKATSUKA, T; SUGAWARA, I; MORI, S; YAMAMOTO, T; TOYOSHIMA, K			MONOCLONAL-ANTIBODIES TO THE AMINO-TERMINAL SEQUENCE OF THE C-YES GENE-PRODUCT AS SPECIFIC PROBES OF ITS EXPRESSION	ONCOGENE			English	Note									UNIV TOKYO,INST MED SCI,DEPT ONCOL,4-6-1 SHIROKANEDAI,MINATO KU,TOKYO 108,JAPAN; UNIV TOKYO,INST MED SCI,DEPT PATHOL,MINATO KU,TOKYO 108,JAPAN; NATL INST HLTH,DEPT ENTEROVIRUSES,SHINAGAWA KU,TOKYO 141,JAPAN	University of Tokyo; University of Tokyo								CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; COLLET MS, 1987, P NATL ACAD SCI USA, V75, P2021; COOPER JA, 1990, IN PRESS PROTEIN PEP; GHYSDAEL J, 1981, P NATL ACAD SCI-BIOL, V78, P2611, DOI 10.1073/pnas.78.4.2611; KATAGIRI T, 1989, P NATL ACAD SCI USA, V86, P10064, DOI 10.1073/pnas.86.24.10064; KAWAI S, 1980, P NATL ACAD SCI-BIOL, V77, P6199, DOI 10.1073/pnas.77.10.6199; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MAGOTA K, 1984, J BACTERIOL, V157, P909, DOI 10.1128/JB.157.3.909-917.1984; MCKEARN TJ, 1980, MONOCLONAL ANTIBODIE, P368; MORI S, 1989, LAB INVEST, V61, P93; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; SEMBA K, 1985, SCIENCE, V227, P1038, DOI 10.1126/science.2983418; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1988, NUCLEIC ACIDS RES, V16, P9876, DOI 10.1093/nar/16.20.9876; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YAMAMOTO T, 1989, IN PRESS MECHANISMS; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538	21	23	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					611	614						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183163				2022-12-28	WOS:A1990DB85300023
J	DUTT, K; SCOTT, M; DELMONTE, M; AGARWAL, N; STERNBERG, P; SRIVASTAVA, SK; SRINIVASAN, A				DUTT, K; SCOTT, M; DELMONTE, M; AGARWAL, N; STERNBERG, P; SRIVASTAVA, SK; SRINIVASAN, A			ESTABLISHMENT OF HUMAN RETINAL-PIGMENT EPITHELIAL-CELL LINES BY ONCOGENES	ONCOGENE			English	Article									W KELLOG EYE CTR,DEPT OPHTHALMOL,ANN ARBOR,MI 48105; UNIFORMED SERV UNIV HLTH SCI,DEPT PATHOL,BETHESDA,MD 20814; WISTAR INST,PHILADELPHIA,PA 19104; EMORY UNIV,SCH MED,DEPT OPHTHALMOL,ATLANTA,GA 30322; UNIV TEXAS,HLTH SCI CTR,DEPT PATHOL,SAN ANTONIO,TX 78284	Uniformed Services University of the Health Sciences - USA; The Wistar Institute; Emory University; University of Texas System; University of Texas Health San Antonio	DUTT, K (corresponding author), MOREHOUSE SCH MED,DEPT PATHOL,ATLANTA,GA 30310, USA.			Del Monte, Monte/0000-0002-3153-959X	NCRR NIH HHS [RR-08248, G12-RR-03034-03S1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034, S06RR008248] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BAYLEY SA, 1988, EXP CELL RES, V177, P232, DOI 10.1016/0014-4827(88)90042-0; BUITENWERF J, 1982, INTERVIROLOGY, V17, P222, DOI 10.1159/000149292; BUTEL JS, 1984, EXP MOL PATHOL, V40, P79, DOI 10.1016/0014-4800(84)90068-6; CHANG S E, 1986, Biochimica et Biophysica Acta, V823, P161, DOI 10.1016/0304-419X(86)90001-6; CHANG SE, 1982, CANCER RES, V42, P2040; COWELL JK, 1981, CANCER RES, V41, P1508; DAYAGROSJEAN L, 1984, INT J CANCER, V33, P319, DOI 10.1002/ijc.2910330308; DELMONTE MA, 1981, VISION RES, V21, P137, DOI 10.1016/0042-6989(81)90147-4; DELMONTE MA, 1980, IN VITRO EPITHELIAL, V16, P327; DELMONTE MA, 1985, INVEST OPHTHALMOL  S, V26, P339; EDWARDS RB, 1977, SCIENCE, V197, P1001, DOI 10.1126/science.560718; FLOOD MT, 1981, VISION RES, V21, P119, DOI 10.1016/0042-6989(81)90144-9; FOREST C, 1983, CELL BIOL INT REP, V7, P73, DOI 10.1016/0309-1651(83)90106-6; FROST E, 1978, VIROLOGY, V91, P39, DOI 10.1016/0042-6822(78)90353-7; GOODING LR, 1982, J IMMUNOL, V129, P1306; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAGGERTY JG, 1988, P NATL ACAD SCI USA, V85, P6797, DOI 10.1073/pnas.85.18.6797; HAYATA I, 1983, CANCER RES, V43, P367; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LAVAIL MM, 1976, EXP EYE RES, V23, P227, DOI 10.1016/0014-4835(76)90206-2; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; Namba M, 1981, GANN MONOGR CANCER R, V27, P221; OSHIMURA M, 1985, NATURE, V316, P636, DOI 10.1038/316636a0; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; PATHAK S, 1981, GENES CHROMOSOMES NE, P405; Ponten J, 1971, Virol Monogr, V8, P1; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; SRINIVASAN A, 1981, P NATL ACAD SCI-BIOL, V78, P2077, DOI 10.1073/pnas.78.4.2077; TEVETHIA MJ, 1984, VIROLOGY, V137, P414, DOI 10.1016/0042-6822(84)90234-4; TOPP WC, 1980, DNA TUMOR VIRUSES, P205; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSANG VCW, 1983, METHOD ENZYMOL, V92, P377; VOGT M, 1986, MOL CELL BIOL, V6, P3545, DOI 10.1128/MCB.6.10.3545; WILLIAMS DA, 1988, MOL CELL BIOL, V8, P3864, DOI 10.1128/MCB.8.9.3864; WOODWORTH C, 1986, CANCER RES, V46, P4018	40	23	26	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					195	200						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2320373				2022-12-28	WOS:A1990CU02900005
J	LIU, JX; SINGH, B; WLODEK, D; ARLINGHAUS, RB				LIU, JX; SINGH, B; WLODEK, D; ARLINGHAUS, RB			CELL CYCLE-MEDIATED STRUCTURAL AND FUNCTIONAL ALTERATION OF P85GAG-MOS PROTEIN-KINASE ACTIVITY	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC PATHOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED ONCOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center					NCI NIH HHS [CA45125, CA16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA045125] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARLINGHAUS RB, 1985, J GEN VIROL, V66, P1845, DOI 10.1099/0022-1317-66-9-1845; BALL JK, 1973, VIROLOGY, V56, P268, DOI 10.1016/0042-6822(73)90305-X; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BLAIR DG, 1979, VIROLOGY, V95, P303, DOI 10.1016/0042-6822(79)90486-0; BURKE B, 1986, CELL, V44, P639, DOI 10.1016/0092-8674(86)90273-4; CHACKALAPARAMPIL I, 1988, CELL, V52, P801, DOI 10.1016/0092-8674(88)90422-9; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; FRIED J, 1976, J CELL BIOL, V71, P172, DOI 10.1083/jcb.71.1.172; GALLICK GE, 1984, VIROLOGY, V139, P366, DOI 10.1016/0042-6822(84)90382-9; GALLICK GE, 1985, J GEN VIROL, V66, P945, DOI 10.1099/0022-1317-66-5-945; GALLICK GE, 1984, MODERN APPROACHES VA, P407; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HERZOG NK, 1988, ONCOGENE, V3, P225; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUNTER T, 1986, ENZYMES, V17, P191; KESHET E, 1988, ONCOGENE, V2, P235; KLOETZER WS, 1984, VIROLOGY, V138, P143, DOI 10.1016/0042-6822(84)90154-5; KLOETZER WS, 1983, P NATL ACAD SCI-BIOL, V80, P412, DOI 10.1073/pnas.80.2.412; MARK GE, 1984, SCIENCE, V224, P285, DOI 10.1126/science.6324342; MAXWELL SA, 1985, J VIROL, V55, P874, DOI 10.1128/JVI.55.3.874-876.1985; MAXWELL SA, 1985, J GEN VIROL, V66, P2135, DOI 10.1099/0022-1317-66-10-2135; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; Meistrich ML, 1983, CELL SEPARATION METH, V2, P33; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; PAPKOFF J, 1983, CELL, V33, P161, DOI 10.1016/0092-8674(83)90345-8; PAPKOFF J, 1982, CELL, V29, P417, DOI 10.1016/0092-8674(82)90158-1; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; PROPST F, 1988, ONCOGENE, V2, P227; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SETH A, 1987, P NATL ACAD SCI USA, V84, P3560, DOI 10.1073/pnas.84.11.3560; SETH A, 1985, J VIROL, V56, P144, DOI 10.1128/JVI.56.1.144-152.1985; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SHOJI S, 1981, P NATL ACAD SCI-BIOL, V78, P848, DOI 10.1073/pnas.78.2.848; SINGH B, 1986, P NATL ACAD SCI USA, V83, P3629, DOI 10.1073/pnas.83.11.3629; SINGH B, 1986, VIROLOGY, V152, P502, DOI 10.1016/0042-6822(86)90156-X; SINGH B, 1988, ONCOGENE, V3, P79; SINGH B, 1987, J VIROL, V61, P3625, DOI 10.1128/JVI.61.11.3625-3629.1987; SINGH B, 1986, J VIROL, V60, P1148, DOI 10.1128/JVI.60.3.1148-1152.1986; SINGH B, 1988, VIROLOGY, V164, P114, DOI 10.1016/0042-6822(88)90626-5; SINGH B, 1989, IN PRESS VIROLOGY, V172; VANBEVEREN C, 1981, CELL, V27, P97, DOI 10.1016/0092-8674(81)90364-0; WEINMASTER G, 1983, J VIROL, V46, P29, DOI 10.1128/JVI.46.1.29-41.1983	47	23	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					171	178						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2138725				2022-12-28	WOS:A1990CU02900002
J	GHANTA, VK; HIRAMOTO, RN; PARKER, CA; KIDD, VJ; HUMPHREYSBEHER, MG				GHANTA, VK; HIRAMOTO, RN; PARKER, CA; KIDD, VJ; HUMPHREYSBEHER, MG			INVITRO AND INVIVO GROWTH-CONTROL OF TRANSFORMED LYMPHOID-CELLS EXPRESSING PLASMA-MEMBRANE GALACTOSYLTRANSFERASE	ONCOGENE			English	Article									UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT ORAL BIOL,BOX J-424,GAINESVILLE,FL 32610; UNIV ALABAMA,DEPT CELL BIOL & ANAT,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,CTR COMPREHENS CANC,BIRMINGHAM,AL 35294	State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham					NCI NIH HHS [CA-42337] Funding Source: Medline; NIDCR NIH HHS [DE-08778] Funding Source: Medline; NIDDK NIH HHS [DK-36973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAUER CH, 1977, CANCER RES, V37, P1513; BAYNA EM, 1988, CELL, V53, P145, DOI 10.1016/0092-8674(88)90496-5; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; BOSMANN HB, 1974, FEBS LETT, V44, P313, DOI 10.1016/0014-5793(74)81166-X; CACCAM JF, 1970, ARCH BIOCHEM BIOPHYS, V137, P315, DOI 10.1016/0003-9861(70)90445-5; CAPEL ID, 1982, ONCOLOGY, V39, P193, DOI 10.1159/000225635; CHATTERJEE SK, 1979, CANCER RES, V39, P1943; CHATTERJEE SK, 1978, BIOCHEM BIOPH RES CO, V80, P826, DOI 10.1016/0006-291X(78)91319-0; COLLARD JG, 1985, INT J CANCER, V35, P207, DOI 10.1002/ijc.2910350211; DAVEY R, 1986, BRIT J CANCER, V53, P211, DOI 10.1038/bjc.1986.37; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Fleischer S, 1974, Methods Enzymol, V31, P3; GARVIN AM, 1988, MOL CELL BIOL, V8, P3058, DOI 10.1128/MCB.8.8.3058; GMEINER B, 1985, CANCER BIOCHEM BIOPH, V10, P103; GRIMES WJ, 1973, BIOCHEMISTRY-US, V12, P990, DOI 10.1021/bi00729a031; HUMPHREYSBEHER MG, 1987, J BIOL CHEM, V262, P11706; HUMPHREYSBEHER MG, 1984, J BIOL CHEM, V259, P5797; IP C, 1977, CANCER RES, V37, P3442; JENTOFT N, 1976, GLYCOSLYTRANSFERASES, V2, P343; KESSEL D, 1977, J NATL CANCER I, V59, P29, DOI 10.1093/jnci/59.1.29; KIM YS, 1972, J CLIN INVEST, V51, P2033, DOI 10.1172/JCI107009; KLOHS WD, 1982, EXP CELL RES, V141, P365, DOI 10.1016/0014-4827(82)90225-7; KLOHS WD, 1981, CANCER RES, V41, P2611; MARCHASE RB, 1988, J CELL BIOCHEM, V36, P453, DOI 10.1002/jcb.240360413; PAONE JF, 1980, J SURG ONCOL, V15, P56; PARMIANI G, 1982, INT J CANCER, V29, P323, DOI 10.1002/ijc.2910290316; PATT LM, 1975, CANCER RES, V35, P438; PIERCE M, 1980, INT REV CYTOLOGY; PODOLSKY DK, 1978, NEW ENGL J MED, V299, P703, DOI 10.1056/NEJM197809282991306; PODOLSKY DK, 1984, P NATL ACAD SCI-BIOL, V81, P2529, DOI 10.1073/pnas.81.8.2529; PODOLSKY DK, 1975, BIOCHEM BIOPH RES CO, V65, P545, DOI 10.1016/S0006-291X(75)80181-1; PODOLSKY DK, 1979, J BIOL CHEM, V254, P3983; POTTER M, 1972, PHYSIOL REV, V52, P631, DOI 10.1152/physrev.1972.52.3.631; ROTH S, 1971, J CELL BIOL, V51, P536, DOI 10.1083/jcb.51.2.536; ROTH S, 1977, CELL SURFACE GLYCOSY, P245; SANTER UV, 1979, BIOCHEMISTRY-US, V18, P2533, DOI 10.1021/bi00579a016; SHUR BD, 1984, MOL CELL BIOCHEM, V61, P143; SHUR BD, 1979, DEV BIOL, V71, P243, DOI 10.1016/0012-1606(79)90167-2; UEMURA M, 1988, CANCER RES, V48, P5335; UEMURA M, 1988, CANCER RES, V48, P5325; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; WARREN L, 1978, BIOCHIM BIOPHYS ACTA, V516, P97, DOI 10.1016/0304-419X(78)90005-7; WARREN L, 1959, J BIOL CHEM, V234, P1971; WEISER MM, 1981, CRC CR REV CL LAB SC, V14, P189, DOI 10.3109/10408368109105864; WIDNELL CC, 1968, P NATL ACAD SCI USA, V61, P1050, DOI 10.1073/pnas.61.3.1050	45	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1337	1344						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2510114				2022-12-28	WOS:A1989AX65900010
J	PANDIELLA, A; LEHVASLAIHO, H; MAGNI, M; ALITALO, K; MELDOLESI, J				PANDIELLA, A; LEHVASLAIHO, H; MAGNI, M; ALITALO, K; MELDOLESI, J			ACTIVATION OF AN EGFR NEU CHIMERIC RECEPTOR - EARLY INTRACELLULAR SIGNALS AND CELL-PROLIFERATION RESPONSES	ONCOGENE			English	Article									UNIV MILANO,SCI INST S RAFFAELE,VIA OLGETTINA 60,I-20132 MILAN,ITALY; UNIV MILAN,CNR,CTR CYTOPHARMACOL,DEPT PHARMACOL,I-20122 MILAN,ITALY; UNIV HELSINKI,DEPT PATHOL,SF-00100 HELSINKI 10,FINLAND; UNIV HELSINKI,DEPT VIROL,SF-00100 HELSINKI 10,FINLAND	University of Milan; Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Helsinki; University of Helsinki			Alitalo, Kari K/J-5013-2014; Pandiella, Atanasio/O-5180-2014	Alitalo, Kari K/0000-0002-7331-0902; Pandiella, Atanasio/0000-0002-4704-8971				BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNES CP, 1986, BIOCHEM J, V238, P501, DOI 10.1042/bj2380501; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; KOCH BD, 1988, J BIOL CHEM, V263, P216; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PANDIELLA A, 1987, EXP CELL RES, V170, P175, DOI 10.1016/0014-4827(87)90127-3; PANDIELLA A, 1989, J BIOL CHEM, V264, P3122; PANDIELLA A, 1988, BIOCHEM J, V254, P223, DOI 10.1042/bj2540223; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; SAWYER ST, 1981, BIOCHEMISTRY-US, V20, P6280, DOI 10.1021/bi00524a057; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WAHL M, 1988, J BIOL CHEM, V263, P7581; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1987, BIOCHEM BIOPH RES CO, V142, P688, DOI 10.1016/0006-291X(87)91469-0; WHITELEY B, 1986, J CELL BIOL, V103, P1355, DOI 10.1083/jcb.103.4.1355; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	30	27	27	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1299	1305						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2573029				2022-12-28	WOS:A1989AX65900005
J	SEMSEI, I; MA, S; CUTLER, RG				SEMSEI, I; MA, S; CUTLER, RG			TISSUE AND AGE SPECIFIC EXPRESSION OF THE MYC PROTO-ONCOGENE FAMILY THROUGHOUT THE LIFE-SPAN OF THE C57BL/6J MOUSE STRAIN	ONCOGENE			English	Article									NIA,GERONTOL RES CTR,CELLULAR & MOLEC BIOL LAB,MOLEC PHYSIOL & GENET SECT,4940 EASTERN AVE,BETHESDA,MD 20205	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)								ADAMSON ED, 1987, DEVELOPMENT, V99, P449; ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CHEAH MSC, 1984, JNCI-J NATL CANCER I, V73, P1057; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAYCOMB WC, 1987, BIOCHEM J, V247, P701, DOI 10.1042/bj2470701; CLEVELAND DW, 1980, CELL, V20, P96; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CUTLER RG, 1986, GERONTOLOGIST, V26, pA71; CUTLER RG, 1985, MOL BIOL AGING GENE, P307; DEAN R, 1986, BIOCHEM BIOPH RES CO, V135, P105, DOI 10.1016/0006-291X(86)90948-4; DEAN RG, 1985, ARCH GERONTOL GERIAT, V4, P43, DOI 10.1016/0167-4943(85)90017-2; FAHRLANDER PD, 1986, ONCOGENES GROWTH CON, P264; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLORINE DL, 1980, CANCER RES, V40, P519; GODEAU F, 1986, EMBO J, V5, P3571, DOI 10.1002/j.1460-2075.1986.tb04684.x; GUERRERO I, 1987, TRENDS GENET, V3, P269, DOI 10.1016/0168-9525(87)90263-0; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; HUBER BE, 1987, CANCER RES, V47, P3414; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEIBOVITCH MP, 1987, EXP CELL RES, V170, P80, DOI 10.1016/0014-4827(87)90118-2; MATOCHA MF, 1987, BIOCHEM BIOPH RES CO, V147, P1, DOI 10.1016/S0006-291X(87)80078-5; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; OHLSSON RI, 1987, EXP CELL RES, V173, P1, DOI 10.1016/0014-4827(87)90327-2; ONO T, 1985, GERONTOLOGY, V31, P362, DOI 10.1159/000212725; ONO T, 1978, P NATL ACAD SCI USA, V75, P4431, DOI 10.1073/pnas.75.9.4431; ONO T, 1986, BIOCHEM BIOPH RES CO, V139, P1299, DOI 10.1016/S0006-291X(86)80319-9; RICHARDSON A, 1987, J BIOL CHEM, V262, P12821; RICHARDSON A, 1987, BIOL RES AGING, V3, P443; ROTHBERG PG, 1984, MOL CELL BIOL, V4, P1096, DOI 10.1128/MCB.4.6.1096; RUBIN H, 1985, CANCER RES, V45, P2935; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; TSONIS PA, 1985, ANTICANCER RES, V7, P617; WEINSTEIN IB, 1987, J CELL BIOCHEM, V33, P213, DOI 10.1002/jcb.240330308; WILSON VL, 1987, J BIOL CHEM, V262, P9948; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	38	74	74	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					465	471						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2470008				2022-12-28	WOS:A1989U567700011
J	MAVILIO, F; KREIDER, BL; VALTIERI, M; NASO, G; SHIRSAT, N; VENTURELLI, D; REDDY, EP; ROVERA, G				MAVILIO, F; KREIDER, BL; VALTIERI, M; NASO, G; SHIRSAT, N; VENTURELLI, D; REDDY, EP; ROVERA, G			ALTERATION OF GROWTH AND DIFFERENTIATION FACTORS RESPONSE BY KIRSTEN AND HARVEY SARCOMA-VIRUSES IN THE IL-3-DEPENDENT MURINE HEMATOPOIETIC-CELL LINE 32D-C13(G)	ONCOGENE			English	Article									WISTAR INST ANAT & BIOL,36TH ST SPRUCE,PHILADELPHIA,PA 19104	The Wistar Institute			Reddy, E. Premkumar/F-6233-2011; valtieri, mauro/H-1044-2016	valtieri, mauro/0000-0002-9139-6754; Mavilio, Fulvio/0000-0003-0459-4320	NATIONAL CANCER INSTITUTE [P01CA021124, T32CA009171, P30CA010815] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA 09171-13, 5P30 CA10815-21, 2PO1 CA 21124-11] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; ANDERSEN PR, 1981, CELL, V26, P129, DOI 10.1016/0092-8674(81)90041-6; BALMAIN A, 1985, BRIT J CANCER, V51, P1, DOI 10.1038/bjc.1985.1; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BLICK M, 1984, BLOOD, V64, P1234; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; COLLINS SJ, 1987, BLOOD, V70, P1233; COOPER GM, 1983, BIOCHIM BIOPHYS ACTA, V738, P9; DAHR R, 1982, SCIENCE, V217, P934; DEVRIES MV, 1986, GENE, V50, P313; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; EVA A, 1983, P NATL ACAD SCI-BIOL, V80, P4926, DOI 10.1073/pnas.80.16.4926; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; FUSCO A, 1982, CANCER RES, V42, P618; GAMBKE C, 1985, P NATL ACAD SCI USA, V82, P879, DOI 10.1073/pnas.82.3.879; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HANKINS WD, 1981, CELL, V26, P91, DOI 10.1016/0092-8674(81)90036-2; HARTLEY JW, 1976, J VIROL, V19, P19, DOI 10.1128/JVI.19.1.19-25.1976; Hayhoe FGJ, 1988, HAEMATOLOGICAL CYTOC; JANSSEN JWG, 1987, ONCOGENE, V1, P175; JOHNSON KR, 1987, NUCLEIC ACIDS RES, V15, P2013, DOI 10.1093/nar/15.5.2013; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; MAVILIO F, 1986, P NATL ACAD SCI USA, V83, P4934; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; METCALF D, 1984, HEMOPOIETIC COLONIES; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; NEEDLEMAN SW, 1986, BLOOD, V67, P753; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; PIERCE JH, 1982, J EXP MED, V156, P873, DOI 10.1084/jem.156.3.873; PIERCE JH, 1985, MOL CELL BIOL, V5, P667, DOI 10.1128/MCB.5.4.667; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; PULCIANI S, 1982, NATURE, V300, P539, DOI 10.1038/300539a0; RASHEED S, 1976, J VIROL, V19, P13, DOI 10.1128/JVI.19.1.13-18.1976; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; REIN A, 1985, MOL CELL BIOL, V5, P2257, DOI 10.1128/MCB.5.9.2257; ROVERA G, 1987, ONCOGENE, V1, P29; SANTOLI D, 1983, J IMMUNOL, V131, P736; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SOUYRI M, 1983, P NATL ACAD SCI-BIOL, V80, P6676, DOI 10.1073/pnas.80.21.6676; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TWEARDY DJ, 1987, ONCOGENE RES, V1, P209; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WARNER NL, 1969, J NATL CANCER I, V43, P963; WATANABE T, 1985, BIOCHEM BIOPH RES CO, V126, P999, DOI 10.1016/0006-291X(85)90284-0; WEINBERG RA, 1982, ADV CANCER RES, V36, P149, DOI 10.1016/S0065-230X(08)60424-8; WEISSMAN B, 1985, MOL CELL BIOL, V5, P3386, DOI 10.1128/MCB.5.12.3386; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; YUSPA SH, 1985, NATURE, V314, P459, DOI 10.1038/314459a0	65	44	44	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					301	308						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2468124				2022-12-28	WOS:A1989U567600005
J	AMSON, RB; MARCELLE, C; TELERMAN, A				AMSON, RB; MARCELLE, C; TELERMAN, A			IDENTIFICATION OF A 130 KDA BCR RELATED GENE-PRODUCT	ONCOGENE			English	Article									FREE UNIV BRUSSELS,SCH MED,INST INTERDISCIPLINARY RES,CAMPUS ERASME,BLDG C,ROUTE LENNIK 808,B-1070 BRUSSELS,BELGIUM; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Weizmann Institute of Science								BARTRAM CR, 1985, EMBO J, V4, P683, DOI 10.1002/j.1460-2075.1985.tb03683.x; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; BUDARF M, 1988, Genomics, V3, P168, DOI 10.1016/0888-7543(88)90149-8; CANAANI E, 1984, LANCET, V1, P593; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; CROCE CM, 1987, P NATL ACAD SCI USA, V84, P7174, DOI 10.1073/pnas.84.20.7174; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; GALE RP, 1984, P NATL ACAD SCI-BIOL, V81, P5648, DOI 10.1073/pnas.81.18.5648; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; GREENBERG ME, 1983, CELL, V33, P767, DOI 10.1016/0092-8674(83)90019-3; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HARIHARAN IK, 1987, EMBO J, V6, P115, DOI 10.1002/j.1460-2075.1987.tb04727.x; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; LIFSHITZ B, 1988, ONCOGENE, V2, P113; NALDINI L, 1986, MOL CELL BIOL, V6, P1803, DOI 10.1128/MCB.6.5.1803; NOWELL PC, 1960, SCIENCE, V132, P1497; SPINDLER KR, 1984, J VIROL, V49, P132, DOI 10.1128/JVI.49.1.132-141.1984; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; TELERMAN A, 1988, MOL CELL BIOL, V8, P1498, DOI 10.1128/MCB.8.4.1498; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263	29	13	13	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					243	247						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2494632				2022-12-28	WOS:A1989U567500017
J	BEPLER, G; BADING, H; HEIMANN, B; KIEFER, P; HAVEMANN, K; MOELLING, K				BEPLER, G; BADING, H; HEIMANN, B; KIEFER, P; HAVEMANN, K; MOELLING, K			EXPRESSION OF P64C-MYC AND NEURO-ENDOCRINE PROPERTIES DEFINE 3 SUBCLASSES OF SMALL CELL LUNG-CANCER	ONCOGENE			English	Article									MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,D-1000 BERLIN 33,FED REP GER; UNIV MARBURG,MED CTR,DEPT INTERNAL MED,DIV HEMATOL & ONCOL,D-3550 MARBURG,FED REP GER	Max Planck Society; Philipps University Marburg								BADING H, 1987, ONCOGENE, V1, P395; BADING H, 1988, ONCOGENE, V3, P257; BAILLIEJOHNSON H, 1985, BRIT J CANCER, V52, P495, DOI 10.1038/bjc.1985.220; BAYLIN SB, 1980, CANCER RES, V40, P1990; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6349, DOI 10.1021/bi00344a005; BENSCH KG, 1968, CANCER, V22, P1163, DOI 10.1002/1097-0142(196811)22:6<1163::AID-CNCR2820220612>3.0.CO;2-L; BEPLER G, 1987, J CANCER RES CLIN, V113, P253, DOI 10.1007/BF00396382; BEPLER G, 1988, DIFFERENTIATION, V37, P158, DOI 10.1111/j.1432-0436.1988.tb00806.x; BEPLER G, 1987, CANCER RES, V47, P1883; BEPLER G, 1987, J CANCER RES CLIN, V113, P31, DOI 10.1007/BF00389964; BEPLER G, 1986, CANCER RES, V46, P3412; BERGH J, 1985, IMMUNOL SCAND A, V90, P133; BLOBEL GA, 1985, LAB INVEST, V52, P39; CARNEY DN, 1983, CANCER RES, V43, P2806; CARNEY DN, 1985, CANCER RES, V45, P2913; DENHEZ F, 1988, EMBO J, V7, P541, DOI 10.1002/j.1460-2075.1988.tb02843.x; GAZDAR AF, 1985, CANCER RES, V45, P2924; GAZDAR AF, 1985, RECENT RES CANCER, V99, P167; GOULD VE, 1983, PATHOL ANNU, V18, P287; GRIFFIN CA, 1985, RECENT RES CANCER, V99, P237; HAEDER M, 1988, CANCER RES, V48, P1132; KIEFER PE, 1987, CANCER RES, V47, P6236; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LINIAL M, 1982, VIROLOGY, V119, P382, DOI 10.1016/0042-6822(82)90097-6; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MOELLING K, 1987, CONTRIBUTIONS ONCOLO, V24, P76; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; RAPP UR, 1987, MODERN TRENDS HUMAN, V7, P450; SORENSON GD, 1981, CANCER, V47, P1289, DOI 10.1002/1097-0142(19810315)47:6<1289::AID-CNCR2820470610>3.0.CO;2-B; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WHANGPENG J, 1982, SCIENCE, V215, P181, DOI 10.1126/science.6274023	36	25	25	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					45	50						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2536917				2022-12-28	WOS:A1989U567400007
J	EINAT, M; KIMCHI, A				EINAT, M; KIMCHI, A			TRANSFECTION OF FIBROBLASTS WITH ACTIVATED C-MYC CONFERS RESISTANCE TO ANTIGROWTH EFFECTS OF INTERFERON	ONCOGENE			English	Article									WEIZMANN INST SCI,DEPT VIROL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science				Friedman-Einat, Miriam/0000-0002-9451-1025				ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BALKWILL F, 1978, NATURE, V274, P798, DOI 10.1038/274798a0; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DRON D, 1986, MOL CELL BIOL, V6, P1374; EBSWORTH N, 1986, EXP CELL RES, V165, P255, DOI 10.1016/0014-4827(86)90549-5; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EINAT M, 1985, P NATL ACAD SCI USA, V82, P7608, DOI 10.1073/pnas.82.22.7608; GEWERT DR, 1984, EUR J BIOCHEM, V139, P619, DOI 10.1111/j.1432-1033.1984.tb08049.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LAU LF, 1987, P NATL ACAD SCI US, V82, P7608; LEOF EB, 1987, MOL CELL BIOL, V7, P2649, DOI 10.1128/MCB.7.7.2649; LIN SL, 1986, SCIENCE, V233, P356, DOI 10.1126/science.3726533; MOORE G, 1984, EUR J BIOCHEM, V139, P627, DOI 10.1111/j.1432-1033.1984.tb08050.x; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; RAPP UR, 1985, NATURE, V317, P434, DOI 10.1038/317434a0; RESNITZKY D, 1986, CELL, V46, P31, DOI 10.1016/0092-8674(86)90857-3; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SREEVALSAN T, 1980, J CELL PHYSIOL, V104, P1, DOI 10.1002/jcp.1041040102; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; TAYLORPAPADIMITRIOU J, 1981, J INTERFERON RES, V1, P401, DOI 10.1089/jir.1981.1.401; YARDEN A, 1984, EMBO J, V3, P969, DOI 10.1002/j.1460-2075.1984.tb01915.x; YARDEN A, 1986, SCIENCE, V234, P1419, DOI 10.1126/science.3097823; ZERLIN M, 1987, ONCOGENE, V1, P19	32	19	19	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1988	2	5					485	491						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	N4348	2453829				2022-12-28	WOS:A1988N434800010
J	KANNER, SB; PARSONS, SJ; PARSONS, JT; GILMER, TM				KANNER, SB; PARSONS, SJ; PARSONS, JT; GILMER, TM			ACTIVATION OF PP60C-SRC TYROSINE KINASE SPECIFIC ACTIVITY IN TUMOR-DERIVED SYRIAN-HAMSTER EMBRYO CELLS	ONCOGENE			English	Article									UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,CTR CANC,CHARLOTTESVILLE,VA 22908; NIEHS,PULM PATHOBIOL LAB,RES TRIANGLE PK,NC 27709	University of Virginia; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)					NCI NIH HHS [CA40042, CA29243, CA08316] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA008316, P01CA040042, R01CA029243, R37CA029243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNEKOW A, 1986, EMBO J, V5, P701, DOI 10.1002/j.1460-2075.1986.tb04270.x; BARRETT JC, 1978, P NATL ACAD SCI USA, V75, P3761, DOI 10.1073/pnas.75.8.3761; BARRETT JC, 1979, CANCER RES, V39, P1504; BARRETT JC, 1987, MECHANISMS ENV CARCI, V2, P73; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOLEN JB, 1987, ONCOGENE RES, V1, P149; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; BOLEN JB, 1987, J VIROL, V61, P3299, DOI 10.1128/JVI.61.10.3299-3305.1987; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1985, MOL CELL BIOL, V5, P2647, DOI 10.1128/MCB.5.10.2647; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1987, IN PRESS PEPTIDES PR; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; DAVIS RL, 1985, MOL CELL BIOL, V5, P204, DOI 10.1128/MCB.5.1.204; GENTRY LE, 1986, MOL CELL BIOL, V6, P735, DOI 10.1128/MCB.6.2.735; GENTRY LE, 1983, J BIOL CHEM, V258, P1219; GILMER TM, 1982, P NATL ACAD SCI-BIOL, V79, P2152, DOI 10.1073/pnas.79.7.2152; GILMER TM, 1987, CANCER RES, V47, P4663; GILMER TM, 1985, MOL CELL BIOL, V5, P1707, DOI 10.1128/MCB.5.7.1707; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HESTERBERG TW, 1984, CANCER RES, V44, P2170; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KANNER SB, 1986, J IMMUNOL, V137, P674; KANNER SB, 1987, J INFECT DIS, V155, P617, DOI 10.1093/infdis/155.4.617; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDBETTER JA, 1987, MOL CELL BIOL, V7, P650, DOI 10.1128/MCB.7.2.650; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LUTTRELL DK, 1988, IN PRESS MOL CELL BI; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MATTEN WT, 1987, BIOCHEM J, V248, P691, DOI 10.1042/bj2480691; MCCARLEY DJ, 1987, P NATL ACAD SCI USA, V84, P5793, DOI 10.1073/pnas.84.16.5793; MCLACHLAN JA, 1982, CANCER RES, V42, P3040; OSHIMURA M, 1986, CANCER GENET CYTOGEN, V22, P225, DOI 10.1016/0165-4608(86)90159-7; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PARSONS SJ, 1986, BIOCHEM BIOPH RES CO, V134, P736, DOI 10.1016/S0006-291X(86)80482-X; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; SEFTON BM, 1986, CURR TOP MICROBIOL, V123, P39; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; THOMASSEN DG, 1985, CANCER RES, V45, P726; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WONG TW, 1983, J BIOL CHEM, V258, P1022; YONEMOTO W, 1985, P NATL ACAD SCI USA, V82, P4568, DOI 10.1073/pnas.82.14.4568	57	20	20	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1988	2	4					327	335						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	M9472	2452399				2022-12-28	WOS:A1988M947200004
J	DREBIN, JA; LINK, VC; GREENE, MI				DREBIN, JA; LINK, VC; GREENE, MI			MONOCLONAL-ANTIBODIES REACTIVE WITH DISTINCT DOMAINS OF THE NEU ONCOGENE-ENCODED P185 MOLECULE EXERT SYNERGISTIC ANTI-TUMOR EFFECTS INVIVO	ONCOGENE			English	Article									UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,DIV IMMUNOL,PHILADELPHIA,PA 19104	University of Pennsylvania								CERIANI RL, 1987, CANCER RES, V47, P532; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; DREBIN JA, 1988, IN PRESS ONCOGENE; HERLYN D, 1985, J IMMUNOL, V134, P1300; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; Hudson L, 1980, PRACTICAL IMMUNOLOGY, V2nd; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOKAI Y, IN PRESS P NATL ACAD; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MEEKER TC, 1985, BLOOD, V65, P1349, DOI 10.1182/blood.V65.6.1349.bloodjournal6561349; REISFELD RA, 1986, SEMIN ONCOL, V13, P153; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SIBINGA EM, 1987, DEV RECOGNITION TRAN, P59; Slamon D, 1987, SCIENCE, V235, P117; TROWBRIDGE IS, 1981, NATURE, V294, P171, DOI 10.1038/294171a0; VOLLMERS HP, 1983, P NATL ACAD SCI-BIOL, V80, P6863, DOI 10.1073/pnas.80.22.6863	20	137	190	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1988	2	3					273	277						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	M5931	2451200				2022-12-28	WOS:A1988M593100010
J	BOYD, JM; SIMMONS, DT				BOYD, JM; SIMMONS, DT			EVIDENCE THAT SV40 SURFACE TUMOR-ANTIGEN ORIGINATES FROM THE NUCLEUS AND CYTOPLASM	ONCOGENE			English	Article							LARGE-T-ANTIGEN; TRANSPORT-DEFECTIVE MUTANT; SIMIAN VIRUS-40; PLASMA-MEMBRANE; CELL-SURFACE; HYBRID VIRUSES; WILD-TYPE; ASSOCIATION; BINDING; PHOSPHORYLATION	Simian virus 40 large T antigen exposed at the cell surface is oligomerized and phosphorylated in a mature fashion. NP40-soluble surface T antigen, prepared from infected cells, sediments mainly as a tetramer and has a nuclear phosphorylation pattern. Since these are modifications that occur over several hours, surface T appears to be a population of older molecules. This is in apparent contradiction to kinetic studies showing that T antigen arrives at the surface in 20 min. We present a model to account for this apparent discrepancy. It postulates that both newly-synthesized and older, mature molecules are transported to the surface. The newly-synthesized molecules are highly unstable and lost rapidly from the surface whereas the mature molecules are stable and accumulate over time. This stability may be due to oligomerization and/or phosphorylation or to an interaction with other surface molecules that act as anchors. Our model further proposes that most of the T antigen in transit to the surface is newly-synthesized protein from the cytoplasm, while the majority of the T antigen at the surface is mature protein from the nucleus.			BOYD, JM (corresponding author), UNIV DELAWARE,SCH LIFE & HLTH SCI,NEWARK,DE 19716, USA.				NATIONAL CANCER INSTITUTE [R01CA036118] Funding Source: NIH RePORTER; NCI NIH HHS [CA 36118] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BUTEL JS, 1986, BIOCHIM BIOPHYS ACTA, V865, P171, DOI 10.1016/0304-419X(86)90027-2; DEPPERT W, 1982, VIROLOGY, V122, P56, DOI 10.1016/0042-6822(82)90377-4; FANNING E, 1981, J VIROL, V37, P92, DOI 10.1128/JVI.37.1.92-102.1981; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; GREENSPAN DS, 1981, P NATL ACAD SCI-BIOL, V78, P105, DOI 10.1073/pnas.78.1.105; HENNING R, 1983, NATURE, V305, P736, DOI 10.1038/305736a0; JARVIS DL, 1984, VIROLOGY, V134, P168, DOI 10.1016/0042-6822(84)90282-4; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KLOCKMANN U, 1985, J VIROL, V56, P541, DOI 10.1128/JVI.56.2.541-548.1985; KLOCKMANN U, 1983, EMBO J, V2, P1151, DOI 10.1002/j.1460-2075.1983.tb01560.x; KLOCKMANN U, 1983, VIROLOGY, V126, P717, DOI 10.1016/S0042-6822(83)80029-4; LANFORD RE, 1980, VIROLOGY, V105, P314, DOI 10.1016/0042-6822(80)90033-1; LANFORD RE, 1980, VIROLOGY, V105, P303, DOI 10.1016/0042-6822(80)90032-X; LANFORD RE, 1982, VIROLOGY, V119, P169, DOI 10.1016/0042-6822(82)90074-5; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; LEVITSKY K, 1983, INT J CANCER, V32, P597, DOI 10.1002/ijc.2910320513; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MCCORMICK F, 1980, J VIROL, V34, P213, DOI 10.1128/JVI.34.1.213-224.1980; RINKE Y, 1989, VIROLOGY, V170, P424, DOI 10.1016/0042-6822(89)90433-9; SANTOS M, 1984, J VIROL, V51, P376, DOI 10.1128/JVI.51.2.376-383.1984; SANTOS M, 1984, J VIROL, V49, P50, DOI 10.1128/JVI.49.1.50-56.1984; SANTOS M, 1982, VIROLOGY, V120, P1, DOI 10.1016/0042-6822(82)90002-2; SCHEIDTMANN KH, 1986, VIROLOGY, V150, P85, DOI 10.1016/0042-6822(86)90268-0; SCHEIDTMANN KH, 1982, J VIROL, V44, P116, DOI 10.1128/JVI.44.1.116-133.1982; SCHEIDTMANN KH, 1984, J VIROL, V50, P636, DOI 10.1128/JVI.50.2.636-640.1984; SCHICKEDANZ J, 1986, VIROLOGY, V148, P47, DOI 10.1016/0042-6822(86)90402-2; SCHMIEG FI, 1988, VIROLOGY, V164, P132, DOI 10.1016/0042-6822(88)90628-9; SCHMIEG FI, 1984, J VIROL, V52, P350, DOI 10.1128/JVI.52.2.350-355.1984; SIMMONS D, 1980, VIROLOGY, V34, P650; SIMMONS DT, 1984, J BIOL CHEM, V259, P8633; SIMMONS DT, 1990, J VIROL, V64, P1973, DOI 10.1128/JVI.64.5.1973-1983.1990; SIMMONS DT, 1977, J VIROL, V24, P319, DOI 10.1128/JVI.24.1.319-325.1977; SOULE HR, 1982, INT J CANCER, V29, P337, DOI 10.1002/ijc.2910290318; WALSER A, 1989, J VIROL, V63, P3926, DOI 10.1128/JVI.63.9.3926-3933.1989; WALSER A, 1989, ONCOGENE, V4, P249	36	0	0	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					379	387						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011395				2022-12-28	WOS:A1991FT34400005
J	SOZZI, G; PIEROTTI, MA; MIOZZO, M; DONGHI, R; RADICE, P; DEBENEDETTI, V; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; MATHEW, CGP; PONDER, BAJ; SPURR, NK; DELLAPORTA, G				SOZZI, G; PIEROTTI, MA; MIOZZO, M; DONGHI, R; RADICE, P; DEBENEDETTI, V; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; MATHEW, CGP; PONDER, BAJ; SPURR, NK; DELLAPORTA, G			REFINED LOCALIZATION TO CONTIGUOUS REGIONS ON CHROMOSOME-10Q OF THE 2 GENES (H4 AND RET) THAT FORM THE ONCOGENIC SEQUENCE PTC	ONCOGENE			English	Note							THYROID PAPILLARY CARCINOMAS; HUMAN-MOUSE HYBRIDS; PROTO-ONCOGENE; ASSIGNMENT; ACTIVATION	In this report we confirm the localization of the human RET proto-oncogene to chromosome 10q11.2, both by Southern blot analysis of a panel of human-rodent somatic cell hybrids and by in situ hybridization on human metaphase chromosomes. Previously, we had assigned to the same chromosome region the gene termed H4. In about 25% of papillary thyroid carcinomas, this gene was shown to rearrange with RET to give rise to the transforming sequence PTC. The analysis of different cell hybrids containing subfragments of chromosome 10, in conjunction with pulse field gel electrophoresis, established that H4 is mapped distally to RET at a distance not less than 280 kb. These findings suggest that intrachromosomal rearrangements are responsible for PTC activation in papillary thyroid carcinomas.	IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,VIA G VENEZIAN,I-20133 MILAN,ITALY; NAPLES UNIV,FAC MED & CHIRURG 2,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80131 NAPLES,ITALY; GUYS HOSP,PEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND; INST CANC RES,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,SUTTON SM2 5PX,SURREY,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND; CLARE HALL LABS,IMPERIAL CANC RES FUND,S MIMMS EN6 3LID,HERTS,ENGLAND	Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Guy's & St Thomas' NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge			Mathew, Christopher G/G-3434-2015; Radice, Paolo/O-3119-2013; sozzi, gabriella/G-8259-2011	Mathew, Christopher G/0000-0003-4178-1838; Radice, Paolo/0000-0001-6298-4111; sozzi, gabriella/0000-0001-9360-6914; Grieco, Michele/0000-0002-4212-7814; Fusco, Alfredo/0000-0003-3332-5197; Pierotti, Marco Alessandro/0000-0002-7431-8332; Miozzo, Monica/0000-0002-6523-4575				ANAND R, 1986, TRENDS GENET, V2, P278, DOI 10.1016/0168-9525(86)90269-6; BAI Y, 1982, ANN HUM GENET, V46, P337, DOI 10.1111/j.1469-1809.1982.tb01584.x; BONGARZONE I, 1989, ONCOGENE, V4, P1457; DONGHI R, 1989, ONCOGENE, V4, P521; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; ISHIZAKA Y, 1989, ONCOGENE, V4, P1519; JONES EA, 1976, SOMAT CELL GENET, V2, P483, DOI 10.1007/BF01542686; MATHEW CGP, 1990, ANN HUM GENET, V54, P121, DOI 10.1111/j.1469-1809.1990.tb00368.x; MAYALL BH, 1975, AUTOMATION CYTOGENET; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; NARUM RA, 1988, AM J HUM GENET, V43, pA154; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; RADICE P, 1988, NUCLEIC ACIDS RES, V18, P5062; SOLOMON E, 1976, SOMAT CELL GENET, V2, P125, DOI 10.1007/BF01542626; SOLOMON E, 1979, ANN HUM GENET, V42, P273, DOI 10.1111/j.1469-1809.1979.tb00661.x; SWALLOW DM, 1977, CYTOGENET CELL GENET, V18, P136, DOI 10.1159/000130758; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021; 1989, CYTOGENET CELL GENET, V51, P1	21	45	46	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					339	342						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000227				2022-12-28	WOS:A1991FZ13400022
J	ADACHI, M; TSUJIMOTO, Y				ADACHI, M; TSUJIMOTO, Y			POTENTIAL Z-DNA ELEMENTS SURROUND THE BREAKPOINTS OF CHROMOSOME-TRANSLOCATION WITHIN THE 5' FLANKING REGION OF BCL-2 GENE	ONCOGENE			English	Note									WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104	The Wistar Institute					NCI NIH HHS [R01-CA50551] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050551] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI M, 1990, J EXP MED, V171, P559, DOI 10.1084/jem.171.2.559; ADACHI M, 1989, P NATL ACAD SCI USA, V86, P2771, DOI 10.1073/pnas.86.8.2771; ADACHI M, 1989, ONCOGENE, V4, P1073; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BULLOCK P, 1986, MOL CELL BIOL, V6, P3948, DOI 10.1128/MCB.6.11.3948; CHEN SJ, 1989, NUCLEIC ACIDS RES, V17, P7631, DOI 10.1093/nar/17.19.7631; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; COHEN JB, 1982, NUCLEIC ACIDS RES, V10, P3353, DOI 10.1093/nar/10.11.3353; FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9; FREUND AM, 1989, P NATL ACAD SCI USA, V86, P7465, DOI 10.1073/pnas.86.19.7465; HAMADA H, 1982, NATURE, V298, P396, DOI 10.1038/298396a0; KILPATRICK MW, 1984, J BIOL CHEM, V259, P7268; KLYSIK J, 1982, J BIOL CHEM, V257, P152; LAFER EM, 1981, P NATL ACAD SCI-BIOL, V78, P3546, DOI 10.1073/pnas.78.6.3546; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; NORDHEIM A, 1982, CELL, V31, P309, DOI 10.1016/0092-8674(82)90124-6; NORDHEIM A, 1983, P NATL ACAD SCI-BIOL, V80, P1821, DOI 10.1073/pnas.80.7.1821; NUNEZ G, 1989, P NATL ACAD SCI USA, V86, P4589, DOI 10.1073/pnas.86.12.4589; PECK LJ, 1982, P NATL ACAD SCI-BIOL, V79, P4560, DOI 10.1073/pnas.79.15.4560; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; STRINGER JR, 1982, NATURE, V296, P363, DOI 10.1038/296363a0; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; TSUJIMOTO Y, 1987, P NATL ACAD SCI USA, V84, P1329, DOI 10.1073/pnas.84.5.1329; TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WEINREB A, 1988, P NATL ACAD SCI USA, V85, P529, DOI 10.1073/pnas.85.2.529	38	46	49	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1653	1657						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176281				2022-12-28	WOS:A1990EL40100006
J	SCHROEDER, C; RAYNOSCHEK, C; FUHRMANN, U; DAMM, K; VENNSTROM, B; BEUG, H				SCHROEDER, C; RAYNOSCHEK, C; FUHRMANN, U; DAMM, K; VENNSTROM, B; BEUG, H			THE V-ERB A ONCOGENE CAUSES REPRESSION OF ERYTHROCYTE-SPECIFIC GENES AND AN IMMATURE, ABERRANT DIFFERENTIATION PHENOTYPE IN NORMAL ERYTHROID PROGENITORS	ONCOGENE			English	Article									INST MOLEC PATHOL,DR BOHR GASSE 7,A-1030 VIENNA,AUSTRIA; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY; KAROLINSKA INST,DEPT MOLEC BIOL,CMB,S-10401 STOCKHOLM 60,SWEDEN	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL); Karolinska Institutet								BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BEUG H, 1986, J VIROL, V57, P1127, DOI 10.1128/JVI.57.3.1127-1138.1986; BEUG H, 1985, VIROLOGY, V145, P141, DOI 10.1016/0042-6822(85)90209-0; BEUG H, 1981, VIROLOGY, V111, P201, DOI 10.1016/0042-6822(81)90665-6; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1977, EXP CELL RES, V107, P417, DOI 10.1016/0014-4827(77)90363-9; BEUG H, 1984, CELL, V36, P963, DOI 10.1016/0092-8674(84)90046-1; BEUG H, 1985, MODERN TRENDS HUMA 6, V29, P290; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FORREST D, 1990, IN PRESS ONCOGENE; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUHRMANN U, 1989, GENE DEV, V3, P2027; FUNG YKT, 1983, CELL, V33, P357, DOI 10.1016/0092-8674(83)90417-8; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GRAF T, 1973, VIROLOGY, V54, P398, DOI 10.1016/0042-6822(73)90152-9; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRAF T, 1982, BIOCHIM BIOPHYS ACTA, V651, P245, DOI 10.1016/0304-419X(82)90014-2; HAYMAN MJ, 1982, J CELL BIOCHEM, V18, P351, DOI 10.1002/jcb.1982.240180308; HIHARA H, 1983, J NATL CANCER I, V70, P891; KAHN P, 1984, P NATL ACAD SCI-BIOL, V81, P7122, DOI 10.1073/pnas.81.22.7122; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KAHN P, 1986, P HAMBURG, P41; KHAZAIE K, 1988, EMBO J, V7, P3067; KNIGHT J, 1988, GENE DEV, V2, P247, DOI 10.1101/gad.2.2.247; KOWENZ E, 1986, MODERN TRENDS HUMA 7, V31, P199; MAIHLE N J, 1988, Biochimica et Biophysica Acta, V948, P287; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; SAMARUT J, 1980, J CELL PHYSIOL, V105, P553, DOI 10.1002/jcp.1041050320; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHMIDT JA, 1986, LEUKEMIA RES, V10, P257, DOI 10.1016/0145-2126(86)90023-8; SCHMIDT JA, 1986, CELL, V46, P41, DOI 10.1016/0092-8674(86)90858-5; SEALY L, 1983, VIROLOGY, V130, P155, DOI 10.1016/0042-6822(83)90125-3; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, IN PRESS CELL	42	49	49	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1445	1453						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	1979159				2022-12-28	WOS:A1990EK50200002
J	GARSON, K; KANG, CY				GARSON, K; KANG, CY			MAPPING OF THE FUNCTIONAL DOMAINS OF THE V-REL ONCOGENE	ONCOGENE			English	Note									UNIV OTTAWA,FAC MED,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA	University of Ottawa								ANDERSON KV, 1985, CELL, V42, P779, DOI 10.1016/0092-8674(85)90274-0; BROWNELL E, 1989, ONCOGENE, V4, P935; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHEN HR, 1986, NUCLEIC ACIDS RES, V14, P3977, DOI 10.1093/nar/14.9.3977; CHEN ISY, 1981, J VIROL, V40, P800, DOI 10.1128/JVI.40.3.800-811.1981; DAVIS N, 1990, J VIROL, V64, P584, DOI 10.1128/JVI.64.2.584-591.1990; GARSON K, 1986, BIOCHEM BIOPH RES CO, V134, P716, DOI 10.1016/S0006-291X(86)80479-X; GARSON K, 1990, VIROLOGY, V177, P106, DOI 10.1016/0042-6822(90)90464-3; GELINAS C, 1988, ONCOGENE, V3, P349; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; GRUMONT RJ, 1989, ONCOGENE RES, V4, P1; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; HERZOG NK, 1986, P NATL ACAD SCI USA, V83, P812, DOI 10.1073/pnas.83.3.812; HOELZER JD, 1979, VIROLOGY, V93, P20, DOI 10.1016/0042-6822(79)90272-1; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORRISON LE, 1989, ONCOGENE, V4, P677; PARKER RC, 1977, P NATL ACAD SCI USA, V74, P851, DOI 10.1073/pnas.74.3.851; RICE NR, 1986, VIROLOGY, V149, P217, DOI 10.1016/0042-6822(86)90123-6; SHAW DJ, 1982, NUCLEIC ACIDS RES, V10, P6119, DOI 10.1093/nar/10.19.6119; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; SYLLA BS, 1986, MOL CELL BIOL, V6, P4709, DOI 10.1128/MCB.6.12.4709; THEILEN GH, 1966, J NATL CANCER I, V37, P731; TUNG HYL, 1988, P NATL ACAD SCI USA, V85, P2479, DOI 10.1073/pnas.85.8.2479; TUNG HYL, 1988, BIOCHEM BIOPH RES CO, V152, P441; WALRO DS, 1987, VIROLOGY, V160, P433, DOI 10.1016/0042-6822(87)90015-8; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984	31	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1431	1434						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216467				2022-12-28	WOS:A1990EC24100025
J	CROOK, T; GREENFIELD, I; HOWARD, J; STANLEY, M				CROOK, T; GREENFIELD, I; HOWARD, J; STANLEY, M			ALTERATIONS IN GROWTH-PROPERTIES OF HUMAN PAPILLOMA-VIRUS TYPE-16 IMMORTALIZED HUMAN CERVICAL KERATINOCYTE CELL-LINE CORRELATE WITH AMPLIFICATION AND OVEREXPRESSION OF C-MYC ONCOGENE	ONCOGENE			English	Note									UNIV CAMBRIDGE, DEPT PATHOL, TENNIS COURT RD, CAMBRIDGE CB2 1QP, ENGLAND; UNIV CAMBRIDGE, IMPERIAL CANC RES FUND, TUMOUR VIRUS GRP, CAMBRIDGE CB2 1QP, ENGLAND	University of Cambridge; University of Cambridge								BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CROOK T, 1989, P NATL ACAD SCI USA, V86, P5713, DOI 10.1073/pnas.86.15.5713; CURRAN T, 1982, J VIROL, V42, P114, DOI 10.1128/JVI.42.1.114-122.1982; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; DUTRILLAUX B, 1981, HUM GENET, V57, P93; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRESHNEY IR, 1984, CULTURE ANIMAL CELLS, P129; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; HAUSEN HZ, 1988, MOL CARCINOGEN, V1, P147, DOI 10.1002/mc.2940010302; MCKAY RDG, 1973, CHROMOSOMA, V44, P1, DOI 10.1007/BF00372569; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RIOU G, 1987, LANCET, V1, P761; STANLEY MA, 1989, INT J CANCER, V43, P672, DOI 10.1002/ijc.2910430422; YOUNG LS, 1989, BRIT MED J, V298, P14, DOI 10.1136/bmj.298.6665.14; YUNIS JJ, 1973, CHROMOSOMA, V44, P15, DOI 10.1007/BF00372570; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	20	28	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					619	622						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2158040				2022-12-28	WOS:A1990DB85300025
J	KURIE, JM; MORSE, HC; PRINCIPATO, MA; WAX, JS; TROPPMAIR, J; RAPP, UR; POTTER, M; MUSHINSKI, JF				KURIE, JM; MORSE, HC; PRINCIPATO, MA; WAX, JS; TROPPMAIR, J; RAPP, UR; POTTER, M; MUSHINSKI, JF			V-MYC AND V-RAF ACT SYNERGISTICALLY TO INDUCE B-CELL TUMORS IN PRISTANE-PRIMED ADULT BALBC MICE	ONCOGENE			English	Article									NCI, GENET LAB, BLDG 37, ROOM 2B04, BETHESDA, MD 20892 USA; NIAID, IMMUNOPATHOL LAB, BETHESDA, MD 20892 USA; HAZLETON LABS AMERICA INC, ROCKVILLE, MD 20850 USA; NCI, FREDERICK CANC RES FACIL, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Troppmair, Jakob/0000-0002-0611-3837; Morse, Herbert/0000-0002-9331-3705				BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; CLYNES R, 1988, P NATL ACAD SCI USA, V85, P6067, DOI 10.1073/pnas.85.16.6067; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; ENRIETTO PJ, 1987, CANCER SURV, V6, P85; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GILL GW, 1974, ACTA CYTOL, V18, P300; GRAF T, 1982, BIOCHIM BIOPHYS ACTA, V651, P245, DOI 10.1016/0304-419X(82)90014-2; HEDRICK SM, 1984, NATURE, V308, P149, DOI 10.1038/308149a0; HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; LANG RB, 1982, NUCLEIC ACIDS RES, V10, P611, DOI 10.1093/nar/10.2.611; MORSE HC, 1986, P NATL ACAD SCI USA, V83, P6868, DOI 10.1073/pnas.83.18.6868; MOUNTZ JD, 1984, SCIENCE, V226, P1087, DOI 10.1126/science.6494925; MUSHINSKI JF, 1988, CELLULAR ONCOGENE AC, P181; OHNO S, 1984, J EXP MED, V159, P1762, DOI 10.1084/jem.159.6.1762; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; POLSKY F, 1978, ANAL BIOCHEM, V87, P397, DOI 10.1016/0003-2697(78)90689-9; POTTER M, 1987, SCIENCE, V235, P787, DOI 10.1126/science.3810165; PRINCIPATO M, 1988, CURR TOP MICROBIOL, V141, P31; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SCOTT CL, 1982, NATURE, V300, P757, DOI 10.1038/300757a0; SNODGRASS HR, 1985, NATURE, V315, P232, DOI 10.1038/315232a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SYMONDS G, 1989, ONCOGENE, V4, P285; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TROPPMAIR J, 1988, CURR TOP MICROBIOL, V141, P110; TROPPMAIR J, 1989, P NATL ACAD SCI USA, V86, P9941, DOI 10.1073/pnas.86.24.9941; VANNESS BG, 1982, P NATL ACAD SCI-BIOL, V79, P262; VENNSTROM B, 1981, J VIROL, V39, P625; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WEINBERG RA, 1984, BLOOD, V64, P1143; WOLFF L, 1988, J IMMUNOL, V141, P681; YAM LT, 1971, AM J CLIN PATHOL, V55, P283	36	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					577	582						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183159				2022-12-28	WOS:A1990DB85300018
J	CARTER, G; HUGHES, DC; CLARK, RE; MCCORMICK, F; JACOBS, A; WHITTAKER, JA; PADUA, RA				CARTER, G; HUGHES, DC; CLARK, RE; MCCORMICK, F; JACOBS, A; WHITTAKER, JA; PADUA, RA			RAS MUTATIONS IN PATIENTS FOLLOWING CYTOTOXIC THERAPY FOR LYMPHOMA	ONCOGENE			English	Article									UNIV COLL CARDIFF, DEPT HAEMATOL, LEUKAEMIA RES FUND PRELEUKAEMIA UNIT, HEATH PK, CARDIFF CF4 4XN, S GLAM, WALES; CETUS CORP, EMERYVILLE, CA 94608 USA	Cardiff University			Hughes, David/AAB-9237-2019; PADUA, Rose Ann/E-8621-2019; Padua, Rose Ann/GVT-5961-2022	Hughes, David/0000-0002-4539-3093; PADUA, Rose Ann/0000-0001-9964-7864; 				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; BLAYNEY DW, 1987, NEW ENGL J MED, V316, P710, DOI 10.1056/NEJM198703193161203; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; CARTER G, 1989, CANCER CEL, V7, P143; DEMPSEY JL, 1985, CANCER RES, V45, P2873; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; FARR CJ, 1988, ONCOGENE, V3, P673; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; GOW J, 1988, LEUKEMIA RES, V12, P805, DOI 10.1016/0145-2126(88)90033-1; GUERRERO I, 1986, LEUKEMIA RES, V10, P851, DOI 10.1016/0145-2126(86)90306-1; GUERRERO I, 1984, P NATL ACAD SCI-BIOL, V81, P202, DOI 10.1073/pnas.81.1.202; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; KALDOR JM, 1987, INT J CANCER, V39, P571, DOI 10.1002/ijc.2910390506; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, ONCOGENE, V3, P541; LEVINE EG, 1986, CLIN HAEMATOL, V15, P1037; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MORLEY AA, 1983, NATURE, V302, P155, DOI 10.1038/302155a0; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; PADUA RA, 1988, LEUKEMIA, V2, P503; PADUA RA, 1985, MOL CELL BIOL, V5, P582, DOI 10.1128/MCB.5.3.582; PEDERSENBJERGAARD J, 1982, NEW ENGL J MED, V307, P965, DOI 10.1056/NEJM198210143071601; PEDERSENBJERGAARD J, 1987, LANCET, V2, P83, DOI 10.1016/S0140-6736(87)92744-9; PEDERSENBJERGAARD J, 1988, CANCER RES, V48, P1812; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAWEY MJ, 1987, MOL CELL BIOL, V7, P932, DOI 10.1128/MCB.7.2.932; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SHUKLA VK, 1989, IN PRESS ONCOGENE RE; STEENVOORDEN ACM, 1988, LEUKEMIA, V2, P325; STEVENSON M, 1986, MOL CELL BIOL, V6, P3410, DOI 10.1128/MCB.6.10.3410; STRAUSS GH, 1979, MUTAT RES, V61, P353, DOI 10.1016/0027-5107(79)90140-4; TRICOT G, 1985, BRIT J HAEMATOL, V59, P659, DOI 10.1111/j.1365-2141.1985.tb07361.x; YUNIS JJ, 1989, ONCOGENE, V4, P609; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	39	48	50	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	1990	5	3					411	416						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179819				2022-12-28	WOS:A1990CW41500020
J	HSIAO, WLW; PAI, HLH; MATSUI, MS; WEINSTEIN, IB				HSIAO, WLW; PAI, HLH; MATSUI, MS; WEINSTEIN, IB			EFFECTS OF SPECIFIC FATTY-ACIDS ON CELL-TRANSFORMATION INDUCED BY AN ACTIVATED C-H-RAS ONCOGENE	ONCOGENE			English	Article									COLUMBIA UNIV HLTH SCI,SCH PUBL HLTH,CTR COMPREHENS CANC,NEW YORK,NY 10032; COLUMBIA UNIV HLTH SCI,SCH PUBL HLTH,INST CANC RES,NEW YORK,NY 10032; COLUMBIA UNIV HLTH SCI,SCH PUBL HLTH,DIV ENVIRONM SCI,NEW YORK,NY 10032; COLUMBIA UNIV HLTH SCI,DEPT DERMATOL,NEW YORK,NY 10032	Columbia University; Columbia University; Columbia University; Columbia University					NCI NIH HHS [CA 02656] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AYLSWORTH CF, 1987, LIPIDS, V22, P445, DOI 10.1007/BF02537277; BACCHETTI S, 1977, P NATL ACAD SCI USA, V74, P1590, DOI 10.1073/pnas.74.4.1590; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; CORREA P, 1981, CANCER RES, V41, P3685; FIELD CJ, 1984, NUTR RES, V4, P743, DOI 10.1016/S0271-5317(84)80050-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREEMAN AE, 1970, J NATL CANCER I, V44, P65; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; HSIAO WLW, 1987, MOL CELL BIOL, V7, P3380, DOI 10.1128/MCB.7.10.3380; HSIAO WLW, 1984, SCIENCE, V226, P552, DOI 10.1126/science.6436974; HSIAO WLW, 1986, MOL CELL BIOL, V6, P1087; Kalamegham R, 1984, Nutr Cancer, V6, P22, DOI 10.1080/01635588509513803; LEVINE L, 1981, ADV CANCER RES, V35, P49, DOI 10.1016/S0065-230X(08)60908-2; LOPES CA, 1989, IN PRESS MOL CARCINO; MATSUI MS, 1987, CANCER RES, V47, P2385; MCGEE R, 1981, BIOCHIM BIOPHYS ACTA, V663, P314, DOI 10.1016/0005-2760(81)90217-4; MERRILL AH, 1989, NUTR REV, V47, P161; MORRISON WR, 1964, J LIPID RES, V5, P600; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; REDDY BS, 1981, CANCER RES, V41, P3700; TSAI MH, 1989, SCIENCE, V243, P522, DOI 10.1126/science.2536192; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; WEINSTEIN IB, 1978, CARCINOGENESIS, V2, P313; WELSCH CW, 1983, J NATL CANCER I, V70, P215; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WYNDER EL, 1979, CANCER, V43, P1955, DOI 10.1002/1097-0142(197905)43:5+<1955::AID-CNCR2820430702>3.0.CO;2-K	30	16	16	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					417	421						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2107493				2022-12-28	WOS:A1990CW41500021
J	MATSUI, M; TOKUHARA, M; KONUMA, Y; NOMURA, N; ISHIZAKI, R				MATSUI, M; TOKUHARA, M; KONUMA, Y; NOMURA, N; ISHIZAKI, R			ISOLATION OF HUMAN FOS-RELATED GENES AND THEIR EXPRESSION DURING MONOCYTE-MACROPHAGE DIFFERENTIATION	ONCOGENE			English	Article											MATSUI, M (corresponding author), NIPPON VET & ZOOTECH COLL, MOLEC ONCOL LAB, 1-10-19 UENOSAKURAGI, TAITO KU, TOKYO 110, JAPAN.		Matsui, Minami/A-5235-2016	Matsui, Minami/0000-0001-5162-2668				ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COLLART MA, 1989, ONCOGENE, V4, P237; CURRAN T, 1984, VIROLOGY, V135, P218, DOI 10.1016/0042-6822(84)90132-6; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1982, J VIROL, V42, P114, DOI 10.1128/JVI.42.1.114-122.1982; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWET JR, 1984, DNA-J MOLEC CELL BIO, V3, P437, DOI 10.1089/dna.1.1984.3.437; DIALYNAS DP, 1986, P NATL ACAD SCI USA, V83, P2619, DOI 10.1073/pnas.83.8.2619; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GOLD DP, 1986, NATURE, V321, P431, DOI 10.1038/321431a0; GRASSO RJ, 1969, NATURE, V224, P882, DOI 10.1038/224882a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRENTZ R, 1989, SCIENCE, V243, P1695; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOGNESS RW, 1974, J VIROL, V14, P8; JENUWEIN T, 1987, CELL, V48, P647, DOI 10.1016/0092-8674(87)90243-1; KANEHISA M, 1984, NUCLEIC ACIDS RES, V12, P203, DOI 10.1093/nar/12.1Part1.203; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; Maniatis T., 1982, MOL CLONING LAB MANU, P191; MILLAN JL, 1987, P NATL ACAD SCI USA, V84, P5311, DOI 10.1073/pnas.84.15.5311; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; Nilsson K, 1981, Haematol Blood Transfus, V26, P215; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RAUSCHER FJ, 1989, GENE DEV, V2, P1689; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; SALSER W, 1970, J MOL BIOL, V49, P271, DOI 10.1016/0022-2836(70)90246-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARIBAN E, 1988, MOL CELL BIOL, V8, P340, DOI 10.1128/MCB.8.1.340; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	52	193	197	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	1990	5	3					249	255						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2107490				2022-12-28	WOS:A1990CW41500001
J	STEELE, RE; DENG, JC; GHOSN, CR; FERO, JB				STEELE, RE; DENG, JC; GHOSN, CR; FERO, JB			STRUCTURE AND EXPRESSION OF FYN GENES IN XENOPUS-LAEVIS	ONCOGENE			English	Article									UNIV CALIF IRVINE,CTR DEV BIOL,IRVINE,CA 92717	University of California System; University of California Irvine	STEELE, RE (corresponding author), UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717, USA.							AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BOSCH TCG, 1989, MOL CELL BIOL, V9, P4141, DOI 10.1128/MCB.9.10.4141; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; CHIEN YH, 1984, MOL CELL BIOL, V4, P507, DOI 10.1128/MCB.4.3.507; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLETT MS, 1980, NATURE, V285, P167, DOI 10.1038/285167a0; COOPER JA, 1989, MOL CELL BIOL, V9, P3143, DOI 10.1128/MCB.9.7.3143; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1989, IN PRESS PEPTIDES PR; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUNPHY WG, 1989, CELL, V58, P181, DOI 10.1016/0092-8674(89)90414-5; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GREGORY RJ, 1987, MOL CELL BIOL, V7, P2119, DOI 10.1128/MCB.7.6.2119; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOFFMANN FM, 1983, CELL, V35, P393, DOI 10.1016/0092-8674(83)90172-1; HOSBACH HA, 1983, CELL, V32, P45, DOI 10.1016/0092-8674(83)90495-6; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINSON AD, 1980, J BIOL CHEM, V255, P1973; LOHKA MJ, 1987, MOL CELL BIOL, V7, P760, DOI 10.1128/MCB.7.2.760; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MARCHILDON GA, 1984, P NATL ACAD SCI-BIOL, V81, P7679, DOI 10.1073/pnas.81.24.7679; MARTENS GJM, 1984, NATURE, V310, P251, DOI 10.1038/310251a0; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MAY FEB, 1983, J MOL BIOL, V168, P229, DOI 10.1016/S0022-2836(83)80016-3; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; POLISKY B, 1975, P NATL ACAD SCI USA, V72, P3310, DOI 10.1073/pnas.72.9.3310; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; REINSCHMIDT DC, 1979, J EXP ZOOL, V210, P137, DOI 10.1002/jez.1402100115; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; SALIM M, 1981, NATURE, V291, P205, DOI 10.1038/291205a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; STEELE RE, 1989, J BIOL CHEM, V264, P10649; STEELE RE, 1989, ONCOGENE RES, V4, P223; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WAHLI W, 1982, P NATL ACAD SCI-BIOL, V79, P6832, DOI 10.1073/pnas.79.22.6832; WARE VC, 1983, NUCLEIC ACIDS RES, V11, P7795, DOI 10.1093/nar/11.22.7795; ZIEGLER SF, 1989, MOL CELL BIOL, V9, P2724, DOI 10.1128/MCB.9.6.2724	62	34	37	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					369	376						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179818				2022-12-28	WOS:A1990CW41500015
J	CACERES, J; GLIKIN, G; BRAVO, R; WEINMANN, R				CACERES, J; GLIKIN, G; BRAVO, R; WEINMANN, R			C-FOS MEDIATED STIMULATION OF AN AP-1 DNA-BINDING ACTIVITY IN UNDIFFERENTIATED TERATOCARCINOMA CELL-LINES	ONCOGENE			English	Article									WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104; SQUIBB INST MED RES,PRINCETON,NJ 08543; UNIV BUENOS AIRES,INST INVEST INGN GENET & BIOL MOLEC,RA-1428 BUENOS AIRES,ARGENTINA; UNIV BUENOS AIRES,FAC CIENCIAS EXACTAS & NAT,RA-1428 BUENOS AIRES,ARGENTINA	The Wistar Institute; University of Buenos Aires; University of Buenos Aires			Caceres, Javier F/D-5260-2013	Caceres, Javier F/0000-0001-8025-6169	NCI NIH HHS [CA-44466, CA-10815] Funding Source: Medline; NIAID NIH HHS [AI-13231] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA010815, R01CA044466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013231] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CARCAMO J, 1989, J BIOL CHEM, V264, P7704; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; JACOB F, 1977, P ROY SOC LOND B BIO, V201, P249; JAKOB H, 1973, ANN INST PASTEUR MIC, VB124, P269; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KELLY F, 1982, BIOCHIM BIOPHYS ACTA, V651, P105, DOI 10.1016/0304-419X(82)90009-9; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRYSZKE MH, 1987, NATURE, V328, P254, DOI 10.1038/328254a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEHMAN JM, 1974, J CELL PHYSIOL, V84, P13, DOI 10.1002/jcp.1040840103; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MUELLER CR, 1984, MOL CELL BIOL, V4, P2594, DOI 10.1128/MCB.4.12.2594; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NICOLAS JF, 1976, CANCER RES, V36, P4224; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SHONTHAL A, 1989, ONCOGENE, V4, P629; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5556; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; VELDMAN GM, 1985, MOL CELL BIOL, V5, P649, DOI 10.1128/MCB.5.4.649; WASYLYK B, 1988, P NATL ACAD SCI USA, V85, P7952, DOI 10.1073/pnas.85.21.7952; WIRAK DO, 1985, MOL CELL BIOL, V5, P2924, DOI 10.1128/MCB.5.11.2924; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	45	10	10	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					59	67						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157182				2022-12-28	WOS:A1990CM62000009
J	REIHSAUS, E; KOHLER, M; KRAISS, S; OREN, M; MONTENARH, M				REIHSAUS, E; KOHLER, M; KRAISS, S; OREN, M; MONTENARH, M			REGULATION OF THE LEVEL OF THE ONCOPROTEIN-P53 IN NON-TRANSFORMED AND TRANSFORMED-CELLS	ONCOGENE			English	Article									UNIV ULM, DEPT BIOCHEM, POB 4066, W-7900 ULM, GERMANY; UNIV ULM, DEPT BIOCHEM, W-7900 ULM, GERMANY	Ulm University; Ulm University			Montenarh, Mathias/AAB-6689-2020					ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHEN S, 1983, P NATL ACAD SCI-BIOL, V80, P5670, DOI 10.1073/pnas.80.18.5670; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DEPPERT W, 1986, MOL CELL BIOL, V6, P2233, DOI 10.1128/MCB.6.6.2233; DEPPERT W, 1987, MOL CELL BIOL, V7, P4453, DOI 10.1128/MCB.7.12.4453; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FISCHERFANTUZZI L, 1985, P NATL ACAD SCI USA, V82, P1891, DOI 10.1073/pnas.82.7.1891; GRONOSTAJSKI RM, 1984, MOL CELL BIOL, V4, P442, DOI 10.1128/MCB.4.3.442; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1988, ONCOGENE HDB, P403; KESSLER SW, 1975, J IMMUNOL, V115, P1617; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MICHALOVITZ D, 1986, MOL CELL BIOL, V6, P3531, DOI 10.1128/MCB.6.10.3531; MICHALOVITZ D, 1987, J VIROL, V61, P2648, DOI 10.1128/JVI.61.8.2648-2654.1987; MILNER J, 1989, ONCOGENE, V4, P665; MILNER J, 1986, VIROLOGY, V154, P21, DOI 10.1016/0042-6822(86)90426-5; MONTENARH M, 1987, J VIROL, V61, P940, DOI 10.1128/JVI.61.3.940-944.1987; MONTENARH M, 1983, J VIROL, V45, P531, DOI 10.1128/JVI.45.2.531-538.1983; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; OREN M, 1982, MOL CELL BIOL, V2, P443, DOI 10.1128/MCB.2.4.443; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; ROSENBERG BH, 1981, J VIROL METHODS, V3, P167, DOI 10.1016/0166-0934(81)90051-3; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SHEN DW, 1983, P NATL ACAD SCI-BIOL, V80, P5919, DOI 10.1073/pnas.80.19.5919; STURZBECHER HW, 1987, ONCOGENE, V1, P201; THOMAS R, 1983, VIROLOGY, V131, P502, DOI 10.1016/0042-6822(83)90516-0; WOLF D, 1984, MOL CELL BIOL, V4, P552, DOI 10.1128/MCB.4.3.552; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	45	136	138	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1990	5	1					137	145						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157179				2022-12-28	WOS:A1990CM62000019
J	MOREAUGACHELIN, F; RAY, D; MATTEI, MG; TAMBOURIN, P; TAVITIAN, A				MOREAUGACHELIN, F; RAY, D; MATTEI, MG; TAMBOURIN, P; TAVITIAN, A			THE PUTATIVE ONCOGENE SPI-1 - MURINE CHROMOSOMAL LOCALIZATION AND TRANSCRIPTIONAL ACTIVATION IN MURINE ACUTE ERYTHROLEUKEMIAS	ONCOGENE			English	Article									HOP ENFANTS LA TIMONE,INSERM,U242,F-13385 MARSEILLE,FRANCE; HOP COCHIN,INSERM,U152,F-75674 PARIS 14,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	MOREAUGACHELIN, F (corresponding author), FAC MED LARIBOISIERE,INSERM,U248,10 AVE VERDUN,F-75010 PARIS,FRANCE.		Ray-Gallet, Dominique/A-9224-2019					BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BENOIST C, 1980, NUCLEIC ACIDS RES, V8, P127, DOI 10.1093/nar/8.1.127; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BORDEREAUX D, 1987, J VIROL, V61, P4043, DOI 10.1128/JVI.61.12.4043-4045.1987; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5298; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; FUNG YKT, 1983, CELL, V33, P357, DOI 10.1016/0092-8674(83)90417-8; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LINEMEYER DL, 1982, J VIROL, V43, P223, DOI 10.1128/JVI.43.1.223-233.1982; MAGER DL, 1981, P NATL ACAD SCI-BIOL, V78, P1703, DOI 10.1073/pnas.78.3.1703; MATHIS DJ, 1981, NATURE, V290, P310, DOI 10.1038/290310a0; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MOREAUGACHELIN F, 1981, J NATL CANCER I, V66, P1121, DOI 10.1093/jnci/66.6.1121; MOREAUGACHELIN F, 1985, J VIROL, V53, P292, DOI 10.1128/JVI.53.1.292-295.1985; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; RAY D, 1987, MOL CELL BIOL, V7, P940, DOI 10.1128/MCB.7.2.940; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; ROBERTLEZENES J, 1984, LEUKEMIA RES, V8, P975, DOI 10.1016/0145-2126(84)90051-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; SPIRO C, 1988, J VIROL, V62, P4129, DOI 10.1128/JVI.62.11.4129-4135.1988; TAMBOURIN P, 1971, NATURE-NEW BIOL, V234, P230, DOI 10.1038/newbio234230a0; TAMBOURIN P, 1981, BLOOD CELLS, V7, P133; TROXLER DH, 1977, P NATL ACAD SCI USA, V74, P4671, DOI 10.1073/pnas.74.10.4671; WENDLING F, 1981, P NATL ACAD SCI-BIOL, V78, P3614, DOI 10.1073/pnas.78.6.3614; WOLFF L, 1986, VIROLOGY, V152, P272, DOI 10.1016/0042-6822(86)90393-4; YAMAMOTO Y, 1981, P NATL ACAD SCI-BIOL, V78, P6893, DOI 10.1073/pnas.78.11.6893	38	182	183	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1449	1456						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2594367				2022-12-28	WOS:A1989CB65900005
J	VANWARTHOOD, JE; LINDER, ME; BURR, JG				VANWARTHOOD, JE; LINDER, ME; BURR, JG			TPCK AND QUERCETIN ACT SYNERGISTICALLY WITH VANADATE TO INCREASE PROTEIN-TYROSINE PHOSPHORYLATION IN AVIAN CELLS	ONCOGENE			English	Note									UNIV TEXAS,PROGRAMS MOLEC & CELL BIOL,RICHARDSON,TX 75080	University of Texas System; University of Texas Dallas			Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712				AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Bonting SL, 1970, MEMBRANES ION TRANSP, V1, P257; BROWN DJ, 1984, J BIOL CHEM, V259, P9580; COLLETT MS, 1987, J VIROL, V61, P1593, DOI 10.1128/JVI.61.5.1593-1601.1987; COLLETT MS, 1984, MOL CELL BIOL, V4, P1213, DOI 10.1128/MCB.4.7.1213; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; FAHRNEY DE, 1963, J AM CHEM SOC, V85, P997, DOI 10.1021/ja00890a037; GRAZIANI Y, 1983, EUR J BIOCHEM, V135, P583, DOI 10.1111/j.1432-1033.1983.tb07692.x; GSCHWENDT M, 1984, BIOCHEM BIOPH RES CO, V124, P63, DOI 10.1016/0006-291X(84)90916-1; HORN F, 1985, EUR J BIOCHEM, V148, P533, DOI 10.1111/j.1432-1033.1985.tb08872.x; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; LANG DR, 1974, BIOCHIM BIOPHYS ACTA, V333, P180, DOI 10.1016/0005-2728(74)90002-4; LEIS JF, 1982, P NATL ACAD SCI-BIOL, V79, P6507, DOI 10.1073/pnas.79.21.6507; LEVIN RM, 1976, MOL PHARMACOL, V12, P581; LINDER ME, 1988, J VIROL, V62, P2665, DOI 10.1128/JVI.62.8.2665-2673.1988; LINDER ME, 1988, P NATL ACAD SCI USA, V85, P2608, DOI 10.1073/pnas.85.8.2608; MOSS DE, 1978, BIOCHEM PHARMACOL, V27, P2693, DOI 10.1016/0006-2952(78)90044-8; NELSON RL, 1984, MOL CELL BIOL, V4, P1003, DOI 10.1128/MCB.4.6.1003; PONG SS, 1975, J BIOL CHEM, V250, P240; RICHERT N, 1979, CELL, V18, P369, DOI 10.1016/0092-8674(79)90056-4; ROSS AH, 1985, J CELL PHYSIOL, V124, P499, DOI 10.1002/jcp.1041240321; RYDER JW, 1987, MOL CELL BIOL, V7, P1139, DOI 10.1128/MCB.7.3.1139; SHAW E, 1970, PHYSIOL REV, V50, P244, DOI 10.1152/physrev.1970.50.2.244; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; SWARUP G, 1982, J BIOL CHEM, V257, P7298; TONOKURA M, 1986, J BIOL CHEM, V261, P10749; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YONEMOTO W, 1987, MOL CELL BIOL, V7, P905, DOI 10.1128/MCB.7.2.905	34	8	8	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1267	1271						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2552375				2022-12-28	WOS:A1989AU50800016
J	BONNIEU, A; RECH, J; JEANTEUR, P; FORT, P				BONNIEU, A; RECH, J; JEANTEUR, P; FORT, P			REQUIREMENTS FOR C-FOS MESSENGER-RNA DOWN REGULATION IN GROWTH STIMULATED MURINE CELLS	ONCOGENE			English	Article									UNIV MONTPELLIER 2, BIOL MOLEC LAB, CNRS, UA 1191, F-34060 MONTPELLIER, FRANCE; CTR PAUL LAMARQUE, BIOCHIM LAB, F-34094 MONTPELLIER, FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier			Bonnieu, Anne/ABA-7182-2020; Fort, Philippe/M-9498-2015	Fort, Philippe/0000-0001-5997-8722				ADAMSON ED, 1985, EMBO J, V4, P941, DOI 10.1002/j.1460-2075.1985.tb03722.x; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BONNIEU A, 1988, ONCOGENE RES, V3, P155; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; BRAVO R, 1985, EMBO J, V4, P1193, DOI 10.1002/j.1460-2075.1985.tb03759.x; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1984, CELL, V36, P259; DEVILLIERS J, 1981, NUCLEIC ACIDS RES, V9, P6251, DOI 10.1093/nar/9.23.6251; deVilliers J., 1983, TECHNIQUES LIFE SCI, P1; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FINKEL MP, 1966, SCIENCE, V151, P698, DOI 10.1126/science.151.3711.698; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GREEENBERG ME, 1985, J BIOL CHEM, V206, P14101; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; MARX JL, 1987, SCIENCE, V237, P854, DOI 10.1126/science.3039659; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MILLER AD, 1984, CELL, V36, P51; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MOHUN T, 1987, EMBO J, V6, P667, DOI 10.1002/j.1460-2075.1987.tb04806.x; MOLDERS H, 1987, ONCOGENE, V82, P4987; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; MULLER R, 1984, EMBO J, V3, P1887, DOI 10.1002/j.1460-2075.1984.tb02063.x; MULLER R, 1983, EMBO J, V2, P679, DOI 10.1002/j.1460-2075.1983.tb01484.x; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RECH J, 1989, IN PRESS NUCLEIC ACI; RENZ M, 1985, EMBO J, V4, P3711, DOI 10.1002/j.1460-2075.1985.tb04139.x; ROSS J, 1986, J MOL BIOL, V188, P579, DOI 10.1016/S0022-2836(86)80008-0; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VANOOYEN A, 1979, SCIENCE, V206, P337, DOI 10.1126/science.482942; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WATSON RJ, 1988, ONCOGENE, V2, P267; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	62	27	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1989	4	7					881	888						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE584	2502753				2022-12-28	WOS:A1989AE58400010
J	SCHONTHAL, A; BUSCHER, M; ANGEL, P; RAHMSDORF, HJ; PONTA, H; HATTORI, K; CHIU, R; KARIN, M; HERRLICH, P				SCHONTHAL, A; BUSCHER, M; ANGEL, P; RAHMSDORF, HJ; PONTA, H; HATTORI, K; CHIU, R; KARIN, M; HERRLICH, P			THE FOS AND JUN/AP-1 PROTEINS ARE INVOLVED IN THE DOWN-REGULATION OF FOS TRANSCRIPTION	ONCOGENE			English	Article									UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093	University of California System; University of California San Diego	SCHONTHAL, A (corresponding author), KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH,INST GENET & TOXIKOL,POSTFACH 3640,D-7500 KARLSRUHE 1,FED REP GER.		Piris, Miguel A/AAP-1445-2020	Piris, Miguel A/0000-0001-5839-3634; Schonthal, Axel/0000-0003-0662-5653				ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ANGEL P, 1985, CANCER CELL, V3, P315; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; BUSCHER M, 1988, ONCOGENE, V3, P301; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; CURRAN T, 1984, CELL, V36, P259; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; JENUWEIN T, 1987, CELL, V48, P647, DOI 10.1016/0092-8674(87)90243-1; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NISHIKURA M, 1986, MOL CELL BIOL, V7, P639; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P10; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHONTHAL A, 1988, IN PRESS COLD SPRING, V53; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VERMA IM, 1986, TRENDS GENET, V2, P93, DOI 10.1016/0168-9525(86)90191-5; WILLIAMS JG, 1985, NUCLEIC ACID HYBRIDI	43	154	155	1	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					629	636						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2498806				2022-12-28	WOS:A1989U768800014
J	RO, J; BRESSER, J; RO, JY; BRASFIELD, F; HORTOBAGYI, G; BLICK, M				RO, J; BRESSER, J; RO, JY; BRASFIELD, F; HORTOBAGYI, G; BLICK, M			SIS PDGF-B EXPRESSION IN BENIGN AND MALIGNANT HUMAN-BREAST LESIONS	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL BIOL THERAPY,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT ANAT PATHOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	RO, J (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED ONCOL,1515 HOLCOMBE,BOX 78,HOUSTON,TX 77030, USA.				NCRR NIH HHS [RR5511-25] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARSKY SH, 1982, AM J PATHOL, V108, P276; BOWENPOPE DF, 1983, J CELL BIOL, V96, P679, DOI 10.1083/jcb.96.3.679; BOWENPOPE DF, 1984, P NATL ACAD SCI-BIOL, V81, P2396, DOI 10.1073/pnas.81.8.2396; BRESSER J, 1987, GENE ANAL TECH, V4, P89, DOI 10.1016/0735-0651(87)90002-1; CANALIS E, 1981, METABOLISM, V30, P970, DOI 10.1016/0026-0495(81)90094-9; CHIU IM, 1984, CELL, V37, P123; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; KAO RT, 1984, AM J PATHOL, V115, P109; LIOTTA LA, 1983, LAB INVEST, V49, P636; OWEN AJ, 1982, P NATL ACAD SCI-BIOL, V79, P3203, DOI 10.1073/pnas.79.10.3203; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; ROZENGURT E, 1985, INT J CANCER, V36, P247, DOI 10.1002/ijc.2910360218; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SEEMAYER TA, 1979, AM J SURG PATHOL, V3, P525, DOI 10.1097/00000478-197912000-00005; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; VANZOELEN EJJ, 1985, MOL CELL BIOL, V5, P2289, DOI 10.1128/MCB.5.9.2289; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490	26	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					351	354						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2649848				2022-12-28	WOS:A1989U567600011
J	COLLART, MA; BELIN, D; BRIOTTET, C; THORENS, B; VASSALLI, JD; VASSALLI, P				COLLART, MA; BELIN, D; BRIOTTET, C; THORENS, B; VASSALLI, JD; VASSALLI, P			RECEPTOR-MEDIATED PHAGOCYTOSIS BY MACROPHAGES INDUCES A CALCIUM-DEPENDENT TRANSIENT INCREASE IN C-FOS TRANSCRIPTION	ONCOGENE			English	Article									UNIV GENEVA, SCH MED, DEPT PATHOL, 1 RUE MICHEL SERVET, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, SCH MED, INST HISTOL & EMBRYOL, CH-1211 GENEVA 4, SWITZERLAND	University of Geneva; University of Geneva								BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; COLLART MA, 1987, J IMMUNOL, V139, P949; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DONNER L, 1982, J VIROL, V41, P489, DOI 10.1128/JVI.41.2.489-500.1982; DOTTO GP, 1986, EMBO J, V5, P2853, DOI 10.1002/j.1460-2075.1986.tb04579.x; GALLIN EK, 1986, J LEUKOCYTE BIOL, V39, P241, DOI 10.1002/jlb.39.3.241; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GORDON S, 1974, J EXP MED, V140, P995, DOI 10.1084/jem.140.4.995; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAMILTON TA, 1987, IMMUNOL TODAY, V8, P151, DOI 10.1016/0167-5699(87)90145-9; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; HORWITZ SB, 1981, J CELL BIOL, V91, P798, DOI 10.1083/jcb.91.3.798; KASSIS S, 1982, J BIOL CHEM, V257, P2148; KAWAHARA Y, 1988, BIOCHEM BIOPH RES CO, V150, P52, DOI 10.1016/0006-291X(88)90485-8; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; MCNEIL PL, 1986, J CELL BIOL, V102, P1586, DOI 10.1083/jcb.102.5.1586; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MONTESANO R, 1983, J CELL BIOL, V96, P1227, DOI 10.1083/jcb.96.5.1227; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MULLER R, 1986, TRENDS BIOCHEM SCI, V11, P129, DOI 10.1016/0968-0004(86)90066-6; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; PRENTKI M, 1983, J BIOL CHEM, V258, P7597; RADZIOCH D, 1987, MOL CELL BIOL, V7, P595, DOI 10.1128/MCB.7.2.595; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; RESINK TJ, 1986, EUR J BIOCHEM, V154, P451, DOI 10.1111/j.1432-1033.1986.tb09418.x; ROUSSEAU GG, 1984, BIOCHEM J, V224, P1; ROUXLOMBARD P, 1986, CELL IMMUNOL, V97, P286, DOI 10.1016/0008-8749(86)90399-0; SANO U, 1982, J BIOL CHEM, V257, P7847; SCHATZMAN RC, 1983, BIOCHIM BIOPHYS ACTA, V755, P144, DOI 10.1016/0304-4165(83)90284-2; SCHNYDER J, 1978, J EXP MED, V148, P1449, DOI 10.1084/jem.148.6.1449; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; THORENS B, 1987, CELL, V48, P671, DOI 10.1016/0092-8674(87)90245-5; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WRIGHT SD, 1983, J EXP MED, V158, P2016, DOI 10.1084/jem.158.6.2016; YAMAMOTO K, 1984, J EXP MED, V159, P405, DOI 10.1084/jem.159.2.405; YOUNG JDE, 1984, P NATL ACAD SCI-BIOL, V81, P5430, DOI 10.1073/pnas.81.17.5430	43	19	19	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1989	4	2					237	241						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2538793				2022-12-28	WOS:A1989U567500016
J	LACAL, PM; PENNINGTON, CY; LACAL, JC				LACAL, PM; PENNINGTON, CY; LACAL, JC			TRANSFORMING ACTIVITY OF RAS-PROTEINS TRANSLOCATED TO THE PLASMA-MEMBRANE BY A MYRISTOYLATION SEQUENCE FROM THE SRC-GENE PRODUCT	ONCOGENE			English	Article									NCI,CELLULAR & MOLEC BIOL LAB,BLDG 37,ROOM 1E24,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Lacal, Pedro M/A-1481-2013; Lacal, Juan Carlos/AAL-2235-2020; Lacal, Juan Carlos/N-9064-2015	Lacal, Pedro M/0000-0003-1166-4593; Lacal, Juan Carlos/0000-0002-1908-2777				BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BUSS JE, 1986, MOL CELL BIOL, V6, P116, DOI 10.1128/MCB.6.1.116; BUSS JE, 1984, J VIROL, V53, P7; CHEN ZQ, 1985, J VIROL, V56, P607, DOI 10.1128/JVI.56.2.607-612.1985; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; FUJIYAMA A, 1986, P NATL ACAD SCI USA, V83, P1266, DOI 10.1073/pnas.83.5.1266; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GARBER EA, 1983, NATURE, V302, P161, DOI 10.1038/302161a0; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSS M, 1985, MOL CELL BIOL, V5, P1015, DOI 10.1128/MCB.5.5.1015; KRUEGER JG, 1983, CURR TOP MICROBIOL, V107, P51; LACAL JC, 1984, P NATL ACAD SCI-BIOL, V81, P5305, DOI 10.1073/pnas.81.17.5305; LACAL JC, 1986, EMBO J, V5, P679, DOI 10.1002/j.1460-2075.1986.tb04267.x; LACAL JC, 1986, MOL CELL BIOL, V6, P4214, DOI 10.1128/MCB.6.12.4214; LACAL JC, 1988, IN PRESS ONCOGENE HD; LAUTENBERGER JA, 1983, SCIENCE, V221, P858, DOI 10.1126/science.6308763; MANNE V, 1985, P NATL ACAD SCI USA, V82, P376, DOI 10.1073/pnas.82.2.376; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; PELLMAN D, 1985, P NATL ACAD SCI USA, V82, P1623, DOI 10.1073/pnas.82.6.1623; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P3623, DOI 10.1073/pnas.80.12.3623; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; SCHULTZ AM, 1985, SCIENCE, V227, P427, DOI 10.1126/science.3917576; SCOLNICK EM, 1979, P NATL ACAD SCI USA, V76, P5355, DOI 10.1073/pnas.76.10.5355; SEFTON BM, 1982, CELL, V31, P465, DOI 10.1016/0092-8674(82)90139-8; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SHIH TY, 1982, J VIROL, V42, P253, DOI 10.1128/JVI.42.1.253-261.1982; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; WEEKS MO, 1985, J VIROL, V54, P586, DOI 10.1128/JVI.54.2.586-597.1985; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WILLINGHAM MC, 1979, CELL, V18, P125, DOI 10.1016/0092-8674(79)90361-1; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0	34	39	40	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1988	2	6					533	537						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	N8415	2455265				2022-12-28	WOS:A1988N841500001
J	REY, I; SCHWEIGHOFFER, F; BARLAT, I; CAMONIS, J; BOYMARCOTTE, E; GUILBAUD, R; JACQUET, M; TOCQUE, B				REY, I; SCHWEIGHOFFER, F; BARLAT, I; CAMONIS, J; BOYMARCOTTE, E; GUILBAUD, R; JACQUET, M; TOCQUE, B			THE COOH-DOMAIN OF THE PRODUCT OF THE SACCHAROMYCES-CEREVISIAE SCD25 GENE ELICITS ACTIVATION OF P21-RAS PROTEINS IN MAMMALIAN-CELLS	ONCOGENE			English	Note							CDC25 GENE; CYCLASE PATHWAY; TUMOR-PROMOTER; RAS; GAP; SUPPRESSES; MUTATION; CLONING; MUTANTS; GTPASE	The evidence presented here indicates that the domain containing the COOH-terminal part of the Saccharomyces cerevisiae SCD25 gene product (C-domain), which is homologous to the COOH-terminal part of CDC25 protein, can elicit activation of mammalian ras proteins in CHO cells. Transfection of expression vectors carrying the C-domain of SCD25, but not of CDC25, promotes the GTP-bound form of ras proteins as determined by analysis of the guanine nucleotides bound to ras proteins immunoprecipitated by Y13-259 mAb, and enhances transcription of a HIV-LTR-CAT construct. This is the first demonstration of the activation of ras proteins by transfection of a single heterologous gene.	RHONE POULENC SANTE,CRV AIBV,F-94403 VITRY,FRANCE; UNIV PARIS 11,CNRS,URA 1354,INFORMAT GENET & DEV GRP,F-91405 ORSAY,FRANCE	Sanofi-Aventis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ARANZANASEISDED.F, 1989, ONCOGENE, V4, P1359; BOYMARCOTTE E, 1989, GENE, V77, P21, DOI 10.1016/0378-1119(89)90355-7; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CAMONIS JH, 1988, MOL CELL BIOL, V8, P2980, DOI 10.1128/MCB.8.7.2980; CAMONIS JH, 1986, EMBO J, V5, P375, DOI 10.1002/j.1460-2075.1986.tb04222.x; CAMONIS JH, 1990, IN PRESS GENE; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GIBBS JB, 1987, J BIOL CHEM, V262, P10426; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; JACQUET M, 1989, GUANINE NUCLEOTIDE B, V165, P241; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; POWERS S, 1989, MOL CELL BIOL, V9, P390, DOI 10.1128/MCB.9.2.390; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHWEIGHOFFER F, 1989, ADV 2ND MESSENGER PH, V53, P329; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WASYLYK C, 1987, CELL, V48, P525, DOI 10.1016/0092-8674(87)90203-0	23	18	19	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					347	349						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000228				2022-12-28	WOS:A1991FZ13400024
J	BANKS, L; EDMONDS, C; VOUSDEN, KH				BANKS, L; EDMONDS, C; VOUSDEN, KH			ABILITY OF THE HPV16 E7 PROTEIN TO BIND RB AND INDUCE DNA-SYNTHESIS IS NOT SUFFICIENT FOR EFFICIENT TRANSFORMING ACTIVITY IN NIH3T3 CELLS	ONCOGENE			English	Article									ST MARYS HOSP,SCH MED,LUDWIG INST CANC RES,NORFOLK PL,LONDON W2 1PG,ENGLAND; INT CTR GENET ENGN & BIOTECHNOL,I-34012 TRIESTE,ITALY	Imperial College London; Ludwig Institute for Cancer Research; International Center for Genetic Engineering & Biotechnology (ICGEB)								ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BANKS L, 1990, ONCOGENE, V5, P833; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; CROOK T, 1989, EMBO J, V8, P513, DOI 10.1002/j.1460-2075.1989.tb03405.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EDMONDS C, 1989, J VIROL, V63, P2640; GISSMANN L, 1983, P NATL ACAD SCI-BIOL, V80, P560, DOI 10.1073/pnas.80.2.560; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; MATLASHEWSKI G, 1987, CANCER CELL, V5, P195; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; MUNGER K, 1989, J VIROL, V63, P4417; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; SATO H, 1989, VIROLOGY, V170, P311, DOI 10.1016/0042-6822(89)90386-3; SATO H, 1989, VIROLOGY, V168, P195, DOI 10.1016/0042-6822(89)90423-6; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SMITH DH, 1988, MOL CELL BIOL, V8, P3882, DOI 10.1128/MCB.8.9.3882; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SOPRANO KJ, 1983, MOL CELL BIOL, V3, P214, DOI 10.1128/MCB.3.2.214; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; SUBRAMANIAN T, 1988, ONCOGENE, V2, P105; TSUNOKAWA Y, 1986, P NATL ACAD SCI USA, V83, P2200, DOI 10.1073/pnas.83.7.2200; VOUSDEN KH, 1989, ONCOGENE, V4, P153; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WATANABE S, 1990, J VIROL, V64, P207, DOI 10.1128/JVI.64.1.207-214.1990; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YASUMOTO S, 1986, J VIROL, V57, P572, DOI 10.1128/JVI.57.2.572-577.1986; [No title captured]	37	148	154	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1383	1389						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216461				2022-12-28	WOS:A1990EC24100016
J	IWAHANA, H; ORITA, M; KANAZAWA, H; HAYASHI, K; SEKIYA, T				IWAHANA, H; ORITA, M; KANAZAWA, H; HAYASHI, K; SEKIYA, T			A NEW RFLP IN INTRON-1 OF THE HUMAN C-HA-RAS1 GENE AND ITS CLOSE RELATIONSHIP WITH THE VARIABLE TANDEM REPEATS IN THE REGION 3' TO THE GENE	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV ONCOGENE,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN	National Cancer Center - Japan								ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CECCHERININELLI L, 1987, BRIT J CANCER, V56, P1, DOI 10.1038/bjc.1987.143; COHEN JB, 1987, J CELL PHYSL S, V5, P75; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; GERHARD DS, 1987, NATURE, V325, P73, DOI 10.1038/325073a0; HAYWARD NK, 1988, HUM GENET, V78, P115, DOI 10.1007/BF00278178; HEIGHWAY J, 1986, BRIT J CANCER, V53, P453, DOI 10.1038/bjc.1986.72; KASPERCZYK A, 1989, AM J HUM GENET, V45, P689; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEE JH, 1989, CANCER RES, V49, P1220; LIDEREAU R, 1986, JNCI-J NATL CANCER I, V77, P697, DOI 10.1093/jnci/77.3.697; MACKAY J, 1988, LANCET, V2, P1384; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SANGER F, 1981, SCIENCE, V214, P1305; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SHIRAISHI M, 1987, JPN J CANCER RES, V78, P1302; SPANDIDOS DA, 1987, FEBS LETT, V218, P41, DOI 10.1016/0014-5793(87)81014-1; SUTHERLAND C, 1986, BRIT J CANCER, V54, P787, DOI 10.1038/bjc.1986.241; THEILLET C, 1986, CANCER RES, V46, P4776; THEIN SL, 1986, NATURE, V321, P84, DOI 10.1038/321084a0; WANG HP, 1988, CYTOGENET CELL GENET, V48, P72, DOI 10.1159/000132593; WYLLIE FS, 1988, BRIT J CANCER, V57, P135, DOI 10.1038/bjc.1988.28; YOSHIMOTO K, 1989, CANCER RES, V49, P2716	28	13	13	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1049	1053						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973828				2022-12-28	WOS:A1990DP41500014
J	ADDISON, C; JENKINS, JR; STURZBECHER, HW				ADDISON, C; JENKINS, JR; STURZBECHER, HW			THE P53 NUCLEAR-LOCALIZATION SIGNAL IS STRUCTURALLY LINKED TO A P34CDC2 KINASE MOTIF	ONCOGENE			English	Note									MARIE CURIE CANC RES INST,CELL PROLIFERAT LAB,THE CHART,OXTED RH8 0TL,SURREY,ENGLAND									BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; JENKINS JR, 1989, CANCER CELLS MOL DIA, P127; JENKINS JR, 1988, ONCOGENE HDB, P403; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; MCVEY D, 1989, NATURE, V341, P503, DOI 10.1038/341503a0; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NELSON M, 1989, MOL CELL BIOL, V9, P384, DOI 10.1128/MCB.9.2.384; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; RIGAUDY P, 1989, NUCLEIC ACIDS RES, V17, P8375, DOI 10.1093/nar/17.20.8375; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; ROVINSKI B, 1988, ONCOGENE, V2, P445; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; STURZBECHER HW, 1988, ONCOGENE, V3, P405; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6	30	166	167	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					423	426						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156209				2022-12-28	WOS:A1990CW41500022
J	ANDERSON, SM; CARROLL, PM; LEE, FD				ANDERSON, SM; CARROLL, PM; LEE, FD			ABROGATION OF IL-3 DEPENDENT GROWTH REQUIRES A FUNCTIONAL V-SRC GENE-PRODUCT - EVIDENCE FOR AN AUTOCRINE GROWTH-CYCLE	ONCOGENE			English	Article									SUNY STONY BROOK,PROGRAM CELLULAR & DEV BIOL,STONY BROOK,NY 11794; DNAX RES INST MOLEC & CELLULAR BIOL INC,PALO ALTO,CA 94304	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	ANDERSON, SM (corresponding author), SUNY STONY BROOK,DEPT PATHOL,BHS-9,ROOM 153,STONY BROOK,NY 11794, USA.				NCI NIH HHS [CA45241] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045241, R29CA045241] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADKINS B, 1984, CELL, V39, P439, DOI 10.1016/0092-8674(84)90451-3; ANDERSON SM, 1987, VIROLOGY, V160, P263, DOI 10.1016/0042-6822(87)90070-5; ANDERSON SM, 1985, MOL CELL BIOL, V5, P3369, DOI 10.1128/MCB.5.12.3369; ANDERSON SM, 1983, J VIROL, V46, P594, DOI 10.1128/JVI.46.2.594-605.1983; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BOETTIGER D, 1984, CELL, V36, P763, DOI 10.1016/0092-8674(84)90356-8; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; CHATTOPADHYAY SK, 1981, VIROLOGY, V113, P465, DOI 10.1016/0042-6822(81)90175-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU CP, 1988, P NATL ACAD SCI USA, V85, P7099, DOI 10.1073/pnas.85.19.7099; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; FARRAR JJ, 1980, J IMMUNOL, V125, P2555; GREENBERGER JS, 1984, METHODS HEMATOLOGY, V11, P203; KINASHI T, 1986, NATURE, V324, P70, DOI 10.1038/324070a0; KIPREOS ET, 1988, ONCOGENE RES, V2, P277; LEE F, 1986, P NATL ACAD SCI USA, V83, P2061, DOI 10.1073/pnas.83.7.2061; LEUTZ A, 1989, EMBO J, V8, P175, DOI 10.1002/j.1460-2075.1989.tb03362.x; LI CL, 1985, NATURE, V316, P633, DOI 10.1038/316633a0; MATHEYPREVOT B, 1986, MOL CELL BIOL, V6, P4133, DOI 10.1128/MCB.6.11.4133; MATSUDA H, 1988, P NATL ACAD SCI USA, V85, P6508, DOI 10.1073/pnas.85.17.6508; MCCUBREY J, 1989, ONCOGENE RES, V4, P97; METCALF D, 1987, EMBO J, V6, P3703, DOI 10.1002/j.1460-2075.1987.tb02704.x; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; METCALF D, 1985, BLOOD, V65, P357; MIYATAKE S, 1985, EMBO J, V4, P2561, DOI 10.1002/j.1460-2075.1985.tb03971.x; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; OHARA J, 1985, NATURE, V315, P333, DOI 10.1038/315333a0; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; OLIFF A, 1985, P NATL ACAD SCI USA, V82, P3306, DOI 10.1073/pnas.82.10.3306; OVERELL RW, 1987, MOL CELL BIOL, V7, P3394, DOI 10.1128/MCB.7.10.3394; PALACIOS R, 1984, NATURE, V309, P126, DOI 10.1038/309126a0; PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0; PIERCE JH, 1984, P NATL ACAD SCI-BIOL, V81, P2374, DOI 10.1073/pnas.81.8.2374; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; RENNICK DM, 1985, J IMMUNOL, V134, P910; ROVERA G, 1987, ONCOGENE, V1, P29; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; TSUCHIYA M, 1986, P NATL ACAD SCI USA, V83, P7633, DOI 10.1073/pnas.83.20.7633; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; WATSON JD, 1987, J IMMUNOL, V139, P123; YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070; ZIPORI D, 1985, EXP HEMATOL, V13, P603	47	55	55	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					317	325						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2107491				2022-12-28	WOS:A1990CW41500009
J	CAPOBIANCO, AJ; SIMMONS, DL; GILMORE, TD				CAPOBIANCO, AJ; SIMMONS, DL; GILMORE, TD			CLONING AND EXPRESSION OF A CHICKEN C-REL CDNA - UNLIKE P59V-REL, P68C-REL IS A CYTOPLASMIC PROTEIN IN CHICKEN-EMBRYO FIBROBLASTS	ONCOGENE			English	Article									BOSTON UNIV,DEPT BIOL,2 CUMMINGTON ST,BOSTON,MA 02215; HARVARD UNIV,DEPT CELLULAR & DEV BIOL,CAMBRIDGE,MA 02138	Boston University; Harvard University				Capobianco, Anthony/0000-0002-3706-6797	NCI NIH HHS [CA42580, CA47763] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047763, R29CA047763, R35CA042580] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTH CF, 1988, J EXP MED, V167, P89, DOI 10.1084/jem.167.1.89; BRAVO R, 1988, COLD SPRING HARB SYM, V53, P901, DOI 10.1101/SQB.1988.053.01.103; BROWNELL E, 1987, MOL CELL BIOL, V7, P1304, DOI 10.1128/MCB.7.3.1304; BROWNELL E, 1989, ONCOGENE, V4, P935; CHEN HR, 1986, NUCLEIC ACIDS RES, V14, P3977, DOI 10.1093/nar/14.9.3977; CHEN ISY, 1983, J VIROL, V45, P104, DOI 10.1128/JVI.45.1.104-113.1983; DOUGHERTY JP, 1986, MOL CELL BIOL, V6, P4387, DOI 10.1128/MCB.6.12.4387; GARSON K, 1986, BIOCHEM BIOPH RES CO, V134, P716, DOI 10.1016/S0006-291X(86)80479-X; GELINAS C, 1988, ONCOGENE, V3, P349; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GILMORE TD, 1986, CELL, V44, P971; GRUMONT RJ, 1989, ONCOGENE RES, V4, P1; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HERZOG NK, 1986, J VIROL, V57, P371, DOI 10.1128/JVI.57.1.371-375.1986; HERZOG NK, 1986, P NATL ACAD SCI USA, V83, P812, DOI 10.1073/pnas.83.3.812; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MILLER CK, 1986, J VIROL, V58, P75, DOI 10.1128/JVI.58.1.75-80.1986; MOORE BE, 1988, VIROLOGY, V162, P377, DOI 10.1016/0042-6822(88)90478-3; MOORE BE, 1989, ONCOGENE, V4, P845; MORRISON LE, 1989, ONCOGENE, V4, P677; RICE NR, 1986, VIROLOGY, V149, P217, DOI 10.1016/0042-6822(86)90123-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SIMEK S, 1988, ONCOGENE RES, V2, P103; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; SIMEK SL, 1986, J VIROL, V59, P120, DOI 10.1128/JVI.59.1.120-126.1986; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STEWARD R, 1988, CELL, V55, P487, DOI 10.1016/0092-8674(88)90035-9; THIELEN GH, 1966, J NATL CANCER I, V37, P747; WATANABE S, 1983, MOL CELL BIOL, V3, P2241, DOI 10.1128/MCB.3.12.2241; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984	36	114	115	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					257	265						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179815				2022-12-28	WOS:A1990CW41500002
J	FORREST, D; MUNOZ, A; RAYNOSCHEK, C; VENNSTROM, B; BEUG, H				FORREST, D; MUNOZ, A; RAYNOSCHEK, C; VENNSTROM, B; BEUG, H			REQUIREMENT FOR THE C-TERMINAL DOMAIN OF THE V-ERBA ONCOGENE PROTEIN FOR BIOLOGICAL FUNCTION AND TRANSCRIPTIONAL REPRESSION	ONCOGENE			English	Article									KAROLINSKA INST,CTR MOLEC BIOL,DEPT MOLEC BIOL,S-10401 STOCKHOLM 60,SWEDEN; INST MOLEC PATHOL,A-1030 VIENNA,AUSTRIA; UNIV AUTONOMA MADRID,FAC MED,INST INVEST BIOMED,E-28029 MADRID,SPAIN	Karolinska Institutet; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Autonomous University of Madrid			Munoz, Alberto/O-6393-2014	Munoz, Alberto/0000-0003-3890-4251				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; BENTZEN D, 1987, MOL CELL BIOL, V7, P2416; BEUG H, 1986, J VIROL, V57, P1127, DOI 10.1128/JVI.57.3.1127-1138.1986; BEUG H, 1981, VIROLOGY, V111, P201, DOI 10.1016/0042-6822(81)90665-6; BEUG H, 1980, P NATL ACAD SCI-BIOL, V77, P6683, DOI 10.1073/pnas.77.11.6683; BEUG H, 1985, MODERN TRENDS HUMAN, V6, P290; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BOUCHER P, 1988, J VIROL, V62, P534, DOI 10.1128/JVI.62.2.534-544.1988; CHOI OR, 1986, MOL CELL BIOL, V6, P1751, DOI 10.1128/MCB.6.5.1751; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DEBUIRE B, 1984, SCIENCE, V224, P1456, DOI 10.1126/science.6328658; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; FREAKE HC, 1988, MOL ENDOCRINOL, V2, P986, DOI 10.1210/mend-2-10-986; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; HAYMAN MJ, 1983, CELL, V32, P579, DOI 10.1016/0092-8674(83)90477-4; HENTZEN D, 1987, MOL CELL BIOL, V7, P2416, DOI 10.1128/MCB.7.7.2416; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOROWITZ ZD, 1989, MOL ENDOCRINOL, V3, P148, DOI 10.1210/mend-3-1-148; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JANSSON M, 1987, ONCOGENE, V1, P167; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KAHN P, 1986, 12 S COMP RES LEUK R; KIM HRC, 1988, MOL CELL BIOL, V8, P4416, DOI 10.1128/MCB.8.10.4416; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LAVIN TN, 1988, J BIOL CHEM, V263, P9418; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P893, DOI 10.1210/mend-2-10-893; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; Oppenheimer J. H., 1983, MOL BASIS THYROID HO; ORO AE, 1988, CELL, V55, P1109, DOI 10.1016/0092-8674(88)90255-3; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; VENNSTROM B, 1980, J VIROL, V36, P575; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1	49	28	28	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					309	316						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	1969136				2022-12-28	WOS:A1990CW41500008
J	BARBOSA, MS; SCHLEGEL, R				BARBOSA, MS; SCHLEGEL, R			THE E6 AND E7 GENES OF HPV-18 ARE SUFFICIENT FOR INDUCING 2-STAGE INVITRO TRANSFORMATION OF HUMAN KERATINOCYTES	ONCOGENE			English	Note									NCI, TUMOR VIRUS BIOL, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	BARBOSA, MS (corresponding author), NCI, CELLULAR ONCOL LAB, BETHESDA, MD 20892 USA.				NCI NIH HHS [5T32CA09030] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009030] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BARBOSA MS, 1987, J VIROL, V61, P2938, DOI 10.1128/JVI.61.9.2938-2942.1987; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; BEDELL MA, 1987, J VIROL, V61, P3635, DOI 10.1128/JVI.61.11.3635-3640.1987; CROOK T, 1989, EMBO J, V8, P513, DOI 10.1002/j.1460-2075.1989.tb03405.x; DURST M, 1987, ONCOGENE, V1, P251; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; HAUSEN HZ, 1987, PAPOVAVIRIDAE, V2, P245; KANDA T, 1988, VIROLOGY, V165, P321, DOI 10.1016/0042-6822(88)90694-0; KAUR P, 1988, J VIROL, V62, P1917, DOI 10.1128/JVI.62.6.1917-1924.1988; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; LE JY, 1988, J VIROL, V62, P4420, DOI 10.1128/JVI.62.11.4420-4426.1988; PECORARO G, 1989, P NATL ACAD SCI USA, V86, P563, DOI 10.1073/pnas.86.2.563; PFISTER H, 1984, REV PHYSIOL BIOCH P, V99, P111, DOI 10.1007/BFb0027716; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PIRISI L, 1988, CARCINOGENESIS, V9, P1573, DOI 10.1093/carcin/9.9.1573; PIRISI L, 1987, J VIROL, V61, P1061, DOI 10.1128/JVI.61.4.1061-1066.1987; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; SCHLEGEL R, 1988, EMBO J, V7, P3181, DOI 10.1002/j.1460-2075.1988.tb03185.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; TANAKA A, 1989, J VIROL, V63, P1465, DOI 10.1128/JVI.63.3.1465-1469.1989; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WOODWORTH CD, 1989, J VIROL, V63, P159, DOI 10.1128/JVI.63.1.159-164.1989; YUTSUDO M, 1988, VIROLOGY, V166, P594, DOI 10.1016/0042-6822(88)90532-6	26	207	211	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1989	4	12					1529	1532						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2556677				2022-12-28	WOS:A1989CB65900018
J	TOURKINE, N; MECHTI, N; PIECHACZYK, M; JEANTEUR, P; BLANCHARD, JM				TOURKINE, N; MECHTI, N; PIECHACZYK, M; JEANTEUR, P; BLANCHARD, JM			INSITU AND INVITRO EVIDENCE FOR INTRAGENIC BINDING OF NUCLEAR FACTORS AT THE MURINE C-MYC LOCUS	ONCOGENE			English	Article									UNIV MONTPELLIER 2,CNRS,URA 1191,BIOL MOLEC LAB,F-34060 MONTPELLIER,FRANCE; UNIV MONTPELLIER 2,CNRS,URA 1191,BIOCHIM PROT LAB,F-34060 MONTPELLIER,FRANCE; CTR PAUL LAMARQUE,BIOCHIM LAB,F-34094 MONTPELLIER,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier			PIECHACZYK, Marc/E-7896-2013	PIECHACZYK, Marc/0000-0003-1367-2597				BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLANCHARD JM, 1988, BIOCHIMIE, V70, P877, DOI 10.1016/0300-9084(88)90228-3; BLANCHARD JM, 1988, LYMPHOCYTE ACTIVATIO, P339; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYSON PJ, 1985, EMBO J, V4, P2885, DOI 10.1002/j.1460-2075.1985.tb04018.x; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FAHRLANDER PD, 1985, EMBO J, V4, P3195, DOI 10.1002/j.1460-2075.1985.tb04065.x; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; JULIUS MA, 1988, ONCOGENE, V2, P469; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; NEPVEU A, 1987, ONCOGENE, V1, P243; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PIECHACZYK M, 1988, GENE, V72, P287, DOI 10.1016/0378-1119(88)90154-0; PIECHACZYK M, 1987, TRENDS GENET, V3, P47, DOI 10.1016/0168-9525(87)90166-1; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; RIFKIND RA, 1983, ANN NY ACAD SCI, V411, P141, DOI 10.1111/j.1749-6632.1983.tb47296.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510	33	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					973	978						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2548146				2022-12-28	WOS:A1989AJ29700004
J	THEILLET, C; LEROY, X; DELAPEYRIERE, O; GROSGEORGES, J; ADNANE, J; RAYNAUD, SD; SIMONYLAFONTAINE, J; GOLDFARB, M; ESCOT, C; BIRNBAUM, D; GAUDRAY, P				THEILLET, C; LEROY, X; DELAPEYRIERE, O; GROSGEORGES, J; ADNANE, J; RAYNAUD, SD; SIMONYLAFONTAINE, J; GOLDFARB, M; ESCOT, C; BIRNBAUM, D; GAUDRAY, P			AMPLIFICATION OF FGF-RELATED GENES IN HUMAN-TUMORS - POSSIBLE INVOLVEMENT OF HST IN BREAST CARCINOMAS	ONCOGENE			English	Article									UER MED, LGMCH, AVE VALOMBROSE, F-06034 NICE, FRANCE; CTR PAUL LAMARQUE, CNRS, URA 199, F-34094 MONTPELLIER, FRANCE; INSERM, U148, F-34100 MONTPELLIER, FRANCE; INSERM, U119, F-13009 MARSEILLE, FRANCE; COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Columbia University			Theillet, Charles/O-7634-2018	Theillet, Charles/0000-0001-5555-2759				ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ADELAIDE J, 1988, ONCOGENE, V2, P413; Bisconte J C, 1979, Int Rev Cytol, V57, P75, DOI 10.1016/S0074-7696(08)61462-X; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BURGESS WH, 1985, J BIOL CHEM, V260, P1389; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CROCE CM, 1986, CANCER RES, V46, P6019; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; GEBHART E, 1986, BREAST CANCER RES TR, V8, P125, DOI 10.1007/BF01807701; GEORGE DL, 1984, CANCER SURV, V3, P497; GOSPODAROWICZ D, 1987, J CELL PHYSIOL, P15; JEWETT HJ, 1946, J UROLOGY, V55, P366, DOI 10.1016/S0022-5347(17)69924-5; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LIDEREAU R, 1985, P NATL ACAD SCI USA, V82, P7068, DOI 10.1073/pnas.82.20.7068; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Maniatis T., 1982, MOL CLONING; MARIANICOSTANTINI R, 1988, CANCER RES, V48, P199; MARICS I, 1989, ONCOGENE, V4, P335; MARSHALL VF, 1956, CANCER, V9, P543, DOI 10.1002/1097-0142(195605/06)9:3<543::AID-CNCR2820090318>3.0.CO;2-0; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; NAKAGAMA H, 1987, JPN J CANCER RES, V78, P651; NGUYEN C, 1988, ONCOGENE, V3, P703; RAYBAUD F, 1988, CANCER RES, V48, P950; ROGELJ S, 1988, NATURE, V331, P173, DOI 10.1038/331173a0; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SASADA R, 1988, MOL CELL BIOL, V8, P588, DOI 10.1128/MCB.8.2.588; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONNENBERG A, 1987, EMBO J, V6, P121, DOI 10.1002/j.1460-2075.1987.tb04728.x; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; THEILLET C, 1988, IN PRESS CANCER CELL, V7; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; TRENT JM, 1987, GROWTH FACTORS ONCOG, P142; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; VARLEY JM, 1988, ONCOGENE, V3, P87; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487; ZHOU DJ, 1988, ONCOGENE, V2, P279; 1982, WHO HISTOLOGICAL TYP	52	194	195	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1989	4	7					915	922						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE584	2474139				2022-12-28	WOS:A1989AE58400015
J	BARTHOLOMEW, C; MORISHITA, K; ASKEW, D; BUCHBERG, A; JENKINS, NA; COPELAND, NG; IHLE, JN				BARTHOLOMEW, C; MORISHITA, K; ASKEW, D; BUCHBERG, A; JENKINS, NA; COPELAND, NG; IHLE, JN			RETROVIRAL INSERTIONS IN THE CB-1/FIM-3 COMMON SITE OF INTEGRATION ACTIVATE EXPRESSION OF THE EVI-1 GENE	ONCOGENE			English	Article									ST JUDE CHILDRENS RES HOSP,DEPT BIOCHEM,332 N LAUDERDALE,MEMPHIS,TN 38101; NCI,FREDERICK CANC RES FACIL,BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21701	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)				Buchberg, Arthur/0000-0002-0543-5631; Askew, David/0000-0002-6477-2515	NCI NIH HHS [P30CA21765, N01-CO-74101] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLATT C, 1988, EMBO J, V7, P4283, DOI 10.1002/j.1460-2075.1988.tb03326.x; BORDEREAUX D, 1987, J VIROL, V61, P4043, DOI 10.1128/JVI.61.12.4043-4045.1987; BROWN AMC, 1987, MOL CELL BIOL, V7, P3971, DOI 10.1128/MCB.7.11.3971; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CUYPERS HT, 1984, CELL, V37, P141; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P6687, DOI 10.1073/pnas.82.19.6687; ICHIKAWA Y, 1969, J CELL PHYSIOL, V74, P223, DOI 10.1002/jcp.1040740303; IHLE JN, 1982, J IMMUNOL, V129, P2431; IHLE JN, 1982, J IMMUNOL, V129, P1377; IHLE JN, 1984, ADV VIRAL ONCOL, V4, P95; Maniatis T., 1982, MOL CLONING; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MUCENSKI ML, 1988, ONCOGENE RES, V2, P219; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SOLA B, 1988, J VIROL, V62, P3973, DOI 10.1128/JVI.62.11.3973-3978.1988; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WARNER NL, 1969, J NATL CANCER I, V43, P963; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WEINSTEIN Y, 1987, J VIROL, V61, P2339, DOI 10.1128/JVI.61.7.2339-2343.1987	30	71	72	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					529	534						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2542863				2022-12-28	WOS:A1989U768800001
J	MCKENZIE, SJ; MARKS, PJ; LAM, T; MORGAN, J; PANICALI, DL; TRIMPE, KL; CARNEY, WP				MCKENZIE, SJ; MARKS, PJ; LAM, T; MORGAN, J; PANICALI, DL; TRIMPE, KL; CARNEY, WP			GENERATION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR THE HUMAN NEU ONCOGENE PRODUCT, P185	ONCOGENE			English	Article									DUPONT CO,BILLERICA,MA 01862	DuPont	MCKENZIE, SJ (corresponding author), APPL BIO TECHNOL,CAMBRIDGE,MA 02142, USA.							BERGER MS, 1988, CANCER RES, V48, P1238; CLINE MJ, 1987, J CLIN ONCOL, V5, P999, DOI 10.1200/JCO.1987.5.7.999; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; DREBIN JA, 1988, ONCOGENE, V2, P387; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEPPALA I, 1981, SCAND J IMMUNOL, V14, P335, DOI 10.1111/j.1365-3083.1981.tb00573.x; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STOW ND, 1976, J GEN VIROL, V33, P447, DOI 10.1099/0022-1317-33-3-447; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VARLEY JM, 1987, ONCOGENE, V1, P423; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; ZHOU DJ, 1987, CANCER RES, V47, P6123	21	132	166	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					543	548						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2566965				2022-12-28	WOS:A1989U768800003
J	NISHIMURA, T; VOGT, PK				NISHIMURA, T; VOGT, PK			THE AVIAN CELLULAR HOMOLOG OF THE ONCOGENE JUN	ONCOGENE			English	Article									UNIV SO CALIF,SCH MED,DEPT MICROBIOL,2011 ZONAL AVE,LOS ANGELES,CA 90033	University of Southern California			Vogt, Peter K./R-7547-2019	Vogt, Peter K./0000-0002-4519-7500	NCI NIH HHS [CA42564] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA042564] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKHURST RJ, 1987, J MOL BIOL, V194, P193, DOI 10.1016/0022-2836(87)90368-8; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BALL AR, 1988, IN PRESS COLD SPRING, V53; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; CHANG SC, 1987, P NATL ACAD SCI USA, V84, P680, DOI 10.1073/pnas.84.3.680; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; FUJITA T, 1985, CELL, V41, P489, DOI 10.1016/S0092-8674(85)80022-2; HOUGHTON M, 1981, NUCLEIC ACIDS RES, V9, P247, DOI 10.1093/nar/9.2.247; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MAXSON R, 1983, ANNU REV GENET, V17, P239, DOI 10.1146/annurev.ge.17.120183.001323; MCKNIGHT SL, 1981, CELL, V25, P385, DOI 10.1016/0092-8674(81)90057-X; OHNO S, 1981, P NATL ACAD SCI-BIOL, V78, P5305, DOI 10.1073/pnas.78.9.5305; RAUSCHER RJ, 1988, SCIENCE, V240, P1010; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1988, SCIENCE, V85, P1487; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; SUCOV HM, 1987, DEV BIOL, V120, P507, DOI 10.1016/0012-1606(87)90254-5; TAVERNIER J, 1981, NUCLEIC ACIDS RES, V9, P461, DOI 10.1093/nar/9.3.461; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; TUY PD, 1988, EUR J BIOCHEM, V173, P507; VANBEVEREN C, 1981, NATURE, V289, P258, DOI 10.1038/289258a0; VOGT PK, 1988, ONCOGENE, V3, P3; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; WANG LH, 1987, ONCOGENE RES, V1, P43	35	103	104	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					659	663						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577867				2022-12-28	WOS:A1988R646000006
J	RAWSON, C; SHIRAHATA, S; COLLODI, P; NATSUNO, T; BARNES, D				RAWSON, C; SHIRAHATA, S; COLLODI, P; NATSUNO, T; BARNES, D			ONCOGENE TRANSFORMATION FREQUENCY OF NONSENESCENT SFME CELLS IS INCREASED BY C-MYC	ONCOGENE			English	Note							MOUSE EMBRYO CELLS; RAS ONCOGENES; CULTURE; SERUM; GENE; FIBROBLASTS; INHIBITION	Immortalized, postcrisis mouse embryo cell cultures derived in serum-containing medium display genomic abnormalities and an altered, preneoplastic phenotype. These lines can be transformed with single oncogenes, such as Ha-ras, while efficient transformation of precrisis, genomically unaltered rodent embryo cultures require cooperating oncogenes, such as Ha-ras and the mouse c-myc gene constitutively expressed. Serum-free mouse embryo (SFME) cells, cultured under conditions in which serum is replaced by growth factors and other supplements, are 'immortalized' in the genomically unaltered state. SFME cells do not exhibit growth crisis or gross chromosomal aberration, and are dependent on epidermal growth factor for survival, growth inhibited by serum, and are nontumorigenic. Transformation of SFME cells can be achieved with ras alone, but the introduction of c-myc increased the transfection frequency upon subsequent transfection with ras by as much as twenty fold. Similar results were obtained with mutationally activated neu oncogene and with genomic human tumor DNA. Constitutive expression of c-myc alone did not alter the properties of the SFME cells. These results demonstrate that c-myc alters cellular responses to oncogenes in a culture system in which oncogene-induced immortalization is not a factor, indicating that the effects of myc may extend beyond an 'immortalization' function in these cells.	OREGON STATE UNIV,ENVIRONM HLTH SCI CTR,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331	Oregon State University					NCPDCID CDC HHS [NCI-01226] Funding Source: Medline	NCPDCID CDC HHS		AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; CORSARO CM, 1981, SOMAT CELL GENET, V7, P603, DOI 10.1007/BF01549662; GOSPODAROWICZ D, 1984, METHODS MOL CELL BIO, V1, P69; Ham R G, 1979, Methods Enzymol, V58, P44; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LOO D, 1990, J CELL PHYSIOL, V142, P210, DOI 10.1002/jcp.1041420126; LOO D, 1989, J CELL PHYSIOL, V139, P484, DOI 10.1002/jcp.1041390306; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; LOO DT, 1989, CELL GROWTH CELL DIV, P17; Maniatis T., 1982, MOL CLONING; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; RAWSON C, 1990, EXP CELL RES, V186, P177, DOI 10.1016/0014-4827(90)90224-X; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; SHIRAHATA S, 1990, J CELL PHYSIOL, V144, P69, DOI 10.1002/jcp.1041440110; SORRENTINO V, 1987, P NATL ACAD SCI USA, V84, P4131, DOI 10.1073/pnas.84.12.4131; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299	22	20	20	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					487	489						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011405				2022-12-28	WOS:A1991FT34400022
J	HANNINK, M; TEMIN, HM				HANNINK, M; TEMIN, HM			STRUCTURE AND AUTOREGULATION OF THE C-REL PROMOTER	ONCOGENE			English	Article							VIRUS STRAIN-T; AVIAN RETICULOENDOTHELIOSIS VIRUS; CHICKEN SPLEEN-CELLS; PROTO-ONCOGENE; MESSENGER-RNA; SUPPRESSES TRANSFORMATION; CELLULAR HOMOLOG; MAMMALIAN-CELLS; RECEPTOR GENE; GROWTH-FACTOR	Precise regulation of proto-oncogene expression appears to be essential for the proper growth and development of multi-cellular organisms. One aspect of this regulation is at the level of transcription from the proto-oncogene promoter(s). In order to characterize the promoter for the chicken c-rel proto-oncogene, we have isolated and sequenced genomic DNA containing the first exon of the chicken c-rel proto-oncogene. The c-rel promoter is structurally similar to the promoters of the so-called housekeeping genes, lacking the CAATT and TATA elements found in some cellular genes, but containing a G/C-rich box near the transcription start sites. There are multiple transcription start sites for the c-rel mRNA, which map near putative binding sites for the transcription factors HIP-1 and NF-kB. The c-rel promoter was functionally characterized by its ability to support expression of the firefly luciferase gene. The c-rel promoter is a relatively weak promoter, 100-times less active than the promoter within the spleen necrosis virus long terminal repeat (LTR). We have defined the c-rel promoter by analysis of a series of 5' deletion mutants of the c-rel promoter fused to the firefly luciferase gene. A DNA fragment containing 97 bp of 5' flanking sequence and 72 bp of 3' flanking sequence is sufficient for c-rel promoter function. Co-transfection of the c-rel promoter with a retroviral vector expressing the c-rel protein resulted in a decrease in expression from the minimal c-rel promoter. These results indicate that expression of the c-rel proto-oncogene is tightly regulated both at the level of basal promoter activity and by autoregulation of transcription by the c-rel protein.	UNIV WISCONSIN, MCARDLE LAB CANC RES, DEPT BIOCHEM, M121 MED SCI BLDG, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA-22443, CA-07175] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA022443, P30CA007175] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLARD DW, 1990, UNPUB; BARTH CF, 1988, MOL CELL BIOL, V8, P5358, DOI 10.1128/MCB.8.12.5358; BECK TW, 1990, MOL CELL BIOL, V10, P3325, DOI 10.1128/MCB.10.7.3325; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Bishop JM, 1985, RNA TUMOR VIRUSES, P249; BLAIR DG, 1981, SCIENCE, V212, P941, DOI 10.1126/science.7233190; BRASIER AR, 1989, BIOTECHNIQUES, V7, P1116; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROWN K, 1988, MOL CARCINOGEN, V1, P161, DOI 10.1002/mc.2940010304; CAPOBIANCO AJ, 1990, ONCOGENE, V5, P257; CHEN ISY, 1982, CELL, V31, P111, DOI 10.1016/0092-8674(82)90410-X; CHEN ISY, 1983, J VIROL, V45, P104, DOI 10.1128/JVI.45.1.104-113.1983; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; DAVIS N, 1990, J VIROL, V64, P584, DOI 10.1128/JVI.64.2.584-591.1990; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DOUGHERTY JP, 1986, MOL CELL BIOL, V6, P4387, DOI 10.1128/MCB.6.12.4387; GELINAS C, 1988, ONCOGENE, V3, P349; GHOSH S, 1990, IN PRESS CELL; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALEY J, 1987, ONCOGENE RES, V1, P375; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; KAMENS J, 1990, MOL CELL BIOL, V10, P2840, DOI 10.1128/MCB.10.6.2840; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KIERAN M, 1990, IN PRESS CELL; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LEWIS RB, 1981, CELL, V25, P421, DOI 10.1016/0092-8674(81)90060-X; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MILLER CK, 1986, J VIROL, V58, P75, DOI 10.1128/JVI.58.1.75-80.1986; MORRISON LE, 1989, ONCOGENE, V4, P677; RUSHLOW C, 1987, NATURE, V330, P583, DOI 10.1038/330583a0; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SHIBUYA T, 1982, CANCER RES, V42, P2722; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; STINSKI MF, 1985, J VIROL, V55, P431, DOI 10.1128/JVI.55.2.431-441.1985; THEILEN G, 1966, JNCI-J NATL CANCER I, V37, P747; TUNG HYL, 1988, P NATL ACAD SCI USA, V80, P6229; WALRO DS, 1987, VIROLOGY, V160, P433, DOI 10.1016/0042-6822(87)90015-8; WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WILHELMSEN KC, 1984, J VIROL, V49, P521, DOI 10.1128/JVI.49.2.521-529.1984	55	77	77	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1990	5	12					1843	1850						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284104				2022-12-28	WOS:A1990ET43600016
J	PEACOCK, JW; MATLASHEWSKI, GJ; BENCHIMOL, S				PEACOCK, JW; MATLASHEWSKI, GJ; BENCHIMOL, S			SYNERGISM BETWEEN PAIRS OF IMMORTALIZING GENES IN TRANSFORMATION ASSAYS OF RAT EMBRYO FIBROBLASTS	ONCOGENE			English	Article							LARGE TUMOR-ANTIGEN; LARGE T-ANTIGEN; HUMAN RETINOBLASTOMA GENE; ADENOVIRUS E1A PROTEINS; P53 GENE; PRIMARY-CELLS; CELLULAR P53; SV40-TRANSFORMED CELLS; HYDROPHOBIC REGION; COMPLEX-FORMATION	A number of cellular and viral genes encode proteins that play a role in the establishment of normal cells in culture. In addition, these genes cooperate with activated ras genes to induce cellular transformation. We show that ras-dependent transformation of rat embryo fibroblasts is more efficient when two establishment genes are used together compared with one alone. Both quantitative and qualitative differences in the efficiency of transformation were detected. The number of transformed foci generated was greater than the sum of the foci obtained with ras and each of the establishment genes used separately. In addition, the foci had a distinct morphology. Synergism was seen between the HPV-16 E7 gene and certain mutant alleles of the cellular p53 gene as well as between E7 and c-myc.	ONTARIO CANC INST,500 SHERBOURNE ST,TORONTO M4X 1K9,ONTARIO,CANADA; UNIV TORONTO,DEPT MED BIOPHYS,TORONTO M4X 1K9,ONTARIO,CANADA; MCGILL UNIV,INST PARASITOL,ST ANNE BELLEVUE H9X 1C0,QUEBEC,CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; McGill University				Benchimol, Samuel/0000-0003-3433-890X				AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BEDELL MA, 1989, J VIROL, V63, P1247, DOI 10.1128/JVI.63.3.1247-1255.1989; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; CHEN S, 1990, J VIROL, V64, P3350, DOI 10.1128/JVI.64.7.3350-3357.1990; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; DYSON N, 1989, CELL, V58, P249, DOI 10.1016/0092-8674(89)90839-8; EDMONDS C, 1989, J VIROL, V63, P2650, DOI 10.1128/JVI.63.6.2650-2656.1989; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KANDA T, 1988, VIROLOGY, V165, P321, DOI 10.1016/0042-6822(88)90694-0; KELMAN Z, 1989, BLOOD, V74, P2318; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MASHAL R, 1990, BLOOD, V75, P180; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; MONTENARH M, 1986, FEBS LETT, V204, P51, DOI 10.1016/0014-5793(86)81386-2; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; MUNROE DG, 1990, MOL CELL BIOL, V10, P3307, DOI 10.1128/MCB.10.7.3307; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PEDEN KWC, 1989, VIROLOGY, V168, P13, DOI 10.1016/0042-6822(89)90398-X; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; ROVINSKI B, 1988, ONCOGENE, V2, P445; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; RULEY HE, 1987, ADV VIRAL ONCOL, P1; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHMIEG FI, 1988, VIROLOGY, V164, P132, DOI 10.1016/0042-6822(88)90628-9; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOMPAYRAC LM, 1983, MOL CELL BIOL, V3, P290, DOI 10.1128/MCB.3.2.290; SRINIVASAN A, 1989, J VIROL, V63, P5459, DOI 10.1128/JVI.63.12.5459-5463.1989; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; TACK LC, 1989, J VIROL, V63, P3362, DOI 10.1128/JVI.63.8.3362-3367.1989; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0	63	14	15	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1769	1774						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2178238				2022-12-28	WOS:A1990ET43600005
J	PAL, N; WADEY, RB; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK				PAL, N; WADEY, RB; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK			PREFERENTIAL LOSS OF MATERNAL ALLELES IN SPORADIC WILMS-TUMOR	ONCOGENE			English	Article									INST CHILD HLTH,DEPT HAEMATOL & ONCOL,IMPERIAL CANC RES FUND,MOLEC GENET LAB,LONDON WC1N 1EH,ENGLAND; GREAT ORMOND ST HOSP SICK CHILDREN,DEPT HAEMATOL & ONCOL,LONDON WC1,ENGLAND	Cancer Research UK; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust				Cowell, John/0000-0002-2079-5950				ALLISON J, 1981, BIOCHEM J, V199, P725, DOI 10.1042/bj1990725; ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; COUILLIN P, 1989, HUM GENET, V82, P171, DOI 10.1007/BF00284053; COWELL JK, 1989, HUM GENET, V82, P123, DOI 10.1007/BF00284042; DAO DD, 1987, AM J HUM GENET, V41, P202; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ECCLES MR, 1984, HUM GENET, V67, P190, DOI 10.1007/BF00272999; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HOPPENER JWM, 1984, HUM GENET, V66, P309, DOI 10.1007/BF00287635; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; Maniatis T., 1982, MOL CLONING; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; VANDERMEY AGL, 1989, LANCET, V2, P1291; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; WADEY RB, 1989, NUCLEIC ACIDS RES, V17, P3332, DOI 10.1093/nar/17.8.3332; WADEY RB, 1990, IN PRESS ONCOGENE; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WILLIAMS JC, 1989, LANCET, V1, P283; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	40	86	86	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1665	1668						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	1980007				2022-12-28	WOS:A1990EL40100008
J	BUSCH, SJ; SASSONECORSI, P				BUSCH, SJ; SASSONECORSI, P			FOS, JUN AND CREB BASIC-DOMAIN PEPTIDES HAVE INTRINSIC DNA-BINDING ACTIVITY ENHANCED BY A NOVEL STABILIZING FACTOR	ONCOGENE			English	Article									FAC MED STRASBOURG,INST CHIM BIOL,INSERM,UNITE BIOL MOLEC & GENIE GENET 184,CNRS,F-67085 STRASBOURG,FRANCE; MERRELL DOW RES INST,F-67084 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Sassone-Corsi, Paolo/H-6182-2011					AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; BUSCH SJ, 1989, LIFE SCI, V45, P615, DOI 10.1016/0024-3205(89)90047-7; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DETOGNI P, 1988, MOL CELL BIOL, V8, P2251, DOI 10.1128/MCB.8.5.2251; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1425; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KAO L, 1988, P NATL ACAD SCI USA, V85, P4491, DOI 10.1073/pnas.85.12.4491; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MARTIN GA, 1988, J BIOL CHEM, V263, P10907; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SASSONECORSI P, 1990, ONCOGENE, V5, P427; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701	29	34	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1549	1556						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2147467				2022-12-28	WOS:A1990EK50200015
J	VEILLETTE, A; FOURNEL, M				VEILLETTE, A; FOURNEL, M			THE CD4 ASSOCIATED TYROSINE PROTEIN-KINASE P56LCK IS POSITIVELY REGULATED THROUGH ITS SITE OF AUTOPHOSPHORYLATION	ONCOGENE			English	Article									MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,QUEBEC,CANADA	McGill University	VEILLETTE, A (corresponding author), MCGILL UNIV,MCGILL CANC CTR,ROOM 701,3655 DRUMMOND ST,MONTREAL H3G 1Y6,QUEBEC,CANADA.							ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; BIERER BE, 1989, ANNU REV IMMUNOL, V7, P579, DOI 10.1146/annurev.immunol.7.1.579; CARTIER M, 1987, MOL CELL BIOL, V7, P1623, DOI 10.1128/MCB.7.5.1623; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; HURLEY TR, 1989, ONCOGENE, V4, P265; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; JUNE CH, 1990, J IMMUNOL, V144, P1591; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MARCHILDON GA, 1984, P NATL ACAD SCI-BIOL, V81, P7679, DOI 10.1073/pnas.81.24.7679; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SIMPSON SC, 1989, ONCOGENE, V4, P1141; SLECKMAN BP, 1988, J IMMUNOL, V141, P49; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; TOURVIEILLE B, 1986, SCIENCE, V234, P610, DOI 10.1126/science.3094146; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; VEILLETTE A, 1987, ONCOGENE RES, V1, P357; VEILLETTE A, 1989, NATURE, V338, P357; VEILLETTE A, 1990, IN PRESS EUR J IMMUN; VORONOVA AF, 1984, MOL CELL BIOL, V4, P2705, DOI 10.1128/MCB.4.12.2705; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WILDE DB, 1983, J IMMUNOL, V131, P2178; ZAMOYSKA R, 1989, NATURE, V342, P278, DOI 10.1038/342278a0	39	74	75	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1455	1462						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250907				2022-12-28	WOS:A1990EK50200003
J	WATSON, DK; MAVROTHALASSITIS, GJ; JORCYK, CL; SMYTH, FE; PAPAS, TS				WATSON, DK; MAVROTHALASSITIS, GJ; JORCYK, CL; SMYTH, FE; PAPAS, TS			MOLECULAR-ORGANIZATION AND DIFFERENTIAL POLYADENYLATION SITES OF THE HUMAN ETS2 GENE	ONCOGENE			English	Article									PROGRAM RESOURCES INC,NUCLEIC ACID & PROT SYNTH LAB,FREDERICK,MD 21701		WATSON, DK (corresponding author), NCI,MOLEC ONCOL LAB,FREDERICK,MD 21701, USA.							BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERGET SM, 1984, NATURE, V309, P179, DOI 10.1038/309179a0; BHAT NK, 1989, J IMMUNOL, V142, P672; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BOND BJ, 1986, MOL CELL BIOL, V6, P2080, DOI 10.1128/MCB.6.6.2080; CAPETANAKI YG, 1983, CELL, V35, P411, DOI 10.1016/0092-8674(83)90174-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHISHOLM D, 1989, BIOTECHNIQUES, V7, P21; FUJIWARA S, 1988, ONCOGENE, V2, P99; FUJIWARA S, 1990, MOL CELL BIOL, V10, P1249, DOI 10.1128/MCB.10.3.1249; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; KAUFMAN RJ, 1983, MOL CELL BIOL, V3, P1598, DOI 10.1128/MCB.3.9.1598; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; Maniatis T., 1982, MOL CLONING; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; Maxam A M, 1980, Methods Enzymol, V65, P499; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; NUNN M, 1984, VIROLOGY, V139, P330, DOI 10.1016/0042-6822(84)90378-7; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1987, P NATL ACAD SCI USA, V84, P6131, DOI 10.1073/pnas.84.17.6131; ROBERTSON DL, 1979, J VIROL, V30, P576, DOI 10.1128/JVI.30.2.576-589.1979; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SETH A, 1989, P NATL ACAD SCI USA, V86, P7833, DOI 10.1073/pnas.86.20.7833; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; URANO Y, 1986, J BIOL CHEM, V261, P3244; WATSON DK, 1988, VIROLOGY, V164, P99, DOI 10.1016/0042-6822(88)90624-1; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P2146, DOI 10.1073/pnas.80.8.2146; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611	34	17	18	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1521	1527						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250910				2022-12-28	WOS:A1990EK50200011
J	TAMURA, T; SIMON, E; GESCHWILL, K; NIEMANN, H				TAMURA, T; SIMON, E; GESCHWILL, K; NIEMANN, H			CDC2/PP56-62 ARE INVITRO SUBSTRATES FOR THE TYROSINE KINASE ENCODED BY THE V-FMS ONCOGENE	ONCOGENE			English	Note									PHARMACIA LKB,W-7800 FREIBURG,GERMANY; BFA,INST MIKROBIOL,W-7400 TUBINGEN,GERMANY		TAMURA, T (corresponding author), UNIV GIESSEN,INST VIROL,FRANKFURTER STR 107,W-6300 GIESSEN,GERMANY.							BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; BARBACID M, 1981, J VIROL, V40, P812, DOI 10.1128/JVI.40.3.812-821.1981; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HADWIGER A, 1986, EMBO J, V5, P689, DOI 10.1002/j.1460-2075.1986.tb04268.x; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; LANGAN TA, 1980, PROTEIN PHOSPHORYLAT, P1; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REYNOLDS FH, 1981, J VIROL, V38, P1084, DOI 10.1128/JVI.38.3.1084-1089.1981; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; RICHERT ND, 1982, J BIOL CHEM, V257, P7143; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; SCHMITZ M, 1986, VIROLOGY, V148, P23, DOI 10.1016/0042-6822(86)90400-9; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; TAMURA T, 1989, J CANCER RES CLIN, V115, P235, DOI 10.1007/BF00391695; TAMURA T, 1983, CELL, V34, P587, DOI 10.1016/0092-8674(83)90391-4; TAMURA T, 1984, FEBS LETT, V177, P151, DOI 10.1016/0014-5793(84)81001-7; TAMURA T, 1988, J VIROL, V62, P2150, DOI 10.1128/JVI.62.6.2150-2157.1988; TAMURA T, 1986, MOL CELL BIOL, V6, P4745, DOI 10.1128/MCB.6.12.4745	28	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1259	1263						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2118246				2022-12-28	WOS:A1990DX36100021
J	SHIBANUMA, M; KUROKI, T; NOSE, K				SHIBANUMA, M; KUROKI, T; NOSE, K			STIMULATION BY HYDROGEN-PEROXIDE OF DNA-SYNTHESIS, COMPETENCE FAMILY GENE-EXPRESSION AND PHOSPHORYLATION OF A SPECIFIC PROTEIN IN QUIESCENT BALB/3T3 CELLS	ONCOGENE			English	Article									UNIV TOKYO,INST MED SCI,DEPT CANC CELL RES,4-6-1 SHIROKANEDAI,MINATO KU,TOKYO 108,JAPAN	University of Tokyo			Kuroki, Toshio/A-9500-2011	Kuroki, Toshio/0000-0001-6369-4351				BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BOYNTON AL, 1983, ADV CYCLIC NUCL PROT, V15, P193; CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433; CHAMBARD JC, 1983, J BIOL CHEM, V258, P1706; CHIDA K, 1986, CANCER RES, V46, P1055; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CRAWFORD D, 1988, ONCOGENE, V3, P27; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; ERNST V, 1978, P NATL ACAD SCI USA, V75, P4110, DOI 10.1073/pnas.75.9.4110; FISCHER SM, 1985, CANCER RES, V45, P3130; FOERDER CA, 1978, P NATL ACAD SCI USA, V75, P3183, DOI 10.1073/pnas.75.7.3183; FRIEDMAN J, 1983, CARCINOGENESIS, V4, P1425, DOI 10.1093/carcin/4.11.1425; GINDHART TD, 1985, CARCINOGENESIS, V6, P309, DOI 10.1093/carcin/6.2.309; HARRISON JR, 1986, CANCER RES, V46, P5571; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HYSLOP PA, 1988, J BIOL CHEM, V263, P1665; KENSLER TW, 1983, SCIENCE, V221, P75, DOI 10.1126/science.6857269; KOHNO M, 1985, J BIOL CHEM, V260, P1771; LARSSON R, 1988, J BIOL CHEM, V263, P17452; MANIATIS T, 1982, LABORATORY MANUAL; MAY JM, 1979, J BIOL CHEM, V254, P9017; MUKHERJEE SP, 1978, BIOCHEM PHARMACOL, V27, P2589, DOI 10.1016/0006-2952(78)90332-5; NISHIZUKA Y, 1984, NATURE, V308, P673; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SHIBANUMA M, 1988, ONCOGENE, V3, P17; SHIBANUMA M, 1987, EUR J BIOCHEM, V164, P15, DOI 10.1111/j.1432-1033.1987.tb10985.x; SHIBANUMA M, 1988, J CELL PHYSIOL, V136, P379, DOI 10.1002/jcp.1041360224; SHIBANUMA M, 1987, BIOCHEM BIOPH RES CO, V144, P1317, DOI 10.1016/0006-291X(87)91454-9; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; YAMADA T, 1988, BIOCHEM BIOPH RES CO, V155, P569; ZAITSU K, 1980, ANAL BIOCHEM, V109, P109, DOI 10.1016/0003-2697(80)90017-2; ZIMMERMAN RJ, 1989, CANCER RES, V49, P1644	37	140	142	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1025	1032						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115640				2022-12-28	WOS:A1990DP41500010
J	SOUSSI, T; DEFROMENTEL, CC; MAY, P				SOUSSI, T; DEFROMENTEL, CC; MAY, P			STRUCTURAL ASPECTS OF THE P53 PROTEIN IN RELATION TO GENE EVOLUTION	ONCOGENE			English	Review									INST SCI RECH CANC, UNITE ONCOL MOLEC, F-94800 VILLEJUIF, FRANCE				de Fromentel, Claude Caron/Y-9715-2019	de Fromentel, Claude Caron/0000-0001-7566-3958; soussi, thierry/0000-0001-8184-3293				ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BENCHIMOL S, 1985, SOMAT CELL MOLEC GEN, V11, P505, DOI 10.1007/BF01534845; BENCHIMOL S, 1984, CANCER CELL, V2, P383; BENDORI R, 1987, VIROLOGY, V161, P607, DOI 10.1016/0042-6822(87)90159-0; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BIENZTADMOR B, 1985, EMBO J, V4, P3209, DOI 10.1002/j.1460-2075.1985.tb04067.x; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; CHOW V, 1987, J VIROL, V61, P2777, DOI 10.1128/JVI.61.9.2777-2781.1987; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; COULIER F, 1985, EMBO J, V4, P3413, DOI 10.1002/j.1460-2075.1985.tb04098.x; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; CRAWFORD LV, 1982, INT J CANCER, V30, P403, DOI 10.1002/ijc.2910300404; CZOSNEK HH, 1984, MOL CELL BIOL, V4, P1638, DOI 10.1128/MCB.4.8.1638; DAVID YB, 1988, ONCOGENE, V3, P179; DEFROMENTEL CC, 1987, INT J CANCER, V39, P185, DOI 10.1002/ijc.2910390211; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; EHRHART JC, 1988, ONCOGENE, V3, P595; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GILBERT W, 1986, CELL, V46, P151, DOI 10.1016/0092-8674(86)90730-0; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; JENKINS JR, 1988, ONCOGENE HDB, P403; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; KRESS M, 1979, J VIROL, V31, P472, DOI 10.1128/JVI.31.2.472-483.1979; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOUIS JM, 1988, BIOCHIM BIOPHYS ACTA, V950, P395, DOI 10.1016/0167-4781(88)90136-4; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MATLASHEWSKI G, 1987, ONCOGENE RES, V1, P77; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MELERO JA, 1979, VIROLOGY, V93, P466, DOI 10.1016/0042-6822(79)90250-2; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILLER C, 1986, NATURE, V319, P783, DOI 10.1038/319783a0; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MUNROE DG, 1988, ONCOGENE, V2, P621; OREN M, 1982, MOL CELL BIOL, V2, P443, DOI 10.1128/MCB.2.4.443; OREN M, 1983, EMBO J, V2, P1633, DOI 10.1002/j.1460-2075.1983.tb01637.x; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; OREN M, 1983, P NATL ACAD SCI-BIOL, V80, P56, DOI 10.1073/pnas.80.1.56; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PELHAM H, 1988, NATURE, V332, P776, DOI 10.1038/332776a0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PENNICA D, 1984, VIROLOGY, V134, P477, DOI 10.1016/0042-6822(84)90316-7; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; PRASOLOV VS, 1988, MOL BIOL+, V22, P1105; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REISMAN D, 1989, ONCOGENE, V4, P945; REISMAN D, 1988, P NATL ACAD SCI USA, V85, P5146, DOI 10.1073/pnas.85.14.5146; RIGAUDY P, 1989, NUCLEIC ACIDS RES, V17, P8375, DOI 10.1093/nar/17.20.8375; RODERICK TH, 1984, CYTOGENET CELL GENET, V37, P312, DOI 10.1159/000132013; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROTTER V, 1984, MOL CELL BIOL, V4, P383, DOI 10.1128/MCB.4.2.383; ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SEE PY, 1989, PROTEIN STRUCTURE PR, P1; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHOHAT O, 1987, ONCOGENE, V1, P277; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11383, DOI 10.1093/nar/16.23.11383; SOUSSI T, 1987, ONCOGENE, V1, P71; SOUSSI T, 1989, J VIROL, V63, P3894, DOI 10.1128/JVI.63.9.3894-3901.1989; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; STURZBECHER HW, 1987, ONCOGENE, V1, P201; STURZBECHER HW, 1988, MOL CELL BIOL, V8, P3740; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; TYMOWSKA J, 1973, CHROMOSOMA, V44, P335, DOI 10.1007/BF00291027; VANROY F, 1981, J VIROL, V40, P28, DOI 10.1128/JVI.40.1.28-44.1981; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x; ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0	90	691	708	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1990	5	7					945	952						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2142762				2022-12-28	WOS:A1990DP41500001
J	SUZUKI, Y; ORITA, M; SHIRAISHI, M; HAYASHI, K; SEKIYA, T				SUZUKI, Y; ORITA, M; SHIRAISHI, M; HAYASHI, K; SEKIYA, T			DETECTION OF RAS GENE-MUTATIONS IN HUMAN LUNG CANCERS BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS OF POLYMERASE CHAIN-REACTION PRODUCTS	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV ONCOGENE,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN	National Cancer Center - Japan								ALBINO AP, 1989, ONCOGENE, V4, P1363; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1986, NUCLEIC ACIDS RES, V14, P1209, DOI 10.1093/nar/14.3.1209; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; BOS JL, 1989, CANCER RES, V49, P4682; BROWETT PJ, 1989, ONCOGENE, V4, P1029; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; BURMER GC, 1989, CANCER RES, V49, P2141; BURMER GC, 1989, P NATL ACAD SCI USA, V86, P2403, DOI 10.1073/pnas.86.7.2403; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; FARR CJ, 1988, ONCOGENE, V3, P673; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEINBERG AP, 1983, SCIENCE, V220, P1175, DOI 10.1126/science.6304875; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GONZALEZCADAVID NF, 1989, ONCOGENE, V4, P1137; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P3605, DOI 10.1093/nar/17.9.3605; IRELAND CM, 1989, CANCER RES, V49, P5530; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; JIANG W, 1989, ONCOGENE, V4, P923; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; LANDEGREN U, 1988, SCIENCE, V242, P229, DOI 10.1126/science.3051381; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, CANCER RES, V48, P4459; LIU E, 1987, NATURE, V300, P186; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MIYAKI M, 1985, JPN J CANCER RES, V76, P260; MULDER MP, 1989, ONCOGENE, V4, P1345; NAKANO H, 1984, P NATL ACAD SCI-BIOL, V81, P71, DOI 10.1073/pnas.81.1.71; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; REDDY EP, 1983, SCIENCE, V220, P1061, DOI 10.1126/science.6844927; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; RODENHUIS S, 1988, CANCER RES, V48, P5738; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SEKIYA T, 1985, JPN J CANCER RES, V76, P555; SEKIYA T, 1984, P NATL ACAD SCI-BIOL, V81, P4771, DOI 10.1073/pnas.81.15.4771; STRATTON MR, 1989, CANCER RES, V49, P6324; TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x; TOKSOZ D, 1987, ONCOGENE, V1, P409; VALENZUELA DM, 1986, NUCLEIC ACIDS RES, V14, P843, DOI 10.1093/nar/14.2.843; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; YAMADA H, 1986, JPN J CANCER RES, V77, P370; YAMAMOTO F, 1984, NUCLEIC ACIDS RES, V12, P8873, DOI 10.1093/nar/12.23.8873; YANEZ L, 1987, ONCOGENE, V1, P315; YUNIS JJ, 1989, ONCOGENE, V4, P609	55	425	444	0	10	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1037	1043						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2197591				2022-12-28	WOS:A1990DP41500012
J	LUBBERT, M; JONAS, D; MILLER, CW; HERRMANN, F; MERTELSMANN, R; MCCORMICK, F; KOEFFLER, HP				LUBBERT, M; JONAS, D; MILLER, CW; HERRMANN, F; MERTELSMANN, R; MCCORMICK, F; KOEFFLER, HP			RETROSPECTIVE ANALYSIS OF RAS GENE ACTIVATION IN MYELOID LEUKEMIC-CELLS	ONCOGENE			English	Article									UNIV CALIF LOS ANGELES, DEPT MED,DIV HEMATOL ONCOL,11-240 FACTOR BLDG, 10833 LE CONTE AVE, LOS ANGELES, CA 90024 USA; UNIV FREIBURG, DEPT MED 1, W-7800 FREIBURG, GERMANY; CETUS CORP, DEPT MOLEC BIOL, EMERYVILLE, CA 94608 USA	University of California System; University of California Los Angeles; University of Freiburg					NCI NIH HHS [CA 32737, CA 26038, CA 33936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033936, R01CA026038, P01CA032737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARDY KJ, 1985, P NATL ACAD SCI USA, V82, P8173, DOI 10.1073/pnas.82.23.8173; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; JANSSEN JWG, 1987, ONCOGENE, V1, P175; JANSSEN JWG, 1989, LEUKEMIA, V3, P235; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; JANSSEN JWG, 1987, NUCLEIC ACIDS RES, V15, P5669, DOI 10.1093/nar/15.14.5669; JOLLY DJ, 1983, NUCLEIC ACIDS RES, V11, P1855, DOI 10.1093/nar/11.6.1855; KOEFFLER HP, 1978, SCIENCE, V200, P1153, DOI 10.1126/science.306682; LYONS J, 1988, BLOOD, V71, P1707; PAABO S, 1989, J BIOL CHEM, V264, P9709; PADUA RA, 1988, LEUKEMIA, V2, P503; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SPANDIDOS DA, 1984, NATURE, V304, P602; TAINSKY MA, 1984, SCIENCE, V225, P643, DOI 10.1126/science.6740333	22	10	10	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					583	587						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183160				2022-12-28	WOS:A1990DB85300019
J	ANDREWS, DF; TOMPKINS, CK; HENDRICKSON, SL; SINGER, JW				ANDREWS, DF; TOMPKINS, CK; HENDRICKSON, SL; SINGER, JW			CLONING AND SEQUENCING OF THE HUMAN C-ABL 3' UNTRANSLATED REGION	ONCOGENE			English	Note									UNIV WASHINGTON,SCH MED,DEPT MED,SEATTLE,WA 98195; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	ANDREWS, DF (corresponding author), VET ADM MED CTR,DEPT MED 111,1660 S COLUMBIAN WAY,SEATTLE,WA 98108, USA.			Singer, Jack/0000-0003-4001-4549	NCI NIH HHS [CA18028, CA01333, CA16448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA016448, K08CA001333, R01CA016448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS DF, 1989, P NATL ACAD SCI USA, V86, P6788, DOI 10.1073/pnas.86.17.6788; ANDREWS DF, 1987, LEUKEMIA, V1, P718; ANDREWS DF, 1989, MOL CELL BIOL, V9, P2748, DOI 10.1128/MCB.9.6.2748; BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; COLLINS SJ, 1984, SCIENCE, V225, P72, DOI 10.1126/science.6587568; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GODDARD JM, 1986, P NATL ACAD SCI USA, V83, P2172, DOI 10.1073/pnas.83.7.2172; HOFFMANFALK H, 1983, CELL, V32, P589, DOI 10.1016/0092-8674(83)90478-6; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KRUYS V, 1987, P NATL ACAD SCI USA, V84, P6030, DOI 10.1073/pnas.84.17.6030; MANIATIS T, 1983, MOL CLONING LABORATO, P387; MEIJER D, 1987, EMBO J, V6, P4041, DOI 10.1002/j.1460-2075.1987.tb02749.x; MUELLER R, 1982, NATURE, V299, P640; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; PUSTELL J, 1982, NUCLEIC ACIDS RES, V10, P51, DOI 10.1093/nar/10.1.51; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SHTIVELMAN E, 1986, CELL, V47, P227; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WANG JYJ, 1983, MOL CELL BIOL, V3, P773, DOI 10.1128/MCB.3.5.773; WANG JYJ, 1984, CELL, V36, P349; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490	25	2	2	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					441	444						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179820				2022-12-28	WOS:A1990CW41500026
J	BEIMLING, P; MOELLING, K				BEIMLING, P; MOELLING, K			TAX-INDEPENDENT BINDING OF MULTIPLE CELLULAR FACTORS TO TAX-RESPONSE ELEMENT DNA OF HTLV-I	ONCOGENE			English	Article									MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,W-1000 BERLIN 33,GERMANY	Max Planck Society								ALTMAN R, 1988, J VIROL, V62, P1339, DOI 10.1128/JVI.62.4.1339-1346.1988; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ARYA SK, 1988, AIDS RES HUM RETROV, V4, P175, DOI 10.1089/aid.1988.4.175; BEIMLING P, 1989, ONCOGENE, V4, P511; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6349, DOI 10.1021/bi00344a005; BRADY J, 1987, J VIROL, V61, P2175, DOI 10.1128/JVI.61.7.2175-2181.1987; CANN AJ, 1985, NATURE, V318, P571, DOI 10.1038/318571a0; CHEN ISY, 1985, SCIENCE, V229, P54, DOI 10.1126/science.2990037; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; FELBER BK, 1985, SCIENCE, V229, P675, DOI 10.1126/science.2992082; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FUJISAWA J, 1989, J VIROL, V63, P3234, DOI 10.1128/JVI.63.8.3234-3239.1989; FUJISAWA J, 1985, P NATL ACAD SCI USA, V82, P2277, DOI 10.1073/pnas.82.8.2277; FUJISAWA J, 1986, EMBO J, V5, P713, DOI 10.1002/j.1460-2075.1986.tb04272.x; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GIAM CZ, 1986, P NATL ACAD SCI USA, V83, P7192, DOI 10.1073/pnas.83.19.7192; GOH WC, 1985, SCIENCE, V227, P1227, DOI 10.1126/science.2983419; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; INOUE J, 1986, EMBO J, V5, P2883, DOI 10.1002/j.1460-2075.1986.tb04583.x; JEANG KT, 1988, J VIROL, V62, P4499, DOI 10.1128/JVI.62.12.4499-4509.1988; JOSEPHS SF, 1984, VIROLOGY, V139, P340, DOI 10.1016/0042-6822(84)90379-9; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KALYANARAMAN VS, 1981, NATURE, V294, P271, DOI 10.1038/294271a0; KALYANARAMAN VS, 1982, P NATL ACAD SCI-BIOL, V79, P1653, DOI 10.1073/pnas.79.5.1653; KIYOKAWA T, 1985, VIROLOGY, V147, P462, DOI 10.1016/0042-6822(85)90149-7; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; MARUYAMA M, 1987, CELL, V48, P343, DOI 10.1016/0092-8674(87)90437-5; MIYATAKE S, 1988, MOL CELL BIOL, V8, P5581, DOI 10.1128/MCB.8.12.5581; MIYATAKE S, 1988, NUCLEIC ACIDS RES, V16, P6547, DOI 10.1093/nar/16.14.6547; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NERENBERG M, 1987, SCIENCE, V237, P1324, DOI 10.1126/science.2888190; NYBORG JK, 1988, P NATL ACAD SCI USA, V85, P1457, DOI 10.1073/pnas.85.5.1457; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; PARK RE, 1988, ONCOGENE, V3, P275; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; ROSEN CA, 1985, P NATL ACAD SCI USA, V82, P6502, DOI 10.1073/pnas.82.19.6502; ROSEN CA, 1987, P NATL ACAD SCI USA, V84, P4919, DOI 10.1073/pnas.84.14.4919; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; SAITO S, 1988, J VIROL, V62, P6444; SALAHUDDIN SZ, 1983, VIROLOGY, V129, P51, DOI 10.1016/0042-6822(83)90395-1; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SEIKI M, 1986, EMBO J, V5, P561, DOI 10.1002/j.1460-2075.1986.tb04247.x; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIEKEVITZ M, 1987, P NATL ACAD SCI USA, V84, P5389, DOI 10.1073/pnas.84.15.5389; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SODROSKI JG, 1985, J VIROL, V55, P831, DOI 10.1128/JVI.55.3.831-835.1985; SODROSKI JG, 1984, SCIENCE, V226, P177; SODROSKI JG, 1985, SCIENCE, V228, P430; TAN TH, 1989, MOL CELL BIOL, V9, P1733, DOI 10.1128/MCB.9.4.1733; WONGSTAAL F, 1983, NATURE, V302, P626, DOI 10.1038/302626a0; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031	56	8	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					361	368						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2314899				2022-12-28	WOS:A1990CW41500014
J	BRUSKIN, A; JACKSON, J; BISHOP, JM; MCCARLEY, DJ; SCHATZMAN, RC				BRUSKIN, A; JACKSON, J; BISHOP, JM; MCCARLEY, DJ; SCHATZMAN, RC			6 AMINO-ACIDS FROM THE RETROVIRAL GENE GAG GREATLY ENHANCE THE TRANSFORMING POTENTIAL OF THE ONCOGENE V-ERB-B	ONCOGENE			English	Article									SYNTEX INC,53-1,3401 HILLVIEW AVE,PALO ALTO,CA 94304; UNIV CALIF SAN FRANCISCO,GEORGE WILLIAMS HOOPER FDN,SAN FRANCISCO,CA 94143	Syntex Corporation; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R35CA044338, R01CA012705] Funding Source: NIH RePORTER; NCI NIH HHS [CA12705, CA44338] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; ANDERSON SM, 1980, J VIROL, V36, P676, DOI 10.1128/JVI.36.3.676-683.1980; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BASSIRI M, 1986, J VIROL, V58, P525; BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BEUG H, 1984, CELL, V36, P963, DOI 10.1016/0092-8674(84)90046-1; BISHOP JM, 1985, RNA TUMOR VIRUSES S, V2, P249; BISTER K, 1980, P NATL ACAD SCI-BIOL, V77, P7142, DOI 10.1073/pnas.77.12.7142; BISTER K, 1979, P NATL ACAD SCI USA, V76, P5023, DOI 10.1073/pnas.76.10.5023; BROWN AMC, 1987, DNA CLONING, V3, P189; DAVIS AR, 1981, P NATL ACAD SCI-BIOL, V78, P5376, DOI 10.1073/pnas.78.9.5376; DEBUIRE B, 1984, SCIENCE, V224, P1456, DOI 10.1126/science.6328658; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; FREEMAN AE, 1973, P NATL ACAD SCI USA, V70, P2415, DOI 10.1073/pnas.70.8.2415; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUNG YKT, 1983, CELL, V33, P357, DOI 10.1016/0092-8674(83)90417-8; GAMETT DC, 1986, P NATL ACAD SCI USA, V83, P6053, DOI 10.1073/pnas.83.16.6053; GAZIT A, 1986, J VIROL, V60, P19, DOI 10.1128/JVI.60.1.19-28.1986; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; GRAF T, 1976, VIROLOGY, V71, P423, DOI 10.1016/0042-6822(76)90370-6; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAYMAN MJ, 1979, VIROLOGY, V92, P31, DOI 10.1016/0042-6822(79)90212-5; HAYMAN MJ, 1983, CELL, V32, P579, DOI 10.1016/0092-8674(83)90477-4; HENRY C, 1985, VIROLOGY, V140, P179, DOI 10.1016/0042-6822(85)90457-X; HJELLE B, 1988, P NATL ACAD SCI USA, V85, P4355, DOI 10.1073/pnas.85.12.4355; HU SSF, 1978, VIROLOGY, V89, P162, DOI 10.1016/0042-6822(78)90049-1; ISHIZAKI R, 1979, CANCER RES, V30, P2827; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1983, J VIROL, V48, P565, DOI 10.1128/JVI.48.3.565-572.1983; KLINKEN SP, 1988, ONCOGENE RES, V3, P187; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LAI MMC, 1980, VIROLOGY, V100, P475, DOI 10.1016/0042-6822(80)90537-1; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; MANIATIS T, 1982, MOL CLONING LABORATO, P157; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MAXIM AM, 1977, P NATL ACAD SCI USA, V74, P560; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0; PAWSON T, 1980, J VIROL, V34, P280, DOI 10.1128/JVI.34.1.280-284.1980; PIERCE JH, 1986, CURR TOP MICROBIOL, V132, P55; PRIVALSKY ML, 1982, P NATL ACAD SCI-BIOL, V79, P3958, DOI 10.1073/pnas.79.13.3958; PRIVALSKY ML, 1984, P NATL ACAD SCI-BIOL, V81, P704, DOI 10.1073/pnas.81.3.704; PRIVALSKY ML, 1983, CELL, V32, P1257, DOI 10.1016/0092-8674(83)90307-0; RAINES MA, 1985, P NATL ACAD SCI USA, V82, P2287, DOI 10.1073/pnas.82.8.2287; RETTENMIER CW, 1979, J VIROL, V32, P749, DOI 10.1128/JVI.32.3.749-761.1979; RUSHLOW KE, 1982, SCIENCE, V216, P1421, DOI 10.1126/science.6283631; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHATZMAN RC, 1986, MOL CELL BIOL, V6, P1329, DOI 10.1128/MCB.6.4.1329; SEALY L, 1983, VIROLOGY, V130, P155, DOI 10.1016/0042-6822(83)90125-3; SEALY L, 1983, VIROLOGY, V130, P179, DOI 10.1016/0042-6822(83)90126-5; SHEINESS D, 1981, CELL, V23, P291, DOI 10.1016/0092-8674(81)90293-2; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; VENNSTROM B, 1980, J VIROL, V36, P575; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WELLS A, 1988, P NATL ACAD SCI USA, V85, P7597, DOI 10.1073/pnas.85.20.7597; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X	61	24	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					15	24						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	1969616				2022-12-28	WOS:A1990CM62000003
J	NASI, S; SIRINIAN, MI; PANETTA, G; MARCHETTI, A; JUCKER, R				NASI, S; SIRINIAN, MI; PANETTA, G; MARCHETTI, A; JUCKER, R			INDUCTION OF THE NEOPLASTIC PHENOTYPE OF EBV-ESTABLISHED LYMPHOCYTES-B BY THE HUMAN HA-RAS ONCOGENE	ONCOGENE			English	Article											NASI, S (corresponding author), UNIV LA SAPIENZA,DIPARTIMENTO GENET & BIOL MOLEC,CNR,CTR STUDIO ACIDI NUCL,P A MORO 5,I-00185 ROME,ITALY.		Marchetti, Alessandra/AAD-5498-2019	MARCHETTI, ALESSANDRA/0000-0001-9706-848X				Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BENEDICT WF, 1987, ADV VIRAL ONCOL, V7, P19; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CHANG EH, 1982, NATURE, V297, P479, DOI 10.1038/297479a0; CICHUTEK K, 1986, P NATL ACAD SCI USA, V83, P2340, DOI 10.1073/pnas.83.8.2340; DETHE G, 1970, INT J CANCER, V6, P189, DOI 10.1002/ijc.2910060206; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FISCHERFANTUZZI L, 1987, ONCOGENE RES, V1, P229; FOON KA, 1986, BLOOD, V68, P1; GORDON J, 1985, INT J CANCER, V35, P251, DOI 10.1002/ijc.2910350218; GREAVES MF, 1986, BLOOD, V67, P1; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KLEIN G, 1985, IMMUNOL TODAY, V6, P208, DOI 10.1016/0167-5699(85)90036-2; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; MORSE B, 1989, MOL CELL BIOL, V9, P74, DOI 10.1128/MCB.9.1.74; NILSSON K, 1977, INT J CANCER, V19, P337, DOI 10.1002/ijc.2910190309; NILSSON K, 1982, ADV CANCER RES, V37, P319, DOI 10.1016/S0065-230X(08)60886-6; PATERSON H, 1987, CELL, V51, P803, DOI 10.1016/0092-8674(87)90103-6; PIERCE JH, 1982, J EXP MED, V156, P873, DOI 10.1084/jem.156.3.873; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; PULVERTA.RJ, 1965, J CLIN PATHOL, V18, P261, DOI 10.1136/jcp.18.3.261; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RAGONA G, 1986, CELL BIOL INT REP, V10, P315, DOI 10.1016/0309-1651(86)90002-0; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SEREMETIS S, 1989, SCIENCE, V243, P660, DOI 10.1126/science.2536954; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; STANBRIDGE EJ, 1982, SCIENCE, V215, P252, DOI 10.1126/science.7053574; STEVENSON M, 1986, MOL CELL BIOL, V6, P3410, DOI 10.1128/MCB.6.10.3410; SULLIVAN NF, 1986, CANCER RES, V46, P6427; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WINTER E, 1986, MOL CELL BIOL, V6, P2562, DOI 10.1128/MCB.6.7.2562; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904	49	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					117	122						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157177				2022-12-28	WOS:A1990CM62000016
J	SCHATZL, HM; VONDERHELM, K				SCHATZL, HM; VONDERHELM, K			V-SIS GENE (SSV) IS EXPRESSED TRANSIENTLY AND INDEPENDENTLY OF V-GAG (SSAV) AFTER INFECTION OF FIBROBLASTS WITH SSV SSAV	ONCOGENE			English	Article									UNIV MUNICH, MAX VONPETTENKOFER INST HYG & MED MICROBIOL, D-8000 MUNICH 2, GERMANY	University of Munich			Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740				ALITALO R, 1987, EMBO J, V6, P1213, DOI 10.1002/j.1460-2075.1987.tb02356.x; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1986, P NATL ACAD SCI USA, V83, P6440, DOI 10.1073/pnas.83.17.6440; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; BORN M, 1982, EMBO J, V1, P1029, DOI 10.1002/j.1460-2075.1982.tb01291.x; BOWENPOPE DF, 1984, P NATL ACAD SCI-BIOL, V81, P2396, DOI 10.1073/pnas.81.8.2396; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COLAMONICI OR, 1986, MOL CELL BIOL, V6, P1847, DOI 10.1128/MCB.6.5.1847; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; CROCE CM, 1984, CANCER CELL, V2, P235; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; DEINHARDT F, 1978, Z NATURFORSCH C, V33, P969; DEINHARDT F, 1980, VIRAL ONCOLOGY, P357; DELLAFAVERA R, 1981, NATURE, V292, P31; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; FORSBERG K, 1988, J CELL PHYSIOL, V136, P266, DOI 10.1002/jcp.1041360208; GARRETT JS, 1984, P NATL ACAD SCI-BIOL, V81, P7466, DOI 10.1073/pnas.81.23.7466; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; JOHNSSON A, 1986, EMBO J, V5, P1535, DOI 10.1002/j.1460-2075.1986.tb04394.x; JOHNSSON A, 1985, P NATL ACAD SCI USA, V82, P1721, DOI 10.1073/pnas.82.6.1721; KELLY JM, 1985, EUR J BIOCHEM, V153, P367, DOI 10.1111/j.1432-1033.1985.tb09312.x; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRONKE M, 1987, P NATL ACAD SCI USA, V84, P469, DOI 10.1073/pnas.84.2.469; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; MAJESKY MW, 1988, P NATL ACAD SCI USA, V85, P1524, DOI 10.1073/pnas.85.5.1524; MAKELA TP, 1987, MOL CELL BIOL, V7, P3656; Maniatis T., 1982, MOL CLONING; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1986, TRENDS BIOCHEM SCI, V11, P129, DOI 10.1016/0968-0004(86)90066-6; PANTAZIS P, 1986, P NATL ACAD SCI USA, V83, P6455, DOI 10.1073/pnas.83.17.6455; REED JC, 1985, P NATL ACAD SCI USA, V82, P4221, DOI 10.1073/pnas.82.12.4221; ROBBINS KC, 1981, P NATL ACAD SCI-BIOL, V78, P2918, DOI 10.1073/pnas.78.5.2918; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SELIGER B, 1987, J VIROL, V61, P2567, DOI 10.1128/JVI.61.8.2567-2572.1987; STACEY DW, 1987, MOL CELL BIOL, V7, P523, DOI 10.1128/MCB.7.1.523; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WOLFE LG, 1971, JNCI-J NATL CANCER I, V47, P1115; WYLLIE AH, 1987, BRIT J CANCER, V56, P251, DOI 10.1038/bjc.1987.186; ZULLO J, 1987, P NATL ACAD SCI USA, V84, P1210, DOI 10.1073/pnas.84.5.1210; ZULLO JN, 1985, CELL, V43, P793, DOI 10.1016/0092-8674(85)90252-1	52	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	1989	4	9					1095	1101						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AM531	2550873				2022-12-28	WOS:A1989AM53100007
J	PENDERGAST, AM; CLARK, R; KAWASAKI, ES; MCCORMICK, FP; WITTE, ON				PENDERGAST, AM; CLARK, R; KAWASAKI, ES; MCCORMICK, FP; WITTE, ON			BACULOVIRUS EXPRESSION OF FUNCTIONAL P210 BCR-ABL ONCOGENE PRODUCT	ONCOGENE			English	Article									UNIV CALIF LOS ANGELES,INST MOLEC BIOL,405 HILGARD AVE,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT MICROBIOL,LOS ANGELES,CA 90024; CETUS CORP,DEPT MOLEC BIOL,EMERYVILLE,CA 94608; HOWARD HUGHES MED INST,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute				Pendergast, Ann Marie/0000-0002-1250-6880				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CLARK SS, 1988, SCIENCE, V239, P775, DOI 10.1126/science.3422516; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; COLLINS SJ, 1984, SCIENCE, V225, P72, DOI 10.1126/science.6587568; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; DAVIS RL, 1985, MOL CELL BIOL, V5, P204, DOI 10.1128/MCB.5.1.204; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; FERGUSON B, 1985, J BIOL CHEM, V260, P3652; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; GROSVELD G, 1986, MOL CELL BIOL, V6, P607, DOI 10.1128/MCB.6.2.607; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HUNTER T, 1986, ENZYMES, V17, P191; JEANG KT, 1987, J VIROL, V61, P1761, DOI 10.1128/JVI.61.5.1761-1764.1987; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MAIORELLA B, 1988, IN PRESS BIOTECHNOLO; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MESMASSON AM, 1986, P NATL ACAD SCI USA, V83, P9768, DOI 10.1073/pnas.83.24.9768; MIYAMOTO C, 1985, MOL CELL BIOL, V5, P2860, DOI 10.1128/MCB.5.10.2860; MURPHY CI, 1988, J VIROL, V62, P2951, DOI 10.1128/JVI.62.8.2951-2959.1988; NOWELL PC, 1960, SCIENCE, V132, P1497; OLLO R, 1987, P NATL ACAD SCI USA, V84, P5700, DOI 10.1073/pnas.84.16.5700; RICE WC, 1987, J VIROL, V61, P1712, DOI 10.1128/JVI.61.5.1712-1716.1987; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHNEIDER C, 1982, J BIOL CHEM, V257, P766; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; SMITH GE, 1985, P NATL ACAD SCI USA, V82, P8404, DOI 10.1073/pnas.82.24.8404; Summers MD, 1987, TEXAS AGR EXPT STATI; WANG JYJ, 1985, J BIOL CHEM, V260, P64; YOUNG JC, 1988, MOL CELL BIOL, V8, P4079, DOI 10.1128/MCB.8.10.4079; ZIEGLER SF, 1981, CELL, V27, P477, DOI 10.1016/0092-8674(81)90389-5	41	32	36	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1989	4	6					759	766						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2499863				2022-12-28	WOS:A1989AA66000012
J	BOS, TJ; RAUSCHER, FJ; CURRAN, T; VOGT, PK				BOS, TJ; RAUSCHER, FJ; CURRAN, T; VOGT, PK			THE CARBOXY TERMINUS OF THE VIRAL JUN ONCOPROTEIN IS REQUIRED FOR COMPLEX-FORMATION WITH THE CELLULAR FOS PROTEIN	ONCOGENE			English	Article									UNIV SO CALIF,SCH MED,DEPT MICROBIOL,2011 ZONAL AVE,HMR 401,LOS ANGELES,CA 90033; ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110	University of Southern California			Curran, Tom/C-1164-2008; Curran, Thomas/AAE-7631-2019; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018	Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Vogt, Peter K/0000-0002-4519-7500	NATIONAL CANCER INSTITUTE [F32CA008411, R35CA042564] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42564, CA 08411] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BALL AR, 1988, IN PRESS COLD SPRING, V53; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1988, IN PRESS COLD SPRING, V53; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; NISHIMURA T, 1988, IN PRESS ONCOGENE; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0	22	28	28	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					123	126						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2494630				2022-12-28	WOS:A1989U567500001
J	COHEN, JA; WEINER, DB; MORE, KF; KOKAI, Y; WILLIAMS, WV; MAGUIRE, HC; LIVOLSI, VA; GREENE, MI				COHEN, JA; WEINER, DB; MORE, KF; KOKAI, Y; WILLIAMS, WV; MAGUIRE, HC; LIVOLSI, VA; GREENE, MI			EXPRESSION PATTERN OF THE NEU (NGL) GENE-ENCODED GROWTH-FACTOR RECEPTOR PROTEIN (P185NEU) IN NORMAL AND TRANSFORMED EPITHELIAL TISSUES OF THE DIGESTIVE-TRACT	ONCOGENE			English	Article									UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania			Weiner, David B/H-8579-2014	Williams, William/0000-0003-3611-9284				ALLEN DC, 1987, J CLIN PATHOL, V40, P157, DOI 10.1136/jcp.40.2.157; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BERGER MS, 1988, CANCER RES, V48, P1238; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; CICLITIRA PJ, 1987, J PATHOL, V151, P293, DOI 10.1002/path.1711510409; CLINE MJ, 1987, CANCER, V60, P2669, DOI 10.1002/1097-0142(19871201)60:11<2669::AID-CNCR2820601116>3.0.CO;2-4; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIXON WJ, 1969, INTRO STATISTICAL AN; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; FURTH ME, 1987, ONCOGENE, V1, P47; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORI S, 1987, VIRCHOWS ARCH B, V54, P8, DOI 10.1007/BF02899192; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SCHEJTER ED, 1986, CELL, V46, P1092; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONDIK EJ, 1986, NIH872789 NCI PUBL; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STEWART J, 1986, BRIT J CANCER, V53, P1, DOI 10.1038/bjc.1986.1; STOICA G, 1984, AM J PATHOL, V116, P319; SU TS, 1985, BIOCHEM BIOPH RES CO, V132, P264, DOI 10.1016/0006-291X(85)91017-4; TANAKA T, 1986, CANCER RES, V46, P1465; THOR A, 1984, NATURE, V311, P562, DOI 10.1038/311562a0; TROJANOWSKI JQ, 1983, J HISTOCHEM CYTOCHEM, V31, P1217, DOI 10.1177/31.10.6350434; TSUBOI K, 1987, BIOCHEM BIOPH RES CO, V146, P699, DOI 10.1016/0006-291X(87)90585-7; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; WILLIAMSON RCN, 1978, NEW ENGL J MED, V298, P1444, DOI 10.1056/NEJM197806292982604; WILLIAMSON RCN, 1978, NEW ENGL J MED, V298, P1393, DOI 10.1056/NEJM197806222982505; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YOKOTA J, 1988, ONCOGENE, V2, P283; YOKOTA J, 1986, LANCET, V1, P765; ZHANG XK, 1987, BIOCHEM BIOPH RES CO, V142, P932, DOI 10.1016/0006-291X(87)91503-8; ZHOU DJ, 1987, CANCER RES, V47, P6123	50	134	158	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					81	88						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2563577				2022-12-28	WOS:A1989U567400012
J	ETIEMBLE, J; MOROY, T; JACQUEMIN, E; TIOLLAIS, P; BUENDIA, MA				ETIEMBLE, J; MOROY, T; JACQUEMIN, E; TIOLLAIS, P; BUENDIA, MA			FUSED TRANSCRIPTS OF C-MYC AND A NEW CELLULAR LOCUS, HCR IN A PRIMARY LIVER-TUMOR	ONCOGENE			English	Article									HOP BICETRE,INSERM,U56,F-94275 KREMLIN BICETRE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	ETIEMBLE, J (corresponding author), INST PASTEUR,UNITE RECOMBINAISON & EXPRESS GENET,CNRS,UA 271,INSERM,U163,F-75724 PARIS 15,FRANCE.		Moroy, Tarik/D-9923-2011; jacquemin, emmanuel/J-8673-2013					ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ALEXANDER WS, 1987, MOL CELL BIOL, V7, P1436, DOI 10.1128/MCB.7.4.1436; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BORNKAMM GW, 1988, CELLULAR ONCOGENE AC; CHUNG J, 1987, CELL, V51, P1001, DOI 10.1016/0092-8674(87)90586-1; CORCORAN LM, 1985, CELL, V40, P71, DOI 10.1016/0092-8674(85)90310-1; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DANI C, 1984, P NATL ACAD SCI USA, V83, P295; DEAN M, 1983, NATURE, V305, P443, DOI 10.1038/305443a0; FERRE F, 1986, CR ACAD SCI III-VIE, V303, P633; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6419, DOI 10.1093/nar/15.16.6419; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; KAKKIS E, 1988, NUCLEIC ACIDS RES, V16, P77, DOI 10.1093/nar/16.1.77; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; Maniatis T., 1982, MOL CLONING; MOROY T, 1985, EMBO J, V4, P1507, DOI 10.1002/j.1460-2075.1985.tb03810.x; MOROY T, 1986, NATURE, V324, P276, DOI 10.1038/324276a0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NISHIKURA K, 1984, SCIENCE, V224, P399, DOI 10.1126/science.6424234; NISHIKURA K, 1983, P NATL ACAD SCI-BIOL, V80, P4822, DOI 10.1073/pnas.80.15.4822; PACHL C, 1983, CELL, V33, P335, DOI 10.1016/0092-8674(83)90415-4; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; PREHN J, 1984, NUCLEIC ACIDS RES, V23, P8987; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; RAY D, 1987, MOL CELL BIOL, V7, P940, DOI 10.1128/MCB.7.2.940; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SNYDER RL, 1980, COLD SPRING HARBOR C, V7, P447; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STANTON LW, 1984, NATURE, V310, P423, DOI 10.1038/310423a0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322; SULLIVAN NF, 1986, COLD SPRING HARB SYM, V51, P943, DOI 10.1101/SQB.1986.051.01.107; TAYLOR MV, 1986, EMBO J, V5, P3563, DOI 10.1002/j.1460-2075.1986.tb04683.x; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175	49	36	40	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					51	57						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2644611				2022-12-28	WOS:A1989U567400008
J	BRADY, G; WILLIAMS, RL; NORDSTROM, K; VENNSTROM, B; ISCOVE, NN				BRADY, G; WILLIAMS, RL; NORDSTROM, K; VENNSTROM, B; ISCOVE, NN			A SELECTABLE TEMPERATURE-SENSITIVE V-SRC MOLONEY RETROVIRUS	ONCOGENE			English	Article									EUROPEAN MOLEC BIOL LAB, D-6900 HEIDELBERG, FED REP GER; KAROLINSKA INST, CMB, S-10401 STOCKHOLM 60, SWEDEN	European Molecular Biology Laboratory (EMBL); Karolinska Institutet	BRADY, G (corresponding author), ONTARIO CANC INST, 500 SHERBOURNE ST, TORONTO M4X 1K9, ONTARIO, CANADA.							ANDERSON SM, 1987, VIROLOGY, V160, P263, DOI 10.1016/0042-6822(87)90070-5; ANDERSON SM, 1983, J VIROL, V46, P594, DOI 10.1128/JVI.46.2.594-605.1983; BOULTER CA, 1987, NUCLEIC ACIDS RES, V15, P7194, DOI 10.1093/nar/15.17.7194; BOULTER CA, 1988, ONCOGENE, V2, P207; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; COOPER JA, 1981, MOL CELL BIOL, V1, P165, DOI 10.1128/MCB.1.2.165; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; GRAF T, 1973, VIROLOGY, V56, P369, DOI 10.1016/0042-6822(73)90314-0; GRAF T, 1976, VIROLOGY, V72, P283, DOI 10.1016/0042-6822(76)90332-9; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; WATSON JD, 1987, J IMMUNOL, V139, P123; WYKE JA, 1987, BIOCHIM BIOPHYS ACTA, V907, P47, DOI 10.1016/0304-419X(87)90018-7; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	19	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					687	689						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2485257				2022-12-28	WOS:A1988R646000010
J	NICOLAIEW, N; TRIQUENEAUX, G; DAUTRY, F				NICOLAIEW, N; TRIQUENEAUX, G; DAUTRY, F			ORGANIZATION OF THE HUMAN N-RAS LOCUS - CHARACTERIZATION OF A GENE LOCATED IMMEDIATELY UPSTREAM OF N-RAS	ONCOGENE			English	Article							PROTO-ONCOGENE; MESSENGER-RNA; DROSOPHILA-MELANOGASTER; PROMOTER REGION; EXPRESSION; MOUSE; CDNA; ACTIVATION; SEQUENCE; CLONING	The mammalian ras genes have been implicated in a wide variety of natural and experimental tumors. They code for small GTP binding proteins which are believed to play a central role in the control of cellular proliferation and differentiation. We have investigated the transcriptional organization of the human N-ras locus and characterized a transcription unit located immediately upstream of N-ras, which we designate by NRU for N-ras Upstream. NRU messages contain an open reading frame of 767 amino acids which shows no similarity with the ras proteins and provides no clue to the function of the corresponding protein. Of the order of 150 nucleotides separate the N-ras transcription initiation sites from the last NRU polyadenylation site and the same organization is present in the murine genome. Both genes are simultaneously expressed in all the cell lines and murine tissues we have analysed, and in all cases NRU messages accumulate to a higher level than those of N-ras. The small intergenic distance implies that, during transcription of NRU, RNA polymerases transcribe a substantial part of the N-ras gene, suggesting that this genetic organization participates in the regulation of N-ras expression.	INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,UA 1158,F-94805 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy	DAUTRY, F (corresponding author), INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,UA 1158,F-94805 VILLEJUIF,FRANCE.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; Berger S.L., 1987, METHODS ENZYMOLOGY, V152; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; CHANG EC, 1982, NATURE, V304, P507; CHANG HY, 1987, ONCOGENE RES, V1, P129; CHARDIN P, 1988, BIOCHIMIE, V70, P865, DOI 10.1016/0300-9084(88)90226-X; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; DONIGER J, 1987, ONCOGENE, V1, P331; DONIGER J, 1988, NUCLEIC ACIDS RES, V16, P969, DOI 10.1093/nar/16.3.969; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FIORUCCI G, 1988, BIOCHIM BIOPHYS ACTA, V950, P81, DOI 10.1016/0167-4781(88)90076-0; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; HILL SA, 1988, J NATL CANCER I, V80, P484, DOI 10.1093/jnci/80.7.484; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592; HUMPHREY T, 1988, TRENDS GENET, V4, P243, DOI 10.1016/0168-9525(88)90028-5; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; JEFFERS M, 1990, NUCLEIC ACIDS RES, V18, P4891; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LEWIN B, 1990, GENES, V4; LOWNDES NF, 1989, MOL CELL BIOL, V9, P3758, DOI 10.1128/MCB.9.9.3758; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MCHUGH KM, 1988, MOL CELL BIOL, V8, P5224, DOI 10.1128/MCB.8.12.5224; MEIJER D, 1987, EMBO J, V6, P4041, DOI 10.1002/j.1460-2075.1987.tb02749.x; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; Sambrook J., 1989, MOL CLONING; SCHULZ RA, 1989, GENE DEV, V3, P232, DOI 10.1101/gad.3.2.232; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; Weil D, 1988, Oncogene Res, V3, P409; WILLIAMS T, 1988, P NATL ACAD SCI USA, V85, P3527, DOI 10.1073/pnas.85.10.3527; YANICOSTAS C, 1989, MOL CELL BIOL, V9, P2526, DOI 10.1128/MCB.9.6.2526	38	22	23	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					721	730						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052355				2022-12-28	WOS:A1991GT82500006
J	COPPOLA, JA; LEWIS, BA; COLE, MD				COPPOLA, JA; LEWIS, BA; COLE, MD			INCREASED RETINOBLASTOMA GENE-EXPRESSION IS ASSOCIATED WITH LATE STAGES OF DIFFERENTIATION IN MANY DIFFERENT CELL-TYPES	ONCOGENE			English	Note									PRINCETON UNIV,DEPT BIOL,PRINCETON,NJ 08544	Princeton University								ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; BUKOVICH K, 1989, CELL, V58, P1097; CARAVATTI M, 1982, J MOL BIOL, V160, P59, DOI 10.1016/0022-2836(82)90131-0; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DECAPRIO, 1989, CELL, V54, P275; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5; KYRITSIS AP, 1984, NATURE, V307, P471, DOI 10.1038/307471a0; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MURPHREE AL, 1984, SCIENCE, V223, P1028, DOI 10.1126/science.6320372; REZNIKOFF CA, 1973, CANCER RES, V33, P3231; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; TERADA M, 1977, P NATL ACAD SCI USA, V74, P248, DOI 10.1073/pnas.74.1.248	25	78	78	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1731	1733						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267138				2022-12-28	WOS:A1990EL40100018
J	HART, PA; MARSHALL, CJ				HART, PA; MARSHALL, CJ			AMINO-ACID 61 IS A DETERMINANT OF SENSITIVITY OF RAP PROTEINS TO THE RAS GTPASE ACTIVATING PROTEIN	ONCOGENE			English	Note									INST CANC RES,CHESTER BEATTY LABS,FULHAM RD,LONDON SW3 6JB,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; GARRETT MD, 1989, J BIOL CHEM, V264, P10; HALL A, 1990, G PROTEINS MEDIATORS, P173; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PIZON V, 1988, ONCOGENE, V3, P201; QUINN MT, 1989, NATURE, V342, P198, DOI 10.1038/342198a0; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646	23	23	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1099	1101						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115644				2022-12-28	WOS:A1990DP41500025
J	MILLER, WH; MOY, D; LI, A; GRIPPO, JF; DMITROVSKY, E				MILLER, WH; MOY, D; LI, A; GRIPPO, JF; DMITROVSKY, E			RETINOIC ACID INDUCES DOWN-REGULATION OF SEVERAL GROWTH-FACTORS AND PROTOONCOGENES IN A HUMAN EMBRYONAL CANCER CELL-LINE	ONCOGENE			English	Article									CORNELL UNIV,MED CTR,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT MED,DIV SOLID TUMOR ONCOL,NEW YORK,NY 10021; HOFFMANN LA ROCHE INC,DEPT TOXICOL & PATHOL,NUTLEY,NJ 07110	Cornell University; Memorial Sloan Kettering Cancer Center; Roche Holding								ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ADAMSON ED, 1979, CELL, V17, P469, DOI 10.1016/0092-8674(79)90254-X; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1986, DIFFERENTIATION, V31, P119, DOI 10.1111/j.1432-0436.1986.tb00392.x; ANDREWS PW, 1984, LAB INVEST, V50, P147; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BROOKES S, 1989, ONCOGENE, V4, P429; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CUYPERS HT, 1984, CELL, V37, P141; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; DESCHAMPS J, 1987, P NATL ACAD SCI USA, V84, P1304, DOI 10.1073/pnas.84.5.1304; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DMITROVSKY E, 1990, IN PRESS ONCOGENE RE; DONY C, 1988, DIFFERENTIATION, V37, P115, DOI 10.1111/j.1432-0436.1988.tb00803.x; DONY C, 1985, NATURE, V317, P636, DOI 10.1038/317636a0; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; EDWARDS SA, 1986, EXP CELL RES, V165, P473, DOI 10.1016/0014-4827(86)90600-2; EDWARDS SA, 1988, DEV BIOL, V129, P91, DOI 10.1016/0012-1606(88)90164-9; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; FINKLESTEIN R, 1988, ONCOGENE RES, V3, P287; Fogh J, 1978, Natl Cancer Inst Monogr, P5; FUNG YKT, 1985, MOL CELL BIOL, V5, P3337, DOI 10.1128/MCB.5.12.3337; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRIEP AE, 1986, P NATL ACAD SCI USA, V83, P5539, DOI 10.1073/pnas.83.15.5539; GRIEP AE, 1988, P NATL ACAD SCI USA, V85, P6806, DOI 10.1073/pnas.85.18.6806; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HALABAN R, 1988, ONCOGENE RES, V3, P177; HAUSER CA, 1985, CELL, V43, P19, DOI 10.1016/0092-8674(85)90008-X; HELMAN LJ, 1988, J BIOL CHEM, V263, P11559; INGVARSSON S, 1988, ONCOGENE, V3, P679; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KAYE F, 1988, MOL CELL BIOL, V8, P186, DOI 10.1128/MCB.8.1.186; LEE VMY, 1986, J NEUROSCI, V6, P514; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MULLER R, 1986, TRENDS BIOCHEM SCI, V11, P129, DOI 10.1016/0968-0004(86)90066-6; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; MYERS MW, 1987, EMBO J, V6, P1617, DOI 10.1002/j.1460-2075.1987.tb02409.x; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; PIERCE GB, 1974, CURRENT TOPICS MOL B, P223; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; REES AR, 1979, NATURE, V281, P309, DOI 10.1038/281309a0; RIZZINO A, 1988, DEV BIOL, V129, P61, DOI 10.1016/0012-1606(88)90161-3; RIZZINO A, 1987, CANCER RES, V47, P4386; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SAMBUCETTI LC, 1986, GENE, V43, P69, DOI 10.1016/0378-1119(86)90009-0; SCOTT RW, 1984, NATURE, V310, P562, DOI 10.1038/310562a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STERNFELD MD, 1988, J CELL PHYSIOL, V136, P297, DOI 10.1002/jcp.1041360212; STRICKLAND S, 1980, DEV BIOL, V78, P76, DOI 10.1016/0012-1606(80)90319-X; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TSUTSUI Y, 1987, CELL DIFFER DEV, V21, P137, DOI 10.1016/0045-6039(87)90421-0; VERMA IM, 1987, ADV CANCER RES, V49, P29, DOI 10.1016/S0065-230X(08)60793-9; WANG N, 1980, CANCER RES, V40, P796; WANG SY, 1983, P NATL ACAD SCI-BIOL, V80, P5880, DOI 10.1073/pnas.80.19.5880; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V157, P618, DOI 10.1016/S0006-291X(88)80295-X; ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0; ZEUTHEN J, 1980, INT J CANCER, V25, P19, DOI 10.1002/ijc.2910250104	72	102	102	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					511	517						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2158037				2022-12-28	WOS:A1990DB85300009
J	MAHADEVAN, LC; WILLS, AJ; HIRST, EA; RATHJEN, PD; HEATH, JK				MAHADEVAN, LC; WILLS, AJ; HIRST, EA; RATHJEN, PD; HEATH, JK			2-AMINOPURINE ABOLISHES EGF-STIMULATED AND TPA-STIMULATED PP33 PHOSPHORYLATION AND C-FOS INDUCTION WITHOUT AFFECTING THE ACTIVATION OF PROTEIN KINASE-C	ONCOGENE			English	Article											MAHADEVAN, LC (corresponding author), UNIV OXFORD,DEPT BIOCHEM,S PARKS RD,OXFORD OX1 3QU,ENGLAND.							ALEXANDER DR, 1989, BIOCHEM J, V260, P893, DOI 10.1042/bj2600893; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; BERRIDGE MJ, 1988, COLD SPRING HARB SYM, V53, P927, DOI 10.1101/SQB.1988.053.01.107; BLAKELEY MD, 1989, BIOCHEM J, V258, P177; BRAVO R, 1986, ONCOGENES GROWTH CON, P253; CHEN TA, 1987, P NATL ACAD SCI USA, V84, P5252, DOI 10.1073/pnas.84.15.5252; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOWNES CP, 1986, MOL ASPECTS CELLULAR, V4, P3; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; ERIKSON E, 1986, J BIOL CHEM, V261, P350; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; GANZ MB, 1989, NATURE, V337, P648, DOI 10.1038/337648a0; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALL DJ, 1989, MOL CELL BIOL, V9, P1705, DOI 10.1128/MCB.9.4.1705; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HEATH JK, 1986, EMBO J, V5, P1809, DOI 10.1002/j.1460-2075.1986.tb04430.x; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; HOCKBERGER P, 1989, NATURE, V338, P340, DOI 10.1038/338340a0; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; HUNTER T, 1988, COLD SPRING HARB SYM, V53, P131, DOI 10.1101/SQB.1988.053.01.019; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; JONES SD, 1988, COLD SPRING HARB SYM, V53, P531, DOI 10.1101/SQB.1988.053.01.061; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LIM RW, 1987, ONCOGENE, V1, P263; MAHADEVAN LC, 1987, EMBO J, V6, P921, DOI 10.1002/j.1460-2075.1987.tb04839.x; MAHADEVAN LC, 1989, ONCOGENE, V4, P699; MAHADEVAN LC, 1988, ONCOGENE, V2, P249; MAHADEVAN LC, 1989, IN PRESS RECEPTORS P; Maniatis T., 1982, MOL CLONING; MIYAMOTO NG, 1985, EMBO J, V5, P2577; MOOLENAAR WH, 1986, ONCOGENES GROWTH CON, P160; MOON SO, 1984, P NATL ACAD SCI-BIOL, V81, P2298, DOI 10.1073/pnas.81.8.2298; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; PRYWES R, 1987, MOL CELL BIOL, V7, P3482, DOI 10.1128/MCB.7.10.3482; PRYWES R, 1988, P NATL ACAD SCI USA, V85, P7206, DOI 10.1073/pnas.85.19.7206; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; ROZENGURT E, 1988, COLD SPRING HARB SYM, V53, P935; RYAN WA, 1989, EMBO J, V8, P1785, DOI 10.1002/j.1460-2075.1989.tb03572.x; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SARDET C, 1988, COLD SPRING HARB SYM, V53, P1011, DOI 10.1101/SQB.1988.053.01.116; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WEI C, 1987, CELL, V50, P1047; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; ZINN K, 1988, SCIENCE, V240, P210, DOI 10.1126/science.3281258	68	47	49	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					327	335						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2107492				2022-12-28	WOS:A1990CW41500010
J	THEILLET, C; ADNANE, J; SZEPETOWSKI, P; SIMON, MP; JEANTEUR, P; BIRNBAUM, D; GAUDRAY, P				THEILLET, C; ADNANE, J; SZEPETOWSKI, P; SIMON, MP; JEANTEUR, P; BIRNBAUM, D; GAUDRAY, P			BCL-1 PARTICIPATES IN THE 11Q13 AMPLIFICATION FOUND IN BREAST-CANCER	ONCOGENE			English	Note									UER MED & PHARM,LGMCH,F-06034 NICE,FRANCE; INSERM,U119,F-13009 MARSEILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	THEILLET, C (corresponding author), CTR PAUL LAMARQUE,CNRS,UNITE 1191,F-34094 MONTPELLIER,FRANCE.		SIMON, Marie-Pierre/B-8017-2012; Theillet, Charles/O-7634-2018	Theillet, Charles/0000-0001-5555-2759				ADELAIDE J, 1988, ONCOGENE, V2, P413; ADNANE J, 1989, ONCOGENE, V4, P147; ALI IU, 1989, ONCOGENE, V4, P89; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; GEBHART E, 1986, BREAST CANCER RES TR, V8, P125, DOI 10.1007/BF01807701; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P150, DOI 10.1159/000132313; HAYMAN MJ, 1985, P NATL ACAD SCI USA, V82, P8237, DOI 10.1073/pnas.82.23.8237; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; MOSCOW JA, 1988, P NATL ACAD SCI USA, V85, P6518, DOI 10.1073/pnas.85.17.6518; NGUYEN C, 1988, ONCOGENE, V3, P703; RABBITTS PH, 1988, ONCOGENE, V3, P99; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; THEILLET C, 1989, ONCOGENE, V4, P915; TRENT JM, 1987, GROWTH FACTORS ONCOG, P142; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; VARLEY JM, 1988, ONCOGENE, V3, P87; WADA A, 1988, BIOCHEM BIOPH RES CO, V157, P828, DOI 10.1016/S0006-291X(88)80324-3; WAHL GM, 1989, CANCER RES, V49, P1333; WILLIAMS BP, 1988, ONCOGENE, V3, P345; ZHOU DJ, 1988, ONCOGENE, V2, P279	24	116	116	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					147	149						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181375				2022-12-28	WOS:A1990CM62000020
J	DOLCETTI, R; RIZZO, S; VIEL, A; MAESTRO, R; DE RE, V; FERIOTTO, G; BOIOCCHI, M				DOLCETTI, R; RIZZO, S; VIEL, A; MAESTRO, R; DE RE, V; FERIOTTO, G; BOIOCCHI, M			N-MYC ACTIVATION BY PROVIRAL INSERTION IN MCF 247-INDUCED MURINE T-CELL LYMPHOMAS	ONCOGENE			English	Article									CTR RIFERIMENTO ONCOL, DIV EXPTL ONCOL 1, VIA PEDEMONTANA OCCIDENTALE, I-33081 AVIANO, ITALY	IRCCS Aviano (CRO)			Viel, Alessandra/J-7116-2018; Maestro, Roberta/M-1846-2015; DE RE, VALLI/AAA-1374-2019; Dolcetti, Riccardo/O-3832-2015; Maestro, Roberta/P-9748-2019; De Re, Valli/K-4121-2016; Rizzo, Silvana/AAW-1132-2020	Viel, Alessandra/0000-0003-2804-0840; Maestro, Roberta/0000-0002-6642-5592; DE RE, VALLI/0000-0001-6100-9373; Dolcetti, Riccardo/0000-0003-1625-9853; Maestro, Roberta/0000-0002-6642-5592; De Re, Valli/0000-0001-6100-9373; Rizzo, Silvana/0000-0002-7156-1783				ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; AMY CM, 1987, CANCER RES, V47, P6310; BOIOCCHI M, 1984, TUMORI, V70, P467, DOI 10.1177/030089168407000601; CHATTOPADHYAY SK, 1982, NATURE, V295, P25, DOI 10.1038/295025a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; CUYPERS HT, 1984, CELL, V37, P141; DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DOLCETTI R, 1988, EUR J CANCER CLIN ON, V24, P1321, DOI 10.1016/0277-5379(88)90223-4; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; FUNG YK, 1983, CELL, V33, P37; HARTLEY JW, 1977, P NATL ACAD SCI USA, V74, P789, DOI 10.1073/pnas.74.2.789; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; KAWASHIMA K, 1976, P NATL ACAD SCI USA, V73, P4680, DOI 10.1073/pnas.73.12.4680; KELLY M, 1983, J VIROL, V45, P291, DOI 10.1128/JVI.45.1.291-298.1983; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LI Y, 1984, P NATL ACAD SCI-BIOL, V81, P6808, DOI 10.1073/pnas.81.21.6808; LOWY DR, 1980, P NATL ACAD SCI-BIOL, V77, P614, DOI 10.1073/pnas.77.1.614; Maniatis T., 1982, MOL CLONING; MEIER R, 1980, NUCLEIC ACIDS, V16, P2340; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; NEEL BG, 1981, CELL, V23, P323, DOI 10.1016/0092-8674(81)90128-8; NEIL JC, 1983, NATURE, V108, P814; NISEN PD, 1986, CANCER RES, V46, P6217; NOWINSKI RC, 1978, J VIROL, V27, P13, DOI 10.1128/JVI.27.1.13-18.1978; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; ODONNELL PV, 1985, J VIROL, V55, P500, DOI 10.1128/JVI.55.2.500-503.1985; ONEILL RR, 1986, J VIROL, V58, P359, DOI 10.1128/JVI.58.2.359-366.1986; PAYNE GS, 1982, NATURE, V295, P209, DOI 10.1038/295209a0; PEDERSEN FS, 1981, J VIROL, V35, P211; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SELTEN G, 1984, EMBO J, V3, P3215, DOI 10.1002/j.1460-2075.1984.tb02281.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; TAYA Y, 1986, EMBO J, V5, P1215, DOI 10.1002/j.1460-2075.1986.tb04349.x; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WIRSCHUBSKY Z, 1986, INT J CANCER, V38, P739, DOI 10.1002/ijc.2910380518	43	23	23	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1009	1014						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2548143				2022-12-28	WOS:A1989AJ29700010
J	VARLEY, JM; ARMOUR, J; SWALLOW, JE; JEFFREYS, AJ; PONDER, BAJ; TANG, A; FUNG, YKT; BRAMMAR, WJ; WALKER, RA				VARLEY, JM; ARMOUR, J; SWALLOW, JE; JEFFREYS, AJ; PONDER, BAJ; TANG, A; FUNG, YKT; BRAMMAR, WJ; WALKER, RA			THE RETINOBLASTOMA GENE IS FREQUENTLY ALTERED LEADING TO LOSS OF EXPRESSION IN PRIMARY BREAST-TUMORS	ONCOGENE			English	Article									UNIV LEICESTER,DEPT GENET,LEICESTER LE1 7RH,ENGLAND; UNIV LEICESTER,DEPT PATHOL,LEICESTER LE1 7RH,ENGLAND; INST CANC RES,SUTTON SM2 5NG,SURREY,ENGLAND; UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,DIV HEMATOL ONCOL,LOS ANGELES,CA 90027; UNIV SO CALIF,DEPT OPHTHAMOL & PEDIAT,LOS ANGELES,CA 90027	University of Leicester; University of Leicester; University of London; Institute of Cancer Research - UK; Children's Hospital Los Angeles; University of Southern California; University of Southern California	VARLEY, JM (corresponding author), UNIV LEICESTER,ICI UNIV JOINT LAB,LEICESTER LE1 7RH,ENGLAND.			Armour, John/0000-0002-8558-8506				ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEVESA SS, 1975, AM J OPHTHALMOL, V80, P263, DOI 10.1016/0002-9394(75)90143-9; DRAPER GJ, 1986, BRIT J CANCER, V53, P661, DOI 10.1038/bjc.1986.110; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; ELSTON CW, 1982, BRIT J CANCER, V45, P4834; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GORDON H, 1974, MED GENETICS TODAY; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HARTLEY AL, 1986, BRIT J CANCER, V54, P819, DOI 10.1038/bjc.1986.245; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OTTMAN R, 1986, AM J EPIDEMIOL, V123, P15, DOI 10.1093/oxfordjournals.aje.a114209; SANDERS BM, 1988, BRIT J OPHTHALMOL, V72, P576, DOI 10.1136/bjo.72.8.576; SATTIN RW, 1985, JAMA-J AM MED ASSOC, V253, P1908, DOI 10.1001/jama.253.13.1908; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; VARLEY JM, 1987, ONCOGENE, V1, P423; VARLEY JM, 1988, ONCOGENE, V3, P87; VARLEY JM, 1989, IN PRESS REV END REL; WHITTAKER JL, 1986, INT J CANCER, V38, P651, DOI 10.1002/ijc.2910380506; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WONG Z, 1987, ANN HUM GENET, V51, P259; YUNIS JJ, 1978, AM J DIS CHILD, V132, P161, DOI 10.1001/archpedi.1978.02120270059012	36	253	254	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1989	4	6					725	729						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543943				2022-12-28	WOS:A1989AA66000008
J	MILNER, J; GAMBLE, J; COOK, A				MILNER, J; GAMBLE, J; COOK, A			P53 IS ASSOCIATED WITH A 35KD PROTEIN IN CELLS TRANSFORMED BY SIMIAN VIRUS-40	ONCOGENE			English	Note											MILNER, J (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,DIV VIROL,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.							BOSSERT A, 1985, J VIROL, V56, P325, DOI 10.1128/JVI.56.1.325-327.1985; CHOW V, 1987, J VIROL, V61, P2777, DOI 10.1128/JVI.61.9.2777-2781.1987; CLARKE CF, 1988, MOL CELL BIOL, V8, P1206, DOI 10.1128/MCB.8.3.1206; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DEPPERT W, 1986, MOL CELL BIOL, V6, P2233, DOI 10.1128/MCB.6.6.2233; DEPPERT W, 1987, MOL CELL BIOL, V7, P4453, DOI 10.1128/MCB.7.12.4453; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GAMBLE J, 1988, VIROLOGY, V162, P452, DOI 10.1016/0042-6822(88)90486-2; GRUSSENMEYER T, 1987, J VIROL, V61, P3902, DOI 10.1128/JVI.61.12.3902-3909.1987; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KACZMAREK L, 1986, EXP CELL RES, V162, P268, DOI 10.1016/0014-4827(86)90445-3; KLEIN G, 1982, ADV VIRAL ONCOLOGY, V2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MCCORMICK F, 1980, J VIROL, V34, P213, DOI 10.1128/JVI.34.1.213-224.1980; MCCORMICK F, 1981, NATURE, V292, P63, DOI 10.1038/292063a0; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; METCALFE S, 1984, BRIT J CANCER, V49, P337, DOI 10.1038/bjc.1984.53; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; MILNER J, 1985, VIROLOGY, V147, P206, DOI 10.1016/0042-6822(85)90240-5; MILNER J, 1986, VIROLOGY, V150, P265, DOI 10.1016/0042-6822(86)90286-2; MILNER J, 1981, VIROLOGY, V112, P785, DOI 10.1016/0042-6822(81)90327-5; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; POHL J, 1988, MOL CELL BIOL, V8, P2078, DOI 10.1128/MCB.8.5.2078; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; RUNDELL K, 1987, J VIROL, V61, P1240, DOI 10.1128/JVI.61.4.1240-1243.1987; RUSCETTI SK, 1983, J VIROL, V46, P1022, DOI 10.1128/JVI.46.3.1022-1026.1983; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; STURZBECHER HW, 1987, ONCOGENE, V1, P201; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	43	21	21	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					665	668						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2542865				2022-12-28	WOS:A1989U768800019
J	KLEMPNAUER, KH				KLEMPNAUER, KH			ASSOCIATION OF V-MYC PROTEIN WITH CHROMATIN	ONCOGENE			English	Note											KLEMPNAUER, KH (corresponding author), UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,NEUENHEIMER FELD 282,D-6900 HEIDELBERG,FED REP GER.							ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BISTER K, 1987, ONCOGENE, V1, P97; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOYLE WJ, 1985, MOL CELL BIOL, V5, P3017, DOI 10.1128/MCB.5.11.3017; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; KADDURAHDAOUK R, 1987, GENE DEV, V1, P347, DOI 10.1101/gad.1.4.347; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; KLEMPNAUER KH, 1988, ONCOGENE, V2, P545; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SPECTOR DL, 1987, ONCOGENE, V1, P5; STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322; SYMONDS G, 1986, MOL CELL BIOL, V6, P1796, DOI 10.1128/MCB.6.5.1796; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	29	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					115	118						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2644610				2022-12-28	WOS:A1989U567400018
J	SIRCAR, S; RODRIGUES, M; WEBER, JM				SIRCAR, S; RODRIGUES, M; WEBER, JM			RESISTANCE TO RETRANSFORMATION BY ADENOVIRUS BUT NOT BY HETEROLOGOUS ONCOGENES IN AN E1-POSITIVE TRANSFORMATION REVERTANT CELL-LINE MAY BE MEDIATED BY A CELLULAR FUNCTION	ONCOGENE			English	Article									CHU SHERBROOKE,FAC MED,DEPT MICROBIOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA	University of Sherbrooke								BABISS LE, 1983, J VIROL, V46, P454, DOI 10.1128/JVI.46.2.454-465.1983; BAUER M, 1987, J VIROL, V61, P1821, DOI 10.1128/JVI.61.6.1821-1827.1987; BOUCHARD L, 1986, VIROLOGY, V155, P1, DOI 10.1016/0042-6822(86)90162-5; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHEN MJ, 1987, NATURE, V330, P581, DOI 10.1038/330581a0; FLINT SJ, 1981, DNA TUMOR VIRUSES, P383; GALLIMORE PH, 1977, CELL, V10, P669, DOI 10.1016/0092-8674(77)90100-3; GOODING LR, 1988, CELL, V53, P341, DOI 10.1016/0092-8674(88)90154-7; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRODZICKER T, 1980, CELL, V21, P453, DOI 10.1016/0092-8674(80)90482-1; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JOHNSON MD, 1987, MOL CELL BIOL, V7, P2821, DOI 10.1128/MCB.7.8.2821; KNUDSON AG, 1985, CANCER RES, V45, P1437; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEOF EB, 1987, MOL CELL BIOL, V7, P2649, DOI 10.1128/MCB.7.7.2649; MAK I, 1986, BIOCHEM CELL BIOL, V64, P256, DOI 10.1139/o86-036; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OHARA BM, 1987, MOL CELL BIOL, V7, P2941, DOI 10.1128/MCB.7.8.2941; OWEN RD, 1987, MOL CELL BIOL, V7, P2512, DOI 10.1128/MCB.7.7.2512; RODRIGUES MT, 1987, BIOCHEM BIOPH RES CO, V147, P675, DOI 10.1016/0006-291X(87)90983-1; RYAN KW, 1985, MOL CELL BIOL, V5, P3577, DOI 10.1128/MCB.5.12.3577; SAGER R, 1986, CANCER RES, V46, P1573; SAMID D, 1987, MOL CELL BIOL, V7, P2196, DOI 10.1128/MCB.7.6.2196; SIMON MC, 1987, MOL CELL BIOL, V7, P2884, DOI 10.1128/MCB.7.8.2884; SIRCAR S, 1988, J CELL PHYSIOL, V134, P467, DOI 10.1002/jcp.1041340319; SIRCAR S, 1987, CANCER RES, V47, P1339; STENMAN G, 1987, P NATL ACAD SCI USA, V84, P9099, DOI 10.1073/pnas.84.24.9099; STOW ND, 1982, NUCLEIC ACIDS RES, V10, P5105, DOI 10.1093/nar/10.17.5105; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	31	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					725	728						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577877				2022-12-28	WOS:A1988R646000017
J	STEIN, J; RETTENMIER, CW				STEIN, J; RETTENMIER, CW			PROTEOLYTIC PROCESSING OF A PLASMA MEMBRANE-BOUND PRECURSOR TO HUMAN MACROPHAGE COLONY-STIMULATING FACTOR (CSF-1) IS ACCELERATED BY PHORBOL ESTER	ONCOGENE			English	Article							FACTOR-I RECEPTOR; HUMAN-MONOCYTES; GROWTH-FACTOR; INDEPENDENT MECHANISMS; MOLECULAR-CLONING; EXPRESSION; CELLS; BINDING; PROTEIN; GENE	A transmembrane precursor to human macrophage colony-stimulating factor (M-CSF, CSF-1) is stably expressed at the cell surface where it is slowly and inefficiently cleaved to yield a soluble form of the growth factor. Incubation in the presence of phorbol ester resulted in rapid cleavage of the plasma membrane-bound precursor and release of soluble CSF-1. Within 60 min after phorbol treatment the quantity of growth factor recovered in the medium was more than 30-fold greater than that observed in the absence of the agent. The growth factor released in the presence of phorbol was biologically active and exhibited the same electrophoretic mobility as that obtained in the absence of the drug. Phorbol ester-accelerated processing of the cell surface CSF-1 precursor was abrogated by long-term exposure to phorbol, but was not inhibited by pretreatment with cycloheximide or incubation in serum-free medium. These results suggest that the enhanced post-translational processing of the CSF-1 precursor resulted from activation of a pre-existing cellular protease via a mechanism involving phorbol ester-mediated stimulation of protein kinase C.	ST JUDE CHILDRENS RES HOSP, DEPT TUMOR CELL BIOL, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital					NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL040603] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765] Funding Source: Medline; NHLBI NIH HHS [HL40603] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHEN BDM, 1983, J CELL PHYSIOL, V116, P207, DOI 10.1002/jcp.1041160212; COCHET C, 1984, J BIOL CHEM, V259, P2553; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; ERNST TJ, 1989, J BIOL CHEM, V264, P5700; GUILBERT LJ, 1983, J CELL PHYSIOL, V115, P276, DOI 10.1002/jcp.1041150310; HALENBECK R, 1988, J BIOTECHNOL, V8, P45, DOI 10.1016/0168-1656(88)90067-3; HEARD JM, 1987, ONCOGENE RES, V1, P423; HORIGUCHI J, 1986, BIOCHEM BIOPH RES CO, V141, P924, DOI 10.1016/S0006-291X(86)80131-0; HORIGUCHI J, 1987, BLOOD, V69, P1259; HORIGUCHI J, 1988, MOL CELL BIOL, V8, P3951, DOI 10.1128/MCB.8.9.3951; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; KAWASAKI ES, 1985, SCIENCE, V230, P291, DOI 10.1126/science.2996129; LADNER MB, 1987, EMBO J, V6, P2693, DOI 10.1002/j.1460-2075.1987.tb02561.x; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; MANOS MM, 1988, MOL CELL BIOL, V8, P5035, DOI 10.1128/MCB.8.11.5035; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; OSTER W, 1987, BLOOD, V70, P1700; RALPH P, 1986, BLOOD, V68, P633; RAMBALDI A, 1988, J CLIN INVEST, V81, P1030, DOI 10.1172/JCI113413; RAMBALDI A, 1987, BLOOD, V69, P1409; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; RETTENMIER CW, 1989, HEMATOL ONCOL CLIN N, V3, P479, DOI 10.1016/S0889-8588(18)30543-4; RETTENMIER CW, 1986, J CLIN INVEST, V77, P1740, DOI 10.1172/JCI112496; RETTENMIER CW, 1988, MOL CELL BIOL, V8, P5026, DOI 10.1128/MCB.8.11.5026; ROUSSEL MF, 1984, MOL CELL BIOL, V4, P1999, DOI 10.1128/MCB.4.10.1999; SACCA R, 1986, P NATL ACAD SCI USA, V83, P3331, DOI 10.1073/pnas.83.10.3331; SHADLE PJ, 1989, J CELL BIOCHEM, V40, P91, DOI 10.1002/jcb.240400110; SHERR CJ, 1990, HDB EXPT PHARM, V95, P667; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; STANLEY ER, 1986, METHOD ENZYMOL, V116, P563; STEIN J, 1990, BLOOD, V76, P1308, DOI 10.1182/blood.V76.7.1308.bloodjournal7671308; WONG GG, 1987, SCIENCE, V235, P1504, DOI 10.1126/science.3493529	32	45	46	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					601	605						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030912				2022-12-28	WOS:A1991FR93900015
J	MITCHELL, CD; VENTRIS, JA; WARR, TJ; COWELL, JK				MITCHELL, CD; VENTRIS, JA; WARR, TJ; COWELL, JK			MOLECULAR DEFINITION IN A SOMATIC-CELL HYBRID OF A SPECIFIC 2-13 TRANSLOCATION BREAKPOINT IN CHILDHOOD RHABDOMYOSARCOMA	ONCOGENE			English	Article							RETINOBLASTOMA SUSCEPTIBILITY LOCUS; ESTERASE-D GENE; CHROMOSOMAL TRANSLOCATION; ALVEOLAR RHABDOMYOSARCOMA; DNA; FRAGMENTS; SEQUENCES; LINKAGE	A consistent, balanced, reciprocal chromosomal translocation t(2:13) (q35:q14) has been identified in alveolar rhabdomyosarcoma. Somatic cell hybrids have been constructed between rhabdomyosarcoma cell lines carrying the (2:13) translocation and mouse 3T3 cells. One hybrid cell line was shown to have retained the derivative (13:2) chromosome, but segregated the normal chromosome 13 and the derivative (2:13) chromosome. Using available DNA probes from human chromosome 13 we find that the loci for retinoblastoma, esterase D, p7D2, pG24E6.8 and pG14E1.9 lie distally to the 13q14 breakpoint, whereas those for p7F12, pHU10 and pG2E3.1 all lie proximally. Thus we have defined a region of 13q14 of approximately 28 mB which contains the breakpoint associated with this rearrangement.	INST CHILD HLTH,IMPERIAL CANC RES FUND,MOLEC ONCOL LAB,LONDON WC1N 1EH,ENGLAND	Cancer Research UK; University of London; University College London	MITCHELL, CD (corresponding author), INST CHILD HLTH,LEUKAEMIA RES FUND,DEPT HAEMATOL & ONCOL,GUILFORD ST,LONDON WC1N 1EH,ENGLAND.			Cowell, John/0000-0002-2079-5950				BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CAVENEE W, 1984, AM J HUM GENET, V36, P10; COWELL JK, 1980, J NATL CANCER I, V65, P955; COWELL JK, 1989, CYTOGENET CELL GENET, V52, P1, DOI 10.1159/000132827; COWELL JK, 1986, HUMAN CYTOGENETICS P, P202; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; HAYASHI Y, 1988, CANCER GENET CYTOGEN, V30, P343, DOI 10.1016/0165-4608(88)90208-7; HIGGINS MJ, 1990, P NATL ACAD SCI USA, V87, P3415, DOI 10.1073/pnas.87.9.3415; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; LEPPERT M, 1987, HUMAN GENE MAPPING, V9; MITCHELL CD, 1988, HUM GENET, V81, P57, DOI 10.1007/BF00283730; MITCHELL CD, 1989, ONCOGENE, V4, P253; MORIYAMA M, 1986, CANCER GENET CYTOGEN, V22, P177, DOI 10.1016/0165-4608(86)90204-9; ROWE D, 1987, BRIT J CANCER, V56, P379, DOI 10.1038/bjc.1987.207; Sambrook J, 1989, MOL CLONING LABORATO; SCHEFFER H, 1986, HUM GENET, V74, P249, DOI 10.1007/BF00282543; SCHEFFER H, 1986, NUCLEIC ACIDS RES, V14, P3148, DOI 10.1093/nar/14.7.3148; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SQUIRE J, 1986, P NATL ACAD SCI USA, V83, P6573, DOI 10.1073/pnas.83.17.6573; SQUIRE J, 1985, HUM GENET, V70, P291, DOI 10.1007/BF00295364; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; VALENTINE M, 1989, CYTOGENET CELL GENET, V52, P128, DOI 10.1159/000132861; YOUNG BD, 1988, BRIT J CANCER, V58, P58	29	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					89	92						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992447				2022-12-28	WOS:A1991EY03900012
J	WAITZ, W; LOIDL, P				WAITZ, W; LOIDL, P			CELL-CYCLE DEPENDENT ASSOCIATION OF C-MYC PROTEIN WITH THE NUCLEAR MATRIX	ONCOGENE			English	Article							PHYSARUM-POLYCEPHALUM; DNA-REPLICATION; MESSENGER-RNA; V-MYC; TRANSCRIPTIONAL ENHANCER; GENE; EXPRESSION; ONCOGENES; ORGANIZATION; LOCALIZATION	We demonstrate the presence of a c-myc protein with an apparent molecular weight of 67 kd in the lower eukaryote Physarum polycephalum with polyclonal and monoclonal anti-c-myc-antibodies. It is shown that the amount of myc protein present in the nucleus does not fluctuate during the naturally synchronous cell cycle of Physarum. The myc protein remains firmly associated with the nuclear matrix after a variety of matrix preparation procedures. Although the level of c-myc protein is invariant during the cell cycle, the matrix-bound portion of c-myc protein is higher during S-phase as compared to G2-period. In immunoelectron microscopy the immunosignal was considerably stronger in the nuclear matrix compared with unfractionated nuclei, indicating increased accessibility of c-myc protein in nuclear scaffold structures. We show that the nuclear localization of c-myc protein changes during the cell cycle, being transiently but specifically bound to the periphery of the nuclear matrix structure during S-phase.	UNIV INNSBRUCK, FAK MED, INST MIKROBIOL, FRITZ PREGLSTR 3, A-6020 INNSBRUCK, AUSTRIA; INST PATHOL ANAT, A-6020 INNSBRUCK, AUSTRIA	University of Innsbruck								ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COOPER S, 1988, J THEOR BIOL, V135, P393, DOI 10.1016/S0022-5193(88)80253-4; Daniel J. W., 1964, METHOD CELL PHYSIOL, P9; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; GROBNER P, 1985, BIOCHEM J, V232, P21; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; JACKSON DA, 1985, EMBO J, V4, P913, DOI 10.1002/j.1460-2075.1985.tb03718.x; KARNJ, 1989, ONCOGENE, V4, P773; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEBKOWSKI JS, 1982, J MOL BIOL, V156, P325, DOI 10.1016/0022-2836(82)90332-1; LOIDL P, 1987, J BIOL CHEM, V262, P10195; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NEWMAN GR, 1989, COLLOIDAL GOLD PRINC, V2, P47; NOTHACKER KD, 1986, EUR J CELL BIOL, V39, P278; OKUDA A, 1989, EXP CELL RES, V185, P258, DOI 10.1016/0014-4827(89)90054-2; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; SHEINESS D, 1979, J VIROL, V31, P514, DOI 10.1128/JVI.31.2.514-521.1979; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SPECTOR DL, 1987, ONCOGENE, V1, P5; STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turnock G, 1979, Prog Nucleic Acid Res Mol Biol, V23, P53; VANSTRAATEN JP, 1987, ONCOGENE RES, V1, P221; VAUGHN JP, 1990, NUCLEIC ACIDS RES, V18, P1965, DOI 10.1093/nar/18.8.1965; WAITZ W, 1988, J CELL SCI, V90, P621	41	68	70	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					29	35						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992443				2022-12-28	WOS:A1991EY03900004
J	MILNER, J; WATSON, JV				MILNER, J; WATSON, JV			ADDITION OF FRESH MEDIUM INDUCES CELL-CYCLE AND CONFORMATION CHANGES IN P53, A TUMOR SUPPRESSOR PROTEIN	ONCOGENE			English	Article									MRC, MED RES COUNCIL CTR, CLIN ONCOL UNIT, CAMBRIDGE, ENGLAND	UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	MILNER, J (corresponding author), UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE, ENGLAND.							BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; CHOW V, 1987, J VIROL, V61, P2777, DOI 10.1128/JVI.61.9.2777-2781.1987; COOK A, 1990, IN PRESS BR J CANCER; DEPPERT W, 1986, MOL CELL BIOL, V6, P2233, DOI 10.1128/MCB.6.6.2233; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; EHRHART JC, 1988, ONCOGENE, V3, P595; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GAMBLE J, 1988, VIROLOGY, V162, P452, DOI 10.1016/0042-6822(88)90486-2; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KARN J, 1989, ONCOGENE, V4, P773; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MCCORMICK F, 1980, J VIROL, V34, P213, DOI 10.1128/JVI.34.1.213-224.1980; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; MILNER J, 1987, ONCOGENE, V1, P453; MILNER J, 1981, VIROLOGY, V112, P785, DOI 10.1016/0042-6822(81)90327-5; MILNER J, 1986, VIROLOGY, V154, P21, DOI 10.1016/0042-6822(86)90426-5; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MUNROE DG, 1988, ONCOGENE, V2, P621; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980; ROVINSKI B, 1988, ONCOGENE, V2, P445; SMITH PJ, 1985, EXP CELL RES, V159, P37, DOI 10.1016/S0014-4827(85)80035-5; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WATSON JV, 1985, J IMMUNOL METHODS, V83, P179, DOI 10.1016/0022-1759(85)90071-7; WATSON JV, 1987, NATURE, V325, P741, DOI 10.1038/325741a0; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	41	125	125	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1990	5	11					1683	1690						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176282				2022-12-28	WOS:A1990EL40100011
J	DATI, C; ANTONIOTTI, S; TAVERNA, D; PERROTEAU, I; DEBORTOLI, M				DATI, C; ANTONIOTTI, S; TAVERNA, D; PERROTEAU, I; DEBORTOLI, M			INHIBITION OF C-ERBB-2 ONCOGENE EXPRESSION BY ESTROGENS IN HUMAN BREAST-CANCER CELLS	ONCOGENE			English	Article									UNIV TURIN,DEPT ANIM BIOL,MOLEC CELL BIOL LAB,VIA ACC ALBERTINA 17,I-10123 TURIN,ITALY	University of Turin			taverna, daniela/J-8358-2016; De Bortoli, Michele/B-5418-2013	taverna, daniela/0000-0002-6365-527X; De Bortoli, Michele/0000-0002-6666-9052; Perroteau, Isabelle/0000-0001-9797-2276				ADNANE J, 1989, ONCOGENE, V4, P1389; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERGER MS, 1988, CANCER RES, V48, P1238; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; COWLEY BD, 1989, J BIOL CHEM, V264, P8389; DEBORTOLI M, 1986, ENDOCRINOLOGY MALIGN, P104; DEBORTOLI ME, 1985, BIOCHEM BIOPH RES CO, V127, P699, DOI 10.1016/S0006-291X(85)80218-7; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GUERIN M, 1988, ONCOGENE RES, V3, P21; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; HISSOM JR, 1989, ENDOCRINOLOGY, V125, P418, DOI 10.1210/endo-125-1-418; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; ISHII S, 1987, P NATL ACAD SCI USA, V84, P4374, DOI 10.1073/pnas.84.13.4374; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LACROIX H, 1989, ONCOGENE, V4, P145; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MURPHY LJ, 1986, CANCER RES, V46, P728; NISHIKURA K, 1983, P NATL ACAD SCI-BIOL, V80, P4822, DOI 10.1073/pnas.80.15.4822; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SHIU RPC, 1984, CANCER RES, V44, P1178; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAL M, 1987, MOL CELL BIOL, V7, P2597, DOI 10.1128/MCB.7.7.2597; THOMAS DB, 1984, CANCER-AM CANCER SOC, V53, P595, DOI 10.1002/1097-0142(19840201)53:3+<595::AID-CNCR2820531304>3.0.CO;2-Y; THOMPSON NL, 1986, CANCER RES, V46, P3111; TSUDA H, 1989, CANCER RES, V49, P3104; VANDERBURG B, 1989, MOL CELL ENDOCRINOL, V64, P223, DOI 10.1016/0303-7207(89)90149-4; VARLEY JM, 1987, ONCOGENE, V1, P423; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; Vonderhaar B, 1984, CONTROL CELL GROWTH, P11; Vonderhaar B. K., 1985, Biological Responses in Cancer, V4, P125; WRIGHT C, 1989, CANCER RES, V49, P2087; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0	41	167	190	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1001	1006						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973827				2022-12-28	WOS:A1990DP41500007
J	HENRARD, DR; THORNLEY, AT; BROWN, ML; RHEINWALD, JG				HENRARD, DR; THORNLEY, AT; BROWN, ML; RHEINWALD, JG			SPECIFIC EFFECTS OF RAS ONCOGENE EXPRESSION ON THE GROWTH AND HISTOGENESIS OF HUMAN EPIDERMAL-KERATINOCYTES	ONCOGENE			English	Article									HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CELL GROWTH & REGULAT,44 BINNEY ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School								ALLENHOFFMANN BL, 1984, P NATL ACAD SCI-BIOL, V81, P7802, DOI 10.1073/pnas.81.24.7802; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BANKSSCHLEGEL SP, 1982, J CELL BIOL, V93, P551, DOI 10.1083/jcb.93.3.551; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARRANDON Y, 1987, CELL, V50, P1131, DOI 10.1016/0092-8674(87)90179-6; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P415; BARTEK J, 1986, HISTOCHEM J, V18, P565, DOI 10.1007/BF01675198; BOSCH FX, 1988, J CELL BIOL, V106, P1635, DOI 10.1083/jcb.106.5.1635; BOUKAMP P, 1985, CANCER RES, V45, P5582; Boyce S.T., 1983, J INVEST DERMATOL S, V81, P33; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; CARTER RL, 1984, PRECANCEROUS STATES; COMPERE SJ, 1989, MOL CELL BIOL, V9, P6, DOI 10.1128/MCB.9.1.6; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; COROMINAS M, 1989, P NATL ACAD SCI USA, V86, P6372, DOI 10.1073/pnas.86.16.6372; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; DALE BA, 1979, J INVEST DERMATOL, V72, P257, DOI 10.1111/1523-1747.ep12531715; DELLIBOVI P, 1988, MOL CELL BIOL, V8, P2933, DOI 10.1128/MCB.8.7.2933; Dixon I S, 1984, Mol Biol Med, V2, P37; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; FALCO JP, 1988, ONCOGENE, V2, P573; FALLER DV, 1988, J CELL PHYSIOL, V134, P47, DOI 10.1002/jcp.1041340106; FEIG LA, 1987, MOL ENDOCRINOL, V1, P127, DOI 10.1210/mend-1-2-127; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; KAPLAN PL, 1987, J VIROL, V61, P1731, DOI 10.1128/JVI.61.5.1731-1734.1987; KARSTEN U, 1985, EUR J CANCER CLIN ON, V21, P733, DOI 10.1016/0277-5379(85)90271-8; LINDBERG K, 1989, AM J PATHOL, V134, P89; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; MOLL R, 1982, DIFFERENTIATION, V23, P170, DOI 10.1111/j.1432-0436.1982.tb01280.x; MORGAN JR, 1987, SCIENCE, V237, P1476; MORGAN PR, 1987, EPITHELIA, V1, P31; NEUFELD G, 1987, J CELL PHYSIOL, V131, P131, DOI 10.1002/jcp.1041310119; PARKINSON EK, 1985, BRIT J CANCER, V52, P479, DOI 10.1038/bjc.1985.219; PEEHL DM, 1980, IN VITRO CELL DEV B, V16, P526; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; RHEINWALD JG, 1981, CANCER RES, V41, P1657; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; ROLLINS BJ, 1989, J CELL PHYSIOL, V139, P455, DOI 10.1002/jcp.1041390302; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; TUBO RA, 1987, ONCOGENE RES, V1, P407; WAGNER JA, 1986, J CELL BIOL, V103, P1363, DOI 10.1083/jcb.103.4.1363; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WORST PKM, 1974, JNCI-J NATL CANCER I, V53, P1061, DOI 10.1093/jnci/53.4.1061; YOAKUM GH, 1985, SCIENCE, V227, P1174, DOI 10.1126/science.3975607; YUSPA SH, 1985, NATURE, V314, P459, DOI 10.1038/314459a0; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	56	17	17	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					475	481						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183155				2022-12-28	WOS:A1990DB85300004
J	VANROY, F; LIEBAUT, G; MAREEL, M; FIERS, W				VANROY, F; LIEBAUT, G; MAREEL, M; FIERS, W			PARTIAL TRANSFORMATION OF HUMAN TUMOR-CELL LINES SHOWING DEFECTIVE INTERACTION BETWEEN UNUSUAL P53 GENE-PRODUCT AND SV40 LARGE-T ANTIGEN	ONCOGENE			English	Article									STATE UNIV GHENT,EXPTL CANCEROL LAB,B-9000 GHENT,BELGIUM	Ghent University	VANROY, F (corresponding author), STATE UNIV GHENT,MOLEC BIOL LAB,B-9000 GHENT,BELGIUM.		van Roy, Frans M/C-6123-2009	van Roy, Frans M/0000-0003-4358-1039				AZZARONE B, 1985, RETROVIRUSES HUMAN P, P473; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; CHANG S E, 1986, Biochimica et Biophysica Acta, V823, P161, DOI 10.1016/0304-419X(86)90001-6; CHO HY, 1976, SCIENCE, V194, P951, DOI 10.1126/science.62397; CRAWFORD L, 1985, BIOESSAYS, V3, P117, DOI 10.1002/bies.950030307; CRAWFORD L, 1982, J VIROL, V42, P612, DOI 10.1128/JVI.42.2.612-620.1982; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEFROMENTEL CC, 1985, EXP CELL RES, V160, P83, DOI 10.1016/0014-4827(85)90238-1; EHRHART JC, 1988, ONCOGENE, V3, P595; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FANNING E, 1981, J GEN VIROL, V55, P367, DOI 10.1099/0022-1317-55-2-367; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Gluzman Y, 1980, Cold Spring Harb Symp Quant Biol, V44 Pt 1,, P293; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARLOW E, 1981, J VIROL, V37, P564, DOI 10.1128/JVI.37.2.564-573.1981; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KLEIN G, 1982, ADV VIRAL ONCOLOGY, V2; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; MAREEL M, 1979, VIRCHOWS ARCH B, V30, P95; Mareel M M, 1987, J Cell Sci Suppl, V8, P141; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; OHARA BM, 1988, ONCOGENE, V3, P295; OREILLY DR, 1986, BIOL CELL, V57, P187, DOI 10.1111/j.1768-322X.1986.tb00475.x; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; POHL J, 1988, MOL CELL BIOL, V8, P2078, DOI 10.1128/MCB.8.5.2078; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; RHIM JS, 1977, INT J CANCER, V19, P505, DOI 10.1002/ijc.2910190411; RHIM JS, 1975, INT J CANCER, V16, P840, DOI 10.1002/ijc.2910160516; ROVINSKI B, 1988, ONCOGENE, V2, P445; SOUSSI T, 1989, J VIROL, V63, P3894, DOI 10.1128/JVI.63.9.3894-3901.1989; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAINSKY MA, 1987, MOL CELL BIOL, V7, P1280, DOI 10.1128/MCB.7.3.1280; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; THATHAMANGALAM U, 1986, VIROLOGY, V155, P132, DOI 10.1016/0042-6822(86)90174-1; TODARO GJ, 1974, J NATL CANCER I, V52, P167, DOI 10.1093/jnci/52.1.167; VANROY F, 1983, J VIROL, V45, P315, DOI 10.1128/JVI.45.1.315-331.1983; VANROY F, 1981, J VIROL, V40, P28, DOI 10.1128/JVI.40.1.28-44.1981; VANROY FM, 1986, CANCER RES, V46, P4787; VILCEK J, 1973, P NATL ACAD SCI USA, V70, P3909, DOI 10.1073/pnas.70.12.3909; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4	62	16	16	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					207	218						12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2157184				2022-12-28	WOS:A1990CU02900007
J	HERZOG, NK; RAMAGLI, LS; ARLINGHAUS, RB				HERZOG, NK; RAMAGLI, LS; ARLINGHAUS, RB			SOMATIC-CELL EXPRESSION OF THE C-MOS PROTEIN	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,TEXAS MED CTR,DEPT MOLEC PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center					NCI NIH HHS [CA08570, CA16672, CA45125] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, F32CA008570, R01CA045125] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARLINGHAUS RB, 1985, J GEN VIROL, V66, P1845, DOI 10.1099/0022-1317-66-9-1845; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; GALLICK GE, 1985, J GEN VIROL, V66, P945, DOI 10.1099/0022-1317-66-5-945; GATTONI S, 1982, MOL CELL BIOL, V2, P42, DOI 10.1128/MCB.2.1.42; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; GOYETTE M, 1984, MOL CELL BIOL, V4, P1493, DOI 10.1128/MCB.4.8.1493; Green M. C., 1981, Genetic variants and strains of the laboratory mouse., P8; HARLOW E, 1988, ANTIBODIES LABORATOR; HERZOG NK, 1988, ONCOGENE, V3, P225; HUNTER T, 1986, ENZYMES, V17, P192; JONES M, 1980, P NATL ACAD SCI-BIOL, V77, P2651, DOI 10.1073/pnas.77.5.2651; KECKWICK RA, 1940, BIOCHEM J, V149, P1248; KESHET E, 1988, ONCOGENE, V2, P235; KLOETZER WS, 1984, VIROLOGY, V138, P143, DOI 10.1016/0042-6822(84)90154-5; KLOETZER WS, 1983, P NATL ACAD SCI-BIOL, V80, P412, DOI 10.1073/pnas.80.2.412; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAQUIRE RT, 1983, P NATL ACAD SCI USA, V80, P1947; MAXWELL SA, 1985, J VIROL, V55, P874, DOI 10.1128/JVI.55.3.874-876.1985; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MINTZ B, 1955, ANAT REC, V122, P443; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; MUTTER GL, 1988, EMBO J, V7, P683, DOI 10.1002/j.1460-2075.1988.tb02863.x; OGISO Y, 1986, BIOCHEM BIOPH RES CO, V140, P477, DOI 10.1016/0006-291X(86)90757-6; OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788; PAULES RS, 1988, ONCOGENE, V3, P59; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; PROPST F, 1988, ONCOGENE, V2, P227; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SCHMIDT M, 1988, MOL CELL BIOL, V8, P923, DOI 10.1128/MCB.8.2.923; SINGH B, 1986, VIROLOGY, V152, P502, DOI 10.1016/0042-6822(86)90156-X; SINGH B, 1988, ONCOGENE, V3, P79; SINGH B, 1986, J VIROL, V60, P1148, DOI 10.1128/JVI.60.3.1148-1152.1986; SWAN D, 1982, J VIROL, V44, P753; VANBEVEREN C, 1981, CELL, V27, P97, DOI 10.1016/0092-8674(81)90364-0; VANDERHOORN FA, 1984, NUCLEIC ACIDS RES, V12, P2147, DOI 10.1093/nar/12.4.2147; WOOD TG, 1984, P NATL ACAD SCI-BIOL, V81, P7817, DOI 10.1073/pnas.81.24.7817	43	33	33	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1307	1315						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2530484				2022-12-28	WOS:A1989AX65900006
J	PARKIN, NT; SONENBERG, N				PARKIN, NT; SONENBERG, N			IDENTIFICATION OF A PROTEIN THAT BINDS SPECIFICALLY TO RNA FROM THE 1ST EXON OF C-MYC	ONCOGENE			English	Article									MCGILL UNIV,DEPT BIOCHEM,3655 DRUMMOND ST,MONTREAL H3G 1Y6,QUEBEC,CANADA; MCGILL UNIV,MCGILL CANC CTR,MONTREAL H3G 1Y6,QUEBEC,CANADA	McGill University; McGill University			Parkin, Neil/P-2724-2019					ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BROOME HE, 1987, MOL CELL BIOL, V7, P2988, DOI 10.1128/MCB.7.8.2988; BUTNICK NZ, 1985, MOL CELL BIOL, V5, P3009, DOI 10.1128/MCB.5.11.3009; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CORCORAN LM, 1985, CELL, V40, P71, DOI 10.1016/0092-8674(85)90310-1; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DARVEAU A, 1985, P NATL ACAD SCI USA, V82, P2315, DOI 10.1073/pnas.82.8.2315; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; ERIKSON J, 1985, P NATL ACAD SCI USA, V82, P4212, DOI 10.1073/pnas.82.12.4212; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; GRABOWSKI PJ, 1984, CELL, V37, P415, DOI 10.1016/0092-8674(84)90372-6; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6419, DOI 10.1093/nar/15.16.6419; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KELLY K, 1988, J BIOL CHEM, V263, P4828; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAZARUS P, 1988, ONCOGENE, V3, P517; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; Maniatis T., 1982, MOL CLONING; MANLEY JL, 1984, TRANSCRIPTION TRANSL, P71; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NILSEN TW, 1984, MOL CELL BIOL, V4, P2235, DOI 10.1128/MCB.4.10.2235; NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PELLETIER J, 1985, MOL CELL BIOL, V5, P3222, DOI 10.1128/MCB.5.11.3222; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PROCHOWNIK EV, 1988, MOL CELL BIOL, V8, P3683, DOI 10.1128/MCB.8.9.3683; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; ROSE JK, 1978, P NATL ACAD SCI USA, V75, P2732, DOI 10.1073/pnas.75.6.2732; RUPPERT C, 1986, EMBO J, V5, P1897, DOI 10.1002/j.1460-2075.1986.tb04442.x; SCHWEINFEST CW, 1988, MOL CELL BIOL, V8, P3080, DOI 10.1128/MCB.8.8.3080; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; STEWART TA, 1984, SCIENCE, V226, P707, DOI 10.1126/science.6494906; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; WATT R, 1983, P NATL ACAD SCI-BIOL, V80, P6307, DOI 10.1073/pnas.80.20.6307; WATT R, 1983, NATURE, V303, P725, DOI 10.1038/303725a0; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448; WIMAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6798, DOI 10.1073/pnas.81.21.6798; YANG JQ, 1985, EMBO J, V4, P1441, DOI 10.1002/j.1460-2075.1985.tb03800.x; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510	71	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1989	4	7					815	822						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE584	2502752				2022-12-28	WOS:A1989AE58400001
J	DONGHI, R; SOZZI, G; PIEROTTI, MA; BIUNNO, I; MIOZZO, M; FUSCO, A; GRIECO, M; SANTORO, M; VECCHIO, G; SPURR, NK; DELLAPORTA, G				DONGHI, R; SOZZI, G; PIEROTTI, MA; BIUNNO, I; MIOZZO, M; FUSCO, A; GRIECO, M; SANTORO, M; VECCHIO, G; SPURR, NK; DELLAPORTA, G			THE ONCOGENE ASSOCIATED WITH HUMAN PAPILLARY THYROID-CARCINOMA (PTC) IS ASSIGNED TO CHROMOSOME-10 Q11-Q12 IN THE SAME REGION AS MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A (MEN2A)	ONCOGENE			English	Note									IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,VIA G VENEZIAN 1,I-20133 MILAN,ITALY; UNIV NAPLES,FAC MED & CHIRURG 2,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80131 NAPLES,ITALY; IMPERIAL CANC RES FUND,CLARE HALL LABS,S MIMMS EN6 3LID,HERTS,ENGLAND	Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II			sozzi, gabriella/G-8259-2011	sozzi, gabriella/0000-0001-9360-6914; Grieco, Michele/0000-0002-4212-7814; Fusco, Alfredo/0000-0003-3332-5197; Pierotti, Marco Alessandro/0000-0002-7431-8332; , IDA_2/0000-0002-1068-4763; Miozzo, Monica/0000-0002-6523-4575				BAI Y, 1982, ANN HUM GENET, V46, P337, DOI 10.1111/j.1469-1809.1982.tb01584.x; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HECHT F, 1988, CANCER GENET CYTOGEN, V31, P142; JONES EA, 1976, SOMAT CELL GENET, V2, P483, DOI 10.1007/BF01542686; LEONARD WJ, 1985, SCIENCE, V228, P1547, DOI 10.1126/science.3925551; MATHEW CGP, 1987, NATURE, V328, P527, DOI 10.1038/328527a0; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; RADICE P, 1988, NUCLEIC ACIDS RES, V18, P5062; SIMPSON NE, 1987, NATURE, V328, P528, DOI 10.1038/328528a0; SOLOMON E, 1976, SOMAT CELL GENET, V2, P125, DOI 10.1007/BF01542626; SOLOMON E, 1979, ANN HUM GENET, V42, P273, DOI 10.1111/j.1469-1809.1979.tb00661.x; SWALLOW DM, 1977, CYTOGENET CELL GENET, V18, P136, DOI 10.1159/000130758; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021	16	80	81	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					521	523						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2566146				2022-12-28	WOS:A1989U567700019
J	HARVEY, RC; MARTENEIRE, C; SUN, LHK; WILLIAMS, D; SHOWE, LC				HARVEY, RC; MARTENEIRE, C; SUN, LHK; WILLIAMS, D; SHOWE, LC			TRANSLOCATIONS AND REARRANGEMENTS IN T-CELL ACUTE LEUKEMIAS WITH THE T(11-14) (P13-Q11) CHROMOSOMAL TRANSLOCATIONS	ONCOGENE			English	Article									WISTAR INST ANAT & BIOL,36TH & SPRUCE ST,PHILADELPHIA,PA 19104	The Wistar Institute				Harvey, Richard/0000-0002-4904-9767	NCI NIH HHS [T32 CA09485, CA25875-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009485, P01CA025875] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; BAER R, 1988, EMBO J, V7, P1661, DOI 10.1002/j.1460-2075.1988.tb02993.x; BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BIRD J, 1988, J EXP MED, V168, P229, DOI 10.1084/jem.168.1.229; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1988, EMBO J, V7, P2011, DOI 10.1002/j.1460-2075.1988.tb03040.x; CACCIA N, 1985, J EXP MED, V161, P1255, DOI 10.1084/jem.161.5.1255; CALMAN AF, 1986, J EXP MED, V164, P1940, DOI 10.1084/jem.164.6.1940; CHAMPAGNE E, 1988, EUR J IMMUNOL, V18, P1033, DOI 10.1002/eji.1830180710; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CROCE CM, 1985, SCIENCE, V227, P1044, DOI 10.1126/science.3919442; DENNY CT, 1986, SCIENCE, V234, P197, DOI 10.1126/science.3092355; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; DEVILLARTAY JP, 1987, P NATL ACAD SCI USA, V84, P8608; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; ERIKSON J, 1985, SCIENCE, V229, P784, DOI 10.1126/science.3875152; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; FOA R, 1984, J CLIN INVEST, V74, P1756, DOI 10.1172/JCI111594; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; HATA S, 1988, SCIENCE, V240, P1541, DOI 10.1126/science.3259726; HAYDAY AC, 1985, NATURE, V316, P828, DOI 10.1038/316828a0; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; KIMURA N, 1987, EUR J IMMUNOL, V17, P375, DOI 10.1002/eji.1830170312; KIRSH IR, 1988, T CELL RECEPTORS, P651; KITCHINGMAN GR, 1986, BLOOD, V67, P698; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; LENOIR GM, 1982, NATURE, V298, P474, DOI 10.1038/298474a0; LEWIS WH, 1985, NATURE, V317, P544, DOI 10.1038/317544a0; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LURIA S, 1987, EMBO J, V6, P3307, DOI 10.1002/j.1460-2075.1987.tb02650.x; Maniatis T., 1982, MOL CLONING; MAROLLEAU JP, 1988, CELL, V55, P291, DOI 10.1016/0092-8674(88)90052-9; MENGLEGAW L, 1987, EMBO J, V6, P2273, DOI 10.1002/j.1460-2075.1987.tb02501.x; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCOTT AF, 1979, P NATL ACAD SCI USA, V76, P4563, DOI 10.1073/pnas.76.9.4563; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SEIDMAN JG, 1980, NATURE, V286, P779, DOI 10.1038/286779a0; SHOWE LC, 1987, ANNU REV IMMUNOL, V5, P253, DOI 10.1146/annurev.iy.05.040187.001345; UESHIMA Y, 1984, BLOOD, V63, P1028; WEISS A, 1986, P NATL ACAD SCI USA, V83, P6998, DOI 10.1073/pnas.83.18.6998; WILLIAMS DL, 1984, CELL, V36, P101, DOI 10.1016/0092-8674(84)90078-3; WINOTO A, 1985, NATURE, V316, P832, DOI 10.1038/316832a0; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOSHIKAI Y, 1986, J EXP MED, V164, P90, DOI 10.1084/jem.164.1.90	51	23	23	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					341	349						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2523031				2022-12-28	WOS:A1989U567600010
J	TAPLEY, P; HORWITZ, A; BUCK, C; DUGGAN, K; ROHRSCHNEIDER, L				TAPLEY, P; HORWITZ, A; BUCK, C; DUGGAN, K; ROHRSCHNEIDER, L			INTEGRINS ISOLATED FROM ROUS-SARCOMA VIRUS-TRANSFORMED CHICKEN-EMBRYO FIBROBLASTS	ONCOGENE			English	Article									UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; The Wistar Institute	TAPLEY, P (corresponding author), FRED HUTCHINSON CANC RES CTR,DEPT CELL BIOL,1124 COLUMBIA ST,SEATTLE,WA 98104, USA.				NATIONAL CANCER INSTITUTE [R37CA019144, R01CA020551, R01CA019144, R01CA040987] Funding Source: NIH RePORTER; NCI NIH HHS [CA19144, CA40987, CA20551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA SK, 1986, J CELL BIOL, V102, P442, DOI 10.1083/jcb.102.2.442; AKIYAMA SK, 1987, J BIOL CHEM, V262, P17536; ALI IU, 1977, CELL, V11, P115, DOI 10.1016/0092-8674(77)90322-1; AMINI S, 1986, MOL CELL BIOL, V6, P2305, DOI 10.1128/MCB.6.7.2305; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARANY G, 1979, PEPTIDES, P3; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; BUCK CA, 1986, J CELL BIOL, V103, P2421, DOI 10.1083/jcb.103.6.2421; BURNS GF, 1988, J CELL BIOL, V107, P1225, DOI 10.1083/jcb.107.3.1225; BURR JG, 1980, P NATL ACAD SCI-BIOL, V77, P3484, DOI 10.1073/pnas.77.6.3484; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; BURRIDGE K, 1980, CELL, V19, P587, DOI 10.1016/S0092-8674(80)80035-3; BURRIDGE K, 1986, Cancer Reviews, V4, P18; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; CHEN JM, 1987, CELL, V48, P193, DOI 10.1016/0092-8674(87)90423-5; CHEN WT, 1985, J CELL BIOL, V100, P1103, DOI 10.1083/jcb.100.4.1103; CHEN WT, 1986, J CELL BIOL, V103, P1649, DOI 10.1083/jcb.103.5.1649; CHEN YC, 1979, J BIOL CHEM, V254, P1678; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; DAMSKY CH, 1985, J CELL BIOL, V100, P1528, DOI 10.1083/jcb.100.5.1528; DECLUE JE, 1987, MOL CELL BIOL, V7, P371, DOI 10.1128/MCB.7.1.371; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; EDWARDS AM, 1988, MOL CELL BIOL, V8, P2655, DOI 10.1128/MCB.8.6.2655; EVANS RR, 1984, J BIOL CHEM, V259, P3916; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; GIBSON W, 1974, VIROLOGY, V62, P319, DOI 10.1016/0042-6822(74)90395-X; HANAFUSA H, 1977, COMPREHENSIVE VIROLO, V10, P401; HEMLER ME, 1987, J BIOL CHEM, V262, P3300; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HORWITZ A, 1986, NATURE, V320, P531, DOI 10.1038/320531a0; HORWITZ A, 1985, J CELL BIOL, V101, P2134, DOI 10.1083/jcb.101.6.2134; HUNTER T, 1982, J BIOL CHEM, V257, P4843; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; ITO S, 1983, J BIOL CHEM, V258, P4626; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KNUDSEN KA, 1985, EXP CELL RES, V157, P218, DOI 10.1016/0014-4827(85)90164-8; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; PIERCE M, 1986, J BIOL CHEM, V261, P772; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROHRSCHNEIDER L, 1983, MOL CELL BIOL, V3, P731, DOI 10.1128/MCB.3.4.731; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; ROSOK MJ, 1983, MOL CELL BIOL, V3, P475, DOI 10.1128/MCB.3.3.475; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SCHROER E, 1985, EUR J BIOCHEM, V153, P515, DOI 10.1111/j.1432-1033.1985.tb09332.x; SEFTON BM, 1980, CELL, V20, P807, DOI 10.1016/0092-8674(80)90327-X; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SPIEGEL S, 1986, J CELL BIOL, V102, P1898, DOI 10.1083/jcb.102.5.1898; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; WILKINS JA, 1986, J CELL BIOL, V102, P1085, DOI 10.1083/jcb.102.3.1085; YONEMOTO W, 1987, MOL CELL BIOL, V7, P905, DOI 10.1128/MCB.7.2.905	59	248	250	1	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					325	333						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2468126				2022-12-28	WOS:A1989U567600008
J	OKA, T; RAIRKAR, A; CHEN, JH				OKA, T; RAIRKAR, A; CHEN, JH			STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE REGULATORY SEQUENCES OF THE ETS-1 GENE	ONCOGENE			English	Article							LONG TERMINAL REPEAT; ONCOGENE C-ETS; TRANSCRIPTION FACTOR; EXPRESSION SYSTEM; ENHANCER; LEUKEMIA; PROMOTER; BINDING; LOCALIZATION; CLONING	The ets-1 gene is a human homolog of the oncogene v-ets of avian acute leukemia virus E26. The ets-1 gene is preferentially expressed in lymphoid cells. To understand the regulation of the ets-1 gene expression the regulatory sequences of this gene were identified and isolated. The promoter is found to be functioning in the lymphoid cell line Daudi and the erythromyeloid cell line K562 but not in the promyelocytic cell line HL60. Sequence analysis indicates that the ets-1 promoter does not contain the TATA or CAT box. It contains multiple transcription initiation sites in a tight cluster. The promoter contains one binding site each for AP1 and AP2. It has one definitive and five presumptive sp1-binding sites. In addition, the ets-1 promoter contains one ets-1 protein-binding site. Functional analysis has shown that c-jun enhances the activity of the ets-1 promoter, whereas the combination of c-fos and c-jun expressions has no synergistic effect. The expression of exogenous AP2 and ets-1 also enhances the activity of the ets-1 promoter. These results suggest that the AP1, AP2 and ets-1 proteins have a positive regulatory effect. The presence of the ets-I protein-binding site indicates the existence of an autoregulatory mechanism for the expression of the ets-1 gene. Our results suggested that the presence of a negative regulatory element upstream of the region where most of the positive regulators are located.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT EXPTL PEDIATR,BOX 88,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center								Abate C, 1990, Semin Cancer Biol, V1, P19; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BOULUKOS KD, 1989, MOL CELL BIOL, V95, P5718; CHEN JH, 1985, MOL CELL BIOL, V5, P2993, DOI 10.1128/MCB.5.11.2993; CHEN JH, 1990, ONCOGENE RES, V5, P277; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; FUJIWARA S, 1988, ONCOGENE, V2, P99; GHYSDAEL J, 1986, P NATL ACAD SCI USA, V83, P1714, DOI 10.1073/pnas.83.6.1714; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KANEKO Y, 1986, BLOOD, V67, P484; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; MAJERUS MA, 1990, 6TH ANN M ON FRED, P193; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; WOOD WM, 1989, J BIOL CHEM, V264, P14840	27	45	45	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2077	2083						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945412				2022-12-28	WOS:A1991GX11900019
J	EAGER, KB				EAGER, KB			MOLECULAR CHARACTERIZATION OF HUMAN TRK PROTOONCOGENE PRODUCT MONOCLONAL-ANTIBODIES	ONCOGENE			English	Article							POINT MUTATION; BIOCHEMICAL-CHARACTERIZATION; KINASE DOMAIN; ACTIVATION; SEQUENCES; RECOMBINATION; DELETION; PROTOONCOGENE; FUSION	Monoclonal antibodies specific for the human trk proto-oncogene product, a tyrosine kinase receptor, have been produced from mice in which tumors were generated by injection of stably transfected NIH3T3 cells expressing the human trk proto-oncogene product. The panel of eleven antibodies are reactive in ELISA, immunostaining and immunoprecipitation. These antibodies bind to the extracellular domain of the human trk proto-oncogene product and demonstrate no cross-reactivity to the trk oncogene or murine trkB gene products. The antibodies are equally effective in recognizing human proto-trk when expressed by transfected human or mouse cell lines. These antibodies either bind to the carbohydrate moieties or are dependent upon the conformational structure created by the extensive glycosylations. The localization and nature of the epitopes recognized by these monoclonal antibodies were defined by immunoprecipitation analyses using several different trk oncoproteins. Potential applications of these antibodies are discussed.	BRISTOL MYERS SQUIBB PHARMACEUT RES INST,DEPT MOLEC BIOL,PRINCETON,NJ 08543	Bristol-Myers Squibb	EAGER, KB (corresponding author), AMER CYANAMID CO,POB 400,PRINCETON,NJ 08543, USA.							BARBACID M, 1980, J VIROL, V33, P196, DOI 10.1128/JVI.33.1.196-207.1980; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BONGARZONE I, 1989, ONCOGENE, V4, P1457; COULIER F, 1990, MOL CELL BIOL, V10, P4202, DOI 10.1128/MCB.10.8.4202; COULIER F, 1989, MOL CELL BIOL, V9, P15, DOI 10.1128/MCB.9.1.15; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Kennett R H, 1978, Curr Top Microbiol Immunol, V81, P77; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPSON LA, 1980, MONOCLONAL ANTIBODIE, P395; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1990, GENE DEV, V4, P683, DOI 10.1101/gad.4.5.683; MITRA G, 1987, P NATL ACAD SCI USA, V84, P6707, DOI 10.1073/pnas.84.19.6707; OSKAM R, 1988, P NATL ACAD SCI USA, V85, P2964, DOI 10.1073/pnas.85.9.2964; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; ZIEMIECKI A, 1990, EMBO J, V9, P191, DOI 10.1002/j.1460-2075.1990.tb08095.x	24	7	12	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					819	824						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052359				2022-12-28	WOS:A1991GT82500018
J	SUTRAVE, P; HUGHES, SH				SUTRAVE, P; HUGHES, SH			THE SKI ONCOGENE	ONCOGENE			English	Review							SEQUENCE; VIRUSES; MUSCLE; CELLS; GENE		NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,POB B,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick					NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKAS AE, 1986, VIROLOGY, V151, P131, DOI 10.1016/0042-6822(86)90111-X; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; STAVNEZER E, 1986, J VIROL, V57, P1073, DOI 10.1128/JVI.57.3.1073-1083.1986; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Stavnezer E., 1988, ONCOGENE HDB, P393; SUTRAVE P, 1990, MOL CELL BIOL, V10, P3137, DOI 10.1128/MCB.10.6.3137; SUTRAVE P, 1989, MOL CELL BIOL, V9, P4046, DOI 10.1128/MCB.9.9.4046; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462	13	27	27	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					353	356						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011394				2022-12-28	WOS:A1991FT34400001
J	BINETRUY, B; SCHILLER, J; LOWY, D; CERNI, C; CUZIN, F				BINETRUY, B; SCHILLER, J; LOWY, D; CERNI, C; CUZIN, F			NONSELECTIVE ANALYSIS OF THE TRANSFORMATION OF FR3T3 RAT-CELLS BY BOVINE PAPILLOMAVIRUS TYPE-1 - REGULATIONS OF VIRAL TRANSCRIPTION ASSOCIATED WITH PHENOTYPIC TRANSFORMATION	ONCOGENE			English	Article									NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892; UNIV VIENNA,INST TUMOR BIOL & CANC RES,A-1090 VIENNA,AUSTRIA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Vienna	BINETRUY, B (corresponding author), UNIV NICE,CTR BIOCHEM,INSERM,U273,F-06034 NICE,FRANCE.		Schiller, John/ABK-8287-2022; Binetruy, Bernard/S-2062-2019; Binetruy, Bernard/AFL-7188-2022; Binetruy, Bernard/A-6465-2009; Binetruy, Bernard/AAG-7139-2022	Binetruy, Bernard/0000-0001-8012-7092; 				AHOLA H, 1987, J VIROL, V61, P2240, DOI 10.1128/JVI.61.7.2240-2244.1987; BAKER CC, 1987, EMBO J, V6, P1027, DOI 10.1002/j.1460-2075.1987.tb04855.x; BINETRUY B, 1982, EMBO J, V1, P621, DOI 10.1002/j.1460-2075.1982.tb01218.x; BINETRUY B, 1987, CANCER CELL, V5, P223; BURKHARDT A, 1987, EMBO J, V6, P2381, DOI 10.1002/j.1460-2075.1987.tb02515.x; CHEN EY, 1982, NATURE, V299, P529, DOI 10.1038/299529a0; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DIMAIO D, 1986, P NATL ACAD SCI USA, V83, P1797, DOI 10.1073/pnas.83.6.1797; DIMAIO D, 1986, J VIROL, V57, P475, DOI 10.1128/JVI.57.2.475-480.1986; DIMAIO D, 1988, EMBO J, V7, P1197, DOI 10.1002/j.1460-2075.1988.tb02931.x; DIMAIO D, 1982, P NATL ACAD SCI-BIOL, V79, P4030, DOI 10.1073/pnas.79.13.4030; DIMAIO D, 1987, CANCER CELLS, V5, P187; GLAICHENHAUS N, 1987, CELL, V50, P1081, DOI 10.1016/0092-8674(87)90174-7; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GRISONI M, 1984, VIROLOGY, V135, P406, DOI 10.1016/0042-6822(84)90196-X; HAUGEN TH, 1987, EMBO J, V6, P145, DOI 10.1002/j.1460-2075.1987.tb04732.x; HERMONAT PL, 1988, EMBO J, V7, P2815, DOI 10.1002/j.1460-2075.1988.tb03137.x; LAMBERT PF, 1988, ANNU REV GENET, V22, P235, DOI 10.1146/annurev.ge.22.120188.001315; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LAMBERT PF, 1988, J VIROL, V62, P4009, DOI 10.1128/JVI.62.11.4009-4015.1988; Maniatis T., 1982, MOL CLONING; MENEGUZZI G, 1984, EMBO J, V3, P365, DOI 10.1002/j.1460-2075.1984.tb01813.x; MOUGNEAU E, 1988, ONCOGENE RES, V2, P177; NEARY K, 1989, J VIROL, V63, P259, DOI 10.1128/JVI.63.1.259-266.1989; PRAKASH SS, 1988, J VIROL, V62, P3608, DOI 10.1128/JVI.62.10.3608-3613.1988; RISSER R, 1974, VIROLOGY, V59, P477, DOI 10.1016/0042-6822(74)90457-7; SARVER N, 1982, P NATL ACAD SCI-BIOL, V79, P7147, DOI 10.1073/pnas.79.23.7147; SARVER N, 1984, J VIROL, V52, P377, DOI 10.1128/JVI.52.2.377-388.1984; SCHILLER JT, 1984, P NATL ACAD SCI-BIOL, V81, P7880, DOI 10.1073/pnas.81.24.7880; SCHILLER JT, 1986, J VIROL, V57, P1; SEIF R, 1977, J VIROL, V24, P721, DOI 10.1128/JVI.24.3.721-728.1977; SPALHOLZ BA, 1987, J VIROL, V61, P2128, DOI 10.1128/JVI.61.7.2128-2137.1987; STENLUND A, 1985, J MOL BIOL, V182, P541, DOI 10.1016/0022-2836(85)90240-2; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; YANG YC, 1985, NATURE, V318, P575, DOI 10.1038/318575a0; ZERLIN M, 1987, ONCOGENE, V1, P19; ZHANG YL, 1987, J VIROL, V61, P2924, DOI 10.1128/JVI.61.9.2924-2928.1987	38	4	4	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1645	1651						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176280				2022-12-28	WOS:A1990EL40100005
J	WU, J; ZHU, JQ; HAN, KK; ZHU, DX				WU, J; ZHU, JQ; HAN, KK; ZHU, DX			THE ROLE OF THE C-FMS ONCOGENE IN THE REGULATION OF HL-60 CELL-DIFFERENTIATION	ONCOGENE			English	Article									INSERM,U16,F-59045 LILLE,FRANCE; NANJING UNIV,DEPT BIOCHEM,NANJING 210008,PEOPLES R CHINA	Institut National de la Sante et de la Recherche Medicale (Inserm); Nanjing University								CAYRE Y, 1987, P NATL ACAD SCI USA, V84, P7619, DOI 10.1073/pnas.84.21.7619; CHEN BDM, 1984, J CELL SCI, V70, P147; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DELAMARTER JF, 1987, NUCLEIC ACIDS RES, V15, P2389, DOI 10.1093/nar/15.5.2389; Gait M. J, 1984, OLIGONUCLEOTIDE SYNT; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; HONMA Y, 1980, BIOCHEM BIOPH RES CO, V95, P507, DOI 10.1016/0006-291X(80)90813-X; KREIPE H, 1986, DIFFERENTIATION, V33, P56, DOI 10.1111/j.1432-0436.1986.tb00410.x; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LOTEM J, 1979, P NATL ACAD SCI USA, V76, P5158, DOI 10.1073/pnas.76.10.5158; MIYAURA C, 1981, BIOCHEM BIOPH RES CO, V102, P937, DOI 10.1016/0006-291X(81)91628-4; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SARIBAN E, 1985, NATURE, V316, P64, DOI 10.1038/316064a0; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; YAM LT, 1971, AM J CLIN PATHOL, V55, P283; YEN A, 1987, EXP CELL RES, V168, P247, DOI 10.1016/0014-4827(87)90432-0	20	28	33	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					873	877						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2141686				2022-12-28	WOS:A1990DP55300013
J	SHIBUYA, M; YAMAGUCHI, S; YAMANE, A; IKEDA, T; TOJO, A; MATSUSHIME, H; SATO, M				SHIBUYA, M; YAMAGUCHI, S; YAMANE, A; IKEDA, T; TOJO, A; MATSUSHIME, H; SATO, M			NUCLEOTIDE-SEQUENCE AND EXPRESSION OF A NOVEL HUMAN RECEPTOR-TYPE TYROSINE KINASE GENE (FLT) CLOSELY RELATED TO THE FMS FAMILY	ONCOGENE			English	Article											SHIBUYA, M (corresponding author), UNIV TOKYO,INST MED SCI,DEPT GENET,MINATO KU,TOKYO 108,JAPAN.							BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHINNADURAI G, 1978, J VIROL, V26, P195, DOI 10.1128/JVI.26.1.195-199.1978; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAS SK, 1982, J BIOL CHEM, V257, P13679; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ESCOBEDO JA, 1988, NATURE, V335, P85, DOI 10.1038/335085a0; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; JOHNSSON A, 1984, EMBO J, V3, P921, DOI 10.1002/j.1460-2075.1984.tb01908.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUSHIME H, 1987, JPN J CANCER RES, V78, P655; PATTILLO RA, 1968, SCIENCE, V159, P1467, DOI 10.1126/science.159.3822.1467; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATOH H, 1987, JPN J CANCER RES, V78, P772; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WALKER C, 1987, P NATL ACAD SCI USA, V84, P1804, DOI 10.1073/pnas.84.7.1804; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	31	902	1016	0	16	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					519	524						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2158038				2022-12-28	WOS:A1990DB85300010
J	MOWAT, M; SAUDER, M; PEREIRA, D				MOWAT, M; SAUDER, M; PEREIRA, D			THE ACTIVATED FORM OF P53 IS NOT A TRANSACTIVATOR OF THE INTRACISTERNAL-A PARTICLE LONG TERMINAL REPEAT PROMOTER	ONCOGENE			English	Note									UNIV MANITOBA,DEPT PHYSIOL,WINNIPEG R3T 2N2,MANITOBA,CANADA	University of Manitoba	MOWAT, M (corresponding author), MANITOBA INST CELL BIOL,100 OLIVIA ST,WINNIPEG R3E 0V9,MANITOBA,CANADA.							BEGEMANN M, 1988, MOL CARCINOGEN, V1, P196, DOI 10.1002/mc.2940010308; BENCHIMOL S, 1989, IN PRESS CANCER CELL, V7; BENDAVID Y, 1988, ONCOGENE, V3, P179; BRAITHWAITE A, 1987, NATURE, V329, P456; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHOW V, 1987, J VIROL, V61, P2777, DOI 10.1128/JVI.61.9.2777-2781.1987; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FLANAGAN JR, 1989, MOL CELL BIOL, V9, P739, DOI 10.1128/MCB.9.2.739; Gai X X, 1988, Oncogene Res, V3, P377; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HICKS GG, 1988, J VIROL, V62, P4752, DOI 10.1128/JVI.62.12.4752-4755.1988; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, ONCOGENE HDB, P403; KACZMAREK L, 1986, EXP CELL RES, V162, P268, DOI 10.1016/0014-4827(86)90445-3; KINGSTON RE, 1985, CELL, V41, P3, DOI 10.1016/0092-8674(85)90049-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LURIA S, 1986, J VIROL, V57, P998, DOI 10.1128/JVI.57.3.998-1003.1986; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1981, VIROLOGY, V112, P785, DOI 10.1016/0042-6822(81)90327-5; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MUNROE DG, 1988, ONCOGENE, V2, P621; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINHASI O, 1984, MOL CELL BIOL, V4, P2180, DOI 10.1128/MCB.4.10.2180; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROSVINSKI B, 1987, MOL CELL BIOL, V7, P847; ROVINSKI B, 1988, ONCOGENE, V2, P445; SHOHAT O, 1987, ONCOGENE, V1, P277; SLEIGH MJ, 1986, ANAL BIOCHEM, V156, P251, DOI 10.1016/0003-2697(86)90180-6; SOLAZZO M, 1989, EUR J IMMUNOL, V19, P453; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STURZBECHER HW, 1988, ONCOGENE, V3, P405; STURZBECHER HW, 1988, MOL CELL BIOL, V8, P3740; TACK LC, 1989, J VIROL, V63, P1310, DOI 10.1128/JVI.63.3.1310-1317.1989; VARMUS HE, 1987, SCIENCE, V238, P1337, DOI 10.1126/science.2825348; WOLF D, 1984, MOL CELL BIOL, V4, P1402, DOI 10.1128/MCB.4.7.1402; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790	47	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					241	244						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2138726				2022-12-28	WOS:A1990CU02900012
J	ROMANO, JW; EHRHART, JC; DUTHU, A; KIM, CM; APPELLA, E; MAY, P				ROMANO, JW; EHRHART, JC; DUTHU, A; KIM, CM; APPELLA, E; MAY, P			IDENTIFICATION AND CHARACTERIZATION OF A P53 GENE MUTATION IN A HUMAN OSTEO-SARCOMA CELL-LINE	ONCOGENE			English	Article									INST RECH SCI CANC,UNITE ONCOL MOLEC,F-94802 VILLEJUIF,FRANCE		ROMANO, JW (corresponding author), NCI,CELL BIOL LAB,BETHESDA,MD 20892, USA.							BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BENEDICT WF, 1987, ADV VIRAL ONCOL, V7, P19; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; CALABRETTA B, 1986, CANCER RES, V46, P5738; CARLONI G, 1988, FEBS LETT, V229, P333, DOI 10.1016/0014-5793(88)81151-7; CHO HY, 1976, SCIENCE, V194, P951, DOI 10.1126/science.62397; Crawford L V, 1984, Mol Biol Med, V2, P261; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; EHRHART JC, 1988, ONCOGENE, V3, P595; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KNUDSON AG, 1987, ADV VIRAL ONCOL, V7, P1; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LUBBERT M, 1989, ONCOGENE, V4, P643; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; MERCER WE, 1985, EXP CELL RES, V160, P31, DOI 10.1016/0014-4827(85)90233-2; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MORA PT, 1982, MOL CELL BIOL, V2, P763, DOI 10.1128/MCB.2.7.763; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; RHIM JS, 1975, INT J CANCER, V15, P23, DOI 10.1002/ijc.2910150104; RHIM JS, 1975, NATURE, V256, P751, DOI 10.1038/256751a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROVINSKI B, 1988, ONCOGENE, V2, P445; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11383, DOI 10.1093/nar/16.23.11383; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11384, DOI 10.1093/nar/16.23.11384; SOUSSI T, 1987, ONCOGENE, V2, P71; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STURZBECHER HW, 1987, ONCOGENE, V1, P201; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	51	129	134	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1483	1488						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2531855				2022-12-28	WOS:A1989CB65900010
J	ADACHI, M; TSUJIMOTO, Y				ADACHI, M; TSUJIMOTO, Y			JUXTAPOSITION OF HUMAN BCL-2 AND IMMUNOGLOBULIN-LAMBDA LIGHT CHAIN GENE IN CHRONIC LYMPHOCYTIC-LEUKEMIA IS THE RESULT OF A RECIPROCAL CHROMOSOME-TRANSLOCATION BETWEEN CHROMOSOME-18 AND CHROMOSOME-22	ONCOGENE			English	Article									WISTAR INST,36TH ST & SPRUCE,PHILADELPHIA,PA 19104	The Wistar Institute								ADACHI M, 1989, P NATL ACAD SCI USA, V86, P2771, DOI 10.1073/pnas.86.8.2771; BAKHSHI A, 1987, P NATL ACAD SCI USA, V84, P2396, DOI 10.1073/pnas.84.8.2396; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CROCE CM, 1986, COLD SPRING HARB SYM, V51, P891, DOI 10.1101/SQB.1986.051.01.102; DREAZEN O, 1987, LANCET, V1, P1402; HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0; HOLLIS GF, 1984, NATURE, V307, P752, DOI 10.1038/307752a0; MORRIS CM, 1986, NATURE, V320, P281, DOI 10.1038/320281a0; NOWELL PC, 1988, CANCER GENET CYTOGEN, V33, P155, DOI 10.1016/0165-4608(88)90025-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TSUJIMOTO Y, 1987, P NATL ACAD SCI USA, V84, P1329, DOI 10.1073/pnas.84.5.1329; TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0	16	34	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1989	4	9					1073	1075						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AM531	2506501				2022-12-28	WOS:A1989AM53100003
J	SACCHI, N; WENDTNER, CM; THIELE, CJ				SACCHI, N; WENDTNER, CM; THIELE, CJ			SINGLE-CELL DETECTION OF ETS-1 TRANSCRIPTS IN HUMAN NEUROECTODERMAL CELLS	ONCOGENE			English	Note							EWINGS-SARCOMA; DNA-BINDING; PROTOONCOGENE EXPRESSION; TRANSFORMING GENE; PROTO-ONCOGENES; SEQUENCE; PROTEINS; ERYTHROBLASTOSIS; LINES; NEUROEPITHELIOMA	The genes of the ets family are thought to code for a novel class of transcriptional factors. These proteins have a specific DNA-binding domain different from the basic domain of both the helix-loop-helix and leucine zipper families of DNA-binding proteins. The ets-1 gene product has been shown to bind to the enhancer region of the human T-cell receptor alpha-gene during thymocyte ontogeny. This finding explains the high expression of ets-1 observed in T cells and the correlation between ets-1 expression and the expression of the T-cell receptor gene during fetal development. The ets-1 gene is also possibly biologically active in neural cells. By using RNA in situ hybridization analysis, we demonstrate the presence of ets-1 transcripts in cells of peripheral embryonal neuroectodermal tumors, specifically neuroepithelioma and neuroblastoma. In addition, the gene is found transcribed in Ewing's sarcoma, postulated to be ontogenetically related to tumors derived from the neural crest.	NCI, PEDIAT ONCOL BRANCH, MOLEC GENET LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	SACCHI, N (corresponding author), NCI, MOLEC ONCOL LAB, FREDERICK, MD 21702 USA.							AMOUYEL P, 1988, BRAIN RES, V447, P149, DOI 10.1016/0006-8993(88)90976-6; BHAT NK, 1989, J IMMUNOL, V142, P672; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BIEDLER JL, 1989, CANCER RES, V41, P4678; BOULUKOS KE, 1988, EMBO J, V7, P697, DOI 10.1002/j.1460-2075.1988.tb02865.x; BRESSER J, 1987, GENE ANAL TECH, V4, P89, DOI 10.1016/0735-0651(87)90002-1; CAVAZZANA AO, 1987, AM J PATHOL, V127, P507; DONNER L, 1985, ADV NEUROBLASTOMA RE, P347; GLASS CK, 1990, CELL, V63, P729, DOI 10.1016/0092-8674(90)90139-6; GOLAY J, 1988, CELL, V55, P1147, DOI 10.1016/0092-8674(88)90259-0; HO IC, 1990, SCIENCE, V250, P814, DOI 10.1126/science.2237431; ISRAEL MA, 1989, PRINCIPLES PRACTICE, P623; JORCYK CL, 1991, ONCOGENE, V6, P523; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KOIZUMI S, 1990, ONCOGENE, V5, P675; KOVAR H, 1990, ONCOGENE, V5, P1067; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LIPINSKI M, 1987, CANCER RES, V47, P183; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; MAVROTHALASSITIS GJ, 1991, CELL GROWTH DIFFER, V2, P215; MCKEON C, 1988, CANCER RES, V48, P4307; MUJOO K, 1987, CANCER RES, V47, P1098; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; NUNN MF, 1989, J VIROL, V63, P398, DOI 10.1128/JVI.63.1.398-402.1989; PAPAS TS, 1990, AM J MED GENET, P251; PRIBYL LJ, 1988, DEV BIOL, V127, P45, DOI 10.1016/0012-1606(88)90187-X; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1988, ONCOGENE RES, V3, P239; REDDY ESP, 1987, P NATL ACAD SCI USA, V84, P6131, DOI 10.1073/pnas.84.17.6131; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; SACCHI N, 1988, LEUKEMIA, V2, P12; SETH A, 1990, ONCOGENESIS, P207; SHYAM E, 1990, CANCER RES, V50, P5013; THIELE CJ, 1988, ONCOGENE, V3, P281; THIELE CJ, 1987, J CLIN INVEST, V80, P804, DOI 10.1172/JCI113137; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WATSON D K, 1990, Critical Reviews in Oncogenesis, V1, P409; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907	45	16	16	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1991	6	11					2149	2154						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945417				2022-12-28	WOS:A1991GX11900028
J	GRANDORI, C; SUDOL, M; HANAFUSA, H				GRANDORI, C; SUDOL, M; HANAFUSA, H			C-YES PROTEIN-KINASE IS ASSOCIATED WITH A 38-KD PROTEIN IN CEREBELLUM	ONCOGENE			English	Note							MIDDLE-T-ANTIGEN; GENE-PRODUCT; TYROSINE PHOSPHORYLATION; PP60C-SRC; POLYOMAVIRUS; ACTIVATION; P56LCK; DEPHOSPHORYLATION; TRANSFORMATION; IDENTIFICATION	p62c-yes, the protein product of the yes proto-oncogene, was found in association with a cellular protein of 38 kD in chicken cerebella. The complex was detected by immunoprecipitation of cerebellar membranes with affinity purified anti-yes IgG followed by in vitro phosphorylation of the immunocomplex. Both proteins were found to be phosphorylated exclusively on tyrosine. The sedimentation profile of the yes kinase indicated that a fraction of p62c-yes was complexed with the 38 kD protein and comigrated in the gradient with a molecular mass of approximately 150 kD. We have previously described the association of p60c-src with a 38 kD protein, referred to as p38 [Grandori, C. and Hanafusa, H., J. Cell Biol. (1988), 107: 2125-2135]. Comparison of the src-associated p38 with the yes-associated 38 kD protein indicates that they are indistinguishable by one-dimensional peptide mapping. Association of p38 with more than one member of the src-family of tyrosine kinases makes this protein an attractive probe to study the structural and functional aspects of these enzymes.	ROCKEFELLER UNIV,MOLEC ONCOL LAB,1230 YORK AVE,NEW YORK,NY 10021	Rockefeller University	SUDOL, M (corresponding author), ROCKEFELLER UNIV,MOLEC ONCOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.				NATIONAL CANCER INSTITUTE [R29CA045757, R35CA044356] Funding Source: NIH RePORTER; NCI NIH HHS [CA45757, CA44356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLETT MS, 1979, J VIROL, V29, P770, DOI 10.1128/JVI.29.2.770-781.1979; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COURTNEIDGE S, 1984, NATURE, V303, P435; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GRANDORI C, 1988, J CELL BIOL, V107, P2125, DOI 10.1083/jcb.107.6.2125; GRANDORI C, 1989, THESIS ROCKEFELLER U; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KORNBLUTH S, 1987, NATURE, V325, P171, DOI 10.1038/325171a0; KYPTA RM, 1988, EMBO J, V7, P3837, DOI 10.1002/j.1460-2075.1988.tb03269.x; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MAYER BJ, 1990, P NATL ACAD SCI USA, V87, P2638, DOI 10.1073/pnas.87.7.2638; PANG DT, 1988, P NATL ACAD SCI USA, V85, P762, DOI 10.1073/pnas.85.3.762; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1988, NUCLEIC ACIDS RES, V16, P9876, DOI 10.1093/nar/16.20.9876; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0	27	10	10	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					1063	1066						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067844				2022-12-28	WOS:A1991GU62200024
J	JORCYK, CL; WATSON, DK; MAVROTHALASSITIS, GJ; PAPAS, TS				JORCYK, CL; WATSON, DK; MAVROTHALASSITIS, GJ; PAPAS, TS			THE HUMAN ETS1 GENE - GENOMIC STRUCTURE, PROMOTER CHARACTERIZATION AND ALTERNATIVE SPLICING	ONCOGENE			English	Article							LONG TERMINAL REPEAT; ONCOGENE C-ETS; PROTO-ONCOGENE; TRANSCRIPTION FACTOR; FUNCTIONAL-CHARACTERIZATION; TRANSFORMING GENE; NUCLEAR PROTEINS; LEUKEMIA VIRUSES; E26 RETROVIRUS; SARCOMA-VIRUS	Genomic clones encompassing the human ETS1 gene were isolated and utilized to define its molecular organization. This gene consists of eight exons spanning over 60 kb. The 5' end of the human ETS1 gene was subcloned and characterized. S1 nuclease, primer extension and RNAase protection analyses of human mRNAs showed multiple transcription initiation sites. DNA sequence analysis indicated a high G + C content in the promoter region and the absence of either a 'TATA' box or a 'CAAT' box. Six consensus recognition sequences for the transcription factor SP1, two AP1 consensus sequences and one consensus AP2 recognition sequence were identified, as well as two GC elements with dyad symmetry. A palindromic region similar to the serum response element of the c-fos gene and two octamer consensus recognition sequences were located upstream of the promoter region. A series of promoter deletion constructs positioned upstream from the bacterial chloramphenicol acetyl transferase gene were transfected into HeLa cells and their functional promoter activity assayed. The deletion constructs identified the 5' boundary for maximum promoter activity at 486 bp upstream of the first initiation site and suggest possible positive and negative regulatory regions. Polymerase chain reaction analysis of ETS1 cDNA identified several amplified products, indicating alternative splicing. In addition to the presence of mRNA products lacking exon VII, products lacking exon IV, as well as ones lacking both exons IV and VII, were found.			JORCYK, CL (corresponding author), NCI, MOLEC ONCOL LAB, FREDERICK, MD 21702 USA.							ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; BERG PE, 1989, NUCLEIC ACIDS RES, V17, P8833, DOI 10.1093/nar/17.21.8833; BHAT NK, 1990, P NATL ACAD SCI USA, V87, P3723, DOI 10.1073/pnas.87.10.3723; BHAT NK, 1989, J IMMUNOL, V142, P672; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BOULUKOS KE, 1989, MOL CELL BIOL, V9, P5718, DOI 10.1128/MCB.9.12.5718; BOYLE WJ, 1984, P NATL ACAD SCI-BIOL, V81, P4265, DOI 10.1073/pnas.81.14.4265; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; CHEN JH, 1988, ONCOGENE RES, V2, P371; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DESIMONE V, 1989, NUCLEIC ACIDS RES, V17, P9407, DOI 10.1093/nar/17.22.9407; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; EVANS T, 1988, J MOL BIOL, V199, P61, DOI 10.1016/0022-2836(88)90379-8; FIELD LJ, 1985, P NATL ACAD SCI USA, V82, P6196, DOI 10.1073/pnas.82.18.6196; GEGONNE A, 1987, MOL CELL BIOL, V7, P806, DOI 10.1128/MCB.7.2.806; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAF T, 1979, VIROLOGY, V99, P431, DOI 10.1016/0042-6822(79)90024-2; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; HAMPE A, 1989, ONCOGENE RES, V4, P9; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOFFMAN EK, 1987, MOL CELL BIOL, V7, P2592, DOI 10.1128/MCB.7.7.2592; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JAKOBOVITS EB, 1988, MOL CELL BIOL, V8, P5549, DOI 10.1128/MCB.8.12.5549; JOHNSON DG, 1990, MOL CELL BIOL, V10, P982, DOI 10.1128/MCB.10.3.982; JOHNSTON BH, 1988, SCIENCE, V241, P1800, DOI 10.1126/science.2845572; KEOHAVONG P, 1982, NUCLEIC ACIDS RES, V10, P1215, DOI 10.1093/nar/10.4.1215; KIM SJ, 1989, J BIOL CHEM, V264, P402; KOIZUMI S, 1990, ONCOGENE, V5, P675; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; LEPRINCE D, 1988, J VIROL, V62, P3233, DOI 10.1128/JVI.62.9.3233-3241.1988; Maniatis T., 1982, MOL CLONING; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; Maxam A M, 1980, Methods Enzymol, V65, P499; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MOSCOVICI C, 1981, VIROLOGY, V113, P765, DOI 10.1016/0042-6822(81)90205-1; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1988, ONCOGENE RES, V3, P239; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; ROVIGATTI U, 1986, SCIENCE, V232, P398, DOI 10.1126/science.3457468; SACCHI N, 1988, LEUKEMIA, V2, P12; SACCHI N, 1986, SCIENCE, V231, P379, DOI 10.1126/science.3941901; SALIER JP, 1989, BIOTECHNIQUES, V7, P30; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULMAN H, 1988, ADV SEC MESS PHOSPH, V22, P39; SETH A, 1991, IN PRESS ONCOGENE; WATSON D K, 1990, Critical Reviews in Oncogenesis, V1, P409; WATSON DK, 1988, VIROLOGY, V164, P99, DOI 10.1016/0042-6822(88)90624-1; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WATSON DK, 1985, P NATL ACAD SCI USA, V82, P7294, DOI 10.1073/pnas.82.21.7294; WIDEN SG, 1988, J BIOL CHEM, V263, P16992; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220	64	102	102	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1991	6	4					523	532						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030910				2022-12-28	WOS:A1991FR93900005
J	TAKAHASHI, M; BUMA, Y; TANIGUCHI, M				TAKAHASHI, M; BUMA, Y; TANIGUCHI, M			IDENTIFICATION OF THE RET PROTOONCOGENE PRODUCTS IN NEUROBLASTOMA AND LEUKEMIA-CELLS	ONCOGENE			English	Article							EXPRESSION; PROTOONCOGENE; RNA	Monoclonal and/or polyclonal antibodies were generated against the products synthesized from two portions of the ret proto-oncogene (c-ret) cDNA expressed in Escherichia coli. These antibodies were reactive in immunoblotting with 150 kd and 170 kd proteins in cell lysates from three human neuroblastoma cell lines expressing the ret proto-oncogene. When the neuroblastoma cells were treated with tunicamycin, a protein with an apparent molecular weight of 120 kd, which is consistent with that of the c-ret protein predicted from the cDNA sequence, appeared on immunoblots. These results indicated that the 150 kd and 170 kd proteins in neuroblastoma cells are produced from a single polypeptide of 120 kd by post-translational glycosylation. Furthermore, the antibodies detected a unique 190 kd protein as well as 150 kd protein in a cell lysate from THP-1 human monocytic leukemia cell line, suggesting that glycosylated forms of the c-ret protein are different between neuroblastoma and leukemia cells.	AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN	Aichi Cancer Center	TAKAHASHI, M (corresponding author), NAGOYA UNIV,SCH MED,DEPT PATHOL 2,65 TSURUMAI CHO,NAGOYA,AICHI 466,JAPAN.		TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020	Takahashi, Masahide/0000-0002-2803-2683				IKEDA I, 1990, ONCOGENE, V5, P1291; KIKUCHI T, 1990, HYBRIDOMA, V9, P189, DOI 10.1089/hyb.1990.9.189; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; NAGAO M, 1990, JPN J CANCER RES, V81, P309, DOI 10.1111/j.1349-7006.1990.tb02566.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8; TAHIRA T, 1990, ONCOGENE, V5, P97; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571	12	102	105	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					297	301						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000222				2022-12-28	WOS:A1991FZ13400016
J	KIEM, HP; NOURSE, J; SALTMAN, DL; BLUME, KG; CLEARY, ML				KIEM, HP; NOURSE, J; SALTMAN, DL; BLUME, KG; CLEARY, ML			CONCURRENT ACTIVATION OF C-MYC AND INACTIVATION OF BCL-2 BY CHROMOSOMAL TRANSLOCATION IN A LYMPHOBLASTIC LYMPHOMA CELL-LINE	ONCOGENE			English	Article							BREAKPOINT-CLUSTER REGION; FOLLICULAR LYMPHOMA; BURKITT-LYMPHOMA; T(14-18) TRANSLOCATION; MALIGNANT-LYMPHOMAS; ONCOGENE; LEUKEMIA; DNA; CLONING; GENE	We have characterized a chromosomal translocation in a cell line (SU-DUL5) established from a patient with lymphoblastic lymphoma in which the c-myc gene on chromosome 8 was juxtaposed to a t(14:18). Cytogenetic analysis of this cell line showed 14q+, 18q-, and 8p+ q+ marker chromosomes in the absence of t(14:18). Genomic Southern blot analysis showed juxtaposition of the immunoglobulin heavy chain joining region (JH) with chromosome 18 near the minor breakpoint cluster region (mcr) of the bcl-2 gene. There was also a rearranged c-myc gene detectable with a 5' c-myc probe. Molecular cloning studies showed that the c-myc gene was joined to chromosome 18 DNA. Nucleotide sequence analysis of cloned breakpoint DNA revealed that the crossover between chromosomes 8 and 18 occurred at the 3' end of the bcl-2 gene resulting in replacement of the bcl-2 gene on the 14q+ chromosome with the c-myc gene. As a result of this translocation the SU-DUL5 cell line contains no detectable bcl-2 mRNA or protein but has abundant levels of c-myc mRNA. Our data suggest that bcl-2 inactivation occurred simultaneously with c-myc translocation in a B cell lymphoblastic lymphoma.	STANFORD UNIV, MED CTR, SCH MED, DEPT PATHOL, EXPTL ONCOL LAB, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR,SCH MED,DIV HEMATOL, BONE MARROW TRANSPLANT PROGRAM, STANFORD, CA 94305 USA	Stanford University; Stanford University					NCI NIH HHS [CA42971, CA49605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042971, R37CA042971, P01CA049605] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1986, J EXP MED, V164, P315, DOI 10.1084/jem.164.1.315; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; Croce C M, 1986, Adv Immunol, V38, P245, DOI 10.1016/S0065-2776(08)60008-5; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; GAUWERKY CE, 1988, ONCOGENE, V2, P431; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; GUERRASIO A, 1987, J NATL CANCER I, V78, P845; HECHT BK, 1985, CANCER GENET CYTOGEN, V14, P205, DOI 10.1016/0165-4608(85)90186-4; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; LEE JT, 1989, J CLIN INVEST, V84, P1454, DOI 10.1172/JCI114320; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; MUFTI GJ, 1983, BLOOD, V62, P1142; NGAN BY, 1989, BLOOD, V73, P1759; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; PETTERSSON U, 1973, J MOL BIOL, V73, P125, DOI 10.1016/0022-2836(73)90164-2; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; ROWLEY JD, 1984, CANCER RES, V44, P3159; SALTMAN D, 1989, J CELL SCI, V94, P743; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WEISS LM, 1987, NEW ENGL J MED, V317, P1185, DOI 10.1056/NEJM198711053171904; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	36	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1990	5	12					1815	1819						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284100				2022-12-28	WOS:A1990ET43600011
J	SCHAEFERREGO, KE; LEIBOWITZ, D; MEARS, JG				SCHAEFERREGO, KE; LEIBOWITZ, D; MEARS, JG			CHROMATIN ALTERATIONS SURROUNDING THE BCR/ABL FUSION GENE IN K562 CELLS	ONCOGENE			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR COMPREHENS CANC,NEW YORK,NY 10032; DEPT MED,INDIANAPOLIS,IN; DEPT MED GENET,INDIANAPOLIS,IN; WALTHER ONCOL CTR,INDIANAPOLIS,IN	Columbia University; Columbia University; Walther Cancer Institute					NATIONAL CANCER INSTITUTE [R01CA037193, R01CA044028] Funding Source: NIH RePORTER; NCI NIH HHS [CA44028, CA37193] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COLLINS SJ, 1984, SCIENCE, V225, P72, DOI 10.1126/science.6587568; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DIMERY IW, 1983, EXP HEMATOL, V11, P601; GALE RP, 1984, P NATL ACAD SCI-BIOL, V81, P5648, DOI 10.1073/pnas.81.18.5648; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; KLOETZER W, 1985, VIROLOGY, V140, P230, DOI 10.1016/0042-6822(85)90361-7; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; LACHMAN HM, 1983, NUCLEIC ACIDS RES, V17, P6065; LEIBOWITZ D, 1985, BLOOD, V65, P526; LEIBOWITZ D, 1985, BLOOD, V66, P243; MANIATIS T, 1973, P NATL ACAD SCI USA, V72, P184; POPENOE DW, 1986, BLOOD, V68, P1123; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SCHTIVELMAN E, 1985, NATURE, V315, P550; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WEINTRAUB H, 1985, CELL, V42, P705, DOI 10.1016/0092-8674(85)90267-3	17	7	7	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1669	1673						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267134				2022-12-28	WOS:A1990EL40100009
J	KASHISHIAN, A; MACAULEY, A; COOPER, JA				KASHISHIAN, A; MACAULEY, A; COOPER, JA			PROPERTIES OF TRIPARTITE CHIMERAS BETWEEN SRC AND LCK	ONCOGENE			English	Article									FRED HUTCHINSON CANC RES CTR, 1124 COLUMBIA ST, SEATTLE, WA 98104 USA	Fred Hutchinson Cancer Center					NCI NIH HHS [CA-41072] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041072, R37CA041072] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BRUGGE JS, 1984, J BIOL CHEM, V259, P4550; BURR JG, 1980, P NATL ACAD SCI-BIOL, V77, P3484, DOI 10.1073/pnas.77.6.3484; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CASNELLIE JE, 1982, J BIOL CHEM, V257, P3877; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312; HURLEY TR, 1989, ONCOGENE, V4, P265; JOVE R, 1989, ONCOGENE RES, V5, P49; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KATO JY, 1986, MOL CELL BIOL, V6, P4155, DOI 10.1128/MCB.6.12.4155; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KORMAN AJ, 1987, P NATL ACAD SCI USA, V84, P2150, DOI 10.1073/pnas.84.8.2150; LEVINSON AD, 1981, P NATL ACAD SCI-BIOL, V78, P1624, DOI 10.1073/pnas.78.3.1624; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOEB DM, 1987, J VIROL, V61, P2420, DOI 10.1128/JVI.61.8.2420-2427.1987; LOUIE RR, 1988, J VIROL, V62, P4673, DOI 10.1128/JVI.62.12.4673-4679.1988; MACAULEY A, 1988, MOL CELL BIOL, V8, P3560, DOI 10.1128/MCB.8.8.3560; MACAULEY A, 1989, MOL CELL BIOL, V9, P2648, DOI 10.1128/MCB.9.6.2648; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MILLER AD, 1986, SOMAT CELL MOLEC GEN, V12, P175, DOI 10.1007/BF01560664; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; PARSONS SJ, 1986, J VIROL, V59, P755, DOI 10.1128/JVI.59.3.755-758.1986; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; Potts W M, 1988, Oncogene Res, V3, P343; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; SATO M, 1989, J VIROL, V63, P683, DOI 10.1128/JVI.63.2.683-688.1989; SEFTON BM, 1982, J VIROL, V41, P813, DOI 10.1128/JVI.41.3.813-820.1982; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013	40	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1990	5	10					1463	1470						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250908				2022-12-28	WOS:A1990EK50200004
J	SACCA, R; COCHRAN, BH				SACCA, R; COCHRAN, BH			IDENTIFICATION OF A PDGF-RESPONSIVE ELEMENT IN THE MURINE C-MYC GENE	ONCOGENE			English	Article									MIT, CTR CANC RES, 77 MASSACHUSETTS AVE, E17-517, CAMBRIDGE, MA 02139 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)				Cochran, Brent/0000-0002-7598-5604	NCI NIH HHS [P01 CA42063] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA042063] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; ASSELIN C, 1989, ONCOGENE, V4, P549; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLAKE MC, 1989, MOL CELL BIOL, V9, P4994, DOI 10.1128/MCB.9.11.4994; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COCHRAN BH, 1988, CELLULAR FACTORS DEV; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DEAN M, 1986, J BIOL CHEM, V261, P9161; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; DERSE D, 1986, SCIENCE, V231, P1437, DOI 10.1126/science.3006241; GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALL DJ, 1987, J BIOL CHEM, V262, P15302; HALL DJ, 1990, ONCOGENE, V5, P47; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KELLY K, 1988, J BIOL CHEM, V263, P4828; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; MANSOUR SL, 1986, MOL CELL BIOL, V6, P2684, DOI 10.1128/MCB.6.7.2684; MARCU KB, 1988, CURR TOP MICROBIOL, V141, P253; MERRILL GF, 1984, MOL CELL BIOL, V4, P1777, DOI 10.1128/MCB.4.9.1777; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NEPVEU A, 1987, ONCOGENE, V1, P243; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; PAYNE GS, 1982, NATURE, V295, P209, DOI 10.1038/295209a0; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; RICHMAN A, 1989, MOL CELL BIOL, V9, P4962, DOI 10.1128/MCB.9.11.4962; SANTERRE RF, 1984, GENE, V30, P147, DOI 10.1016/0378-1119(84)90115-X; SCHER CD, 1978, J CELL PHYSIOL, V97, P371, DOI 10.1002/jcp.1040970312; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x	68	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1990	5	10					1499	1505						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250909				2022-12-28	WOS:A1990EK50200008
J	GINSBERG, D; OREN, M; YANIV, M; PIETTE, J				GINSBERG, D; OREN, M; YANIV, M; PIETTE, J			PROTEIN-BINDING ELEMENTS IN THE PROMOTER REGION OF THE MOUSE P53 GENE	ONCOGENE			English	Article									INST PASTEUR, DEPT BIOL MOLEC,UNITE VIRUS ONCOGENES,CNRS,UA 1149, F-75724 PARIS 15, FRANCE; INST PASTEUR, UNITE NEUROBIOL MOLEC, F-75724 PARIS 15, FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	GINSBERG, D (corresponding author), WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL.			ginsberg, doron/0000-0002-1257-4920				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BIENZTADMOR B, 1985, EMBO J, V4, P3209, DOI 10.1002/j.1460-2075.1985.tb04067.x; CALABRETTA B, 1986, CANCER RES, V46, P5783; COULIER F, 1985, EMBO J, V4, P3413, DOI 10.1002/j.1460-2075.1985.tb04098.x; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DONY C, 1985, NATURE, V317, P636, DOI 10.1038/317636a0; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GALOS RS, 1979, CELL, V17, P945, DOI 10.1016/0092-8674(79)90334-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HIRAI S, 1989, VECTORS TOOLS STUDY, P355; HIRAI SI, 1990, ONCOGENE, V5, P39; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1988, ONCOGENE HDB, P403; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KHOCHBIN S, 1989, EMBO J, V8, P4107, DOI 10.1002/j.1460-2075.1989.tb08595.x; KHOCHBIN S, 1988, J MOL BIOL, V200, P55, DOI 10.1016/0022-2836(88)90333-6; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEVINE AJ, 1989, ICN UCI C V, P21; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; MOSES HL, 1985, CANCER CELL, V3, P65; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NIGRO MJ, 1989, NATURE, V343, P705; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; PIETTE J, 1985, EMBO J, V4, P2675, DOI 10.1002/j.1460-2075.1985.tb03987.x; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; REISMAN D, 1989, ONCOGENE, V4, P945; REISMAN D, 1988, P NATL ACAD SCI USA, V85, P5146, DOI 10.1073/pnas.85.14.5146; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SHARMA A, 1989, P NATL ACAD SCI USA, V86, P491, DOI 10.1073/pnas.86.2.491; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254	51	90	90	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1285	1290						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216454				2022-12-28	WOS:A1990EC24100002
J	MILLER, M; KENNEWELL, A; TAKAYAMA, Y; BRUSKIN, A; BISHOP, JM; JOHNSON, G; SYMONDS, G				MILLER, M; KENNEWELL, A; TAKAYAMA, Y; BRUSKIN, A; BISHOP, JM; JOHNSON, G; SYMONDS, G			TRANSFORMATION OF EARLY ERYTHROID PRECURSOR CELLS (BFU-E) BY A RECOMBINANT MURINE RETROVIRUS CONTAINING V-ERB-B	ONCOGENE			English	Article									CHILDRENS MED RES FDN,POB 61,CAMPERDOWN,NSW 2050,AUSTRALIA; UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA; UNIV CALIF SAN FRANCISCO,GEORGE WILLIAMS HOOPER FDN,SAN FRANCISCO,CA 94143	Children's Medical Research Institute - Australia; University of California System; University of California San Francisco; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R01CA025972, R35CA044338] Funding Source: NIH RePORTER; NCI NIH HHS [CA44338, CA25972] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON SM, 1985, MOL CELL BIOL, V5, P3369, DOI 10.1128/MCB.5.12.3369; BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; Beug H., 1982, CANCER SURV, V1, P205; BISHOP JM, 1985, MOL BIOL TUMOR VIR S, P766; BROWN AMC, 1987, DNA CLONING, V3, P189; BRUSKIN A, 1990, ONCOGENE, V5, P15; CHUNG SW, 1988, BLOOD, V71, P973; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; COPELAND NG, 1980, J VIROL, V33, P1199, DOI 10.1128/JVI.33.3.1199-1202.1980; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; GAZIT A, 1986, J VIROL, V60, P19, DOI 10.1128/JVI.60.1.19-28.1986; GAZZOLO L, 1980, CELL, V22, P683, DOI 10.1016/0092-8674(80)90544-9; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; HANKINS DW, 1982, MOL CELL BIOL, V2, P138; HANKINS WD, 1980, CELL, V22, P693; HANKINS WD, 1978, NATURE, V276, P506, DOI 10.1038/276506a0; HANKINS WD, 1981, CELL, V26, P91, DOI 10.1016/0092-8674(81)90036-2; HAYMAN MJ, 1984, NATURE, V309, P460, DOI 10.1038/309460a0; HAYMAN MJ, 1986, TRENDS GENET, V2, P260, DOI 10.1016/0168-9525(86)90259-3; JOHNSON GR, 1977, P NATL ACAD SCI USA, V74, P3879, DOI 10.1073/pnas.74.9.3879; KLINKEN SP, 1988, ONCOGENE RES, V3, P187; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; KLINKEN SP, 1989, J VIROL, V63, P1489, DOI 10.1128/JVI.63.3.1489-1492.1989; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MOSCOVICI C, 1985, RETROVIRUSES HUMAN P, P177; PIERCE JH, 1986, CURR TOP MICROBIOL, V132, P55; PRIVALSKY ML, 1983, CELL, V32, P1257, DOI 10.1016/0092-8674(83)90307-0; QUADE K, 1979, VIROLOGY, V98, P461, DOI 10.1016/0042-6822(79)90569-5; RAINES MA, 1985, P NATL ACAD SCI USA, V82, P2287, DOI 10.1073/pnas.82.8.2287; SAMARUT J, 1982, CELL, V28, P921, DOI 10.1016/0092-8674(82)90071-X; SEALY L, 1983, VIROLOGY, V130, P155, DOI 10.1016/0042-6822(83)90125-3; SEALY L, 1983, VIROLOGY, V130, P179, DOI 10.1016/0042-6822(83)90126-5; SYMONDS G, 1989, ONCOGENE, V4, P285; SYMONDS G, 1984, MOL CELL BIOL, V4, P1627, DOI 10.1128/MCB.4.8.1627; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; VENNSTROM B, 1980, J VIROL, V36, P575; WANECK GL, 1981, CELL, V26, P79, DOI 10.1016/0092-8674(81)90035-0; WANECK GL, 1986, CELL, V44, P337, DOI 10.1016/0092-8674(86)90768-3; YAMAMOTO T, 1983, CELL, V34, P225, DOI 10.1016/0092-8674(83)90153-8	43	19	19	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1125	1131						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2168027				2022-12-28	WOS:A1990DX36100003
J	YANAGIHARA, K; CIARDIELLO, F; TALBOT, N; MCGEADY, ML; COOPER, H; BENADE, L; SALOMON, DS; BASSIN, RH				YANAGIHARA, K; CIARDIELLO, F; TALBOT, N; MCGEADY, ML; COOPER, H; BENADE, L; SALOMON, DS; BASSIN, RH			ISOLATION OF A NEW CLASS OF FLAT REVERTANTS FROM RAS-TRANSFORMED NIH3T3 CELLS USING CIS-4-HYDROXY-L-PROLINE	ONCOGENE			English	Article									NCI,DIV CANC BIOL & DIAG,TUMOR IMMUNOL & BIOL LAB,BLDG 10,RM 8B05,BETHESDA,MD 20892; AMER RED CROSS,TRANSMISSIBLE DIS LAB,ROCKVILLE,MD 20855	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Red Cross			Cutler, Mary L/G-5735-2017	Cutler, Mary L/0000-0001-9727-4320; Ciardiello, Fortunato/0000-0002-3369-4841				BASSIN RH, 1971, NATURE, V229, P564, DOI 10.1038/229564b0; BASSIN RH, 1987, ADV VIRAL ONCOL, V6, P103; BASSIN RH, 1984, CANCER CELLS ONCOGEN, V2, P462; BERNSTEIN SC, 1985, P NATL ACAD SCI USA, V82, P1726, DOI 10.1073/pnas.82.6.1726; BUSS JE, 1989, SCIENCE, V243, P1600, DOI 10.1126/science.2648572; CIARDIELLO F, 1988, CANCER RES, V48, P2483; EGAN SE, 1987, SCIENCE, V238, P202, DOI 10.1126/science.3659911; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; HAYNES JR, 1988, MOL CELL BIOL, V8, P2419, DOI 10.1128/MCB.8.6.2419; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Maniatis T., 1982, MOL CLONING; MATHEYPREVOT B, 1984, J VIROL, V50, P325, DOI 10.1128/JVI.50.2.325-334.1984; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; OZANNE B, 1974, J VIROL, V14, P239, DOI 10.1128/JVI.14.2.239-248.1974; PIZON V, 1988, ONCOGENE, V3, P201; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; SAMID D, 1987, MOL CELL BIOL, V7, P2196, DOI 10.1128/MCB.7.6.2196; SCHAEFER R, 1988, P NATL ACAD SCI USA, V85, P1590, DOI 10.1073/pnas.85.5.1590; SCOLNICK EM, 1979, P NATL ACAD SCI USA, V76, P5355, DOI 10.1073/pnas.76.10.5355; SHIH TY, 1979, VIROLOGY, V96, P64, DOI 10.1016/0042-6822(79)90173-9; SIRCAR S, 1988, ONCOGENE, V3, P725; TAGLIAFERRI P, 1987, INT J CANCER, V4, P653; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; YANAGIHARA K, 1985, JPN J CANCER RES, V76, P331; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	29	29	29	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1179	1186						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202950				2022-12-28	WOS:A1990DX36100010
J	BARBU, V; DAUTRY, F				BARBU, V; DAUTRY, F			MEVALONATE DEPRIVATION ALTERS THE INDUCTION OF FOS AND MYC BY GROWTH-FACTORS	ONCOGENE			English	Note									INST GUSTAVE ROUSSY,CNRS,ONCOL MOLEC LAB,F-94805 VILLEJUIF,FRANCE; CHU ST ANTOINE,BIOCHIM LAB,F-75571 PARIS 12,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite								BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARBU V, 1989, NUCLEIC ACIDS RES, V17, P7115, DOI 10.1093/nar/17.17.7115; BECK LA, 1988, J CELL BIOL, V107, P1307, DOI 10.1083/jcb.107.4.1307; BROWN MS, 1980, J LIPID RES, V21, P505; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DAUTRY F, 1988, J BIOL CHEM, V263, P17615; DEAN M, 1986, J BIOL CHEM, V261, P9161; FAIRBANKS KP, 1984, J BIOL CHEM, V259, P1546; FAIRBANKS KP, 1986, J CELL PHYSIOL, V127, P216, DOI 10.1002/jcp.1041270205; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; MALTESE WA, 1987, J CELL PHYSIOL, V133, P471, DOI 10.1002/jcp.1041330307; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; QUESNEYHUNEEUS V, 1983, J BIOL CHEM, V258, P378; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; REPKO EM, 1989, J BIOL CHEM, V264, P9945; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHMIDT RA, 1984, J BIOL CHEM, V259, P175; SINENSKY M, 1985, P NATL ACAD SCI USA, V82, P3257, DOI 10.1073/pnas.82.10.3257; STACEY DW, 1987, MOL CELL BIOL, V7, P523, DOI 10.1128/MCB.7.1.523; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; WITTE LD, 1982, J BIOL CHEM, V257, P5392; WITTE LD, 1985, ANN NY ACAD SCI, P261; WOLDA SL, 1988, J BIOL CHEM, V263, P5997	28	20	20	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1077	1080						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115642				2022-12-28	WOS:A1990DP41500020
J	HALVERSON, D; MODI, W; DEAN, M; GELMANN, EP; DUNN, KJ; CLANTON, D; OSKARSSON, M; OBRIEN, SJ; BLAIR, DG				HALVERSON, D; MODI, W; DEAN, M; GELMANN, EP; DUNN, KJ; CLANTON, D; OSKARSSON, M; OBRIEN, SJ; BLAIR, DG			AN ONCOGENIC CHROMOSOME-8-9 GENE FUSION ISOLATED FOLLOWING TRANSFECTION OF HUMAN OVARIAN-CARCINOMA CELL-LINE DNA	ONCOGENE			English	Note									NCI, MOLEC ONCOL LAB, POB B, FREDERICK, MD 21701 USA; PROGRAM RESOURCES INC, FREDERICK, MD 21701 USA; NCI, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA; GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, DIV MED ONCOL, WASHINGTON, DC 20007 USA; BIONET RES LABS INC, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University			Dean, Michael C/G-8172-2012; OBRIEN, STEPHEN/ABD-1346-2020; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; OBRIEN, STEPHEN/0000-0001-7857-0757	OFFICE OF THE DIRECTOR, NCI [N01CO074101, N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102, N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMIN W, 1987, CANCER RES, V47, P6040; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; GALLI MC, 1981, CANCER-AM CANCER SOC, V47, P1297, DOI 10.1002/1097-0142(19810315)47:6<1297::AID-CNCR2820470611>3.0.CO;2-D; GIBAS Z, 1984, CANCER RES, V44, P1257; GIBAS Z, 1986, CANCER GENET CYTOGEN, V19, P229, DOI 10.1016/0165-4608(86)90051-8; HAGEMEIJER A, 1982, CANCER GENET CYTOGEN, V5, P95, DOI 10.1016/0165-4608(82)90001-2; HAMILTON TC, 1983, CANCER RES, V43, P5379; HAYASHI S, 1978, HISTOCHEM CYTOCHEM, V26, P667; KONALCZYK J, 1983, CANCER GENET CYTOGEN, V9, P383; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; LATHROP M, 1988, GENOMICS, V3, P361, DOI 10.1016/0888-7543(88)90128-0; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Maniatis T., 1982, MOL CLONING; MODI WS, 1987, GENE ANAL TECH, V4, P75; MURRAY MJ, 1981, CELL, V25, P355, DOI 10.1016/0092-8674(81)90054-4; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; OHARA BM, 1986, CANCER RES, V46, P4695; PARK M, 1989, METABOLIC BASIS INHE; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	31	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1990	5	7					1085	1089						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973829				2022-12-28	WOS:A1990DP41500022
J	MORISHITA, K; PARGANAS, E; DOUGLASS, EC; IHLE, JN				MORISHITA, K; PARGANAS, E; DOUGLASS, EC; IHLE, JN			UNIQUE EXPRESSION OF THE HUMAN EVI-1 GENE IN AN ENDOMETRIAL CARCINOMA CELL-LINE - SEQUENCE OF CDNAS AND STRUCTURE OF ALTERNATIVELY SPLICED TRANSCRIPTS	ONCOGENE			English	Article									ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38105 USA; ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital					NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BARTHOLOMEW C, 1989, ONCOGENE, V4, P529; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P6687, DOI 10.1073/pnas.82.19.6687; IHLE JN, 1984, ADV VIRAL ONCOL, V4, P95; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KURAMOTO H, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P47; KURAMOTO H, 1972, AM J OBSTET GYNECOL, V114, P1012, DOI 10.1016/0002-9378(72)90861-7; Maniatis T., 1982, MOL CLONING; MATSUGI T, 1990, MOL CELL BIOL, V10, P1259, DOI 10.1128/MCB.10.3.1259; MORISHITA K, 1990, ONCOGENE RES, V5, P221; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0	18	101	105	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					963	971						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115646				2022-12-28	WOS:A1990DP41500003
J	WADEY, RB; PAL, N; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK				WADEY, RB; PAL, N; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK			LOSS OF HETEROZYGOSITY IN WILMS-TUMOR INVOLVES 2 DISTINCT REGIONS OF CHROMOSOME-11	ONCOGENE			English	Article									INST CHILD HLTH,DEPT HEMATOL & ONCOL,IMPERIAL CANC RES FUND,MOLEC GENET LAB,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND; HOSP SICK CHILDREN,DEPT HAEMATOL & ONCOL,LONDON WC1N 3JH,ENGLAND	Cancer Research UK; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust				Cowell, John/0000-0002-2079-5950				ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ALLISON J, 1981, BIOCHEM J, V199, P725, DOI 10.1042/bj1990725; ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOEHM T, 1988, ONCOGENE, V3, P691; BRAUCH H, 1987, NEW ENGL J MED, V317, P1109, DOI 10.1056/NEJM198710293171803; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; COMPTON DA, 1988, CELL, V55, P827, DOI 10.1016/0092-8674(88)90138-9; COUILLIN P, 1989, HUM GENET, V82, P171, DOI 10.1007/BF00284053; COWELL JK, 1989, HUM GENET, V82, P123, DOI 10.1007/BF00284042; DAO DD, 1987, AM J HUM GENET, V41, P202; DRACOPOLI NC, 1985, P NATL ACAD SCI USA, V82, P1470, DOI 10.1073/pnas.82.5.1470; ECCLES MR, 1984, HUM GENET, V67, P190, DOI 10.1007/BF00272999; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; GREEN AR, 1988, BRIT J CANCER, V58, P115, DOI 10.1038/bjc.1988.176; GRUNDY P, 1988, NATURE, V336, P375; HAYWARD NK, 1988, CANCER GENET CYTOGEN, V30, P127, DOI 10.1016/0165-4608(88)90100-8; HEIGHWAY J, 1986, BRIT J CANCER, V53, P453, DOI 10.1038/bjc.1986.72; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HOPPENER JWM, 1985, HUM GENET, V70, P259; HUFF V, 1987, NUCLEIC ACIDS RES, V15, P7651, DOI 10.1093/nar/15.18.7651; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUFF V, 1989, IN PRESS HUMAN GENET; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; JUNIEN C, 1989, CYTOGENET CELL GENET, V51, P226, DOI 10.1159/000132793; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LEWIS W H, 1988, Genomics, V3, P25, DOI 10.1016/0888-7543(88)90154-1; LITTLE MH, 1988, HUM GENET, V79, P186, DOI 10.1007/BF00280564; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; Maniatis T., 1982, MOL CLONING; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; MATSUNAGA E, 1981, HUM GENET, V57, P231; MILLER RW, 1964, NEW ENGL J MED, V270, P922, DOI 10.1056/NEJM196404302701802; NARAHARA K, 1984, HUM GENET, V66, P181, DOI 10.1007/BF00286597; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PING AJ, 1989, AM J HUM GENET, V44, P720; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOLIS V, 1988, CANCER GENET CYTOGEN, V34, P223, DOI 10.1016/0165-4608(88)90264-6; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THEILLET C, 1986, CANCER RES, V46, P4776; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TURLEAU C, 1984, HUM GENET, V67, P455, DOI 10.1007/BF00291410; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; WADEY RB, 1989, NUCLEIC ACIDS RES, V17, P3332, DOI 10.1093/nar/17.8.3332; WALMSLEY RM, 1984, NATURE, V310, P157, DOI 10.1038/310157a0; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WIEDEMANN HR, 1983, EUR J PEDIATR, V141, P129, DOI 10.1007/BF00496807; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; YOKATO J, 1987, P NATL ACAD SCI USA, V84, P9252; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	75	113	114	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					901	907						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2163053				2022-12-28	WOS:A1990DP55300017
J	KALKBRENNER, F; GUEHMANN, S; MOELLING, K				KALKBRENNER, F; GUEHMANN, S; MOELLING, K			TRANSCRIPTIONAL ACTIVATION BY HUMAN C-MYB AND V-MYB GENES	ONCOGENE			English	Article									MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,W-1000 BERLIN 33,GERMANY	Max Planck Society								BADING H, 1987, ONCOGENE, V1, P395; BADING H, 1988, ONCOGENE, V3, P257; BADING H, 1987, MODERN TRENDS HUMAN, V7, P488; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; CAREY M, 1989, IN PRESS J MOL BIOL; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; GERONDAKIS S, 1986, MOL CELL BIOL, V6, P3677, DOI 10.1128/MCB.6.11.3677; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; IBANEZ CE, 1988, J VIROL, V62, P1981, DOI 10.1128/JVI.62.6.1981-1988.1988; KAKIDANI H, 1988, CELL, V52, P161, DOI 10.1016/0092-8674(88)90504-1; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; LAUGHON A, 1984, MOL CELL BIOL, V4, P260, DOI 10.1128/MCB.4.2.260; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MCMAHON J, 1988, ONCOGENE, V3, P717; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REMAUT E, 1981, GENE, V15, P81, DOI 10.1016/0378-1119(81)90106-2; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SHEINESS D, 1984, MOL CELL BIOL, V4, P1206, DOI 10.1128/MCB.4.7.1206; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; SILVER PA, 1984, P NATL ACAD SCI-BIOL, V81, P5951, DOI 10.1073/pnas.81.19.5951; SLAMON DJ, 1986, SCIENCE, V233, P247; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; WEBSTER N, 1988, CELL, V52, P169, DOI 10.1016/0092-8674(88)90505-3; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	43	88	89	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					657	661						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189102				2022-12-28	WOS:A1990DG37400004
J	SAFRAN, A; AVIVI, A; ORRURTEREGER, A; NEUFELD, G; LONAI, P; GIVOL, D; YARDEN, Y				SAFRAN, A; AVIVI, A; ORRURTEREGER, A; NEUFELD, G; LONAI, P; GIVOL, D; YARDEN, Y			THE MURINE FLG GENE ENCODES A RECEPTOR FOR FIBROBLAST GROWTH-FACTOR	ONCOGENE			English	Article									WEIZMANN INST SCI, DEPT CHEM IMMUNOL, IL-76100 REHOVOT, ISRAEL; TECHNION ISRAEL INST TECHNOL, DEPT BIOL, IL-32000 HAIFA, ISRAEL	Weizmann Institute of Science; Technion Israel Institute of Technology			Neufeld, Gera/F-1524-2019; YARDEN, YOSEF/K-1467-2012	Orr-Urtreger, Avi/0000-0001-9305-6203				ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRIESEL R, 1986, J BIOL CHEM, V261, P7581; FRIESEL R, 1989, MOL CELL BIOL, V9, P1857, DOI 10.1128/MCB.9.5.1857; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAYEK A, 1987, BIOCHEM BIOPH RES CO, V147, P876, DOI 10.1016/0006-291X(87)91011-4; HOGAN B, 1986, MANIPULATING MOUSE E; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; JAYE M, 1985, SCIENCE, V228, P882, DOI 10.1126/science.3890179; KAN M, 1988, J BIOL CHEM, V263, P11306; KIMELMAN D, 1988, SCIENCE, V242, P1053, DOI 10.1126/science.3194757; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; MARUYAMA T, 1986, NUCLEIC ACIDS RES, V14, pR151, DOI 10.1093/nar/14.suppl.r151; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; NEUFELD G, 1986, J BIOL CHEM, V261, P5631; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; RUTA M, 1988, ONCOGENE, V3, P9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH JC, 1989, DEVELOPMENT, V105, P665; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALICKE PA, 1989, J BIOL CHEM, V264, P4120; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	54	114	121	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1990	5	5					635	643						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2161096				2022-12-28	WOS:A1990DG37400002
J	DMITROVSKY, E; MURTY, VVVS; MOY, D; MILLER, WH; NANUS, D; ALBINO, AP; SAMANIEGO, F; BOSL, G; CHAGANTI, RSK				DMITROVSKY, E; MURTY, VVVS; MOY, D; MILLER, WH; NANUS, D; ALBINO, AP; SAMANIEGO, F; BOSL, G; CHAGANTI, RSK			ISOCHROMOSOME 12P IN NONSEMINOMA CELL-LINES - KARYOLOGIC AMPLIFICATION OF C-KI-RAS2 WITHOUT POINT-MUTATIONAL ACTIVATION	ONCOGENE			English	Article									MEM HOSP CANC & ALLIED DIS,DEPT MED,SOLID TUMOR SERV,GENITOURINARY SECT,NEW YORK,NY 10021; SLOAN KETTERING MEM CANC CTR,IMMUNOL PROGRAM,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	DMITROVSKY, E (corresponding author), CORNELL UNIV,MED CTR,COLL MED,MEM SLOAN KETTERING CANC CTR,DEPT,CANC GENET & CYTOGENET LAB,NEW YORK,NY 10021, USA.				NCI NIH HHS [CA-05826] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA005826] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ANDREWS PW, 1984, LAB INVEST, V50, P147; ATKIN NB, 1982, LANCET, V2, P1349; ATKIN NB, 1983, CANCER GENET CYTOGEN, V10, P199, DOI 10.1016/0165-4608(83)90125-5; BALAZS I, 1984, HUM GENET, V68, P57, DOI 10.1007/BF00293873; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; BOSL GJ, 1989, J NATL CANCER I, V81, P1874; CASTEDO SMMJ, 1988, CANCER GENET CYTOGEN, V32, P51, DOI 10.1016/0165-4608(88)90311-1; CASTEDO SMMJ, 1989, CANCER RES, V49, P672; CASTEDO SMMJ, 1989, CANCER RES, V49, P439; CHAGANTI RSK, 1986, MALIGNANT LYMPHOMA, P184; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELOZIERBLANCHET CD, 1985, CANCER GENET CYTOGEN, V15, P375, DOI 10.1016/0165-4608(85)90182-7; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Fogh J, 1978, Natl Cancer Inst Monogr, P5; FUNG YKT, 1985, MOL CELL BIOL, V5, P3337, DOI 10.1128/MCB.5.12.3337; Harnden DG, 1985, INT SYSTEM HUMAN CYT; HEIM S, 1987, CANCER CYTOGENETICS, P227; KAZAZIAN HH, 1987, CYTOGENET CELL GENET, V46, P189; MCBRIDE LJ, 1988, BIOTECHNIQUES, V6, P362; MCCOY MS, 1984, MOL CELL BIOL, V4, P1577, DOI 10.1128/MCB.4.8.1577; MILLER WE, IN PRESS ONCOGENE; POPESCU NC, 1985, SOMAT CELL MOLEC GEN, V11, P149, DOI 10.1007/BF01534703; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TURCCAREL C, 1987, ONCOGENE RES, V1, P397; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WANG LC, 1987, CANCER RES, V47, P4192; WANG N, 1980, CANCER RES, V40, P796; ZEUTHEN J, 1980, INT J CANCER, V25, P19, DOI 10.1002/ijc.2910250104	32	36	36	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					543	548						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183156				2022-12-28	WOS:A1990DB85300013
J	KING, FJ; COLE, MD				KING, FJ; COLE, MD			MOLECULAR-CLONING AND SEQUENCING OF THE MURINE C-FGR GENE	ONCOGENE			English	Article											KING, FJ (corresponding author), PRINCETON UNIV,DEPT BIOL,LEWIS THOMAS LAB,PRINCETON,NJ 08544, USA.							ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; BAUMBACH WR, 1987, MOL CELL BIOL, V7, P664, DOI 10.1128/MCB.7.2.664; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; CHEAH MSC, 1986, NATURE, V319, P238, DOI 10.1038/319238a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CROSS FR, 1985, MOL CELL BIOL, V5, P2789, DOI 10.1128/MCB.5.10.2789; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; FOSTER DA, 1986, MOL CELL BIOL, V6, P325, DOI 10.1128/MCB.6.1.325; GARBER EA, 1985, MOL CELL BIOL, V5, P2781, DOI 10.1128/MCB.5.10.2781; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KAMPS MP, 1986, CELL, V45, P105, DOI 10.1016/0092-8674(86)90542-8; KAPPES B, 1989, ONCOGENE, V4, P363; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KATO JY, 1986, MOL CELL BIOL, V6, P4155, DOI 10.1128/MCB.6.12.4155; KEATH EJ, 1984, CELL, V37, P521, DOI 10.1016/0092-8674(84)90382-9; KOREN HS, 1975, J IMMUNOL, V114, P894; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; Maniatis T., 1982, MOL CLONING; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; METCALF D, 1969, J NATL CANCER I, V43, P983; METCALF D, 1982, INT J CANCER, V30, P773, DOI 10.1002/ijc.2910300616; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; NAHARRO G, 1983, J VIROL, V47, P611, DOI 10.1128/JVI.47.3.611-619.1983; NAHARRO G, 1983, VIROLOGY, V125, P502, DOI 10.1016/0042-6822(83)90223-4; NICOLA NA, 1982, J CELL PHYSIOL, V112, P257, DOI 10.1002/jcp.1041120215; PERLMUTTER R M, 1988, Biochimica et Biophysica Acta, V948, P245; PERRICAUDET M, 1980, P NATL ACAD SCI-BIOL, V77, P3778, DOI 10.1073/pnas.77.7.3778; Potts W M, 1988, Oncogene Res, V3, P343; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RASHEED S, 1982, VIROLOGY, V117, P238, DOI 10.1016/0042-6822(82)90522-0; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; RESH MD, 1988, MOL CELL BIOL, V8, P1896, DOI 10.1128/MCB.8.5.1896; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; YI TL, 1989, ONCOGENE, V4, P1081; ZELLER MJ, 1983, J BIOL CHEM, V256, P10837	49	16	19	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					337	344						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179817				2022-12-28	WOS:A1990CW41500011
J	VANDAM, H; OFFRINGA, R; SMITS, AMM; BOS, JL; JONES, NC; VANDEREB, AJ				VANDAM, H; OFFRINGA, R; SMITS, AMM; BOS, JL; JONES, NC; VANDEREB, AJ			THE REPRESSION OF THE GROWTH FACTOR-INDUCIBLE GENES JE, C-MYC AND STROMELYSIN BY ADENOVIRUS E1A IS MEDIATED BY CONSERVED REGION-1	ONCOGENE			English	Article									LEIDEN STATE UNIV,SYLVIUS LABS,MOLEC CARCINOGENESIS LAB,POB 9503,2312 AV LEIDEN,NETHERLANDS; IMPERIAL CANC RES FUND,GENE REGULAT LAB,LONDON WC2A 3PX,ENGLAND	Leiden University; Leiden University - Excl LUMC; Cancer Research UK				van Dam, Hans/0000-0002-8307-4325				ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; BOS JL, 1983, VIROLOGY, V129, P393, DOI 10.1016/0042-6822(83)90178-2; BRANDS JHGM, 1986, EUR J BIOCHEM, V155, P167, DOI 10.1111/j.1432-1033.1986.tb09472.x; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; FLINT SJ, 1980, MOL BIOL TUMOR VIRUS, V2, P547; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HEN R, 1985, SCIENCE, V230, P1391, DOI 10.1126/science.2999984; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; IMBRA RJ, 1986, NATURE, V323, P555, DOI 10.1038/323555a0; JOCHEMSEN AG, 1987, EMBO J, V6, P3399, DOI 10.1002/j.1460-2075.1987.tb02663.x; JOCHEMSEN AG, 1987, THESIS LEIDEN; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; OFFRINGA R, 1988, NUCLEIC ACIDS RES, V16, P10973, DOI 10.1093/nar/16.23.10973; PEAR WS, 1986, P NATL ACAD SCI USA, V83, P7376, DOI 10.1073/pnas.83.19.7376; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STABEL S, 1985, EMBO J, V4, P2329, DOI 10.1002/j.1460-2075.1985.tb03934.x; STEPHENS C, 1987, EMBO J, V6, P2027, DOI 10.1002/j.1460-2075.1987.tb02467.x; SUBRAMANIAN T, 1988, ONCOGENE, V2, P105; TIMMERS HTM, 1988, ONCOGENE RES, V3, P67; TIMMERS HTM, 1989, J VIROL, V63, P1470, DOI 10.1128/JVI.63.3.1470-1473.1989; ULFENDAHL PJ, 1987, EMBO J, V6, P2037, DOI 10.1002/j.1460-2075.1987.tb02468.x; VANDEREB AJ, 1984, CANCER CELL, V2, P501; VELCICH A, 1988, MOL CELL BIOL, V8, P2177, DOI 10.1128/MCB.8.5.2177; WASYLYK C, 1987, CELL, V48, P525, DOI 10.1016/0092-8674(87)90203-0; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821	39	59	60	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1207	1212						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2529466				2022-12-28	WOS:A1989AU50800007
J	CHEN, SJ; CHEN, Z; DAURIOL, L; LECONIAT, M; GRAUSZ, D; BERGER, R				CHEN, SJ; CHEN, Z; DAURIOL, L; LECONIAT, M; GRAUSZ, D; BERGER, R			PH1+BCR- ACUTE LEUKEMIAS - IMPLICATION OF ALU SEQUENCES IN A CHROMOSOMAL TRANSLOCATION OCCURRING IN THE NEW CLUSTER REGION WITHIN THE BCR GENE	ONCOGENE			English	Article									HOP ST LOUIS,INSERM,U301,1 AV CLAUDE VELLEFAUX,F-75475 PARIS 10,FRANCE; HOP ST LOUIS,CENT HEMATOL LAB,F-75475 PARIS 10,FRANCE; HOP ST LOUIS,CNRS,HEMATOL EXPTL LAB,LOI,UM7,F-75475 PARIS 10,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite								AGUILERA RJ, 1987, CELL, V51, P909, DOI 10.1016/0092-8674(87)90578-2; AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ASSOULINE Z, 1988, BIOCHEM BIOPH RES CO, V153, P1159, DOI 10.1016/S0006-291X(88)81349-4; AVIVI L, 1980, HUM GENET, V55, P281, DOI 10.1007/BF00290206; BAER R, 1985, CELL, V43, P705, DOI 10.1016/0092-8674(85)90243-0; BERNARD O, 1988, ONCOGENE, V2, P195; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; CHEN SJ, 1988, LEUKEMIA, V2, P634; CHEN SJ, 1988, LEUKEMIA, V2, P261; CHEN Z, IN PRESS BLOOD; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; COLLINS S, 1987, MOL CELL BIOL, V7, P2870, DOI 10.1128/MCB.7.8.2870; CREMER T, 1988, EXP CELL RES, V176, P199, DOI 10.1016/0014-4827(88)90325-4; DARBY MK, 1986, EMBO J, V5, P2257, DOI 10.1002/j.1460-2075.1986.tb04493.x; DEKLEIN A, 1986, NUCLEIC ACIDS RES, V14, P7071, DOI 10.1093/nar/14.17.7071; DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4; ELDER JT, 1981, NUCLEIC ACIDS RES, V9, P1171, DOI 10.1093/nar/9.5.1171; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; Fox G M, 1983, Cold Spring Harb Symp Quant Biol, V47 Pt 2, P1131; GALE RP, 1988, LEUKEMIA, V2, P321; GROFFEN J, 1986, COLD SPRING HARB SYM, V51, P911, DOI 10.1101/SQB.1986.051.01.104; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HARTL P, 1987, MOL CELL BIOL, V7, P2037, DOI 10.1128/MCB.7.6.2037; HEIM S, 1987, CANCER CYTOGENETICS, P141; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HEISTERKAMP N, 1985, NATURE, V317, P559, DOI 10.1038/317559b0; HERMANS A, 1987, CELL, V51, P33, DOI 10.1016/0092-8674(87)90007-9; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4774; KLOBECK HG, 1987, NUCLEIC ACIDS RES, V15, P4877, DOI 10.1093/nar/15.12.4877; KURZROCK R, 1987, NATURE, V325, P631, DOI 10.1038/325631a0; KURZROCK R, 1987, BLOOD, V70, P1584; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; LIFSHITZ B, 1988, ONCOGENE, V2, P113; LIN CS, 1988, CELL, V54, P153, DOI 10.1016/0092-8674(88)90547-8; MATHIEUMAHUL D, 1985, EMBO J, V4, P3427, DOI 10.1002/j.1460-2075.1985.tb04100.x; PAOLELLA G, 1983, EMBO J, V2, P691, DOI 10.1002/j.1460-2075.1983.tb01486.x; PEAR WS, 1988, ONCOGENE, V2, P499; RABBITTS PH, 1988, ONCOGENE, V3, P99; ROGERS J, 1985, NATURE, V317, P559, DOI 10.1038/317559a0; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; RUSSO G, 1988, CELL, V53, P137, DOI 10.1016/0092-8674(88)90495-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TSUJIMOTO Y, 1988, ONCOGENE, V2, P347; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; VERMA RS, 1988, INT J CANCER, V41, P829, DOI 10.1002/ijc.2910410609; YUNIS JJ, 1978, CYTOGENET CELL GENET, V22, P679, DOI 10.1159/000131052	57	82	87	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					195	202						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648256				2022-12-28	WOS:A1989U567500011
J	PORTELLA, G; FERULANO, G; SANTORO, M; GRIECO, M; FUSCO, A; VECCHIO, G				PORTELLA, G; FERULANO, G; SANTORO, M; GRIECO, M; FUSCO, A; VECCHIO, G			THE KIRSTEN MURINE SARCOMA-VIRUS INDUCES RAT-THYROID CARCINOMAS INVIVO	ONCOGENE			English	Article									FAC MED & CHIRURG CATANZARO,IST ONCOL CLIN & SPERIMENTALE,CATANZARO,ITALY; FAC MED & CHIRURG NAPOLI 2,DIPARTIMENTO BIOL & PATOL & CELLULARE & MOLEC,NAPOLI,ITALY; FAC MED & CHIRURG NAPOLI 2,IST CHIRURG GEN & SCI GASTROENTEROL,NAPOLI,ITALY	Magna Graecia University of Catanzaro; University of Naples Federico II; University of Naples Federico II	PORTELLA, G (corresponding author), FAC MED & CHIRURG NAPOLI 2,CNR,CTR ENDOCRINOL 8 ONCOL SPERIMENTALE,NAPOLI,ITALY.		Portella, Giuseppe/AFU-6826-2022	PORTELLA, Giuseppe/0000-0001-8276-9769; Fusco, Alfredo/0000-0003-3332-5197; Grieco, Michele/0000-0002-4212-7814				AARONSON SA, 1983, CANCER RES, V43, P1; ADAMS SL, 1977, P NATL ACAD SCI USA, V74, P3399, DOI 10.1073/pnas.74.8.3399; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; AUERSPERG N, 1977, INT J CANCER, V19, P81, DOI 10.1002/ijc.2910190112; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; COLLETTA G, 1986, SCIENCE, V233, P458, DOI 10.1126/science.3726540; COLLETTA G, 1983, MOL CELL BIOL, V3, P2099, DOI 10.1128/MCB.3.11.2099; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DILAURO R, 1982, GENE, V19, P117, DOI 10.1016/0378-1119(82)90196-2; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; FUSCO A, 1985, J VIROL, V56, P284, DOI 10.1128/JVI.56.1.284-292.1985; FUSCO A, 1982, CANCER RES, V42, P618; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; KONIG MP, 1981, ADV THYROID NEOPLASI, P177; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Maniatis T., 1982, MOL CLONING; PULCIANI S, 1982, NATURE, V300, P539, DOI 10.1038/300539a0; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; ROYBURMAN P, 1975, J GEN VIROL, V28, P193, DOI 10.1099/0022-1317-28-2-193; SUAREZ HG, 1988, ONCOGENE, V2, P403; VARMUS HE, 1984, ANNU REV GENET, V18, P553; WEISS R, 1982, RNA TUMOR VIRUSES, P209; WOLLMAN SH, 1963, RECENT PROG HORM RES, V19, P579; YUSPA SH, 1985, NATURE, V314, P459, DOI 10.1038/314459a0	30	31	32	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					181	188						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2538791				2022-12-28	WOS:A1989U567500009
J	EAGER, KB; PFIZENMAIER, K; RICCIARDI, RP				EAGER, KB; PFIZENMAIER, K; RICCIARDI, RP			MODULATION OF MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I GENES IN ADENOVIRUS-12 TRANSFORMED-CELLS - INTERFERON-GAMMA INCREASES CLASS-I EXPRESSION BY A MECHANISM THAT CIRCUMVENTS E1A INDUCED-REPRESSION AND TUMOR NECROSIS FACTOR ENHANCES THE EFFECT OF INTERFERON-GAMM	ONCOGENE			English	Article									WISTAR INST ANAT & BIOL,36TH & SPRUCE ST,PHILADELPHIA,PA 19104; UNIV GOTTINGEN,MAX PLANCK SOC,CLIN RES GRP,D-3400 GOTTINGEN,FED REP GER	The Wistar Institute; Max Planck Society; University of Gottingen					NCI NIH HHS [CA-29797, CA-09171] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA029797, T32CA009171] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BONNER WM, 1974, EUR J BIOCHEM, V46, P83; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CHEN E, 1986, MOL CELL BIOL, V6, P1698, DOI 10.1128/MCB.6.5.1698; CHEN MJ, 1987, NATURE, V330, P581, DOI 10.1038/330581a0; COLLINS T, 1986, P NATL ACAD SCI USA, V83, P446, DOI 10.1073/pnas.83.2.446; CROCE CM, 1981, P NATL ACAD SCI-BIOL, V78, P5754, DOI 10.1073/pnas.78.9.5754; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; EAGER KB, 1985, P NATL ACAD SCI USA, V82, P5525, DOI 10.1073/pnas.82.16.5525; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EVANS GA, 1982, P NATL ACAD SCI-BIOL, V79, P1994, DOI 10.1073/pnas.79.6.1994; FELLOUS M, 1982, P NATL ACAD SCI-BIOL, V79, P3082, DOI 10.1073/pnas.79.10.3082; FRIEDMAN DJ, 1988, VIROLOGY, V165, P303, DOI 10.1016/0042-6822(88)90689-7; FRIEDMAN RL, 1985, NATURE, V314, P637, DOI 10.1038/314637a0; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FRIEDMAN RM, 1983, ADV IMMUNOL, V34, P97, DOI 10.1016/S0065-2776(08)60378-8; GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842; HAYASHI H, 1985, CELL, V43, P263, DOI 10.1016/0092-8674(85)90031-5; HELSON L, 1975, NATURE, V258, P731, DOI 10.1038/258731a0; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; ISRAEL A, 1986, NATURE, V322, P743, DOI 10.1038/322743a0; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KHALILI K, 1983, GENE, V21, P9, DOI 10.1016/0378-1119(83)90142-7; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; KNIGHT E, 1985, P NATL ACAD SCI USA, V82, P1151, DOI 10.1073/pnas.82.4.1151; KNOWLES BB, 1979, J IMMUNOL, V122, P1798; KORBER B, 1988, SCIENCE, V239, P1302, DOI 10.1126/science.3125612; KRONKE M, 1987, P NATL ACAD SCI USA, V84, P469, DOI 10.1073/pnas.84.2.469; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; Maniatis T., 1982, MOL CLONING; MAY LT, 1986, P NATL ACAD SCI USA, V83, P8957, DOI 10.1073/pnas.83.23.8957; MIYAZAKI J, 1986, P NATL ACAD SCI USA, V83, P9537, DOI 10.1073/pnas.83.24.9537; OZATO K, 1982, TRANSPLANTATION, V34, P113, DOI 10.1097/00007890-198209000-00001; PARNES JR, 1981, P NATL ACAD SCI-BIOL, V78, P2253, DOI 10.1073/pnas.78.4.2253; PFEFFER LM, 1982, GENETIC EXPRESSION C, P289; PFIZENMAIER K, 1987, J IMMUNOL, V138, P975; ROSENTHAL A, 1984, NATURE, V310, P415, DOI 10.1038/310415a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; SCHEURICH P, 1986, INT J CANCER, V38, P127, DOI 10.1002/ijc.2910380120; SCHEURICH P, 1986, IMMUNOBIOLOGY, V172, P281; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SCOTT MO, 1984, J VIROL, V50, P895, DOI 10.1128/JVI.50.3.895-903.1984; SHIRAYOSHI Y, 1987, MOL CELL BIOL, V7, P4542, DOI 10.1128/MCB.7.12.4542; STALLCUP KC, 1981, J IMMUNOL, V127, P923; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; TANAKA K, 1985, SCIENCE, V228, P26, DOI 10.1126/science.3975631; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; VASAVADA R, 1986, P NATL ACAD SCI USA, V83, P5257, DOI 10.1073/pnas.83.14.5257; VOGEL J, 1986, MOL CELL BIOL, V6, P3550, DOI 10.1128/MCB.6.10.3550; WAN YJY, 1987, J CELL PHYSIOL, V130, P276, DOI 10.1002/jcp.1041300214; WEIL J, 1983, NATURE, V301, P437, DOI 10.1038/301437a0; WONG GHW, 1984, EUR J IMMUNOL, V14, P52, DOI 10.1002/eji.1830140110; YARDEN A, 1986, SCIENCE, V234, P1419, DOI 10.1126/science.3097823	59	24	24	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					39	44						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2521704				2022-12-28	WOS:A1989U567400006
J	OLOFSSON, B; CHARDIN, P; TOUCHOT, N; ZAHRAOUI, A; TAVITIAN, A				OLOFSSON, B; CHARDIN, P; TOUCHOT, N; ZAHRAOUI, A; TAVITIAN, A			EXPRESSION OF THE RAS-RELATED RALA, RHO12 AND RAB GENES IN ADULT-MOUSE TISSUES	ONCOGENE			English	Note											OLOFSSON, B (corresponding author), UNIV PARIS 07,FAC MED LARIBOISIERE ST LOUIS,GENET & EXPRESS ONCOGENES LAB,INSERM UNITE 248,F-75010 PARIS,FRANCE.							AMARA SG, 1984, MOL CELL BIOL, V4, P2151, DOI 10.1128/MCB.4.10.2151; ANDERSON PS, 1987, MOL CELL BIOL, V7, P3620, DOI 10.1128/MCB.7.10.3620; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARROWMAN MM, 1986, NATURE, V319, P504, DOI 10.1038/319504a0; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BURGOYNE RD, 1987, NATURE, V328, P112, DOI 10.1038/328112a0; BURGOYNE RD, 1987, NATURE, V326, P448, DOI 10.1038/326448a0; CHARDIN P, 1986, EMBO J, V5, P2203, DOI 10.1002/j.1460-2075.1986.tb04485.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; GALLWITZ D, 1983, NATURE, V306, P704, DOI 10.1038/306704a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GUERRERO I, 1986, LEUKEMIA RES, V10, P851, DOI 10.1016/0145-2126(86)90306-1; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; HELFMAN DM, 1986, MOL CELL BIOL, V6, P3582, DOI 10.1128/MCB.6.11.3582; KAMATA T, 1984, NATURE, V310, P147, DOI 10.1038/310147a0; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; LEV Z, 1985, MOL CELL BIOL, V5, P1540, DOI 10.1128/MCB.5.6.1540; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; MILCAREK C, 1985, MOL CELL BIOL, V5, P2514, DOI 10.1128/MCB.5.10.2514; OLOFSSON B, 1986, EUR J BIOCHEM, V160, P261, DOI 10.1111/j.1432-1033.1986.tb09965.x; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHMITT HD, 1986, CELL, V47, P401, DOI 10.1016/0092-8674(86)90597-0; SEGAL D, 1986, MOL CELL BIOL, V6, P2241, DOI 10.1128/MCB.6.6.2241; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SEGEV N, 1987, MOL CELL BIOL, V7, P2367, DOI 10.1128/MCB.7.7.2367; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; YERAMIAN P, 1987, NUCLEIC ACIDS RES, V15, P1869, DOI 10.1093/nar/15.4.1869; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4; ZAHRAOUI A, 1988, NUCLEIC ACIDS RES, V16, P1204, DOI 10.1093/nar/16.3.1204	33	106	106	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1988	3	2					231	234						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Q0534	2457862				2022-12-28	WOS:A1988Q053400016
J	ZAHM, P; HOFSCHNEIDER, PH; KOSHY, R				ZAHM, P; HOFSCHNEIDER, PH; KOSHY, R			THE HBV X-ORF ENCODES A TRANSACTIVATOR - A POTENTIAL FACTOR IN VIRAL HEPATOCARCINOGENESIS	ONCOGENE			English	Article									MAX PLANCK INST BIOCHEM,D-8033 MARTINSRIED,FED REP GER	Max Planck Society								BEASLEY RP, 1982, HEPATOLOGY S, V2, P21; BERK AJ, 1979, CELL, V17, P935, DOI 10.1016/0092-8674(79)90333-7; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOHNLEIN E, 1985, NUCLEIC ACIDS RES, V13, P4789, DOI 10.1093/nar/13.13.4789; BROOME S, 1985, CELL, V40, P537, DOI 10.1016/0092-8674(85)90202-8; BRUCK C, 1987, CONTR ONCOL, V24, P166; CATTANEO R, 1983, EMBO J, V2, P511, DOI 10.1002/j.1460-2075.1983.tb01455.x; CHANG HK, 1987, NUCLEIC ACIDS RES, V15, P2261, DOI 10.1093/nar/15.5.2261; COLBEREGARAPIN F, 1981, J MOL BIOL, V150, P1, DOI 10.1016/0022-2836(81)90321-1; CROSS SL, 1987, CELL, V49, P47, DOI 10.1016/0092-8674(87)90754-9; DEJEAN A, 1986, NATURE, V322, P70, DOI 10.1038/322070a0; ELFASSI E, 1986, P NATL ACAD SCI USA, V83, P2219, DOI 10.1073/pnas.83.7.2219; ELKAREH A, 1985, P NATL ACAD SCI USA, V82, P1002, DOI 10.1073/pnas.82.4.1002; FASEL N, 1982, EMBO J, V11, P3; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GORMAN CM, 1982, MOL CELL BIOL, V2, P1046; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HESS JL, 1985, SCIENCE, V229, P482, DOI 10.1126/science.2990051; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; KAY A, 1985, EMBO J, V4, P1287, DOI 10.1002/j.1460-2075.1985.tb03774.x; KODAMA K, 1985, J VIROL, V56, P978, DOI 10.1128/JVI.56.3.978-986.1985; KOSHY R, 1987, CONTRIB ONCOL, V24, P97; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LUSKY M, 1985, J VIROL, V53, P955, DOI 10.1128/JVI.53.3.955-965.1985; LUSKY M, 1981, NATURE, V293, P79, DOI 10.1038/293079a0; MEYERS ML, 1986, J VIROL, V57, P101, DOI 10.1128/JVI.57.1.101-109.1986; MILLER RH, 1986, P NATL ACAD SCI USA, V83, P2531, DOI 10.1073/pnas.83.8.2531; MIYAKI M, 1986, J GEN VIROL, V67, P1449, DOI 10.1099/0022-1317-67-7-1449; MORIARTY AM, 1985, SCIENCE, V227, P429, DOI 10.1126/science.2981434; NAGAYA T, 1987, GENE DEV, V1, P773, DOI 10.1101/gad.1.8.773; PERSING DH, 1986, J VIROL, V60, P177, DOI 10.1128/JVI.60.1.177-184.1986; ROOSSINCK MJ, 1986, MOL CELL BIOL, V6, P1393, DOI 10.1128/MCB.6.5.1393; ROSEN CA, 1985, SCIENCE, V227, P320, DOI 10.1126/science.2981432; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SASSONECORSI P, 1985, NATURE, V313, P458, DOI 10.1038/313458a0; SHAUL Y, 1985, EMBO J, V4, P427, DOI 10.1002/j.1460-2075.1985.tb03646.x; SIDDIQUI A, 1987, P NATL ACAD SCI USA, V84, P2513, DOI 10.1073/pnas.84.8.2513; SODROSKI J, 1985, SCIENCE, V228, P1430, DOI 10.1126/science.2990028; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; SPANDAU FD, 1988, J VIROL, V62, P427; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TOGNONI A, 1985, NUCLEIC ACIDS RES, V13, P7457, DOI 10.1093/nar/13.20.7457; TREININ M, 1987, MOL CELL BIOL, V7, P545, DOI 10.1128/MCB.7.1.545; ULFENDAHL PJ, 1987, EMBO J, V6, P2037, DOI 10.1002/j.1460-2075.1987.tb02468.x; VONLORINGHOVEN AF, 1985, EMBO J, V4, P249, DOI 10.1002/j.1460-2075.1985.tb02343.x; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0; YAGINUMA K, 1987, P NATL ACAD SCI USA, V84, P2678, DOI 10.1073/pnas.84.9.2678	49	161	163	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1988	3	2					169	177						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Q0534	2457861				2022-12-28	WOS:A1988Q053400007
J	HERRMANN, CPE; KRAISS, S; MONTENARH, M				HERRMANN, CPE; KRAISS, S; MONTENARH, M			ASSOCIATION OF CASEIN KINASE-II WITH IMMUNOPURIFIED P53	ONCOGENE			English	Article							LARGE-T-ANTIGEN; CELLULAR TUMOR-ANTIGEN; PROTEIN-KINASE; SIMIAN VIRUS-40; TRANSFORMED-CELLS; CYCLE CONTROL; 3T3 CELLS; SV40-TRANSFORMED CELLS; MONOCLONAL-ANTIBODIES; POLYACRYLAMIDE GELS	Viral and cellular oncogene products sometimes activate protein kinases, are protein kinases themselves, or share phosphorylation sequence motifs for different protein kinases. We have recently shown that a protein kinase activity is tightly associated with immunopurified p53. We have now expressed p53 in a baculovirus expression system and characterized this protein kinase activity in more detail. We found that casein could compete with p53 in the kinase reaction. Heparin efficiently inhibited the p53 associated protein kinase whereas the polyamine spermidine stimulated enzymatic activity. A synthetic peptide which was shown to be specifically phosphorylated by casein kinase II blocked the in vitro phosphorylation of p53, whereas a synthetic peptide with a potential phosphorylation site on human p53 at ser 315 was ineffective in blocking the phosphorylation of p53. GTP as well as ATP can be used as a phosphate donor in the in vitro kinase reaction. An antibody directed against casein kinase II coprecipitated p53 from insect cells as well as from mammalian cells. These data strongly indicate that casein kinase II is associated with immunopurified p53 and contributes to the phosphorylation of p53. A mutant p53 with a ser 389 to ala exchange was not phosphorylated in vitro by the p53 associated protein kinase.	UNIV ULM, DEPT BIOCHEM, PARKSTR 11, W-7900 ULM, GERMANY	Ulm University	MONTENARH, M (corresponding author), UNIV ULM, DEPT BIOCHEM, PARKSTR 11, W-7900 ULM, GERMANY.		Montenarh, Mathias/AAB-6689-2020					Anderson CW., 1986, CANC CELLS, V4, P395; BISCHOFF JR, 1990, P NATL ACAD SCI USA, V87, P4766, DOI 10.1073/pnas.87.12.4766; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARROLL D, 1989, J BIOL CHEM, V264, P7345; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; COCHET C, 1980, ENDOCRINOLOGY, V106, P750, DOI 10.1210/endo-106-3-750; COX RF, 1973, EUR J BIOCHEM, V39, P49, DOI 10.1111/j.1432-1033.1973.tb03102.x; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DURBAN E, 1985, EMBO J, V4, P2921, DOI 10.1002/j.1460-2075.1985.tb04024.x; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FEIGE JJ, 1980, FEBS LETT, V121, P139, DOI 10.1016/0014-5793(80)81283-X; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FLANAGAN JF, 1967, J CELL PHYSIOL, V69, P117, DOI 10.1002/jcp.1040690114; GRASSER FA, 1988, VIROLOGY, V165, P13, DOI 10.1016/0042-6822(88)90653-8; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARLOW E, 1981, J VIROL, V37, P564, DOI 10.1128/JVI.37.2.564-573.1981; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HAYLES J, 1986, J CELL SCI, P155; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KESSLER SW, 1975, J IMMUNOL, V115, P1617; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KRAISS S, 1990, ONCOGENE, V5, P845; KRAISS S, 1991, EXP CELL RES, V192, P157, DOI 10.1016/0014-4827(91)90170-Y; KRAISS S, 1990, LEUKEMIA RES, V14, P1041, DOI 10.1016/0145-2126(90)90118-S; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEVINE AJ, 1990, BIOCHIM BIOPHYS ACTA, V1032, P119, DOI 10.1016/0304-419X(90)90015-S; LEVINE AJ, 1990, VIROLOGY, V177, P419, DOI 10.1016/0042-6822(90)90505-L; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; LUSCHER B, 1990, NATURE, V344, P517, DOI 10.1038/344517a0; MAENPAA PH, 1977, BIOCHIM BIOPHYS ACTA, V498, P294, DOI 10.1016/0304-4165(77)90267-7; MCCORMICK F, 1980, J VIROL, V34, P213, DOI 10.1128/JVI.34.1.213-224.1980; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILLER DW, 1986, GENETIC ENG, V8; MILNER J, 1989, ONCOGENE, V4, P665; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; MILNER J, 1990, EMBO J, V9, P2885, DOI 10.1002/j.1460-2075.1990.tb07478.x; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; NURSE P, 1985, TRENDS GENET, V1, P51, DOI 10.1016/0168-9525(85)90023-X; OLIVECRONA T, 1977, FED PROC, V36, P60; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; RIABOWOL K, 1989, CELL, V57, P393, DOI 10.1016/0092-8674(89)90914-8; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SCHEIDTMANN KH, 1990, J VIROL, V64, P672, DOI 10.1128/JVI.64.2.672-679.1990; SCHNEIDER HR, 1988, BIOCHEM BIOPH RES CO, V156, P1390, DOI 10.1016/S0006-291X(88)80786-1; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SOUSSI T, 1990, ONCOGENE, V5, P945; STURZBECHER HW, 1990, ONCOGENE, V5, P795; SUMMERS MD, 1987, TEX AGR EXP ST B, V1555; TAKIO K, 1987, P NATL ACAD SCI USA, V84, P4851, DOI 10.1073/pnas.84.14.4851; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	67	113	114	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1991	6	5					877	884						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052362				2022-12-28	WOS:A1991GT82500027
J	MAKOVER, D; CUDDY, M; YUM, S; BRADLEY, K; ALPERS, J; SUKHATME, V; REED, JC				MAKOVER, D; CUDDY, M; YUM, S; BRADLEY, K; ALPERS, J; SUKHATME, V; REED, JC			PHORBOL ESTER-MEDIATED INHIBITION OF GROWTH AND REGULATION OF PROTOONCOGENE EXPRESSION IN THE HUMAN T-CELL LEUKEMIA LINE JURKAT	ONCOGENE			English	Article							C-MYC; FOLLICULAR LYMPHOMA; MOLECULAR-CLONING; SARCOMA VIRUS; CDNA CLONE; GENE; DIFFERENTIATION; ENCODES; FOS; SEQUENCE	The expression and function of several proto-oncogenes were examined in a human acute T cell leukemia line, JURKAT, during phorbol ester-induced terminal differentiation. Treating JURKAT cells with the phorbol ester tetradecanoyl phorbol acetate (TPA) inhibited their proliferation and induced expression of the gene for the interleukin 2 receptor alpha chain (IL2R-alpha), consistent with previous reports. In unstimulated proliferating JURKAT cells, high levels of C-MYC, N-RAS, and BCL2 mRNAs were found that diminished rapidly following TPA-induced cessation of growth. In contrast, accumulation of mRNAs for the C-FOS, C-JUN, and EGR-1 genes increased markedly in TPA-treated cells and preceded the induction of IL2R-alpha mRNA. Expression of the C-MYB, C-RAF-1, C-LCK, C-FYN, and C-FGR proto-oncogenes was relatively unchanged. To explore directly the function of two of these proto-oncogenes in regulating the growth of JURKAT T cells, we stably transferred C-MYC and BCL2 expression plasmids into these cells. Despite sustained expression of C-MYC, BCL2, or the combination of these proto-oncogenes, TPA continued to inhibit JURKAT cell growth and to induce IL2R expression. Thus, although C-MYC and BCL2 proto-oncogene expression correlated with proliferation in TPA-treated JURKAT cells, continuous over-expression of even the combination of these oncogenes was insufficient for abrogating the effects of TPA in these leukemic T cells. Because human lymphoid malignancies frequently contain chromosomal translocations that deregulate the expression of C-MYC and BCL2, our findings could have relevance for attempts to induce terminal differentiation of leukemic cells by in vitro exposure of patients' bone marrow cells to phorbol esters.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PATHOL,PHILADELPHIA,PA 19104; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	University of Pennsylvania; University of Pennsylvania; University of Chicago			Sukhatme, Vikas/W-2776-2019		NCI NIH HHS [CA47956] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047956] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHM JL, 1986, CANCER RES, V46, P3711; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; BOHNMANN D, 1987, SCIENCE, V238, P1386; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P155; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; DELORBE WJ, 1980, J VIROL, V36, P50, DOI 10.1128/JVI.36.1.50-61.1980; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCHINI G, 1983, P  NATL ACAD SCI US, V80, P7380; GAUWERKY CE, 1988, ONCOGENE, V2, P431; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; GREENE WC, 1984, J IMMUNOL, V133, P1042; GROSSO LE, 1985, CANCER RES, V45, P847; INOUE K, 1987, ONCOGENE, V1, P301; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KAUFMAN JD, 1987, MOL CELL BIOL, V7, P3759, DOI 10.1128/MCB.7.10.3759; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; KUME TU, 1988, J MOL BIOL, V202, P779, DOI 10.1016/0022-2836(88)90558-X; LEE WMF, 1989, ONCOGENES, P37; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LEONARD WJ, 1984, NATURE, V311, P636; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; MILLER AD, 1984, CELL, V36, P51; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PEGORARO L, 1980, BLOOD, V55, P859; PERLMUTTER RM, 1989, SCIENCE, V245, P344, DOI 10.1126/science.2787933; PLUMB M, 1983, NUCLEIC ACIDS RES, V11, P2391, DOI 10.1093/nar/11.8.2391; RAPP UR, 1988, HDB ONCOGENES, P213; REED J, 1990, IN PRESS P INT S CHI; REED J, 1988, INTERLEUKIN, V2, P367; REED JC, 1990, P NATL ACAD SCI USA, V87, P3660, DOI 10.1073/pnas.87.10.3660; REED JC, 1985, MOL CELL BIOL, V5, P3361, DOI 10.1128/MCB.5.12.3361; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; REED JC, 1987, DEV RECOGNITION TRAN, P39; RETTENMIER CW, 1986, J CLIN INVEST, V77, P1740, DOI 10.1172/JCI112496; ROVERA G, 1979, SCIENCE, V204, P868, DOI 10.1126/science.286421; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SOOD AK, 1981, P NATL ACAD SCI-BIOL, V78, P616, DOI 10.1073/pnas.78.1.616; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YOKOYAMA K, 1987, P NATL ACAD SCI USA, V84, P7363, DOI 10.1073/pnas.84.21.7363	52	29	29	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					455	460						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011401				2022-12-28	WOS:A1991FT34400016
J	THOMAS, NSB; BURKE, LC; BYBEE, A; LINCH, DC				THOMAS, NSB; BURKE, LC; BYBEE, A; LINCH, DC			THE PHOSPHORYLATION STATE OF THE RETINOBLASTOMA (RB) PROTEIN IN G0 G1 IS DEPENDENT ON GROWTH STATUS	ONCOGENE			English	Article							SUSCEPTIBILITY GENE-PRODUCT; CELL-CYCLE; OSTEO-SARCOMA; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INTERFERON; SEQUENCE; MITOSIS; KINASE	The product of the retinoblastoma gene (RB) is a nuclear phosphoprotein which is thought to regulate the proliferation of cells. Its phosphorylation state changes with passage through the cell cycle and it has been proposed that RB protein in its hypo-phosphorylated form prevents cells proliferating. We have investigated the phosphorylation state of the RB protein in an actively-dividing human B-lymphoblastoid cell line and after cell cycle arrest caused by alpha-Interferon (alpha-IFN). We show that the phosphorylation state of the RB protein in cells with 2N DNA content depends on whether the cells are actively cycling. Our data is compatible with the proposal that dephosphorylation of the RB protein allows cells to enter a quiescent state. This study sheds light on the molecular mechanisms which may mediate the cytostatic effects of alpha-IFN.			THOMAS, NSB (corresponding author), UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,98 CHENIES MEWS,LONDON WC1E 6HX,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOOKSTEIN R, 1989, MOL CELL BIOL, V9, P1628, DOI 10.1128/MCB.9.4.1628; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CLEMENS MJ, 1985, BIOCHEM J, V226, P345, DOI 10.1042/bj2260345; COOPER JA, 1989, CELL, V58, P1009, DOI 10.1016/0092-8674(89)90495-9; DARZYNKIEWICZ Z, 1982, J CELL PHYSIOL, V113, P465, DOI 10.1002/jcp.1041130316; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GERDES J, 1984, J IMMUNOL, V133, P1710; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1988, J CELL BIOCHEM, V38, P213, DOI 10.1002/jcb.240380309; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MASON DY, 1975, BRIT J HAEMATOL, V31, P361, DOI 10.1111/j.1365-2141.1975.tb00867.x; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SILVERMAN RH, 1982, EUR J BIOCHEM, V126, P333; TANG A, 1989, ONCOGENE, V4, P401; TAYA Y, 1989, BIOCHEM BIOPH RES CO, V164, P580, DOI 10.1016/0006-291X(89)91759-2; THOMAS NSB, 1989, J BIOL CHEM, V264, P13697; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VARLEY JM, 1989, ONCOGENE, V4, P725; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; XU HJ, 1989, ONCOGENE, V4, P807; YOKOTA J, 1988, ONCOGENE, V3, P471	35	42	43	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					317	322						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000225				2022-12-28	WOS:A1991FZ13400019
J	LORENZ, U; SOCK, E; GRUMMT, F; MOELLING, K				LORENZ, U; SOCK, E; GRUMMT, F; MOELLING, K			ANALYSIS OF DNA-SEQUENCES PRESENT IN COMPLEXES OF V-MYC AND CELLULAR DNA	ONCOGENE			English	Article							AVIAN MYELOCYTOMATOSIS VIRUS; TRANSCRIPTIONAL ENHANCER; TRANSFORMING ABILITY; GENE-PRODUCT; MOUSE CELLS; REPLICATION; LOCALIZATION; ONCOGENE; PROTEIN; BINDING	We have isolated cellular DNA sequences from the myelocytomatosis virus-transformed quail fibroblastic cell-line (MC29-Q8) by indirect immunoprecipitation of v-Myc-DNA complexes and subsequent cloning of the DNA. The v-Myc-DNA complexes were obtained from isolated nuclei pretreated with 150 mM salt and indirect immunoprecipitation of the p110 Gag-Myc protein with the IgG of a Gag-specific monoclonal antibody. A non-specific monoclonal IgG was used as control to account for non-specific interactions. The DNA from the precipitates was isolated, cloned and characterized. 21 positive and 13 control clones with inserts ranging in size from 25 to 330 nucleotides were sequenced and analysed for sequence homologies to known DNA-motives. Some of the sequences over-represented in the specific DNA fragments corresponded to elements which have been previously described to promote DNA amplification. Six of these DNA fragments were tested for their ability to promote DNA amplification by insertion into a plasmid containing the HSV-1 tk gene with a truncated promoter. These constructs were transfected into mouse Ltk- cells which grow under HAT selection only upon amplification of the tk-carrying plasmids. Two of the six DNA fragments showed the capability to amplify their plasmids in cis and create stable cellular clones. Copy numbers of the amplified plasmids in these Ltk+ clones ranged from 470 to 680 whereby the amplified sequences were integrated as large clusters of head-to-tail tandems. The data presented here suggest that the Myc protein may be involved in DNA amplification and therefore may play a role in DNA replication.	MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,W-1000 BERLIN 33,GERMANY; UNIV WURZBURG,INST BIOCHEM,W-8700 WURZBURG,GERMANY	Max Planck Society; University of Wurzburg				Sock, Elisabeth/0000-0001-9925-3136; Lorenz, Ulrike/0000-0002-7933-6855				ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BADER JP, 1985, J VIROL, V53, P509, DOI 10.1128/JVI.53.2.509-514.1985; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6349, DOI 10.1021/bi00344a005; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DELUCIA AL, 1983, J VIROL, V46, P143, DOI 10.1128/JVI.46.1.143-150.1983; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DONNER P, 1983, P NATL ACAD SCI-BIOL, V80, P2861, DOI 10.1073/pnas.80.10.2861; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREISERWILKE I, 1981, J VIROL, V39, P325, DOI 10.1128/JVI.39.1.325-329.1981; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HOLST A, 1988, CELL, V52, P355; HOLST A, 1989, CELL, V56, P143; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; IGUCHIARIGA SMM, 1987, NUCLEIC ACIDS RES, V15, P4889, DOI 10.1093/nar/15.12.4889; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LAIMINS LA, 1984, J VIROL, V49, P183, DOI 10.1128/JVI.49.1.183-189.1984; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; Maniatis T., 1982, MOL CLONING; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; RAMSAY G, 1982, EMBO J, V1, P1111, DOI 10.1002/j.1460-2075.1982.tb01305.x; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; RAMSAY GM, 1982, J VIROL, V41, P745, DOI 10.1128/JVI.41.3.745-753.1982; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIH CK, 1984, P NATL ACAD SCI-BIOL, V81, P4697, DOI 10.1073/pnas.81.15.4697; Stinchcomb D. T, 1981, INITIATION DNA REPLI, P473, DOI 10.1016/b978-0-12-583580-0.50036-4; VARMUS HE, 1987, MOL BASIS BLOOD DISE, P271; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P9909, DOI 10.1093/nar/17.23.9909; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P8783, DOI 10.1093/nar/17.21.8783; ZASTROW G, 1989, NUCLEIC ACIDS RES, V17, P1867, DOI 10.1093/nar/17.5.1867	41	4	4	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					51	57						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992445				2022-12-28	WOS:A1991EY03900007
J	MORELLO, D; LAVENU, A; BABINET, C				MORELLO, D; LAVENU, A; BABINET, C			DIFFERENTIAL REGULATION AND EXPRESSION OF JUN, C-FOS AND C-MYC PROTOONCOGENES DURING MOUSE-LIVER REGENERATION AND AFTER INHIBITION OF PROTEIN-SYNTHESIS	ONCOGENE			English	Article											MORELLO, D (corresponding author), UNITE GENET MAMMIFERES,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.							ASSELIN C, 1989, ONCOGENE, V4, P549; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BAUER SR, 1989, ONCOGENE, V4, P615; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BONNIEU A, 1989, ONCOGENE, V4, P881; BRAVO R, 1985, EMBO J, V4, P1193, DOI 10.1002/j.1460-2075.1985.tb03759.x; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CORRAL M, 1988, EXP CELL RES, V174, P107, DOI 10.1016/0014-4827(88)90146-2; CORRAL M, 1985, EXP CELL RES, V160, P427, DOI 10.1016/0014-4827(85)90190-9; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FAUSTO N, 1987, S FUNDAM CANCER RES, V39, P69; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GOYETTE M, 1984, MOL CELL BIOL, V4, P1493, DOI 10.1128/MCB.4.8.1493; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HORIKAWA S, 1987, BIOCHEM BIOPH RES CO, V144, P1049, DOI 10.1016/S0006-291X(87)80070-0; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KEATH EJ, 1984, CELL, V37, P521, DOI 10.1016/0092-8674(84)90382-9; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KRUIJER W, 1986, J BIOL CHEM, V261, P7929; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LEVINE RA, 1986, MOL CELL BIOL, V6, P4112, DOI 10.1128/MCB.6.11.4112; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MECHTA F, 1989, New Biologist, V1, P297; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; MORELLO D, 1989, ONCOGENE, V4, P955; MORELLO D, 1985, IMMUNOGENETICS, V22, P441, DOI 10.1007/BF00418090; MORELLO D, 1990, IN PRESS MOL CELL BI; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; NEPVEU A, 1987, ONCOGENE, V1, P243; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PEI R, 1988, MOL CELL BIOL, V8, P2860, DOI 10.1128/MCB.8.7.2860; PIECHACZYK M, 1987, TRENDS GENET, V3, P47, DOI 10.1016/0168-9525(87)90166-1; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHONTHAL A, 1989, ONCOGENE, V4, P629; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SETOYAMA C, 1986, P NATL ACAD SCI USA, V83, P3213, DOI 10.1073/pnas.83.10.3213; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; SOBCZAK J, 1989, ONCOGENE, V4, P1503; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SWARTWOUT SG, 1989, MOL CELL BIOL, V9, P288, DOI 10.1128/MCB.9.1.288; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; THOMPSON NL, 1986, CANCER RES, V46, P3111; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WEISINGER G, 1988, ONCOGENE, V3, P635; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x; YOKOYAMA K, 1987, P NATL ACAD SCI USA, V84, P7363, DOI 10.1073/pnas.84.21.7363; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	90	76	77	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1511	1519						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2123531				2022-12-28	WOS:A1990EK50200010
J	FRY, DG; MILAM, LD; DILLBERGER, JE; MAHER, VM; MCCORMICK, JJ				FRY, DG; MILAM, LD; DILLBERGER, JE; MAHER, VM; MCCORMICK, JJ			MALIGNANT TRANSFORMATION OF AN INFINITE LIFE-SPAN HUMAN FIBROBLAST CELL STRAIN BY TRANSFECTION WITH V-KI-RAS	ONCOGENE			English	Note									MICHIGAN STATE UNIV,DEPT MICROBIOL,CARCINOGENESIS LAB,FEE HALL,E LANSING,MI 48824; MICHIGAN STATE UNIV,DEPT BIOCHEM,E LANSING,MI 48824	Michigan State University; Michigan State University					NATIONAL CANCER INSTITUTE [R01CA021289] Funding Source: NIH RePORTER; NCI NIH HHS [CA21289] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Battey, 1986, BASIC METHODS MOL BI; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; CARLONI G, 1988, FEBS LETT, V229, P333, DOI 10.1016/0014-5793(88)81151-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; HURLIN PJ, 1987, CANCER RES, V47, P5237; NAMBA M, 1988, MUTAT RES, V199, P415, DOI 10.1016/0027-5107(88)90218-7; NAMBA M, 1986, INT J CANCER, V37, P419, DOI 10.1002/ijc.2910370314; OBRIEN W, 1986, P NATL ACAD SCI USA, V83, P8659; TSUCHIDA N, 1981, J VIROL, V38, P720, DOI 10.1128/JVI.38.2.720-727.1981; TSUCHIDA N, 1982, SCIENCE, V217, P937, DOI 10.1126/science.6287573; WILSON DM, 1990, IN PRESS CANCER RES	13	19	19	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1415	1418						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216465				2022-12-28	WOS:A1990EC24100022
J	MISCHAK, H; KOLCH, W; HOFER, F; WEISSINGER, E; GESSL, A; DAVIDSON, WF; AIELLO, FB; BLAAS, D; RAPP, UR				MISCHAK, H; KOLCH, W; HOFER, F; WEISSINGER, E; GESSL, A; DAVIDSON, WF; AIELLO, FB; BLAAS, D; RAPP, UR			A RAF/MYC VIRUS IMMORTALIZED MACROPHAGE CELL-LINE WHICH SUPPORTS THE GROWTH OF B-CELL AND B-CELL HYBRIDOMAS	ONCOGENE			English	Article									NCI, FREDERICK CANC RES FACIL, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA; INST BIOCHEM, A-1090 VIENNA, AUSTRIA; INST EXPTL PATHOL, A-1090 VIENNA, AUSTRIA; NCI, FREDERICK CANC RES FACIL, PROGRAM RESOURCES INC, BIOL CARCINOGENESIS & DEV PROGRAM, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	MISCHAK, H (corresponding author), NCI, GENET LAB, BLDG 37, BETHESDA, MD 20892 USA.		Mischak, Harald/E-8685-2011; Kolch, Walter/ABF-2102-2021	Kolch, Walter/0000-0001-5777-5016; Mischak, Harald/0000-0003-0323-0306				Aarden L, 1985, LYMPHOKINES, V10, P175; AIELLO FB, 1990, J IMMUNOL, V144, P2572; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BOLDICKE T, 1988, EUR J BIOCHEM, V175, P259, DOI 10.1111/j.1432-1033.1988.tb14191.x; CHIPLUNKAR S, 1986, J IMMUNOL, V137, P3748; CLEVELAND JL, 1986, CURR TOP MICROBIOL, V132, P44; DAHMUS ME, 1988, MOL IMMUNOL, V25, P997, DOI 10.1016/0161-5890(88)90006-5; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HOLLEY RW, 1983, CELL BIOL INT REP, V7, P141, DOI 10.1016/0309-1651(83)90027-9; HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443; KAYE J, 1984, J IMMUNOL, V133, P1339; KLINKEN SP, 1988, P NATL ACAD SCI USA, V85, P8506, DOI 10.1073/pnas.85.22.8506; KLINKEN SP, 1989, J VIROL, V63, P1489, DOI 10.1128/JVI.63.3.1489-1492.1989; KOLCH W, 1990, IN PRESS CRC REV CAN; KOLCH W, 1990, IN PRESS ONCOGENE; KUNIMOTO DY, 1989, J IMMUNOL, V143, P2230; LANE RD, 1988, HYBRIDOMA, V7, P289, DOI 10.1089/hyb.1988.7.289; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MISCHAK H, 1989, BIOCHIM BIOPHYS ACTA, V990, P1, DOI 10.1016/S0304-4165(89)80003-0; MIZEL SB, 1978, J IMMUNOL, V120, P1497; MOLLER SA, 1985, J IMMUNOL METHODS, V79, P195, DOI 10.1016/0022-1759(85)90099-7; MORSE HC, 1988, CELLULAR ONCOGENE AC, P335; NOELLE R, 1984, P NATL ACAD SCI-BIOL, V81, P6149, DOI 10.1073/pnas.81.19.6149; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; PIKE BL, 1985, P NATL ACAD SCI USA, V82, P8153, DOI 10.1073/pnas.82.23.8153; PRINCIPATO M, 1988, CURR TOP MICROBIOL, V141, P31; PRINCIPATO M, 1990, IN PRESS MOL CELL BI; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RAPP UR, 1988, HDB ONCOGENES, P213; RAPP UR, 1986, RETROVIRUSES HUMAN P, P449; ROBERSON SM, 1988, CELL IMMUNOL, V116, P341, DOI 10.1016/0008-8749(88)90236-5; SIRAGANIAN RP, 1983, METHOD ENZYMOL, V92, P17; SUDA T, 1989, J IMMUNOL METHODS, V120, P173, DOI 10.1016/0022-1759(89)90239-1; TREANOR J, 1988, P NATL ACAD SCI USA, V85, P3613, DOI 10.1073/pnas.85.10.3613; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; VANNESS J, 1984, P NATL ACAD SCI-BIOL, V81, P7897; WONG GG, 1988, IMMUNOL TODAY, V9, P137, DOI 10.1016/0167-5699(88)91200-5	40	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	1990	5	9					1377	1382						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216460				2022-12-28	WOS:A1990EC24100015
J	GODWIN, AK; LIEBERMAN, MW				GODWIN, AK; LIEBERMAN, MW			EARLY AND LATE RESPONSES TO INDUCTION OF RAST24 EXPRESSION IN RAT-1 CELLS	ONCOGENE			English	Article									FOX CHASE CANC INST,DEPT PATHOL,PHILADELPHIA,PA 19111	Fox Chase Cancer Center					NCI NIH HHS [R37-CA39392, CA-06927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA039392, P30CA006927] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; ALITALO K, 1982, ADV CANCER RES, V37, P111, DOI 10.1016/S0065-230X(08)60883-0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BOHLEN P, 1973, ARCH BIOCHEM BIOPHYS, V155, P213, DOI 10.1016/S0003-9861(73)80023-2; CHIN JR, 1985, J BIOL CHEM, V260, P2367; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DENHARDT DT, 1987, ONCOGENE, V2, P55; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DEVOUGE MW, 1982, VIROLOGY, V121, P327, DOI 10.1016/0042-6822(82)90172-6; EGAN SE, 1987, MOL CELL BIOL, V7, P830, DOI 10.1128/MCB.7.2.830; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; GREIG RG, 1985, P NATL ACAD SCI USA, V82, P3698, DOI 10.1073/pnas.82.11.3698; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; Iten E, 1989, Recent Results Cancer Res, V113, P78; JAKOWLEW SB, 1988, ONCOGENE RES, V2, P135; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; LACAL JC, 1984, P NATL ACAD SCI-BIOL, V81, P5305, DOI 10.1073/pnas.81.17.5305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P5936; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LANIA L, 1980, VIROLOGY, V101, P217, DOI 10.1016/0042-6822(80)90497-3; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LEE WMF, 1985, MOL CELL BIOL, V5, P3345, DOI 10.1128/MCB.5.12.3345; LI YC, 1988, P NATL ACAD SCI USA, V85, P344, DOI 10.1073/pnas.85.2.344; LIAU G, 1985, J BIOL CHEM, V260, P531; MANIATIS T, 1985, COLD SPRING HARBOR L; MANNE V, 1984, P NATL ACAD SCI-BIOL, V81, P6953, DOI 10.1073/pnas.81.22.6953; MARTIN GS, 1971, P NATL ACAD SCI USA, V6, P2739; MARTINSSON T, 1988, ONCOGENE, V3, P437; MATRISIAN LM, 1986, P NATL ACAD SCI USA, V83, P9413, DOI 10.1073/pnas.83.24.9413; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; MUSCHEL R, 1988, CARCINOGENESIS, V9, P705, DOI 10.1093/carcin/9.5.705; MUSCHEL RJ, 1985, AM J PATHOL, V121, P1; NAGATA K, 1989, J BIOL CHEM, V264, P17000; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; REDMOND SMS, 1988, ONCOGENE, V2, P259; REYNOLDS VL, 1987, ONCOGENE, V1, P323; RICKETTS MH, 1988, MOL CELL BIOL, V8, P1460, DOI 10.1128/MCB.8.4.1460; RULEY HE, 1983, NATURE, V304, P596; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; SISTONEN L, 1989, EMBO J, V8, P815, DOI 10.1002/j.1460-2075.1989.tb03442.x; SISTONEN L, 1987, EXP CELL RES, V168, P518, DOI 10.1016/0014-4827(87)90024-3; SORRENTINO V, 1988, ONCOGENE RES, V2, P189; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; SPANDIDOS DA, 1987, MUTAT RES, V185, P271, DOI 10.1016/0165-1110(87)90020-0; SUAREZ HG, 1987, ONCOGENE RES, V1, P201; TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TROEN BR, 1988, J BIOL CHEM, V263, P254; TSUBOI K, 1987, BIOCHEM BIOPH RES CO, V146, P699, DOI 10.1016/0006-291X(87)90585-7; VALENZUELA P, 1981, NATURE, V289, P650, DOI 10.1038/289650a0; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; WEEKS MO, 1985, J VIROL, V54, P586, DOI 10.1128/JVI.54.2.586-597.1985; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WEINBERG RA, 1989, CANCER RES, V49, P3713; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; WILLUMSEN BM, 1986, MOL CELL BIOL, V6, P2646, DOI 10.1128/MCB.6.7.2646; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; YASWEN P, 1985, MOL CELL BIOL, V5, P780, DOI 10.1128/MCB.5.4.780; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	76	37	37	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1231	1241						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202952				2022-12-28	WOS:A1990DX36100017
J	COHEN, DR; CURRAN, T				COHEN, DR; CURRAN, T			ANALYSIS OF DIMERIZATION AND DNA-BINDING FUNCTIONS IN FOS AND JUN BY DOMAIN-SWAPPING - INVOLVEMENT OF RESIDUES OUTSIDE THE LEUCINE ZIPPER BASIC REGION	ONCOGENE			English	Article											COHEN, DR (corresponding author), ROCHE INST MOLEC BIOL,ROCHE RES CTR,DEPT MOLEC ONCOL & VIROL,NUTLEY,NJ 07110, USA.		Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019	Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Cohen, Donna/0000-0002-0419-9542				ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; ABATE C, 1990, IN PRESS SEMINARS CA; AGRE P, 1989, SCIENCE, V246, P922, DOI 10.1126/science.2530632; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1989, ONCOGENE, V4, P123; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1982, VIROLOGY, V116, P221, DOI 10.1016/0042-6822(82)90415-9; CURRAN T, 1984, CELL, V36, P259; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FRANZA BR, 1987, ONCOGENE, V1, P213; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOUGHTON JE, 1989, NATURE, V338, P172, DOI 10.1038/338172a0; JENUWEIN T, 1987, CELL, V48, P647, DOI 10.1016/0092-8674(87)90243-1; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; NEUBERG M, 1989, NATURE, V341, P243, DOI 10.1038/341243a0; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RENZ M, 1987, NUCLEIC ACIDS RES, V15, P277, DOI 10.1093/nar/15.1.277; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SAMBUCETTI LC, 1986, SCIENCE, V234, P1417, DOI 10.1126/science.3491427; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SELLERS JW, 1989, NATURE, V341, P74, DOI 10.1038/341074a0; SETOYAMA C, 1986, P NATL ACAD SCI USA, V83, P3213, DOI 10.1073/pnas.83.10.3213; SETOYAMA C, 1986, BIOCHEM BIOPH RES CO, V136, P1042, DOI 10.1016/0006-291X(86)90438-9; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; SUZUKI M, 1989, J MOL BIOL, V207, P61, DOI 10.1016/0022-2836(89)90441-5; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	51	79	80	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					929	939						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2113670				2022-12-28	WOS:A1990DP55300022
J	SUAREZ, HG; DUVILLARD, JA; SEVERINO, M; CAILLOU, B; SCHLUMBERGER, M; TUBIANA, M; PARMENTIER, C; MONIER, R				SUAREZ, HG; DUVILLARD, JA; SEVERINO, M; CAILLOU, B; SCHLUMBERGER, M; TUBIANA, M; PARMENTIER, C; MONIER, R			PRESENCE OF MUTATIONS IN ALL 3 RAS GENES IN HUMAN THYROID-TUMORS	ONCOGENE			English	Article									INST GUSTAVE ROUSSY,CNRS,UA 1158,F-94805 VILLEJUIF,FRANCE; INST RECH SCI CANC,CNRS,F-94802 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS)								ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1986, NUCLEIC ACIDS RES, V14, P1209, DOI 10.1093/nar/14.3.1209; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BROWETT PJ, 1989, ONCOGENE, V4, P1029; DEVRIES MV, 1986, GENE, V50, P313; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FUJITA J, 1988, CANCER RES, V48, P5251; FUJITA J, 1985, P NATL ACAD SCI USA, V82, P3849, DOI 10.1073/pnas.82.11.3849; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, CANCER RES, V48, P4459; LEMOINE NR, 1988, ONCOGENE, V3, P541; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; RIOU G, 1988, ONCOGENE, V3, P329; RODENHUIS S, 1988, CANCER RES, V48, P5738; ROSAI J, 1981, ACKERMANS SURGICAL P, P30; SMIT VTHBM, 1988, NUCLEIC ACIDS RES, V16, P7773, DOI 10.1093/nar/16.16.7773; SPANDIDOS DA, 1987, ANTICANCER RES, V7, P991; SUAREZ HG, 1988, ONCOGENE, V2, P403; SUAREZ HG, 1985, RETROVIRUSES HUMAN P, P509; TUBIANA M, 1985, CANCER-AM CANCER SOC, V55, P794, DOI 10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114, DOI 10.1128/MCB.9.7.3114; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WILLIAMS ED, 1979, CLIN ENDOCRINOL META, V8, P193, DOI 10.1016/S0300-595X(79)80017-1; WILLIAMS ED, 1980, RECENT RES CANCER, P47; WRIGHT PA, 1989, BRIT J CANCER, V60, P576, DOI 10.1038/bjc.1989.316; YUNIS JJ, 1989, ONCOGENE, V4, P609	30	262	262	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					565	570						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183158				2022-12-28	WOS:A1990DB85300016
J	AKIYAMA, T; TOYOSHIMA, K				AKIYAMA, T; TOYOSHIMA, K			MARKED ALTERATION IN PHOSPHORYLATION OF THE RB PROTEIN DURING DIFFERENTIATION OF HUMAN PROMYELOCYTIC HL60 CELLS	ONCOGENE			English	Article											AKIYAMA, T (corresponding author), UNIV TOKYO,INST MED SCI,DEPT ONCOL,4-6-1 SHIROKANEDAI,MINATO KU,TOKYO 108,JAPAN.							AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; PRYWES R, 1988, P NATL ACAD SCI USA, V85, P7206, DOI 10.1073/pnas.85.19.7206; SAKSELA K, 1989, EMBO J, V8, P149, DOI 10.1002/j.1460-2075.1989.tb03359.x; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; SIMMONS DT, 1986, J VIROL, V60, P888, DOI 10.1128/JVI.60.3.888-894.1986; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOKOTA J, 1988, ONCOGENE, V3, P471	28	33	35	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					179	183						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2320372				2022-12-28	WOS:A1990CU02900003
J	SCHARTL, M; HOLSTEIN, T; ROBERTSON, SM; BARNEKOW, A				SCHARTL, M; HOLSTEIN, T; ROBERTSON, SM; BARNEKOW, A			PREFERENTIAL EXPRESSION OF A PP60C-SRC RELATED PROTEIN TYROSINE KINASE-ACTIVITY IN NERVE-CELLS OF THE EARLY METAZOAN HYDRA (COELENTERATES)	ONCOGENE			English	Article									INST MED VIROL,D-6300 GIESSEN,FED REP GER; ZOOL INST,D-8000 MUNICH 2,FED REP GER		SCHARTL, M (corresponding author), MAX PLANCK INST BIOCHEM,CTR GENE,KLOPFERSPITZ 18A,D-8033 MARTINSRIED,FED REP GER.			Holstein, Thomas/0000-0003-0480-4674; Schartl, Manfred/0000-0001-9882-5948				ANDERS F, 1984, ADV CANCER RES, V42, P191, DOI 10.1016/S0065-230X(08)60459-5; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BARNEKOW A, 1986, DIFFERENTIATION, V33, P29, DOI 10.1111/j.1432-0436.1986.tb00407.x; BARNEKOW A, 1984, MOL CELL BIOL, V4, P1179, DOI 10.1128/MCB.4.6.1179; BARNEKOW A, 1987, COMP BIOCHEM PHYS B, V87, P663, DOI 10.1016/0305-0491(87)90371-3; BARNEKOW A, 1986, EMBO J, V5, P701, DOI 10.1002/j.1460-2075.1986.tb04270.x; BARNEKOW A, 1984, BIOCHIM BIOPHYS ACTA, V782, P94, DOI 10.1016/0167-4781(84)90110-6; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BODE HR, 1978, PROG BIOPHYS MOL BIO, V33, P189; BRUGGE J, 1987, GENE DEV, V1, P287, DOI 10.1101/gad.1.3.287; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; DAVID CN, 1974, J CELL SCI, V16, P359; DAVID CN, 1974, AM ZOOL, V14, P537; DAVID CN, 1986, GENETIC REGULATION D, P389; DELORBE WJ, 1980, J VIROL, V36, P50, DOI 10.1128/JVI.36.1.50-61.1980; DUNNE JF, 1985, DEV BIOL, V109, P41, DOI 10.1016/0012-1606(85)90344-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GEE CE, 1986, P NATL ACAD SCI USA, V83, P5131, DOI 10.1073/pnas.83.14.5131; GESSLER M, 1984, BIOSCIENCE REP, V4, P757, DOI 10.1007/BF01128817; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; HOFFMANFALK H, 1983, CELL, V32, P589, DOI 10.1016/0092-8674(83)90478-6; HOLSTEIN T, 1986, DEV BIOL, V115, P9, DOI 10.1016/0012-1606(86)90222-8; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LEVY BT, 1984, DEV BIOL, V104, P9, DOI 10.1016/0012-1606(84)90031-9; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; LOOMIS WF, 1956, J EXP ZOOL, V132, P555, DOI 10.1002/jez.1401320309; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MANESS PF, 1986, J NEUROSCI RES, V16, P127, DOI 10.1002/jnr.490160113; Marcum B.A., 1980, P429; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MAUELER W, 1988, ONCOGENE, V2, P421; RAULF F, 1989, IN PRESS J NEUROSCI; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SCHALLER HC, 1981, P NATL ACAD SCI-BIOL, V78, P7000, DOI 10.1073/pnas.78.11.7000; SCHARTL M, 1982, DIFFERENTIATION, V23, P109, DOI 10.1111/j.1432-0436.1982.tb01273.x; SCHARTL M, 1984, DEV BIOL, V105, P415, DOI 10.1016/0012-1606(84)90298-7; SCHMIDT T, 1986, J CELL SCI, V85, P197; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; SUGIYAMA T, 1978, J CELL SCI, V29, P35; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TERADA H, 1988, DEV BIOL, V126, P263, DOI 10.1016/0012-1606(88)90137-6; VANGRIMMELIKHUI.CG, 1982, HISTOCHEMISTRY, V73, P499; VARDIMON L, 1986, MOL CELL BIOL, V6, P4109, DOI 10.1128/MCB.6.11.4109; WALAAS SI, 1988, MOL BRAIN RES, V3, P215, DOI 10.1016/0169-328X(88)90044-7; WESTFALL JA, 1973, J ULTRA MOL STRUCT R, V42, P268, DOI 10.1016/S0022-5320(73)90055-5; ZIEMIECKI A, 1980, J GEN VIROL, V50, P211, DOI 10.1099/0022-1317-50-1-211	59	11	11	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1185	1191						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2477783				2022-12-28	WOS:A1989AU50800004
J	WEINER, DB; KOKAI, Y; WADA, T; COHEN, JA; WILLIAMS, WV; GREENE, MI				WEINER, DB; KOKAI, Y; WADA, T; COHEN, JA; WILLIAMS, WV; GREENE, MI			LINKAGE OF TYROSINE KINASE-ACTIVITY WITH TRANSFORMING ABILITY OF THE P185NEU ONCOPROTEIN	ONCOGENE			English	Article									UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania	WEINER, DB (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,571 MALONEY BLDG,3600 SPRUCE ST,PHILADELPHIA,PA 19104, USA.		Weiner, David B/H-8579-2014	Williams, William/0000-0003-3611-9284				BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BELL JC, 1987, NATURE, V325, P552, DOI 10.1038/325552a0; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COHEN JC, 1989, ONCOGENE, V4, P67; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; DANIEL TO, 1985, PNAS, V82, P2084; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAULTON GN, 1986, J IMMUNOL, V136, P2470; GILMORE T, 1985, CELL, V40, P609, DOI 10.1016/0092-8674(85)90209-0; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNINK M, 1985, P NATL ACAD SCI USA, V82, P7894, DOI 10.1073/pnas.82.23.7894; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Maniatis T., 1982, MOL CLONING; MOLLER W, 1985, FEBS LETT, V186, P1, DOI 10.1016/0014-5793(85)81326-0; NICHOLS EJ, 1985, MOL CELL BIOL, V5, P3467, DOI 10.1128/MCB.5.12.3467; PADHY LC, 1982, CELL, V28, P365; RUSSO MW, 1985, J BIOL CHEM, V260, P5205; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEGATTO O, 1988, MOL CELL BIOL, V8, P5570, DOI 10.1128/MCB.8.12.5570; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SNYDER MA, 1985, MOL CELL BIOL, V5, P1772, DOI 10.1128/MCB.5.7.1772; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1984, FEBS LETT, V175, P387, DOI 10.1016/0014-5793(84)80774-7; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; WEINER BD, 1988, PNAS, V85, P6077; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; WEINMASTER G, 1986, EMBO J, V5, P69, DOI 10.1002/j.1460-2075.1986.tb04179.x; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZICK Y, 1984, BIOCHEM BIOPH RES CO, V119, P6, DOI 10.1016/0006-291X(84)91610-3	56	97	103	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1175	1183						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2571965				2022-12-28	WOS:A1989AU50800003
J	LI, Y; LIEBERMAN, MW				LI, Y; LIEBERMAN, MW			2 GENES ASSOCIATED WITH LIVER-CANCER ARE REGULATED BY DIFFERENT MECHANISMS IN RAST24 TRANSFORMED LIVER EPITHELIAL-CELLS	ONCOGENE			English	Article									FOX CHASE CANC CTR, DEPT PATHOL, PHILADELPHIA, PA 19111 USA	Fox Chase Cancer Center					NCI NIH HHS [R37-CA39392, CA-06927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006927, R37CA039392] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAMERON R, 1978, CANCER RES, V38, P823; CLEMENS MJ, 1984, TRANSCRIPTION TRANSL, P211; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; FARBER E, 1984, CANCER RES, V44, P5463; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; HOLTTA E, 1988, J BIOL CHEM, V263, P4500; KITAHARA A, 1984, CANCER RES, V44, P2698; KROWCZYNSKA A, 1985, J MOL BIOL, V181, P231, DOI 10.1016/0022-2836(85)90087-7; LI YC, 1988, P NATL ACAD SCI USA, V85, P344, DOI 10.1073/pnas.85.2.344; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; SATO K, 1984, GANN, V75, P199; SATOH K, 1985, P NATL ACAD SCI USA, V82, P3964, DOI 10.1073/pnas.82.12.3964; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SEYAMA T, 1988, MOL CARCINOGEN, V1, P89, DOI 10.1002/mc.2940010204; SINGER RH, 1972, NATURE, V240, P100, DOI 10.1038/240100a0; SUGIOKA Y, 1985, CANCER RES, V45, P365; TAMM I, 1978, ADV VIRUS RES, V22, P188; TSAO MS, 1985, CANCER RES, V45, P5134	21	30	30	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1989	4	6					795	798						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2567500				2022-12-28	WOS:A1989AA66000016
J	XU, HJ; HU, SX; HASHIMOTO, T; TAKAHASHI, R; BENEDICT, WF				XU, HJ; HU, SX; HASHIMOTO, T; TAKAHASHI, R; BENEDICT, WF			THE RETINOBLASTOMA SUSCEPTIBILITY GENE-PRODUCT - A CHARACTERISTIC PATTERN IN NORMAL-CELLS AND ABNORMAL EXPRESSION IN MALIGNANT-CELLS	ONCOGENE			English	Article									BAYLOR COLL MED, CTR BIOTECHNOL, 4000 RES FOREST DR, WOODLANDS, TX 77381 USA	Baylor College of Medicine					NEI NIH HHS [EYO6195, EYO2715] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002715] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; TANG A, 1989, ONCOGENE, V4, P401; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YOKOTA J, 1988, ONCOGENE, V3, P471	17	138	147	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1989	4	6					807	812						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2471953				2022-12-28	WOS:A1989AA66000019
J	SMITH, KT; CAMPO, MS				SMITH, KT; CAMPO, MS			AMPLIFICATION OF SPECIFIC DNA-SEQUENCES IN C127 MOUSE CELLS TRANSFORMED BY BOVINE PAPILLOMAVIRUS TYPE-4	ONCOGENE			English	Article											SMITH, KT (corresponding author), BEATSON INST CANC RES,GARSCUBE ESTATE,SWITCHBACK RD,GLASGOW G61 1BD,SCOTLAND.							ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; AMTMANN E, 1985, EXP CELL RES, V161, P541, DOI 10.1016/0014-4827(85)90109-0; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; CAMPO MS, 1985, EMBO J, V4, P1819, DOI 10.1002/j.1460-2075.1985.tb03856.x; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; GALLOWAY DA, 1983, NATURE, V302, P21, DOI 10.1038/302021a0; HEILBRONN R, 1985, INT J CANCER, V36, P85, DOI 10.1002/ijc.2910360114; LEHN H, 1985, P NATL ACAD SCI USA, V82, P5540, DOI 10.1073/pnas.82.16.5540; MACNAB JCM, 1987, J GEN VIROL, V68, P2525, DOI 10.1099/0022-1317-68-10-2525; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; OCADIZ R, 1987, CANCER RES, V47, P4173; RIOU G, 1988, ONCOGENE, V3, P329; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SMITH KT, 1988, VIROLOGY, V164, P39, DOI 10.1016/0042-6822(88)90617-4; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0	15	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					409	413						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2541389				2022-12-28	WOS:A1989U567700003
J	MOROY, T; ETIEMBLE, J; BOUGUELERET, L; HADCHOUEL, M; TIOLLAIS, P; BUENDIA, MA				MOROY, T; ETIEMBLE, J; BOUGUELERET, L; HADCHOUEL, M; TIOLLAIS, P; BUENDIA, MA			STRUCTURE AND EXPRESSION OF HCR, A LOCUS REARRANGED WITH C-MYC IN A WOODCHUCK HEPATOCELLULAR-CARCINOMA	ONCOGENE			English	Article									INST PASTEUR,UNITE RECOMBINAISON & EXPRESS GENET,CNRS,UA 271,INSERM,U163,F-75724 PARIS 15,FRANCE; HOP BICETRE,INSERM,U56,F-94275 KREMLIN BICETRE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)			Moroy, Tarik/D-9923-2011					BIRCHMEIER C, 1984, P NATL ACAD SCI-BIOL, V81, P1057, DOI 10.1073/pnas.81.4.1057; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BORNKAMM GW, 1988, CELLULAR ONCOGENE AC, P223; CALZONE FJ, 1988, GENE DEV, V2, P305, DOI 10.1101/gad.2.3.305; CLAVERIE JM, 1986, NUCLEIC ACIDS RES, V14, P179, DOI 10.1093/nar/14.1.179; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; GODBOUT R, 1988, MOL CELL BIOL, V8, P1169, DOI 10.1128/MCB.8.3.1169; GOODMAN RH, 1979, BIOCHEM BIOPH RES CO, V91, P932, DOI 10.1016/0006-291X(79)91969-7; GUBLER U, 1983, P NATL ACAD SCI-BIOL, V80, P4311, DOI 10.1073/pnas.80.14.4311; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HERBERT E, 1983, TRENDS BIOCHEM SCI, V6, P184; JAISWAL AK, 1987, NUCLEIC ACIDS RES, V15, P6755, DOI 10.1093/nar/15.16.6755; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Maniatis T., 1982, MOL CLONING; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOROY T, 1985, EMBO J, V4, P1507, DOI 10.1002/j.1460-2075.1985.tb03810.x; MOROY T, 1986, NATURE, V324, P276, DOI 10.1038/324276a0; NEGRINI M, 1987, CELL, V49, P455, DOI 10.1016/0092-8674(87)90448-X; NEVINS JR, 1983, ANNU REV BIOCHEM, V52, P441, DOI 10.1146/annurev.bi.52.070183.002301; NISHIKURA K, 1984, SCIENCE, V224, P399, DOI 10.1126/science.6424234; PATEY G, 1986, ANN ENDOCRINOL-PARIS, V47, P71; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAUL Y, 1987, EMBO J, V6, P1913, DOI 10.1002/j.1460-2075.1987.tb02451.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SNYDER RL, 1980, COLD SPRING HARBOR C, V7, P447; SONIGO P, 1987, P NATL ACAD SCI USA, V84, P3768, DOI 10.1073/pnas.84.11.3768; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P141, DOI 10.1093/nar/10.1.141; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; UYEDA A, 1987, NUCLEIC ACIDS RES, V15, P6738, DOI 10.1093/nar/15.16.6738; VARMUS HE, 1984, ANNU REV GENET, V18, P553; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	43	29	32	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					59	65						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2536918				2022-12-28	WOS:A1989U567400009
J	INGVARSSON, S; SUNDARESAN, S; JIN, P; FRANCKE, U; ASKER, C; SUMEGI, J; KLEIN, G; SEJERSEN, T				INGVARSSON, S; SUNDARESAN, S; JIN, P; FRANCKE, U; ASKER, C; SUMEGI, J; KLEIN, G; SEJERSEN, T			CHROMOSOME LOCALIZATION AND EXPRESSION PATTERN OF LMYC AND BMYC IN MURINE EMBRYONAL CARCINOMA-CELLS	ONCOGENE			English	Article									KAROLINSKA INST, DEPT MED CELL GENET, S-10401 STOCKHOLM 60, SWEDEN; YALE UNIV, SCH MED, DEPT HUMAN GENET, NEW HAVEN, CT 06510 USA	Karolinska Institutet; Yale University	INGVARSSON, S (corresponding author), KAROLINSKA INST, DEPT TUMOR BIOL, S-10401 STOCKHOLM 60, SWEDEN.		Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105] Funding Source: NIH RePORTER; NCI NIH HHS [3R01CA140554] Funding Source: Medline; NIGMS NIH HHS [GM26105] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ASKER C, 1988, LEUKEMIA RES, V12, P523, DOI 10.1016/0145-2126(88)90120-8; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARTON DE, 1986, HUM GENET, V72, P221, DOI 10.1007/BF00291881; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; BROOKS BJ, 1987, ADV VIRAL ONCOL, V7, P155; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CAVALIERI F, 1988, ONCOGENE, V2, P289; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; CLEVELAND JL, 1987, VIRAL CARCINOG, V24, P339; DALLAFAVERA R, 1982, NATURE, V299, P61; DEAN M, 1987, ONCOGENE RES, V1, P279; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DEPINHO R, 1987, J CELL BIOCHEM, V33, P257, DOI 10.1002/jcb.240330404; DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827; DEPINHO RA, 1987, J CELL BIOCHEM, V1, P1311; EDMONDS M, 1969, J BIOL CHEM, V244, P1314; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; EICK D, 1985, EMBO J, V4, P3717, DOI 10.1002/j.1460-2075.1985.tb04140.x; EVANS G, 1988, IN PRESS CURR TOP MI, V138; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P57, DOI 10.1159/000130799; FRANCKE U, 1979, P NATL ACAD SCI USA, V76, P5230, DOI 10.1073/pnas.76.10.5230; HAYATA I, 1983, CANCER RES, V43, P367; HENRIKSSON M, 1988, IN PRESS ONCOGENE, V3; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; INGVARSSON S, 1988, MOL CELL BIOL, V8, P3168, DOI 10.1128/MCB.8.8.3168; INGVARSSON S, 1987, SOMAT CELL MOLEC GEN, V13, P335, DOI 10.1007/BF01534927; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; KOHL NE, 1986, NATURE, V319, P73, DOI 10.1038/319073a0; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; LALLEY PA, 1987, CYTOGENET CELL GENET, V46, P367, DOI 10.1159/000132486; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NESBITT MN, 1974, CHROMOSOMA, V46, P217, DOI 10.1007/BF00332519; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; RIZZINO A, 1980, P NATL ACAD SCI-BIOL, V77, P457, DOI 10.1073/pnas.77.1.457; ROSENBAUM H, 1989, IN PRESS EMBO J; SCHWAB M, 1985, NATURE, V315, P345, DOI 10.1038/315345a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SEJERSEN T, 1987, EXP CELL RES, V172, P304, DOI 10.1016/0014-4827(87)90389-2; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; SUMEGI J, 1985, INT J CANCER, V36, P367; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; YANCOPOULOS GD, 1985, P NATL ACAD SCI USA, V82, P5455, DOI 10.1073/pnas.82.16.5455; YOSHIDA MC, 1978, CYTOGENET CELL GENET, V22, P606, DOI 10.1159/000131034; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	51	17	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					679	685						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577870				2022-12-28	WOS:A1988R646000009
J	KUMAR, R; BARBACID, M				KUMAR, R; BARBACID, M			ONCOGENE DETECTION AT THE SINGLE CELL LEVEL	ONCOGENE			English	Article											KUMAR, R (corresponding author), NCI, FREDERICK CANC RES FACIL, DEV ONCOL SECT, BASIC RES PROGRAM, FREDERICK, MD 21701 USA.				OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; DUCNGUYEN H, 1966, J BACTERIOL, V92, P1133, DOI 10.1128/JB.92.4.1133-1140.1966; ENGELKE DR, 1988, P NATL ACAD SCI USA, V85, P544, DOI 10.1073/pnas.85.2.544; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; KWOK S, 1987, J VIROL, V61, P1690, DOI 10.1128/JVI.61.5.1690-1694.1987; LEE MS, 1987, SCIENCE, V237, P175, DOI 10.1126/science.3110950; LIU E, 1987, NATURE, V330, P186, DOI 10.1038/330186a0; MCMAHON G, 1987, P NATL ACAD SCI USA, V84, P4974, DOI 10.1073/pnas.84.14.4974; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	25	96	104	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					647	651						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2578002				2022-12-28	WOS:A1988R646000004
J	LETWIN, K; YEE, SP; PAWSON, T				LETWIN, K; YEE, SP; PAWSON, T			NOVEL PROTEIN-TYROSINE KINASE CDNAS RELATED TO FPS/FES AND EPH CLONED USING ANTI-PHOSPHOTYROSINE ANTIBODY	ONCOGENE			English	Article									MT SINAI HOSP,RES INST,DIV MOLEC & DEV BIOL,600 UNIV AVE,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto			Pawson, Tony J/E-4578-2013					ARQUINT M, 1987, P NATL ACAD SCI USA, V84, P600, DOI 10.1073/pnas.84.2.600; BARKER WC, 1982, P NATL ACAD SCI-BIOL, V79, P2836, DOI 10.1073/pnas.79.9.2836; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BUECHLER JA, 1988, IN PRESS BIOCHEMISTR; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5394; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; EDWARDS AM, 1988, MOL CELL BIOL, V8, P2655, DOI 10.1128/MCB.8.6.2655; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; FELDMAN RA, 1986, MOL CELL BIOL, V6, P1065, DOI 10.1128/MCB.6.4.1065; FOSTER DA, 1986, MOL CELL BIOL, V6, P325, DOI 10.1128/MCB.6.1.325; GREER PA, 1988, MOL CELL BIOL, V8, P578, DOI 10.1128/MCB.8.2.578; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HENKEMEYER MJ, 1988, MOL CELL BIOL, V8, P843, DOI 10.1128/MCB.8.2.843; HENKEMEYER MJ, 1987, CELL, V51, P821, DOI 10.1016/0092-8674(87)90105-X; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOFFMANN FM, 1983, CELL, V35, P393, DOI 10.1016/0092-8674(83)90172-1; HUANG CC, 1985, J MOL BIOL, V181, P175, DOI 10.1016/0022-2836(85)90083-X; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KRUH GD, 1986, SCIENCE, V234, P1545, DOI 10.1126/science.3787260; LINDBERG RL, 1988, IN PRESS ONCOGENE, V3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P2001; Maniatis T., 1982, MOL CLONING; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARU Y, 1988, MOL CELL BIOL, V8, P3770, DOI 10.1128/MCB.8.9.3770; MATHEYPREVOT B, 1982, CELL, V28, P297; MAYER BJ, 1988, NATURE, V332, P275; MORAN MF, 1988, IN PRESS ONCOGENE, V3; PAWSON T, 1980, CELL, V22, P767, DOI 10.1016/0092-8674(80)90553-X; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; ROHRSCHNEIDER LR, 1984, ADV VIRAL ONCOL, V4, P269; RUTA Y, 1988, ONCOGENE, V3, P9; SADOWSKI I, 1987, ONCOGENE, V1, P181; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SIMON MA, 1985, CELL, V42, P831, DOI 10.1016/0092-8674(85)90279-X; STAHL MA, 1986, NATURE, V332, P269; STONE JC, 1984, CELL, V37, P549, DOI 10.1016/0092-8674(84)90385-4; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VOGEL OS, 1988, NATURE, V335, P90; WEINMASTER G, 1986, EMBO J, V5, P69, DOI 10.1002/j.1460-2075.1986.tb04179.x; WITTE ON, 1980, NATURE, V283, P826, DOI 10.1038/283826a0; WOOLFORD J, 1984, VIROLOGY, V135, P168, DOI 10.1016/0042-6822(84)90127-2; YACIUK P, 1986, MOL CELL BIOL, V6, P2807, DOI 10.1128/MCB.6.8.2807; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276; ZOLLER MJ, 1981, J BIOL CHEM, V256, P837	65	176	194	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					621	627						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2485255				2022-12-28	WOS:A1988R646000001
J	TENDIJKE, P; VANKESSEL, AHMG; FOULKES, JG; LEBEAU, MM				TENDIJKE, P; VANKESSEL, AHMG; FOULKES, JG; LEBEAU, MM			TRANSFORMING GROWTH-FACTOR TYPE-BETA-3 MAPS TO HUMAN CHROMOSOME-14, REGION Q23-Q24	ONCOGENE			English	Article									ONCOGENE SCI INC,350 COMMUN DR,MANHASSET,NY 11030; ERASMUS UNIV,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS; UNIV CHICAGO,JOINT SECT HEMATOL ONCOL,CHICAGO,IL 60637	Erasmus University Rotterdam; University of Chicago			Dijke, Peter ten/AAG-4660-2021; van Kessel, Ad Geurts/A-2810-2010	Dijke, Peter ten/0000-0002-7234-342X; 				ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; BARTON DE, 1987, CYTOGENET CELL GENET, V46, P578; BLOOMFIELD CD, 1987, CYTOGENET CELL GENET, V46, P344, DOI 10.1159/000132485; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; DEMARTIN R, 1987, EMBO J, V6, P3673, DOI 10.1002/j.1460-2075.1987.tb02700.x; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DERYNCK R, 1987, NUCLEIC ACIDS RES, V15, P3187, DOI 10.1093/nar/15.7.3187; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; HANKS SK, 1988, P NATL ACAD SCI USA, V85, P79, DOI 10.1073/pnas.85.1.79; IKEDA T, 1987, BIOCHEMISTRY-US, V26, P2406, DOI 10.1021/bi00383a002; JAKOWLEW SB, 1988, MOL ENDOCRINOL, V2, P747, DOI 10.1210/mend-2-8-747; LEBEAU MM, 1984, NATURE, V312, P70, DOI 10.1038/312070a0; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; MADISEN L, 1988, DNA-J MOLEC CELL BIO, V7, P1, DOI 10.1089/dna.1988.7.1; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6381; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; OWERBACH D, 1981, P NATL ACAD SCI-BIOL, V78, P3123, DOI 10.1073/pnas.78.5.3123; ROPERS HH, 1987, CYTOGENET CELL GENET, V46, P243; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SEYEDIN SM, 1986, J BIOL CHEM, V261, P5693; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; TENDIJKE P, 1988, IN PRESS BIOTECHNOLO; VANKESSEL AG, 1983, P NATL ACAD SCI USA, V80, P3728; VANOBBERGHENSCHILLING E, 1987, MOL ENDOCRINOL, V1, P693, DOI 10.1210/mend-1-10-693; WRANN M, 1987, EMBO J, V6, P1633, DOI 10.1002/j.1460-2075.1987.tb02411.x	33	31	33	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					721	724						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577876				2022-12-28	WOS:A1988R646000016
J	NANUS, DM; LYNCH, SA; RAO, PH; ANDERSON, SM; JHANWAR, SC; ALBINO, AP				NANUS, DM; LYNCH, SA; RAO, PH; ANDERSON, SM; JHANWAR, SC; ALBINO, AP			TRANSFORMATION OF HUMAN KIDNEY PROXIMAL TUBULE CELLS BY A SRC-CONTAINING RETROVIRUS	ONCOGENE			English	Article							HUMAN RENAL-CANCER; MOUSE MONOCLONAL-ANTIBODIES; MURINE LEUKEMIA VIRUSES; AVIAN-SARCOMA VIRUSES; SURFACE ANTIGENS; NEOPLASTIC TRANSFORMATION; CARCINOMA; INVITRO; GAP; PROTEINS	Analysis of the cell-surface antigenic phenotypes of normal and malignant renal cells demonstrates that almost-equal-to 90% of cultured normal human kidney cells and virtually all renal cell carcinomas (RCC) derive from the proximal tubule (PT) cell of the nephron. In the present study, the v-src oncogene was introduced into cultured normal human PT cells, and the effects of the v-src-encoded protein (pp60v-src) on the biologic and genetic phenotype of these cells were determined. V-src-containing PT cells underwent a series of phenotypic changes characteristic of renal cells in vivo. These included (i) alterations in morphology, (ii) an increase in proliferative capacity, (iii) loss of contact inhibition, (iv) immortalization and (v) tumorigenicity. Moreover, v-src-infected PT cells developed non-random clonal karyotypic abnormalities which are commonly observed in RCCs, including a deletion of chromosomal region 3p14-21, one of the most frequent deletions observed in human renal tumors. These results indicate that pp60v-src can initiate a complex process leading to the transformation of PT cells. This process includes the induction of genetic instability. Finally, these data provide experimental evidence corroborating cytogenetic and molecular data that a deletion of genes on chromosome 3p is a critical event in the transformation of the human renal cell.	MEM SLOAN KETTERING CANC CTR, MAMMALIAN CELL TRANSFORMAT LAB, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT MED, DIV SOLID TUMOR ONCOL, GENITOURINARY ONCOL SERV, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, SOLID TUMOR IMMUNOL LAB, NEW YORK, NY 10021 USA; MEM SLOAN KETTERING CANC CTR, DEPT PATHOL, CYTOGENET SERV, NEW YORK, NY 10021 USA; SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [R29CA045241] Funding Source: NIH RePORTER; NCI NIH HHS [CA09149, R29 CA45241] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBINO AP, 1986, J EXP MED, V164, P1710, DOI 10.1084/jem.164.5.1710; ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; ANDERSON SM, 1983, J VIROL, V46, P594, DOI 10.1128/JVI.46.2.594-605.1983; ANGLARD P, 1991, CANCER RES, V51, P1071; BANDER NH, 1987, J UROLOGY, V137, P603, DOI 10.1016/S0022-5347(17)44154-1; BANDER NH, 1985, J UROLOGY, V133, P502, DOI 10.1016/S0022-5347(17)49041-0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERGERHEIM U, 1989, CANCER RES, V49, P1390; BROTT BK, 1991, P NATL ACAD SCI USA, V88, P755, DOI 10.1073/pnas.88.3.755; CARDO CC, 1987, AM J PATHOL, V126, P269; CARROLL PR, 1987, CANCER GENET CYTOGEN, V26, P253, DOI 10.1016/0165-4608(87)90059-8; CHATTOPADHYAY SK, 1981, J VIROL, V39, P777, DOI 10.1128/JVI.39.3.777-791.1981; COLLARD JG, 1987, CANCER RES, V47, P6666; EBERT T, 1990, CANCER RES, V50, P5531; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FINSTAD CL, 1985, P NATL ACAD SCI USA, V82, P2955, DOI 10.1073/pnas.82.9.2955; FRADET Y, 1984, P NATL ACAD SCI-BIOL, V81, P224, DOI 10.1073/pnas.81.1.224; GOLDEN A, 1988, ONCOGENE HDB, P149; Harnden DG, 1985, INT SYSTEM HUMAN CYT; HARRIS CC, 1987, CANCER RES, V47, P1; HJELLE B, 1988, P NATL ACAD SCI USA, V85, P4355, DOI 10.1073/pnas.85.12.4355; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; KAWAI S, 1980, J VIROL, V34, P772, DOI 10.1128/JVI.34.3.772-776.1980; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOVACS G, 1987, INT J CANCER, V40, P171, DOI 10.1002/ijc.2910400208; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MILES J, 1988, CANCER GENET CYTOGEN, V34, P135, DOI 10.1016/0165-4608(88)90180-X; NANUS DM, 1990, J UROLOGY, V143, P175, DOI 10.1016/S0022-5347(17)39905-6; NANUS DM, 1989, J EXP MED, V169, P953, DOI 10.1084/jem.169.3.953; OGAWA O, 1991, CANCER RES, V51, P949; PARSONS JT, 1989, CURR TOP MICROBIOL, V147, P79; PINCUS T, 1975, VIROLOGY, V65, P333, DOI 10.1016/0042-6822(75)90039-2; PRESTI JC, 1991, CANCER RES, V51, P1544; RABOTTI G, 1987, J NATL CANCER I, V78, P817; RHIM JS, 1988, LEUKEMIA, V2, pS151; RHIM JS, 1989, ANTICANCER RES, V9, P1345; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; RHIM JS, 1990, CANCER RES, V50, pS5653; RHIM JS, 1982, P SOC EXP BIOL MED, V170, P350; RITZ J, 1982, LANCET, V2, P60; ROSEN N, 1986, J BIOL CHEM, V261, P3754; Sambrook J, 1989, MOL CLONING LABORATO; SCHABER MD, 1989, PROTEINS, V6, P306, DOI 10.1002/prot.340060313; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; UEDA R, 1979, J EXP MED, V150, P564, DOI 10.1084/jem.150.3.564; UEDA R, 1981, P NATL ACAD SCI-BIOL, V78, P5122, DOI 10.1073/pnas.78.8.5122; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WALTER TA, 1989, CANCER GENET CYTOGEN, V43, P15, DOI 10.1016/0165-4608(89)90123-4; YOSHIDA MA, 1986, CANCER RES, V46, P2139; Zbar B, 1989, Important Adv Oncol, P41; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	54	20	20	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1991	6	11					2105	2111						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945415				2022-12-28	WOS:A1991GX11900022
J	QURESHI, SA; JOSEPH, CK; RIM, MH; MARONEY, A; FOSTER, DA				QURESHI, SA; JOSEPH, CK; RIM, MH; MARONEY, A; FOSTER, DA			V-SRC ACTIVATES BOTH PROTEIN-KINASE C-DEPENDENT AND INDEPENDENT SIGNALING PATHWAYS IN MURINE FIBROBLASTS	ONCOGENE			English	Article							3T3 CELLS; GROWTH-FACTORS; PHOSPHATIDYLINOSITOL KINASE; TRANSFORMED FIBROBLASTS; MAMMALIAN-CELLS; GENE; DNA; EXPRESSION; BINDING; PHOSPHORYLATION	Activating the protein-tyrosine kinase activity of v-Src rapidly induced expression of the two 'primary response' genes, TIS10 and Egr-1, in Balb/c 3T3 cells. Depleting cells of protein kinase C (PKC) by prolonged exposure to 12-O-tetradecanoylphorbol 13-acetate (TPA), blocked v-Src-induced TIS10 expression, but had no effect on v-Src-induced Egr-1 gene expression. in addition, the induction of TIS10 and Egr-1 by v-Src could be distinguished using protein kinase inhibitors. Thus, v-Src induced gene expression in murine fibroblasts via two distinguishable signaling pathways: one dependent upon PKC and another that is independent of PKC. Consistent with the use of PKC-mediated signaling pathway by v-Src in murine fibroblasts, we found that activating the kinase activity of v-Src led to increased phosphorylation of a major PKC substrate. Thus, data presented here suggest that v-Src-induced transformation involves the activation of multiple signalling pathways, one of which requires PKC.	CUNY HUNTER COLL,INST BIOMOLEC STRUCT,695 PK AVE,NEW YORK,NY 10021; CUNY HUNTER COLL,DEPT BIOL SCI,NEW YORK,NY 10021; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,DEPT MICROBIOL,PHILADELPHIA,PA 19104	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY); Howard Hughes Medical Institute; University of Pennsylvania	FOSTER, DA (corresponding author), CUNY HUNTER COLL,INST BIOMOLEC STRUCT,695 PK AVE,NEW YORK,NY 10021, USA.				NCI NIH HHS [CA4667] Funding Source: Medline; NCRR NIH HHS [RRO-3037-03] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; Battey, 1986, BASIC METHODS MOL BI; BUTLERGRALLA E, 1981, J CELL PHYSIOL, V107, P59, DOI 10.1002/jcp.1041070108; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; DRUCKER BJ, 1989, NEW ENGL J MED, V321, P1383; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRAY GM, 1988, J BIOL CHEM, V263, P10714; HALSEY DL, 1986, J BIOL CHEM, V261, P2234; HAN JW, 1990, ONCOGENE, V5, P467; HATCH CL, 1987, ANAL BIOCHEM, V162, P283, DOI 10.1016/0003-2697(87)90038-8; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEMAIRE P, 1990, MOL CELL BIOL, V10, P3456, DOI 10.1128/MCB.10.7.3456; LIM RW, 1987, ONCOGENE, V1, P263; LOOMIS CR, 1988, J BIOL CHEM, V263, P1682; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NORI M, 1990, MOL CELL BIOL, V10, P4155, DOI 10.1128/MCB.10.8.4155; QURESHI SA, 1991, MOL CELL BIOL, V11, P102, DOI 10.1128/MCB.11.1.102; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROSEN A, 1989, J BIOL CHEM, V264, P9118; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPANGLER R, 1989, P NATL ACAD SCI USA, V86, P7017, DOI 10.1073/pnas.86.18.7017; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546	41	61	65	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					995	999						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067850				2022-12-28	WOS:A1991GU62200014
J	KERKHOFF, E; BISTER, K				KERKHOFF, E; BISTER, K			MYC PROTEIN-STRUCTURE - LOCALIZATION OF DNA-BINDING AND PROTEIN DIMERIZATION DOMAINS	ONCOGENE			English	Article							AVIAN MYELOCYTOMATOSIS VIRUS; NUCLEOTIDE-SEQUENCE; CARBOXY TERMINUS; GENE; MC29; TRANSFORMATION; MUTANTS; REGION; FIBROBLASTS; DELETION	Wildtype and mutant v-Myc proteins were overexpressed in Escherichia coli using the T7 RNA polymerase system, and the in vitro DNA-binding activities of partially or highly purified proteins were analysed by native DNA-cellulose chromatography. For the construction of the expression plasmids, cloned proviral DNA from wildtype MC29 or from its spontaneous deletion mutant Q10C was used, the latter lacking internal v-myc sequences. Both the wildtype (p59) and the mutant (p42) recombinant protein contain at their amino termini 12 amino acids encoded by the vector, followed by 11 gag amino acids and 9 amino acids encoded by v-myc sequences derived from noncoding c-myc sequences. In addition, p59 contains 416 amino acids encoded by v-myc sequences derived from the complete chicken c-myc coding region, whereas p42 lacks 120 amino acids from the central region of the Myc protein including the highly acidic domain. Two additional proteins were engineered which contain the first 309 (p53) or the last 107 (p16) amino acids, respectively, of the Myc protein sequence in addition to vector-encoded amino acids. The p16 protein represents the carboxyl terminus of the Myc protein sequence containing both a muscle determination gene (MyoD1) homology region, including a basic motif and an amphipathic helix-loop-helix motif, and a leucine heptad repeat. All proteins, except p53 which lacks the carboxyl-terminal Myc protein sequences, bound to native DNA-cellulose and were eluted with 200-500 mM NaCl. Based on the DNA-binding activities of recombinant or spontaneous mutant v-Myc proteins extracted from bacterial or from transformed avian cells, we conclude that the DNA-binding domain of avian Myc proteins is confined within the last 86 carboxyl-terminal amino acids. The same region is also shown to be necessary and sufficient for Myc protein dimerization. This 86-amino acid region essentially encompasses a putative basic DNA contact surface and a tandem array of two presumed protein dimerization motifs, helix-loop-helix and leucine repeat.	UNIV COLOGNE,FAK MED,INST BIOCHEM,W-5000 COLOGNE 41,GERMANY	University of Cologne			Bister, Klaus/AFA-9400-2022	Bister, Klaus/0000-0001-6545-5653				ABEL T, 1989, NATURE, V341, P24, DOI 10.1038/341024a0; ALBIGES-RIZO C, 1990, J MOL BIOL, V212, P247, DOI 10.1016/0022-2836(90)90121-2; BADER JP, 1985, J VIROL, V53, P509, DOI 10.1128/JVI.53.2.509-514.1985; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BIEGALKE BJ, 1987, J VIROL, V61, P2138, DOI 10.1128/JVI.61.7.2138-2142.1987; BISTER K, 1986, ADV CANCER RES, V47, P99, DOI 10.1016/S0065-230X(08)60199-2; BISTER K, 1977, VIROLOGY, V82, P431, DOI 10.1016/0042-6822(77)90017-4; BISTER K, 1982, J VIROL, V41, P754, DOI 10.1128/JVI.41.3.754-766.1982; BISTER K, 1987, ONCOGENE, V1, P97; BOS TJ, 1989, ONCOGENE, V4, P123; CROUCH DH, 1990, ONCOGENE, V5, P683; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DANG CV, 1989, MOL CELL BIOL, V9, P2477, DOI 10.1128/MCB.9.6.2477; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; ENRIETTO PJ, 1983, VIROLOGY, V124, P164, DOI 10.1016/0042-6822(83)90300-8; ENRIETTO PJ, 1989, VIROLOGY, V168, P256, DOI 10.1016/0042-6822(89)90265-1; HEANEY ML, 1986, J VIROL, V60, P167, DOI 10.1128/JVI.60.1.167-176.1986; HERMANN R, 1981, BIOCHEMISTRY-US, V20, P5195, DOI 10.1021/bi00521a015; JANSEN HW, 1983, J VIROL, V48, P61, DOI 10.1128/JVI.48.1.61-73.1983; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; PATSCHINSKY T, 1986, J VIROL, V59, P341, DOI 10.1128/JVI.59.2.341-353.1986; PATSCHINSKY T, 1984, VIROLOGY, V136, P348, DOI 10.1016/0042-6822(84)90171-5; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P2500, DOI 10.1073/pnas.80.9.2500; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vogt P K, 1990, Semin Cancer Biol, V1, P27; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WALTHER N, 1986, VIROLOGY, V154, P219, DOI 10.1016/0042-6822(86)90444-7; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448	39	30	32	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					93	102						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992448				2022-12-28	WOS:A1991EY03900013
J	EICK, D; POLACK, A; KOFLER, E; LENOIR, GM; RICKINSON, AB; BORNKAMM, GW				EICK, D; POLACK, A; KOFLER, E; LENOIR, GM; RICKINSON, AB; BORNKAMM, GW			EXPRESSION OF P0- AND P3-RNA FROM THE NORMAL AND TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA CELLS	ONCOGENE			English	Article									INST MED MIKROBIOL & HYG,VIROL ABT,W-7800 FREIBURG,GERMANY; CTR INT RECH CANC,F-69372 LYONS 08,FRANCE; UNIV BIRMINGHAM,CTR CANC STUDIES,CANC RES CAMPAIGN LABS,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND	World Health Organization; International Agency for Research on Cancer (IARC); University of Birmingham	EICK, D (corresponding author), GESELL STRAHLEN & UMWELTFORSCH MBH,INST KLIN MOLEK BIOL & TUMORGENET,MARCHIONINISTR 25,W-8000 MUNICH 70,GERMANY.							ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BORNKAMM GW, 1988, CELLULAR ONCOGENE AC, P223; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; EICK D, 1989, EMBO J, V8, P1965, DOI 10.1002/j.1460-2075.1989.tb03602.x; EICK D, 1985, EMBO J, V4, P3717, DOI 10.1002/j.1460-2075.1985.tb04140.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GAZIN C, 1986, EMBO J, V5, P2241, DOI 10.1002/j.1460-2075.1986.tb04491.x; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LENOIR GM, 1985, IARC SCI PUBL, V60, P309; Maniatis T., 1982, MOL CLONING; NISHIKURA K, 1987, J MOL BIOL, V193, P497, DOI 10.1016/0022-2836(87)90262-2; NISHIKURA K, 1983, P NATL ACAD SCI-BIOL, V80, P4822, DOI 10.1073/pnas.80.15.4822; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RAY D, 1987, MOL CELL BIOL, V7, P940, DOI 10.1128/MCB.7.2.940; RAY D, 1989, ONCOGENE RES, V5, P73; ROONEY CM, 1986, J NATL CANCER I, V77, P681, DOI 10.1093/jnci/77.3.681; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7	29	33	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1397	1402						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216463				2022-12-28	WOS:A1990EC24100018
J	HORI, Y; KAIBUCHI, K; FUKUMOTO, Y; OKU, N; TAKAI, Y				HORI, Y; KAIBUCHI, K; FUKUMOTO, Y; OKU, N; TAKAI, Y			ACTIVATION OF THE SERUM-RESPONSE AND TPA-RESPONSE ELEMENTS BY EXPRESSION OF THE V-ABL PROTEIN - COMPARISON OF THE MODE OF ACTION OF THE V-ABL PROTEIN WITH THOSE OF PROTEIN-KINASE-C, CYCLIC AMP-DEPENDENT PROTEIN-KINASE, AND THE ACTIVATED C-RAF PROTEIN	ONCOGENE			English	Article									KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN	Kobe University					NATIONAL CANCER INSTITUTE [R01CA014054] Funding Source: NIH RePORTER; NCI NIH HHS [5RO1CA14054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COOK WD, 1987, MOL CELL BIOL, V7, P2631, DOI 10.1128/MCB.7.7.2631; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DAVIS RL, 1985, MOL CELL BIOL, V5, P204, DOI 10.1128/MCB.5.1.204; DESCHAMPS J, 1985, SCIENCE, V230, P1174, DOI 10.1126/science.3865371; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; FUJII M, 1989, MOL CELL BIOL, V9, P2493, DOI 10.1128/MCB.9.6.2493; FUKUMOTO Y, 1990, J BIOL CHEM, V265, P774; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HUNTER T, 1984, NATURE, V311, P414, DOI 10.1038/311414a0; JAKEN S, 1981, CANCER RES, V41, P2175; KAIBUCHI K, 1989, J BIOL CHEM, V264, P20855; KAIBUCHI K, 1986, J BIOL CHEM, V261, P1187; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MITSUNOBU F, 1989, ONCOGENE, V4, P437; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MURAMATSU MA, 1989, MOL CELL BIOL, V9, P831, DOI 10.1128/MCB.9.2.831; OLIFF A, 1985, P NATL ACAD SCI USA, V82, P3306, DOI 10.1073/pnas.82.10.3306; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P3623, DOI 10.1073/pnas.80.12.3623; REESJONES RW, 1989, MOL CELL BIOL, V9, P278, DOI 10.1128/MCB.9.1.278; ROHRSCHNEIDER LR, 1984, J VIROL, V551, P547; ROSENBERG N, 1975, P NATL ACAD SCI USA, V72, P1932, DOI 10.1073/pnas.72.5.1932; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHER CD, 1975, NATURE, V253, P729, DOI 10.1038/253729a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SRINIVASAN A, 1981, P NATL ACAD SCI-BIOL, V78, P2077, DOI 10.1073/pnas.78.4.2077; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; TSUDA T, 1986, FEBS LETT, V208, P39, DOI 10.1016/0014-5793(86)81527-7; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; Wang J Y, 1983, Prog Clin Biol Res, V119, P57; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YAMAMOTO KK, 1988, NATURE, V334, P4914	50	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1201	1206						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2118245				2022-12-28	WOS:A1990DX36100013
J	SISTONEN, L; KOSKINEN, PJ; LEHVASLAIHO, H; LEHTOLA, L; BRAVO, R; ALITALO, K				SISTONEN, L; KOSKINEN, PJ; LEHVASLAIHO, H; LEHTOLA, L; BRAVO, R; ALITALO, K			DOWN-REGULATION OF THE EARLY GENOMIC GROWTH-FACTOR RESPONSE IN NEU ONCOGENE-TRANSFORMED CELLS	ONCOGENE			English	Article									UNIV HELSINKI, DEPT VIROL, CANC BIOL LAB, HAARTMANINK 3, SF-00290 HELSINKI 29, FINLAND; UNIV HELSINKI, DEPT PATHOL, CANC BIOL LAB, SF-00290 HELSINKI, FINLAND; SQUIBB INST MED RES, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA	University of Helsinki; University of Helsinki			Alitalo, Kari K/J-5013-2014; Koskinen, Päivi J/G-8939-2014	Alitalo, Kari K/0000-0002-7331-0902; Sistonen, Lea/0000-0003-1341-2867				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; BRAVO R, 1990, IN PRESS GROWTH FACT; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; KOSKINEN P, 1990, ONCOGENE, V5, P615; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lehtola L, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000256; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LEHVASLAIHO H, 1990, J CELL BIOCHEM, V42, P123, DOI 10.1002/jcb.240420303; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIN AH, 1988, MOL CELL BIOL, V8, P5052, DOI 10.1128/MCB.8.11.5052; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NESTOR JJ, 1985, BIOCHEM BIOPH RES CO, V129, P226, DOI 10.1016/0006-291X(85)91426-3; PANDIELLA A, 1989, ONCOGENE, V4, P1299; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; RUSSELL WC, 1975, NATURE, V253, P461, DOI 10.1038/253461a0; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; SISTONEN L, 1989, J CELL BIOL, V109, P1911, DOI 10.1083/jcb.109.5.1911; SISTONEN L, 1989, EMBO J, V8, P815, DOI 10.1002/j.1460-2075.1989.tb03442.x; SISTONEN L, 1987, EXP CELL RES, V168, P518, DOI 10.1016/0014-4827(87)90024-3; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YARDEN Y, 1989, P NATL ACAD SCI USA, V86, P3179, DOI 10.1073/pnas.86.9.3179; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	44	10	10	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					815	821						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	1972791				2022-12-28	WOS:A1990DP55300006
J	AGHIB, DF; BISHOP, JM; OTTOLENGHI, S; GUERRASIO, A; SERRA, A; SAGLIO, G				AGHIB, DF; BISHOP, JM; OTTOLENGHI, S; GUERRASIO, A; SERRA, A; SAGLIO, G			A 3' TRUNCATION OF MYC CAUSED BY CHROMOSOMAL TRANSLOCATION IN A HUMAN T-CELL LEUKEMIA INCREASES MESSENGER-RNA STABILITY	ONCOGENE			English	Article									UNIV MILAN, DIPARTIMENTO GENET BIOL MICROORGANISMI, I-20133 MILAN, ITALY; DIPARTIMENTO SCI BIOMED & ONCOL UMANA, I-10126 TURIN, ITALY; CTR STUDIO PATOL CELLULARE, I-20133 MILAN, ITALY; UNIV TURIN, IST MICROBIOL, I-10126 TURIN, ITALY	University of Milan; University of Turin				Saglio, Giuseppe/0000-0002-1046-3514				AGHIB D, 1987, ANN NY ACAD SCI, V511, P338, DOI 10.1111/j.1749-6632.1987.tb36262.x; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHEN SJ, 1989, NUCLEIC ACIDS RES, V17, P7631, DOI 10.1093/nar/17.19.7631; COLE MD, 1985, NATURE, V318, P510, DOI 10.1038/318510a0; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CROCE CM, 1985, BLOOD, V65, P1; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; ERIKSON J, 1986, SCIENCE, V232, P884, DOI 10.1126/science.3486470; FINGER LR, 1986, SCIENCE, V234, P982, DOI 10.1126/science.3490692; FINGER LR, 1988, P NATL ACAD SCI USA, V85, P9158, DOI 10.1073/pnas.85.23.9158; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; HOLLIS GF, 1988, MOL CELL BIOL, V8, P124, DOI 10.1128/MCB.8.1.124; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; Maxam A M, 1980, Methods Enzymol, V65, P499; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; SAGLIO G, 1986, CANCER RES, V46, P1413; SAITO H, 1983, P NATL ACAD SCI-BIOL, V80, P7476, DOI 10.1073/pnas.80.24.7476; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	26	66	66	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1990	5	5					707	711						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189107				2022-12-28	WOS:A1990DG37400011
J	SCHUURING, E; VANDERLEEDE, BJ; WILLEMS, R; DAAMS, H; VANDERVALK, M; VANDEVIJVER, M; VANLEEUWEN, F; SONNENBERG, A; NUSSE, R				SCHUURING, E; VANDERLEEDE, BJ; WILLEMS, R; DAAMS, H; VANDERVALK, M; VANDEVIJVER, M; VANLEEUWEN, F; SONNENBERG, A; NUSSE, R			DIFFERENTIATION-DEPENDENT EXPRESSION OF PROVIRUS-ACTIVATED INT-1 ONCOGENE IN CLONAL CELL-LINES DERIVED FROM A MOUSE MAMMARY-TUMOR	ONCOGENE			English	Article									NETHERLANDS CANC INST,ANTONI VANLEEUWENHOEKHUIS,DIV MOLEC BIOL,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,ANTONIO VANLEEUWENHOEKHUIS,DEPT TUMOR BIOL,1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,ANTONIO VANLEEUWENHOEKHUIS,DEPT MOLEC GENET,1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute			van Leeuwen, Frank/AAQ-6799-2020; Willems, Rob JL/E-3681-2010	van Leeuwen, Frank/0000-0003-1107-6513; Willems, Rob JL/0000-0002-7370-0812				BENNETT DC, 1978, CELL, V15, P283, DOI 10.1016/0092-8674(78)90104-6; BROWN AMC, 1987, MOL CELL BIOL, V7, P3971, DOI 10.1128/MCB.7.11.3971; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; DEXTER DL, 1978, CANCER RES, V38, P3174; DULBECCO R, 1981, P NATL ACAD SCI-BIOL, V78, P2345, DOI 10.1073/pnas.78.4.2345; DUNNINGTON DJ, 1983, J NATL CANCER I, V71, P1227; FUNG YKT, 1985, MOL CELL BIOL, V5, P3337, DOI 10.1128/MCB.5.12.3337; HAGER JC, 1981, CANCER RES, V41, P1720; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; Maniatis T., 1982, MOL CLONING; NUSSE R, 1986, TRENDS GENET, V2, P244, DOI 10.1016/0168-9525(86)90247-7; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; PAPKOFF J, 1989, MOL CELL BIOL, V9, P3377, DOI 10.1128/MCB.9.8.3377; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; PARRY G, 1987, J CELL BIOL, V105, P2043, DOI 10.1083/jcb.105.5.2043; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; RIJSEWIJK FAM, 1986, NUCLEIC ACIDS RES, V14, P693, DOI 10.1093/nar/14.2.693; ROOP DR, 1985, ANN NY ACAD SCI, V455, P426, DOI 10.1111/j.1749-6632.1985.tb50426.x; ROSS SR, 1985, P NATL ACAD SCI USA, V82, P5880, DOI 10.1073/pnas.82.17.5880; RUDLAND PS, 1980, CONTROL MECHANISMS A, P341; SCHUURING E, 1989, MOL CELL BIOL, V9, P1357, DOI 10.1128/MCB.9.3.1357; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SONNENBERG A, 1986, J HISTOCHEM CYTOCHEM, V34, P1037, DOI 10.1177/34.8.2426332; SONNENBERG A, 1987, EMBO J, V6, P121, DOI 10.1002/j.1460-2075.1987.tb04728.x; SONNENBERG A, 1986, CANCER RES, V46, P5913; SOULE HD, 1981, CANCER RES, V41, P1154; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANOOYEN A, 1984, CELL, V39, P233, DOI 10.1016/0092-8674(84)90209-5; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; YANG J, 1983, INT REV CYTOL, V81, P249, DOI 10.1016/S0074-7696(08)62340-2	33	11	11	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					459	465						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2326076				2022-12-28	WOS:A1990DB85300002
J	LACROIX, H; IGLEHART, JD; SKINNER, MA; KRAUS, MH				LACROIX, H; IGLEHART, JD; SKINNER, MA; KRAUS, MH			OVEREXPRESSION OF ERBB-2 OR EGF RECEPTOR PROTEINS PRESENT IN EARLY STAGE MAMMARY-CARCINOMA IS DETECTED SIMULTANEOUSLY IN MATCHED PRIMARY TUMORS AND REGIONAL METASTASES	ONCOGENE			English	Article									NCI,BIOL ANIM LAB,BETHESDA,MD 20205; DUKE UNIV,DEPT SURG,DURHAM,NC 27706	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University					NCI NIH HHS [CA40640] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040640] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1988, SCIENCE, V240, P1795, DOI 10.1126/science.3289120; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BERGER MS, 1988, CANCER RES, V48, P1238; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; CLINE MJ, 1987, J CLIN ONCOL, V5, P999, DOI 10.1200/JCO.1987.5.7.999; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEGATTO O, 1988, IN PRESS MOL CELL BI; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1988, SCIENCE, V240, P1796, DOI 10.1126/science.240.4860.1796; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VARLEY JM, 1987, ONCOGENE, V1, P423; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WRANN MM, 1979, J BIOL CHEM, V254, P8083; XU YH, 1984, NATURE, V309, P806, DOI 10.1038/309806a0; YAMAMOTO T, 1986, CANCER RES, V46, P414; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YOKOTA J, 1986, LANCET, V1, P765; ZHOU DJ, 1987, CANCER RES, V47, P6123	34	187	192	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					145	151						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2564657				2022-12-28	WOS:A1989U567500004
J	VOUSDEN, KH; JAT, PS				VOUSDEN, KH; JAT, PS			FUNCTIONAL SIMILARITY BETWEEN HPV16 E7, SV40 LARGE T AND ADENOVIRUS E1A PROTEINS	ONCOGENE			English	Article											VOUSDEN, KH (corresponding author), ST MARYS HOSP,SCH MED,LUDWIG INST CANC RES,NORFOLK PL,LONDON W2 1PG,ENGLAND.							ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DOEBERITZ MV, 1988, CANCER RES, V8, P3780; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; GISSMANN L, 1987, CANCER CELL, V5, P275; KANDA T, 1988, J VIROL, V62, P610, DOI 10.1128/JVI.62.2.610-613.1988; KANDA T, 1988, VIROLOGY, V165, P321, DOI 10.1016/0042-6822(88)90694-0; KNUDSON AG, 1987, ADV VIRAL ONCOL, V7, P1; LINZER DIH, 1988, TRENDS GENET, V4, P245, DOI 10.1016/0168-9525(88)90029-7; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; RILEY TEW, 1988, THESIS CAMBRIDGE UK; ROBERTS RJ, 1987, NUCLEIC ACIDS RES, V15, pR189, DOI 10.1093/nar/15.suppl.r189; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; SUGDEN B, 1985, MOL CELL BIOL, V5, P410, DOI 10.1128/MCB.5.2.410; TEGTMEYER P, 1975, J VIROL, V15, P613, DOI 10.1128/JVI.15.3.613-618.1975; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373	24	73	77	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					153	158						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2538790				2022-12-28	WOS:A1989U567500005
J	GALLAND, F; PIRISI, V; DELAPEYRIERE, O; BIRNBAUM, D				GALLAND, F; PIRISI, V; DELAPEYRIERE, O; BIRNBAUM, D			RESTRICTION AND COMPLEXITY OF MCF2 PROTOONCOGENE EXPRESSION	ONCOGENE			English	Article							B-CELL LYMPHOMA; TRANSFORMING SEQUENCE; TRANSCRIPT FERT; DBL-ONCOGENE; X-CHROMOSOME; GERM-CELLS; GENE; SPERMATOGENESIS; DELETION; PRODUCT	MCF2/DBL is an X-linked proto-oncogene encoding a protein with a yet undetermined function. It can be activated in vitro by loss of 5' sequences in NIH3T3 bioassays; in vivo, deletion of the gene has been found in some hemophilia B patients. PCR analysis of its expression in mouse tissues shows a restriction to the gonads and tissues of neuroectodermal origin. It also identifies an exon encoding 42 amino acids that is alternatively spliced in murine, but not human testis.	INSERM,U119,27 BD LEI ROURE,F-13009 MARSEILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	BIRNBAUM, D (corresponding author), INSERM,U119,27 BD LEI ROURE,F-13009 MARSEILLE,FRANCE.							ANSON DS, 1988, EMBO J, V7, P2795, DOI 10.1002/j.1460-2075.1988.tb03134.x; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1987, ONCOGENE, V1, P355; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; FASSANO O, 1984, MOL CELL BIOL, V4, P1695; FISCHMAN K, 1990, MOL CELL BIOL, V10, P146, DOI 10.1128/MCB.10.1.146; GALLAND F, BIOCHIMIE, V72, P759; GRANT SG, 1990, CYTOGENET CELL GENET, V54, P175, DOI 10.1159/000132988; GRAZIANI G, 1989, ONCOGENE, V4, P823; KESHET E, 1990, MOL CELL BIOL, V10, P5021, DOI 10.1128/MCB.10.9.5021; LETWIN K, 1988, ONCOGENE, V3, P621; MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261; MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041; NGUYEN C, 1987, EMBO J, V6, P3285, DOI 10.1002/j.1460-2075.1987.tb02647.x; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; NOGUCHI T, 1988, ONCOGENE, V3, P709; PROPST F, 1988, ONCOGENE, V2, P227; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1989, ONCOGENE, V4, P1067; SCHLESSINGER D, 1990, TRENDS GENET, V6, P248, DOI 10.1016/0168-9525(90)90207-M; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SORRENTINO V, 1988, P NATL ACAD SCI USA, V85, P2191, DOI 10.1073/pnas.85.7.2191; SRIVASTAVA SK, 1986, P NATL ACAD SCI USA, V83, P8868, DOI 10.1073/pnas.83.23.8868; VECCHIO G, 1989, ONCOGENE, V4, P897; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907	27	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					833	839						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052360				2022-12-28	WOS:A1991GT82500020
J	KATO, JY; SHERR, CJ				KATO, JY; SHERR, CJ			A DOMINANT SUPPRESSIVE MUTATION IN A CELLULAR GENE RESTORES THE NONTRANSFORMED PHENOTYPE TO V-FMS-TRANSFORMED MINK CELLS	ONCOGENE			English	Article							FELINE SARCOMA-VIRUS; STIMULATING FACTOR-I; PROTO-ONCOGENE PRODUCT; VIRAL ONCOGENE; FLAT REVERTANTS; KINASE-ACTIVITY; GROWTH-FACTOR; WILD-TYPE; RAS; INHIBITION	A nontransformed revertant subclone (GVR17) was isolated from mutagen-treated populations of mink epithelial cells which had been transformed by the Susan McDonough strain of feline sarcoma virus (SM-FeSV). The revertant cells, although contact-inhibited for growth and unable to form colonies in semisolid medium, contained two copies of integrated SM-FeSV proviral DNA, expressed high levels of the v-fms oncogene product and its associated tyrosine kinase activity, and yielded rescuable viruses able to transform parental mink epithelial and mouse NIH3T3 cells. The transformed phenotype was suppressed in cell hybrids generated by fusing revertant and v-fms-transformed mink cells, indicating that GVR17 cells harbored a dominant cellular mutation that inhibited transformation by the v-fms oncogene. The revertant cells were refractory to retransformation by retroviruses containing v-fms or v-abl oncogenes, but could be transformed by v-ras-, v-raf-, and v-fes- containing retroviruses. Thus, the suppressing activity in GVR17 cells discriminates between transforming signals mediated by different tyrosine kinases and fails to block the transforming activity of two oncoproteins exhibiting either GTP-binding or serine/threonine kinase activity.	ST JUDE CHILDRENS RES HOSP, HOWARD HUGHES MED INST, DEPT TUMOR CELL BIOL, 332 N LAUDERDALE, MEMPHIS, TN 38105 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT BIOCHEM, MEMPHIS, TN 38163 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	SHERR, CJ (corresponding author), ST JUDE CHILDRENS RES HOSP, HOWARD HUGHES MED INST, DEPT TUMOR CELL BIOL, 332 N LAUDERDALE, MEMPHIS, TN 38105 USA.		Sherr, Charles J/N-8074-2018	Sherr, Charles J/0000-0002-5516-6206	NCI NIH HHS [CA21765] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON SJ, 1984, J VIROL, V51, P730, DOI 10.1128/JVI.51.3.730-741.1984; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHATTOPADHYAY SK, 1981, J VIROL, V39, P777, DOI 10.1128/JVI.39.3.777-791.1981; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; CRAIG RW, 1985, P NATL ACAD SCI USA, V82, P2062, DOI 10.1073/pnas.82.7.2062; DEPPERT W, 1986, MOL CELL BIOL, V6, P2233, DOI 10.1128/MCB.6.6.2233; DONNER L, 1980, J VIROL, V35, P129, DOI 10.1128/JVI.35.1.129-140.1980; DONNER L, 1982, J VIROL, V41, P489, DOI 10.1128/JVI.41.2.489-500.1982; DOWNING JR, 1988, MOL CELL BIOL, V8, P1795, DOI 10.1128/MCB.8.4.1795; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FRANKEL AE, 1979, J VIROL, V30, P821, DOI 10.1128/JVI.30.3.821-827.1979; Frech M, 1990, SCIENCE, V249, P169, DOI 10.1126/science.2164710; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GLASS DJ, 1990, ONCOGENE RES, V5, P175; HAYNES JR, 1988, MOL CELL BIOL, V8, P2419, DOI 10.1128/MCB.8.6.2419; HENDERSON IC, 1974, VIROLOGY, V60, P282, DOI 10.1016/0042-6822(74)90386-9; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; INOUE H, 1983, VIROLOGY, V125, P242, DOI 10.1016/0042-6822(83)90078-8; JACKOWSKI S, 1990, J BIOL CHEM, V265, P6611; JOHNSON LV, 1982, CELL, V28, P7, DOI 10.1016/0092-8674(82)90369-5; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; NORTON JD, 1984, J VIROL, V50, P439, DOI 10.1128/JVI.50.2.439-444.1984; RAPP UR, 1983, J VIROL, V45, P914, DOI 10.1128/JVI.45.3.914-924.1983; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; ROBBINS PD, 1990, NATURE, V346, P668, DOI 10.1038/346668a0; ROTTER V, 1983, EMBO J, V2, P1041, DOI 10.1002/j.1460-2075.1983.tb01543.x; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; ROUSSEL MF, 1984, MOL CELL BIOL, V4, P1999, DOI 10.1128/MCB.4.10.1999; RUSCETTI SK, 1980, J VIROL, V35, P259, DOI 10.1128/JVI.35.1.259-264.1980; SAMID D, 1987, MOL CELL BIOL, V7, P2196, DOI 10.1128/MCB.7.6.2196; SCHAEFER R, 1988, P NATL ACAD SCI USA, V85, P1590, DOI 10.1073/pnas.85.5.1590; SHERR CJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P225, DOI 10.1016/0304-419X(88)90011-X; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHERR CJ, 1979, J VIROL, V32, P860, DOI 10.1128/JVI.32.3.860-875.1979; SHERR CJ, IN PRESS ORIGINS HUM; SHURTLEFF SA, 1990, EMBO J, V9, P2415, DOI 10.1002/j.1460-2075.1990.tb07417.x; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; VAIRO G, 1990, J BIOL CHEM, V265, P2692; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; YANAGIHARA K, 1990, ONCOGENE, V5, P1179; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	51	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					687	693						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052353				2022-12-28	WOS:A1991GT82500002
J	WRIGHT, PA; WILLIAMS, ED; LEMOINE, NR; WYNFORDTHOMAS, D				WRIGHT, PA; WILLIAMS, ED; LEMOINE, NR; WYNFORDTHOMAS, D			RADIATION-ASSOCIATED AND SPONTANEOUS HUMAN THYROID CARCINOMAS SHOW A DIFFERENT PATTERN OF RAS ONCOGENE MUTATION	ONCOGENE			English	Note							ENZYMATIC AMPLIFICATION; ACTIVATION; TUMORS	Activated ras oncogenes in experimentally induced rodent tumours have been demonstrated to show specific patterns of oncogene activation which depend on the inducing agent, with H-ras activation in nitrosomethylurea (NMU) induced tumours, and K-ras activation in tumours induced by ionising radiation. We report a study of 12 radiation-associated human thyroid tumours, using polymerase chain reaction (PCR) amplification of paraffin-embedded material and allele-specific hybridisation with mutant-specific probes for the 3 ras oncogenes. Compared to 68 'spontaneous' human thyroid tumours, the radiation-associated cases show the same overall prevalence of ras mutation. However there is a significantly higher rate of K-ras mutation in radiation-associated follicular carcinomas than in 'spontaneous' follicular carcinomas (60% compared to 6%, P < 0.05), suggesting that radiation may preferentially activate k-ras in human as well as rodent tumours.			WRIGHT, PA (corresponding author), UNIV COLL CARDIFF,DEPT PATHOL,THYROID TUMOUR BIOL RES GRP,CANC RES CAMPAIGN,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.							DONIACH I, 1958, BRIT MED BULL, V14, P181, DOI 10.1093/oxfordjournals.bmb.a069666; DUFFY BJ, 1950, J CLIN ENDOCRINOL, V10, P1296, DOI 10.1210/jcem-10-10-1296; GUERRERO I, 1984, P NATL ACAD SCI-BIOL, V81, P202, DOI 10.1073/pnas.81.1.202; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; LEMOINE NR, 1988, ONCOGENE, V3, P541; NODA M, 1989, P NATL ACAD SCI USA, V86, P162, DOI 10.1073/pnas.86.1.162; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAWEY MJ, 1987, MOL CELL BIOL, V7, P932, DOI 10.1128/MCB.7.2.932	8	75	76	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					471	473						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011403				2022-12-28	WOS:A1991FT34400019
J	HAGAG, N; DIAMOND, L; PALERMO, R; LYUBSKY, S				HAGAG, N; DIAMOND, L; PALERMO, R; LYUBSKY, S			HIGH EXPRESSION OF RAS P21 CORRELATES WITH INCREASED RATE OF ABNORMAL MITOSIS IN NIH3T3 CELLS	ONCOGENE			English	Article									SUNY STONY BROOK, HLTH SCI CTR, DEPT PATHOL, STONY BROOK, NY 11794 USA; VET ADM MED CTR, LAB SERV, NORTHPORT, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	HAGAG, N (corresponding author), SUNY STONY BROOK, HLTH SCI CTR, DIV ONCOL, STONY BROOK, NY 11794 USA.							AGRANOFF BW, 1983, J BIOL CHEM, V258, P2076; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BERGER R, 1985, CYTOGENET CELL GENET, V40, P490, DOI 10.1159/000132181; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOURGUIGNON LYW, 1977, P NATL ACAD SCI USA, V74, P5031, DOI 10.1073/pnas.74.11.5031; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; BRINKLEY BR, 1975, P NATL ACAD SCI USA, V72, P4981, DOI 10.1073/pnas.72.12.4981; CHAFOULEAS JG, 1981, P NATL ACAD SCI-BIOL, V78, P996, DOI 10.1073/pnas.78.2.996; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; DELATTRE O, 1989, LANCET, V2, P353; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DURKIN JP, 1986, MOL CELL BIOL, V6, P1386, DOI 10.1128/MCB.6.5.1386; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FERAMISCO JR, 1985, NATURE, V314, P639, DOI 10.1038/314639a0; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FUKUSHIMA S, 1981, AM J PATHOL, V102, P373; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GARBISA S, 1987, CANCER RES, V47, P1523; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HERSTERBERG TW, 1985, CARCINOGENESIS, V6, P473; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; JACOBS JB, 1976, CANCER RES, V36, P2512; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; LACAL JC, 1986, CELL, V44, P609, DOI 10.1016/0092-8674(86)90270-9; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEVINSON AD, 1986, TRENDS GENET, V2, P81, DOI 10.1016/0168-9525(86)90184-8; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; PAWELETZ N, 1988, EUR J CELL BIOL, V47, P334; PIMENTEL E, 1985, CANCER GENET CYTOGEN, V14, P347, DOI 10.1016/0165-4608(85)90201-8; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; RICHARDS GK, 1981, MITOSIS CYTOKINESIS, P103; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; ROVENSKY YA, 1984, INT REV CYTOL, V90, P273, DOI 10.1016/S0074-7696(08)61492-8; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SANDBERG AA, 1980, CHROMOSOMES HUMAN CA, P776; SCOLNICK EM, 1979, P NATL ACAD SCI USA, V76, P5355, DOI 10.1073/pnas.76.10.5355; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SHIH TY, 1982, J VIROL, V42, P253, DOI 10.1128/JVI.42.1.253-261.1982; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; SISKEN JE, 1982, J CELL PHYSIOL, V113, P219, DOI 10.1002/jcp.1041130206; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; TONEGUZZO F, 1986, P NATL ACAD SCI USA, V83, P3496, DOI 10.1073/pnas.83.10.3496; TSUTSUI T, 1983, CANCER RES, V43, P3814; VARMUS HE, 1984, ANNU REV GENET, V18, P553; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575	63	34	34	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1990	5	10					1481	1489						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2174524				2022-12-28	WOS:A1990EK50200006
J	MIGNOTTE, B; LARCHER, JC; ZHENG, DQ; ESNAULT, C; COULAUD, D; FEUNTEUN, J				MIGNOTTE, B; LARCHER, JC; ZHENG, DQ; ESNAULT, C; COULAUD, D; FEUNTEUN, J			SV40 INDUCED CELLULAR IMMORTALIZATION - PHENOTYPIC CHANGES ASSOCIATED WITH THE LOSS OF PROLIFERATIVE CAPACITY IN A CONDITIONALLY IMMORTALIZED CELL-LINE	ONCOGENE			English	Article									INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,F-94805 VILLEJUIF,FRANCE; COLL FRANCE,BIOCHIM CELLULAIRE,F-75231 PARIS,FRANCE; INST GUSTAVE ROUSSY,MICROSCOPIE CELLULAIRE & MOLEC LAB,F-94805 VILLEJUIF,FRANCE; INST GUSTAVE ROUSSY,BIOCHIM & ENZYMOL LAB,F-94805 VILLEJUIF,FRANCE	UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; College de France; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy			Feunteun, Jean/AAZ-1267-2020; Mignotte, Bernard/A-3499-2009	Mignotte, Bernard/0000-0002-8512-8518; Feunteun, Jean/0000-0003-1212-9189				ANDERSON L, 1981, P NATL ACAD SCI-BIOL, V78, P2407, DOI 10.1073/pnas.78.4.2407; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; CORRAL M, 1989, EXP CELL RES, V184, P158, DOI 10.1016/0014-4827(89)90374-1; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; EHRHART JC, 1988, ONCOGENE, V3, P595; ESNAULT C, 1984, CANCER RES, V44, P4355; GLAICHENHAUS N, 1986, EMBO J, V5, P1261, DOI 10.1002/j.1460-2075.1986.tb04355.x; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; JACQUEMINSABLON H, 1990, BIOL CELL, V68, P227, DOI 10.1016/0248-4900(90)90312-Q; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; KAO HT, 1983, MOL CELL BIOL, V3, P2058, DOI 10.1128/MCB.3.11.2058; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LOWE DG, 1986, J BIOL CHEM, V261, P2102; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; MODICANAPOLITANO JS, 1989, CANCER RES, V49, P3369; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; NASS MMK, 1983, EXP CELL RES, V148, P47; OBERLEY LW, 1989, MOL CELL BIOCHEM, V84, P147; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PETIT CA, 1983, VIROLOGY, V127, P74, DOI 10.1016/0042-6822(83)90372-0; RASSOULZADEGAN M, 1983, P NATL ACAD SCI-BIOL, V80, P4354, DOI 10.1073/pnas.80.14.4354; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; SOUSSI T, 1989, J VIROL, V63, P3894, DOI 10.1128/JVI.63.9.3894-3901.1989; TAYLOR ICA, 1989, J BIOL CHEM, V264, P16160; VAYSSIERE JL, 1987, BIOCHEM BIOPH RES CO, V145, P443, DOI 10.1016/0006-291X(87)91341-6; WALDINGER D, 1989, EUR J CELL BIOL, V50, P435; WEINBERG RA, 1989, CANCER RES, V49, P3713; WU BJ, 1986, MOL CELL BIOL, V6, P2994, DOI 10.1128/MCB.6.8.2994; ZUCKERMAN SH, 1984, BIOCHIM BIOPHYS ACTA, V804, P285, DOI 10.1016/0167-4889(84)90131-9	33	16	17	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1529	1533						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2174526				2022-12-28	WOS:A1990EK50200012
J	BOUCHER, P; PRIVALSKY, ML				BOUCHER, P; PRIVALSKY, ML			MAPPING OF FUNCTIONAL DOMAINS WITHIN THE V-ERB A ONCOGENE PROTEIN - THE REMNANTS OF THE HORMONE BINDING DOMAIN PLAY MULTIPLE, VITAL ROLES IN PROTEIN ACTION	ONCOGENE			English	Article											BOUCHER, P (corresponding author), UNIV CALIF DAVIS,DEPT MICROBIOL,DAVIS,CA 95616, USA.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERG JM, 1989, CELL, V57, P1065, DOI 10.1016/0092-8674(89)90042-1; BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; BOUCHER P, 1988, J VIROL, V62, P534, DOI 10.1128/JVI.62.2.534-544.1988; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DANG CV, 1989, J BIOL CHEM, V264, P18019; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; EUL J, 1989, EMBO J, V8, P83, DOI 10.1002/j.1460-2075.1989.tb03351.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FLUG F, 1987, J BIOL CHEM, V262, P6373; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FORREST D, IN PRESS ONCOGENE; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HORROWITZ ZD, 1989, MOL ENDOCRINOL, V3, P148; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAVIN TN, 1988, J BIOL CHEM, V263, P9418; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MEISELD R, 1987, SCIENCE, V263, P423; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NORMAN MF, 1989, J BIOL CHEM, V264, P12063; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHAUER M, 1989, P NATL ACAD SCI USA, V86, P1123, DOI 10.1073/pnas.86.4.1123; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZHENG SY, 1987, J BIOL CHEM, V262, P6313	48	21	21	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1303	1311						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2170895				2022-12-28	WOS:A1990EC24100005
J	STRATTON, MR; MOSS, S; WARREN, W; PATTERSON, H; CLARK, J; FISHER, C; FLETCHER, CDM; BALL, A; THOMAS, M; GUSTERSON, BA; COOPER, CS				STRATTON, MR; MOSS, S; WARREN, W; PATTERSON, H; CLARK, J; FISHER, C; FLETCHER, CDM; BALL, A; THOMAS, M; GUSTERSON, BA; COOPER, CS			MUTATION OF THE P53 GENE IN HUMAN SOFT-TISSUE SARCOMAS - ASSOCIATION WITH ABNORMALITIES OF THE RB1 GENE	ONCOGENE			English	Article									INST CANC RES,CHEM CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST CANC RES,PATHOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; ST THOMAS HOSP,DEPT HISTOPATHOL,LONDON SE1,ENGLAND; ROYAL MARSDEN HOSP,LONDON SW3 6JJ,ENGLAND	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust			gusterson, barry a/D-3752-2009					AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; COOPER CS, 1986, EMBO J, V5, P2623, DOI 10.1002/j.1460-2075.1986.tb04543.x; COOPER CS, 1984, CANCER RES, V44, P1; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GARVIN AJ, 1986, AM J PATHOL, V125, P208; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MACKAY J, 1988, LANCET, V2, P1384; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MUNROE DG, 1988, ONCOGENE, V2, P621; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SOUSSI T, 1987, ONCOGENE, V1, P71; STEFFEN D, 1978, CELL, V15, P1003, DOI 10.1016/0092-8674(78)90284-2; STRATTON MR, 1989, BRIT J CANCER, V60, P202, DOI 10.1038/bjc.1989.251; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	37	218	220	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1297	1301						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216456				2022-12-28	WOS:A1990EC24100004
J	BLASBAND, AJ; GILLIGAN, DM; WINCHELL, LF; WONG, ST; LUETTEKE, NC; ROGERS, KT; LEE, DC				BLASBAND, AJ; GILLIGAN, DM; WINCHELL, LF; WONG, ST; LUETTEKE, NC; ROGERS, KT; LEE, DC			EXPRESSION OF THE TGF-ALPHA INTEGRAL MEMBRANE PRECURSOR INDUCES TRANSFORMATION OF NRK CELLS	ONCOGENE			English	Article									UNIV N CAROLINA,LINEBERGER CANC RES CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NCI NIH HHS [CA43793, CA08542, CA08519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA008519, F32CA008542, R01CA043793] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AUSTIN J, 1989, CELL, V58, P565, DOI 10.1016/0092-8674(89)90437-6; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; BRINGMAN TS, 1987, CELL, V48, P429, DOI 10.1016/0092-8674(87)90194-2; CHE WS, 1989, CELL, V59, P33; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1987, CANCER RES, V47, P707; GENTRY LE, 1987, MOL CELL BIOL, V7, P1585, DOI 10.1128/MCB.7.5.1585; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; GREENWALD I, 1985, CELL, V43, P583, DOI 10.1016/0092-8674(85)90230-2; HAN VKM, 1987, MOL CELL BIOL, V7, P2335, DOI 10.1128/MCB.7.7.2335; IGNOTZ RA, 1986, P NATL ACAD SCI USA, V83, P6307, DOI 10.1073/pnas.83.17.6307; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KOBRIN MS, 1986, J BIOL CHEM, V261, P4414; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; LEE DC, 1985, MOL CELL BIOL, V5, P3644, DOI 10.1128/MCB.5.12.3644; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LUETTEKE NC, 1988, BIOCHEMISTRY-US, V27, P6487, DOI 10.1021/bi00417a043; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MARQUARDT H, 1984, SCIENCE, V223, P1079, DOI 10.1126/science.6320373; MASSAGUE J, 1983, J BIOL CHEM, V258, P3614; MAXFIELD FR, 1979, P NATL ACAD SCI USA, V76, P5731, DOI 10.1073/pnas.76.11.5731; MCCUNE BK, 1989, J BIOL CHEM, V264, P15501; MERCOLA M, 1988, SCIENCE, V241, P1223, DOI 10.1126/science.3413486; PIKE LJ, 1982, J BIOL CHEM, V257, P4628; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; STROOBANT P, 1985, CELL, V42, P383, DOI 10.1016/S0092-8674(85)80133-1; TEIXIDO J, 1987, NATURE, V326, P883, DOI 10.1038/326883a0; TEIXIDO J, 1988, J BIOL CHEM, V263, P3924; TEIXIDO J, 1990, IN PRESS J BIOL CHEM; TODARO GJ, 1976, NATURE, V264, P26, DOI 10.1038/264026a0; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; VALVERIUS EM, 1989, MOL ENDOCRINOL, V3, P203, DOI 10.1210/mend-3-1-203; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILCOX JN, 1988, MOL CELL BIOL, V8, P3415, DOI 10.1128/MCB.8.8.3415; WILCOX JN, 1988, J NEUROSCI, V8, P1901; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	49	34	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1213	1221						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392325				2022-12-28	WOS:A1990DX36100015
J	NICOLSON, GL; GALLICK, GE; DULSKI, KM; SPOHN, WH; LEMBO, TM; TAINSKY, MA				NICOLSON, GL; GALLICK, GE; DULSKI, KM; SPOHN, WH; LEMBO, TM; TAINSKY, MA			LACK OF CORRELATION BETWEEN INTERCELLULAR JUNCTIONAL COMMUNICATION, P21RASEJ EXPRESSION, AND SPONTANEOUS METASTATIC PROPERTIES OF RAT MAMMARY CELLS AFTER TRANSFECTION WITH C-H-RASEJ OR NEO GENES	ONCOGENE			English	Article											NICOLSON, GL (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,BOX 108,1515 HOLCOMBE BLVD,HOUSTON,TX 77030, USA.			Tainsky, Michael/0000-0002-0261-831X	NATIONAL CANCER INSTITUTE [R35CA044352, R01CA048210, R23CA039803] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA48210, R35-CA44352, R23-CA39803] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATKINSON MM, 1986, J MEMBRANE BIOL, V91, P53, DOI 10.1007/BF01870214; AZARNIA R, 1987, MOL CELL BIOL, V7, P946, DOI 10.1128/MCB.7.2.946; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P191, DOI 10.1007/BF01871629; Bennett M. V. L., 1985, GAP JUNCTIONS; BERG P, 1982, MOL APPL GENET, V1, P327; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; CARNEY WP, 1986, J CELL BIOCHEM, V32, P207, DOI 10.1002/jcb.240320307; CHANG CC, 1985, P NATL ACAD SCI USA, V82, P5360, DOI 10.1073/pnas.82.16.5360; DOTTO GP, 1989, ONCOGENE, V4, P637; EAGAN SE, 1987, MOL CELL BIOL, V7, P830; ELFOULY MH, 1987, EXP CELL RES, V168, P422, DOI 10.1016/0014-4827(87)90014-0; ENOMOTO T, 1985, CANCER RES, V45, P2681; ENOMOTO T, 1984, CANCER RES, V44, P5200; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GALLICK GE, 1985, P NATL ACAD SCI USA, V82, P1795, DOI 10.1073/pnas.82.6.1795; GALLICK GE, 1985, J GEN VIROL, V66, P945, DOI 10.1099/0022-1317-66-5-945; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIEG RG, 1985, P NATL ACAD SCI USA, V82, P3698; HAMADA J, 1988, CANCER RES, V48, P5129; HEPPNER GH, 1983, BIOCHIM BIOPHYS ACTA, V695, P215, DOI 10.1016/0304-419X(83)90012-4; HILL SA, 1988, J NATL CANCER I, V80, P484, DOI 10.1093/jnci/80.7.484; KANNO Y, 1985, JPN J PHYSIOL, V35, P693, DOI 10.2170/jjphysiol.35.693; KERBEL RS, 1987, P NATL ACAD SCI USA, V84, P1263, DOI 10.1073/pnas.84.5.1263; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; MACDONALD C, 1985, ESSAYS BIOCHEM, V21, P86; MAREEL MM, 1986, ANTICANCER RES, V6, P419; MUSCHEL RJ, 1985, AM J PATHOL, V121, P1; NERI A, 1982, J NATL CANCER I, V68, P507; NICOLSON GL, 1988, P NATL ACAD SCI USA, V85, P473, DOI 10.1073/pnas.85.2.473; NICOLSON GL, 1984, CANCER METAST REV, V3, P25, DOI 10.1007/BF00047691; NICOLSON GL, 1988, CANCER RES, V48, P399; NICOLSON GL, 1987, CANCER RES, V47, P1473; NICOLSON GL, 1990, IN PRESS CANCER RES; NORTH SM, 1985, BRIT J CANCER, V52, P747, DOI 10.1038/bjc.1985.253; OHUCHI N, 1986, CANCER RES, V46, P2511; PITTS JD, 1986, J CELL SCI S, V4, P239; RUBIN H, 1985, CANCER RES, V45, P2935; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; TROSKO JE, 1983, CANCER INVEST, V1, P511, DOI 10.3109/07357908309020276; VOUSDEN KH, 1986, INT J CANCER, V37, P425, DOI 10.1002/ijc.2910370315; WELCH DR, 1983, INVAS METAST, V3, P65; WELCH DR, 1984, CLIN EXP METASTAS, V2, P333, DOI 10.1007/BF00135172	45	30	30	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					747	753						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189108				2022-12-28	WOS:A1990DG37400016
J	SZENTIRMAY, Z; ISHIZAKA, Y; OHGAKI, H; TAHIRA, T; NAGAO, M; ESUMI, H				SZENTIRMAY, Z; ISHIZAKA, Y; OHGAKI, H; TAHIRA, T; NAGAO, M; ESUMI, H			DEMONSTRATION BY INSITU HYBRIDIZATION OF RET PROTOONCOGENE MESSENGER-RNA IN DEVELOPING PLACENTA DURING MIDTERM OF RAT GESTATION	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV BIOCHEM,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV CARCINOGENESIS,CHUO KU,TOKYO 104,JAPAN	National Cancer Center - Japan; National Cancer Center - Japan								ADAMSON ED, 1981, NATURE, V291, P656, DOI 10.1038/291656a0; ALDEN RH, 1948, AM J ANAT, V83, P143, DOI 10.1002/aja.1000830106; BRESSER J, 1987, GENE ANAL TECH, V4, P89, DOI 10.1016/0735-0651(87)90002-1; CHEGINI N, 1985, J CLIN ENDOCR METAB, V61, P529, DOI 10.1210/jcem-61-3-529; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; GUITTENY AF, 1988, J HISTOCHEM CYTOCHEM, V36, P563, DOI 10.1177/36.6.3259249; Hebei R., 1986, ANATOMY EMBRYOLOGY L, P237; ISHIZAKA Y, 1989, ONCOGENE, V4, P789; ISHIZAKA Y, 1988, ONCOGENE RES, V3, P193; LARGENT BL, 1988, P NATL ACAD SCI USA, V85, P2864, DOI 10.1073/pnas.85.8.2864; LEONG ASY, 1985, J PATHOL, V146, P313, DOI 10.1002/path.1711460404; LEONG ASY, 1988, J PATHOL, V156, P275, DOI 10.1002/path.1711560402; LOGIN GR, 1986, J HISTOCHEM CYTOCHEM, V34, P381, DOI 10.1177/34.3.3950387; MACBRIDE LJ, 1983, TETRAHEDRON LETT, V24, P245; MARTI R, 1987, J HISTOCHEM CYTOCHEM, V35, P1415, DOI 10.1177/35.12.3680934; METZ J, 1980, ANAT EMBRYOL, V159, P289, DOI 10.1007/BF00317652; MULLER R, 1983, NATURE, V304, P454, DOI 10.1038/304454a0; MULLER R, 1983, EMBO J, V2, P679, DOI 10.1002/j.1460-2075.1983.tb01484.x; PFEIFEROHLSSON S, 1984, CELL, V38, P585, DOI 10.1016/0092-8674(84)90513-0; RENTROP M, 1986, HISTOCHEM J, V18, P271, DOI 10.1007/BF01676237; ROSS CA, 1988, P NATL ACAD SCI USA, V85, P9831, DOI 10.1073/pnas.85.24.9831; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; STROMBERG K, 1982, BIOCHEM BIOPH RES CO, V106, P354, DOI 10.1016/0006-291X(82)91117-2; TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8; TAHIRA T, 1990, ONCOGENE, V5, P97; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; UHL GR, 1985, P NATL ACAD SCI USA, V82, P5555, DOI 10.1073/pnas.82.16.5555	31	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					701	705						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189106				2022-12-28	WOS:A1990DG37400010
J	DAHLLOF, B				DAHLLOF, B			DOWN-REGULATION OF MHC CLASS-I ANTIGENS IS NOT A GENERAL MECHANISM FOR THE INCREASED TUMORIGENICITY CAUSED BY C-MYC AMPLIFICATION	ONCOGENE			English	Note											DAHLLOF, B (corresponding author), LUDWIG INST CANC RES,BOX 60202,S-10401 STOCKHOLM,SWEDEN.							BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; DAHLLOF B, 1984, EXP CELL RES, V152, P415, DOI 10.1016/0014-4827(84)90642-6; DOYLE A, 1985, J EXP MED, V161, P1135, DOI 10.1084/jem.161.5.1135; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; MARTINSSON T, 1988, ONCOGENE, V3, P437; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; TANAKA K, 1988, ANNU REV IMMUNOL, V6, P359; VERSTEEG R, 1988, EMBO J, V7, P1023, DOI 10.1002/j.1460-2075.1988.tb02909.x; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	12	7	7	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					433	435						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156210				2022-12-28	WOS:A1990CW41500024
J	KARLIN, S; BRENDEL, V				KARLIN, S; BRENDEL, V			CHARGE CONFIGURATIONS IN ONCOGENE PRODUCTS AND TRANSFORMING PROTEINS	ONCOGENE			English	Article											KARLIN, S (corresponding author), STANFORD UNIV,DEPT MATH,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM10452-26, GM39907-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM010452, R01GM039907] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; GAMBLE JR, 1988, SCIENCE, V242, P97; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KARLIN S, 1988, P NATL ACAD SCI USA, V85, P9396, DOI 10.1073/pnas.85.24.9396; KARLIN S, 1989, J MOL BIOL, V205, P165, DOI 10.1016/0022-2836(89)90373-2; KARLIN S, IN PRESS METHODS ENZ; KARLIN S, 1990, IN PRESS 6TH P CONV, V1; KINGSTON RE, 1985, CELL, V41, P3, DOI 10.1016/0092-8674(85)90049-2; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; NECKAMEYER WS, 1985, J VIROL, V53, P879, DOI 10.1128/JVI.53.3.879-884.1985; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PERUTZ MF, 1988, NATURE, V336, P202, DOI 10.1038/336202a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REDDY EPA, 1988, ONCOGENE HDB; REED JC, 1988, NATURE, V336, P259, DOI 10.1038/336259a0; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; UZVOLGYI E, 1988, P NATL ACAD SCI USA, V85, P3034, DOI 10.1073/pnas.85.9.3034; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VARMUS H, 1988, SCIENCE, V240, P1427, DOI 10.1126/science.3287617; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	72	10	10	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					85	95						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181379				2022-12-28	WOS:A1990CM62000012
J	DUDEK, H; REDDY, EP				DUDEK, H; REDDY, EP			MURINE MYELOID LEUKEMIAS WITH ABERRANT MYB LOCI SHOW HETEROGENEOUS EXPRESSION OF NOVEL MYB PROTEINS	ONCOGENE			English	Article											DUDEK, H (corresponding author), WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104, USA.		Reddy, E. Premkumar/F-6233-2011		NATIONAL CANCER INSTITUTE [R01CA044463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NCI NIH HHS [1R01 CA 44463] Funding Source: Medline; NIGMS NIH HHS [5T32 GM 07229] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; BADING H, 1987, ONCOGENE, V1, P395; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1983, P NATL ACAD SCI-BIOL, V80, P2834, DOI 10.1073/pnas.80.10.2834; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; CHALLBERG MD, 1979, P NATL ACAD SCI USA, V76, P655, DOI 10.1073/pnas.76.2.655; DUDEK H, 1989, ONCOGENE, V4, P1061; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; GONDA TJ, 1989, EMBO J, V8, P1777, DOI 10.1002/j.1460-2075.1989.tb03571.x; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVU S, 1986, NUCLEIC ACIDS RES, V14, P5309, DOI 10.1093/nar/14.13.5309; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MOSCOVICI MG, 1980, IN VIVO IN VITRO ERY, P503; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; PAIGE CJ, 1978, J IMMUNOL, V121, P641; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; POTTER M, 1978, NATL CANCER I MONOGR, V48, P311; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; REDDY EP, 1988, ONCOGENE HDB, P327; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; RUSHLOW KE, 1982, SCIENCE, V216, P1421, DOI 10.1126/science.6283631; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SHENONG GLC, 1987, EMBO J, V6, P4035, DOI 10.1002/j.1460-2075.1987.tb02748.x; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	35	17	17	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1489	1495						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2480562				2022-12-28	WOS:A1989CB65900011
J	TADOKORO, K; UEDA, M; OHSHIMA, T; FUJITA, K; RIKIMARU, K; TAKAHASHI, N; ENOMOTO, S; TSUCHIDA, N				TADOKORO, K; UEDA, M; OHSHIMA, T; FUJITA, K; RIKIMARU, K; TAKAHASHI, N; ENOMOTO, S; TSUCHIDA, N			ACTIVATION OF ONCOGENES IN HUMAN ORAL-CANCER CELLS - A NOVEL CODON-13 MUTATION OF C-H-RAS-1 AND CONCURRENT AMPLIFICATIONS OF C-ERBB-1 AND C-MYC	ONCOGENE			English	Article									TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL MICROBIOL,BUNKYO KU,TOKYO 113,JAPAN; TOKYO MED & DENT UNIV,FAC DENT,DEPT ORAL & MAXILLOFACIAL SURG 2,BUNKYO KU,TOKYO 113,JAPAN	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)								ANDERSEN PR, 1981, CELL, V26, P129, DOI 10.1016/0092-8674(81)90041-6; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DHAR R, 1982, SCIENCE, V217, P934, DOI 10.1126/science.6287572; DOTTO GP, 1985, NATURE, V318, P472; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HIRAI H, 1987, NATURE, V327, P430, DOI 10.1038/327430a0; KOIKE K, 1983, NUCLEIC ACIDS RES, V11, P5391, DOI 10.1093/nar/11.16.5391; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIU E, 1987, NATURE, V330, P186, DOI 10.1038/330186a0; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Maniatis T., 1982, MOL CLONING; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MIYAKI M, 1980, GANN, V71, P797; Momose F., 1986, J JPN STOMATOL SOC, V35, P485, DOI [10.11277/stomatology1952.35.485, DOI 10.11277/STOMATOLOGY1952.35.485]; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; NAMBA M, 1986, INT J CANCER, V37, P419, DOI 10.1002/ijc.2910370314; PATER A, 1986, J VIROL, V58, P680, DOI 10.1128/JVI.58.2.680-683.1986; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; RHIM JS, 1975, INT J CANCER, V16, P840, DOI 10.1002/ijc.2910160516; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; RUBIN CM, 1980, NATURE, V284, P372, DOI 10.1038/284372a0; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P952, DOI 10.1073/pnas.83.4.952; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPANDIDOS DA, 1984, NATURE, V310, P469, DOI 10.1038/310469a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x; TSUCHIDA N, 1981, J VIROL, V38, P720, DOI 10.1128/JVI.38.2.720-727.1981; TSUCHIDA N, 1982, SCIENCE, V217, P937, DOI 10.1126/science.6287573; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WALTER M, 1986, SCIENCE, V233, P649, DOI 10.1126/science.3487832; WEISS R, 1985, RNA TUMOR VIRUSES, V2; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; XU YH, 1984, NATURE, V309, P806, DOI 10.1038/309806a0; YAMAMOTO T, 1986, CANCER RES, V46, P414; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	58	54	55	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					499	505						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2654810				2022-12-28	WOS:A1989U567700015
J	LEMOINE, NR; MAYALL, ES; WYLLIE, FS; WILLIAMS, ED; GOYNS, M; STRINGER, B; WYNFORDTHOMAS, D				LEMOINE, NR; MAYALL, ES; WYLLIE, FS; WILLIAMS, ED; GOYNS, M; STRINGER, B; WYNFORDTHOMAS, D			HIGH-FREQUENCY OF RAS ONCOGENE ACTIVATION IN ALL STAGES OF HUMAN THYROID TUMORIGENESIS	ONCOGENE			English	Article									UNIV WALES COLL MED, DEPT PATHOL, CTR CANC RES, THYROID TUMOUR BIOL RES GRP, CARDIFF CF4 4XN, S GLAM, WALES; POLYTECH CENT LONDON, DEPT BIOTECHNOL, LONDON W1M 8JS, ENGLAND; UNIV WALES COLL MED, DEPT MED, CARDIFF CF4 4XN, S GLAM, WALES	Cardiff University; Cardiff University								ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIZUB D, 1986, P NATL ACAD SCI USA, V83, P6048, DOI 10.1073/pnas.83.16.6048; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; Hedinger C, 1974, HISTOLOGICAL TYPING; HEITZ P, 1976, CANCER, V37, P2329, DOI 10.1002/1097-0142(197605)37:5<2329::AID-CNCR2820370523>3.0.CO;2-7; HIRAI H, 1987, NATURE, V327, P430, DOI 10.1038/327430a0; HOCHWALT AE, 1988, CANCER RES, V48, P556; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; LEMOINE NR, 1988, CANCER RES, V48, P4459; LEMOINE NR, IN PRESS PATHOBIOLOG; LEMOINE NR, 1988, IN PRESS ONCOGENE; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIU E, 1987, NATURE, V330, P186, DOI 10.1038/330186a0; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MCMAHON G, 1987, P NATL ACAD SCI USA, V84, P4974, DOI 10.1073/pnas.84.14.4974; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; ROSAI J, 1981, ACKERMANS SURGICAL P, P330; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SHIBATA DK, 1988, J EXP MED, V167, P225, DOI 10.1084/jem.167.1.225; SOMMERS SC, 1982, ENDOCR PATHOL, P155; SUAREZ HG, 1988, ONCOGENE, V2, P403; WILLIAMS ED, 1979, CLIN ENDOCRINOL META, V8, P193, DOI 10.1016/S0300-595X(79)80017-1; WISEMAN RW, 1986, P NATL ACAD SCI USA, V83, P5825, DOI 10.1073/pnas.83.16.5825; YAMASAKI H, 1987, INT J CANCER, V40, P818, DOI 10.1002/ijc.2910400619; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	34	427	432	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1989	4	2					159	164						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648253				2022-12-28	WOS:A1989U567500006
J	TAKADA, S; KOIKE, K				TAKADA, S; KOIKE, K			ACTIVATED N-RAS GENE WAS FOUND IN HUMAN HEPATOMA TISSUE BUT ONLY IN A SMALL FRACTION OF THE TUMOR-CELLS	ONCOGENE			English	Article									JAPANESE FDN CANC RES,INST CANC,DEPT GENE RES,KAMI IKEBUKURO 1-37-1,TOSHIMA KU,TOKYO 170,JAPAN	Japanese Foundation for Cancer Research								BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; Cooper G M, 1984, Biochim Biophys Acta, V738, P9, DOI 10.1016/0304-419X(84)90017-9; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; DER CJ, 1983, CELL, V32, P201, DOI 10.1016/0092-8674(83)90510-X; DUESBERG PH, 1985, SCIENCE, V228, P669, DOI 10.1126/science.3992240; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GU JR, 1986, SCI CHINA SER B, V29, P173; HALL A, 1985, NUCLEIC ACIDS RES, V13, P5255, DOI 10.1093/nar/13.14.5255; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; KOIKE K, 1983, NUCLEIC ACIDS RES, V11, P5391, DOI 10.1093/nar/11.16.5391; Maxam A M, 1980, Methods Enzymol, V65, P499; NOTARIO V, 1984, CANCER CELLS ONCOGEN, P425; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SHEN WPV, 1987, ONCOGENE, V1, P157; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P383, DOI 10.1073/pnas.80.2.383; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TOKSOZ D, 1987, ONCOGENE, V1, P409; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; YAGINUMA K, 1987, J VIROL, V61, P1808, DOI 10.1128/JVI.61.6.1808-1813.1987; YAGINUMA K, 1984, JPN J CANCER RES, V75, P743; YUASA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3670, DOI 10.1073/pnas.81.12.3670; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	32	49	48	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					189	193						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2538792				2022-12-28	WOS:A1989U567500010
J	NGUYEN, C; ROUX, D; MATTEI, MG; DELAPEYRIERE, O; GOLDFARB, M; BIRNBAUM, D; JORDAN, BR				NGUYEN, C; ROUX, D; MATTEI, MG; DELAPEYRIERE, O; GOLDFARB, M; BIRNBAUM, D; JORDAN, BR			THE FGF-RELATED ONCOGENES HST AND INT 2, AND THE BCL 1 LOCUS ARE CONTAINED WITHIN ONE MEGABASE IN BAND Q13 OF CHROMOSOME-11, WHILE THE FGF 5 ONCOGENE MAPS TO 4Q21	ONCOGENE			English	Article									CNRS, INSERM, CTR IMMUNOL, CASE 906, F-13288 MARSEILLE 9, FRANCE; HOP ENFANTS TIMONE, INSERM U242, F-13385 MARSEILLE 5, FRANCE; INSERM, U119, F-13009 MARSEILLE, FRANCE; COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Columbia University			Nguyen, Catherine/M-4119-2016	Nguyen, Catherine/0000-0001-9376-6360				ADELAIDE J, 1988, ONCOGENE, V2, P413; BERENSON J, 1988, P AACR, V29, P1754; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; DEBRAEKELEER M, 1986, CANCER GENET CYTOGEN, V23, P333, DOI 10.1016/0165-4608(86)90017-8; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; HAYMAN MJ, 1985, P NATL ACAD SCI USA, V82, P8237, DOI 10.1073/pnas.82.23.8237; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; LIDEREAU R, 1988, IN PRESS ONCOGENE RE; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MERGIA A, 1986, BIOCHEM BIOPH RES CO, V138, P644, DOI 10.1016/S0006-291X(86)80545-9; NAKAGAMA H, 1987, JPN J CANCER RES, V78, P651; NGUYEN C, 1987, EMBO J, V6, P3285, DOI 10.1002/j.1460-2075.1987.tb02647.x; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; ZEHNBAUER BA, 1988, MOL CELL BIOL, V8, P522, DOI 10.1128/MCB.8.2.522; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN X, 1988, IN PRESS MOL CELL BI; ZHOU DJ, 1988, ONCOGENE, V2, P279	30	70	70	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					703	708						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577873				2022-12-28	WOS:A1988R646000013
J	BLAKE, TJ; SHAPIRO, M; MORSE, HC; LANGDON, WY				BLAKE, TJ; SHAPIRO, M; MORSE, HC; LANGDON, WY			THE SEQUENCES OF THE HUMAN AND MOUSE C-CBL PROTOONCOGENES SHOW V-CBL WAS GENERATED BY A LARGE TRUNCATION ENCOMPASSING A PROLINE-RICH DOMAIN AND A LEUCINE ZIPPER-LIKE MOTIF	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; LYMPHOMAS	The murine Cas NS-1 retrovirus carries the v-cbl oncogene and induces pre-B cell lymphomas and myeloid leukemias. The cellular homolog of v-cbl has been identified in mouse and human DNA, and was recently mapped to mouse chromosome 9 and human chromosome 11q23. To determine the coding sequences of the human and mouse c-cbl proto-oncogenes cDNA clones were isolated from libraries prepared from the human T cell leukemia lines CCRF-CEM and HUT 78, and the mouse pre-B cell line 70Z/3. DNA sequencing revealed an open reading frame encoding 906 amino acids in the human cDNAs and 896 amino acids in 70Z/3. The sequence showed that v-cbl is a markedly truncated form of murine c-cbl containing 355 N-terminal amino acids. The nucleotide sequence of v-cbl is identical to murine c-cbl in this region, and the human sequence has only five amino acid changes in the v-cbl portion. The most notable features of the sequence which was lost in the generation of v-cbl is a C-terminal leucine zipper and a stretch of 208 amino acids containing 23% proline and 19% serine/threonine residues. This proline-rich sequence has similarities to the transcriptional activation domains of some transcription factors, and v-cbl's transforming potential may be due to the loss of this region and the leucine zipper.	INST MED & VET SCI,DIV HUMAN IMMUNOL,ADELAIDE,SA 5000,AUSTRALIA; NIAID,IMMUNOPATHOL LAB,BETHESDA,MD 20892	Institute Medical & Veterinary Science Australia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)				Morse, Herbert/0000-0002-9331-3705				BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BOHMANN D, 1989, CELL, V59, P709, DOI 10.1016/0092-8674(89)90017-2; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; GAZDAR AF, 1980, BLOOD, V55, P409; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; PAIGE CJ, 1978, J IMMUNOL, V121, P641; REGNIER DC, 1989, J VIROL, V63, P3678, DOI 10.1128/JVI.63.9.3678-3682.1989; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAVAGE PD, 1990, IN PRESS CANCEER GEN; YUNIS JJ, 1986, CLIN HAEMATOL, V15, P597	17	259	266	1	6	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					653	657						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030914				2022-12-28	WOS:A1991FR93900022
J	HASHIMOTO, T; TAKAHASHI, R; YANDELL, DW; XU, HJ; HU, SX; GUNNELL, S; BENEDICT, WF				HASHIMOTO, T; TAKAHASHI, R; YANDELL, DW; XU, HJ; HU, SX; GUNNELL, S; BENEDICT, WF			CHARACTERIZATION OF INTRAGENIC DELETIONS IN 2 SPORADIC GERMINAL MUTATION CASES OF RETINOBLASTOMA RESULTING IN ABNORMAL GENE-EXPRESSION	ONCOGENE			English	Note							SUSCEPTIBILITY GENE; CELL-CYCLE; GENOMIC ORGANIZATION; PRODUCT; PHOSPHORYLATION; SEQUENCES; PROTEIN; MITOSIS; CANCER	Two gross intragenic deletions of the retinoblastoma (RB) gene from patients with sporadic hereditary disease were analysed in detail. This study was undertaken to determine whether there were common mechanisms for these deletions and whether changes found in the tumors were identical to those found in the constitutional cells. Short repeats at the deletion breakpoints were found in both tumors, one resulting in a 2.0 kb deletion including exons 21 and 22, and the other producing a 3.7 kb deletion including exons 14-17. In addition, the identical sequence changes documented in genomic DNAs and transcripts of these tumors were also observed in the constitutional cells. Both deletions were in-frame and resulted in a truncated transcript and protein identical to the expected size based on the exons deleted. These studies provide further documentation of the events which represent the actual 'two hits' originally hypothesized to be responsible for retinoblastoma development.	BAYLOR UNIV,CTR BIOTECHNOL,4000 RES FOREST DR,THE WOODLANDS,TX 77381; MASSACHUSETTS EYE & EAR HOSP,DEPT OPHTHALMOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Baylor College of Medicine; Baylor University; Harvard University; Harvard Medical School					NATIONAL EYE INSTITUTE [R01EY002715] Funding Source: NIH RePORTER; NEI NIH HHS [EY02715, EY06195] Funding Source: Medline; DRS NIH HHS [BRSG 790G16254] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DRS NIH HHS		BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; BOOKSTEIN R, 1989, MOL CELL BIOL, V9, P1628, DOI 10.1128/MCB.9.4.1628; BRUNIER D, 1989, EMBO J, V8, P3127, DOI 10.1002/j.1460-2075.1989.tb08465.x; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CANNING S, 1989, P NATL ACAD SCI USA, V86, P5044, DOI 10.1073/pnas.86.13.5044; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HONG FD, 1989, P NATL ACAD SCI USA, V86, P5502, DOI 10.1073/pnas.86.14.5502; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MANIATIS T, 1982, MOL CLONING LABORATO, P187; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; Shew J.-Y., 1989, ONCOGENE RES, V1, P205; SMITH CL, 1989, J VIROL, V63, P1569, DOI 10.1128/JVI.63.4.1569-1577.1989; TANG A, 1989, ONCOGENE, V4, P401; TAYA Y, 1989, BIOCHEM BIOPH RES CO, V164, P580, DOI 10.1016/0006-291X(89)91759-2; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; XU HJ, 1989, ONCOGENE, V4, P807; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501	27	35	35	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					463	469						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011402				2022-12-28	WOS:A1991FT34400018
J	KODURU, PRK; OFFIT, K				KODURU, PRK; OFFIT, K			MOLECULAR-STRUCTURE OF DOUBLE RECIPROCAL TRANSLOCATIONS - SIGNIFICANCE IN B-CELL LYMPHOMAGENESIS	ONCOGENE			English	Note							C-MYC ONCOGENE; BCL-2 GENE; FOLLICULAR LYMPHOMA; BURKITT-LYMPHOMA; CHROMOSOME-TRANSLOCATION; LOCUS; ACTIVATION; LEUKEMIA; REGION; REARRANGEMENTS	The molecular structure of reciprocal translocations associated with low grade and high grade non-Hodgkin's lymphomas occurring together was analysed in two tumors. Sequential biopsies documented histological transformation of a large cell lymphoma to an immunoblastic lymphoma bearing t(14;18)(q32;q21) and t(8;22)(q24;q11). A second tumor, a small non-cleaved cell lymphoma, demonstrated a t(8;14)(q24;q11) as well as t(18;22)(q21;q11). DNA analysis from these tumors showed rearrangements at the Ig heavy chain, kappa and lambda light chains, BCL2 and c-MYC loci. Utilizing multiple enzyme digests and different probes spanning the BCL2, c-MYC and Ig genes, mapping of DNA break-points was performed. In both these tumors primary translocation events dysregulating the BCL2 or c-MYC were identified to have occurred in a pre-B-cell. Based on these results and those published previously, a sequence of B-cell development during which somatic recombination errors lead to the genesis of specific translocations is proposed. From these studies it is inferred that secondary dysregulation of a c-MYC in a lymphoma tumor carrying dysregulated BCL2 gene leads to rapid progression to high grade disease.	MEM SLOAN KETTERING CANC CTR, CANC GENET & CYTOGENET LAB, NEW YORK, NY 10021 USA; CORNELL UNIV, N SHORE UNIV HOSP, COLL MED, SPECIAL CYTOGENET LAB, MANHASSET, NY 11030 USA; MEM SLOAN KETTERING CANC CTR, DEPT MED, LYMPHOMA SERV, NEW YORK, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Northwell Health; North Shore University Hospital; Memorial Sloan Kettering Cancer Center					NCI NIH HHS [CA 34775] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034775] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI M, 1989, P NATL ACAD SCI USA, V86, P2771, DOI 10.1073/pnas.86.8.2771; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; BAKSHI A, 1985, CELL, V41, P889; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CROCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P6922, DOI 10.1073/pnas.80.22.6922; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0; HIETER PA, 1981, NATURE, V290, P368, DOI 10.1038/290368a0; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEE JT, 1989, J CLIN INVEST, V84, P1454, DOI 10.1172/JCI114320; MAGRATH I, 1983, SCIENCE, V222, P1094, DOI 10.1126/science.6316501; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MUFTI GJ, 1983, BLOOD, V62, P1142; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884; RICHARDSON ME, 1987, BLOOD, V70, P444; SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0; SHOWE LC, 1987, P NATL ACAD SCI USA, V84, P2824, DOI 10.1073/pnas.84.9.2824; TSUJIMOTO Y, 1987, P NATL ACAD SCI USA, V84, P1329, DOI 10.1073/pnas.84.5.1329; TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WIMAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6798, DOI 10.1073/pnas.81.21.6798; YUNIS JJ, 1987, NEW ENGL J MED, V316, P79, DOI 10.1056/NEJM198701083160204	32	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					145	148						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992441				2022-12-28	WOS:A1991EY03900020
J	ZHAO, YH; KRUEGER, JG; SUDOL, M				ZHAO, YH; KRUEGER, JG; SUDOL, M			EXPRESSION OF CELLULAR-YES PROTEIN IN MAMMALIAN-TISSUES	ONCOGENE			English	Article									ROCKEFELLER UNIV,MOLEC ONCOL LAB,NEW YORK,NY 10021; ROCKEFELLER UNIV,INVEST DERMATOL LAB,NEW YORK,NY 10021	Rockefeller University; Rockefeller University					NATIONAL CANCER INSTITUTE [R29CA045757] Funding Source: NIH RePORTER; NCI NIH HHS [CA45757] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GHYSDAEL J, 1981, VIROLOGY, V111, P386, DOI 10.1016/0042-6822(81)90342-1; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYTON L, 1989, CELL, V57, P1123, DOI 10.1016/0092-8674(89)90049-4; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; PAWSON T, 1988, ONCOGENE, V3, P491; RESH MD, 1985, J CELL BIOL, V100, P409, DOI 10.1083/jcb.100.2.409; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; SUDOL M, 1989, J NEUROSCI RES, V24, P1, DOI 10.1002/jnr.490240103; SUDOL M, 1988, BRAIN RES REV, V13, P391, DOI 10.1016/0165-0173(88)90014-8; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1988, NUCLEIC ACIDS RES, V16, P9876, DOI 10.1093/nar/16.20.9876; SUDOL M, 1989, MOL CELL BIOL, V9, P4545, DOI 10.1128/MCB.9.10.4545; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; ZHENG XF, 1989, ONCOGENE, V4, P99	24	91	92	1	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1629	1635						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267131				2022-12-28	WOS:A1990EL40100003
J	RUSSELL, SEH; HICKEY, GI; LOWRY, WS; WHITE, P; ATKINSON, RJ				RUSSELL, SEH; HICKEY, GI; LOWRY, WS; WHITE, P; ATKINSON, RJ			ALLELE LOSS FROM CHROMOSOME-17 IN OVARIAN-CANCER	ONCOGENE			English	Note									QUEENS UNIV BELFAST,SCH BIOL & BIOCHEM,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	Queens University Belfast	RUSSELL, SEH (corresponding author), QUEENS UNIV BELFAST,DEPT ONCOL,WHITLA MED BLDG,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND.							ATKIN NB, 1981, CANCER GENET CYTOGEN, V3, P275, DOI 10.1016/0165-4608(81)90095-9; BOLTZ EM, 1989, INT J CANCER, V43, P428, DOI 10.1002/ijc.2910430314; EHLEN T, 1990, ONCOGENE, V5, P219; FILMUS JE, 1985, CANCER RES, V45, P4468; LEE JH, 1989, CANCER RES, V49, P1220; LYNCH HT, 1989, OVARIAN CANCER BIOL, P7; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; VOGELSTEIN B, 1989, SCIENCE, V244, P206; WAKE N, 1980, CANCER RES, V40, P4512; WHANGPENG J, 1984, CANCER GENET CYTOGEN, V11, P91, DOI 10.1016/0165-4608(84)90102-X; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898; ZHOU DJ, 1988, CANCER, V62, P1573, DOI 10.1002/1097-0142(19881015)62:8<1573::AID-CNCR2820620819>3.0.CO;2-M	13	165	166	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1581	1583						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250914				2022-12-28	WOS:A1990EK50200019
J	RYSECK, RP; KOVARY, K; BRAVO, R				RYSECK, RP; KOVARY, K; BRAVO, R			INTEGRITY OF FOS B-LEUCINE ZIPPER IS ESSENTIAL FOR ITS INTERACTION WITH JUN PROTEINS	ONCOGENE			English	Note											RYSECK, RP (corresponding author), SQUIBB INST MED RES,DEPT MOLEC BIOL,POB 4000,PRINCETON,NJ 08543, USA.		Kovary, Karla/E-3979-2013					ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRAVO R, 1989, GROWTH FACTORS DIFFE; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PAYRE F, 1988, FEBS LETT, V234, P245, DOI 10.1016/0014-5793(88)80091-7; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	19	18	18	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1091	1093						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115643				2022-12-28	WOS:A1990DP41500023
J	BLONDEL, B; TALBOT, N; MERLO, GR; WYCHOWSKI, C; YOKOZAKI, H; VALVERIUS, EM; SALOMON, DS; BASSIN, RH				BLONDEL, B; TALBOT, N; MERLO, GR; WYCHOWSKI, C; YOKOZAKI, H; VALVERIUS, EM; SALOMON, DS; BASSIN, RH			EFFICIENT INDUCTION OF FOCUS FORMATION IN A SUBCLONE OF NIH3T3 CELLS BY C-MYC AND ITS INHIBITION BY SERUM AND BY GROWTH-FACTORS	ONCOGENE			English	Article									NCI,TUMOR IMMUNOL & BIOL LAB,BETHESDA,MD 20892; NIAID,INFECT DIS LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)				Yokozaki, Hiroshi/0000-0001-5276-3331				ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; CAVALIERI F, 1987, MOL CELL BIOL, V7, P3554, DOI 10.1128/MCB.7.10.3554; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COLLINS S, 1982, NATURE, V298, P679, DOI 10.1038/298679a0; COPELAND NG, 1980, J VIROL, V33, P1199, DOI 10.1128/JVI.33.3.1199-1202.1980; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DALLAFAVERA R, 1982, NATURE, V299, P61; DANIELPOUR D, 1989, J CELL PHYSIOL, V138, P79, DOI 10.1002/jcp.1041380112; DAVENPORT EA, 1988, ANTICANCER RES, V8, P959; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; ENGEL JN, 1981, P NATL ACAD SCI-BIOL, V78, P4674, DOI 10.1073/pnas.78.8.4674; FALCONE G, 1987, EXP CELL RES, V168, P273, DOI 10.1016/0014-4827(87)90435-6; FERNANDEZPOL JA, 1987, BIOCHEM BIOPH RES CO, V144, P1197, DOI 10.1016/0006-291X(87)91438-0; FISHER PB, 1982, P NATL ACAD SCI-BIOL, V79, P3527, DOI 10.1073/pnas.79.11.3527; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KEATH EJ, 1984, CELL, V39, P339, DOI 10.1016/0092-8674(84)90012-6; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KNABBE C, 1987, CELL, V48, P417, DOI 10.1016/0092-8674(87)90193-0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LAUTENBERGER JA, 1981, P NATL ACAD SCI-BIOL, V78, P1518, DOI 10.1073/pnas.78.3.1518; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LEE WMF, 1985, MOL CELL BIOL, V5, P3345, DOI 10.1128/MCB.5.12.3345; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; LOWY DR, 1978, J VIROL, V26, P291, DOI 10.1128/JVI.26.2.291-298.1978; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER SC, 1988, MOL CELL BIOL, V8, P2295, DOI 10.1128/MCB.8.6.2295; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; RAY R, 1989, ONCOGENE, V4, P593; RIZZINO A, 1988, DEV BIOL, V130, P411, DOI 10.1016/0012-1606(88)90337-5; ROMEO G, 1989, TRENDS GENET, V5, P19, DOI 10.1016/0168-9525(89)90007-3; RUBIN H, 1989, P NATL ACAD SCI USA, V86, P1860, DOI 10.1073/pnas.86.6.1860; RUBIN H, 1960, VIROLOGY, V12, P14, DOI 10.1016/0042-6822(60)90146-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; SMALL MB, 1987, MOL CELL BIOL, V7, P1638, DOI 10.1128/MCB.7.5.1638; STANTON LW, 1984, NATURE, V310, P423, DOI 10.1038/310423a0; STUDZINSKY GP, 1985, CELL, V43, P243; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; SYMONDS G, 1989, ONCOGENE, V4, P285; TORTI FM, 1989, J CELL BIOL, V108, P1105, DOI 10.1083/jcb.108.3.1105; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P2146, DOI 10.1073/pnas.80.8.2146; WEINBERG RA, 1989, CANCER RES, V49, P3713; YARDEN A, 1986, SCIENCE, V234, P1419, DOI 10.1126/science.3097823; ZERLIN M, 1987, ONCOGENE, V1, P19	60	8	9	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					857	865						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2193293				2022-12-28	WOS:A1990DP55300011
J	BOEUF, H; JANSENDURR, P; KEDINGER, C				BOEUF, H; JANSENDURR, P; KEDINGER, C			EIA-MEDIATED TRANSACTIVATION OF THE ADENOVIRUS EIIA EARLY PROMOTER IS RESTRICTED IN UNDIFFERENTIATED F9 CELLS	ONCOGENE			English	Article									FAC MED STRASBOURG,CNRS,GENET MOLEC LAB,INSERM,U184,UNITE BIOL MOLEC & GENIE GENET,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Jansen-Dürr, Pidder/ABG-2466-2020	Jansen-Dürr, Pidder/0000-0001-7771-3429				BABISS LE, 1989, J VIROL, V63, P2709, DOI 10.1128/JVI.63.6.2709-2717.1989; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BOEUF H, 1987, NUCLEIC ACIDS RES, V15, P509, DOI 10.1093/nar/15.2.509; BOEUF H, 1990, IN PRESS P NATL ACAD; BOHLER K, 1983, COLD SPRING HARBOR C, V10, P39; BONNEROT C, 1987, P NATL ACAD SCI USA, V84, P6795, DOI 10.1073/pnas.84.19.6795; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; CHENG C, 1982, VIROLOGY, V123, P45, DOI 10.1016/0042-6822(82)90293-8; GODING C, 1985, EMBO J, V4, P1523, DOI 10.1002/j.1460-2075.1985.tb03812.x; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HARDY S, 1989, MOL CELL BIOL, V9, P4495, DOI 10.1128/MCB.9.10.4495; HARDY S, 1989, GENE DEV, V3, P1062, DOI 10.1101/gad.3.7.1062; HOGAN BLM, 1986, LABORATORY MANUAL, P262; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HUANG MM, 1989, GENE DEV, V3, P1699, DOI 10.1101/gad.3.11.1699; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; JALINOT P, 1987, MOL CELL BIOL, V7, P3806, DOI 10.1128/MCB.7.10.3806; JANSENDURR P, 1988, NUCLEIC ACIDS RES, V16, P3771, DOI 10.1093/nar/16.9.3771; JANSENDURR P, 1989, EMBO J, V8, P3365, DOI 10.1002/j.1460-2075.1989.tb08499.x; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KELLY F, 1976, NATURE, V262, P409, DOI 10.1038/262409a0; KEMLER R, 1981, IMMUNE SYSTEM, V1, P102; KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180; KOVESDI I, 1986, CELL, V45, P219, DOI 10.1016/0092-8674(86)90386-7; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LATHANGUE NB, 1987, CELL, V49, P507, DOI 10.1016/0092-8674(87)90453-3; LATHANGUE NB, 1988, TRANSCRIPTION SPLICI, P1; LEONG K, 1986, P NATL ACAD SCI USA, V83, P5844, DOI 10.1073/pnas.83.16.5844; LEWIS ED, 1985, MOL CELL BIOL, V5, P2433, DOI 10.1128/MCB.5.9.2433; MONTANO X, 1987, MOL CELL BIOL, V7, P1782, DOI 10.1128/MCB.7.5.1782; NOMIYAMA H, 1987, P NATL ACAD SCI USA, V84, P7881, DOI 10.1073/pnas.84.22.7881; REICHEL R, 1987, CELL, V48, P501, DOI 10.1016/0092-8674(87)90200-5; REICHEL R, 1989, J VIROL, V63, P3643, DOI 10.1128/JVI.63.9.3643-3650.1989; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SASSONECORSI P, 1985, COLD SPRING HARB SYM, V50, P747, DOI 10.1101/SQB.1985.050.01.092; SASSONECORSI P, 1988, P NATL ACAD SCI USA, V85, P7192, DOI 10.1073/pnas.85.19.7192; STAFFORD J, 1983, NATURE, V306, P77, DOI 10.1038/306077a0; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; SUEMORI H, 1988, MOL CELL BIOL, V8, P3553, DOI 10.1128/MCB.8.8.3553; THOMAS GP, 1980, CELL, V22, P523; ZAJCHOWSKI DA, 1987, GENE, V58, P243, DOI 10.1016/0378-1119(87)90379-9; ZAJCHOWSKI DA, 1985, EMBO J, V4, P1293, DOI 10.1002/j.1460-2075.1985.tb03775.x	43	6	6	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					691	699						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2161097				2022-12-28	WOS:A1990DG37400009
J	YUASA, Y; KAMIYAMA, T; KATO, M; IWAMA, T; IKEUCHI, T; TONOMURA, A				YUASA, Y; KAMIYAMA, T; KATO, M; IWAMA, T; IKEUCHI, T; TONOMURA, A			TRANSFORMING GENES FROM FAMILIAL ADENOMATOUS POLYPOSIS PATIENT CELLS DETECTED BY A TUMORIGENICITY ASSAY	ONCOGENE			English	Article									TOKYO MED & DENT UNIV, SCH MED, DEPT SURG 2, TOKYO 113, JAPAN; TOKYO MED & DENT UNIV, MED RES INST, TOKYO 113, JAPAN	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	YUASA, Y (corresponding author), TOKYO MED & DENT UNIV, DEPT HYG & ONCOL, BUNKYO KU, TOKYO 113, JAPAN.							BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; Maniatis T., 1982, MOL CLONING; MURRAY MJ, 1981, CELL, V25, P355, DOI 10.1016/0092-8674(81)90054-4; NEEDLEMAN SW, 1983, SCIENCE, V222, P173, DOI 10.1126/science.6623066; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YAMAMOTO A, 1989, BIOCHEM BIOPH RES CO, V159, P1100, DOI 10.1016/0006-291X(89)92222-5; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; YUASA Y, 1986, JPN J CANCER RES, V77, P901; YUASA Y, 1987, JPN J CANCER RES, V78, P1036; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	24	6	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					589	596						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970154				2022-12-28	WOS:A1990DB85300020
J	ROUSSEL, MF; DOWNING, JR; SHERR, CJ				ROUSSEL, MF; DOWNING, JR; SHERR, CJ			TRANSFORMING ACTIVITIES OF HUMAN CSF-1 RECEPTORS WITH DIFFERENT POINT MUTATIONS AT CODON-301 IN THEIR EXTRACELLULAR DOMAINS	ONCOGENE			English	Article									UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT BIOCHEM, MEMPHIS, TN 38163 USA; ST JUDE CHILDRENS RES HOSP, DEPT PATHOL, MEMPHIS, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	ROUSSEL, MF (corresponding author), ST JUDE CHILDRENS RES HOSP, HOWARD HUGHES MED INST, DEPT TUMOR CELL BIOL, MEMPHIS, TN 38105 USA.		Downing, James R./N-8102-2018; Sherr, Charles J/N-8074-2018; Roussel, Martine F/F-1469-2016	Sherr, Charles J/0000-0002-5516-6206; Roussel, Martine F/0000-0002-1740-8139	NCI NIH HHS [P30-CA21765, R35-CA47064, K08-CA01429] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R35CA047064, K08CA001429] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON SJ, 1984, J VIROL, V51, P730, DOI 10.1128/JVI.51.3.730-741.1984; ASHMUN RA, 1989, BLOOD, V73, P827; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; BESMER P, 1986, J VIROL, V60, P194, DOI 10.1128/JVI.60.1.194-203.1986; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; BROWNING PJ, 1986, P NATL ACAD SCI USA, V83, P7800, DOI 10.1073/pnas.83.20.7800; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DONNER L, 1982, J VIROL, V41, P489, DOI 10.1128/JVI.41.2.489-500.1982; DOWNING JR, 1988, MOL CELL BIOL, V8, P1795, DOI 10.1128/MCB.8.4.1795; DOWNING JR, 1989, IN PRESS EMBO J; FURMAN WL, 1986, VIROLOGY, V152, P432, DOI 10.1016/0042-6822(86)90145-5; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; HADWIGER A, 1986, EMBO J, V5, P689, DOI 10.1002/j.1460-2075.1986.tb04268.x; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HARTMANN T, 1989, IN PRESS GROWTH FACT; HEARD JM, 1987, ONCOGENE RES, V1, P423; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; KATO JY, 1989, MOL CELL BIOL, V9, P4069, DOI 10.1128/MCB.9.9.4069; LYMAN SD, 1988, ONCOGENE, V3, P391; MCDONOUGH SK, 1971, CANCER RES, V31, P953; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; NICHOLS EJ, 1985, MOL CELL BIOL, V5, P3467, DOI 10.1128/MCB.5.12.3467; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; RETTENMIER CW, 1986, J CLIN INVEST, V77, P1740, DOI 10.1172/JCI112496; RETTENMIER CW, 1985, SCIENCE, V228, P320, DOI 10.1126/science.2580348; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; ROUSSEL MF, 1984, MOL CELL BIOL, V4, P1999, DOI 10.1128/MCB.4.10.1999; SACCA R, 1986, P NATL ACAD SCI USA, V83, P3331, DOI 10.1073/pnas.83.10.3331; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SHERR CJ, 1989, BLOOD, V73, P1786; SHERR CJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P225, DOI 10.1016/0304-419X(88)90011-X; SHERR CJ, 1988, COLD SPRING HARB SYM, V53, P521, DOI 10.1101/SQB.1988.053.01.060; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; WOOLFORD J, 1985, MOL CELL BIOL, V5, P3458, DOI 10.1128/MCB.5.12.3458; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	44	35	36	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					25	30						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157180				2022-12-28	WOS:A1990CM62000004
J	BONGARZONE, I; PIEROTTI, MA; MONZINI, N; MONDELLINI, P; MANENTI, G; DONGHI, R; PILOTTI, S; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; DELLAPORTA, G				BONGARZONE, I; PIEROTTI, MA; MONZINI, N; MONDELLINI, P; MANENTI, G; DONGHI, R; PILOTTI, S; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; DELLAPORTA, G			HIGH-FREQUENCY OF ACTIVATION OF TYROSINE KINASE ONCOGENES IN HUMAN PAPILLARY THYROID-CARCINOMA	ONCOGENE			English	Article									IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,VIA G VENEZIAN 1,I-20133 MILAN,ITALY; IST NAZL TUMORI,FAC MED & CHIRURG 2,DIPARTIMENTO BIOL & PATOL CELLULARE & MOLEC,CNR,I-20133 MILAN,ITALY; NAPLES UNIV,DIV ANAT PATOL,I-80131 NAPLES,ITALY	Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Naples Federico II			Bongarzone, Italia/B-9544-2017; Manenti, Giacomo/J-3339-2017	Bongarzone, Italia/0000-0003-2530-9170; Manenti, Giacomo/0000-0002-4887-4482; Pierotti, Marco Alessandro/0000-0002-7431-8332; Grieco, Michele/0000-0002-4212-7814; Fusco, Alfredo/0000-0003-3332-5197				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BRENNAN MF, 1985, CANCER PRINCIPLES PR, P1179; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; DONGHI R, 1989, ONCOGENE, V4, P521; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; HEMPELMANN LH, 1975, J NATL CANCER I, V55, P519, DOI 10.1093/jnci/55.3.519; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEMOINE NR, 1988, CANCER RES, V48, P4459; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MITRA G, 1987, P NATL ACAD SCI USA, V84, P6707, DOI 10.1073/pnas.84.19.6707; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; OSKAM R, 1988, P NATL ACAD SCI USA, V85, P2964, DOI 10.1073/pnas.85.9.2964; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUYRI M, 1983, P NATL ACAD SCI-BIOL, V80, P6676, DOI 10.1073/pnas.80.21.6676; SUAREZ HG, 1988, ONCOGENE, V2, P403; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; WILLIAMS ED, 1979, CLIN ENDOCRINOL META, V8, P193, DOI 10.1016/S0300-595X(79)80017-1	20	286	307	0	6	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1457	1462						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2594368				2022-12-28	WOS:A1989CB65900006
J	SHORE, SK; REDDY, EP				SHORE, SK; REDDY, EP			TRANSFORMATION OF NIH3T3 CELLS BY A-MULV PROVIRAL DNA - EFFECT OF PLASMID LINEARIZATION AND CARRIER DNA ON TRANSFORMATION EFFICIENCY	ONCOGENE			English	Note											SHORE, SK (corresponding author), WISTAR INST, 3601 SPRUCE ST, PHILADELPHIA, PA 19104 USA.		Reddy, E. Premkumar/F-6233-2011		NATIONAL CANCER INSTITUTE [R01CA047937] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47937-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; GOFF SP, 1982, J VIROL, V41, P271, DOI 10.1128/JVI.41.1.271-285.1982; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; KRUMPKONVALINKOVA V, 1981, VIROLOGY, V109, P215, DOI 10.1016/0042-6822(81)90491-8; REDDY EP, 1988, ONCOGENE HDB, P3; ROSENBERG N, 1988, ADV VIRUS RES, V35, P39; SRINIVASAN A, 1981, P NATL ACAD SCI-BIOL, V78, P2077, DOI 10.1073/pnas.78.4.2077; SRINIVASAN A, 1982, P NATL ACAD SCI-BIOL, V79, P5508, DOI 10.1073/pnas.79.18.5508; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; ZIEGLER SF, 1981, CELL, V27, P477, DOI 10.1016/0092-8674(81)90389-5	10	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1989	4	11					1411	1413						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554240				2022-12-28	WOS:A1989AX65900020
J	HRABARENEVEY, S; TURLER, H; KRESS, M; SALOMON, C; WEIL, R				HRABARENEVEY, S; TURLER, H; KRESS, M; SALOMON, C; WEIL, R			SV40-INDUCED EXPRESSION OF MOUSE GENE-24P3 INVOLVES A POST-TRANSCRIPTIONAL MECHANISM	ONCOGENE			English	Article									INST RECH SCI CANC,UNITE ONCOL MOLEC,F-94802 VILLEJUIF,FRANCE		HRABARENEVEY, S (corresponding author), UNIV GENEVA,DEPT MOLEC BIOL,30 QUAI ERNEST ANSERMET,CH-1211 GENEVA 4,SWITZERLAND.							ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANDERSON KP, 1984, P NATL ACAD SCI-BIOL, V81, P4023, DOI 10.1073/pnas.81.13.4023; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BOUCK N, 1978, P NATL ACAD SCI USA, V75, P2473, DOI 10.1073/pnas.75.5.2473; BRICKELL PM, 1985, NATURE, V316, P162, DOI 10.1038/316162a0; CAFFARELLI E, 1987, EMBO J, V6, P3493, DOI 10.1002/j.1460-2075.1987.tb02674.x; CARNEIRO M, 1984, J MOL BIOL, V178, P869, DOI 10.1016/0022-2836(84)90316-4; CARROLL RB, 1988, ONCOGENE, V2, P437; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COLE CN, 1979, J VIROL, V30, P683, DOI 10.1128/JVI.30.3.683-691.1979; COLE CN, 1977, J VIROL, V24, P277, DOI 10.1128/JVI.24.1.277-294.1977; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DARLIX JL, 1984, P NATL ACAD SCI-BIOL, V81, P5425, DOI 10.1073/pnas.81.17.5425; DEFROMENTEL CC, 1986, EXP CELL RES, V164, P35, DOI 10.1016/0014-4827(86)90452-0; DIXON K, 1982, NATURE, V296, P672, DOI 10.1038/296672a0; FEUNTEUN J, 1978, P NATL ACAD SCI USA, V75, P4455, DOI 10.1073/pnas.75.9.4455; FLAVELL AJ, 1977, J MOL BIOL, V115, P237, DOI 10.1016/0022-2836(77)90099-7; FRIED V, 1986, CANCER CELLS DNA TUM; FRISKE RJ, 1979, COLD SPRING HARB SYM, V39, P325; FULTON R, 1985, NUCLEIC ACIDS RES, V13, P6467, DOI 10.1093/nar/13.18.6467; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; GAUCHAT JF, 1986, NUCLEIC ACIDS RES, V14, P9339, DOI 10.1093/nar/14.23.9339; GEHRING MR, 1987, J BIOL CHEM, V262, P446; GOAD WB, 1982, NUCLEIC ACIDS RES, V10, P247, DOI 10.1093/nar/10.1.247; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUDAS JM, 1988, P NATL ACAD SCI USA, V85, P4705, DOI 10.1073/pnas.85.13.4705; GUTMAN D, 1988, SCIENCE, V241, P1492, DOI 10.1126/science.3047873; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HRABARENEVEY S, 1987, THESIS U GENEVA SWIT; HUYNH TV, 1985, DNA CLONING PRACTICA; KAO HT, 1986, NUCLEIC ACIDS RES, V14, P7253, DOI 10.1093/nar/14.18.7253; KHANDJIAN EW, 1982, P NATL ACAD SCI-BIOL, V79, P1139, DOI 10.1073/pnas.79.4.1139; KHANDJIAN EW, 1980, P NATL ACAD SCI-BIOL, V77, P1476, DOI 10.1073/pnas.77.3.1476; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; KHANDJIAN EW, 1988, ONCOGENE, V3, P195; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LEWIS AM, 1979, P NATL ACAD SCI USA, V76, P4299, DOI 10.1073/pnas.76.9.4299; LINZER DIH, 1983, P NATL ACAD SCI-BIOL, V80, P4271, DOI 10.1073/pnas.80.14.4271; Maniatis T., 1982, MOL CLONING; MARTIN RG, 1979, CELL, V17, P635, DOI 10.1016/0092-8674(79)90271-X; MARTIN RG, 1979, J VIROL, V31, P596, DOI 10.1128/JVI.31.3.596-607.1979; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MATTER JM, 1983, NUCLEIC ACIDS RES, V11, P6611, DOI 10.1093/nar/11.19.6611; MAY E, 1973, P NATL ACAD SCI USA, V70, P1654, DOI 10.1073/pnas.70.6.1654; MAY E, 1971, P NATL ACAD SCI USA, V68, P1280; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MUELLER C, 1978, CELL, V15, P579, DOI 10.1016/0092-8674(78)90026-0; MURPHY D, 1983, CELL, V35, P865, DOI 10.1016/0092-8674(83)90119-8; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PUSTELL J, 1982, NUCLEIC ACIDS RES, V10, P4765, DOI 10.1093/nar/10.15.4765; PUVION E, 1988, EXP CELL RES, V177, P73, DOI 10.1016/0014-4827(88)90026-2; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SALZMAN NP, 1986, PAPOVAVIRUSES, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SCHUTZBANK T, 1982, CELL, V30, P481, DOI 10.1016/0092-8674(82)90245-8; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; SEILERTUYNS A, 1981, J MOL BIOL, V151, P607, DOI 10.1016/0022-2836(81)90426-5; SHENK TE, 1976, J VIROL, V18, P664, DOI 10.1128/JVI.18.2.664-671.1976; SINGH K, 1985, NATURE, V314, P553, DOI 10.1038/314553a0; SINGH K, 1985, MOL CELL BIOL, V5, P2590, DOI 10.1128/MCB.5.10.2590; SIVE HL, 1984, MOL CELL BIOL, V4, P2723, DOI 10.1128/MCB.4.12.2723; SLEIGH MJ, 1978, CELL, V14, P79, DOI 10.1016/0092-8674(78)90303-3; STIMAC E, 1984, MOL CELL BIOL, V4, P2082, DOI 10.1128/MCB.4.10.2082; SUKHATME VP, 1988, CELL, V56, P337; Tooze J., 1980, MOL BIOL TUMOR VIR 2; TOPP WC, 1981, VIROLOGY, V111, P341, DOI 10.1016/0042-6822(81)90338-X; TURLER H, 1985, J VIROL, V53, P579; VANHEUVERSWYN H, 1979, J VIROL, V30, P936, DOI 10.1128/JVI.30.3.936-941.1979; VANNICE JL, 1984, P NATL ACAD SCI-BIOL, V81, P4241, DOI 10.1073/pnas.81.14.4241; WEIL R, 1978, BIOCHIM BIOPHYS ACTA, V516, P301, DOI 10.1016/0304-419X(78)90012-4; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445; YAMAMOTO M, 1983, P NATL ACAD SCI-BIOL, V80, P7524, DOI 10.1073/pnas.80.24.7524	80	130	141	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					601	608						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2542864				2022-12-28	WOS:A1989U768800010
J	ROTH, WK; WERNER, S; SCHIRREN, CG; HOFSCHNEIDER, PH				ROTH, WK; WERNER, S; SCHIRREN, CG; HOFSCHNEIDER, PH			DEPLETION OF PDGF FROM SERUM INHIBITS GROWTH OF AIDS-RELATED AND SPORADIC KAPOSIS SARCOMA-CELLS IN CULTURE	ONCOGENE			English	Article									UNIV MUNICH,DERMATOL KLIN,D-8000 MUNICH 2,FED REP GER	University of Munich	ROTH, WK (corresponding author), MAX PLANCK INST BIOCHEM,VIRUSFORSCH ABT,KLOPFERSPITZ 18A,D-8033 MARTINSRIED,FED REP GER.			Werner, Sabine/0000-0001-7397-8710				ALBINI A, 1988, J CELL BIOCHEM, V36, P369, DOI 10.1002/jcb.240360406; BETSHOLTZ C, 1984, J CELL PHYSIOL, V118, P203, DOI 10.1002/jcp.1041180213; CHIU IM, 1984, CELL, V37, P123; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DICORLETO PE, 1983, P NATL ACAD SCI-BIOL, V80, P1919, DOI 10.1073/pnas.80.7.1919; GOTTLIEB GJ, 1982, HUM PATHOL, V13, P882, DOI 10.1016/S0046-8177(82)80047-6; HAVERKOS HW, 1985, NEW ENGL J MED, V312, P1518; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; LITTLE D, 1986, J PATHOL, V149, P89, DOI 10.1002/path.1711490203; Maniatis T., 1982, MOL CLONING; MARTINET Y, 1986, NATURE, V319, P158, DOI 10.1038/319158a0; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; SALAHUDDIN SZ, 1988, SCIENCE, V242, P430, DOI 10.1126/science.2459779; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	14	49	50	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					483	487						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2541390				2022-12-28	WOS:A1989U567700013
J	TRENCH, GC; SOUTHALL, M; SMITH, P; KIDSON, C				TRENCH, GC; SOUTHALL, M; SMITH, P; KIDSON, C			ALLELIC VARIATION OF THE C-RAF-1 PROTO-ONCOGENE IN HUMAN LYMPHOMA AND LEUKEMIA	ONCOGENE			English	Article											TRENCH, GC (corresponding author), QUEENSLAND INST MED RES,BRAMSTON TERRACE,HERSTON,QLD 4006,AUSTRALIA.							BERARD CW, 1981, ANN INTERN MED, V94, P218, DOI 10.7326/0003-4819-94-2-218; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; CHENEVIXTRENCH G, 1987, LEUKEMIA, V1, P82; CLEVELAND JL, 1986, J CELL BIOCHEM, V30, P195, DOI 10.1002/jcb.240300303; COLL J, 1983, EMBO J, V2, P2189, DOI 10.1002/j.1460-2075.1983.tb01722.x; COX DW, 1987, AM J HUM GENET, V41, P891; HAYWARD NK, 1988, HUM GENET, V78, P115, DOI 10.1007/BF00278178; JACK AS, 1986, J PATHOL, V149, P25, DOI 10.1002/path.1711490107; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; Maniatis T., 1982, MOL CLONING; MCKEITHAN TW, 1986, P NATL ACAD SCI USA, V83, P6636, DOI 10.1073/pnas.83.17.6636; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; PETO TEA, 1988, AM J HUM GENET, V42, P615; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; THEIN SL, 1986, NATURE, V321, P84, DOI 10.1038/321084a0	19	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					507	510						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2566145				2022-12-28	WOS:A1989U567700016
J	WEISINGER, G; REMMERS, EF; HEARING, P; MARCU, KB				WEISINGER, G; REMMERS, EF; HEARING, P; MARCU, KB			MULTIPLE NEGATIVE ELEMENTS UPSTREAM OF THE MURINE C-MYC GENE SHARE NUCLEAR FACTOR BINDING-SITES WITH SV40 AND POLYOMA ENHANCERS	ONCOGENE			English	Article									SUNY STONY BROOK, DEPT BIOCHEM, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, DEPT MICROBIOL, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook				Remmers, Elaine F/0000-0002-9522-1249	NCI NIH HHS [NCI CA36246] Funding Source: Medline; NCPDCID CDC HHS [NCI-44673] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036246] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCPDCID CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BIENZTADMOR B, 1985, EMBO J, V4, P3209, DOI 10.1002/j.1460-2075.1985.tb04067.x; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; CREMISI C, 1986, J VIROL, V59, P761, DOI 10.1128/JVI.59.3.761-763.1986; DAVIDSON I, 1986, NATURE, V323, P544, DOI 10.1038/323544a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; EHRLICH R, 1988, MOL CELL BIOL, V8, P695, DOI 10.1128/MCB.8.2.695; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; IMLER JL, 1987, MOL CELL BIOL, V7, P2558, DOI 10.1128/MCB.7.7.2558; IRANI MH, 1983, CELL, V32, P783, DOI 10.1016/0092-8674(83)90064-8; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KADESCH T, 1986, NUCLEIC ACIDS RES, V14, P8209, DOI 10.1093/nar/14.20.8209; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; LANG RB, 1982, NUCLEIC ACIDS RES, V10, P611, DOI 10.1093/nar/10.2.611; LARSEN PR, 1986, P NATL ACAD SCI USA, V83, P8283, DOI 10.1073/pnas.83.21.8283; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAJUMDAR A, 1984, P NATL ACAD SCI-BIOL, V81, P6100, DOI 10.1073/pnas.81.19.6100; Maniatis T., 1982, MOL CLONING; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MOSTHAF L, 1985, NATURE, V315, P597, DOI 10.1038/315597a0; MUGLIA L, 1986, P NATL ACAD SCI USA, V83, P7653, DOI 10.1073/pnas.83.20.7653; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; OSTAPCHUK P, 1986, P NATL ACAD SCI USA, V83, P8550, DOI 10.1073/pnas.83.22.8550; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Ptashne M., 1986, A GENETIC SWITCH; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; SASSONECORSI P, 1986, TRENDS GENET, V2, P215, DOI 10.1016/0168-9525(86)90233-7; SASSONECORSI P, 1987, ONCOGENE RES, V1, P113; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SCHIRM S, 1987, GENE DEV, V1, P65, DOI 10.1101/gad.1.1.65; SERFLING E, 1985, TRENDS GENET, V1, P224, DOI 10.1016/0168-9525(85)90088-5; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; STRUHL K, 1985, NATURE, V317, P822, DOI 10.1038/317822a0; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; THIERRY F, 1987, EMBO J, V6, P3391, DOI 10.1002/j.1460-2075.1987.tb02662.x; WEINBERGER J, 1988, MOL CELL BIOL, V8, P988, DOI 10.1128/MCB.8.2.988; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x	51	28	29	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					635	646						12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577865				2022-12-28	WOS:A1988R646000003
J	GOLDMAN, DS; KIESSLING, AA; COOPER, GM				GOLDMAN, DS; KIESSLING, AA; COOPER, GM			POST-TRANSCRIPTIONAL PROCESSING SUGGESTS THAT C-MOS FUNCTIONS AS A MATERNAL MESSAGE IN MOUSE EGGS	ONCOGENE			English	Article									HARVARD UNIV,SCH MED,HUMAN REPROD & REPROD BIOL LAB,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MICROBIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MOLEC GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT OBSTET GYNECOL & REPROD BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	GOLDMAN, DS (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016561] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA028946, P01CA021082] Funding Source: NIH RePORTER; NCI NIH HHS [CA21082, CA28946] Funding Source: Medline; NICHD NIH HHS [HD16561] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; BORNSLAEGER EA, 1986, DEV BIOL, V114, P453, DOI 10.1016/0012-1606(86)90209-5; BRAUDE P, 1979, NATURE, V282, P102, DOI 10.1038/282102a0; CASCIO SM, 1982, DEV BIOL, V89, P397, DOI 10.1016/0012-1606(82)90328-1; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CLEGG KB, 1983, DEV BIOL, V95, P331, DOI 10.1016/0012-1606(83)90034-9; COLOT HV, 1982, DEV BIOL, V94, P79, DOI 10.1016/0012-1606(82)90070-7; Davidson E. H., 1986, GENE ACTIVITY EARLY; DWORKIN MB, 1985, DEV BIOL, V112, P451, DOI 10.1016/0012-1606(85)90417-8; GIEBELHAUS DH, 1983, DEV BIOL, V98, P148, DOI 10.1016/0012-1606(83)90343-3; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HOWLETT SK, 1985, J EMBRYOL EXP MORPH, V87, P175; HOWLETT SK, 1986, CELL, V45, P387, DOI 10.1016/0092-8674(86)90324-7; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; KLEENE KC, 1984, DEV BIOL, V105, P71, DOI 10.1016/0012-1606(84)90262-8; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; PHILPOTT CC, 1987, DEV BIOL, V121, P568, DOI 10.1016/0012-1606(87)90192-8; PIKO L, 1982, DEV BIOL, V89, P362, DOI 10.1016/0012-1606(82)90325-6; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; POUEYMIROU WT, 1987, DEV BIOL, V121, P489, DOI 10.1016/0012-1606(87)90185-0; PRATT HPM, 1983, CIBA F SYMP, V98, P197; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; ROSENTHAL ET, 1987, DEV BIOL, V121, P237, DOI 10.1016/0012-1606(87)90155-2; ROSENTHAL ET, 1986, DEV BIOL, V117, P55, DOI 10.1016/0012-1606(86)90347-7; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; STEWARD R, 1987, SCIENCE, V238, P692, DOI 10.1126/science.3118464; VANBLERKOM J, 1981, P NATL ACAD SCI-BIOL, V78, P7629; VANBLERKOM J, 1981, CELLULAR MOL ASPECTS, P155; VOURNAKIS JN, 1975, P NATL ACAD SCI USA, V72, P2959, DOI 10.1073/pnas.72.8.2959; WASSARMAN PM, 1976, NATURE, V261, P73, DOI 10.1038/261073a0; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	35	30	30	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1988	3	2					159	162						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Q0534	2457860				2022-12-28	WOS:A1988Q053400005
J	KAMPS, MP; SEFTON, BM				KAMPS, MP; SEFTON, BM			IDENTIFICATION OF MULTIPLE NOVEL POLYPEPTIDE SUBSTRATES OF THE V-SRC, V-YES, V-FPS, V-ROS, AND V-ERB-B ONCOGENIC TYROSINE PROTEIN-KINASES UTILIZING ANTISERA AGAINST PHOSPHOTYROSINE	ONCOGENE			English	Article									UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego	KAMPS, MP (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92138, USA.				NCI NIH HHS [CA-14195, CA 09523, CA-17289] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA017289] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTLER AM, 1985, MOL CELL BIOL, V5, P263, DOI 10.1128/MCB.5.1.263; BEEMON K, 1982, J VIROL, V42, P742, DOI 10.1128/JVI.42.2.742-747.1982; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6419; BRUGGE JS, 1984, J BIOL CHEM, V259, P4550; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; BURR JG, 1980, P NATL ACAD SCI-BIOL, V77, P3484, DOI 10.1073/pnas.77.6.3484; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER J, 1983, J VIROL, V46, P15, DOI 10.1128/JVI.46.1.15-28.1983; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1983, NATURE, V302, P218, DOI 10.1038/302218a0; COOPER JA, 1981, MOL CELL BIOL, V1, P394, DOI 10.1128/MCB.1.5.394; COOPER JA, 1983, J BIOL CHEM, V258, P1108; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; DECLUE JE, 1987, MOL CELL BIOL, V7, P371, DOI 10.1128/MCB.7.1.371; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; EK B, 1984, J BIOL CHEM, V259, P1145; FOULKES JG, 1983, J BIOL CHEM, V258, P431; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; FUKAMI Y, 1986, P NATL ACAD SCI USA, V83, P4190, DOI 10.1073/pnas.83.12.4190; GACON G, 1982, EUR J BIOCHEM, V125, P453, DOI 10.1111/j.1432-1033.1982.tb06704.x; GALLIS B, 1981, P NATL ACAD SCI-BIOL, V78, P6689, DOI 10.1073/pnas.78.11.6689; GILMORE T, 1985, CELL, V40, P609, DOI 10.1016/0092-8674(85)90209-0; GILMORE TD, 1982, MOL CELL BIOL, V2, P199, DOI 10.1128/MCB.2.2.199; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HUNTER T, 1981, CELL, V24, P741, DOI 10.1016/0092-8674(81)90100-8; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JACOBS S, 1983, J BIOL CHEM, V258, P9581; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KAMPS MP, 1986, CELL, V45, P105, DOI 10.1016/0092-8674(86)90542-8; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; LANDT M, 1978, BIOCHEMISTRY-US, V17, P915, DOI 10.1021/bi00598a027; MARTINEZ R, 1982, MOL CELL BIOL, V2, P653, DOI 10.1128/MCB.2.6.653; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; NECKAMEYER WS, 1984, J VIROL, V50, P914, DOI 10.1128/JVI.50.3.914-921.1984; NECKAMEYER WS, 1986, MOL CELL BIOL, V6, P1478, DOI 10.1128/MCB.6.5.1478; NELSON RL, 1984, MOL CELL BIOL, V4, P1003, DOI 10.1128/MCB.4.6.1003; NILSEN TW, 1985, CELL, V41, P719, DOI 10.1016/S0092-8674(85)80052-0; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; OHTSUKA M, 1984, INT J CANCER, V34, P855, DOI 10.1002/ijc.2910340618; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; RADKE K, 1979, P NATL ACAD SCI USA, V76, P5212, DOI 10.1073/pnas.76.10.5212; RADKE K, 1980, CELL, V21, P821, DOI 10.1016/0092-8674(80)90445-6; RADKE K, 1983, J CELL BIOL, V97, P1601, DOI 10.1083/jcb.97.5.1601; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; RUBIN JB, 1983, NATURE, V305, P438, DOI 10.1038/305438a0; SCHERR CJ, 1985, CELL, V41, P665; SEFTON BM, 1986, CURR TOP MICROBIOL, V123, P39; SEFTON BM, 1980, CELL, V20, P807, DOI 10.1016/0092-8674(80)90327-X; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; TABACHNICK M, 1960, J BIOL CHEM, V235, P1051; TABACHNICK M, 1959, J BIOL CHEM, V234, P1726; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X; ZIPPEL R, 1986, BIOCHIM BIOPHYS ACTA, V881, P54, DOI 10.1016/0304-4165(86)90096-6	64	410	416	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1988	2	4					305	315						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	M9472	2452398				2022-12-28	WOS:A1988M947200002
J	MURAKAMI, Y; KATAHIRA, M; MAKINO, R; HAYASHI, K; HIROHASHI, S; SEKIYA, T				MURAKAMI, Y; KATAHIRA, M; MAKINO, R; HAYASHI, K; HIROHASHI, S; SEKIYA, T			INACTIVATION OF THE RETINOBLASTOMA GENE IN A HUMAN LUNG-CARCINOMA CELL-LINE DETECTED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS OF THE POLYMERASE CHAIN-REACTION PRODUCT OF CDNA	ONCOGENE			English	Article							SUSCEPTIBILITY GENE; HUMAN DNA; C-MYC; EXPRESSION; AMPLIFICATION; MUTATIONS; SEQUENCE; CANCER; IDENTIFICATION; ORGANIZATION	Combined use of a simple, sensitive method of DNA analysis of nucleotide substitutions, namely, single-strand conformation polymorphism analysis of polymerase chain reation products (PCR-SSCP), and the reverse transcriptase reaction (RT) is an effective method for mRNA analysis. We used this RT-PCR-SSCP method to detect abnormal retinoblastoma (RB) gene transcripts in human tumor cell lines. Results showed the presence of two types of RB gene transcripts in a giant cell lung carcinoma cell line Lu65: a minor mRNA species with a base substitution that created a stop codon in the nucleotide sequence corresponding to exon 2 of the gene, and a major species of mRNA without the nucleotide sequence corresponding to that of exon 2. PCR-SSCP analysis of the genomic DNA also revealed that Lu65 cells contained the mutated RB allele, but not the normal allele. These results suggested that in Lu65 cells, both RB alleles were inactivated. The transcript without the exon 2 sequence, probably due to alternative splicing, was also found in all the other human cells examined, as a very minor species.	NATL CANC CTR,RES INST,DIV ONCOGENE,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV PATHOL,TOKYO 104,JAPAN	National Cancer Center - Japan; National Cancer Center - Japan								CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P3605, DOI 10.1093/nar/17.9.3605; HONG FD, 1989, P NATL ACAD SCI USA, V86, P5502, DOI 10.1073/pnas.86.14.5502; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; TANG A, 1989, ONCOGENE, V4, P401; TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x; XU HJ, 1989, ONCOGENE, V4, P807; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; YAMADA T, 1985, JPN J CANCER RES, V76, P967; YOKOTA J, 1988, ONCOGENE, V3, P471; YOSHIMOTO K, 1986, JPN J CANCER RES, V77, P540	30	45	49	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					37	42						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992444				2022-12-28	WOS:A1991EY03900005
J	SHAULSKY, G; BENZEEV, A; ROTTER, V				SHAULSKY, G; BENZEEV, A; ROTTER, V			SUBCELLULAR-DISTRIBUTION OF THE P53 PROTEIN DURING THE CELL-CYCLE OF BALB/C 3T3 CELLS	ONCOGENE			English	Article									WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science	SHAULSKY, G (corresponding author), WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL.			Shaulsky, Gad/0000-0002-0532-0551; ben-ze'ev, avri/0000-0001-6113-3921				ADDISON C, 1990, ONCOGENE, V5, P423; AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; BAER JS, 1989, SCIENCE, V244, P217; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; DANG CV, 1989, J BIOL CHEM, V264, P18019; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KELMAN Z, 1989, BLOOD, V74, P2318; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; MORA PT, 1980, NATURE, V288, P722, DOI 10.1038/288722a0; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MUNROE DG, 1988, ONCOGENE, V2, P621; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; ROTTER V, 1983, EMBO J, V2, P1041, DOI 10.1002/j.1460-2075.1983.tb01543.x; ROTTER V, 1985, P NATL ACAD SCI USA, V82, P790; SHOHAT O, 1987, ONCOGENE, V1, P277; STURZBECHER HW, 1988, ONCOGENE, V3, P405; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WILLIAMS NW, 1989, EXP CELL RES, V184, P316, DOI 10.1016/0014-4827(89)90331-5; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; WYNFORDTHOMAS D, 1985, EXP CELL RES, V159, P191, DOI 10.1016/S0014-4827(85)80048-3; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	41	209	211	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1707	1711						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267137				2022-12-28	WOS:A1990EL40100014
J	ECCLES, MR; BAUMBACH, WR; COLE, MD				ECCLES, MR; BAUMBACH, WR; COLE, MD			EXAMINATION OF THE ROLE OF CSF-1 INDEPENDENCE IN MYC RETROVIRUS INDUCED MONOCYTE TUMORIGENESIS	ONCOGENE			English	Article									PRINCETON UNIV,LEWIS THOMAS LAB,DEPT BIOL,PRINCETON,NJ 08544; UNIV OTAGO,DEPT BIOCHEM,DUNEDIN,NEW ZEALAND; AMER CYANAMID CO,DEPT MOLEC BIOL,PRINCETON,NJ 08540	Princeton University; University of Otago; American Cyanamid Company					FOGARTY INTERNATIONAL CENTER [F05TW003942] Funding Source: NIH RePORTER; FIC NIH HHS [F05 TW03942] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; BAUMBACH WR, 1988, J VIROL, V62, P3151, DOI 10.1128/JVI.62.9.3151-3155.1988; BAUMBACH WR, 1987, MOL CELL BIOL, V7, P664, DOI 10.1128/MCB.7.2.664; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; WHEELER EF, 1986, NATURE, V324, P377, DOI 10.1038/324377a0	16	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1535	1539						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250911				2022-12-28	WOS:A1990EK50200013
J	RESH, MD				RESH, MD			MEMBRANE INTERACTIONS OF PP60V-SRC - A MODEL FOR MYRISTYLATED TYROSINE PROTEIN-KINASES	ONCOGENE			English	Review											RESH, MD (corresponding author), PRINCETON UNIV,LEWIS THOMAS LAB,DEPT MOLEC BIOL,PRINCETON,NJ 08544, USA.			Resh, Marilyn/0000-0001-6118-9466				AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P191, DOI 10.1007/BF01871629; BALLMERHOFER K, 1988, ONCOGENE, V3, P365; BARNEKOW A, 1980, Biochemical Society Transactions, V8, P735; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BENZEEV A, 1979, CELL, V17, P859, DOI 10.1016/0092-8674(79)90326-X; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; BOSS MA, 1981, J VIROL, V40, P472, DOI 10.1128/JVI.40.2.472-481.1981; BROOKSWILSON AR, 1989, MOL CELL BIOL, V9, P2214, DOI 10.1128/MCB.9.5.2214; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; BURR JG, 1980, P NATL ACAD SCI-BIOL, V77, P3484, DOI 10.1073/pnas.77.6.3484; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CHOW M, 1987, NATURE, V327, P482, DOI 10.1038/327482a0; COLLETT MS, 1980, NATURE, V285, P167, DOI 10.1038/285167a0; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; COURTNEIDGE SA, 1982, P NATL ACAD SCI-BIOL, V79, P7117, DOI 10.1073/pnas.79.23.7117; CROSS FR, 1985, MOL CELL BIOL, V5, P2789, DOI 10.1128/MCB.5.10.2789; CROSS FR, 1984, MOL CELL BIOL, V4, P1834, DOI 10.1128/MCB.4.9.1834; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; DEHAZYA P, 1985, VIROLOGY, V143, P407, DOI 10.1016/0042-6822(85)90381-2; DEICHAITE I, 1988, MOL CELL BIOL, V8, P4295, DOI 10.1128/MCB.8.10.4295; DONNER P, 1981, J BIOL CHEM, V256, P8786; DURONIO RJ, 1989, SCIENCE, V243, P796, DOI 10.1126/science.2644694; ERIKSON E, 1978, NATURE, V274, P919, DOI 10.1038/274919a0; FEUERMAN MH, 1985, J VIROL, V54, P804, DOI 10.1128/JVI.54.3.804-816.1985; FUNG YKT, 1983, P NATL ACAD SCI-BIOL, V80, P353, DOI 10.1073/pnas.80.2.353; GARBER EA, 1982, VIROLOGY, V118, P419, DOI 10.1016/0042-6822(82)90361-0; GARBER EA, 1983, VIROLOGY, V126, P73, DOI 10.1016/0042-6822(83)90462-2; GARBER EA, 1987, P NATL ACAD SCI USA, V84, P80, DOI 10.1073/pnas.84.1.80; GARBER EA, 1987, J VIROL, V61, P354, DOI 10.1128/JVI.61.2.354-360.1987; GARBER EA, 1985, MOL CELL BIOL, V5, P2781, DOI 10.1128/MCB.5.10.2781; GILMER TM, 1981, NATURE, V294, P771, DOI 10.1038/294771a0; GODDARD C, 1989, J BIOL CHEM, V264, P15173; GRIFFITHS G, 1984, J CELL BIOL, V98, P2133, DOI 10.1083/jcb.98.6.2133; HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312; HAMAGUCHI M, 1990, MOL CELL BIOL, V10, P830, DOI 10.1128/MCB.10.2.830; HANAFUSA H, 1977, COMPREHENSIVE VIROLO, V10, P401; HEUCKEROTH RO, 1989, P NATL ACAD SCI USA, V86, P5262, DOI 10.1073/pnas.86.14.5262; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KAMPS MP, 1986, CELL, V45, P105, DOI 10.1016/0092-8674(86)90542-8; KAPLAN JM, 1988, MOL CELL BIOL, V8, P2435, DOI 10.1128/MCB.8.6.2435; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KOZMA LM, 1990, MOL CELL BIOL, V10, P837, DOI 10.1128/MCB.10.2.837; KRUEGER JG, 1984, MOL CELL BIOL, V4, P454, DOI 10.1128/MCB.4.3.454; KRUEGER JG, 1980, P NATL ACAD SCI-BIOL, V77, P4142, DOI 10.1073/pnas.77.7.4142; KRUEGER JG, 1980, VIROLOGY, V101, P25, DOI 10.1016/0042-6822(80)90480-8; KRUEGER JG, 1982, CELL, V28, P889, DOI 10.1016/0092-8674(82)90068-X; KRUEGER JG, 1983, CURR TOP MICROBIOL I, V107, P52; KRZYZEK RA, 1980, J VIROL, V36, P805, DOI 10.1128/JVI.36.3.805-815.1980; LEE JS, 1979, J BIOL CHEM, V254, P8015; LEVINSON AD, 1981, P NATL ACAD SCI-BIOL, V78, P1624, DOI 10.1073/pnas.78.3.1624; LOEB DM, 1987, J VIROL, V61, P2420, DOI 10.1128/JVI.61.8.2420-2427.1987; MANGER R, 1986, J VIROL, V59, P66, DOI 10.1128/JVI.59.1.66-72.1986; MCGRATH JP, 1982, NATURE, V295, P423, DOI 10.1038/295423a0; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NIGG EA, 1982, P NATL ACAD SCI-BIOL, V79, P5322, DOI 10.1073/pnas.79.17.5322; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; OPPERMANN H, 1981, VIROLOGY, V113, P736, DOI 10.1016/0042-6822(81)90202-6; PALMITER RD, 1978, P NATL ACAD SCI USA, V75, P94, DOI 10.1073/pnas.75.1.94; PARSONS JT, 1989, CURR TOP MICROBIOL I, V147, P80; PAWSON T, 1988, ONCOGENE, V3, P491; PELLMAN D, 1985, P NATL ACAD SCI USA, V82, P1623, DOI 10.1073/pnas.82.6.1623; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; PRIVALSKY ML, 1987, J VIROL, V61, P1938, DOI 10.1128/JVI.61.6.1938-1948.1987; PURCHIO AF, 1977, P NATL ACAD SCI USA, V74, P4661, DOI 10.1073/pnas.74.10.4661; PURCHIO AF, 1978, P NATL ACAD SCI USA, V75, P1567, DOI 10.1073/pnas.75.3.1567; REIN A, 1986, P NATL ACAD SCI USA, V83, P7246, DOI 10.1073/pnas.83.19.7246; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; RESH MD, 1985, J CELL BIOL, V100, P409, DOI 10.1083/jcb.100.2.409; RESH MD, 1988, MOL CELL BIOL, V8, P1896, DOI 10.1128/MCB.8.5.1896; RESH MD, 1985, MOL CELL BIOL, V5, P916, DOI 10.1128/MCB.5.5.916; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; ROHRSCHNEIDER L, 1983, MOL CELL BIOL, V3, P731, DOI 10.1128/MCB.3.4.731; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; ROHRSCHNEIDER LR, 1979, CELL, V16, P11, DOI 10.1016/0092-8674(79)90183-1; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Rous P, 1910, J EXP MED, V12, P344, DOI 10.1084/jem.12.3.344; SCHULTZ AM, 1985, SCIENCE, V227, P427, DOI 10.1126/science.3917576; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; SEFTON BM, 1979, J VIROL, V30, P311, DOI 10.1128/JVI.30.1.311-318.1979; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHRIVER K, 1981, J CELL BIOL, V89, P525, DOI 10.1083/jcb.89.3.525; STOKER AW, 1986, J VIROL, V58, P876, DOI 10.1128/JVI.58.3.876-883.1986; TAKEYA T, 1982, J VIROL, V44, P12, DOI 10.1128/JVI.44.1.12-18.1982; TANAKA T, 1984, VIROLOGY, V133, P202, DOI 10.1016/0042-6822(84)90440-9; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; WANG HCR, 1989, J VIROL, V63, P291, DOI 10.1128/JVI.63.1.291-302.1989; WELHAM MJ, 1988, J VIROL, V62, P1898, DOI 10.1128/JVI.62.6.1898-1906.1988; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; WILKERSON VW, 1985, J VIROL, V55, P314, DOI 10.1128/JVI.55.2.314-321.1985; WILLINGHAM MC, 1979, CELL, V18, P125, DOI 10.1016/0092-8674(79)90361-1; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	103	69	72	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1437	1444						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250906				2022-12-28	WOS:A1990EK50200001
J	AHUJA, HG; TESTA, MP; CLINE, MJ				AHUJA, HG; TESTA, MP; CLINE, MJ			VARIATION IN THE PROTEIN CODING REGION OF THE HUMAN P53 GENE	ONCOGENE			English	Note											AHUJA, HG (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,JONSSON COMPREHENS CANC CTR,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024, USA.				PHS HHS [50275] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; ELIYAHU D, 1988, ONCOGENE, V3, P313; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WOLF D, 1984, MOL CELL BIOL, V4, P1402, DOI 10.1128/MCB.4.7.1402	13	33	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1409	1410						2	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	1977117				2022-12-28	WOS:A1990EC24100020
J	BAKKUS, MHC; PEER, KMJB; MICHIELS, JJ; VANTVEER, MB; BENNER, R				BAKKUS, MHC; PEER, KMJB; MICHIELS, JJ; VANTVEER, MB; BENNER, R			AMPLIFICATION OF THE C-MYC AND THE PVT-LIKE REGION IN HUMAN MULTIPLE-MYELOMA	ONCOGENE			English	Article									DR DANIEL DENHOED CANC CTR,DEPT HEMATOL,ROTTERDAM,NETHERLANDS; ACAD HOSP ROTTERDAM,DEPT IMMUNOL,DIJKZIGT,NETHERLANDS; ACAD HOSP ROTTERDAM,DEPT HEMATOL,DIJKZIGT,NETHERLANDS; ERASMUS UNIV,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam								ADAMS JM, 1986, CURR TOP MICROBIOL, V132, P1; ASKER C, 1988, LEUKEMIA RES, V12, P523, DOI 10.1016/0145-2126(88)90120-8; BANERJEE M, 1985, EMBO J, V4, P3183, DOI 10.1002/j.1460-2075.1985.tb04063.x; BARLOGIE B, 1986, MULTIPLE MYELOMA OTH, P154; BENHAM FJ, 1984, EMBO J, V3, P2635, DOI 10.1002/j.1460-2075.1984.tb02186.x; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; CROCE CM, 1985, BLOOD, V65, P1; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DEWALD GW, 1985, BLOOD, V66, P380; DURIE BGM, 1985, BLOOD, V66, P548; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERTI A, 1984, CANCER GENET CYTOGEN, V12, P247, DOI 10.1016/0165-4608(84)90036-0; GAZDAR AF, 1986, BLOOD, V67, P1542; GRAHAM M, 1986, EMBO J, V5, P2845, DOI 10.1002/j.1460-2075.1986.tb04578.x; GRAHAM M, 1985, NATURE, V314, P740, DOI 10.1038/314740a0; GRIESSER H, 1986, BLOOD, V68, P592; HUMPHRIES JE, 1989, BLOOD, V74, pA375; JERNBERG H, 1987, BLOOD, V69, P1605; KATAGIRI S, 1985, INT J CANCER, V36, P241, DOI 10.1002/ijc.2910360217; LATREILLE J, 1982, BLOOD, V59, P43; Lewis J P, 1984, Hematol Oncol, V2, P307; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Maniatis T., 1982, MOL CLONING; MELLSTEDT H, 1984, ADV CANCER RES, V41, P257; MELTZER P, 1987, BLOOD, V70, pA985; MENGLEGAW L, 1987, EMBO J, V6, P1959, DOI 10.1002/j.1460-2075.1987.tb02458.x; PEGORARO L, 1989, BLOOD, V73, P1020; POTTER M, 1984, CANCER INVEST, V2, P285, DOI 10.3109/07357908409018443; RANNI NS, 1987, CANCER GENET CYTOGEN, V25, P309, DOI 10.1016/0165-4608(87)90192-0; RDL J, 1990, BRIT J CANCER, V61, P276; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SELVANAYAGAM P, 1988, BLOOD, V71, P30; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; SHTIVELMAN E, 1990, MOL CELL BIOL, V10, P1835, DOI 10.1128/MCB.10.4.1835; SHTIVELMAN E, 1989, P NATL ACAD SCI USA, V86, P3257, DOI 10.1073/pnas.86.9.3257; SIEGELMAN MH, 1985, J EXP MED, V161, P850, DOI 10.1084/jem.161.4.850; SUMEGI J, 1985, INT J CANCER, V36, P367; TSICHLIS PN, 1989, P NATL ACAD SCI USA, V86, P5487, DOI 10.1073/pnas.86.14.5487; VANDONGEN JJM, 1987, APPLICATION MONOCLON, P87	43	27	28	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1359	1364						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216459				2022-12-28	WOS:A1990EC24100012
J	CLASSON, M; HENRIKSSON, M; KLEIN, G; SUMEGI, J				CLASSON, M; HENRIKSSON, M; KLEIN, G; SUMEGI, J			THE EFFECT OF MYC PROTEINS ON SV40 REPLICATION IN HUMAN LYMPHOID-CELLS	ONCOGENE			English	Article											CLASSON, M (corresponding author), KAROLINSKA INST, DEPT TUMOR BIOL, S-10401 STOCKHOLM 60, SWEDEN.		Henriksson, Marie Arsenian/F-5010-2015		NATIONAL CANCER INSTITUTE [R01CA014054] Funding Source: NIH RePORTER; NCI NIH HHS [5RO1 CA14054-14] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P100, DOI 10.1073/pnas.80.1.100; ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; BIRRER MJ, 1989, MOL CELL BIOL, V9, P2734, DOI 10.1128/MCB.9.6.2734; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; BROOKS BJ, 1986, ADV VIRAL ONCOL, V7, P155; CAVALIERI F, 1988, ONCOGENE, V2, P289; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DANG CV, 1989, MOL CELL BIOL, V9, P2477, DOI 10.1128/MCB.9.6.2477; DEGREVE J, 1988, MOL CELL BIOL, V8, P4381, DOI 10.1128/MCB.8.10.4381; DEPAMPHILIS ML, 1986, PAPOVAVIRIDAE, V1, P99; DEPINHO RA, 1986, P NATL ACAD SCI USA, V83, P1827, DOI 10.1073/pnas.83.6.1827; DEPINHO RA, 1987, GENE DEV, V1, P1311, DOI 10.1101/gad.1.10.1311; DILDROP R, 1989, EMBO J, V8, P1121, DOI 10.1002/j.1460-2075.1989.tb03482.x; EVAN GI, 1988, CURR TOP MICROBIOL, V141, P189; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; HAMMARSKJOLD ML, 1986, GENE, V43, P41, DOI 10.1016/0378-1119(86)90006-5; HENRIKSSON M, 1988, CURR TOP MICROBIOL, V141, P202; HENRIKSSON M, 1988, ONCOGENE, V3, P587; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; INGVARSSON S, 1987, SOMAT CELL MOLEC GEN, V13, P335, DOI 10.1007/BF01534927; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KIRSCH IR, 1986, J CELL BIOCHEM, V32, P11, DOI 10.1002/jcb.240320103; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LEGOUY E, 1987, EMBO J, V6, P3359, DOI 10.1002/j.1460-2075.1987.tb02657.x; MARGOLSKEE RF, 1984, J VIROL, V49, P386, DOI 10.1128/JVI.49.2.386-393.1984; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MENEZES J, 1975, BIOMEDICINE, V22, P276; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; SCHWAB M, 1988, P NATL ACAD SCI USA, V85, P9585, DOI 10.1073/pnas.85.24.9585; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; TAYA Y, 1986, EMBO J, V5, P1215, DOI 10.1002/j.1460-2075.1986.tb04349.x; TEGTMEYER P, 1972, J VIROL, V10, P591, DOI 10.1128/JVI.10.4.591-598.1972; YANCOPOULOS GD, 1985, P NATL ACAD SCI USA, V82, P5455, DOI 10.1073/pnas.82.16.5455; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	52	13	13	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	1990	5	9					1371	1376						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2170898				2022-12-28	WOS:A1990EC24100014
J	ERLANDSSON, R; BERGERHEIM, USR; BOLDOG, F; MARCSEK, Z; KUNIMI, K; LIN, BYT; INGVARSSON, S; CASTRESANA, JS; LEE, WH; LEE, E; KLEIN, G; SUMEGI, J				ERLANDSSON, R; BERGERHEIM, USR; BOLDOG, F; MARCSEK, Z; KUNIMI, K; LIN, BYT; INGVARSSON, S; CASTRESANA, JS; LEE, WH; LEE, E; KLEIN, G; SUMEGI, J			A GENE NEAR THE D3F15S2 SITE ON 3P IS EXPRESSED IN NORMAL HUMAN KIDNEY BUT NOT OR ONLY AT A SEVERELY REDUCED LEVEL IN 11 OF 15 PRIMARY RENAL-CELL CARCINOMAS (RCC)	ONCOGENE			English	Article									KAROLINSKA HOSP, LUNDIG INST CANC RES, S-10401 STOCKHOLM 60, SWEDEN; UNIV CALIF SAN DIEGO, SCH MED, DEPT PATHOL, LA JOLLA, CA 92093 USA	Karolinska Institutet; Karolinska University Hospital; University of California System; University of California San Diego	ERLANDSSON, R (corresponding author), KAROLINSKA INST, DEPT TUMOR BIOL, BOX 60400, S-10401 STOCKHOLM 60, SWEDEN.		Ingvarsson, Sigurdur/E-7448-2011; Castresana, Javier S/AFT-2167-2022	Ingvarsson, Sigurdur/0000-0003-4125-1714; Castresana, Javier S./0000-0002-2373-482X				BABU VR, 1987, CANCER RES, V47, P6800; BERGERHEIM U, 1989, CANCER RES, V49, P1390; BOLDOG F, 1989, CANCER GENET CYTOGEN, V42, P295, DOI 10.1016/0165-4608(89)90098-8; BULLERDIEK J, 1987, CANCER GENET CYTOGEN, V27, P177, DOI 10.1016/0165-4608(87)90273-1; CARRITT B, 1986, AM J HUM GENET, V38, P428; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; ERLANDSSON R, 1988, CANCER GENET CYTOGEN, V36, P197, DOI 10.1016/0165-4608(88)90145-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOODE ME, 1986, AM J HUM GENET, V38, P437; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HEIM S, 1989, ADV CANCER RES, V52, P1; KIDD KK, 1985, CYTOGENET CELL GENET, V40, P107, DOI 10.1159/000132171; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MULERIS M, 1987, INT J CANCER, V39, P595, DOI 10.1002/ijc.2910390509; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; NAYLOR SL, 1989, GENOMICS, V4, P355, DOI 10.1016/0888-7543(89)90342-X; OHYASHIKI K, 1986, CANCER RES, V46, P5282; PATHAK S, 1982, SCIENCE, V217, P939, DOI 10.1126/science.7112106; POPESCU NC, 1988, CANCER RES, V48, P142; QUINN LA, 1979, CANCER RES, V39, P4914; RHIM JS, 1975, INT J CANCER, V15, P23, DOI 10.1002/ijc.2910150104; ROWE M, 1989, ADV VIRAL ONCOL, V8, P237; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; TORY K, 1989, J NATL CANCER I, V81, P1097, DOI 10.1093/jnci/81.14.1097; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VANDERHOUT AH, 1988, CANCER GENET CYTOGEN, V32, P281, DOI 10.1016/0165-4608(88)90292-0; WANG N, 1984, CANCER GENET CYTOGEN, V11, P479, DOI 10.1016/0165-4608(84)90028-1; WHANGPENG J, 1988, J NATL CANCER I, V80, P1253, DOI 10.1093/jnci/80.15.1253; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; ZHANG R, 1989, CANCER RES, V49, P444	36	42	42	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	1990	5	8					1207	1211						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392324				2022-12-28	WOS:A1990DX36100014
J	WESTIN, EH; GORSE, KM; CLARKE, MF				WESTIN, EH; GORSE, KM; CLARKE, MF			ALTERNATIVE SPLICING OF THE HUMAN C-MYB GENE	ONCOGENE			English	Article									VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MED,DIV HEMATOL ONCOL,RICHMOND,VA 23298; UNIV MICHIGAN,DEPT MED,DIV HEMATOL ONCOL,ANN ARBOR,MI 48109	Virginia Commonwealth University; University of Michigan System; University of Michigan								ALBRETSEN C, 1988, ANAL BIOCHEM, V170, P193, DOI 10.1016/0003-2697(88)90108-X; BADING H, 1987, ONCOGENE, V1, P395; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; EVINGERHODGES MJ, 1987, LEUKEMIA, V1, P597; FRANCHINI G, 1983, P NATL ACAD SCI-BIOL, V80, P7385, DOI 10.1073/pnas.80.24.7385; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GOODWIN RG, 1986, MOL CELL BIOL, V6, P3128, DOI 10.1128/MCB.6.9.3128; IBANEZ CE, 1988, J VIROL, V62, P1981, DOI 10.1128/JVI.62.6.1981-1988.1988; ISHIKURA H, 1987, CANCER RES, V47, P1052; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; KORNELUK RG, 1985, GENE, V40, P317, DOI 10.1016/0378-1119(85)90055-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAVU S, 1986, NUCLEIC ACIDS RES, V14, P5309, DOI 10.1093/nar/14.13.5309; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; LEPRINCE D, 1988, J VIROL, V62, P3233, DOI 10.1128/JVI.62.9.3233-3241.1988; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; PETERS CWB, 1987, EMBO J, V6, P3085, DOI 10.1002/j.1460-2075.1987.tb02616.x; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTONI MJ, 1989, EMBO J, V8, P385, DOI 10.1002/j.1460-2075.1989.tb03389.x; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHENONG GLC, 1987, EMBO J, V6, P4035, DOI 10.1002/j.1460-2075.1987.tb02748.x; SLAMON DJ, 1986, SCIENCE, V233, P347, DOI 10.1126/science.3014652; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STANTON LW, 1987, MOL CELL BIOL, V7, P4266, DOI 10.1128/MCB.7.12.4266; STRAUSS EC, 1986, ANAL BIOCHEM, V154, P353, DOI 10.1016/0003-2697(86)90536-1; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	45	24	29	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1117	1124						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202948				2022-12-28	WOS:A1990DX36100002
J	GANDINO, L; DIRENZO, MF; GIORDANO, S; BUSSOLINO, F; COMOGLIO, PM				GANDINO, L; DIRENZO, MF; GIORDANO, S; BUSSOLINO, F; COMOGLIO, PM			PROTEIN KINASE-C ACTIVATION INHIBITS TYROSINE PHOSPHORYLATION OF THE C-MET PROTEIN	ONCOGENE			English	Article									UNIV TURIN,DEPT BIOMED SCI & ONCOL,C SO M DAZEGLIO 52,I-10126 TURIN,ITALY; UNIV TURIN,DEPT GENET BIOL & CHEM MED,I-10126 TURIN,ITALY	University of Turin; University of Turin			Bussolino, Federico/AES-3951-2022; Giordano, Silvia/J-9858-2018; DI RENZO, Maria Flavia/B-6091-2012; Bussolino, Federico/K-2500-2016	Giordano, Silvia/0000-0003-1854-1086; DI RENZO, Maria Flavia/0000-0002-5093-3373; Bussolino, Federico/0000-0002-5348-1341				BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BROWN KD, 1979, BIOCHEM BIOPH RES CO, V86, P1037, DOI 10.1016/0006-291X(79)90221-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; COCHET C, 1984, J BIOL CHEM, V259, P2553; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DAVIS RJ, 1984, J BIOL CHEM, V259, P8545; DIRENZO MF, 1986, EUR J BIOCHEM, V158, P383; DOWNING JR, 1989, MOL CELL BIOL, V9, P2890, DOI 10.1128/MCB.9.7.2890; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; FRIEDMAN BA, 1984, P NATL ACAD SCI-BIOL, V81, P3034, DOI 10.1073/pnas.81.10.3034; GIORDANO S, 1988, MOL CELL BIOL, V8, P3510, DOI 10.1128/MCB.8.8.3510; GIORDANO S, 1988, J CELL BIOCHEM, V38, P229, DOI 10.1002/jcb.240380402; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; HEPLER JR, 1988, J BIOL CHEM, V263, P7610; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; JACOBS S, 1983, P NATL ACAD SCI-BIOL, V80, P6211, DOI 10.1073/pnas.80.20.6211; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KING CS, 1986, J BIOL CHEM, V261, P73; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN MF, 1988, MOL CELL BIOL, V8, P5477, DOI 10.1128/MCB.8.12.5477; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; MOTOYAMA T, 1984, ACTA MED BIOL, V27, P49; NESTLER EJ, 1983, NATURE, V305, P583, DOI 10.1038/305583a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; RANDO RR, 1988, FASEB J, V2, P2348, DOI 10.1096/fasebj.2.8.3282960; ROOME J, 1988, BIOCHEM J, V256, P493, DOI 10.1042/bj2560493; SHACKELFORD DA, 1984, J BIOL CHEM, V259, P1706; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; STURANI E, 1988, MOL CELL BIOL, V8, P1345, DOI 10.1128/MCB.8.3.1345; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TEMPEST PR, 1988, BRIT J CANCER, V58, P3, DOI 10.1038/bjc.1988.150; TEMPEST PR, 1986, FEBS LETT, V209, P357, DOI 10.1016/0014-5793(86)81142-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHITELEY B, 1986, J CELL BIOL, V103, P1355, DOI 10.1083/jcb.103.4.1355	40	70	72	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					721	725						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2111905				2022-12-28	WOS:A1990DG37400013
J	HAN, JW; GAUT, J; BURSTEIN, E; SADOWSKI, H; YOUNG, D; MACARA, IG				HAN, JW; GAUT, J; BURSTEIN, E; SADOWSKI, H; YOUNG, D; MACARA, IG			THE ONCOGENIC PROTEIN P60V-SRC HAS COMPETENCE ACTIVITY BUT DOES NOT ACTIVATE PHOSPHATIDYLINOSITOL TURNOVER OR PROTEIN KINASE-C IN BALB/C 3T3 CELLS	ONCOGENE			English	Article									UNIV ROCHESTER,MED CTR,DEPT MED,ROCHESTER,NY 14642	University of Rochester	HAN, JW (corresponding author), UNIV ROCHESTER,MED CTR,DEPT BIOPHYS,ENVIRONM HLTH SCI CTR,601 ELMWOOD AVE,ROCHESTER,NY 14642, USA.				NATIONAL CANCER INSTITUTE [R01CA038888, R01CA047650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016177] Funding Source: NIH RePORTER; NCI NIH HHS [CA 38888, CA 47650] Funding Source: Medline; NIDDK NIH HHS [DK-16177] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ANTONIADES HN, 1975, P NATL ACAD SCI USA, V72, P2635, DOI 10.1073/pnas.72.7.2635; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; CHIARUGI V, 1987, ONCOGENE, V2, P37; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; ESCOBEDO JA, 1988, J BIOL CHEM, V263, P1482; FALETTO DL, 1985, CELL, V43, P315, DOI 10.1016/0092-8674(85)90037-6; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; GRAY GM, 1988, J BIOL CHEM, V263, P10714; HASEGAWASASAKI H, 1985, BIOCHEM J, V232, P99, DOI 10.1042/bj2320099; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAPLAN DR, 1986, P NATL ACAD SCI USA, V83, P3624, DOI 10.1073/pnas.83.11.3624; KRUG E, 1987, J BIOL CHEM, V262, P11852; LEVENSON RM, 1986, ANAL BIOCHEM, V158, P294, DOI 10.1016/0003-2697(86)90553-1; MACARA IG, 1985, AM J PHYSIOL, V248, pC3, DOI 10.1152/ajpcell.1985.248.1.C3; MACARA IG, 1984, P NATL ACAD SCI-BIOL, V81, P2728, DOI 10.1073/pnas.81.9.2728; MACARA IG, 1986, J BIOL CHEM, V261, P9321; MARTINS TJ, 1989, J CELL BIOL, V108, P683, DOI 10.1083/jcb.108.2.683; MATUOKA K, 1988, SCIENCE, V239, P640, DOI 10.1126/science.2829356; MAYTIN EV, 1983, J BIOL CHEM, V258, P2718; OLASHAW NE, 1986, P NATL ACAD SCI USA, V83, P3834, DOI 10.1073/pnas.83.11.3834; PLEDGER WJ, 1978, P NATL ACAD SCI USA, V75, P2839, DOI 10.1073/pnas.75.6.2839; PREISS J, 1986, J BIOL CHEM, V261, P8597; REDDY S, 1988, MOL CELL BIOL, V8, P704, DOI 10.1128/MCB.8.2.704; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; SAGARA J, 1986, CANCER RES, V46, P5291; SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956; SNYDER MA, 1983, CELL, V32, P891, DOI 10.1016/0092-8674(83)90074-0; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; SUGIMOTO Y, 1985, MOL CELL BIOL, V5, P3194, DOI 10.1128/MCB.5.11.3194; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; THOM RE, 1987, FEBS LETT, V222, P104, DOI 10.1016/0014-5793(87)80200-4; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; YOUNG DA, 1983, METHOD ENZYMOL, V91, P190	36	12	12	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					467	474						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2158036				2022-12-28	WOS:A1990DB85300003
J	BENBROOK, DM; JONES, NC				BENBROOK, DM; JONES, NC			HETERODIMER FORMATION BETWEEN CREB AND JUN PROTEINS	ONCOGENE			English	Article									IMPERIAL CANC RES FUND,GENE REGUL LAB,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK								ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1987, ONCOGENE, V2, P79; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HARDY S, 1988, P NATL ACAD SCI USA, V85, P4171, DOI 10.1073/pnas.85.12.4171; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; KANEIISHII C, 1989, NUCLEIC ACIDS RES, V17, P1521, DOI 10.1093/nar/17.4.1521; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KRYSZKE MH, 1987, NATURE, V328, P254, DOI 10.1038/328254a0; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LEE KAW, 1989, MOL CELL BIOL, V9, P4390, DOI 10.1128/MCB.9.10.4390; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V341, P243, DOI 10.1038/341243a0; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SELLERS JW, 1989, NATURE, V341, P74, DOI 10.1038/341074a0; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	47	361	362	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					295	302						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2138276				2022-12-28	WOS:A1990CW41500006
J	STETTER, G; MONTENARH, M				STETTER, G; MONTENARH, M			COMPLEX INTERACTION OF SV40 LARGE T-ANTIGEN WITH THE CONTROL REGION ON THE SV40-DNA	ONCOGENE			English	Article									UNIV ULM,DEPT BIOCHEM,POB 4066,D-7900 ULM,FED REP GER	Ulm University			Montenarh, Mathias/AAB-6689-2020					ALWINE JC, 1977, J VIROL, V24, P22, DOI 10.1128/JVI.24.1.22-27.1977; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BRADY J, 1985, P NATL ACAD SCI USA, V82, P7299, DOI 10.1073/pnas.82.21.7299; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; DEB S, 1987, J VIROL, V61, P2143, DOI 10.1128/JVI.61.7.2143-2149.1987; DIMAIO D, 1982, J MOL BIOL, V156, P531, DOI 10.1016/0022-2836(82)90265-0; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; HANSEN U, 1981, CELL, V27, P603, DOI 10.1016/0092-8674(81)90402-5; KELLER JM, 1985, MOL CELL BIOL, V5, P1859, DOI 10.1128/MCB.5.8.1859; MONTENARH M, 1987, FEBS LETT, V204, P51; MULLER D, 1987, VIROLOGY, V161, P81, DOI 10.1016/0042-6822(87)90173-5; MYERS RM, 1980, P NATL ACAD SCI-BIOL, V77, P6491, DOI 10.1073/pnas.77.11.6491; MYERS RM, 1981, CELL, V25, P373, DOI 10.1016/0092-8674(81)90056-8; RIO D, 1980, P NATL ACAD SCI-BIOL, V77, P5706, DOI 10.1073/pnas.77.10.5706; RIO DC, 1983, CELL, V32, P1227, DOI 10.1016/0092-8674(83)90305-7; RUNZLER R, 1987, J VIROL, V61, P2076, DOI 10.1128/JVI.61.7.2076-2083.1987; RYDER K, 1985, CELL, V42, P539, DOI 10.1016/0092-8674(85)90111-4; SCHURMANN C, 1985, VIROLOGY, V146, P1, DOI 10.1016/0042-6822(85)90047-9; SHORTLE DR, 1979, P NATL ACAD SCI USA, V76, P6128, DOI 10.1073/pnas.76.12.6128; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; STETTER G, 1988, VIROLOGY, V164, P309, DOI 10.1016/0042-6822(88)90543-0; TEGTMEYER P, 1975, J VIROL, V15, P613, DOI 10.1128/JVI.15.3.613-618.1975; TOOZE J, 1981, DNA TUMOUR VIRUSES; WACHTER M, 1985, J VIROL, V56, P520, DOI 10.1128/JVI.56.2.520-526.1985; WIEKOWSKI M, 1987, J VIROL, V61, P411, DOI 10.1128/JVI.61.2.411-418.1987; WILSON VG, 1982, J VIROL, V44, P458, DOI 10.1128/JVI.44.2.458-466.1982	27	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1353	1357						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554237				2022-12-28	WOS:A1989AX65900012
J	AZARNIA, R; MITCHO, M; SHALLOWAY, D; LOEWENSTEIN, WR				AZARNIA, R; MITCHO, M; SHALLOWAY, D; LOEWENSTEIN, WR			JUNCTIONAL INTERCELLULAR COMMUNICATION IS COOPERATIVELY INHIBITED BY ONCOGENES IN TRANSFORMATION	ONCOGENE			English	Article									PENN STATE UNIV, DEPT MOLEC & CELL BIOL, UNIVERSITY PK, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	AZARNIA, R (corresponding author), UNIV MIAMI, SCH MED, DEPT PHYSIOL & BIOPHYS, MIAMI, FL 33101 USA.				NCI NIH HHS [CA01139, CA14464, CA47333] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047333] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; ATKINSON MM, 1988, AM J PHYSIOL, V255, pC674, DOI 10.1152/ajpcell.1988.255.5.C674; AZARNIA R, 1987, MOL CELL BIOL, V7, P946, DOI 10.1128/MCB.7.2.946; AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P191, DOI 10.1007/BF01871629; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P213, DOI 10.1007/BF01871631; AZARNIA R, 1984, J MEMBRANE BIOL, V82, P207, DOI 10.1007/BF01871630; AZARNIA R, 1988, 4TH INT C CELL BIOL, P233; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHANG CC, 1985, P NATL ACAD SCI USA, V82, P5360, DOI 10.1073/pnas.82.16.5360; CHEN MJ, 1987, NATURE, V330, P581, DOI 10.1038/330581a0; COOK JL, 1986, P NATL ACAD SCI USA, V83, P6965, DOI 10.1073/pnas.83.18.6965; COOK JL, 1989, J IMMUNOL, V142, P4527; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; EPSTEIN ML, 1977, J CELL BIOL, V75, P769, DOI 10.1083/jcb.75.3.769; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; FLAGGNEWTON JL, 1981, J MEMBRANE BIOL, V63, P105, DOI 10.1007/BF01969452; FLETCHER WH, 1987, J IMMUNOL, V139, P956; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; HUNTER GK, 1981, J CELL SCI, V49, P163; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KINGSTON RE, 1985, CELL, V41, P3, DOI 10.1016/0092-8674(85)90049-2; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAND H, 1986, MOL CELL BIOL, V6, P1917, DOI 10.1128/MCB.6.6.1917; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOEWENST.WR, 1966, ANN NY ACAD SCI, V137, P441, DOI 10.1111/j.1749-6632.1966.tb50175.x; LOEWENSTEIN WR, 1988, ANN NY ACAD SCI, V551, P337, DOI 10.1111/j.1749-6632.1988.tb22359.x; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOEWENSTEIN WR, 1987, CELL, V48, P725, DOI 10.1016/0092-8674(87)90067-5; LOEWENSTEIN WR, 1979, BIOCHIM BIOPHYS ACTA, V560, P1, DOI 10.1016/0304-419X(79)90002-7; LOEWENSTEIN WR, 1964, J CELL BIOL, V22, P565, DOI 10.1083/jcb.22.3.565; MACAULEY A, 1988, J VIROL, V62, P4712, DOI 10.1128/JVI.62.12.4712-4721.1988; MADHUKAR BV, 1989, CARCINOGENESIS, V10, P13, DOI 10.1093/carcin/10.1.13; MALDONADO PE, 1988, J MEMBRANE BIOL, V106, P203, DOI 10.1007/BF01872158; MANJUNATH CK, 1987, BIOCHEM BIOPH RES CO, V142, P228, DOI 10.1016/0006-291X(87)90475-X; MEHTA PP, 1989, J CELL BIOL, V108, P1053, DOI 10.1083/jcb.108.3.1053; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MICHALKE W, 1971, NATURE, V232, P121, DOI 10.1038/232121b0; NICHOLSON BJ, 1985, J BIOL CHEM, V260, P6514; NONNER WF, 1989, J CELL BIOL, V108, P1063; PERRICAUDET M, 1980, NATURE, V288, P174, DOI 10.1038/288174a0; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REDDY S, 1988, MOL CELL BIOL, V8, P704, DOI 10.1128/MCB.8.2.704; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; ROSE B, 1986, J MEMBRANE BIOL, V94, P129, DOI 10.1007/BF01871193; ROSEN A, 1988, CANCER RES, V48, P3485; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SHALLOWAY D, 1987, MOL CELL BIOL, V7, P3582, DOI 10.1128/MCB.7.10.3582; SHALLOWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P7071, DOI 10.1073/pnas.81.22.7071; Socolar S J, 1979, METHODS MEMBRANE BIO, V10, P123; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPECTOR DJ, 1986, VIROLOGY, V151, P329, DOI 10.1016/0042-6822(86)90053-X; TAKEYA T, 1982, J VIROL, V44, P12, DOI 10.1128/JVI.44.1.12-18.1982; YADA T, 1985, J MEMBRANE BIOL, V88, P217, DOI 10.1007/BF01871087	58	17	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1989	4	10					1161	1168						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2477782				2022-12-28	WOS:A1989AU50800001
J	RUGGIERO, M; SRIVASTAVA, SK; FLEMING, TP; RON, D; EVA, A				RUGGIERO, M; SRIVASTAVA, SK; FLEMING, TP; RON, D; EVA, A			NIH3T3 FIBROBLASTS TRANSFORMED BY THE DBL ONCOGENE SHOW ALTERED EXPRESSION OF BRADYKININ RECEPTORS - EFFECT ON INOSITOL LIPID TURNOVER	ONCOGENE			English	Article									NCI,CELLULAR & MOLEC BIOL LAB,BLDG 37,RM 1E24,BETHESDA,MD 20892; UNIFORMED SERV UNIV HLTH SCI,DEPT PATHOL & SURG,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA			Eva, Alessandra/J-8268-2016	Eva, Alessandra/0000-0003-2949-078X	NCI NIH HHS [CA-46455] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA046455] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERRIDGE MJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P33, DOI 10.1016/0304-419X(87)90017-5; BERRIDGE MJ, 1987, PHILOS T ROY SOC B, V317, P525, DOI 10.1098/rstb.1987.0079; BERRIIDGE MJ, 1983, BIOCHEM J, V212, P843; CHIARUGI V, 1987, ONCOGENE, V2, P37; CHIARUGI V, 1987, CANCER INVEST, V5, P215, DOI 10.3109/07357908709011738; CHIARUGI VP, 1986, BIOCHEM BIOPH RES CO, V141, P591, DOI 10.1016/S0006-291X(86)80214-5; DOWNWARD J, 1988, P NATL ACAD SCI USA, V86, P2648; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1983, P NATL ACAD SCI-BIOL, V80, P4926, DOI 10.1073/pnas.80.16.4926; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; FINZI E, 1987, P NATL ACAD SCI USA, V84, P3733, DOI 10.1073/pnas.84.11.3733; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FOWLER CJ, 1987, PHARMACOL TOXICOL, V60, P274, DOI 10.1111/j.1600-0773.1987.tb01751.x; FRY MJ, 1985, EMBO J, V4, P3173, DOI 10.1002/j.1460-2075.1985.tb04061.x; HEPLER JR, 1987, J BIOL CHEM, V262, P2951; KATO M, 1987, J BIOL CHEM, V262, P5696; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LAPETINA EG, 1985, J BIOL CHEM, V260, P7078; MACARA IG, 1984, P NATL ACAD SCI-BIOL, V81, P2728, DOI 10.1073/pnas.81.9.2728; MANNING DC, 1982, NATURE, V299, P256, DOI 10.1038/299256a0; MILLER RJ, 1987, TRENDS NEUROSCI, V10, P226, DOI 10.1016/0166-2236(87)90161-5; PALMER S, 1986, BIOCHEM J, V238, P491, DOI 10.1042/bj2380491; PARRIES G, 1987, P NATL ACAD SCI USA, V84, P2648, DOI 10.1073/pnas.84.9.2648; PREISS J, 1986, J BIOL CHEM, V261, P8597; REGOLI D, 1980, PHARMACOL REV, V32, P1; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; ROSCHER AA, 1983, J CLIN INVEST, V72, P626, DOI 10.1172/JCI111012; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SNYDER SH, 1980, SCIENCE, V209, P976, DOI 10.1126/science.6157191; SRIVASTAVA SK, 1986, P NATL ACAD SCI USA, V83, P8868, DOI 10.1073/pnas.83.23.8868; WAEKELAM MJO, 1988, FEBS LETT, V228, P182; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; WHITFIELD JF, 1970, P SOC EXP BIOL MED, V133, P1270; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; YANO K, 1984, J BIOL CHEM, V259, P201	35	36	36	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1989	4	6					767	771						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543945				2022-12-28	WOS:A1989AA66000013
J	PELLET, P; BERGER, R; BERNHEIM, A; BROUET, JC; TSAPIS, A				PELLET, P; BERGER, R; BERNHEIM, A; BROUET, JC; TSAPIS, A			MOLECULAR ANALYSIS OF A T(9-14)(P11-Q32) TRANSLOCATION OCCURRING IN A CASE OF HUMAN ALPHA-HEAVY CHAIN DISEASE	ONCOGENE			English	Article									HOP ST LOUIS,INSERM,U301,CYTOGENET LAB,F-75475 PARIS 10,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	PELLET, P (corresponding author), HOP ST LOUIS,INSERM,U108,IMMUNOCHEM & IMMUNOPATHOL LAB,1 AVE CLAUDE YELLEFAUX,F-75475 PARIS 10,FRANCE.							ALEXANDER A, 1988, J CLIN INVEST, V82, P1244, DOI 10.1172/JCI113722; BAKHSHI A, 1987, P NATL ACAD SCI USA, V84, P2396, DOI 10.1073/pnas.84.8.2396; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERGER R, 1986, CANCER GENET CYTOGEN, V22, P219, DOI 10.1016/0165-4608(86)90158-5; BERNHEIM A, 1983, P NATL ACAD SCI USA, V79, P2971; BRITOBABAPULLE V, 1987, LEUKEMIA, V1, P789; CARE A, 1986, EMBO J, V5, P905, DOI 10.1002/j.1460-2075.1986.tb04302.x; CARROLL AJ, 1987, BLOOD, V70, P1962; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; ERIKSON J, 1982, P NATL ACAD SCI-BIOL, V79, P5611, DOI 10.1073/pnas.79.18.5611; FAN YS, 1988, CANCER GENET CYTOGEN, V31, P263, DOI 10.1016/0165-4608(88)90226-9; FLANAGAN JG, 1984, CELL, V36, P681, DOI 10.1016/0092-8674(84)90348-9; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; GELMANN EP, 1983, NATURE, V306, P799, DOI 10.1038/306799a0; HALUSKA FG, 1987, P NATL ACAD SCI USA, V84, P6835, DOI 10.1073/pnas.84.19.6835; HALUSKA FG, 1986, NATURE, V324, P158, DOI 10.1038/324158a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HAYDAY AC, 1984, NATURE, V307, P334, DOI 10.1038/307334a0; KLEIN G, 1985, IMMUNOL TODAY, V6, P208, DOI 10.1016/0167-5699(85)90036-2; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Maniatis T., 1982, MOL CLONING; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROWLEY JD, 1982, SCIENCE, V216, P749, DOI 10.1126/science.7079737; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SELIGMANN M, 1968, SCIENCE, V162, P1396, DOI 10.1126/science.162.3860.1396; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WABL M, 1985, P NATL ACAD SCI USA, V82, P479, DOI 10.1073/pnas.82.2.479; WIMAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6798, DOI 10.1073/pnas.81.21.6798; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	41	26	26	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					653	657						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2498807				2022-12-28	WOS:A1989U768800017
J	EGAN, C; BAYLEY, ST; BRANTON, PE				EGAN, C; BAYLEY, ST; BRANTON, PE			BINDING OF THE RB1 PROTEIN TO E1A PRODUCTS IS REQUIRED FOR ADENOVIRUS TRANSFORMATION	ONCOGENE			English	Article									MCMASTER UNIV, MOLEC VIROL & IMMUNOL PROGRAM, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT BIOL, HAMILTON L8N 3Z5, ONTARIO, CANADA; MCMASTER UNIV, DEPT PATHOL, HAMILTON L8N 3Z5, ONTARIO, CANADA	McMaster University; McMaster University; McMaster University								BRANTON PE, 1984, BIOCHIM BIOPHYS ACTA, V780, P67, DOI 10.1016/0304-419X(84)90007-6; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BYRD P, 1982, NATURE, V298, P69, DOI 10.1038/298069a0; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DUMONT DJ, 1988, IN PRESS J VIROL; EGAN C, 1987, VIROLOGY, V160, P292, DOI 10.1016/0042-6822(87)90077-8; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; FLINT SJ, 1986, ADV VIRUS RES, V31, P169, DOI 10.1016/S0065-3527(08)60264-X; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; HANSEN MF, 1988, TRENDS GENET, V4, P125, DOI 10.1016/0168-9525(88)90134-5; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; JELSMA TN, 1988, VIROLOGY, V163, P494, DOI 10.1016/0042-6822(88)90290-5; KRIPPL B, 1985, P NATL ACAD SCI USA, V82, P7480, DOI 10.1073/pnas.82.22.7480; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; MCFALL RC, 1977, CANCER RES, V37, P1003; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; NEVINS JR, 1987, MICROBIOL REV, V51, P419, DOI 10.1128/MMBR.51.4.419-430.1987; PERRICAUDET M, 1979, NATURE, V281, P694, DOI 10.1038/281694a0; ROWE DT, 1983, VIROLOGY, V127, P253, DOI 10.1016/0042-6822(83)90142-3; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; TREMBLAY ML, 1988, J BIOL CHEM, V263, P6375; TREMBLAY ML, 1989, IN PRESS VIROLOGY; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; YEE SP, 1983, J VIROL, V46, P1003, DOI 10.1128/JVI.46.3.1003-1013.1983; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X	37	119	122	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	1989	4	3					383	388						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2523032				2022-12-28	WOS:A1989U567600016
J	HURLEY, TR; SEFTON, BM				HURLEY, TR; SEFTON, BM			ANALYSIS OF THE ACTIVITY AND PHOSPHORYLATION OF THE LCK PROTEIN IN LYMPHOID-CELLS	ONCOGENE			English	Article											HURLEY, TR (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92138, USA.				NCI NIH HHS [CA 42350, CA 14195] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014195, R01CA042350] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADLER HT, 1988, J VIROL, V62, P4113, DOI 10.1128/JVI.62.11.4113-4122.1988; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1985, MOL CELL BIOL, V5, P2647, DOI 10.1128/MCB.5.10.2647; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CASNELLIE JE, 1982, J BIOL CHEM, V257, P3877; CASNELLIE JE, 1983, J BIOL CHEM, V258, P738; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COUSSENS PM, 1985, MOL CELL BIOL, V5, P2753, DOI 10.1128/MCB.5.10.2753; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; GLYNN JP, 1964, CANCER RES, V24, P502; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; HARRIS AW, 1973, J IMMUNOL, V110, P431; HORIBATA K, 1970, EXP CELL RES, V60, P61, DOI 10.1016/0014-4827(70)90489-1; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HYMAN R, 1972, J NATL CANCER I, V48, P173; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; HYMAN R, 1980, IMMUNOGENETICS, V10, P261, DOI 10.1007/BF01561574; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KAMPS MP, 1988, ONCOGENE RES, V3, P105; KAMPS MP, 1988, ONCOGENE, V2, P305; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAMELSON LE, 1986, NATURE, V324, P674, DOI 10.1038/324674a0; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SEFTON BM, 1980, J VIROL, V33, P220, DOI 10.1128/JVI.33.1.220-229.1980; THOM RE, 1987, FEBS LETT, V222, P104, DOI 10.1016/0014-5793(87)80200-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREVILLYAN JM, 1986, BIOCHIM BIOPHYS ACTA, V888, P286, DOI 10.1016/0167-4889(86)90228-4; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1987, ONCOGENE RES, V1, P357; VOGT M, 1979, VIROLOGY, V93, P226, DOI 10.1016/0042-6822(79)90290-3; VORONOVA AF, 1987, MOL CELL BIOL, V7, P4407, DOI 10.1128/MCB.7.12.4407; VORONOVA AF, 1984, MOL CELL BIOL, V4, P2705, DOI 10.1128/MCB.4.12.2705; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WONG TW, 1983, J BIOL CHEM, V258, P1022	43	84	84	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					265	272						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2468122				2022-12-28	WOS:A1989U567600001
J	SYMONDS, G; HARTSHORN, A; KENNEWELL, A; OMARA, MA; BRUSKIN, A; BISHOP, JM				SYMONDS, G; HARTSHORN, A; KENNEWELL, A; OMARA, MA; BRUSKIN, A; BISHOP, JM			TRANSFORMATION OF MURINE MYELOMONOCYTIC CELLS BY MYC - POINT MUTATIONS IN V-MYC CONTRIBUTE SYNERGISTICALLY TO TRANSFORMING POTENTIAL	ONCOGENE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,GEORGE WILLIAMS HOOPER FDN,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	SYMONDS, G (corresponding author), CHILDRENS MED RES FDN,POB 61,CAMPERDOWN,NSW 2050,AUSTRALIA.							ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P100, DOI 10.1073/pnas.80.1.100; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BAUMBACH WR, 1986, J VIROL, V59, P276, DOI 10.1128/JVI.59.2.276-283.1986; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Beug H., 1982, CANCER SURV, V1, P205; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BISHOP JM, 1985, MOL BIOL TUMOR VIRUS, P249; BISTER K, 1987, ONCOGENE, V1, P97; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BRAUN MJ, 1985, J VIROL, V55, P177, DOI 10.1128/JVI.55.1.177-183.1985; BRIGHTMAN BK, 1986, J VIROL, V60, P68, DOI 10.1128/JVI.60.1.68-81.1986; BROWN AMC, 1987, DNA CLONING, V3, P189; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; DURBAN EM, 1981, P NATL ACAD SCI-BIOL, V78, P3600, DOI 10.1073/pnas.78.6.3600; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; ENRIETTO PJ, 1983, VIROLOGY, V124, P164, DOI 10.1016/0042-6822(83)90300-8; ENRIETTO PJ, 1982, J VIROL, V44, P711, DOI 10.1128/JVI.44.2.711-715.1982; FRYKBERG L, 1987, ONCOGENE, V1, P415; GAZZOLO L, 1979, CELL, V16, P627, DOI 10.1016/0092-8674(79)90036-9; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRAF T, 1981, EXP CELL RES, V131, P331, DOI 10.1016/0014-4827(81)90236-6; GRAF T, 1986, CELL, V45, P357, DOI 10.1016/0092-8674(86)90321-1; HAYFLICK J, 1985, P NATL ACAD SCI USA, V82, P2718, DOI 10.1073/pnas.82.9.2718; HAYMAN MJ, 1983, CURR TOP MICROBIOL, V103, P109; HEANEY ML, 1986, J VIROL, V60, P167, DOI 10.1128/JVI.60.1.167-176.1986; HUME DA, 1983, J EXP MED, V158, P1522, DOI 10.1084/jem.158.5.1522; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; LEUTZ A, 1984, EMBO J, V3, P3191, DOI 10.1002/j.1460-2075.1984.tb02278.x; LOTEM J, 1979, P NATL ACAD SCI USA, V76, P5158, DOI 10.1073/pnas.76.10.5158; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARTIN P, 1986, EMBO J, V5, P1529, DOI 10.1002/j.1460-2075.1986.tb04393.x; METCALF D, 1984, CLOINAL CULTURE HEMO, P109; Moscovici C., 1973, Methods Cell Biol, V7, P313; Moscovici C., 1982, ADV VIRAL ONCOL, V1, P83; PALMIERI S, 1983, EMBO J, V2, P2385, DOI 10.1002/j.1460-2075.1983.tb01750.x; PALMIERI S, 1986, J VIROL, V58, P134, DOI 10.1128/JVI.58.1.134-141.1986; PAPAS TS, 1985, NATURE, V318, P237, DOI 10.1038/318237a0; PATSCHINSKY T, 1986, J VIROL, V59, P341, DOI 10.1128/JVI.59.2.341-353.1986; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; RAMSAY GM, 1982, J VIROL, V41, P745, DOI 10.1128/JVI.41.3.745-753.1982; SARID J, 1987, P NATL ACAD SCI USA, V84, P170, DOI 10.1073/pnas.84.1.170; SHAW J, 1985, J VIROL, V56, P943, DOI 10.1128/JVI.56.3.943-950.1985; SHOWE LC, 1985, MOL CELL BIOL, V5, P501, DOI 10.1128/MCB.5.3.501; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; STONE J, 1987, MOL CELL BIOL, V7, P1697, DOI 10.1128/MCB.7.5.1697; SYMONDS G, 1982, EMBO J, V1, P1343, DOI 10.1002/j.1460-2075.1982.tb01320.x; SYMONDS G, 1986, MOL CELL BIOL, V6, P1796, DOI 10.1128/MCB.6.5.1796; VARMUS HE, 1984, ANNU REV GENET, V18, P553; VENNSTROM B, 1984, EMBO J, V3, P3223, DOI 10.1002/j.1460-2075.1984.tb02282.x; WALTHER N, 1986, VIROLOGY, V154, P219, DOI 10.1016/0042-6822(86)90444-7; WATSON DK, 1983, P NATL ACAD SCI-BIOL, V80, P2146, DOI 10.1073/pnas.80.8.2146; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WESTAWAY D, 1984, P NATL ACAD SCI-BIOL, V81, P843, DOI 10.1073/pnas.81.3.843; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WILLIAMS WJ, 1977, HEMATOLOGY; WYKE JA, 1980, VIROLOGY, V106, P217, DOI 10.1016/0042-6822(80)90246-9	62	55	55	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					285	294						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2649846				2022-12-28	WOS:A1989U567600003
J	MORRIS, JDH; PRICE, B; LLOYD, AC; SELF, AJ; MARSHALL, CJ; HALL, A				MORRIS, JDH; PRICE, B; LLOYD, AC; SELF, AJ; MARSHALL, CJ; HALL, A			SCRAPE-LOADING OF SWISS 3T3 CELLS WITH RAS PROTEIN RAPIDLY ACTIVATES PROTEIN KINASE-C IN THE ABSENCE OF PHOSPHOINOSITIDE HYDROLYSIS	ONCOGENE			English	Article											MORRIS, JDH (corresponding author), ROYAL CANC HOSP,INST CANC RES,CHESTER BEATTY LABS,FULHAM RD,LONDON SW3 6JB,ENGLAND.							ALONSO T, 1988, P NATL ACAD SCI USA, V85, P4271, DOI 10.1073/pnas.85.12.4271; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BROWN KD, 1984, BIOCHEM BIOPH RES CO, V123, P377, DOI 10.1016/0006-291X(84)90424-8; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; HAGAG N, 1987, MOL CELL BIOL, V7, P1984, DOI 10.1128/MCB.7.5.1984; HALL A, 1986, J BIOL CHEM, V261, P963; HANCOCK JF, 1988, ONCOGENE, V3, P187; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; MAHADEVAN LC, 1987, EMBO J, V6, P921, DOI 10.1002/j.1460-2075.1987.tb04839.x; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MCNEIL PL, 1984, J CELL BIOL, V98, P1556, DOI 10.1083/jcb.98.4.1556; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; PATERSON H, 1987, CELL, V51, P803, DOI 10.1016/0092-8674(87)90103-6; PENNINGTON SR, 1988, FEBS LETT, V227, P203, DOI 10.1016/0014-5793(88)80899-8; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; STACEY DW, 1987, MOL CELL BIOL, V7, P523, DOI 10.1128/MCB.7.1.523; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; TRAHEY M, 1987, MOL CELL BIOL, V7, P556; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4	39	111	112	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					27	31						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2536916				2022-12-28	WOS:A1989U567400004
J	VONLINDERN, M; VANAGTHOVEN, T; HAGEMEIJER, A; ADRIAANSEN, H; GROSVELD, G				VONLINDERN, M; VANAGTHOVEN, T; HAGEMEIJER, A; ADRIAANSEN, H; GROSVELD, G			THE HUMAN PIM-1 GENE IS NOT DIRECTLY ACTIVATED BY THE TRANSLOCATION (6-9) IN ACUTE NONLYMPHOCYTIC LEUKEMIA	ONCOGENE			English	Article									ACAD HOSP DIJKZIGT,DEPT IMMUNOL,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC	VONLINDERN, M (corresponding author), ERASMUS UNIV,DEPT CELL BIOL & GENET,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		von Lindern, Marieke/AAH-2350-2020					ADRIAANSEN HJ, 1988, LEUKEMIA, V2, P136; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CUYPERS HT, 1984, CELL, V37, P141; DOMEN J, 1987, ONCOGENE RES, V1, P103; FEINBERG A, 1982, ANAL BIOCHEM, V132, P6; HEIM S, 1986, CANCER GENET CYTOGEN, V22, P195, DOI 10.1016/0165-4608(86)90155-X; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; JEFFREYS AJ, 1977, CELL, V12, P429, DOI 10.1016/0092-8674(77)90119-2; KAMATA T, 1987, ONCOGENE, V1, P19; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; LARSON RA, 1984, AM J MED, V76, P827, DOI 10.1016/0002-9343(84)90994-X; LARSON RA, 1983, CANCER GENET CYTOGEN, V10, P219, DOI 10.1016/0165-4608(83)90050-X; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; LEBEAU MM, 1984, CANCER SURV, V3, P371; Maniatis T., 1982, MOL CLONING; MEEKER TC, 1987, ONCOGENE RES, V1, P87; NAGARAJAN L, 1986, P NATL ACAD SCI USA, V83, P2556, DOI 10.1073/pnas.83.8.2556; PEARSON MG, 1985, AM J HEMATOL, V18, P393, DOI 10.1002/ajh.2830180409; ROWLEY JD, 1976, BLOOD, V47, P705; ROWLEY JD, 1977, LANCET, V1, P549; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; TELERMAN A, 1988, MOL CELL BIOL, V8, P1498, DOI 10.1128/MCB.8.4.1498; VANKESSEL AHMG, 1981, CYTOGENET CELL GENET, V30, P83; WESTBROOK CA, 1985, P NATL ACAD SCI USA, V82, P8742, DOI 10.1073/pnas.82.24.8742; WESTBROOK CA, 1987, P NATL ACAD SCI USA, V84, P251, DOI 10.1073/pnas.84.1.251; YUNIS JJ, 1984, CANCER GENET CYTOGEN, V11, P125, DOI 10.1016/0165-4608(84)90106-7	30	24	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					75	79						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2644612				2022-12-28	WOS:A1989U567400011
J	DOUGLAS, JL; GOPALAKRISHNAN, S; QUINLAN, MP				DOUGLAS, JL; GOPALAKRISHNAN, S; QUINLAN, MP			MODULATION OF TRANSFORMATION OF PRIMARY EPITHELIAL-CELLS BY THE 2ND EXON OF THE AD5 E1A12S GENE	ONCOGENE			English	Article							ADENOVIRUS E1A; GROWTH-FACTOR; FUNCTIONAL DOMAINS; E1A-12S PROTEIN; TERMINAL REGION; DNA FRAGMENTS; TYPE-5; SEQUENCES; INDUCTION; PRODUCTS	Expression of the Ad5 E1A first exon is necessary and sufficient to cooperate with an activated RAS oncogene to transform primary epithelial cells. The second exon, although necessary for immortalization and induction of an epithelial cell growth factor, is not essential for co-transformation with T24 RAS. To determine whether the second exon has a role in the cooperation of ElA with an activated RAS gene, we have performed an extensive mutational analysis of this region. All of the deletion and point mutants that we have generated and analyzed retained the ability to enable the transformants to grow in serum-free media and in soft agar. A region in the C-terminus of the E1A polypeptide encoded by nucleotides 1437-1488 appears to modulate the level of transformation. Co-transfections of T24 RAS and EIA genes with mutations that bring about specific amino acid substitutions or deletions in the C-terminus result in enhanced transformation. There is an increase in the number of transformed foci and they appear earlier. A single amino acid change can bring about this phenotype, which is dominant over wild type. Thus, it seems that expression of the wild-type second exon retards or suppresses transformation. The hypertransforming phenotype does not correlate with any differences in the expression of the mutated E1A or the co-cotransfected RAS gene. The C-terminus encodes a nuclear localization signal for E1A, however the subcellular localization of the mutant polypeptides does not affect their co-transforming ability.	UNIV TENNESSEE CTR HLTH SCI,DEPT MICROBIOL & IMMUNOL,858 MADISON AVE,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center								ADAMI GR, 1990, J VIROL, V64, P3427, DOI 10.1128/JVI.64.7.3427-3436.1990; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; BELLETT AJD, 1985, MOL CELL BIOL, V5, P1933, DOI 10.1128/MCB.5.8.1933; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; DUIGOU GJ, 1990, MOL CELL BIOL, V10, P2027, DOI 10.1128/MCB.10.5.2027; EGAN C, 1989, ONCOGENE, V4, P383; Flint S. J, 1981, DNA TUMOR VIRUSES; FRISCH SM, 1990, ONCOGENE, V5, P75; GALLIMORE PH, 1974, J MOL BIOL, V8, P49; GRAHAM FL, 1974, COLD SPRING HARB SYM, V39, P637, DOI 10.1101/SQB.1974.039.01.077; HALEY KP, 1984, P NATL ACAD SCI-BIOL, V81, P5734, DOI 10.1073/pnas.81.18.5734; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; JELSMA TN, 1989, VIROLOGY, V171, P120, DOI 10.1016/0042-6822(89)90518-7; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LYONS RH, 1987, MOL CELL BIOL, V7, P2451, DOI 10.1128/MCB.7.7.2451; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MONTELL C, 1984, CELL, V36, P951, DOI 10.1016/0092-8674(84)90045-X; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; MORAN E, 1986, J VIROL, V57, P764; POZZATTI R, 1988, MOL CELL BIOL, V8, P2984, DOI 10.1128/MCB.8.7.2984; QUINLAN MP, 1989, ONCOGENE, V4, P1051; QUINLAN MP, 1988, MOL CELL BIOL, V8, P3191, DOI 10.1128/MCB.8.8.3191; QUINLAN MP, 1987, J VIROL, V61, P673, DOI 10.1128/JVI.61.3.673-682.1987; QUINLAN MP, 1987, P NATL ACAD SCI USA, V84, P3283, DOI 10.1073/pnas.84.10.3283; QUINLAN MP, 1986, CANCER CELL, V4, P327; REICH R, 1988, CANCER RES, V48, P3307; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPINDLER KR, 1985, J VIROL, V53, P742, DOI 10.1128/JVI.53.3.742-750.1985; STABEL S, 1985, EMBO J, V4, P2329, DOI 10.1002/j.1460-2075.1985.tb03934.x; SUBRAMANIAN T, 1989, ONCOGENE, V4, P415; SUBRAMANIAN T, 1988, ONCOGENE, V2, P105; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TAUB M, 1979, P NATL ACAD SCI USA, V76, P3338, DOI 10.1073/pnas.76.7.3338; URBANELLI D, 1989, VIROLOGY, V173, P607, DOI 10.1016/0042-6822(89)90572-2; VANORMONDT H, 1980, GENE, V12, P63, DOI 10.1016/0378-1119(80)90016-5; WALTON GM, 1990, J BIOL CHEM, V265, P1750; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887	46	51	54	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2093	2103						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945414				2022-12-28	WOS:A1991GX11900021
J	TRATNER, I; VERMA, IM				TRATNER, I; VERMA, IM			IDENTIFICATION OF A NUCLEAR TARGETING SEQUENCE IN THE FOS PROTEIN	ONCOGENE			English	Article							LEUCINE ZIPPER DOMAIN; JUN INTERACTION; V-FOS; C-FOS; LOCALIZATION; LOCATION; SIGNAL; GENE; EXPRESSION; TRANSPORT	The product of the proto-oncogene fos is a nuclear phosphoprotein. We have investigated if nuclear location of Fos protein is mediated by a nuclear targeting sequence. We show that the cytoplasmic chicken pyruvate kinase protein translocates to the nucleus if fused to the 22 amino acid Fos basic region (amino acids 139-161). However, the nuclear localization of the Fos protein is not affected if the basic region is deleted. We propose that Fos protein contains multiple nuclear targeting sequences which may act independently or in concert with one another.			TRATNER, I (corresponding author), SALK INST,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92186, USA.		Tratner, Isabelle/ABD-6361-2021					ADDISON C, 1990, ONCOGENE, V5, P423; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CURRAN T, 1984, CELL, V36, P259; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DANG CV, 1989, J BIOL CHEM, V264, P18019; DETOGNI P, 1988, MOL CELL BIOL, V8, P2251, DOI 10.1128/MCB.8.5.2251; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; GARCIABUSTOS J, 1991, BIOCHIM BIOPHYS ACTA, V1071, P83, DOI 10.1016/0304-4157(91)90013-M; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; JENUWEIN T, 1987, CELL, V48, P647, DOI 10.1016/0092-8674(87)90243-1; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KINDY MS, 1990, CELL GROWTH DIFFER, V1, P27; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; MATSUI M, 1990, ONCOGENE, V5, P249; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; PAINE PL, 1972, EXP CELL RES, V74, P81, DOI 10.1016/0014-4827(72)90483-1; PETERS R, 1986, BIOCHIM BIOPHYS ACTA, V864, P305, DOI 10.1016/0304-4157(86)90003-1; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; ROBERTS B, 1989, BIOCHIM BIOPHYS ACTA, V1008, P263, DOI 10.1016/0167-4781(89)90016-X; ROBERTS BL, 1987, CELL, V50, P465, DOI 10.1016/0092-8674(87)90500-9; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; STACEY DW, 1984, EXP CELL RES, V154, P283, DOI 10.1016/0014-4827(84)90687-6; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	36	35	36	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2049	2053						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945410				2022-12-28	WOS:A1991GX11900016
J	GRANT, SG; CHAPMAN, VM				GRANT, SG; CHAPMAN, VM			DETAILED GENETIC-MAPPING OF THE A-RAF PROTOONCOGENE ON THE MOUSE X-CHROMOSOME	ONCOGENE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GLYCEROL KINASE-DEFICIENCY; CHRONIC GRANULOMATOUS-DISEASE; ELECTROPHORETIC VARIATION; TRANSFORMING SEQUENCE; CARRYING RETROVIRUS; ADRENAL HYPOPLASIA; SYNOVIAL SARCOMA; FAMILY; EXPRESSION	The transcribed murine A-raf proto-oncogene has been localized to the proximal region of the mouse X chromosome, within the context of four other active genes in this region which together constitute a conserved linkage group between mouse and man. This localization has been accomplished using species-specific restriction fragment length variation and DNAs from a previously defined informative subset of progeny representative of a set of 100 progeny from an interspecific backcross between inbred C57BL/6JRos and wild-derived Mus spretus. This new data regionally orders the mouse A-raf locus relative to the 24 X-linked markers previously examined in this backcross. We find that A-raf co-localizes with two other active genes, tissue inhibitor of metalloproteinases (Timp) and synapsin (Syn-1), 4.0 +/- 2.0 cM distal to the Otc gene at the proximal end of the mouse X chromosome, for a partial gene order in this region of: centromere-Cybb-Otc-Timp/A-raf/Syn-1-Xlr-1-Hprt.	NEW YORK STATE DEPT HLTH, ROSWELL PK MEM INST, DEPT MOLEC & CELLULAR BIOL, BUFFALO, NY 14263 USA	Roswell Park Cancer Institute			Grant, Stephen G/D-6984-2014	Grant, Stephen G/0000-0002-9236-0913	NIGMS NIH HHS [GM24125, GM33160] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024125, R01GM033160] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVNER P, 1987, SOMAT CELL MOLEC GEN, V13, P267, DOI 10.1007/BF01535208; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BARTLEY JA, 1986, J PEDIATR-US, V108, P189, DOI 10.1016/S0022-3476(86)80980-5; BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; BROWN SDM, 1985, TRENDS GENET, V1, P219, DOI 10.1016/0168-9525(85)90086-1; BURMEISTER M, 1988, Genomics, V2, P189, DOI 10.1016/0888-7543(88)90002-X; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; CHAMBERLAIN JS, 1987, SOMAT CELL MOLEC GEN, V13, P671, DOI 10.1007/BF01534487; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; CHAPMAN VM, 1983, GENETICS, V103, P785; CHELLY J, 1988, HUM GENET, V78, P222, DOI 10.1007/BF00291665; DAVIES KE, 1987, CYTOGENET CELL GENET, V46, P277, DOI 10.1159/000132481; DAVISSON M T, 1987, Genomics, V1, P213, DOI 10.1016/0888-7543(87)90047-4; DEFEO D, 1981, P NATL ACAD SCI-BIOL, V78, P3328, DOI 10.1073/pnas.78.6.3328; DEPINHO RA, 1987, GENE DEV, V1, P1311, DOI 10.1101/gad.1.10.1311; DEWALD GW, 1989, CANCER GENET CYTOGEN, V42, P173, DOI 10.1016/0165-4608(89)90085-X; DISTECHE CM, 1989, GENOMICS, V5, P177, DOI 10.1016/0888-7543(89)90044-X; ELLIOTT RW, 1990, GENOMICS, V6, P635, DOI 10.1016/0888-7543(90)90498-J; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1987, ONCOGENE, V1, P355; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FROHMAN MA, 1989, CELL, V56, P145, DOI 10.1016/0092-8674(89)90887-8; GEWERT DR, 1987, EMBO J, V6, P651, DOI 10.1002/j.1460-2075.1987.tb04804.x; GILGENKRANTZ S, 1989, CYTOGENET CELL GENET, V51, P1004; GRANT SG, 1990, IN PRESS CYTOGENET C; GUENET JL, 1986, CURR TOP MICROBIOL, V127, P109; HAMMOND J, 1985, LANCET, V1, P54; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HEIDECKER G, 1989, GENES SIGNAL TRANSDU, P339; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KILIMANN MW, 1985, EMBO J, V4, P1997, DOI 10.1002/j.1460-2075.1985.tb03883.x; KISS Z, 1988, FEBS LETT, V240, P221, DOI 10.1016/0014-5793(88)80372-7; KNUDSON AG, 1989, BRIT J CANCER, V59, P661, DOI 10.1038/bjc.1989.137; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LAFRENIERE RG, 1989, CYTOGENET CELL GENET, V51, P1028; LALLEY PA, 1989, CYTOGENET CELL GENET, V51, P503, DOI 10.1159/000132806; LYON MF, 1988, AM J HUM GENET, V42, P8; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; MIYOSHI J, 1984, NUCLEIC ACIDS RES, V12, P1821, DOI 10.1093/nar/12.4.1821; MORTON CC, 1989, GENOMICS, V4, P367, DOI 10.1016/0888-7543(89)90344-3; MULLINS LJ, 1988, GENOMICS, V3, P187, DOI 10.1016/0888-7543(88)90078-X; MULLINS LJ, 1990, GENOMICS, V7, P19, DOI 10.1016/0888-7543(90)90514-U; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; NIELSEN JT, 1977, GENETICS, V87, P319; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; NOGUCHI T, 1988, ONCOGENE, V3, P709; OBRIEN SJ, 1983, NATURE, V302, P839, DOI 10.1038/302839a0; OBRIEN SJ, 1988, ANNU REV GENET, V22, P323, DOI 10.1146/annurev.ge.22.120188.001543; OHNO S, 1969, ANNU REV GENET, V3, P495, DOI 10.1146/annurev.ge.03.120169.002431; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; REEVES BR, 1989, ONCOGENE, V4, P373; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; STEPHENSON DA, 1988, NUCLEIC ACIDS RES, V16, P1642, DOI 10.1093/nar/16.4.1642; STEPHENSON DA, 1988, CURR TOP MICROBIOL, V137, P18; STEPHENSON DA, 1991, IN PRESS MAMMALIAN G; STORM SM, 1990, ONCOGENE, V5, P345; SZPIRER J, 1985, SOMAT CELL MOLEC GEN, V11, P93, DOI 10.1007/BF01534739; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TRENT JM, 1989, CYTOGENET CELL GENET, V51, P533, DOI 10.1159/000132807; TRONICK SR, 1989, GENOMICS, V5, P546, DOI 10.1016/0888-7543(89)90022-0; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247	72	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	1991	6	3					397	402						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011396				2022-12-28	WOS:A1991FT34400007
J	KUMAR, R; MEDINA, D; SUKUMAR, S				KUMAR, R; MEDINA, D; SUKUMAR, S			ACTIVATION OF H-RAS ONCOGENES IN PRENEOPLASTIC MOUSE MAMMARY TISSUES	ONCOGENE			English	Article									SALK INST BIOL STUDIES, 10010 N TORREY PINES RD, LA JOLLA, CA 92037 USA; BAYLOR UNIV, DEPT CELL BIOL, HOUSTON, TX 77030 USA; SQUIBB INST MED RES, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA	Salk Institute; Baylor University					NATIONAL CANCER INSTITUTE [R01CA033369, R01CA048943] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101, CA33369, CA48943] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSEN PR, 1981, CELL, V26, P129, DOI 10.1016/0092-8674(81)90041-6; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIGGER CAH, 1989, P NATL ACAD SCI USA, V86, P2291, DOI 10.1073/pnas.86.7.2291; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BROWN K, 1990, P NATL ACAD SCI USA, V87, P538, DOI 10.1073/pnas.87.2.538; CARDIFF RD, 1988, ONCOGENE, V3, P205; CARDIFF RD, 1984, ADV CANCER RES, V42, P167, DOI 10.1016/S0065-230X(08)60458-3; DANDEKAR S, 1986, MOL CELL BIOL, V6, P4104, DOI 10.1128/MCB.6.11.4104; DANIELS CW, 1971, FED PROC, V34, P64; DEOME KB, 1959, CANCER RES, V19, P515; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DIPPLE A, 1983, CANCER RES, V43, P4132; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; GRAHAM R, 1976, VIROLOGY, V54, P536; KUMAR R, 1989, ONCOGENE RES, V4, P235; KUMAR R, 1988, ONCOGENE, V3, P647; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; MEDINA D, 1987, J NATL CANCER I, V79, P569; MEDINA D, 1988, CARCINOGENESIS, V9, P1113, DOI 10.1093/carcin/9.7.1113; PINCUS MR, 1987, P NATL ACAD SCI USA, V84, P8375, DOI 10.1073/pnas.84.23.8375; SUKUMAR S, 1989, CURR TOP MICROBIOL, V148, P93; SUKUMAR S, 1990, P NATL ACAD SCI USA, V87, P718, DOI 10.1073/pnas.87.2.718; SUKUMAR S, 1988, SCIENCE, V240, P524, DOI 10.1126/science.3282307; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	26	49	51	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	1990	5	8					1271	1277						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2118247				2022-12-28	WOS:A1990DX36100023
J	BOEHM, T; FORONI, L; KENNEDY, M; RABBITTS, TH				BOEHM, T; FORONI, L; KENNEDY, M; RABBITTS, TH			THE RHOMBOTIN GENE BELONGS TO A CLASS OF TRANSCRIPTIONAL REGULATORS WITH A POTENTIAL NOVEL PROTEIN DIMERIZATION MOTIF	ONCOGENE			English	Note											BOEHM, T (corresponding author), LAB MOLEC BIOL,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Kennedy, Martin A/A-4942-2008; Rabbitts, Terence/D-6262-2016	Kennedy, Martin A/0000-0002-6445-8526; Rabbitts, Terence/0000-0002-4982-2609				BIRKENMEIER EH, 1986, P NATL ACAD SCI USA, V83, P2516, DOI 10.1073/pnas.83.8.2516; BOEHM T, 1990, EMBO J, V9, P857, DOI 10.1002/j.1460-2075.1990.tb08183.x; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BULUWELA L, 1989, NUCLEIC ACIDS RES, V17, P452, DOI 10.1093/nar/17.1.452; BUSCH SJ, 1990, TRENDS GENET, V6, P36, DOI 10.1016/0168-9525(90)90071-D; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0; GREENBERG JM, 1990, NATURE, V344, P158, DOI 10.1038/344158a0; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; KARLSSON O, 1990, NATURE, V344, P879, DOI 10.1038/344879a0; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WAY JC, 1988, CELL, V54, P5, DOI 10.1016/0092-8674(88)90174-2	19	92	92	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1103	1105						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115645				2022-12-28	WOS:A1990DP41500026
J	KRAISS, S; BARNEKOW, A; MONTENARH, M				KRAISS, S; BARNEKOW, A; MONTENARH, M			PROTEIN-KINASE ACTIVITY ASSOCIATED WITH IMMUNOPURIFIED P53-PROTEIN	ONCOGENE			English	Article									UNIV ULM, DEPT BIOCHEM, POB 4066, W-7900 ULM, GERMANY; INST MED VIROL, W-6300 GIESSEN, GERMANY	Ulm University			Montenarh, Mathias/AAB-6689-2020					ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; BAUMANN EA, 1979, P NATL ACAD SCI USA, V76, P3688, DOI 10.1073/pnas.76.8.3688; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRADLEY MK, 1982, CELL, V28, P125, DOI 10.1016/0092-8674(82)90382-8; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FRANSEN L, 1983, J BIOL CHEM, V258, P5276; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GIACHERIO D, 1979, J BIOL CHEM, V254, P8113; GRIFFIN JD, 1979, P NATL ACAD SCI USA, V76, P2610, DOI 10.1073/pnas.76.6.2610; GURNEY EG, 1986, J VIROL, V57, P1168, DOI 10.1128/JVI.57.3.1168-1172.1986; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; JAY G, 1981, P NATL ACAD SCI-BIOL, V78, P2932, DOI 10.1073/pnas.78.5.2932; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KACZMAREK L, 1986, EXP CELL RES, V162, P268, DOI 10.1016/0014-4827(86)90445-3; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KESSLER SW, 1975, J IMMUNOL, V115, P1617; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LAEMMLI UK, 1970, NATURE, V278, P261; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LASSAM NJ, 1979, NATURE, V277, P241, DOI 10.1038/277241a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MCCORMICK F, 1981, NATURE, V292, P63, DOI 10.1038/292063a0; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MICHALOVITZ D, 1986, MOL CELL BIOL, V6, P3531, DOI 10.1128/MCB.6.10.3531; MILLER DW, 1986, GENETIC ENG, V8; MILLER LK, 1987, VECTORS SURVEY MOL C; MILNER J, 1985, VIROLOGY, V147, P206, DOI 10.1016/0042-6822(85)90240-5; MONTENARH M, 1985, EMBO J, V4, P2941, DOI 10.1002/j.1460-2075.1985.tb04027.x; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SCHAFFHAUSEN BS, 1979, CELL, V18, P935, DOI 10.1016/0092-8674(79)90206-X; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SHIROKI K, 1986, MOL CELL BIOL, V6, P4379, DOI 10.1128/MCB.6.12.4379; SHOHAT O, 1987, ONCOGENE, V1, P277; SMITH AE, 1979, CELL, V18, P915, DOI 10.1016/0092-8674(79)90204-6; STURZBECHER HW, 1987, ONCOGENE, V1, P201; STURZBECHER HW, 1987, VIROLOGY, V160, P445; TJIAN R, 1979, P NATL ACAD SCI USA, V76, P610, DOI 10.1073/pnas.76.2.610; VANROY F, 1984, MOL CELL BIOL, V4, P232, DOI 10.1128/MCB.4.2.232; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; WALSER A, 1986, EMBO J, V5, P883, DOI 10.1002/j.1460-2075.1986.tb04299.x; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986	66	35	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1990	5	6					845	855						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2141685				2022-12-28	WOS:A1990DP55300010
J	CAPETANAKI, Y; KUISK, I; ROTHBLUM, K; STARNES, S				CAPETANAKI, Y; KUISK, I; ROTHBLUM, K; STARNES, S			MOUSE VIMENTIN - STRUCTURAL RELATIONSHIP TO FOS, JUN, CREB AND TPR	ONCOGENE			English	Article											CAPETANAKI, Y (corresponding author), BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039617] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39617-01] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALCAREK JM, 1985, NUCLEIC ACIDS RES, V13, P5527, DOI 10.1093/nar/13.15.5527; BARBER JR, 1987, MOL CELL BIOL, V7, P2201, DOI 10.1128/MCB.7.6.2201; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; BROWNING ET, 1981, J CELL BIOL, V90, P803, DOI 10.1083/jcb.90.3.803; CAPETANAKI Y, 1989, P NATL ACAD SCI USA, V86, P4882, DOI 10.1073/pnas.86.13.4882; CAPETANAKI Y, 1989, IN PRESS J CELL BIOL; CAPETANAKI YG, 1982, MOL CELL BIOL, V2, P258, DOI 10.1128/MCB.2.3.258; CAPETANAKI YG, 1983, CELL, V35, P411, DOI 10.1016/0092-8674(83)90174-5; CAPETANAKI YG, 1984, COLD SPRING HARB SYM, P415; CHAN D, 1989, P NATL ACAD SCI USA, V86, P2747, DOI 10.1073/pnas.86.8.2747; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; CRESS AE, 1988, J BIOL CHEM, V263, P19678; CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0; CURRAN T, 1982, VIROLOGY, V116, P221, DOI 10.1016/0042-6822(82)90415-9; CURRAN T, 1982, J VIROL, V42, P114, DOI 10.1128/JVI.42.1.114-122.1982; CURRAN T, 1984, CELL, V36, P259; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P89; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; DODEMONT HJ, 1982, EMBO J, V1, P167, DOI 10.1002/j.1460-2075.1982.tb01142.x; DOGLIO A, 1989, P NATL ACAD SCI USA, V86, P1148, DOI 10.1073/pnas.86.4.1148; DRAGER UC, 1983, NATURE, V303, P169, DOI 10.1038/303169a0; EVANS RM, 1988, FEBS LETT, V234, P73, DOI 10.1016/0014-5793(88)81306-1; EVANS RM, 1988, EUR J CELL BIOL, V46, P152; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GARD DL, 1982, MOL CELL BIOL, V2, P1104, DOI 10.1128/MCB.2.9.1104; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEIGER B, 1980, P NATL ACAD SCI USA, V77, P4679; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1983, EMBO J, V2, P1295, DOI 10.1002/j.1460-2075.1983.tb01584.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; GEISLER N, 1981, P NATL ACAD SCI-BIOL, V78, P4120, DOI 10.1073/pnas.78.7.4120; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; GIBSON CW, 1986, MOL CELL BIOCHEM, V71, P61; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GRANGER BL, 1979, CELL, V18, P1053, DOI 10.1016/0092-8674(79)90218-6; GRANGER BL, 1982, CELL, V30, P263, DOI 10.1016/0092-8674(82)90032-0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; HERMANN H, 1989, DEVELOPMENT, V105, P279; HIRSCHHORN RR, 1984, P NATL ACAD SCI-BIOL, V81, P6004, DOI 10.1073/pnas.81.19.6004; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; HORWITZ B, 1981, EXP CELL RES, V134, P281, DOI 10.1016/0014-4827(81)90427-4; HOUSE C, 1987, J BIOL CHEM, V262, P772; HUANG CK, 1988, BIOCHEM BIOPH RES CO, V150, P1006, DOI 10.1016/0006-291X(88)90728-0; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; INAGAKI M, 1988, J BIOL CHEM, V263, P5970; ISHIKAWA F, 1986, P NATL ACAD SCI USA, V83, P3209, DOI 10.1073/pnas.83.10.3209; ISHIKAWA F, 1987, MOL CELL BIOL, V7, P1226, DOI 10.1128/MCB.7.3.1226; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KHILLAN JS, 1987, GENE DEV, V1, P1327, DOI 10.1101/gad.1.10.1327; KING HWS, 1988, ONCOGENE, V2, P617; KNAPP B, 1986, NUCLEIC ACIDS RES, V14, P751, DOI 10.1093/nar/14.2.751; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUHN S, 1987, J CELL SCI, V87, P543; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; LAURILA P, 1981, EXP CELL RES, V131, P41, DOI 10.1016/0014-4827(81)90403-1; LAWRENCE CB, 1988, COMPUT APPL BIOSCI, V4, P25; LAWRENCE CB, 1986, B MATH BIOL, V48, P569; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LEHTO VP, 1978, NATURE, V272, P175, DOI 10.1038/272175a0; LEWIS SA, 1985, NUCLEIC ACIDS RES, V81, P2743; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; MOLDERS H, 1987, ONCOGENE, V1, P377; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NGAI J, 1984, J CELL BIOL, V99, P306, DOI 10.1083/jcb.99.1.306; OCONNOR CM, 1981, CELL, V23, P135, DOI 10.1016/0092-8674(81)90278-6; OLSON EN, 1989, ONCOGENE, V4, P907; OSBORN M, 1982, COLD SPRING HARB SYM, V46, P413; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PAULING L, 1953, NATURE, V171, P59, DOI 10.1038/171059a0; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8; QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1987, ONCOGENE HDB, P213; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; RITTLING SR, 1989, NUCLEIC ACIDS RES, V17, P1619, DOI 10.1093/nar/17.4.1619; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; SIEBERT PD, 1985, J BIOL CHEM, V260, P3868; SINGH B, 1987, J VIROL, V61, P3625, DOI 10.1128/JVI.61.11.3625-3629.1987; SINGH B, 1989, IN PRESS ONCOGENE; SPRUILL WA, 1983, P NATL ACAD SCI-BIOL, V80, P993, DOI 10.1073/pnas.80.4.993; SPRUILL WA, 1983, P NATL ACAD SCI-BIOL, V80, P760, DOI 10.1073/pnas.80.3.760; STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; STEINERT PM, 1983, NATURE, V302, P794, DOI 10.1038/302794a0; TAPSCOTT SJ, 1981, DEV BIOL, V86, P40, DOI 10.1016/0012-1606(81)90313-4; TEMPEST PR, 1986, CARCINOGENESIS, V7, P2051, DOI 10.1093/carcin/7.12.2051; TRAUB P, 1987, Z NATURFORSCH C, V42, P47; TRAUB P, 1983, J BIOL CHEM, V258, P1456; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; WOODCOCK CLF, 1980, J CELL BIOL, V85, P881, DOI 10.1083/jcb.85.3.881; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; YEN SH, 1981, J CELL BIOL, V88, P115, DOI 10.1083/jcb.88.1.115; ZEHNER ZE, 1983, P NATL ACAD SCI-BIOL, V80, P911, DOI 10.1073/pnas.80.4.911; ZEHNER ZE, 1987, J BIOL CHEM, V262, P8112	125	47	48	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					645	655						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2140597				2022-12-28	WOS:A1990DG37400003
J	EHLEN, T; DUBEAU, L				EHLEN, T; DUBEAU, L			LOSS OF HETEROZYGOSITY ON CHROMOSOMAL SEGMENTS 3P, 6Q AND 11P IN HUMAN OVARIAN CARCINOMAS	ONCOGENE			English	Article									UNIV SO CALIF,SCH MED,KENNETH NORRIS JR COMPREHENS CANC CTR,DEPT PATHOL,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT GYNECOL ONCOL,LOS ANGELES,CA 90033	University of Southern California; University of Southern California								ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; DUBEAU L, 1988, AM J PATHOL, V130, P588; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAREAU JLP, 1988, NUCLEIC ACIDS RES, V16, P1223, DOI 10.1093/nar/16.3.1223; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; LEE JH, 1989, CANCER RES, V49, P1220; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P9889; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; PANANI A, 1985, CANCER GENET CYTOGEN, V16, P65, DOI 10.1016/0165-4608(85)90078-0; SITHANANDAM G, 1989, ONCOGENE, V4, P451; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TRENT JM, 1981, CANCER GENET CYTOGEN, V3, P279, DOI 10.1016/0165-4608(81)90037-6; VANDERHOUT AH, 1988, CANCER GENET CYTOGEN, V32, P281, DOI 10.1016/0165-4608(88)90292-0; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WAKE N, 1980, CANCER RES, V40, P4512; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; WHANGPENG J, 1984, CANCER GENET CYTOGEN, V11, P91, DOI 10.1016/0165-4608(84)90102-X; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0; ZHOU DJ, 1988, CANCER, V62, P1573, DOI 10.1002/1097-0142(19881015)62:8<1573::AID-CNCR2820620819>3.0.CO;2-M	25	191	193	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					219	223						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2320374				2022-12-28	WOS:A1990CU02900008
J	SCHWARTZ, MA; RUPP, EE; FRANGIONI, JV; LECHENE, CP				SCHWARTZ, MA; RUPP, EE; FRANGIONI, JV; LECHENE, CP			CYTOPLASMIC PH AND ANCHORAGE-INDEPENDENT GROWTH INDUCED BY V-KI-RAS, V-SRC OR POLYOMA MIDDLE-T	ONCOGENE			English	Article									HARVARD UNIV, SCH MED, CELLULAR PHYSIOL LAB, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, MIT, DIV HLTH SCI & TECHNOL, CAMBRIDGE, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT)	SCHWARTZ, MA (corresponding author), HARVARD UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, BOSTON, MA 02115 USA.			schwartz, martin/0000-0002-2071-1243	NCRR NIH HHS [5P441RR02064] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BIERMAN AJ, 1988, J BIOL CHEM, V263, P15253; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; CASSEL D, 1987, J BIOL CHEM, V262, P4587; DOPPLER W, 1987, GENE, V54, P147, DOI 10.1016/0378-1119(87)90357-X; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAGAG N, 1987, MOL CELL BIOL, V7, P1984, DOI 10.1128/MCB.7.5.1984; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1982, J CELL BIOL, V95, P369, DOI 10.1083/jcb.95.2.369; INGER DE, 1989, UNPUB; MOOLENAAR WH, 1986, ANNU REV PHYSIOL, V48, P363; MORGAN WC, 1988, J VIROL, V62, P3407, DOI 10.1128/JVI.62.9.3407-3414.1988; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OBER SS, 1987, P NATL ACAD SCI USA, V84, P345; PALLAS DC, 1988, J VIROL, V62, P3934, DOI 10.1128/JVI.62.11.3934-3940.1988; PERONA R, 1988, NATURE, V334, P438, DOI 10.1038/334438a0; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; SCHWARTZ MA, 1989, P NATL ACAD SCI USA, V86, P4525, DOI 10.1073/pnas.86.12.4525; SCHWARTZ MA, IN PRESS J BIOL CHEM; SMETS LA, 1980, BIOCHIM BIOPHYS ACTA, V605, P93, DOI 10.1016/0304-419X(80)90022-0	21	26	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1990	5	1					55	58						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181378				2022-12-28	WOS:A1990CM62000008
J	DEMILIA, J; BULOVAS, K; DERCOLE, K; WOLF, B; STEELE, G; SUMMERHAYES, IC				DEMILIA, J; BULOVAS, K; DERCOLE, K; WOLF, B; STEELE, G; SUMMERHAYES, IC			EXPRESSION OF THE C-ERBB-2 GENE-PRODUCT (P185) AT DIFFERENT STAGES OF NEOPLASTIC PROGRESSION IN THE COLON	ONCOGENE			English	Article									NEW ENGLAND DEACONESS HOSP,DEPT SURG,CANC BIOL LAB,50 BINNEY ST,BOSTON,MA 02115						NCI NIH HHS [CA44704] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA044704] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARNES DM, 1988, BRIT J CANCER, V58, P448, DOI 10.1038/bjc.1988.238; BERGER MS, 1988, CANCER RES, V48, P1238; COHEN JA, 1989, ONCOGENE, V4, P81; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; GUSTERSON BA, 1988, BRIT J CANCER, V58, P453, DOI 10.1038/bjc.1988.239; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAL M, 1988, CANCER RES, V48, P1517; VANDEVIJVER MJ, 1988, ONCOGENE, V2, P175; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YOKOTA J, 1986, LANCET, V1, P765; ZHOU DJ, 1987, CANCER RES, V47, P6123	28	131	133	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1233	1239						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2571966				2022-12-28	WOS:A1989AU50800011
J	UEHARA, Y; ONO, T; KURISHITA, A; KOKURYU, H; OKADA, S				UEHARA, Y; ONO, T; KURISHITA, A; KOKURYU, H; OKADA, S			AGE-DEPENDENT AND TISSUE-SPECIFIC CHANGES OF DNA METHYLATION WITHIN AND AROUND THE C-FOS GENE IN MICE	ONCOGENE			English	Article									TOHOKU UNIV,SCH MED,DEPT RADIAT RES,SEIRYO CHO 2-1,SENDAI,MIYAGI 980,JAPAN; KYOTO UNIV,FAC MED,CTR RADIAT BIOL,KYOTO 606,JAPAN; KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 2,KYOTO 606,JAPAN	Tohoku University; Kyoto University; Kyoto University								ADAMS RLP, 1985, MOL BIOL DNA METHYLA, P115; BENVENISTY N, 1985, P NATL ACAD SCI USA, V82, P267, DOI 10.1073/pnas.82.2.267; BUCKLEY I, 1988, ADV CANCER RES, V50, P71, DOI 10.1016/S0065-230X(08)60435-2; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COOPER DN, 1983, HUM GENET, V64, P315, DOI 10.1007/BF00292363; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; ETKIND PR, 1983, J VIROL, V45, P114, DOI 10.1128/JVI.45.1.114-123.1983; GREENGARD O, 1972, J CELL BIOL, V52, P261, DOI 10.1083/jcb.52.2.261; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; ICHINOSE M, 1988, CANCER RES, V48, P1603; KANAMURA S, 1980, ANAT EMBRYOL, V158, P151, DOI 10.1007/BF00315902; KANAMURA S, 1974, ANAT REC, V181, P635; KASIK JW, 1987, MOL CELL BIOL, V7, P3349, DOI 10.1128/MCB.7.9.3349; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; MAYSHOOPES LL, 1985, MOL BIOL AGING GENE, P49; MILLER AD, 1984, CELL, V36, P51; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; MULLINS LJ, 1987, MOL CELL BIOL, V7, P3916, DOI 10.1128/MCB.7.11.3916; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X; ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8; PAUL J, 1969, CELL TISSUE KINET, V2, P283, DOI 10.1111/j.1365-2184.1969.tb00238.x; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RAZIN A, 1984, INT REV CYTOL, V92, P159; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SETOYAMA C, 1986, P NATL ACAD SCI USA, V83, P3213, DOI 10.1073/pnas.83.10.3213; TANAKA K, 1986, P NATL ACAD SCI USA, V83, P7598, DOI 10.1073/pnas.83.20.7598; TIMIRAS PS, 1972, DEV PHYSL AGING, P129; TRATNER I, 1988, NUCLEIC ACIDS RES, V16, P2749, DOI 10.1093/nar/16.7.2749; VARMUS HE, 1987, MOL BASIS BLOOD DISE, P271; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; VERMA IM, 1987, ADV CANCER RES, V49, P29, DOI 10.1016/S0065-230X(08)60793-9	37	37	37	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1023	1028						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2503800				2022-12-28	WOS:A1989AJ29700012
J	FISCHER, S; WENDLING, F; BOULET, I; COCAULT, L; SOULA, M; FAGARD, R; TAMBOURIN, P				FISCHER, S; WENDLING, F; BOULET, I; COCAULT, L; SOULA, M; FAGARD, R; TAMBOURIN, P			ELEVATED LEVEL OF P60C-SRC IN VIRUS-TRANSFORMED MURINE MEGAKARYOCYTIC CELL-LINES	ONCOGENE			English	Article									HOP COCHIN,INSERM,UNITE 152,F-75674 PARIS 14,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	FISCHER, S (corresponding author), CHU COCHIN,INSERM,UNITE 15,24 RUE FAUBOURG ST JACQUES,F-75014 PARIS,FRANCE.			PETIT, Laurence/0000-0002-2475-9367				BARNEKOW A, 1986, EMBO J, V5, P701, DOI 10.1002/j.1460-2075.1986.tb04270.x; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CARTWRIGHT CA, 1988, P NATL ACAD SCI USA, V85, P3348, DOI 10.1073/pnas.85.10.3348; COOPER JA, 1984, J BIOL CHEM, V259, P7835; FERREL JE, 1988, MOL CELL BIOL, V8, P3609; FISCHER S, 1987, BIOCHEM BIOPH RES CO, V143, P819, DOI 10.1016/0006-291X(87)90322-6; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GACON G, 1982, EMBO J, V1, P1579, DOI 10.1002/j.1460-2075.1982.tb01358.x; GEE CE, 1986, P NATL ACAD SCI USA, V83, P5131, DOI 10.1073/pnas.83.14.5131; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; IBA H, 1984, P NATL ACAD SCI-BIOL, V81, P4424, DOI 10.1073/pnas.81.14.4424; JACKSON CW, 1973, BLOOD, V42, P413, DOI 10.1182/blood.V42.3.413.413; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LONG MW, 1981, BLOOD, V58, P1032; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; Maniatis T., 1982, MOL CLONING; MATHEYPREVOT B, 1985, EMBO J, V4, P1769, DOI 10.1002/j.1460-2075.1985.tb03849.x; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PARSONS SJ, 1986, BIOCHEM BIOPH RES CO, V134, P736, DOI 10.1016/S0006-291X(86)80482-X; PENCIOLELLI JF, 1987, J VIROL, V61, P579, DOI 10.1128/JVI.61.2.579-583.1987; RENDU F, 1989, IN PRESS BLOOD; STENBERG PE, 1986, BLOOD, V68, P696; TAKATA K, 1988, BLOOD, V71, P818; WENDLING F, 1986, VIROLOGY, V149, P242, DOI 10.1016/0042-6822(86)90125-X	25	7	7	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1989	4	7					901	905						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE584	2474138				2022-12-28	WOS:A1989AE58400013
J	DIPAOLO, JA; WOODWORTH, CD; POPESCU, NC; NOTARIO, V; DONIGER, J				DIPAOLO, JA; WOODWORTH, CD; POPESCU, NC; NOTARIO, V; DONIGER, J			INDUCTION OF HUMAN CERVICAL SQUAMOUS-CELL CARCINOMA BY SEQUENTIAL TRANSFECTION WITH HUMAN PAPILLOMAVIRUS-16 DNA AND VIRAL HARVEY RAS	ONCOGENE			English	Article											DIPAOLO, JA (corresponding author), NCI,DIV CANC ETIOL,BIOL LAB,BETHESDA,MD 20892, USA.		/AAB-6461-2022; /AFP-0764-2022					ADAM E, 1974, PREV MED, V3, P122, DOI 10.1016/0091-7435(74)90068-1; ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; ATKIN NB, 1982, CANCER GENET CYTOGEN, V7, P209, DOI 10.1016/0165-4608(82)90068-1; BANGLE R, 1963, CANCER, V16, P1151, DOI 10.1002/1097-0142(196309)16:9<1151::AID-CNCR2820160909>3.0.CO;2-D; BEDELL MA, 1987, J VIROL, V61, P3635, DOI 10.1128/JVI.61.11.3635-3640.1987; BRINTON LA, 1986, JAMA-J AM MED ASSOC, V255, P3265, DOI 10.1001/jama.255.23.3265; CHANG EH, 1980, J VIROL, V35, P76, DOI 10.1128/JVI.35.1.76-92.1980; DEVILLIERS EM, 1987, LANCET, V2, P703; DURST M, 1987, ONCOGENE, V1, P251; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GISSMANN L, 1984, J INVEST DERMATOL, V83, P26; HAUSEN HZ, 1982, LANCET, V2, P1370; HAUSEN HZ, 1977, CURR TOP MICROBIOL I, V78, P1; KANDA T, 1988, J VIROL, V62, P610, DOI 10.1128/JVI.62.2.610-613.1988; KAUR K, 1988, J VIROL, V62, P1917; KAZUMITSU U, 1987, P NATL ACAD SCI USA, V84, P3004; KING JFW, 1980, NY STATE J MED, V1, P1253; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LAUTENBERGER JA, 1981, P NATL ACAD SCI-BIOL, V78, P1518, DOI 10.1073/pnas.78.3.1518; LEVINE RU, 1984, OBSTET GYNECOL, V64, P16; MARTINEZ I, 1969, CANCER, V24, P777, DOI 10.1002/1097-0142(196910)24:4<777::AID-CNCR2820240418>3.0.CO;2-C; ORIEL JD, 1971, BRIT J VENER DIS, V47, P1; PETO R, 1986, BRADBURY REPORT, V21; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; PIRISI L, 1987, J VIROL, V61, P1061, DOI 10.1128/JVI.61.4.1061-1066.1987; PRIDAN H, 1971, ISRAEL J MED SCI, V7, P1465; REEVES WC, 1987, INT J CANCER, V40, P450, DOI 10.1002/ijc.2910400403; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; RIOU G, 1988, ONCOGENE, V3, P329; RIOU G, 1985, PAPILLOMAVIRUSES MOL, P47; ROTKIN ID, 1973, CANCER RES, V33, P1353; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SANDBERG AA, 1980, CHROMOSOMES HUMAN CA; SASSON IM, 1985, NEW ENGL J MED, V312, P315; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SHIRASAWA H, 1987, J GEN VIROL, V68, P583, DOI 10.1099/0022-1317-68-2-583; SINGER A, 1976, AM J OBSTET GYNECOL, V126, P110, DOI 10.1016/0002-9378(76)90474-9; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; VOUSDEN KH, 1988, ONCOGENE RES, V3, P1; WOODWORTH CD, 1989, J VIROL, V63, P159, DOI 10.1128/JVI.63.1.159-164.1989; WOODWORTH CD, 1988, CANCER RES, V48, P4620; YUNIS JJ, 1987, SOMAT CELL MOLEC GEN, V13, P397, DOI 10.1007/BF01534938	43	207	212	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					395	399						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2541388				2022-12-28	WOS:A1989U567700001
J	GRAND, RJA; LEVINE, BA; BYRD, PJ; GALLIMORE, PH				GRAND, RJA; LEVINE, BA; BYRD, PJ; GALLIMORE, PH			THE BINDING OF GUANINE-NUCLEOTIDE TO N-RAS P21 - A PHOSPHORUS AND PROTON MAGNETIC-RESONANCE STUDY	ONCOGENE			English	Article									UNIV OXFORD,INORGAN CHEM LAB,OXFORD OX1 2QR,ENGLAND	University of Oxford	GRAND, RJA (corresponding author), UNIV BIRMINGHAM,DEPT CANC STUDIES,CANC RES CAMPAIGN LABS,BIRMINGHAM B15 2TJ,W MIDLANDS,ENGLAND.							ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CAMPBELLBURK S, 1988, 13TH P INT C MAGN RE; CLANTON DJ, 1986, P NATL ACAD SCI USA, V83, P5076, DOI 10.1073/pnas.83.14.5076; DALGARNO DC, 1983, BIOSCIENCE REP, V3, P443, DOI 10.1007/BF01121955; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DER CJ, 1986, MOL CELL BIOL, V6, P3291, DOI 10.1128/MCB.6.9.3291; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEUERSTEIN J, 1987, EUR J BIOCHEM, V162, P49, DOI 10.1111/j.1432-1033.1987.tb10540.x; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FUJITA J, 1984, NATURE, V309, P404; GAY NJ, 1983, NATURE, V301, P262, DOI 10.1038/301262a0; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAND RJA, 1987, ONCOGENE, V1, P305; HOSHINO M, 1987, J BIOCHEM-TOKYO, V102, P502; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; POE M, 1985, J BIOL CHEM, V260, P3906; ROSCH P, 1986, BIOCHEM BIOPH RES CO, V135, P549, DOI 10.1016/0006-291X(86)90029-X; SCHLICHTING I, 1988, BIOCHEM BIOPH RES CO, V150, P444, DOI 10.1016/0006-291X(88)90540-2; SHRIVER JW, 1981, BIOCHEMISTRY-US, V20, P2004, DOI 10.1021/bi00510a041; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; TOKSOZ D, 1987, ONCOGENE, V1, P409; TONG L, 1989, NATURE, V337, P90, DOI 10.1038/337090a0; TRAHEY M, 1987, MOL CELL BIOL, V7, P541, DOI 10.1128/MCB.7.1.541; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	29	8	8	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					355	361						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2649849				2022-12-28	WOS:A1989U567600012
J	MCMAHON, J; HOWE, KM; WATSON, RJ				MCMAHON, J; HOWE, KM; WATSON, RJ			THE INDUCTION OF FRIEND-ERYTHROLEUKEMIA DIFFERENTIATION IS MARKEDLY AFFECTED BY EXPRESSION OF A TRANSFECTED C-MYB CDNA	ONCOGENE			English	Article									ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DOMINION HOUSE,BARTHOLOMEW CLOSE,LONDON EC1A 7BE,ENGLAND	Cancer Research UK; University of London; Queen Mary University London								ALITALO K, 1984, P NATL ACAD SCI-BIOL, V81, P4534, DOI 10.1073/pnas.81.14.4534; BISHOP JM, 1985, MOL BIOL TUMOR VIR 4, P351; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; BRELVI ZS, 1987, J CELL PHYSIOL, V131, P43, DOI 10.1002/jcp.1041310108; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CASTLE S, 1985, BIOCHEM BIOPH RES CO, V132, P688, DOI 10.1016/0006-291X(85)91187-8; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; COLL J, 1983, EXP CELL RES, V149, P151, DOI 10.1016/0014-4827(83)90388-9; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CRAIG RW, 1984, CANCER RES, V44, P442; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DUPREY SP, 1985, P NATL ACAD SCI USA, V78, P3600; FIBACH E, 1977, CANCER RES, V37, P440; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GUSELLA J, 1976, CELL, V9, P221, DOI 10.1016/0092-8674(76)90113-6; HAYMAN MJ, 1986, VIROLOGY, V150, P270, DOI 10.1016/0042-6822(86)90287-4; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KERBEL RS, 1987, P NATL ACAD SCI USA, V84, P1236; KIRSCH IR, 1986, J CELL BIOCHEM, V32, P11, DOI 10.1002/jcb.240320103; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; NESS SA, 1987, CELL, V51, P41, DOI 10.1016/0092-8674(87)90008-0; PELICCI PG, 1984, SCIENCE, V224, P1117, DOI 10.1126/science.6585957; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHEINESS D, 1984, MOL CELL BIOL, V4, P1206, DOI 10.1128/MCB.4.7.1206; SPANDIDOS DA, 1982, EMBO J, V1, P15, DOI 10.1002/j.1460-2075.1982.tb01117.x; TSIFTSOGLOU AS, 1985, ANTICANCER RES, V5, P81; WATSON RJ, 1987, EMBO J, V6, P1643, DOI 10.1002/j.1460-2075.1987.tb02413.x; WATSON RJ, 1988, ONCOGENE, V2, P267; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; WEIS JH, 1983, NATURE, V302, P72, DOI 10.1038/302072a0; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WILKINSON D, 1988, J EXP MED, V167, P1442, DOI 10.1084/jem.167.4.1442	41	63	64	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					717	720						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577875				2022-12-28	WOS:A1988R646000015
J	CHOWDHURY, M; TAYLOR, JP; TADA, H; RAPPAPORT, J; WONGSTAAL, F; AMINI, S; KHALILI, K				CHOWDHURY, M; TAYLOR, JP; TADA, H; RAPPAPORT, J; WONGSTAAL, F; AMINI, S; KHALILI, K			REGULATION OF THE HUMAN NEUROTROPIC VIRUS PROMOTER BY JCV-T ANTIGEN AND HIV-1 TAT PROTEIN	ONCOGENE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE-DEFICIENCY SYNDROME; LONG TERMINAL REPEAT; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CENTRAL NERVOUS-SYSTEM; TRANS-ACTIVATION; HTLV-III; CEREBROSPINAL-FLUID; SYNDROME AIDS; RNA ENHANCER	We compared the ability of HIV-1 tat protein and JCV T-antigen in inducing transcription from the JCV late promoter, JCV(L). A JCV(L) promoter-chloramphenicol acetyltransferase plasmid (pJC(L)-CAT) was transfected into human glial cells alone or together with plasmids producing T-antigen and tat protein. CAT enzyme activity obtained from the transfected cells indicated that both JCV T-antigen and HIV-1 tat proteins stimulated JCV late gene expressiom. However, the level of induction mediated by tat protein was significantly higher than that obtained with T-antigen. Moreover, in contrast to JCV T-antigen, tat stimulated JCV(L)-promoter activity over a narrow range of ptat expressor plasmid concentration. Co-transfection of both T-antigen and tat plasmids at optimal concentrations resulted in greater than additive CAT activity from the JCV(L) promoter. This synergism suggests that the two activator proteins utilize alternative mechanisms to exert their effects. Using deletion mutations from the 5' end of the JCV(L) promoter, we demonstrated that different regions within the JCV enhancer/promoter are important for T-antigen and tat induction, implying that these activators function through distinct targets to increase JCV(L) promoter activity.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University			Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	NATIONAL CANCER INSTITUTE [R29CA047996] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47996] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; CULLEN BR, 1986, CELL, V46, P973, DOI 10.1016/0092-8674(86)90696-3; FAREED GC, 1978, MICROBIOLOGY 1978, P427; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FEIGENBAUM L, 1987, P NATL ACAD SCI USA, V84, P3695, DOI 10.1073/pnas.84.11.3695; FEINBERG MB, 1986, CELL, V46, P807, DOI 10.1016/0092-8674(86)90062-0; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; GALLO R C, 1987, Scientific American, V256, P47; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GENDELMAN HE, 1986, P NATL ACAD SCI USA, V83, P9759, DOI 10.1073/pnas.83.24.9759; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAUBER J, 1988, J VIROL, V62, P673, DOI 10.1128/JVI.62.3.673-679.1988; HAUBER J, 1986, P NATL ACAD SCI USA, V843, P6364; HO DD, 1985, NEW ENGL J MED, V313, P1493, DOI 10.1056/NEJM198512123132401; JAKABOVITS A, 1988, MOL CELL BIOL, V8, P2555; JEANG KT, 1988, P NATL ACAD SCI USA, V85, P8291, DOI 10.1073/pnas.85.21.8291; JOHNSON RT, 1983, POLYOMAVIRUSES HUMAN, P183; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KENNEY S, 1984, SCIENCE, V226, P1337, DOI 10.1126/science.6095453; KNIGHT DM, 1987, SCIENCE, V236, P837, DOI 10.1126/science.3033827; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; KRUPP LB, 1985, ANN NEUROL, V17, P344, DOI 10.1002/ana.410170407; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LEVY JA, 1985, LANCET, V2, P586; NIELSEN SL, 1984, AM J CLIN PATHOL, V82, P678, DOI 10.1093/ajcp/82.6.678; PADGETT BL, 1977, INFECT IMMUN, V15, P656, DOI 10.1128/IAI.15.2.656-662.1977; PETITO CK, 1985, NEW ENGL J MED, V312, P874, DOI 10.1056/NEJM198504043121402; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; RADONOVICH M, 1989, J VIROL, V63, P2987, DOI 10.1128/JVI.63.7.2987-2994.1989; ROSEN CA, 1986, NATURE, V319, P555, DOI 10.1038/319555a0; SADAIE MR, 1988, SCIENCE, V239, P910, DOI 10.1126/science.3277284; SHARP PA, 1989, CELL, V59, P229, DOI 10.1016/0092-8674(89)90279-1; SHAW GM, 1985, SCIENCE, V227, P177, DOI 10.1126/science.2981429; SNIDER WD, 1983, ANN NEUROL, V14, P403, DOI 10.1002/ana.410140404; STONER GL, 1986, P NATL ACAD SCI USA, V83, P2271, DOI 10.1073/pnas.83.7.2271; TADA H, 1989, J VIROL, V63, P463, DOI 10.1128/JVI.63.1.463-466.1989; TADA H, 1989, IN PRESS P NATL ACAD; TAKEMOTO K, 1979, J VIROL, V80, P384; WALKER DL, 1978, HDB CLIN NEUROLOGY, P307; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; ZURHEIN GM, 1969, PROG MED VIROL, V11, P185	45	64	65	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1737	1742						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2178236				2022-12-28	WOS:A1990ET43600001
J	SCHLEGEL, U; MOOTS, PL; ROSENBLUM, MK; THALER, HT; FURNEAUX, HM				SCHLEGEL, U; MOOTS, PL; ROSENBLUM, MK; THALER, HT; FURNEAUX, HM			EXPRESSION OF TRANSFORMING GROWTH-FACTOR ALPHA IN HUMAN GLIOMAS	ONCOGENE			English	Note							MALIGNANT GLIOMAS; FACTOR RECEPTOR; MESSENGER-RNAS; EGF-RECEPTOR; CELL-LINES; TGF-ALPHA; INDUCTION; KERATINOCYTES; AMPLIFICATION; MACROPHAGES	Expression of transforming growth factor alpha (TGF alpha) is frequently associated with the development of human and animal tumors. Using a sensitive immunohistochemical assay, which can be applied on formalin-fixed, paraffin-embedded tissue, we have examined the expression of TGF alpha in 71 human gliomas (63 untreated and 8 recurrent tumors). Tumors were graded by a 3-grade-system: grade I = low grade gliomas, grade II = anaplastic gliomas and grade III = glioblastomas. A strong positive correlation between tumor grade and extent of TGF alpha expression was found (P < 0.0001). Polymerase chain reaction (PCR) was used to amplify the fourth exon of the TGF alpha gene of 8 glioma DNA specimens and increasing amounts of normal human DNA, which served as a standard. No amplification of the TGF alpha gene copy number in tumors could be detected.	CORNELL UNIV,MED CTR,COLL MED,MEM SLOAN KETTERING CTR CANC RES,DEPT EPIDEMIOL & BIOSTAT,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,COTZIAS LABS NEUROONCOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,DEPT PATHOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,GRAD PROGRAM NEUROSCI,NEW YORK,NY 10021	Cornell University; Cornell University; Cornell University; Cornell University				furneaux, henry/0000-0003-2212-1017; Moots, Paul/0000-0002-2277-802X				BURGER PC, 1982, SURGICAL PATHOLOGY N, P226; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DERYNCK R, 1987, CANCER RES, V47, P707; DIMARCO E, 1989, ONCOGENE, V4, P831; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MARQUARDT H, 1982, J BIOL CHEM, V257, P5220; NISTER M, 1988, CANCER RES, V48, P3910; OZANNE B, 1980, J CELL PHYSIOL, V105, P163, DOI 10.1002/jcp.1041050118; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Sambrook J, 1989, MOL CLONING LAB MANU, pE3; SAMUELS V, 1989, AM J PATHOL, V134, P895; SCHREIBER AB, 1986, SCIENCE, V232, P1250, DOI 10.1126/science.2422759; SORVILLO JM, 1990, ONCOGENE, V5, P377; TODARO GJ, 1980, P NATL ACAD SCI-BIOL, V77, P5258, DOI 10.1073/pnas.77.9.5258; WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899; WONG DTW, 1988, CANCER RES, V48, P3130; YUNG W K A, 1989, Neurology, V39, P261	20	63	65	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1839	1842						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284103				2022-12-28	WOS:A1990ET43600015
J	ALBAGDADI, F; SINGH, B; ARLINGHAUS, RB				ALBAGDADI, F; SINGH, B; ARLINGHAUS, RB			EVIDENCE FOR INVOLVEMENT OF THE PROTEIN-KINASE-C PATHWAY IN THE ACTIVATION OF P37V-MOS PROTEIN-KINASE	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC PATHOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NCI NIH HHS [CA16672, CA45125] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045125, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JC, 1989, BIOCHEM J, V257, P905, DOI 10.1042/bj2570905; ARLINGHAUS RB, 1985, J GEN VIROL, V66, P1845, DOI 10.1099/0022-1317-66-9-1845; BARRETT CB, 1990, MOL CELL BIOL, V10, P310, DOI 10.1128/MCB.10.1.310; BOLD RJ, 1985, MOL CELL BIOL, V5, P3131, DOI 10.1128/MCB.5.11.3131; DONOGHUE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P800, DOI 10.1073/pnas.79.3.800; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; FINIDORILEPICARD J, 1981, NATURE, V292, P255, DOI 10.1038/292255a0; FREEMAN RS, 1989, P NATL ACAD SCI USA, V86, P5805, DOI 10.1073/pnas.86.15.5805; GALLICK G, 1984, MODERN APPROACHES VA, V6, P407; GALLICK GE, 1984, VIROLOGY, V139, P366, DOI 10.1016/0042-6822(84)90382-9; GALLICK GE, 1985, J GEN VIROL, V66, P945, DOI 10.1099/0022-1317-66-5-945; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; HAMILTON BJ, 1989, P NATL ACAD SCI USA, V86, P597, DOI 10.1073/pnas.86.2.597; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNINK M, 1985, P NATL ACAD SCI USA, V82, P7894, DOI 10.1073/pnas.82.23.7894; HERZOG NK, 1989, ONCOGENE, V4, P1307; HERZOG NK, 1988, ONCOGENE, V3, P225; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; INAGAKI M, 1984, J BIOL CHEM, V259, P4321; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KLOETZER WS, 1984, VIROLOGY, V138, P143, DOI 10.1016/0042-6822(84)90154-5; KLOETZER WS, 1983, P NATL ACAD SCI-BIOL, V80, P412, DOI 10.1073/pnas.80.2.412; LACAL JC, 1987, SCIENCE, V238, P533, DOI 10.1126/science.2821623; LEE M, 1988, TRENDS GENET, V4, P287, DOI 10.1016/0168-9525(88)90171-0; LIU JX, 1990, ONCOGENE, V5, P171; MALLER JL, 1979, J BIOL CHEM, V254, P579; MAXWELL SA, 1985, J GEN VIROL, V66, P2135, DOI 10.1099/0022-1317-66-10-2135; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; NODA M, 1983, P NATL ACAD SCI-BIOL, V80, P5602, DOI 10.1073/pnas.80.18.5602; OGISO Y, 1988, BIOCHEM BIOPH RES CO, V154, P339, DOI 10.1016/0006-291X(88)90690-0; OKEEFE SJ, 1989, P NATL ACAD SCI USA, V86, P7038, DOI 10.1073/pnas.86.18.7038; PAPKOFF J, 1983, CELL, V33, P161, DOI 10.1016/0092-8674(83)90345-8; PAPKOFF J, 1982, CELL, V29, P417, DOI 10.1016/0092-8674(82)90158-1; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; ROY LM, 1990, IN PRESS CELL; SADLER SE, 1989, J BIOL CHEM, V264, P856; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1989, SCIENCE, V245, P643, DOI 10.1126/science.2474853; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SETH A, 1985, J VIROL, V56, P144, DOI 10.1128/JVI.56.1.144-152.1985; SINGH B, 1988, ONCOGENE, V3, P79; SINGH B, 1987, J VIROL, V61, P3625, DOI 10.1128/JVI.61.11.3625-3629.1987; SINGH B, 1986, J VIROL, V60, P1148, DOI 10.1128/JVI.60.3.1148-1152.1986; SINGH B, 1989, VIROLOGY, V173, P144, DOI 10.1016/0042-6822(89)90230-4; SINGH B, 1988, VIROLOGY, V164, P114, DOI 10.1016/0042-6822(88)90626-5; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STITH BJ, 1987, EXP CELL RES, V169, P514, DOI 10.1016/0014-4827(87)90211-4; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; VANBEVEREN C, 1981, CELL, V27, P97, DOI 10.1016/0092-8674(81)90364-0; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	54	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1251	1257						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2168030				2022-12-28	WOS:A1990DX36100020
J	WASYLYK, C; SCHNEIKERT, J; WASYLYK, B				WASYLYK, C; SCHNEIKERT, J; WASYLYK, B			ONCOGENE V-JUN MODULATES DNA-REPLICATION	ONCOGENE			English	Note											WASYLYK, C (corresponding author), FAC MED STRASBOURG,FAC CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,F-67085 STRASBOURG,FRANCE.		Wasylyk, Bohdan/ABG-6778-2020	Wasylyk, Bohdan/0000-0002-1718-1237				CAMPBELL BA, 1988, MOL CELL BIOL, V8, P1993, DOI 10.1128/MCB.8.5.1993; DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HERRLICH P, 1989, TRENDS GENET, V5, P112, DOI 10.1016/0168-9525(89)90041-3; Imler J L, 1989, Prog Growth Factor Res, V1, P69, DOI 10.1016/0955-2235(89)90001-X; IMLER JL, 1988, NUCLEIC ACIDS RES, V16, P3005, DOI 10.1093/nar/16.7.3005; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; KELLY TJ, 1988, J BIOL CHEM, V263, P17889; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; OCONNOR DT, 1988, NUCLEIC ACIDS RES, V16, P11207, DOI 10.1093/nar/16.23.11207; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; PRUIJN GJM, 1989, NUCLEIC ACIDS RES, V17, P1845, DOI 10.1093/nar/17.5.1845; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SHARMA A, 1989, P NATL ACAD SCI USA, V86, P491, DOI 10.1073/pnas.86.2.491; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; VOGT PK, 1989, IN PRESS; WASYLYK B, 1988, P NATL ACAD SCI USA, V85, P7952, DOI 10.1073/pnas.85.21.7952; WASYLYK C, 1989, EMBO J, V8, P3371, DOI 10.1002/j.1460-2075.1989.tb08500.x; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; YAMAGUCHI Y, 1989, J VIROL, V63, P1040, DOI 10.1128/JVI.63.3.1040-1048.1989	21	43	43	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1055	1058						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2165232				2022-12-28	WOS:A1990DP41500015
J	WAGNER, S; KNIPPERS, R				WAGNER, S; KNIPPERS, R			AN SV40 LARGE T-ANTIGEN BINDING-SITE IN THE CELLULAR GENOME IS PART OF A CIS-ACTING TRANSCRIPTIONAL ELEMENT	ONCOGENE			English	Article											WAGNER, S (corresponding author), UNIV CONSTANCE,FAK BIOL,W-7750 CONSTANCE,GERMANY.							BAUR CP, 1988, J MOL BIOL, V203, P1009, DOI 10.1016/0022-2836(88)90125-8; BURGER C, 1983, VIROLOGY, V126, P19, DOI 10.1016/0042-6822(83)90459-2; CONRAD SE, 1982, MOL CELL BIOL, V2, P949, DOI 10.1128/MCB.2.8.949; DEB SP, 1987, J VIROL, V61, P3649, DOI 10.1128/JVI.61.12.3649-3654.1987; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEPAMPHILIS ML, 1986, PAPOVAVIRIDAE, V1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DORA S, 1989, J VIROL, V63, P2820, DOI 10.1128/JVI.63.6.2820-2828.1989; Fordis C M, 1987, Methods Enzymol, V151, P382; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GALLO GJ, 1988, MOL CELL BIOL, V8, P1648, DOI 10.1128/MCB.8.4.1648; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; GRUSS C, 1988, VIROLOGY, V167, P349, DOI 10.1016/S0042-6822(88)90095-5; HANSEN U, 1981, CELL, V27, P603, DOI 10.1016/0092-8674(81)90402-5; HUBER B, 1985, VIROLOGY, V146, P188, DOI 10.1016/0042-6822(85)90003-0; JENKINS JR, 1988, ONCOGENE HDB; KINGSTON RE, 1986, MOL CELL BIOL, V6, P3180, DOI 10.1128/MCB.6.9.3180; LANE DP, 1985, PROC R SOC SER B-BIO, V226, P25, DOI 10.1098/rspb.1985.0077; Maniatis T., 1982, MOL CLONING; MCKAY RDG, 1981, J MOL BIOL, V145, P471, DOI 10.1016/0022-2836(81)90540-4; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; POLLWEIN P, 1987, NUCLEIC ACIDS RES, V15, P9741, DOI 10.1093/nar/15.23.9741; PULM W, 1985, MOL CELL BIOL, V5, P295; RIO D, 1980, P NATL ACAD SCI-BIOL, V77, P5706, DOI 10.1073/pnas.77.10.5706; ROBBINS PD, 1986, MOL CELL BIOL, V6, P1283, DOI 10.1128/MCB.6.4.1283; RYDER K, 1985, CELL, V42, P539, DOI 10.1016/0092-8674(85)90111-4; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHEFFNER M, 1989, NUCLEIC ACIDS RES, V17, P93, DOI 10.1093/nar/17.1.93; SCHORPP M, 1988, J MOL BIOL, V199, P83, DOI 10.1016/0022-2836(88)90380-4; SCHORPP M, 1988, J MOL BIOL, V202, P307, DOI 10.1016/0022-2836(88)90460-3; SIMANIS V, 1985, VIROLOGY, V144, P88, DOI 10.1016/0042-6822(85)90308-3; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; STAHL H, 1987, BIOCHIM BIOPHYS ACTA, V910, P1, DOI 10.1016/0167-4781(87)90088-1; TOOZE J, 1982, MOL BIOL TUMOR VIRUS, V2; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6	37	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					353	359						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156208				2022-12-28	WOS:A1990CW41500013
J	HUA, C; RAFFELD, M; KO, HS; FAST, P; BAKHSHI, A; COSSMAN, J				HUA, C; RAFFELD, M; KO, HS; FAST, P; BAKHSHI, A; COSSMAN, J			MECHANISM OF BCL-2 ACTIVATION IN HUMAN FOLLICULAR LYMPHOMA	ONCOGENE			English	Article									NCI,METAB BRANCH,BETHESDA,MD 20892; NCI,PATHOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; BLATT WF, 1986, ANAL BIOCHEM, V26, P151; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; HUA C, 1988, ONCOGENE RES, V2, P263; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; RAFFELD M, 1987, CANCER RES, V47, P2537; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STETLERSTEVENSON M, 1988, BLOOD, V72, P1822; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; YUNIS JJ, 1982, NEW ENGL J MED, V307, P1231, DOI 10.1056/NEJM198211113072002	16	26	27	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					233	235						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2181381				2022-12-28	WOS:A1990CU02900010
J	MOSCINSKI, LC; PRYSTOWSKY, MB				MOSCINSKI, LC; PRYSTOWSKY, MB			IDENTIFICATION OF A SERIES OF DIFFERENTIATION-ASSOCIATED GENE-SEQUENCES FROM GM-CSF STIMULATED BONE-MARROW	ONCOGENE			English	Article									UNIV PENN,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL CANCER INSTITUTE [R01CA048648] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U41RR001685] Funding Source: NIH RePORTER; NCI NIH HHS [T32-CA01940-13, CA-48648] Funding Source: Medline; NCRR NIH HHS [P41RR01685] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BIRNIE GD, 1984, J ROY SOC MED, V77, P289, DOI 10.1177/014107688407700407; BROXMEYER HE, 1987, BLOOD CELLS, V13, P31; BURGESS AW, 1977, J BIOL CHEM, V252, P1998; CEROTTINI JC, 1974, J EXP MED, V140, P703, DOI 10.1084/jem.140.3.703; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; CRAMER E, 1985, BLOOD, V65, P423; DELFORGE A, 1985, ANN NY ACAD SCI, V459, P85, DOI 10.1111/j.1749-6632.1985.tb20818.x; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; GONDO H, 1987, J IMMUNOL, V139, P3840; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; Ihle J N, 1985, Prog Clin Biol Res, V184, P85; JAFFE BD, 1988, ONCOGENE, V2, P167; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MEAD DA, 1985, NUCLEIC ACIDS RES, V13, P1103, DOI 10.1093/nar/13.4.1103; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; METCALF D, 1986, J CELL PHYSIOL, V128, P421, DOI 10.1002/jcp.1041280311; METCALF D, 1986, BLOOD, V67, P257; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PENTECOST BT, 1987, J BIOL CHEM, V262, P8759; PRYSTOWSKY MB, 1983, EXP HEMATOL, V11, P931; RADO TA, 1987, BLOOD, V70, P989; RUSSEL M, 1986, GENE, V45, P333, DOI 10.1016/0378-1119(86)90032-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPANGELO BL, 1987, ANN NY ACAD SCI, V496, P196, DOI 10.1111/j.1749-6632.1987.tb35766.x; SYMONDS G, 1983, EMBO J, V2, P663, DOI 10.1002/j.1460-2075.1983.tb01481.x; WODNARFILIPOWICZ A, 1984, P NATL ACAD SCI-BIOL, V81, P2295, DOI 10.1073/pnas.81.8.2295; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0	31	11	11	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					31	37						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181376				2022-12-28	WOS:A1990CM62000005
J	MUSER, J; KAECH, S; MORONI, C; BALLMERHOFER, K				MUSER, J; KAECH, S; MORONI, C; BALLMERHOFER, K			STIMULATION OF PP60C-SRC KINASE-ACTIVITY IN FDC-P1 CELLS BY POLYOMA MIDDLE-T ANTIGEN AND HEMATOPOIETIC GROWTH-FACTORS	ONCOGENE			English	Article									FRIEDRICH MIESCHER INST,POSTFACH 2543,CH-4002 BASEL,SWITZERLAND	Friedrich Miescher Institute for Biomedical Research				Kaech Petrie, Stefanie/0000-0002-6246-6434; Ballmer-Hofer, Kurt/0000-0002-3800-9129				BALLMERHOFER K, 1987, VIRUS RES, V6, P345, DOI 10.1016/0168-1702(87)90066-9; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; BROWDER TM, 1989, MOL CELL BIOL, V9, P204, DOI 10.1128/MCB.9.1.204; CARMICHAEL GG, 1982, P NATL ACAD SCI-BIOL, V79, P3579, DOI 10.1073/pnas.79.11.3579; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHENG SH, 1988, MOL CELL BIOL, V8, P1736, DOI 10.1128/MCB.8.4.1736; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; COLLETT MS, 1979, J VIROL, V29, P770, DOI 10.1128/JVI.29.2.770-781.1979; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COOPER JA, 1988, BIO ESSDAYS, V4, P9; COURTNEIDGE SA, 1986, CANCER SURV, V5, P173; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; DAWE CJ, 1987, AM J PATHOL, V127, P243; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; FUNG MC, 1984, NATURE, V307, P233, DOI 10.1038/307233a0; GOUGH NM, 1985, EMBO J, V4, P645, DOI 10.1002/j.1460-2075.1985.tb03678.x; GUALTIERI RJ, 1987, EXP HEMATOL, V15, P883; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HUANG SS, 1988, J BIOL CHEM, V263, P12608; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982; JOHNSON PJ, 1985, MOL CELL BIOL, V5, P1073, DOI 10.1128/MCB.5.5.1073; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KIPREOS ET, 1988, ONCOGENE RES, V2, P277; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOYASU S, 1987, EMBO J, V6, P3979, DOI 10.1002/j.1460-2075.1987.tb02740.x; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; LEE JC, 1982, J IMMUNOL, V128, P2393; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MATHEYPREVOT B, 1986, MOL CELL BIOL, V6, P4133, DOI 10.1128/MCB.6.11.4133; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METCALF D, 1987, EMBO J, V6, P3703, DOI 10.1002/j.1460-2075.1987.tb02704.x; METCALF D, 1984, HEMOPOIETIC GROWTH F; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; NICOLA NA, 1987, IMMUNOL TODAY, V8, P134, DOI 10.1016/0167-5699(87)90140-X; PALLAS DC, 1986, J VIROL, V60, P1075, DOI 10.1128/JVI.60.3.1075-1084.1986; PARK LS, 1986, J BIOL CHEM, V261, P205; PIERCE JH, 1985, CELL, V41, P685, DOI 10.1016/S0092-8674(85)80049-0; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RAPTIS L, 1985, MOL CELL BIOL, V5, P2476, DOI 10.1128/MCB.5.9.2476; SCHAFFHAUSEN B, 1981, J VIROL, V40, P184, DOI 10.1128/JVI.40.1.184-196.1981; SEFTON BM, 1986, CANCER SURV, V5, P159; STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7; VONRUDEN T, 1988, EMBO J, V7, P2749, DOI 10.1002/j.1460-2075.1988.tb03129.x; WATSON JD, 1987, J IMMUNOL, V139, P123; WHEELER EF, 1987, MOL CELL BIOL, V7, P1673, DOI 10.1128/MCB.7.5.1673; WHETTON AD, 1986, TRENDS BIOCHEM SCI, V11, P207, DOI 10.1016/0968-0004(86)90008-3; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284; YONEMOTO W, 1985, P NATL ACAD SCI USA, V82, P4568, DOI 10.1073/pnas.82.14.4568	54	17	17	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1433	1439						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2480561				2022-12-28	WOS:A1989CB65900003
J	ADNANE, J; GAUDRAY, P; SIMON, MP; SIMONYLAFONTAINE, J; JEANTEUR, P; THEILLET, C				ADNANE, J; GAUDRAY, P; SIMON, MP; SIMONYLAFONTAINE, J; JEANTEUR, P; THEILLET, C			PROTO-ONCOGENE AMPLIFICATION AND HUMAN-BREAST TUMOR PHENOTYPE	ONCOGENE			English	Article									CTR PAUL LAMARQUE,BIOCHIM LAB,F-34094 MONTPELLIER 2,FRANCE; UER MED & PHARM,LGMCH,F-06034 NICE,FRANCE; CTR PAUL LAMARQUE,VAL AURELLE PARC EUROMED,SERV ANAT PATHOL,F-34094 MONTPELLIER,FRANCE; UNIV MONTPELLIER 2,GENET MOLEC LAB,CNRS,UA 1191,F-34060 MONTPELLIER,FRANCE	Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier			Theillet, Charles/O-7634-2018; SIMON, Marie-Pierre/B-8017-2012	Theillet, Charles/0000-0001-5555-2759				ADELAIDE J, 1988, ONCOGENE, V2, P413; ALI IU, 1988, ONCOGENE RES, V3, P139; ALI IU, 1988, BREAST CANCER CELLUL; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; BERGER MS, 1988, CANCER RES, V48, P1238; BONILLA M, 1988, J NATL CANCER I, V80, P665, DOI 10.1093/jnci/80.9.665; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CROCE CM, 1986, CANCER RES, V46, P6019; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; GOMPEL G, 1983, BREAST PRINCIPLES PR, V1, P11; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P150, DOI 10.1159/000132313; GUERIN M, 1988, ONCOGENE RES, V3, P21; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; MATHIEUMAHUL D, 1985, HUM GENET, V71, P41, DOI 10.1007/BF00295666; MCGUIRE WL, 1986, CANCER SURV, V5, P527; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; RIOU G, 1987, LANCET, V1, P761; SAINSBURY JRC, 1987, LANCET, V1, P1398; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; THEILLET C, 1989, ONCOGENE, V4, P915; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VARLEY JM, 1987, ONCOGENE, V1, P423; VARLEY JM, 1988, ONCOGENE, V3, P87; WAHL GM, 1986, INT C PROGR CANCER R, P71; ZEILLINGER R, 1989, ONCOGENE, V4, P109; ZHOU DJ, 1989, ONCOGENE, V4, P105; ZHOU DJ, 1988, ONCOGENE, V2, P279	29	198	199	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1389	1395						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554239				2022-12-28	WOS:A1989AX65900017
J	GROSSMAN, SR; LAIMINS, LA				GROSSMAN, SR; LAIMINS, LA			E6-PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE-18 BINDS ZINC	ONCOGENE			English	Article									UNIV CHICAGO,DEPT MOLEC GENET & CELL BIOL,920 E 58TH ST,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637	University of Chicago; Howard Hughes Medical Institute; University of Chicago								ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; BARBOSA MS, 1989, J VIROL, V63, P1404, DOI 10.1128/JVI.63.3.1404-1407.1989; BARBOSA MS, 1988, J VIROL, V62, P1088, DOI 10.1128/JVI.62.3.1088-1092.1988; BEDELL M, 1989, IN PRESS J VIROL; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLE ST, 1987, J MOL BIOL, V193, P599, DOI 10.1016/0022-2836(87)90343-3; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1987, P NATL ACAD SCI USA, V84, P4841, DOI 10.1073/pnas.84.14.4841; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GROSSMAN SR, 1989, J VIROL, V63, P366, DOI 10.1128/JVI.63.1.366-374.1989; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KANDA T, 1988, VIROLOGY, V165, P321, DOI 10.1016/0042-6822(88)90694-0; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MALLON RG, 1987, J VIROL, V61, P1655, DOI 10.1128/JVI.61.5.1655-1660.1987; MAZEN A, 1988, ANAL BIOCHEM, V172, P39, DOI 10.1016/0003-2697(88)90408-3; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; NEARY K, 1989, J VIROL, V63, P259, DOI 10.1128/JVI.63.1.259-266.1989; PARRAGA G, 1988, SCIENCE, V241, P1489, DOI 10.1126/science.3047872; SCHIFF LA, 1988, P NATL ACAD SCI USA, V85, P4195, DOI 10.1073/pnas.85.12.4195; SCHILLER JT, 1984, P NATL ACAD SCI-BIOL, V81, P7880, DOI 10.1073/pnas.81.24.7880; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SCHNEIDERGADICKE A, 1988, CANCER RES, V48, P2969; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Summers MD, 1987, TEXAS AGR EXPT STATI; VALEE BL, 1970, PROTEINS, V5, P87; WATANABE S, 1989, J VIROL, V63, P965, DOI 10.1128/JVI.63.2.965-969.1989	30	73	77	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1989	4	9					1089	1093						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AM531	2550872				2022-12-28	WOS:A1989AM53100006
J	MARICS, I; ADELAIDE, J; RAYBAUD, F; MATTEI, MG; COULIER, F; PLANCHE, J; DELAPEYRIERE, O; BIRNBAUM, D				MARICS, I; ADELAIDE, J; RAYBAUD, F; MATTEI, MG; COULIER, F; PLANCHE, J; DELAPEYRIERE, O; BIRNBAUM, D			CHARACTERIZATION OF THE HST-RELATED FGF-6 GENE, A NEW MEMBER OF THE FIBROBLAST GROWTH-FACTOR GENE FAMILY	ONCOGENE			English	Article									INSERM, U119, 27 BD LEI ROURE, F-13009 MARSEILLE, FRANCE; HOP ENFANTS TIMONE, INSERM, U242, F-13385 MARSEILLE 5, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille			ADELAIDE, José JA/O-4390-2017; Coulier, François/G-6098-2015	ADELAIDE, José JA/0000-0003-4364-9857; Coulier, François/0000-0002-6288-7773; Birnbaum, Daniel/0000-0001-7920-9883				ADELAIDE J, 1988, ONCOGENE, V2, P413; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOSPODAROWICZ D, 1987, J CELL PHYSIOL, P15; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; KODA T, 1987, JPN J CANCER RES, V78, P325; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; Maniatis T., 1982, MOL CLONING; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; NGUYEN C, 1988, ONCOGENE, V3, P703; NOGUCHI T, 1988, CANCER DETECT PREV, V12, P383; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; RAYBAUD F, 1988, CANCER RES, V48, P950; SAKAMOTO H, 1988, BIOCHEM BIOPH RES CO, V151, P965, DOI 10.1016/S0006-291X(88)80460-1; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; Schwartz RM, 1978, ATLAS PROTEIN SEQ S3, P353; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; THEILLET C, IN PRESS CANCER CELL; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; VARLEY JM, 1988, ONCOGENE, V3, P87; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YUASA Y, 1987, JPN J CANCER RES, V78, P1036; ZHAN X, 1987, ONCOGENE, V1, P369; ZHAN X, 1986, MOL CELL BIOL, V6, P3541, DOI 10.1128/MCB.6.10.3541; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487; ZHOU DJ, 1988, ONCOGENE, V2, P279	33	305	326	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	1989	4	3					335	340						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2649847				2022-12-28	WOS:A1989U567600009
J	POLACK, A; STROBL, L; FEEDERLE, R; SCHWEIZER, M; KOCH, E; EICK, D; WIEGAND, H; BORNKAMM, GW				POLACK, A; STROBL, L; FEEDERLE, R; SCHWEIZER, M; KOCH, E; EICK, D; WIEGAND, H; BORNKAMM, GW			THE INTRON ENHANCER OF THE IMMUNOGLOBULIN KAPPA GENE ACTIVATES C-MYC BUT DOES NOT INDUCE THE BURKITT-SPECIFIC PROMOTER SHIFT	ONCOGENE			English	Article							PHOSPHORYLATION-DEPENDENT BINDING; LYMPHOMA CELLS; 1ST EXON; TRANS-ACTIVATION; NEGATIVE AUTOREGULATION; TRANSCRIPTION FACTOR; REGULATORY ELEMENT; V-MYC; EXPRESSION; PROTEIN	In Burkitt's lymphoma cells the c-myc gene locus is consistently fused to the constant region of one of the immunoglobulin genes by chromosomal translocation. The translocated c-myc gene is transcriptionally activated and preferentially transcribed from the P1 promoter whenever the exon-intron structure of c-myc remains intact. In order to define elements involved in this promoter shift we have cloned the translocated c-myc allele from Burkitt's lymphoma cell line BL60, which is characterized by several point mutations. The mutated c-myc allele of BL60 was stably introduced into baby hamster kidney and Burkitt's lymphoma cells. S1 nuclease and RNAase protection mapping experiments demonstrated that the mutated c-myc allele was expressed at a low level and with a normal promoter usage (P2 > P1) in Burkitt's lymphoma and baby hamster kidney cells. Furthermore, we have studied the expression of a construct consisting of the mutated c-myc allele, part of the bvr1 (Burkitt's variant rearranging region 1) locus, the human immunoglobulin kappa constant region, and the kappa intron enhancer after stable transfection into Burkitt's lymphoma cells. Although c-myc expression was about fivefold increased, the transcripts still initiated predominantly at promoter P2. This indicates that 5 kb of the constant kappa light-chain locus including the kappa intron enhancer is not sufficient to induce the Burkitt's lymphoma-specific promoter shift.	INST KLIN MIKROBIOL & HYG,VIROL ABT,W-7800 FREIBURG,GERMANY		POLACK, A (corresponding author), GESELL SCHWERIONENFORSCH GMBH,INST KLIN MOLEK BIOL & TUMORGENET,MARCHIONINISTR 25,W-8000 MUNICH 70,GERMANY.		Strobl, Lothar J/M-7357-2014	Strobl, Lothar J/0000-0001-8389-1862				ALEXANDER WS, 1987, MOL CELL BIOL, V7, P1436, DOI 10.1128/MCB.7.4.1436; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BORNKAMM GW, 1988, CELLULAR ONCOGENE AC, P223; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; COONEY M, 1988, SCIENCE, V241, P456, DOI 10.1126/science.3293213; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; EICK D, 1989, EMBO J, V8, P1965, DOI 10.1002/j.1460-2075.1989.tb03602.x; EICK D, 1985, EMBO J, V4, P3717, DOI 10.1002/j.1460-2075.1985.tb04140.x; EICK D, 1988, ONCOGENE, V3, P397; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GOTSCHL M, 1988, BIOCHEM BIOPH RES CO, V157, P379, DOI 10.1016/S0006-291X(88)80058-5; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; HAGMAN J, 1990, GENE DEV, V4, P978, DOI 10.1101/gad.4.6.978; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HENGLEIN B, 1989, MOL CELL BIOL, V9, P2105, DOI 10.1128/MCB.9.5.2105; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KLOBECK HG, 1986, NUCLEIC ACIDS RES, V14, P4591, DOI 10.1093/nar/14.11.4591; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; LIPP M, 1989, ONCOGENE, V4, P535; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LOMBARDI L, 1987, CELL, V49, P161, DOI 10.1016/0092-8674(87)90556-3; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER KB, 1990, NUCLEIC ACIDS RES, V18, P5609, DOI 10.1093/nar/18.19.5609; MEYER KB, 1989, EMBO J, V8, P1959, DOI 10.1002/j.1460-2075.1989.tb03601.x; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PENN LJZ, 1990, MOL CELL BIOL, V10, P4961, DOI 10.1128/MCB.10.9.4961; PICARD D, 1984, NATURE, V307, P80, DOI 10.1038/307080a0; PIETENPOL JA, 1990, CELL, V61, P777, DOI 10.1016/0092-8674(90)90188-K; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; POLACK A, 1987, EMBO J, V6, P2959, DOI 10.1002/j.1460-2075.1987.tb02601.x; QUEEN C, 1984, MOL CELL BIOL, V4, P1042, DOI 10.1128/MCB.4.6.1042; RABBITTS TH, 1984, NATURE, V309, P592, DOI 10.1038/309592a0; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; RAPP UR, 1985, NATURE, V317, P434, DOI 10.1038/317434a0; RICHMAN A, 1989, MOL CELL BIOL, V9, P4962, DOI 10.1128/MCB.9.11.4962; RICHMAN A, 1989, SCIENCE, V246, P494, DOI 10.1126/science.2683072; SACCA R, 1990, ONCOGENE, V5, P1499; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHATT MD, 1990, EMBO J, V9, P481, DOI 10.1002/j.1460-2075.1990.tb08134.x; SCHWARTZ RC, 1986, MOL CELL BIOL, V6, P3221, DOI 10.1128/MCB.6.9.3221; SEN R, 1989, IMMUNOGLOBULIN GENES, P327; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; SPENCER CA, 1991, ADV CANCER RES; SUGDEN B, 1985, MOL CELL BIOL, V5, P410, DOI 10.1128/MCB.5.2.410; SZAJNERT MF, 1987, NUCLEIC ACIDS RES, V15, P4553, DOI 10.1093/nar/15.11.4553; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; THALMEIER K, 1989, GENE DEV, V3, P527, DOI 10.1101/gad.3.4.527; TONEGUZZO F, 1986, MOL CELL BIOL, V6, P703, DOI 10.1128/MCB.6.2.703; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547; ZAJAC-KAYE M, 1988, SCIENCE, V240, P1776, DOI 10.1126/science.2454510; ZIMBERSTROBL U, 1991, J VIROL, V65, P415, DOI 10.1128/JVI.65.1.415-423.1991; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	65	25	25	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2033	2040						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945409				2022-12-28	WOS:A1991GX11900014
J	FEN, Z; DANIEL, TO				FEN, Z; DANIEL, TO			5' UNTRANSLATED SEQUENCES DETERMINE DEGRADATIVE PATHWAY FOR ALTERNATE PDGF B/C-SIS MESSENGER-RNAS	ONCOGENE			English	Article							SIMIAN SARCOMA-VIRUS; CARCINOMA CELL-LINES; FACTOR-B-CHAIN; GROWTH-FACTOR; C-SIS; PROTO-ONCOGENE; DIFFERENT ISOFORMS; ENDOTHELIAL-CELLS; MYC GENE; EXPRESSION	The 5' untranslated sequence (5' UTS) of the platelet-derived growth factor B (PDGF B/c-sis) mRNA is GC rich, includes AUGs upstream of the translation initiation site, and inhibits translation of downstream heterologous and autologous coding sequences. Its primary sequence has been remarkably conserved through evolution. In this study, we identified two additional PDGF B/c-sis mRNAs expressed in endothelial cells. These were shown by Northern, primer extension, and nuclease protection analyses to differ in extent of 5' untranslated first exon sequence. The predominant of these 5' truncated transcripts was 2.8 kb, extended 15nt upstream of the translation start site and was markedly stabilized by cycloheximide and anisomycin, but not puromycin or pactamycin. Cycloheximide increased the half-life of this mRNA approximately 7 fold, without affecting stability of the full length mRNA. Cycloheximide withdrawal caused its abrupt destabilization. The 2.8 kb PDGF B/c-sis mRNA lacks translation inhibitory 5' UTS, encodes the same PDGF B protein, appears initiated from within first exon genomic sequences, and is degraded through a process that is sensitive to translation arrest and distinct from that degrading the 3.8 kb PDGF B/c-sis mRNA.	VANDERBILT UNIV, DEPT MED, MCN 53223, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, DEPT CELL BIOL, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University	DANIEL, TO (corresponding author), VANDERBILT UNIV, DEPT MED, MCN 53223, NASHVILLE, TN 37232 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038517, P50DK039261] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38517, DK39261] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASSELIN C, 1989, ONCOGENE, V4, P549; BARRETT TB, 1987, P NATL ACAD SCI USA, V84, P1099, DOI 10.1073/pnas.84.4.1099; BERNARDS A, 1988, ONCOGENE, V2, P297; BESMER P, 1983, J VIROL, V46, P606, DOI 10.1128/JVI.46.2.606-613.1983; BETSHOLTZ C, 1989, MOL CHEM NEUROPATHOL, V10, P27, DOI 10.1007/BF02969484; BOWENPOPE DF, 1989, J BIOL CHEM, V264, P2502; BOWENPOPE DF, 1984, P NATL ACAD SCI-BIOL, V81, P2396, DOI 10.1073/pnas.81.8.2396; CHIU IM, 1984, CELL, V37, P123; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; COLLINS T, 1985, NATURE, V316, P748, DOI 10.1038/316748a0; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; DANIEL TO, 1987, J BIOL CHEM, V262, P11893; DANIEL TO, 1988, J BIOL CHEM, V263, P19815; DELLAFAVERA R, 1981, NATURE, V292, P31; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; FAN H, 1970, J MOL BIOL, V50, P655, DOI 10.1016/0022-2836(70)90091-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOUSTIN AS, 1985, CELL, V41, P301, DOI 10.1016/0092-8674(85)90083-2; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1989, TRENDS GENET, V5, P108, DOI 10.1016/0168-9525(89)90040-1; HOGAN BLM, 1969, BIOCHIM BIOPHYS ACTA, V182, P264, DOI 10.1016/0005-2787(69)90546-2; IGARASHI H, 1987, ONCOGENE, V1, P79; KAPPEN LS, 1973, P NATL ACAD SCI USA, V70, P22, DOI 10.1073/pnas.70.1.22; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MEDCALF RL, 1986, EMBO J, V5, P2217, DOI 10.1002/j.1460-2075.1986.tb04487.x; PERES R, 1987, CANCER RES, V47, P3425; PRESS RD, 1988, BIOCHEMISTRY-US, V27, P5736, DOI 10.1021/bi00415a051; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; Sambrook J, 1989, MOL CLONING LABORATO; SEAL SN, 1972, BIOCHEM BIOPH RES CO, V46, P1895, DOI 10.1016/0006-291X(72)90067-8; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SMITH R, 1988, EMBO J, V7, P1013, DOI 10.1002/j.1460-2075.1988.tb02908.x; STANLEY E, 1985, EMBO J, V4, P2569, DOI 10.1002/j.1460-2075.1985.tb03972.x; STANTON LW, 1987, MOL CELL BIOL, V7, P4266, DOI 10.1128/MCB.7.12.4266; STEWART TA, 1984, SCIENCE, V226, P707, DOI 10.1126/science.6494906; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; VANDENOUWELAND AMW, 1985, BIOCHIM BIOPHYS ACTA, V825, P140, DOI 10.1016/0167-4781(85)90097-1; VANDENOUWELAND MW, 1986, NUCLEIC ACIDS RES, V14, P765, DOI 10.1093/nar/14.2.765; VANZOELEN EJJ, 1985, MOL CELL BIOL, V5, P2289, DOI 10.1128/MCB.5.9.2289; VORONOVA AF, 1987, MOL CELL BIOL, V7, P4407, DOI 10.1128/MCB.7.12.4407; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2490, DOI 10.1073/pnas.79.8.2490; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	49	33	33	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1991	6	6					953	959						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067847				2022-12-28	WOS:A1991GU62200009
J	KUO, SS; MELLENTIN, JD; COPELAND, NG; GILBERT, DJ; JENKINS, NA; CLEARY, ML				KUO, SS; MELLENTIN, JD; COPELAND, NG; GILBERT, DJ; JENKINS, NA; CLEARY, ML			STRUCTURE, CHROMOSOME MAPPING, AND EXPRESSION OF THE MOUSE LYL-1 GENE	ONCOGENE			English	Article							T-CELL LEUKEMIA; DNA-BINDING DOMAIN; HEMATOPOIETIC-CELLS; PROTO-ONCOGENE; C-JUN; PRE-B; TRANSLOCATION; DIFFERENTIATION; PROTEINS; CLONING	The mouse Lyl-1 gene was cloned and shown to consist of four exons with extensive nucleotide and structural homology to the human LYL1 gene. The Lyl-1 gene was localized to the central region of mouse chromosome 8 which defines a new region of synteny with human chromosome 19p. The predicted mouse Lyl-1 protein is 78% identical to human LYL1. The region of highest similarity occurs in the basic DNA binding and helix-loop-helix dimerization motifs which are nearly identical in mouse and man differing by only one conservative amino acid substitution. Expression of the Lyl-1 gene was found to be low in murine spleen and undetectable in other tissues by Northern blot analysis. In lymphoid cell lines, Lyl-1 was expressed in most B lineage cells but downregulated during terminal differentiation and was not expressed in most T lineage cells. In a human T ALL cell line carrying a translocation that juxtaposed LYL1 with the beta TCR gene, the translocated LYL1 gene was transcriptionally active whereas the nontranslocated gene was transcriptionally silent. We conclude that LYL1 has the properties of a lineage- and differentiation-specific HLH protein that contributes to T-cell neoplasia through its deregulated expression following chromosomal translocation.	NCI,FREDERICK CANC RES FACIL & DEV CTR,ABL BASIC RES PROGRAM,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KUO, SS (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,EXPTL ONCOL LAB,STANFORD,CA 94305, USA.				NATIONAL CANCER INSTITUTE [R37CA042971, R01CA042971, T32CA009302] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [5T32 CA09302, CA42971, N01-CO-74101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BENBROOK DM, 1990, ONCOGENE, V5, P295; BUCHBERG AM, 1988, ONCOGENE RES, V2, P149; BUDARF M, 1990, GENOMICS, V8, P575, DOI 10.1016/0888-7543(90)90047-X; CECI JD, 1990, GENOMICS, V6, P72, DOI 10.1016/0888-7543(90)90449-5; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; DAVIDSON WF, 1984, J IMMUNOL, V133, P744; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; Green EL, 1981, GENETICS PROBABILITY, P77; HOLMES KL, 1986, J EXP MED, V164, P443, DOI 10.1084/jem.164.2.443; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515; Lee W M, 1989, Cancer Treat Res, V47, P37; LEWIS S, 1985, SCIENCE, V228, P677, DOI 10.1126/science.3158075; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Lyon M., 1989, GENETIC VARIANTS STR; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MATTEI MG, 1990, ONCOGENE, V5, P151; MCKEARN JP, 1985, EUR J IMMUNOL, V15, P295, DOI 10.1002/eji.1830150316; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; RUTA M, 1988, ONCOGENE, V3, P9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SMITH SD, 1989, BLOOD, V73, P2182; SPOLSKI R, 1988, EUR J IMMUNOL, V18, P295; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; WARNER NL, 1979, IMMUNOL REV, V48, P197, DOI 10.1111/j.1600-065X.1979.tb00304.x; ZIJLSTRA M, 1986, BIOCHIM BIOPHYS ACTA, V865, P197, DOI 10.1016/0304-419X(86)90028-4	42	46	49	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					961	968						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067848				2022-12-28	WOS:A1991GU62200010
J	TESTA, JR; PARK, M; BLAIR, DG; KALBAKJI, A; ARDEN, K; VANDEWOUDE, GF				TESTA, JR; PARK, M; BLAIR, DG; KALBAKJI, A; ARDEN, K; VANDEWOUDE, GF			ANALYSIS BY PULSED FIELD GEL-ELECTROPHORESIS REVEALS COMPLEX REARRANGEMENTS IN 2 MET ALLELES IN A CHEMICALLY-TREATED HUMAN CELL-LINE, MNNG-HOS	ONCOGENE			English	Article									NCI,DIV CANC ETIOL,MOLEC ONCOL LAB,FREDERICK,MD 21701; NCI,FREDERICK CANC RES FACIL,ABL BASIC RES PROGRAM,FREDERICK,MD 21701; LUDWIG INST CANC RES,MONTREAL H3A 1A1,QUEBEC,CANADA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ludwig Institute for Cancer Research	TESTA, JR (corresponding author), FOX CHASE CANC INST,DEPT MED ONCOL,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NCI NIH HHS [N01-CO-74101] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; COLLINS FS, 1987, SCIENCE, V235, P1046, DOI 10.1126/science.2950591; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DELHANTY JDA, 1989, CANCER GENET CYTOGEN, V42, P263, DOI 10.1016/0165-4608(89)90094-0; Drumm ML, 1988, GENOMICS, V2, P346, DOI 10.1016/0888-7543(88)90024-9; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEMMILL RM, 1987, GENE ANAL TECH, V4, P119, DOI 10.1016/0735-0651(87)90010-0; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; ISHIKAWA F, 1987, MOL CELL BIOL, V7, P1226, DOI 10.1128/MCB.7.3.1226; JULIER C, 1988, AM J HUM GENET, V42, P45; KING HWS, 1988, ONCOGENE, V2, P617; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MAURER BJ, 1987, NATURE, V327, P434, DOI 10.1038/327434a0; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; MICHIELS F, 1987, SCIENCE, V236, P1305, DOI 10.1126/science.3035716; PARK M, 1988, P NATL ACAD SCI USA, V85, P2667, DOI 10.1073/pnas.85.8.2667; PARK M, 1986, COLD SPRING HARB SYM, V51, P967, DOI 10.1101/SQB.1986.051.01.110; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PERRY P, 1975, NATURE, V258, P121, DOI 10.1038/258121a0; RHIM JS, 1975, J NATL CANCER I, V55, P1291, DOI 10.1093/jnci/55.6.1291; RHIM JS, 1975, NATURE, V256, P751, DOI 10.1038/256751a0; ROMMENS JM, 1989, AM J HUM GENET, V45, P932; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P507; VANOMMEN GJB, 1986, HUMAN GENETIC DISEAS, P113; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0	35	8	8	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1565	1571						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250912				2022-12-28	WOS:A1990EK50200017
J	IKEDA, I; ISHIZAKA, Y; TAHIRA, T; SUZUKI, T; ONDA, M; SUGIMURA, T; NAGAO, M				IKEDA, I; ISHIZAKA, Y; TAHIRA, T; SUZUKI, T; ONDA, M; SUGIMURA, T; NAGAO, M			SPECIFIC EXPRESSION OF THE RET PROTOONCOGENE IN HUMAN NEUROBLASTOMA CELL-LINES	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV CARCINOGENESIS,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN; FUKUSHIMA MED SCH,DEPT PATHOL 2,FUKUSHIMA 96012,JAPAN; NIPPON MED COLL HOSP,DEPT SURG 1,BUNKYO KU,TOKYO 113,JAPAN	National Cancer Center - Japan; Fukushima Medical University; Nippon Medical School								BIEDLER JL, 1973, CANCER RES, V33, P2643; BONGARZONE I, 1989, ONCOGENE, V4, P1457; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; IKEDA I, 1988, JPN J CANCER RES, V79, P674, DOI 10.1111/j.1349-7006.1988.tb02220.x; ISHIKAWA S, 1979, ACTA PATHOL JAPON, V29, P289; ISHIKAWA S, 1977, ACTA PATHOL JAPON, V27, P697; ISHIZAKA Y, 1989, ONCOGENE, V4, P789; ISHIZAKA Y, 1989, ONCOGENE, V4, P1519; ISHIZAKA Y, 1989, JPN J CANCER RES, V80, P1149, DOI 10.1111/j.1349-7006.1989.tb01645.x; ISHIZAKA Y, 1988, ONCOGENE RES, V3, P193; ITOH F, IN PRESS TUMOR RES; JACOBS JP, 1979, J BIOL STAND, V7, P113, DOI 10.1016/S0092-1157(79)80043-8; KANEKO Y, 1987, CANCER RES, V47, P311; KUGA N, 1975, GANN, V66, P547; MELLSTROM K, 1987, MOL CELL BIOL, V7, P4178, DOI 10.1128/MCB.7.12.4178; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MIYAKE K, 1973, AUTONOM NERV SYST JP, V10, P115; NAGAO M, 1990, JPN J CANCER RES, V81, P309, DOI 10.1111/j.1349-7006.1990.tb02566.x; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; PAHLMAN S, 1986, LAB INVEST, V54, P554; REYNOLDS CP, 1988, ADV NEUROBLASTOMA RE, V2, P291; ROSS RA, 1983, J NATL CANCER I, V71, P741; ROSS RA, 1980, ADV NEUROBLASTOMA RE, P151; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SUGIMOTO T, 1984, J NATL CANCER I, V73, P51; SUGIMOTO T, 1986, CANCER RES, V46, P4765; SUZUKI T, 1989, CANCER RES, V49, P1095; SZENTIRMAY Z, 1990, ONCOGENE, V5, P701; TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8; TAHIRA T, 1990, ONCOGENE, V5, P97; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; VECCHIO G, 1989, ONCOGENE, V4, P897; WANG LC, 1987, CANCER RES, V47, P4192; WATSON R, 1982, P NATL ACAD SCI-BIOL, V79, P4078, DOI 10.1073/pnas.79.13.4078	42	128	141	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1291	1296						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216455				2022-12-28	WOS:A1990EC24100003
J	MUSTELIN, T; ALTMAN, A				MUSTELIN, T; ALTMAN, A			DEPHOSPHORYLATION AND ACTIVATION OF THE T-CELL TYROSINE KINASE PP56LCK BY THE LEUKOCYTE COMMON ANTIGEN (CD45)	ONCOGENE			English	Article											MUSTELIN, T (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL,10666 N TORREY PINES RD IMM3,LA JOLLA,CA 92037, USA.			Mustelin, Tomas/0000-0001-5912-8840				ALTMAN A, IN PRESS ADV IMMUNOL; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; CASNELLIE JE, 1986, J BIOL CHEM, V261, P4921; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; EMMRICH F, 1988, IMMUNOL TODAY, V9, P296, DOI 10.1016/0167-5699(88)91320-5; FISCHER S, 1987, BIOCHEM BIOPH RES CO, V143, P819, DOI 10.1016/0006-291X(87)90322-6; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HURLEY TR, 1989, ONCOGENE, V4, P265; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; JANEWAY CA, 1989, IMMUNOL TODAY, V10, P234, DOI 10.1016/0167-5699(89)90260-0; KIENER PA, 1989, J IMMUNOL, V143, P23; KLAUSNER RD, 1987, J BIOL CHEM, V262, P12654; KUPFER A, 1988, P NATL ACAD SCI USA, V85, P8216, DOI 10.1073/pnas.85.21.8216; LEDBETTER JA, 1988, P NATL ACAD SCI USA, V85, P8628, DOI 10.1073/pnas.85.22.8628; MARTH JD, 1989, J IMMUNOL, V142, P2430; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MITTLER RS, 1989, P NATL ACAD SCI USA, V86, P8531, DOI 10.1073/pnas.86.21.8531; MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207; MUSTELIN T, 1989, P NATL ACAD SCI USA, V86, P6302, DOI 10.1073/pnas.86.16.6302; MUSTELIN T, 1989, IMMUNOL TODAY, V10, P189, DOI 10.1016/0167-5699(89)90322-8; MUSTELIN T, 1990, IN PRESS SCIENCE; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; OSTERGAARD HL, 1989, P NATL ACAD SCI USA, V86, P8959, DOI 10.1073/pnas.86.22.8959; PINGEL JT, 1989, CELL, V58, P1055, DOI 10.1016/0092-8674(89)90504-7; RIVAS A, 1988, J IMMUNOL, V140, P2912; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SAIZAWA K, 1987, NATURE, V328, P260, DOI 10.1038/328260a0; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TREVILLYAN JM, 1986, BIOCHIM BIOPHYS ACTA, V888, P286, DOI 10.1016/0167-4889(86)90228-4; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0	42	200	209	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					809	813						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2141684				2022-12-28	WOS:A1990DP55300005
J	ALCALAY, M; ANTOLINI, F; VANDEVEN, WJ; LANFRANCONE, L; GRIGNANI, F; PELICCI, PG				ALCALAY, M; ANTOLINI, F; VANDEVEN, WJ; LANFRANCONE, L; GRIGNANI, F; PELICCI, PG			CHARACTERIZATION OF HUMAN AND MOUSE C-FES CDNA CLONES AND IDENTIFICATION OF THE 5' END OF THE GENE	ONCOGENE			English	Article									UNIV PERUGIA,MONTELUCE POLICLIN,IST CLIN MED 1,I-06100 PERUGIA,ITALY; GASTHUISBERG,CTR HUMAN GENET,B-3000 LEUWEN,BELGIUM	University of Perugia			Lanfrancone, Luisa/AAC-8671-2019; Alcalay, Myriam/AAB-4300-2019; Pelicci, Pier Giuseppe/AAL-6572-2020; Alcalay, Myriam/B-3182-2016	Lanfrancone, Luisa/0000-0002-4523-3815; Alcalay, Myriam/0000-0002-5558-4272; Alcalay, Myriam/0000-0002-5558-4272				BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BISHOP JM, 1982, RNA TUMOR VIRUSES, V2, P267; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P4714, DOI 10.1073/pnas.79.15.4714; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; FRANCHINI G, 1981, NATURE, V290, P154, DOI 10.1038/290154a0; FRANCHINI G, 1982, MOL CELL BIOL, V2, P1014, DOI 10.1128/MCB.2.8.1014; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GROFFEN J, 1982, SCIENCE, V216, P1136, DOI 10.1126/science.6281890; HAMPE A, 1982, CELL, V30, P775, DOI 10.1016/0092-8674(82)90282-3; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARPER ME, 1983, NATURE, V304, P169, DOI 10.1038/304169a0; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; HUANG CC, 1985, J MOL BIOL, V181, P175, DOI 10.1016/0022-2836(85)90083-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LANFRANCONE L, 1989, IN PRESS INT J CANCE; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; Maniatis T., 1982, MOL CLONING; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; ROEBROEK AJM, 1986, EMBO J, V5, P2197, DOI 10.1002/j.1460-2075.1986.tb04484.x; ROEBROEK AJM, 1986, MOL BIOL REP, V11, P117, DOI 10.1007/BF00364823; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; ROEBROEK AJM, 1987, J VIROL, V61, P2009, DOI 10.1128/JVI.61.6.2009-2016.1987; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SAMARUT J, 1985, MOL CELL BIOL, V5, P1067, DOI 10.1128/MCB.5.5.1067; SELBY MJ, 1984, J BIOL CHEM, V259, P3131; SHEER D, 1983, CHROMOSOMES CANCER, P183; SHERR CJ, 1984, CANCER CELL, V2, P329; SHIBUYA M, 1982, CELL, V30, P787, DOI 10.1016/0092-8674(82)90283-5; SMITHGALL TE, 1988, J BIOL CHEM, V263, P15050; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TRUS MD, 1982, J BIOL CHEM, V257, P2730; VANDENBERGHE H, 1979, CANCER, V43, P558, DOI 10.1002/1097-0142(197902)43:2<558::AID-CNCR2820430223>3.0.CO;2-6; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; WILKS AF, 1988, ONCOGENE, V3, P289	37	40	44	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					267	275						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2179816				2022-12-28	WOS:A1990CW41500003
J	SHIMIZU, M; YOKOTA, J; MORI, N; SHUIN, T; SHINODA, M; TERADA, M; OSHIMURA, M				SHIMIZU, M; YOKOTA, J; MORI, N; SHUIN, T; SHINODA, M; TERADA, M; OSHIMURA, M			INTRODUCTION OF NORMAL CHROMOSOME-3P MODULATES THE TUMORIGENICITY OF A HUMAN RENAL-CELL CARCINOMA CELL-LINE YCR	ONCOGENE			English	Article									KANAGAWA CANC CTR,RES INST,CYTOGENET LAB,54-2 NAKAO CHO,ASAHI KU,YOKOHAMA 241,JAPAN; NATL CANC CTR,RES INST,CHUO KU,TOKYO 151,JAPAN; YOKOHAMA CITY UNIV,SCH MED,DEPT UROL,MINAMI KU,YOKOHAMA,KANAGAWA 232,JAPAN; HOSHI COLL PHARM,DEPT BIOCHEM,SHINAGAWA KU,TOKYO 142,JAPAN	Kanagawa Prefectural Cancer Center; National Cancer Center - Japan; Yokohama City University; Hoshi University								BENEDICT WF, 1984, CANCER RES, V44, P3471; BERGERHEIM U, 1989, CANCER RES, V49, P1390; CARROLL PR, 1987, CANCER GENET CYTOGEN, V26, P253, DOI 10.1016/0165-4608(87)90059-8; COHEN AJ, 1979, NEW ENGL J MED, V301, P592, DOI 10.1056/NEJM197909133011107; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P319, DOI 10.1073/pnas.74.1.319; GREEN AR, 1988, BRIT J CANCER, V58, P115, DOI 10.1038/bjc.1988.176; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARRIS H, 1988, CANCER RES, V48, P3302; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KOI M, 1989, JPN J CANCER RES, V80, P122, DOI 10.1111/j.1349-7006.1989.tb02278.x; KOI M, 1989, JPN J CANCER RES, V80, P413, DOI 10.1111/j.1349-7006.1989.tb02329.x; KOI M, 1989, MOL CARCINOGEN, V2, P12, DOI 10.1002/mc.2940020103; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; KOVACS G, 1987, INT J CANCER, V40, P171, DOI 10.1002/ijc.2910400208; KUBOTA Y, 1987, FEBS LETT, V212, P159, DOI 10.1016/0014-5793(87)81577-6; OSHIMURA M, 1988, CANCER RES, V48, P1623; OSHIMURA M, 1985, NATURE, V316, P636, DOI 10.1038/316636a0; OSHIMURA M, IN PRESS J CELL BIOC; PATHAK S, 1982, SCIENCE, V217, P939, DOI 10.1126/science.7112106; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SANDBERG AA, 1988, CANCER RES, V48, P1049; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; Stanbridge E.J., 1987, ADV VIRAL ONCOL, V6, P83; STANBRIDGE EJ, 1981, CANCER RES, V41, P573; STANBRIDGE EJ, 1986, CANCER RES, V46, P4759; SZUCS S, 1987, CANCER GENET CYTOGEN, V26, P369, DOI 10.1016/0165-4608(87)90072-0; VANDERHOUT AH, 1988, CANCER GENET CYTOGEN, V32, P281, DOI 10.1016/0165-4608(88)90292-0; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; YOKOTA J, 1989, CANCER RES, V49, P3598; YOSHIDA MA, 1986, CANCER RES, V46, P2139; YOSHIDA MA, 1988, JPN J CANCER RES, V79, P600, DOI 10.1111/j.1349-7006.1988.tb00029.x; YOSHIDA MC, 1975, P JPN ACAD, V51, P181; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	36	109	109	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					185	194						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	1969617				2022-12-28	WOS:A1990CU02900004
J	WELHAM, MJ; WYKE, JA; LANG, A; WYKE, AW				WELHAM, MJ; WYKE, JA; LANG, A; WYKE, AW			MITOGENESIS INDUCED BY PP60V-SRC IS NOT ACCOMPANIED BY INCREASED EXPRESSION OF IMMEDIATE EARLY RESPONSE GENES	ONCOGENE			English	Article									BEATSON INST CANC RES,GARSCUBE ESTATE,SWITCHBACK RD,GLASGOW G61 1BD,SCOTLAND; ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND LABS,LONDON EC1A 7BN,ENGLAND	Beatson Institute; Cancer Research UK; University of London; Queen Mary University London								ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BARBER JR, 1987, MOL CELL BIOL, V7, P201; BELL JG, 1975, J GEN VIROL, V27, P127, DOI 10.1099/0022-1317-27-2-127; Bjerrum OJ, 1986, **NON-TRADITIONAL**, V86th, P315; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; BURR JG, 1980, P NATL ACAD SCI-BIOL, V77, P3484, DOI 10.1073/pnas.77.6.3484; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CHANG JD, 1988, CARCINOGENESIS, V9, P17, DOI 10.1093/carcin/9.1.17; CHIARUGI V, 1987, ONCOGENE, V2, P37; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cleveland J L, 1988, Oncogene Res, V3, P357; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1984, CELL, V36, P259; DURKIN JP, 1985, J CELL PHYSIOL, V125, P51, DOI 10.1002/jcp.1041250108; DURKIN JP, 1984, BIOCHEM BIOPH RES CO, V123, P411, DOI 10.1016/0006-291X(84)90245-6; DURKIN JP, 1984, J CELL PHYSIOL, V120, P135, DOI 10.1002/jcp.1041200205; EICK D, 1987, ONCOGENE, V2, P61; Fourney R.M., 1988, FOCUS, V10, P5; FUJII M, 1989, MOL CELL BIOL, V9, P2493, DOI 10.1128/MCB.9.6.2493; GILLESPIE DAF, 1985, CELL, V41, P279, DOI 10.1016/0092-8674(85)90081-9; GILMER TM, 1983, J VIROL, V45, P462, DOI 10.1128/JVI.45.1.462-465.1983; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAY GM, 1988, J BIOL CHEM, V263, P10714; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAMAGUCHI M, 1987, P NATL ACAD SCI USA, V84, P2312, DOI 10.1073/pnas.84.8.2312; HAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6419, DOI 10.1093/nar/15.16.6419; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KARNITZ L, 1989, MOL CELL BIOL, V9, P1929, DOI 10.1128/MCB.9.5.1929; KELLIE S, 1988, BIOESSAYS, V8, P25, DOI 10.1002/bies.950080107; KRUEGER JG, 1980, VIROLOGY, V101, P25, DOI 10.1016/0042-6822(80)90480-8; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KRZYZEK RA, 1980, J VIROL, V36, P805, DOI 10.1128/JVI.36.3.805-815.1980; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; Maniatis T., 1982, MOL CLONING; MEHMET H, 1988, ONCOGENE RES, V3, P281; MEHMET H, 1989, ONCOGENE RES, V4, P215; MULLER R, 1987, ONCOGENE RES, V2, P19; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; PURCHIO AF, 1978, P NATL ACAD SCI USA, V75, P1567, DOI 10.1073/pnas.75.3.1567; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SAKSELA K, 1989, EMBO J, V8, P149, DOI 10.1002/j.1460-2075.1989.tb03359.x; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SEFTON BM, 1986, CURR TOP MICROBIOL, V123, P39; SIMMONS DL, 1989, P NATL ACAD SCI USA, V86, P1178, DOI 10.1073/pnas.86.4.1178; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; VANDERVALK J, 1987, J BIOL CHEM, V262, P2431; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; WELHAM MJ, 1988, J VIROL, V62, P1898, DOI 10.1128/JVI.62.6.1898-1906.1988; WELHAM MJ, 1988, THESIS U LONDON UK; WHITE MK, 1988, MOL CELL BIOL, V8, P135; WOLFMAN A, 1987, J BIOL CHEM, V262, P16546; WYKE JA, 1987, BIOCHIM BIOPHYS ACTA, V907, P47, DOI 10.1016/0304-419X(87)90018-7; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	70	47	47	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					161	169						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2108404				2022-12-28	WOS:A1990CU02900001
J	RENZO, A; BOUCHARD, L; MONGEAU, CJ; BASTIN, M				RENZO, A; BOUCHARD, L; MONGEAU, CJ; BASTIN, M			EFFECT OF CPG-RICH SEQUENCES IN TRANSFORMATION AND TUMORIGENESIS BY POLYOMAVIRUS	ONCOGENE			English	Article									UNIV SHERBROOKE,DEPT MICROBIOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA; UNIV SHERBROOKE,DEPT PATHOL,SHERBROOKE J1H 5N4,QUEBEC,CANADA	University of Sherbrooke; University of Sherbrooke								ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; ASSELIN C, 1983, MOL CELL BIOL, V3, P1451, DOI 10.1128/MCB.3.8.1451; ATWEH GF, 1988, MOL CELL BIOL, V8, P5047, DOI 10.1128/MCB.8.11.5047; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOUCHARD L, 1984, VIROLOGY, V135, P53, DOI 10.1016/0042-6822(84)90116-8; BOUCHARD L, 1987, J VIROL, V61, P2448, DOI 10.1128/JVI.61.8.2448-2453.1987; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CAZIN C, 1984, EMBO J, V3, P383; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0; COMPERE SJ, 1981, CELL, V25, P233, DOI 10.1016/0092-8674(81)90248-8; COUREY AJ, 1986, CELL, V45, P567, DOI 10.1016/0092-8674(86)90288-6; CROCE CM, 1985, BLOOD, V65, P1; CULLEN BR, 1984, NATURE, V307, P241, DOI 10.1038/307241a0; EMERMAN M, 1984, CELL, V39, P459, DOI 10.1016/0092-8674(84)90453-7; GELINAS C, 1984, J VIROL, V51, P242, DOI 10.1128/JVI.51.1.242-246.1984; IVARIE RD, 1982, P NATL ACAD SCI-BIOL, V79, P2967, DOI 10.1073/pnas.79.9.2967; JONES PA, 1982, P NATL ACAD SCI-BIOL, V79, P1215, DOI 10.1073/pnas.79.4.1215; KAMEN R, 1980, COLD SPRING HARB SYM, V44, P63; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; LAIMINS L, 1986, P NATL ACAD SCI USA, V83, P3151, DOI 10.1073/pnas.83.10.3151; LAN NC, 1984, J BIOL CHEM, V259, P1601; Luria SE, 1943, GENETICS, V28, P491; LUSKY M, 1981, NATURE, V289, P70; MATHEYPREVOT B, 1984, J VIROL, V50, P325, DOI 10.1128/JVI.50.2.325-334.1984; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; PETERSON DO, 1987, MOL CELL BIOL, V7, P1563, DOI 10.1128/MCB.7.4.1563; RABBITTS TH, 1983, NATURE, V306, P806, DOI 10.1038/306806a0; ROGINSKI RS, 1983, CELL, V35, P149, DOI 10.1016/0092-8674(83)90217-9; RULEY HE, 1982, NUCLEIC ACIDS RES, V10, P4515, DOI 10.1093/nar/10.15.4515; SCANGOS GA, 1981, MOL CELL BIOL, V1, P111, DOI 10.1128/MCB.1.2.111; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; WILSON JB, 1986, CELL, V44, P477, DOI 10.1016/0092-8674(86)90469-1	37	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1469	1475						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2556676				2022-12-28	WOS:A1989CB65900008
J	MENEGUZZI, G; LATHE, R; KIENY, MP; VOGT, N				MENEGUZZI, G; LATHE, R; KIENY, MP; VOGT, N			THE E2 TRANS-ACTIVATING PROTEIN OF BOVINE PAPILLOMAVIRUS TYPE-1 (BPV1) IS SERINE-PHOSPHORYLATED INVIVO	ONCOGENE			English	Article									CNRS,GENET MOLEC EUCARYOTES LAB,INSERM,U184,F-67085 STRASBOURG,FRANCE; TRANSGENE SA,F-67000 STRASBOURG,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Transgene SA	MENEGUZZI, G (corresponding author), FAC SCI NICE,CTR BIOCHIM,INSERM,U273,F-06034 NICE,FRANCE.		Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; Meneguzzi, Guerrino/0000-0002-1609-6540; Lathe, Richard/0000-0001-9698-9834				ANDROPHY EJ, 1987, NATURE, V325, P70, DOI 10.1038/325070a0; ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; BARBOSA MS, 1988, J VIROL, V62, P3242, DOI 10.1128/JVI.62.9.3242-3249.1988; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; Dales S, 1981, Virol Monogr, V18, P1; DOSTATNI N, 1988, EMBO J, V7, P3807, DOI 10.1002/j.1460-2075.1988.tb03265.x; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; GUIZANI I, 1988, GENE, V73, P163, DOI 10.1016/0378-1119(88)90322-8; HAUGEN TH, 1988, EMBO J, V7, P4245, DOI 10.1002/j.1460-2075.1988.tb03322.x; HOWLEY PM, 1987, PAPOVAVIRIDAE, V2, P141; HOWLEYNELSON P, 1988, EMBO J, V7, P525; HUBBERT NL, 1988, P NATL ACAD SCI USA, V85, P5864, DOI 10.1073/pnas.85.16.5864; KIENY MP, 1984, NATURE, V312, P163, DOI 10.1038/312163a0; LAMBERT PF, 1989, GENE DEV, V3, P38, DOI 10.1101/gad.3.1.38; LATHE R, 1987, NATURE, V326, P878, DOI 10.1038/326878a0; LI R, 1989, GENE DEV, V3, P510, DOI 10.1101/gad.3.4.510; LOWY DR, 1980, NATURE, V287, P72, DOI 10.1038/287072a0; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; MOHR IJ, 1987, EMBO J, V6, P153, DOI 10.1002/j.1460-2075.1987.tb04733.x; MOSKALUK C, 1987, P NATL ACAD SCI USA, V84, P1215, DOI 10.1073/pnas.84.5.1215; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RAYCHAUDHURI P, 1989, GENE DEV, V3, P620, DOI 10.1101/gad.3.5.620; SMITH GL, 1984, BIOTECHNOL GENET ENG, V2, P383, DOI 10.1080/02648725.1984.10647806; SMOTKIN D, 1987, J VIROL, V61, P1686, DOI 10.1128/JVI.61.5.1686-1689.1987; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SPALHOLZ BA, 1985, CELL, V42, P183, DOI 10.1016/S0092-8674(85)80114-8; STAMATOS NM, 1987, J VIROL, V61, P516, DOI 10.1128/JVI.61.2.516-525.1987; STANWAY CA, 1989, NUCLEIC ACIDS RES, V17, P2187, DOI 10.1093/nar/17.6.2187; TUREK LP, 1987, PAPILLOMAVIRUSES HUM, P410; YANG YC, 1985, P NATL ACAD SCI USA, V82, P1030, DOI 10.1073/pnas.82.4.1030	34	3	3	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1285	1290						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554235				2022-12-28	WOS:A1989AX65900003
J	MORRISON, LE; KABRUN, N; MUDRI, S; HAYMAN, MJ; ENRIETTO, PJ				MORRISON, LE; KABRUN, N; MUDRI, S; HAYMAN, MJ; ENRIETTO, PJ			VIRAL REL AND CELLULAR REL ASSOCIATE WITH CELLULAR PROTEINS IN TRANSFORMED AND NORMAL-CELLS	ONCOGENE			English	Article									SUNY STONY BROOK,DEPT MICROBIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NCI NIH HHS [5P01CA28146-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BEUG H, 1981, VIROLOGY, V115, P295, DOI 10.1016/0042-6822(81)90112-4; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BRUGGE JS, 1986, CURR TOP MICROBIOL, V123, P1; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; GELINAS C, 1988, ONCOGENE, V3, P349; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MOORE BE, 1988, VIROLOGY, V162, P377, DOI 10.1016/0042-6822(88)90478-3; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; RAMSAY GM, 1982, J VIROL, V41, P745, DOI 10.1128/JVI.41.3.745-753.1982; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RICE NR, 1986, VIROLOGY, V149, P217, DOI 10.1016/0042-6822(86)90123-6; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHWARTZ RC, 1988, VIROLOGY, V165, P182, DOI 10.1016/0042-6822(88)90671-X; SIMEK S, 1988, ONCOGENE RES, V2, P103; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; SIMEK SL, 1986, J VIROL, V59, P120, DOI 10.1128/JVI.59.1.120-126.1986; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; SYLLA BS, 1986, MOL CELL BIOL, V6, P4709, DOI 10.1128/MCB.6.12.4709; THEILEN G, 1966, JNCI-J NATL CANCER I, V37, P747; TUNG HYL, 1988, P NATL ACAD SCI USA, V85, P2479, DOI 10.1073/pnas.85.8.2479; WALRO DS, 1987, VIROLOGY, V160, P433, DOI 10.1016/0042-6822(87)90015-8; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984	30	61	62	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1989	4	6					677	683						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543940				2022-12-28	WOS:A1989AA66000002
J	PROCTOR, AJ; COOMBS, LM; CAIRNS, JP; KNOWLES, MA				PROCTOR, AJ; COOMBS, LM; CAIRNS, JP; KNOWLES, MA			AMPLIFICATION AT CHROMOSOME 11Q13 IN TRANSITIONAL CELL TUMORS OF THE BLADDER	ONCOGENE			English	Article							HUMAN ESOPHAGEAL CARCINOMAS; HUMAN-BREAST TUMORS; PROTO-ONCOGENE; URINARY-BLADDER; HUMAN-MELANOMA; GROWTH-FACTOR; KINASE GENE; INT-2 GENES; CANCER; DNA	Amplification of several markers which map to chromosome 11q13 was detected by Southern blotting in transitional cell tumours of the urinary bladder. The oncogenes INT2 and HST and the BCL1 locus were co-amplified in 20/97 (20.6%) tumours and the locus-specific minisatellite probe pMS51 (D11S97) detected amplification in 17/97 (17.5%) tumours. The high frequency of heterozygosity (> 70%) detected by this latter probe on HaeIII-digested DNAs provided a sensitive means to measure low levels of gene amplification (2-fold) by comparing signals obtained from each allele. A number of probes which map to 11q were used in an attempt to map the region of amplification more precisely. PGA, PGR, STMY, D11Z1 and D11S149 were not amplified in any tumours studied. SEA was amplified in 1/59 tumours and D11S146 in 12/89 tumours. A comparison of the patterns of co-amplification of individual markers in this series of tumours revealed that of the 23 tumours with amplification at this site, 11 had co-amplification of D11S97, D11S146, BCL1, INT2 and HST, 3 had co-amplification of D11S97, BCL1, INT2 and HST, 6 had co-amplification of BCL1, INT2 and HST, 1 had co-amplification of D11S97 and D11S146 and 2 had amplification of D11S97 alone. Based on available linkage data for these markers, this suggests that a putative target gene within this amplicon lies centromeric to BCL1. Amplification at 11q13 showed no correlation with tumour grade or with HER2 amplification.	MARIE SKLODOWSKA CURIE MEM INST,EPITHELIAL CARCINOGENESIS LAB,OXTED RH8 0TL,SURREY,ENGLAND		KNOWLES, MA (corresponding author), MARIE SKLODOWSKA CURIE MEM INST,EPITHELIAL CARCINOGENESIS LAB,OXTED RH8 0TL,SURREY,ENGLAND.			Knowles, Margaret/0000-0002-9363-8657				ADELAIDE J, 1988, ONCOGENE, V2, P413; ADNANE J, 1989, ONCOGENE, V4, P1389; ALI IU, 1989, ONCOGENE, V4, P89; ATKIN NB, 1985, CANCER GENET CYTOGEN, V15, P253, DOI 10.1016/0165-4608(85)90169-4; BABU VR, 1987, CANCER RES, V47, P6800; BERENSON JR, 1990, ONCOGENE, V5, P1343; BERGER CS, 1986, CANCER GENET CYTOGEN, V23, P1, DOI 10.1016/0165-4608(86)90145-7; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHODAK GW, 1988, CANCER RES, V48, P2083; COOMBS LM, 1991, IN PRESS BR J CANCER; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIBAS Z, 1984, CANCER RES, V44, P1257; GIBAS Z, 1986, CANCER GENET CYTOGEN, V19, P229, DOI 10.1016/0165-4608(86)90051-8; GUSTAFSON H, 1982, SCAND J UROL NEPHROL, V16, P141, DOI 10.3109/00365598209179743; HAYMAN MJ, 1985, P NATL ACAD SCI USA, V82, P8237, DOI 10.1073/pnas.82.23.8237; HOLM T, 1988, NUCLEIC ACIDS RES, V16, P4746, DOI 10.1093/nar/16.10.4746; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; LAU YF, 1984, P NATL ACAD SCI-BIOL, V81, P414, DOI 10.1073/pnas.81.2.414; LAW ML, 1987, P NATL ACAD SCI USA, V84, P2877, DOI 10.1073/pnas.84.9.2877; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LIMAS C, 1979, CANCER, V44, P2099, DOI 10.1002/1097-0142(197912)44:6<2099::AID-CNCR2820440621>3.0.CO;2-I; LISCIA DS, 1989, ONCOGENE, V4, P1219; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P376, DOI 10.1093/nar/16.1.376; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NGUYEN C, 1988, ONCOGENE, V3, P703; PADUA RA, 1985, MOL CELL BIOL, V5, P582, DOI 10.1128/MCB.5.3.582; RABBITTS PH, 1988, ONCOGENE, V3, P99; RAGHAVAN D, 1990, NEW ENGL J MED, V322, P1129, DOI 10.1056/NEJM199004193221607; RAMAEKERS F, 1985, LAB INVEST, V52, P31; ROYLE NJ, 1987, CYTOGENET CELL GENET, V46, P685; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; SOMERS KD, 1990, ONCOGENE, V5, P915; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; TAGGART RT, 1985, P NATL ACAD SCI USA, V82, P6240, DOI 10.1073/pnas.82.18.6240; THEILLET C, 1990, ONCOGENE, V5, P147; THEILLET C, 1989, ONCOGENE, V4, P915; TSAI YC, 1990, CANCER RES, V50, P44; TSUDA T, 1989, JPN J CLIN ONCOL, V19, P26; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUDA T, 1989, CANCER RES, V49, P5505; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TSUTSUMI M, 1988, JPN J CANCER RES, V79, P428, DOI 10.1111/j.1349-7006.1988.tb01609.x; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VANNI R, 1988, CANCER GENET CYTOGEN, V30, P35, DOI 10.1016/0165-4608(88)90090-8; VARLEY JM, 1988, ONCOGENE, V3, P87; WADA A, 1988, BIOCHEM BIOPH RES CO, V157, P828, DOI 10.1016/S0006-291X(88)80324-3; WAYE JS, 1987, HUM GENET, V77, P151, DOI 10.1007/BF00272383; WHITHAM SE, 1986, BIOCHEM J, V240, P913, DOI 10.1042/bj2400913; WILLIAMS BP, 1987, CYTOGENET CELL GENET, V46, P717; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, BIOCHEM BIOPH RES CO, V142, P1019, DOI 10.1016/0006-291X(87)91516-6; ZHOU DJ, 1988, ONCOGENE, V2, P279; 1978, UNION INT CONTRE CAN	65	170	171	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1991	6	5					789	795						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052357				2022-12-28	WOS:A1991GT82500015
J	WATERS, CM; LITTLEWOOD, TD; HANCOCK, DC; MOORE, JP; EVAN, GI				WATERS, CM; LITTLEWOOD, TD; HANCOCK, DC; MOORE, JP; EVAN, GI			C-MYC PROTEIN EXPRESSION IN UNTRANSFORMED FIBROBLASTS	ONCOGENE			English	Article							MESSENGER-RNA; CELL-CYCLE; ENCODED PROTEINS; GROWTH-FACTORS; ONCOGENE; TRANSCRIPTION; SERUM; GENE; LOCALIZATION; IDENTIFICATION	We have examined and quantitated the expression of c-myc protein in two untransformed fibroblast cell lines, murine Swiss 3T3 and human MRC-5. c-myc protein is not detectable in quiescent cells, but it is rapidly induced upon mitogenic stimulation. Peak expression is seen about 3-5 h after serum stimulation, and corresponds to about 3-6000 molecules per cell (mpc). Thereafter, levels fall back to a quiescent level in confluent fibroblasts, but remain elevated at 1-3000 mpc in subconfluent cells. The c-myc protein is phosphorylated and has the same size and short half-life as seen in tumour cells. Removal of serum growth factors from the culture medium causes very rapid loss of the c-myc protein from all cells, irrespective of their positions in the cell cycle. Thus, c-myc expression is continuously dependent upon the presence of mitogens. However, no single tested mitogen is obligatory for maintenance of expression in proliferating cells. Growth arrest of cells, either by metabolite starvation or by drugs which inhibit DNA synthesis, does not affect expression of the c-myc protein, which remains completely dependent upon the presence of mitogens. These data are consistent with the c-myc protein's having a continuous role in proliferating cells as an intracellular integrator of growth regulatory signalling pathways.			EVAN, GI (corresponding author), IMPERIAL CANC RES FUND, DOMINION HOUSE, 59 BARTHOLOMEW CLOSE, LONDON EC1A 7BE, ENGLAND.							ALITALO K, 1987, BIOCHIM BIOPHYS ACTA, V907, P1, DOI 10.1016/0304-419X(87)90016-3; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEAN M, 1986, J BIOL CHEM, V261, P9161; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; EVAN GI, 1986, CURR TOP MICROBIOL, V132, P362; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; KRONKE M, 1987, P NATL ACAD SCI USA, V84, P469, DOI 10.1073/pnas.84.2.469; LARSSON O, 1985, J CELL SCI, V75, P259; LUSCHER B, 1986, INT S PRINCESS TAKAM, V17, P291; MOORE JP, 1987, ONCOGENE RES, V2, P65; OKUDA A, 1989, EXP CELL RES, V185, P258, DOI 10.1016/0014-4827(89)90054-2; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PERSSON H, 1985, MOL CELL BIOL, V5, P2903, DOI 10.1128/MCB.5.11.2903; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; SAMBUCETTI LC, 1986, SCIENCE, V234, P1417, DOI 10.1126/science.3491427; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; WATERS CM, 1990, ONCOGENE, V5, P669	32	158	162	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1991	6	5					797	805						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052358				2022-12-28	WOS:A1991GT82500016
J	DEMILIA, JC; MATHEYPREVOT, B; JAROS, K; WOLF, B; STEELE, G; SUMMERHAYES, IC				DEMILIA, JC; MATHEYPREVOT, B; JAROS, K; WOLF, B; STEELE, G; SUMMERHAYES, IC			PRENEOPLASTIC LESIONS INDUCED BY MYC AND SRC ONCOGENES IN A HETEROTOPIC RAT COLON	ONCOGENE			English	Article							PROTEIN-KINASE ACTIVITY; TRANSGENIC MICE; CELL-LINES; COLORECTAL CANCERS; GENE-MUTATIONS; HA-RAS; TRANSFORMATION; CARCINOMA; DEREGULATION; VIRUS	With the use of viral vectors harboring myc and src oncogenes, we have assessed the potential contribution of these different elements to colonic neoplasia using a transplantation technique resulting in the formation of a heterotopic colon in Wistar Furth rats. While myc alone induced atypia and some dysplasia, src induced focal dysplastic lesions throughout the colon mucosa with evidence of metaplasia. In contrast, lesions induced by myc and src acting cooperatively, were highly dysplastic with evidence of tumor formation after protracted periods. These results indicated the formation of histologically distinct preneoplastic lesions elicited by the action of a single oncogene in colon implants with the production of adenocarcinomas when such oncogenic elements act cooperatively. This model provides an opportunity for studies of the action of different oncogenes, acting singly or in combination, in the multi-step progression to colon tumor formation.	NEW ENGLAND DEACONESS HOSP, CANC BIOL LAB, 50 BINNEY ST, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT PEDIAT ONCOL, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School					NATIONAL CANCER INSTITUTE [P01CA044704] Funding Source: NIH RePORTER; NCI NIH HHS [CA44704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; EDWARDS PAW, 1988, ONCOGENE, V2, P407; ERISMAN MD, 1988, ONCOGENE, V2, P367; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; JOYCE AD, 1988, J UROLOGY, V140, P1067, DOI 10.1016/S0022-5347(17)41928-8; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; ROSEN N, 1986, J BIOL CHEM, V261, P3754; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STRICKLAND JE, 1988, CANCER RES, V48, P165; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WAGNER HE, 1990, ONCOGENE, V5, P557	23	18	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1991	6	2					303	309						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000223				2022-12-28	WOS:A1991FZ13400017
J	DEVILEE, P; VANVLIET, M; KUIPERSDIJKSHOORN, N; PEARSON, PL; CORNELISSE, CJ				DEVILEE, P; VANVLIET, M; KUIPERSDIJKSHOORN, N; PEARSON, PL; CORNELISSE, CJ			SOMATIC GENETIC CHANGES ON CHROMOSOME-18 IN BREAST CARCINOMAS - IS THE DCC GENE INVOLVED	ONCOGENE			English	Article							COLORECTAL CARCINOMAS; RETINOBLASTOMA GENE; RECESSIVE MUTATION; CELL CARCINOMA; SHORT ARM; HETEROZYGOSITY; CANCER; TUMORS; EXPRESSION; DELETION	Recently, a gene has been isolated from the long arm of chromosome 18 which was shown to be frequently deleted in colorectal carcinomas and hence designated the DCC gene (Fearon et al., 1990). To explore the possible involvement of this gene in breast cancer, we have used 5 polymorphic DNA markers (one for 18p, and four for 18q) to examine the status of chromosome 18 in 49 primary breast carcinomas by comparing the genotypes of lymphocyte and tumour DNA samples. Imbalance of alleles, resulting in allelic loss or duplication, was observed in 17 cases (38% of informative cases). In 13 of these, this imbalance included the locus D18S8 located within the DCC gene region. In the remaining 4 cases this locus was not involved, with the affected chromosome region mapping proximally of D18S8 in 3 cases, and distally in 1 case. These results indicate that chromosome 18 is rearranged in breast cancer more frequently than is expected on the basis of cytogenetic data alone, and warrant a closer inspection of the DCC gene in this tumour.	LEIDEN UNIV,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC			DEVILEE, PETER/ABR-2140-2022					BEERMAN H, 1990, INT J CANCER, V45, P34, DOI 10.1002/ijc.2910450108; BERGERHEIM U, 1989, CANCER RES, V49, P1390; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; DEVILEE P, 1990, CYTOGENET CELL GENET, V53, P52, DOI 10.1159/000132893; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DEVILEE P, 1991, IN PRESS CANCER RES; DEVILEE P, 1990, IN PRESS CANCER SURV; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GENUARDI M, 1989, AM J HUM GENET, V45, P73; HOLLIDAY R, 1989, TRENDS GENET, V5, P42, DOI 10.1016/0168-9525(89)90020-6; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KIDD KK, 1989, CYTOGEN CELL GENET, V51; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MACKAY J, 1988, LANCET, V2, P1384; MITELMAN F, 1988, CATALOG CHROMOSOME A; MONPEZAT JP, 1988, INT J CANCER, V41, P404, DOI 10.1002/ijc.2910410315; MOTOMURA K, 1988, Genomics, V2, P180, DOI 10.1016/0888-7543(88)90101-2; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TRENT JM, 1987, ONCOGENES HORMONES B, P142; VARLEY JM, 1989, ONCOGENE, V4, P725; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	32	98	100	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					311	315						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000224				2022-12-28	WOS:A1991FZ13400018
J	HEERDT, BG; MOLINAS, S; DEITCH, D; AUGENLICHT, LH				HEERDT, BG; MOLINAS, S; DEITCH, D; AUGENLICHT, LH			AGGRESSIVE SUBTYPES OF HUMAN COLORECTAL TUMORS FREQUENTLY EXHIBIT AMPLIFICATION OF THE C-MYC GENE	ONCOGENE			English	Article							HUMAN-COLON CARCINOMA; HUMAN-LUNG CANCER; N-MYC; CELL-CARCINOMA; RAS ONCOGENES; EXPRESSION; MUTATIONS; DNA; NEUROBLASTOMAS; REARRANGEMENT	Expression of the c-myc gene is often elevated in human colorectal tumors, but reported amplification of the locus is rare. Here we demonstrate that modest amplification of c-myc is frequently found in aggressive subtypes of colorectal cancer. Careful quantitation of c-myc copy number has shown amplification in 53.8% (7/13) mucinous tumors, 42.3% (3/7) poorly differentiated tumors and a single poorly differentiated APUD tumor. This contrasts with amplification in 6.9% (2/29) moderately to well differentiated tumors, a value which is in agreement with that in previously published reports. Such changes in gene copy number may represent an important aspect of the genomic alterations which accumulate during the development of colorectal tumors.	MONTEFIORE MED CTR,DEPT PATHOL,BRONX,NY 10467; ALBERT EINSTEIN MED CTR,BRONX,NY 10467	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University	HEERDT, BG (corresponding author), MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467, USA.				NCI NIH HHS [P30-CA1330, CA41372, CA40558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040558, K04CA001330, R01CA041372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANDER RJ, 1986, GASTROENTEROLOGY, V91, P1503, DOI 10.1016/0016-5085(86)90208-8; ALMAGRO UA, 1983, CANCER, V52, P1453, DOI 10.1002/1097-0142(19831015)52:8<1453::AID-CNCR2820520819>3.0.CO;2-9; Augenlicht L. H., 1989, CELL MOL BIOL COLON, P165; AUGENLICHT LH, 1987, CANCER RES, V47, P6017; AUGENLICHT LH, 1982, CANCER RES, V42, P1088; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Battey, 1986, BASIC METHODS MOL BI; BISHOP JM, 1987, ONCOGENES GROWTH FAC, P1; BOS JL, 1989, CANCER RES, V49, P4682; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BURMER GC, 1989, CANCER RES, V49, P2141; BURMER GC, 1989, P NATL ACAD SCI USA, V86, P2403, DOI 10.1073/pnas.86.7.2403; CHOWDHURY JR, 1975, DIS COLON RECTUM, V18, P332, DOI 10.1007/BF02587396; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; ERISMAN MD, 1988, CANCER RES, V48, P1350; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FIDLER IJ, 1981, EUR J CANCER, V17, P487, DOI 10.1016/0014-2964(81)90049-9; FINELY GG, 1989, ONCOGENE, V4, P963; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HEERDT BG, 1990, EXP CELL RES, V186, P54, DOI 10.1016/0014-4827(90)90209-S; HEERDT BG, 1990, CANCER RES, V50, P1596; HEPPNER GH, 1984, CANCER RES, V44, P2259; KOSS LG, 1989, HUM PATHOL, V20, P528, DOI 10.1016/0046-8177(89)90244-X; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LEVIN B, 1986, CANCER GENET CYTOGEN, V19, P159, DOI 10.1016/0165-4608(86)90383-3; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; LUI IOL, 1985, PATHOLOGY, V17, P31, DOI 10.3109/00313028509063720; Maniatis T., 1982, MOL CLONING; MELTZER SJ, 1987, GASTROENTEROLOGY, V92, P1174, DOI 10.1016/S0016-5085(87)91074-2; NAU MM, 1984, CURR TOP MICROBIOL, V113, P172; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PATHAK S, 1989, CELL MOL BIOL COLON, P139; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; SADAHIRO S, 1989, CANCER, V64, P1113, DOI 10.1002/1097-0142(19890901)64:5<1113::AID-CNCR2820640524>3.0.CO;2-5; SASAKI M, 1989, CANCER RES, V49, P4402; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; SLEISENGER MH, 1989, GASTROINTESTINAL DIS, P1535; SYMONDS DA, 1976, CANCER, V37, P1891, DOI 10.1002/1097-0142(197604)37:4<1891::AID-CNCR2820370439>3.0.CO;2-Z; UMPLEBY HC, 1985, BRIT J SURG, V72, P715, DOI 10.1002/bjs.1800720915; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WOLLEY RC, 1982, J NATL CANCER I, V69, P15; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; YANDER G, 1985, CANCER RES, V45, P4433; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	52	69	70	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					125	129						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992440				2022-12-28	WOS:A1991EY03900017
J	HEBERLEIN, C; KAWAI, M; FRANZ, MJ; BECKENGESER, G; DANIEL, CP; OSTERTAG, W; STOCKING, C				HEBERLEIN, C; KAWAI, M; FRANZ, MJ; BECKENGESER, G; DANIEL, CP; OSTERTAG, W; STOCKING, C			RETROTRANSPOSONS AS MUTAGENS IN THE INDUCTION OF GROWTH AUTONOMY IN HEMATOPOIETIC-CELLS	ONCOGENE			English	Article							STIMULATING FACTOR GENE; A-PARTICLE GENE; BONE-MARROW CULTURES; NUCLEOTIDE-SEQUENCE; AUTOCRINE STIMULATION; INTERLEUKIN-3 GENE; SARCOMA-VIRUS; LINE WEHI-3B; LEUKEMIA; STEM	Factor-independent mutants of hematopoietic cells, especially of multipotent cells, are valuable tools to identify genes that regulate stem cell proliferation and differentiation and thus may be important in leukemogenesis. Factor-independent mutants from both myeloid precursor and hematopoietic stem cell lines were isolated. The frequency of such mutants in a given cell population was one to two orders of magnitude lower for the multipotent cell line FDC-Pmix (3.6 x 10(-9)) than for the myeloid precursors, FDC-P1-M (1.7 x 10(-8)) and D35 (2.2 x 10(-7)). Analysis of these mutants revealed several mechanisms by which growth autonomy was obtained, either with or without direct contribution of growth factor gene activation. The molecular basis of spontaneous activation of the Multi-CSF (Interleukin3) gene was determined and compared to activation of the GM-CSF gene in a previous study. Multi-CSF gene activation in both precursor and stem cells was caused by the insertion of an intracisternal A particle (IAP) provirus. In two independent mutants of the D35 cell line, activation of the Multi-CSF or the GM-CSF gene was caused by almost identical IAPs with a 99% homology in the U3 and R region of the long terminal repeat. This result demonstrates that only one class of IAPs, or perhaps a single provirus, is involved in transposition and gene activation in a particular cell line. A unique example of anti-sense promotion from an IAP provirus in one Multi-CSF mutant underlines the versatility of these elements as natural insertional mutagens.	UNIV HAMBURG,HEINRICH PETTE INST EXPTL VIROL & IMMUNOL,MARTINISTR 52,W-2000 HAMBURG 20,GERMANY; AICHI MED UNIV,DEPT MICROBIOL,NAGAKUTE,AICHI 48011,JAPAN; CHRISTIE HOSP & HOLT RADIUM INST,PATERSON LAB,MANCHESTER M20 9BX,LANCS,ENGLAND	Heinrich Pette Institute; University of Hamburg; Aichi Medical University; Christie NHS Foundation Trust; Christie Hospital								AOTA S, 1987, GENE, V56, P1, DOI 10.1016/0378-1119(87)90153-3; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BREINDL M, 1984, CELL, V38, P9, DOI 10.1016/0092-8674(84)90521-X; BROWDER TM, 1989, MOL CELL BIOL, V9, P204, DOI 10.1128/MCB.9.1.204; CHRISTY RJ, 1985, NUCLEIC ACIDS RES, V13, P289, DOI 10.1093/nar/13.1.289; CHRISTY RJ, 1988, MOL CELL BIOL, V8, P1093, DOI 10.1128/MCB.8.3.1093; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; DELARCO JE, 1978, P NATL ACAD SCI USA, V75, P4001; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; DUHRSEN U, 1988, LEUKEMIA, V2, P334; DUHRSEN U, 1988, LEUKEMIA, V2, P329; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; FALZON M, 1988, J VIROL, V62, P4070, DOI 10.1128/JVI.62.11.4070-4077.1988; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GREENBERGER JS, 1980, VIROLOGY, V105, P425, DOI 10.1016/0042-6822(80)90043-4; HAEUPTLE MT, 1989, J CELL BIOL, V108, P1227, DOI 10.1083/jcb.108.4.1227; HOROWITZ M, 1984, EMBO J, V3, P2937, DOI 10.1002/j.1460-2075.1984.tb02235.x; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KLUGE NK, 1986, LEUKEMIA RES, V10, P187, DOI 10.1016/0145-2126(86)90041-X; KOLLEK R, 1984, J VIROL, V50, P717, DOI 10.1128/JVI.50.3.717-724.1984; KOURY MJ, 1982, NATURE, V299, P638, DOI 10.1038/299638a0; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; LAKER C, 1987, P NATL ACAD SCI USA, V84, P8458, DOI 10.1073/pnas.84.23.8458; LAKER C, 1989, MOL CELL BIOL, V9, P5746, DOI 10.1128/MCB.9.12.5746; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; METCALF D, 1984, HEMOPOIETIC COLONIES; MIYATAKE S, 1985, P NATL ACAD SCI USA, V82, P316, DOI 10.1073/pnas.82.2.316; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; NUSSE R, 1988, CELLULAR ONCOGENE AC, P95; ONO M, 1985, J VIROL, V55, P387, DOI 10.1128/JVI.55.2.387-394.1985; ONO M, 1986, J VIROL, V60, P589, DOI 10.1128/JVI.60.2.589-598.1986; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; SHANNON MF, 1988, P NATL ACAD SCI USA, V85, P674, DOI 10.1073/pnas.85.3.674; SHENONG GLC, 1984, J VIROL, V49, P171, DOI 10.1128/JVI.49.1.171-177.1984; SKOWRONSKI J, 1986, COLD SPRING HARB SYM, V51, P457, DOI 10.1101/SQB.1986.051.01.055; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; SPOONCER E, 1984, NATURE, V310, P228, DOI 10.1038/310228a0; SPOONCER E, 1989, CURR TOP MICROBIOL I, V149, P108; STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7; SUEMATSU S, 1990, IN PRESS; TOKSOZ D, 1980, BLOOD, V55, P931; WONG GG, 1988, IMMUNOL TODAY, V9, P137, DOI 10.1016/0167-5699(88)91200-5; WONG PMC, 1989, MOL CELL BIOL, V9, P798, DOI 10.1128/MCB.9.2.798; WYKE JA, 1986, MOL CELL BIOL, V6, P959, DOI 10.1128/MCB.6.3.959; YMER S, 1985, NATURE, V317, P255, DOI 10.1038/317255a0; YMER S, 1986, NUCLEIC ACIDS RES, V14, P5901, DOI 10.1093/nar/14.14.5901; YOUNG DC, 1987, J CLIN INVEST, V79, P100, DOI 10.1172/JCI112769	53	21	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1799	1807						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2178239				2022-12-28	WOS:A1990ET43600009
J	MANO, H; ISHIKAWA, F; NISHIDA, J; HIRAI, H; TAKAKU, F				MANO, H; ISHIKAWA, F; NISHIDA, J; HIRAI, H; TAKAKU, F			A NOVEL PROTEIN-TYROSINE KINASE, TEC, IS PREFERENTIALLY EXPRESSED IN LIVER	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; NUCLEOTIDE-SEQUENCE; HEMATOPOIETIC-CELLS; GROWTH-FACTOR; C-SRC; ONCOGENE; GENE; VIRUS; IDENTIFICATION; RECEPTOR	To identify protein-tyrosine kinases which play an important role in the process of hepatocarcinogenesis, we have screened a murine liver cDNA library with v-fps kinase domain as a probe. Using low stringency screening, we could isolate cDNAs of a putative protein-tyrosine kinase, tec (tyrosine kinase expressed in hepatocellular carcinoma). Nucleotide sequences of the cDNAs show that the C-terminal domain of its predicted protein has significant homology with that of the members of the src family. The tec gene is expressed mainly in liver and faintly in heart, kidney and ovary. Northern analysis further shows that in 2 out of 4 cell lines of human hepatocellular carcinoma (HCC) the tec gene is highly expressed compared to normal human liver. This is the first report showing a protein-tyrosine kinase which may be specifically involved in the cell growth of hepatocytes or in the step of hepatocarcinogenesis.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo			Ishikawa, Fuyuki/AAU-4056-2021	Ishikawa, Fuyuki/0000-0002-5580-2305				ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ALEXANDER JJ, 1976, S AFR MED J, V50, P2124; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BLUMBERG BS, 1981, NEW ENGL J MED, V304, P782, DOI 10.1056/NEJM198103263041312; CHEAH MSC, 1986, NATURE, V319, P238, DOI 10.1038/319238a0; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; GU JR, 1988, CARCINOGENESIS, V9, P697, DOI 10.1093/carcin/9.5.697; HEINKOFF S, 1984, GENE, V28, P351; HSU TY, 1988, CELL, V55, P627, DOI 10.1016/0092-8674(88)90221-8; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KAPLAN JM, 1988, MOL CELL BIOL, V8, P2435, DOI 10.1128/MCB.8.6.2435; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; MACDONALD I, 1985, MOL CELL BIOL, V5, P2543, DOI 10.1128/MCB.5.10.2543; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NOTARIO V, 1984, CANCER CELL, V2, P425; OCHIYA T, 1986, P NATL ACAD SCI USA, V83, P4993, DOI 10.1073/pnas.83.14.4993; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; ROEBROEK AJM, 1985, EMBO J, V4, P2897, DOI 10.1002/j.1460-2075.1985.tb04020.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WILLMAN CL, 1987, P NATL ACAD SCI USA, V84, P4480, DOI 10.1073/pnas.84.13.4480; YANG SS, 1988, LEUKEMIA S, V2, P102	37	154	160	1	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1781	1786						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284097				2022-12-28	WOS:A1990ET43600007
J	CHIBA, I; TAKAHASHI, T; NAU, MM; DAMICO, D; CURIEL, DT; MITSUDOMI, T; BUCHHAGEN, DL; CARBONE, D; PIANTADOSI, S; KOGA, H; REISSMAN, PT; SLAMON, DJ; HOLMES, EC; MINNA, JD				CHIBA, I; TAKAHASHI, T; NAU, MM; DAMICO, D; CURIEL, DT; MITSUDOMI, T; BUCHHAGEN, DL; CARBONE, D; PIANTADOSI, S; KOGA, H; REISSMAN, PT; SLAMON, DJ; HOLMES, EC; MINNA, JD			MUTATIONS IN THE P53 GENE ARE FREQUENT IN PRIMARY, RESECTED NON-SMALL-CELL LUNG-CANCER	ONCOGENE			English	Article									NATL NAVAL MED CTR, NCI, NAVY MED ONCOL BRANCH, BLDG 8, ROOM 5101, BETHESDA, MD 20814 USA; UNIFORMED SERV UNIV HLTH SCI, BETHESDA, MD 20814 USA; JOHNS HOPKINS UNIV HOSP, CTR ONCOL, BALTIMORE, MD 21205 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Mitsudomi, Tetsuya/0000-0001-9860-8505				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Cox DR., 1989, ANAL BINARY DATA; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DOHERTY PJ, 1989, ANAL BIOCHEM, V177, P7, DOI 10.1016/0003-2697(89)90003-1; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG S, 1990, EMBO J, V9, P1815, DOI 10.1002/j.1460-2075.1990.tb08306.x; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; KAELIN WG, 1990, MOL CELL BIOL, V10, P3761, DOI 10.1128/MCB.10.7.3761; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MAZUR M, 1988, SOMAT CELL MOLEC GEN, V14, P393, DOI 10.1007/BF01534647; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MERCER WE, 1990, ONCOGENE, V5, P973; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; Minna JD, 1989, CANCER PRINCIPLES PR, P591; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUSSI T, 1990, J VIROL, V64, P967; SOUSSI T, 1987, ONCOGENE, V1, P71; SOUSSI T, 1989, J VIROL, V63, P3894, DOI 10.1128/JVI.63.9.3894-3901.1989; SOUSSI T, 1990, ONCOGENE, V5, P945; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	56	636	652	0	19	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1603	1610						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	1979160				2022-12-28	WOS:A1990EK50200024
J	KRAFT, AS; WAGNER, F; HOUSEY, GM				KRAFT, AS; WAGNER, F; HOUSEY, GM			OVEREXPRESSION OF PROTEIN-KINASE-C BETA-1 IS NOT SUFFICIENT TO INDUCE FACTOR INDEPENDENCE IN THE INTERLEUKIN-3-DEPENDENT MYELOID CELL-LINE FDC-P1	ONCOGENE			English	Note									PROGEN PHARMACEUT INC,DEPT BIOCHEM & MOLEC BIOPHYS,TARRYTOWN,NY		KRAFT, AS (corresponding author), UNIV ALABAMA,DIV HEMATOL ONCOL,BIRMINGHAM,AL 35294, USA.							BROWDER TM, 1989, MOL CELL BIOL, V9, P204, DOI 10.1128/MCB.9.1.204; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COWAN NJ, 1981, P NATL ACAD SCI-BIOL, V78, P4877, DOI 10.1073/pnas.78.8.4877; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; FARRAR WL, 1985, NATURE, V315, P235, DOI 10.1038/315235a0; FARRAR WL, 1985, NATURE, V315, P233, DOI 10.1038/315233a0; HAPEL AJ, 1986, LYMPHOKINE RES, V5, P249; HASEGAWASASAKI H, 1988, J BIOL CHEM, V263, P12970; HOGANS BB, 1988, J CELL PHYSIOL, V137, P346, DOI 10.1002/jcp.1041370219; HOUSEY GM, 1987, P NATL ACAD SCI USA, V84, P1065, DOI 10.1073/pnas.84.4.1065; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; KRAFT AS, 1988, J BIOL CHEM, V263, P8437; KRAFT AS, 1987, ONCOGENE, V1, P111; KRAFT AS, 1986, P NATL ACAD SCI USA, V83, P1334, DOI 10.1073/pnas.83.5.1334; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; KRAFT AS, 1983, J BIOL CHEM, V258, P9178; KRAUSS RS, 1989, ONCOGENE, V4, P991; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; LOPEZRIVAS A, 1987, P NATL ACAD SCI USA, V84, P5768, DOI 10.1073/pnas.84.16.5768; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; NAIR APK, 1989, MOL CELL BIOL, V9, P1183, DOI 10.1128/MCB.9.3.1183; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OVERELL RW, 1987, MOL CELL BIOL, V7, P3394, DOI 10.1128/MCB.7.10.3394; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; RAMSDELL JS, 1986, J BIOL CHEM, V261, P7073; STABEL S, 1987, J CELL PHYSIOL, V130, P111, DOI 10.1002/jcp.1041300116; STOCKING C, 1988, CELL, V53, P869, DOI 10.1016/S0092-8674(88)90329-7; TALLANT EA, 1987, BIOCHIM BIOPHYS ACTA, V929, P40, DOI 10.1016/0167-4889(87)90239-4; TIGGES MA, 1989, SCIENCE, V243, P781, DOI 10.1126/science.2492678; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; WATSON JD, 1987, J IMMUNOL, V139, P123; WHETTON AD, 1986, J CELL SCI, V84, P93; WHETTON AD, 1986, EMBO J, V5, P3281, DOI 10.1002/j.1460-2075.1986.tb04640.x; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284	34	12	15	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1243	1246						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392326				2022-12-28	WOS:A1990DX36100018
J	YAMADA, H; WAKE, N; FUJIMOTO, S; BARRETT, JC; OSHIMURA, M				YAMADA, H; WAKE, N; FUJIMOTO, S; BARRETT, JC; OSHIMURA, M			MULTIPLE CHROMOSOMES CARRYING TUMOR SUPPRESSOR ACTIVITY FOR A UTERINE ENDOMETRIAL CARCINOMA CELL-LINE IDENTIFIED BY MICROCELL-MEDIATED CHROMOSOME TRANSFER	ONCOGENE			English	Article									TOTTORI UNIV,FAC MED,MOLEC & CELL GENET LAB,YONAGO,TOTTORI 683,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,DEPT REPROD PHYSIOL & ENDOCRINOL,BEPPU,OITA 874,JAPAN; HOKKAIDO UNIV,SCH MED,DEPT OBSTET & GYNECOL,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN; NIEHS,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709	Tottori University; Kyushu University; Hokkaido University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)								ATKIN NB, 1977, HUM GENET, V38, P25, DOI 10.1007/BF00295804; ATKIN NB, 1979, CANCER, V44, P604, DOI 10.1002/1097-0142(197908)44:2<604::AID-CNCR2820440230>3.0.CO;2-G; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P279, DOI 10.1016/0165-4608(86)90206-2; BECHER R, 1983, CANCER RES, V43, P5010; BENEDICT WF, 1984, CANCER RES, V44, P3471; BRITOBABAPULLE V, 1981, CANCER GENET CYTOGEN, V4, P215, DOI 10.1016/0165-4608(81)90015-7; CAVANEE WK, 1983, NATURE, V305, P779; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; COUTURIER J, 1986, INT J CANCER, V38, P17, DOI 10.1002/ijc.2910380104; EVANS EP, 1982, J CELL SCI, V56, P113; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FUJITA H, 1985, CANCER GENET CYTOGEN, V18, P283, DOI 10.1016/0165-4608(85)90149-9; GENUARDI M, 1989, AM J HUM GENET, V45, P73; GIBAS Z, 1987, CANCER GENET CYTOGEN, V25, P21, DOI 10.1016/0165-4608(87)90155-5; GILBERT F, 1984, CANCER RES, V44, P5444; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; HARRIS H, 1988, CANCER RES, V48, P3302; HORGAS G, 1988, CANCER GENET CYTOGEN, V35, P269, DOI 10.1016/0165-4608(88)90250-6; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; ISHIWATA I, 1984, GYNECOL ONCOL, V17, P281, DOI 10.1016/0090-8258(84)90212-9; KAKATI S, 1976, CANCER, V38, P770, DOI 10.1002/1097-0142(197608)38:2<770::AID-CNCR2820380220>3.0.CO;2-0; KLEIN G, 1971, J CELL SCI, V8, P659; KLINGER HP, 1983, JNCI-J NATL CANCER I, V71, P559; KOI M, 1989, JPN J CANCER RES, V80, P122, DOI 10.1111/j.1349-7006.1989.tb02278.x; KOI M, 1989, MOL CARCINOGEN, V2, P12, DOI 10.1002/mc.2940020103; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; LESTER SC, 1980, SOMAT CELL GENET, V6, P241, DOI 10.1007/BF01538799; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; OSHIMURA M, 1984, CANCER RES, V44, P5017; OSHIMURA M, 1988, CANCER RES, V48, P1623; OSHIMURA M, 1990, J CELL BIOCHEM, V42, P135, DOI 10.1002/jcb.240420304; PEEHL DM, 1981, INT J CANCER, V27, P625, DOI 10.1002/ijc.2910270509; SAGER R, 1978, SOMAT CELL GENET, V4, P375, DOI 10.1007/BF01542849; SAGER R, 1986, CANCER RES, V46, P1573; SANDBERG AA, 1988, CANCER RES, V48, P1049; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SHIMIZU M, 1990, ONCOGENE, V5, P185; STANBRIDGE EJ, 1981, SOMAT CELL GENET, V7, P699, DOI 10.1007/BF01538758; STANBRIDGE EJ, 1981, ISRAEL J MED SCI, V17, P563; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; SUGAWARA O, 1990, SCIENCE, V247, P707, DOI 10.1126/science.2300822; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; YAMADA H, 1989, Acta Obstetrica et Gynaecologica Japonica (Japanese Edition), V41, P122; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; YOSHIDA MA, 1986, CANCER GENET CYTOGEN, V20, P159, DOI 10.1016/0165-4608(86)90119-6; ZBAR B, 1987, NATURE, V327, P721, DOI 10.1038/327721a0	52	99	104	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1141	1147						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392323				2022-12-28	WOS:A1990DX36100005
J	BEREBBI, M; MARTIN, PM; BERTHOIS, Y; BERNARD, AM; BLANGY, D				BEREBBI, M; MARTIN, PM; BERTHOIS, Y; BERNARD, AM; BLANGY, D			ESTRADIOL DEPENDENCE OF THE SPECIFIC MAMMARY TISSUE TARGETING OF POLYOMA-VIRUS ONCOGENICITY IN NUDE-MICE	ONCOGENE			English	Article									CNRS,UPR 272,BP 8,F-94801 VILLEJUIF,FRANCE; JE CNRS,F-13009 MARSEILLE,FRANCE; CNRS,URA 1175,F-13326 MARSEILLE 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)			Berthois, Yolande/O-1168-2017	BERTHOIS, Yolande/0000-0001-9603-1626				ANDERSON TJ, 1982, BRIT J CANCER, V46, P376, DOI 10.1038/bjc.1982.213; BARTON MC, 1988, P NATL ACAD SCI USA, V85, P7119, DOI 10.1073/pnas.85.19.7119; BEREBBI M, 1988, ONCOGENE, V2, P149; BRESCIANI F, 1971, BASIC ACTIONS SEX ST, P130; FREUND R, 1987, J VIROL, V61, P2232, DOI 10.1128/JVI.61.7.2232-2239.1987; Fried M, 1975, Cold Spring Harb Symp Quant Biol, V39 Pt 1, P45; HAWKINS RA, 1988, ENDOCRINE MANAGEMENT, P45; HENDERSON BE, 1988, CANCER RES, V48, P246; IQBAL MJ, 1987, BREAST NEWS INT 2, V2, P7; IQBAL MJ, 1986, BREAST NEWS INT 1, V2, P8; ISON EJ, 1981, AM J MED TECHNOL, V47, P38; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; LEGOFF JM, 1988, J STEROID BIOCHEM, V31, P167, DOI 10.1016/0022-4731(88)90050-7; MARTIN PM, 1982, J STEROID BIOCHEM, V16, P215, DOI 10.1016/0022-4731(82)90170-4; MERKEL DE, 1988, ENDOCRIN MANAGEMENT, P84; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0	18	14	14	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					505	509						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970153				2022-12-28	WOS:A1990DB85300008
J	WARD, JM; PERANTONI, AO; SANTOS, E				WARD, JM; PERANTONI, AO; SANTOS, E			COMPARATIVE IMMUNOHISTOCHEMICAL REACTIVITY OF MONOCLONAL AND POLYCLONAL ANTIBODIES TO H-RAS P21 IN NORMAL AND NEOPLASTIC TISSUES OF RODENTS AND HUMANS	ONCOGENE			English	Article									NIAID,MOLEC MICROBIOL LAB,BETHESDA,MD 20892; NCI,FREDERICK CANC RES FACIL,DIV CANC ETIOL,COMPARAT CARCINOGENESIS LAB,DEV BIOL WORKING GRP,FREDERICK,MD 21701	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WARD, JM (corresponding author), NCI,FREDERICK CANC RES FACIL,TUMOR PATHOL & PATHOGENESIS SECT,BLDG 538,RM 205,FREDERICK,MD 21701, USA.				NCI NIH HHS [N01-CO-74102] Funding Source: Medline; OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGNANTIS NJ, 1986, ANTICANCER RES, V6, P1157; ALLEN DC, 1987, J CLIN PATHOL, V40, P157, DOI 10.1136/jcp.40.2.157; AOKI I, 1987, ACTA PATHOL JAPON, V37, P1903; AUGENLICHT LH, 1987, CANCER RES, V47, P3763; BACKER JM, 1986, P NATL ACAD SCI USA, V83, P6357, DOI 10.1073/pnas.83.17.6357; BACKER JM, 1986, BIOCHEM BIOPH RES CO, V135, P316, DOI 10.1016/0006-291X(86)90979-4; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIZUB D, 1987, ONCOGENE, V1, P131; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; CANDLISH W, 1986, J PATHOL, V150, P163, DOI 10.1002/path.1711500303; CARNEY WP, 1986, P NATL ACAD SCI USA, V83, P7485, DOI 10.1073/pnas.83.19.7485; CHESA PG, 1987, P NATL ACAD SCI USA, V84, P3234, DOI 10.1073/pnas.84.10.3234; CIOCCA DR, 1983, J HISTOCHEM CYTOCHEM, V31, P691, DOI 10.1177/31.5.6341459; CLAIR T, 1987, CANCER RES, V47, P5290; CLARK R, 1985, P NATL ACAD SCI USA, V82, P5280, DOI 10.1073/pnas.82.16.5280; CZERNIAK B, 1987, CANCER, V60, P2432, DOI 10.1002/1097-0142(19871115)60:10<2432::AID-CNCR2820601014>3.0.CO;2-1; CZERNIAK B, 1987, AM J PATHOL, V126, P411; EMBLETON MJ, 1988, BRIT J CANCER, V57, P48, DOI 10.1038/bjc.1988.7; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FROMOWITZ FB, 1987, HUM PATHOL, V18, P1268, DOI 10.1016/S0046-8177(87)80412-4; FUJITA J, 1988, J NATL CANCER I, V80, P37, DOI 10.1093/jnci/80.1.37; FURTH ME, 1987, ONCOGENE, V1, P47; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GALAND P, 1988, INT J CANCER, V41, P155, DOI 10.1002/ijc.2910410127; GALLICK GE, 1985, P NATL ACAD SCI USA, V82, P1795, DOI 10.1073/pnas.82.6.1795; GASTL G, 1986, IMMUNOCYTOCHEMISTRY, P273; GAY NJ, 1983, NATURE, V301, P262, DOI 10.1038/301262a0; GHOSH AK, 1986, J CLIN PATHOL, V39, P428, DOI 10.1136/jcp.39.4.428; HABIB NA, 1986, INT SURG, V71, P182; HAND PH, 1987, J NATL CANCER I, V79, P59; HAND PH, 1984, P NATL ACAD SCI-BIOL, V81, P5227, DOI 10.1073/pnas.81.16.5227; HAND PH, 1985, MONOCLONAL ANTIBODIE, V27, P23; JOHNSON TL, 1987, CANCER, V59, P107, DOI 10.1002/1097-0142(19870101)59:1<107::AID-CNCR2820590123>3.0.CO;2-U; JOHNSON TL, 1987, AM J PATHOL, V127, P60; KANAI T, 1987, JPN J CANCER RES, V78, P1314; KERR IB, 1985, BRIT J CANCER, V52, P695, DOI 10.1038/bjc.1985.245; KUZUMAKI N, 1986, J NATL CANCER I, V77, P1273; LACAL JC, 1984, P NATL ACAD SCI-BIOL, V81, P5305, DOI 10.1073/pnas.81.17.5305; LANZA G, 1988, HISTOPATHOLOGY, V12, P595, DOI 10.1111/j.1365-2559.1988.tb01984.x; LEE I, 1987, VIRCHOWS ARCH B, V53, P146, DOI 10.1007/BF02890237; LOKE SL, 1988, AM J PATHOL, V131, P29; LUNDY J, 1986, J CLIN ONCOL, V4, P1321, DOI 10.1200/JCO.1986.4.9.1321; MCKENZIE KJ, 1987, HUM PATHOL, V18, P1282, DOI 10.1016/S0046-8177(87)80414-8; MELTZER SJ, 1987, GASTROENTEROLOGY, V92, P1174, DOI 10.1016/S0016-5085(87)91074-2; MIZUKAMI Y, 1988, CANCER, V61, P873, DOI 10.1002/1097-0142(19880301)61:5<873::AID-CNCR2820610504>3.0.CO;2-W; MONNAT M, 1987, INT J CANCER, V40, P293, DOI 10.1002/ijc.2910400302; NONOMURA A, 1987, LIVER, V7, P142; NONOMURA A, 1987, AM J GASTROENTEROL, V82, P512; OHUCHI N, 1987, CANCER RES, V47, P1413; OHUCHI N, 1986, CANCER RES, V46, P2511; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; PELLING JC, 1987, CARCINOGENESIS, V8, P1481, DOI 10.1093/carcin/8.10.1481; PULCIANI S, 1985, CELL, V48, P1023; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; REYNOLDS SH, 1986, P NATL ACAD SCI USA, V83, P33, DOI 10.1073/pnas.83.1.33; RICHMOND RE, 1988, J HISTOCHEM CYTOCHEM, V36, P179, DOI 10.1177/36.2.3121722; ROBINSON A, 1986, BRIT J CANCER, V54, P877, DOI 10.1038/bjc.1986.256; RODENBURG CJ, 1988, ARCH PATHOL LAB MED, V112, P151; SAMOWITZ WS, 1988, LAB INVEST, V58, pA81; SAMOWITZ WS, 1988, HUM PATHOL, V19, P127, DOI 10.1016/S0046-8177(88)80339-3; SANTOS E, 1988, J BIOL CHEM, V263, P9853; SANTOS E, 1982, NATURE, V298, P243; SHIRATORI Y, 1987, CANCER RES, V47, P6806; SIGAL IS, 1986, P NATL ACAD SCI USA, V83, P4725, DOI 10.1073/pnas.83.13.4725; SORRENTINO V, 1989, IN PRESS ONCOGENE; SRINIVASAPPA J, 1986, J VIROL, V57, P397, DOI 10.1128/JVI.57.1.397-401.1986; STOWERS SJ, 1988, CARCINOGENESIS, V9, P271, DOI 10.1093/carcin/9.2.271; SUKUMAR S, 1986, MOL CELL BIOL, V6, P2716, DOI 10.1128/MCB.6.7.2716; TAHARA E, 1986, JPN J CANCER RES, V77, P517; TANAKA T, 1988, CANCER RES, V48, P1030; TANAKA T, 1986, MOL CELL BIOCHEM, V70, P97; TANAKA T, 1987, MOL CELL BIOCHEM, V75, P23, DOI 10.1007/BF00231605; TANAKA T, 1985, P NATL ACAD SCI USA, V82, P3400, DOI 10.1073/pnas.82.10.3400; TANAKA T, 1986, CANCER RES, V46, P1465; THOR A, 1986, LAB INVEST, V55, P603; THOR A, 1984, NATURE, V311, P562, DOI 10.1038/311562a0; TOKSOZ D, 1987, ONCOGENE, V1, P409; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULSH LS, 1984, MOL CELL BIOL, V4, P1647, DOI 10.1128/MCB.4.8.1647; VIOLA MV, 1985, J EXP MED, V161, P1213, DOI 10.1084/jem.161.5.1213; VIOLA MV, 1986, NEW ENGL J MED, V314, P133, DOI 10.1056/NEJM198601163140301; WARD JM, 1988, JPN J CANCER RES, V79, P152, DOI 10.1111/j.1349-7006.1988.tb01570.x; WARD JM, 1986, CARCINOGENESIS, V7, P645, DOI 10.1093/carcin/7.4.645; WILLIAMS ARW, 1985, BRIT J CANCER, V52, P687, DOI 10.1038/bjc.1985.244; WILLINGHAM MC, 1983, EXP CELL RES, V149, P141, DOI 10.1016/0014-4827(83)90387-7; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WILSON MJ, 1986, FASEB J, V45, P1707; WONG G, 1986, CANCER RES, V46, P6029; YASUI W, 1987, ACTA PATHOL JAPON, V37, P1731; YOSHIDA K, 1988, CANCER RES, V48, P5503; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0	92	31	32	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					203	213						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648257				2022-12-28	WOS:A1989U567500012
J	BAICHWAL, VR; SUGDEN, B				BAICHWAL, VR; SUGDEN, B			THE MULTIPLE MEMBRANE-SPANNING SEGMENTS OF THE BNLF-1 ONCOGENE FROM EPSTEIN-BARR VIRUS ARE REQUIRED FOR TRANSFORMATION	ONCOGENE			English	Article											BAICHWAL, VR (corresponding author), UNIV WISCONSIN,MCARDLE LAB CANC RES,450 N RANDALL AVE,MADISON,WI 53706, USA.				NCI NIH HHS [CA-07175, CA-22443] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA007175, P01CA022443] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAICHWAL VR, 1988, ONCOGENE, V2, P461; BAICHWAL VR, 1987, J VIROL, V61, P866, DOI 10.1128/JVI.61.3.866-875.1987; Bankier A T, 1983, Mol Biol Med, V1, P425; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DIXON RAF, 1987, NATURE, V326, P73, DOI 10.1038/326073a0; FENNEWALD S, 1984, J VIROL, V51, P411, DOI 10.1128/JVI.51.2.411-419.1984; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HANLEY MR, 1987, NATURE, V329, P766, DOI 10.1038/329766a0; HAUSEN HZ, 1981, DNA TUMOR VIRUSES, P747; HERSKOWITZ I, 1987, CELL, V50, P995, DOI 10.1016/0092-8674(87)90162-0; HUDSON GS, 1985, J VIROL, V53, P528, DOI 10.1128/JVI.53.2.528-535.1985; KNUTSON JC, 1989, ADV VIROL ONCOLOGY; LEHMANN EL, 1975, NONPARAMETRICS; LIEBOWITZ D, 1986, J VIROL, V58, P233, DOI 10.1128/JVI.58.1.233-237.1986; LIEBOWITZ D, 1987, MOL CELL BIOL, V7, P2299, DOI 10.1128/MCB.7.7.2299; MANN KP, 1985, J VIROL, V55, P710, DOI 10.1128/JVI.55.3.710-720.1985; MILLER G, 1985, VIROLOGY, P563; SALZMAN NP, 1986, PAPOVAVIRIDAE, P27; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	23	88	88	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					67	74						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2536919				2022-12-28	WOS:A1989U567400010
J	MORAN, MF; KOCH, CA; SADOWSKI, I; PAWSON, T				MORAN, MF; KOCH, CA; SADOWSKI, I; PAWSON, T			MUTATIONAL ANALYSIS OF A PHOSPHOTRANSFER MOTIF ESSENTIAL FOR V-FPS TYROSINE KINASE-ACTIVITY	ONCOGENE			English	Article									UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto	MORAN, MF (corresponding author), MT SINAI HOSP,RES INST,DIV MOLEC & DEV BIOL,600 UNIV AVE,TORONTO M5G 1X5,ONTARIO,CANADA.		Moran, Michael/GYD-3631-2022; Pawson, Tony J/E-4578-2013					BARKER WC, 1982, P NATL ACAD SCI-BIOL, V79, P2836, DOI 10.1073/pnas.79.9.2836; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; BRYANT DL, 1984, MOL CELL BIOL, V4, P862, DOI 10.1128/MCB.4.5.862; BUECHLER JA, 1988, IN PRESS BIOCHEMISTR; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHEN LH, 1986, VIROLOGY, V155, P106, DOI 10.1016/0042-6822(86)90172-8; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Corbin J D, 1974, Methods Enzymol, V38, P287; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FINCHAM VJ, 1986, J VIROL, V58, P694, DOI 10.1128/JVI.58.2.694-699.1986; FOSTER D, 1984, J VIROL, V48, P744; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GROFFEN J, 1983, VIROLOGY, V125, P480, DOI 10.1016/0042-6822(83)90219-2; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HUNTER T, 1986, ENZYMES, V17, P191; KIPREOS ET, 1987, P NATL ACAD SCI USA, V84, P1345, DOI 10.1073/pnas.84.5.1345; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYER BJ, 1986, J VIROL, V60, P858, DOI 10.1128/JVI.60.3.858-867.1986; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MECKLINGHANSEN K, 1987, EMBO J, V6, P659, DOI 10.1002/j.1460-2075.1987.tb04805.x; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SADOWSKI I, 1987, ONCOGENE, V1, P181; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SHIBUYA M, 1982, CELL, V30, P787, DOI 10.1016/0092-8674(82)90283-5; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STONE JC, 1985, J VIROL, V55, P721, DOI 10.1128/JVI.55.3.721-727.1985; STONE JC, 1984, CELL, V37, P549, DOI 10.1016/0092-8674(84)90385-4; TOPP WC, 1981, VIROLOGY, V113, P408, DOI 10.1016/0042-6822(81)90168-9; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WEINMASTER G, 1984, CELL, V37, P559, DOI 10.1016/0092-8674(84)90386-6; WEINMASTER G, 1986, EMBO J, V5, P69, DOI 10.1002/j.1460-2075.1986.tb04179.x; WEINMASTER G, 1986, J BIOL CHEM, V261, P328; WEINMASTER G, 1983, J VIROL, V45, P29; WEINMASTER GA, 1988, J VIROL, V62, P2016, DOI 10.1128/JVI.62.6.2016-2025.1988; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZOLLER MJ, 1987, METHOD ENZYMOL, V154, P329	44	58	58	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					665	672						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577868				2022-12-28	WOS:A1988R646000007
J	ZECHEL, C; SCHLEENBECKER, U; ANDERS, A; ANDERS, F				ZECHEL, C; SCHLEENBECKER, U; ANDERS, A; ANDERS, F			V-ERBB RELATED SEQUENCES IN XIPHOPHORUS THAT MAP TO MELANOMA DETERMINING MENDELIAN LOCI AND OVEREXPRESS IN A MELANOMA CELL-LINE	ONCOGENE			English	Article											ZECHEL, C (corresponding author), UNIV GIESSEN,INST GENET,D-6300 GIESSEN,FED REP GER.							AHUJA MR, 1979, EXPERIENTIA, V35, P28, DOI 10.1007/BF01917856; ANDERS A, 1978, BIOCHIM BIOPHYS ACTA, V516, P61, DOI 10.1016/0304-419X(78)90004-5; Anders A., 1973, P33; ANDERS A, 1985, PIGMENT CELL 1985, P315; ANDERS F, 1967, EXPERIENTIA, V23, P1, DOI 10.1007/BF02142235; ANDERS F, 1984, ADV CANCER RES, V42, P191, DOI 10.1016/S0065-230X(08)60459-5; ANDERS F, 1985, MODERN TRENDS HUMAN, V4, P228; ANDERS F, 1982, BIOCH DIFFERENTIATIO, P91; Anders F., 1987, CUTANEOUS MELANOMA, P351; ANDERS F, 1980, SKIN VERTEBRATES, P211; ANDERS F, 1981, SHORT TERM TESTS CHE, P399; ATZ JAMES W., 1962, ZOOLOGICA [NEW YORK], V47, P153; BARNEKOW A, 1982, CANCER RES, V42, P2429; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Breider H, 1938, Z WISS ZOOL ABT A, V151, P243; CARPENTER G, 1983, P NATL ACAD SCI-BIOL, V80, P5627, DOI 10.1073/pnas.80.18.5627; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHROMCZYNSKI P, 1984, BIOCHEM BIOPH RES CO, V122, P340; FRISCHAUF AM, 1980, NUCLEIC ACIDS RES, V8, P5541, DOI 10.1093/nar/8.23.5541; GORDON M, 1963, FISHES LABORTORY ANI, P345; GORDON M, 1959, PIGMENT CELL BIOL, P215; GORDON M, 1947, J NATL CANCER I, V7, P87; GUO LH, 1983, NUCLEIC ACIDS RES, V11, P5521, DOI 10.1093/nar/11.16.5521; HENZE M, 1977, COMP BIOCH PHYSL B, V56, P33; HUNTER T, 1984, JNCI-J NATL CANCER I, V73, P773; HUNTER T, 1986, NATURE, V322, P14, DOI 10.1038/322014a0; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; Kallman K.D., 1975, P81; KERSTEN H, 1983, BIOCH CLIN ASPECTS P, P367; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOLLINGER G, 1979, J CANCER RES CLIN, V95, P239, DOI 10.1007/BF00410645; KUHN C, 1979, IN VITRO CELL DEV B, V15, P537, DOI 10.1007/BF02618156; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; Maniatis T., 1982, MOL CLONING; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; Radda A.C., 1980, Aquaria (St Gallen), V27, P39; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; REYNOLDS FH, 1981, NATURE, V292, P259, DOI 10.1038/292259a0; ROSEN D E, 1979, Bulletin of the American Museum of Natural History, V162, P267; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHARTL M, 1985, INT J CANCER, V36, P199, DOI 10.1002/ijc.2910360212; SCHARTL M, 1982, CANCER RES, V42, P4222; SCHWAB M, 1978, EXPERIENTIA, V34, P780, DOI 10.1007/BF01947324; SCHWAB M, 1981, NEOPLASMA COMP PATHO, P451; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; STERNBERG N, 1977, GENE, V1, P255, DOI 10.1016/0378-1119(77)90049-X; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VENNSTROM B, 1980, J VIROL, V36, P575; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VIELKIND U, 1977, Z KREBSFORSCHUNG, V80, P285; WAKAMATSU Y, 1981, CANCER RES, V41, P679; XU YH, 1984, P NATL ACAD SCI-BIOL, V81, P7308, DOI 10.1073/pnas.81.23.7308; YAMAMOTO T, 1983, CELL, V35, P71, DOI 10.1016/0092-8674(83)90209-X; YAMAMOTO T, 1986, CANCER RES, V46, P414; Zander C. D., 1967, Mitteilungen der Hamburgischen Zoologischen Museum und Institut, V64, P87; ZANDER C D, 1969, Mitteilungen aus dem Hamburgischen Zoologischen Museum und Institut, V66, P241	61	49	50	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1988	3	5					605	617						13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R5163	2484016				2022-12-28	WOS:A1988R516300018
J	YANG, XM; WALTER, G				YANG, XM; WALTER, G			SPECIFIC KINASE-ACTIVITY AND PHOSPHORYLATION STATE OF PP60C-SRC FROM NEUROBLASTOMAS AND FIBROBLASTS	ONCOGENE			English	Article											YANG, XM (corresponding author), UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093, USA.							BARNEKOW A, 1984, MOL CELL BIOL, V4, P1179, DOI 10.1128/MCB.4.6.1179; BARNEKOW A, 1986, EMBO J, V5, P701, DOI 10.1002/j.1460-2075.1986.tb04270.x; BARNEKOW A, 1984, BIOCHIM BIOPHYS ACTA, V727, P94; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOLEN JB, 1985, P NATL ACAD SCI USA, V82, P7275, DOI 10.1073/pnas.82.21.7275; BRUGGE J, 1987, GENE DEV, V1, P287, DOI 10.1101/gad.1.3.287; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CARTWRIGHT CA, 1986, MOL CELL BIOL, V6, P1562, DOI 10.1128/MCB.6.5.1562; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLETT MS, 1979, J VIROL, V29, P770, DOI 10.1128/JVI.29.2.770-781.1979; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COUSSENS PM, 1985, MOL CELL BIOL, V5, P2753, DOI 10.1128/MCB.5.10.2753; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; GOULD KL, 1988, IN PRESS MOL CELL BI; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; JACOBS C, 1983, CANCER RES, V43, P1696; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOCH W, 1986, MOL CELL BIOL, V6, P1866, DOI 10.1128/MCB.6.6.1866; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MATTEN WT, 1987, BIOCHEM J, V248, P691, DOI 10.1042/bj2480691; OPPERMANN H, 1979, P NATL ACAD SCI USA, V76, P1804, DOI 10.1073/pnas.76.4.1804; OSHAUGHNESSY J, 1987, ONCOGENE RES, V2, P1; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; PURCHIO AF, 1983, MOL CELL BIOL, V3, P1589, DOI 10.1128/MCB.3.9.1589; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; SCHARTL M, 1982, DIFFERENTIATION, V23, P109, DOI 10.1111/j.1432-0436.1982.tb01273.x; SCHEIDTMANN KH, 1984, J VIROL, V50, P1; SEEGER RC, 1977, CANCER RES, V37, P1364; SEFTON BM, 1980, P NATL ACAD SCI-BIOL, V77, P2059, DOI 10.1073/pnas.77.4.2059; SHILO BZ, 1981, P NATL ACAD SCI-BIOL, V78, P6789, DOI 10.1073/pnas.78.11.6789; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; SPECTOR DH, 1978, CELL, V13, P381, DOI 10.1016/0092-8674(78)90206-4; STEHELIN D, 1976, NATURE, V260, P170, DOI 10.1038/260170a0; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; WIESTLER OD, 1988, MOL CELL BIOL, V8, P502, DOI 10.1128/MCB.8.1.502	51	20	20	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1988	3	3					237	244						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Q4367	2462704				2022-12-28	WOS:A1988Q436700001
J	JULIUS, MA; STREET, AJ; FAHRLANDER, PD; YANG, JQ; EISENMAN, RN; MARCU, KB				JULIUS, MA; STREET, AJ; FAHRLANDER, PD; YANG, JQ; EISENMAN, RN; MARCU, KB			TRANSLOCATED C-MYC GENES PRODUCE CHIMERIC TRANSCRIPTS CONTAINING ANTISENSE SEQUENCES OF THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS IN MOUSE PLASMACYTOMAS	ONCOGENE			English	Article									SUNY STONY BROOK,DEPT MICROBIOL & PATHOL,STONY BROOK,NY 11794; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Fred Hutchinson Cancer Center	JULIUS, MA (corresponding author), SUNY STONY BROOK,DEPT BIOCHEM,STONY BROOK,NY 11794, USA.				NCI NIH HHS [CA09176, CA36246] Funding Source: Medline; NIGMS NIH HHS [GM26939] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036246, T32CA009176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026939] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ALEXANDER WS, 1987, MOL CELL BIOL, V7, P1436, DOI 10.1128/MCB.7.4.1436; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BRAUN J, 1983, J IMMUNOL, V130, P2113; CALABI F, 1985, EMBO J, V4, P667, DOI 10.1002/j.1460-2075.1985.tb03681.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORCORAN LM, 1985, CELL, V40, P71, DOI 10.1016/0092-8674(85)90310-1; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CROCE CM, 1984, P NATL ACAD SCI-BIOL, V81, P3170, DOI 10.1073/pnas.81.10.3170; DUNNICK W, 1983, P NATL ACAD SCI-BIOL, V80, P7269, DOI 10.1073/pnas.80.23.7269; EICK D, 1985, EMBO J, V4, P3717, DOI 10.1002/j.1460-2075.1985.tb04140.x; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FAHRLANDER PD, 1985, P NATL ACAD SCI USA, V82, P3746, DOI 10.1073/pnas.82.11.3746; FAHRLANDER PD, 1985, EMBO J, V4, P3195, DOI 10.1002/j.1460-2075.1985.tb04065.x; FAHRLANDER PD, 1986, ONCOGENES GROWTH CON, P264; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; FALKNER FG, 1986, NUCLEIC ACIDS RES, V14, P8819, DOI 10.1093/nar/14.22.8819; GERONDAKIS S, 1984, CELL, V36, P973, DOI 10.1016/0092-8674(84)90047-3; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GROSSCHEDL R, 1985, CELL, V41, P479; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; KAKKIS E, 1986, MOL CELL BIOL, V6, P1357, DOI 10.1128/MCB.6.4.1357; KEATH EJ, 1984, CELL, V37, P521, DOI 10.1016/0092-8674(84)90382-9; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; KLEIN G, 1983, CELL, V32, P311, DOI 10.1016/0092-8674(83)90449-X; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515; MANIATIS T, 1982, MOL CLONING LABORATO; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MARCU KB, 1986, CURRENT TOPICS MICRO, V132, P320; MASON JO, 1985, CELL, V41, P479, DOI 10.1016/S0092-8674(85)80021-0; MESSING J, 1983, METHODS ENZYMOLOGY C, V101; NEUBERGER MS, 1983, NATURE, V305, P240, DOI 10.1038/305240a0; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OLLO R, 1981, P NATL ACAD SCI-BIOL, V78, P2442, DOI 10.1073/pnas.78.4.2442; PARSLOW TG, 1987, SCIENCE, V235, P1498, DOI 10.1126/science.3029871; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; PERRY RP, 1983, CELL, V33, P647, DOI 10.1016/0092-8674(83)90006-5; PONCZ M, 1982, P NATL ACAD SCI-BIOL, V79, P4298, DOI 10.1073/pnas.79.14.4298; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; STANTON LW, 1984, NATURE, V310, P423, DOI 10.1038/310423a0; STANTON LW, 1984, P NATL ACAD SCI-BIOL, V81, P829, DOI 10.1073/pnas.81.3.829; WIRTH T, 1987, NATURE, V329, P174, DOI 10.1038/329174a0; YAMAWAKIKATAOKA Y, 1981, NUCLEIC ACIDS RES, V9, P1365, DOI 10.1093/nar/9.6.1365; YANG JQ, 1985, EMBO J, V4, P1441, DOI 10.1002/j.1460-2075.1985.tb03800.x	57	17	17	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1988	2	5					469	476						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	N4348	2453828				2022-12-28	WOS:A1988N434800008
J	SHAW, P; TARDY, S; BENITO, E; OBRADOR, A; COSTA, J				SHAW, P; TARDY, S; BENITO, E; OBRADOR, A; COSTA, J			OCCURRENCE OF KI-RAS AND P53 MUTATIONS IN PRIMARY COLORECTAL TUMORS	ONCOGENE			English	Article							CHROMOSOME-5 ALLELE LOSS; FAMILIAL POLYPOSIS COLI; SHORT ARM; GENE-MUTATIONS; LONG ARM; CARCINOMAS; ANTIGEN; ONCOGENE; DNA; TRANSFORMATION	Twenty-four colorectal tumors and their paired mucosa were examined for allele loss on chromosomes 5 and 17, using polymerase chain reaction-amplified DNA, and for mutations in the Ki-ras and p53 genes. In addition, 19 benign polyps were analysed for mutations in the p53 gene. RFLP analysis of the long arm of chromosome 5 indicated an allele loss frequency of 47% for malignant tumors, a value somewhat higher than previously observed. Examination of the short arm of chromosome 17 indicated an allele loss of 60%. Sequence analysis of the p53 gene in colorectal tumors indicated that 64% contained a mutation. All tumors showing allele loss on chromosome 17 were mutant for p53, suggesting that mutation of one p53 allele precedes the hemizygotic loss of the wild-type allele. Sequence analysis of the p53 gene in 19 benign polyps, devoid of severe dysplasia, did not reveal any mutants, suggesting that the mutation of one p53 allele is an event that takes place after polyp formation. Ki-ras mutations were observed in 48% of the tumors examined. All tumors which were mutant for Ki-ras, except for one, were also mutant for p53.	EPIDEMIOL UNIT,E-07012 MALLORCA,SPAIN; TUMOR REGISTRY MALLORCA,E-07012 MALLORCA,SPAIN; HOSP SON DURETA ANDREA DORIA,GASTROENTEROL UNIT,E-07014 MALLORCA,SPAIN	Hospital Universitari Son Espases; Hospital Universitari Son Dureta	SHAW, P (corresponding author), UNIV LAUSANNE,INST PATHOL,DIV ONCOL EXPTL,RUE BUGNON 25,CH-1011 LAUSANNE,SWITZERLAND.			Benito Oliver, Enrique/0000-0002-0489-4668				ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BENITO E, 1990, INT J CANCER, V45, P69, DOI 10.1002/ijc.2910450114; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FINDLAY CA, 1989, CELL, V57, P1083; FORESTER K, 1987, NATURE, V327, P298; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; KHAN PM, 1988, HUMAN GENETICS; KLINGER H, 1987, CYTOGENET CELL GENET, V46, P1; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Maniatis T., 1982, MOL CLONING; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MCGRATH JP, 1983, NATURE, V304, P501, DOI 10.1038/304501a0; MILLER C, 1986, NATURE, V319, P783, DOI 10.1038/319783a0; MITCHELL LG, 1989, ANAL BIOCHEM, V178, P239, DOI 10.1016/0003-2697(89)90631-3; MONPEZAT JP, 1988, INT J CANCER, V41, P404, DOI 10.1002/ijc.2910410315; MULERIS M, 1985, CR ACAD SCI III-VIE, P315; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; SAHLI R, 1985, NUCLEIC ACIDS RES, V13, P3617, DOI 10.1093/nar/13.10.3617; SCHIBLER U, 1980, J MOL BIOL, V142, P93, DOI 10.1016/0022-2836(80)90208-9; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; STEWART GD, 1987, NUCLEIC ACIDS RES, V15, P3939, DOI 10.1093/nar/15.9.3939; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WILDRICK DM, 1988, BIOCHEM BIOPH RES CO, V150, P591, DOI 10.1016/0006-291X(88)90434-2	37	85	86	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1991	6	11					2121	2128						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945416				2022-12-28	WOS:A1991GX11900024
J	ITO, E; SWETERLITSCH, LA; TRAN, PBV; RAUSCHER, FJ; NARAYANAN, R				ITO, E; SWETERLITSCH, LA; TRAN, PBV; RAUSCHER, FJ; NARAYANAN, R			INHIBITION OF PC-12 CELL-DIFFERENTIATION BY THE IMMEDIATE EARLY GENE FRA-1	ONCOGENE			English	Article							NERVE GROWTH-FACTOR; PROTO-ONCOGENE FOS; C-FOS; NEURONAL DIFFERENTIATION; ORNITHINE DECARBOXYLASE; PHEOCHROMOCYTOMA CELLS; NEURITE OUTGROWTH; PC12 CELLS; 3T3 CELLS; JUN	The rat pheochromocytoma cell line (PC-12) offers a powerful in vitro model to study the mechanism of growth factor-induced differentiation and proliferation. Within minutes of addition, agents such as nerve growth factor (NGF), epidermal growth factor (EGF), basic fibroblast growth factor (bFGF) and dibutyryl cyclic AMP (db cAMP) rapidly activate cellular immediate early genes such as c-fos, c-jun, jun-B, and egr-1. fra-1, a member of the immediate early gene family, follows a distinctly later time course of induction than c-fos, c-jun, jun-B, and egr-1, suggesting that fra-1 may attenuate the action of genes induced earlier. We demonstrate that constitutive expression of fra-1 in PC-12 cells results in pronounced inhibition of NGF-induced differentiation. Transcriptional activation of c-fos, c-jun, jun-B, and egr-1 by NGF, EGF, and db cAMP was down-regulated to a varying extent whereas NGF-induced ornithine decarboxylase (ODC) was not affected. Expression of jun-D was not affected in PC-12 fra-1 cells. Transfection of fos and egr-1 promoter-chloramphenicol acetyl transferase (CAT) plasmid into these stable fra-1-expressing PC-12 cells revealed that repression of fos and egr-1 was exerted at the promoter level. Thus deregulated fra-1 expression may inhibit PC-12 cell differentiation by altering the patterns of immediate early gene expression.	HOFFMANN LA ROCHE INC,DEPT MOLEC GENET,340 KINGSLAND ST,NUTLEY,NJ 07110; ROCHE INST MOLEC BIOL,DEPT MOLEC ONCOL & VIROL,NUTLEY,NJ 07110	Roche Holding				Ito, Etsuro/0000-0002-0168-2475; Narayanan, Ramaswamy/0000-0001-9346-9083				BOONSTRA J, 1985, BIOCHIMIE, V67, P1177, DOI 10.1016/S0300-9084(85)80117-6; BRTEL DP, 1989, GENE DEV, V3, P304; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1982, J VIROL, V42, P114, DOI 10.1128/JVI.42.1.114-122.1982; Curran T, 1988, ONCOGENE HDB, P307; CURRAN T, 1987, UCLA S MOL CELLULAR, V58, P215; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; FRANZA BR, 1987, ONCOGENE, V1, P213; GIUS D, 1990, MOL CELL BIOL, V10, P4243, DOI 10.1128/MCB.10.8.4243; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENE LA, 1978, NATURE, V276, P191, DOI 10.1038/276191a0; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; HICKOK NJ, 1986, P NATL ACAD SCI USA, V83, P594, DOI 10.1073/pnas.83.3.594; ITO E, 1990, CELL REGUL, V1, P347, DOI 10.1091/mbc.1.4.347; ITO E, 1989, ONCOGENE, V4, P1193; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MARUYAMA K, 1987, ONCOGENE, V1, P361; MATSUI M, 1990, ONCOGENE, V5, P249; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NARAYANAN R, 1989, EXP HEMATOL, V17, P832; NISHINA H, 1990, P NATL ACAD SCI USA, V87, P3619, DOI 10.1073/pnas.87.9.3619; NOMURA N, 1990, NUCLEIC ACIDS RES, V18, P3047, DOI 10.1093/nar/18.10.3047; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RYDEL RE, 1987, J NEUROSCI, V7, P3639; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	49	25	26	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1755	1760						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2178237				2022-12-28	WOS:A1990ET43600003
J	FUKUMOTO, Y; KAIBUCHI, K; HORI, Y; FUJIOKA, H; ARAKI, S; UEDA, T; KIKUCHI, A; TAKAI, Y				FUKUMOTO, Y; KAIBUCHI, K; HORI, Y; FUJIOKA, H; ARAKI, S; UEDA, T; KIKUCHI, A; TAKAI, Y			MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL TYPE OF REGULATORY PROTEIN (GDI) FOR THE RHO PROTEINS, RAS P21-LIKE SMALL GTP-BINDING PROTEINS	ONCOGENE			English	Article									KOBE UNIV,SCH MED,DEPT BIOCHEM,KOBE 650,JAPAN	Kobe University								ADAMVIZI V, 1988, FEBS LETT, V238, P277, DOI 10.1016/0014-5793(88)80496-4; AVRAHAM H, 1989, MOL CELL BIOL, V9, P2058, DOI 10.1128/MCB.9.5.2058; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOURNE HR, 1986, NATURE, V321, P814, DOI 10.1038/321814a0; BRAUN U, 1989, FEBS LETT, V243, P70, DOI 10.1016/0014-5793(89)81220-7; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; CHARDIN P, 1988, NUCLEIC ACIDS RES, V16, P2717, DOI 10.1093/nar/16.6.2717; CHARDIN P, 1989, EMBO J, V8, P1087, DOI 10.1002/j.1460-2075.1989.tb03477.x; DAYHOFF MO, 1978, NATL BIOMED RES F, V3, P345; FUKUMOTO T, 1990, J BIOL CHEM, V265, P775; GARRETT MD, 1989, J BIOL CHEM, V264, P10; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HALL A, 1986, J BIOL CHEM, V261, P963; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; HENIKOFF S, 1984, GENE, V128, P315; HOSHIJIMA M, 1990, MOL BRAIN RES, V7, P9, DOI 10.1016/0169-328X(90)90067-N; HOSHINO M, 1987, J BIOCHEM-TOKYO, V102, P503, DOI 10.1093/oxfordjournals.jbchem.a122082; HOUSE C, 1987, J BIOL CHEM, V262, P772; ISOMURA M, 1990, IN PRESS BIOCH BIOPH; KAIBUCHI K, 1989, J BIOL CHEM, V264, P13489; KANEHISA M, 1982, NUCLEIC ACIDS RES, V10, P183, DOI 10.1093/nar/10.1.183; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; KIKUCHI A, 1989, J BIOL CHEM, V264, P9133; KIKUCHI A, 1988, J BIOL CHEM, V263, P16303; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KURODA S, 1989, BIOCHEM BIOPH RES CO, V163, P674, DOI 10.1016/0006-291X(89)92276-6; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779; MATSUI Y, 1988, J BIOL CHEM, V263, P11071; MATSUI Y, 1990, BIOCHEM BIOPH RES CO, V166, P1010, DOI 10.1016/0006-291X(90)90911-6; MUNDER T, 1988, MOL GEN GENET, V214, P271, DOI 10.1007/BF00337721; NARUMIYA S, 1988, J BIOL CHEM, V263, P17255; OHGA N, 1989, BIOCHEM BIOPH RES CO, V163, P1523, DOI 10.1016/0006-291X(89)91153-4; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; PIZON V, 1988, ONCOGENE, V3, P201; RUBIN EJ, 1988, MOL CELL BIOL, V8, P418, DOI 10.1128/MCB.8.1.418; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO K, 1989, BIOCHEM BIOPH RES CO, V158, P377, DOI 10.1016/S0006-291X(89)80058-0; SASAKI T, 1990, J BIOL CHEM, V265, P2333; SHOJI I, 1989, BIOCHEM BIOPH RES CO, V162, P273, DOI 10.1016/0006-291X(89)91992-X; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TAKAI Y, 1988, PROGR ENDOCRINOLOGY, V2, P995; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; UEDA T, 1989, BIOCHEM BIOPH RES CO, V159, P1411, DOI 10.1016/0006-291X(89)92267-5; UEDA T, 1990, J BIOL CHEM, V265, P9373; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; YAMAMOTO J, 1990, IN PRESS MOL BRAIN R; YAMAMOTO K, 1988, J BIOL CHEM, V263, P9926; YAMAMOTO T, 1990, IN PRESS J BIOL CHEM; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YERAMIAN P, 1987, NUCLEIC ACIDS RES, V15, P1869, DOI 10.1093/nar/15.4.1869	65	301	304	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1321	1328						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2120668				2022-12-28	WOS:A1990EC24100007
J	MAVROTHALASSITIS, GJ; WATSON, DK; PAPAS, TS				MAVROTHALASSITIS, GJ; WATSON, DK; PAPAS, TS			THE HUMAN ETS-2 GENE PROMOTER - MOLECULAR DISSECTION AND NUCLEASE HYPERSENSITIVITY	ONCOGENE			English	Article											MAVROTHALASSITIS, GJ (corresponding author), NCI,MOLEC ONCOL LAB,FREDERICK,MD 21701, USA.							BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; GOLAY J, 1988, CELL, V55, P1147, DOI 10.1016/0092-8674(88)90259-0; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; JOHNSTON BH, 1988, SCIENCE, V241, P1800, DOI 10.1126/science.2845572; KIM SJ, 1989, J BIOL CHEM, V264, P402; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; MACE HAF, 1983, NATURE, V304, P555, DOI 10.1038/304555a0; Maniatis T., 1982, MOL CLONING; MAVROTHALASSITIS GJ, 1990, P NATL ACAD SCI USA, V87, P1047, DOI 10.1073/pnas.87.3.1047; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; PAVLOVIC B, 1988, MOL CELL BIOL, V8, P5513, DOI 10.1128/MCB.8.12.5513; SETH A, 1989, P NATL ACAD SCI USA, V86, P7833, DOI 10.1073/pnas.86.20.7833; THANOS D, 1988, P NATL ACAD SCI USA, V85, P3075, DOI 10.1073/pnas.85.9.3075; VOLOSHIN ON, 1988, NATURE, V333, P475, DOI 10.1038/333475a0; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WEINTRAUB H, 1983, CELL, V32, P1191, DOI 10.1016/0092-8674(83)90302-1; YU YT, 1986, CELL, V45, P743, DOI 10.1016/0092-8674(86)90788-9; YUAN CC, 1989, J VIROL, V63, P205, DOI 10.1128/JVI.63.1.205-215.1989	27	27	27	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1337	1342						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216458				2022-12-28	WOS:A1990EC24100009
J	CLEMENTI, E; MALGARETTI, N; MELDOLESI, J; TARAMELLI, R				CLEMENTI, E; MALGARETTI, N; MELDOLESI, J; TARAMELLI, R			A NEW CONSTITUTIVELY ACTIVATING MUTATION OF THE GS PROTEIN ALPHA-SUBUNIT-GSP ONCOGENE IS FOUND IN HUMAN PITUITARY-TUMORS	ONCOGENE			English	Note									UNIV MILANO,DEPT GENET & BIOL MICROORGANISMS,I-20132 MILAN,ITALY	University of Milan	CLEMENTI, E (corresponding author), UNIV MILANO,SCI INST S RAFFAELE,CNR,CTR CYTOPHARMACOL,DEPT PHARMACOL,VIA OLGETTINA 60,I-20132 MILAN,ITALY.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BILLESTRUP N, 1986, P NATL ACAD SCI USA, V83, P6854, DOI 10.1073/pnas.83.18.6854; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P15475; KOZASA T, 1988, P NATL ACAD SCI USA, V85, P2081, DOI 10.1073/pnas.85.7.2081; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MASTERS SB, 1989, J BIOL CHEM, V264, P15467; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SPADA A, 1984, ENDOCRINOLOGY, V115, P1203, DOI 10.1210/endo-115-3-1203; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0	18	97	99	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1059	1061						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115641				2022-12-28	WOS:A1990DP41500016
J	PRESS, MF; CORDONCARDO, C; SLAMON, DJ				PRESS, MF; CORDONCARDO, C; SLAMON, DJ			EXPRESSION OF THE HER-2/NEU PROTOONCOGENE IN NORMAL HUMAN ADULT AND FETAL TISSUES	ONCOGENE			English	Article									MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	PRESS, MF (corresponding author), UNIV SO CALIF,DEPT PATHOL,2011 ZONAL AVE,LOS ANGELES,CA 90033, USA.				NATIONAL CANCER INSTITUTE [R01CA047538, U01CA047538, R01CA048780] Funding Source: NIH RePORTER; NCI NIH HHS [CA471779, CA48780, CA47538] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTOW S, 1989, LAB INVEST, V62, pA8; COHEN JA, 1989, ONCOGENE, V4, P81; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; GUSTERSON BA, 1988, MOL CELL PROBE, V2, P383; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MORI S, 1989, LAB INVEST, V61, P93; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PRESS MF, 1986, AM J PATHOL, V123, P280; PRESS MF, 1988, AM J PATHOL, V131, P112; PRESS MF, 1984, LAB INVEST, V51, P495; PRESS MF, 1984, LAB INVEST, V50, P480; PRESS MF, 1988, ENDOCRINOLOGY, V122, P1165, DOI 10.1210/endo-122-3-1165; QUIRKE P, 1989, BRIT J CANCER, V60, P64, DOI 10.1038/bjc.1989.221; RO J, 1989, CANCER RES, V49, P6941; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1989, CANCER CEL, V7, P371; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1988, SCIENCE, V240, P1796, DOI 10.1126/science.240.4860.1796; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; WRIGHT C, 1989, CANCER RES, V49, P2087	33	548	604	1	15	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					953	962						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973830				2022-12-28	WOS:A1990DP41500002
J	BORDEREAUX, D; FICHELSON, S; TAMBOURIN, P; GISSELBRECHT, S				BORDEREAUX, D; FICHELSON, S; TAMBOURIN, P; GISSELBRECHT, S			ALTERNATIVE SPLICING OF THE EVI-1 ZINC FINGER GENE GENERATES MESSENGER-RNAS WHICH DIFFER BY THE NUMBER OF ZINC FINGER MOTIFS	ONCOGENE			English	Note									HOP COCHIN,INSERM,U152,IMMUNOL & ONCOL MALAD RETROVIRALES LAB,F-75674 PARIS 14,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite								BARTHOLOMEW C, 1989, ONCOGENE, V4, P529; BORDEREAUX D, 1987, J VIROL, V61, P4043, DOI 10.1128/JVI.61.12.4043-4045.1987; CHAVRIER P, 1989, MOL CELL BIOL, V9, P787, DOI 10.1128/MCB.9.2.787; CUYPERS HT, 1984, CELL, V37, P141; FUNG YKT, 1983, CELL, V33, P357, DOI 10.1016/0092-8674(83)90417-8; GISSELBRECHT S, 1987, NATURE, V329, P259, DOI 10.1038/329259a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HEARD JM, 1983, INT J CANCER, V32, P237, DOI 10.1002/ijc.2910320216; LAROSA GJ, 1988, MOL CELL BIOL, V8, P3906, DOI 10.1128/MCB.8.9.3906; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MORISHITA K, 1988, CELL, V54, P831, DOI 10.1016/S0092-8674(88)91175-0; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; OCONNOR MB, 1988, EMBO J, V7, P435, DOI 10.1002/j.1460-2075.1988.tb02831.x; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; SOLA B, 1988, J VIROL, V62, P3973, DOI 10.1128/JVI.62.11.3973-3978.1988; SOLA B, 1986, J VIROL, V60, P718, DOI 10.1128/JVI.60.2.718-725.1986; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4	19	52	52	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					925	927						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2113669				2022-12-28	WOS:A1990DP55300021
J	SPENCER, CA; GROUDINE, M				SPENCER, CA; GROUDINE, M			TRANSCRIPTION ELONGATION AND EUKARYOTIC GENE-REGULATION	ONCOGENE			English	Review									UNIV WASHINGTON, SCH MED, DEPT RADIAT ONCOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	SPENCER, CA (corresponding author), FRED HUTCHINSON CANC RES CTR, 1124 COLUMBIA ST, SEATTLE, WA 98104 USA.				NATIONAL CANCER INSTITUTE [P01CA028151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI027291] Funding Source: NIH RePORTER; NCI NIH HHS [CA 28151] Funding Source: Medline; NIAID NIH HHS [AI 27291] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHEARN JM, 1987, J BIOL CHEM, V262, P10695; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BACHMANN M, 1990, CELL, V60, P85, DOI 10.1016/0092-8674(90)90718-T; BARIK S, 1987, CELL, V50, P885, DOI 10.1016/0092-8674(87)90515-0; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; BEAR DG, 1988, TRENDS BIOCHEM SCI, V13, P343, DOI 10.1016/0968-0004(88)90104-1; BENDER TP, 1988, CURR TOP MICROBIOL, V141, P324; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BENGAL E, 1989, J BIOL CHEM, V264, P18926; BENGAL E, 1989, J BIOL CHEM, V264, P9791; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; CHAMBERLIN M, 1989, ADV ONCOLOGY, V4, P2; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; CHINSKY JM, 1989, J BIOL CHEM, V264, P14561; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CONNELLY S, 1989, MOL CELL BIOL, V9, P5254, DOI 10.1128/MCB.9.11.5254; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; DEVEGVAR HEN, 1986, CELL, V47, P259; EICK D, 1987, ONCOGENE, V2, P61; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; FLORES O, 1989, J BIOL CHEM, V264, P8913; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; GOTTLIEB E, 1989, EMBO J, V8, P851, DOI 10.1002/j.1460-2075.1989.tb03446.x; GOURSE RL, 1986, CELL, V44, P197, DOI 10.1016/0092-8674(86)90498-8; GRAYHACK EJ, 1985, CELL, V42, P259, DOI 10.1016/S0092-8674(85)80121-5; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HAY N, 1982, CELL, V29, P183, DOI 10.1016/0092-8674(82)90102-7; HAY N, 1985, MOL CELL BIOL, V5, P1327, DOI 10.1128/MCB.5.6.1327; HERNANDEZ N, 1986, CELL, V47, P249, DOI 10.1016/0092-8674(86)90447-2; HERNANDEZ N, 1988, EMBO J, V7, P3125, DOI 10.1002/j.1460-2075.1988.tb03179.x; HORWITZ RJ, 1987, CELL, V51, P631, DOI 10.1016/0092-8674(87)90132-2; JAKOBOVITS A, 1988, MOL CELL BIOL, V8, P2555, DOI 10.1128/MCB.8.6.2555; JOHNSTON JM, 1985, J VIROL, V56, P378, DOI 10.1128/JVI.56.2.378-385.1985; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; KESSLER M, 1989, GENE, V84, P65, DOI 10.1016/0378-1119(89)90140-6; KIM WY, 1988, J BIOL CHEM, V263, P18880; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; KURODA MI, 1986, J BACTERIOL, V167, P792, DOI 10.1128/jb.167.3.792-798.1986; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LATTIER DL, 1989, NUCLEIC ACIDS RES, V17, P1061, DOI 10.1093/nar/17.3.1061; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; MADERIOUS A, 1984, P NATL ACAD SCI-BIOL, V81, P5931, DOI 10.1073/pnas.81.19.5931; MAHADEVAN S, 1987, CELL, V50, P485, DOI 10.1016/0092-8674(87)90502-2; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCGEADY ML, 1986, DNA-J MOLEC CELL BIO, V5, P289, DOI 10.1089/dna.1986.5.289; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; MIDDLETON KM, 1990, MOL CELL BIOL, V10, P727, DOI 10.1128/MCB.10.2.727; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; MORGAN EA, 1986, J BACTERIOL, V168, P1; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; PARRY HD, 1989, NUCLEIC ACIDS RES, V17, P3633, DOI 10.1093/nar/17.10.3633; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; RAMAMURTHY V, 1990, MOL CELL BIOL, V10, P1484, DOI 10.1128/MCB.10.4.1484; RAPPAPORT J, 1987, J BIOL CHEM, V262, P5227; RAPPAPORT J, 1988, MOL CELL BIOL, V8, P3136, DOI 10.1128/MCB.8.8.3136; REDDY CD, 1989, P NATL ACAD SCI USA, V86, P7326, DOI 10.1073/pnas.86.19.7326; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINES D, 1989, J BIOL CHEM, V264, P10799; REZNIKOV O, 1989, J BIOL CHEM, V264, P9953; ROBERT J, 1987, CELL, V51, P483, DOI 10.1016/0092-8674(87)90644-1; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; ROBERTS JW, 1988, CELL, V52, P5, DOI 10.1016/0092-8674(88)90523-5; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SANCAR GB, 1982, CELL, V28, P523, DOI 10.1016/0092-8674(82)90207-0; SCHNEIDERSCHAULIES J, 1987, EUR J IMMUNOL, V17, P713, DOI 10.1002/eji.1830170521; SELBY MJ, 1989, GENE DEV, V3, P547, DOI 10.1101/gad.3.4.547; SELLITTI MA, 1987, P NATL ACAD SCI USA, V84, P3199, DOI 10.1073/pnas.84.10.3199; SHARP PA, 1989, CELL, V59, P229, DOI 10.1016/0092-8674(89)90279-1; SHIMOTSU H, 1986, J BACTERIOL, V166, P461, DOI 10.1128/jb.166.2.461-471.1986; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SIEBERG M, 1987, VIRUS GENES, V1, P97; SKARNES WC, 1988, J MOL BIOL, V203, P153, DOI 10.1016/0022-2836(88)90099-X; SLUDER AE, 1989, J BIOL CHEM, V264, P8963; SOPTA M, 1985, J BIOL CHEM, V260, P353; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; TOMIZAWA J, 1987, CELL, V51, P623, DOI 10.1016/0092-8674(87)90131-0; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; VANDERHOORN F, 1986, NUCLEIC ACIDS RES, V14, P8771, DOI 10.1093/nar/14.22.8771; WARREN F, 1984, P NATL ACAD SCI-BIOL, V81, P3612, DOI 10.1073/pnas.81.12.3612; WATSON RJ, 1988, ONCOGENE, V2, P267; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505; YANG XJ, 1989, P NATL ACAD SCI USA, V86, P5301, DOI 10.1073/pnas.86.14.5301; YANOFSKY C, 1987, TRENDS GENET, V3, P356, DOI 10.1016/0168-9525(87)90297-6; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	104	240	241	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1990	5	6					777	785						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2193290				2022-12-28	WOS:A1990DP55300001
J	BAUM, EZ; BEBERNITZ, GA				BAUM, EZ; BEBERNITZ, GA			K-RAS ONCOGENE EXPRESSION IN XENOPUS-LAEVIS	ONCOGENE			English	Note											BAUM, EZ (corresponding author), AMER CYANAMID CO,LEDERLE LABS,MOLEC BIOL SECT,PEARL RIVER,NY 10965, USA.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BIRCHMEIER C, 1985, CELL, V43, P615, DOI 10.1016/0092-8674(85)90233-8; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; CHANG EH, 1982, P NATL ACAD SCI-BIOL, V79, P4848, DOI 10.1073/pnas.79.16.4848; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; FREEMAN RS, 1989, P NATL ACAD SCI USA, V86, P5805, DOI 10.1073/pnas.86.15.5805; FURTH ME, 1987, ONCOGENE, V1, P47; GODEAU F, 1986, EMBO J, V5, P3571, DOI 10.1002/j.1460-2075.1986.tb04684.x; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; KORN LJ, 1987, SCIENCE, V236, P840, DOI 10.1126/science.3554510; LEGUELLEC R, 1988, NUCLEIC ACIDS RES, V16, P10357; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; MALLER JL, 1977, J BIOL CHEM, V252, P1712; MALLER JL, 1981, DEV BIOL, V85, P309, DOI 10.1016/0012-1606(81)90262-1; Maniatis T., 1982, MOL CLONING; MCCOY MS, 1984, MOL CELL BIOL, V4, P1577, DOI 10.1128/MCB.4.8.1577; MECHALI M, 1988, BIOCHIMIE, V70, P895, DOI 10.1016/0300-9084(88)90230-1; MOREAU J, 1989, ONCOGENE, V4, P443; MULLER R, 1983, MOL CELL BIOL, V3, P1062; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NISHIKURA K, 1987, ONCOGENE RES, V1, P179; NOORDERMEER J, 1989, NUCLEIC ACIDS RES, V17, P11, DOI 10.1093/nar/17.1.11; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; SADLER SE, 1986, MOL CELL BIOL, V6, P719, DOI 10.1128/MCB.6.2.719; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SEGAL D, 1986, MOL CELL BIOL, V6, P2241, DOI 10.1128/MCB.6.6.2241; SOUSSI T, 1987, ONCOGENE, V1, P71; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; STEELE RE, 1989, ONCOGENE RES, V4, P223; STTELE RE, 1989, J BIOL CHEM, V264, P10649; TAYLOR MV, 1986, EMBO J, V5, P3563, DOI 10.1002/j.1460-2075.1986.tb04683.x; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907	37	14	15	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					763	767						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189109				2022-12-28	WOS:A1990DG37400018
J	KESAVAN, P; DAS, P; KERN, J; DAS, M				KESAVAN, P; DAS, P; KERN, J; DAS, M			REGULATION OF STABILITY AND SYNTHESIS OF EGF-RECEPTOR MESSENGER-RNAS ENCODING FOR INTACT AND TRUNCATED RECEPTOR FORMS	ONCOGENE			English	Article									UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania				Kern, Jeffrey/0000-0001-9709-9622	NATIONAL CANCER INSTITUTE [R01CA043787, P01CA015822] Funding Source: NIH RePORTER; NCI NIH HHS [CA-15822, CA-43787] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BJORGE JD, 1989, J BIOL CHEM, V264, P4021; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COHEN S, 1982, J BIOL CHEM, V261, P11247; DEPALO L, 1988, CANCER RES, V48, P1105; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; GRAVES RA, 1987, CELL, V48, P615, DOI 10.1016/0092-8674(87)90240-6; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Maniatis T., 1982, MOL CLONING; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; ROYCHOUDHURY S, 1988, P NATL ACAD SCI USA, V85, P2014, DOI 10.1073/pnas.85.6.2014; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; THOMPSON KL, 1989, J BIOL CHEM, V264, P3230; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WELLS A, 1988, MOL CELL BIOL, V8, P4561, DOI 10.1128/MCB.8.10.4561; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; YAMAMOTO T, 1986, CANCER RES, V46, P414; YEN TJ, 1988, NATURE, V334, P580, DOI 10.1038/334580a0	29	22	24	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					483	488						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2326077				2022-12-28	WOS:A1990DB85300005
J	WADA, T; MYERS, JN; KOKAI, Y; BROWN, VI; HAMURO, J; LEVEA, CM; GREENE, MI				WADA, T; MYERS, JN; KOKAI, Y; BROWN, VI; HAMURO, J; LEVEA, CM; GREENE, MI			ANTIRECEPTOR ANTIBODIES REVERSE THE PHENOTYPE OF CELLS TRANSFORMED BY 2 INTERACTING PROTOONCOGENE ENCODED RECEPTOR PROTEINS	ONCOGENE			English	Article											WADA, T (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,JOHN MORGAN BLDG,36TH & HAMILTON WALK,PHILADELPHIA,PA 19104, USA.							AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; HOUGHTON AN, 1985, P NATL ACAD SCI USA, V82, P1242, DOI 10.1073/pnas.82.4.1242; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8489; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LEBERMANN TA, 1985, NATURE, V313, P144; MEEKER TC, 1985, BLOOD, V65, P1349, DOI 10.1182/blood.V65.6.1349.bloodjournal6561349; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; RODECK U, 1987, CANCER RES, V47, P3692; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; VOLLMERS HP, 1983, P NATL ACAD SCI-BIOL, V80, P6863, DOI 10.1073/pnas.80.22.6863; YAMAMOTO T, 1986, CANCER RES, V46, P414; YOKOTA J, 1986, LANCET, V1, P765	30	37	54	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					489	495						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970151				2022-12-28	WOS:A1990DB85300006
J	GUERIN, M; SHENG, ZM; ANDRIEU, N; RIOU, G				GUERIN, M; SHENG, ZM; ANDRIEU, N; RIOU, G			STRONG ASSOCIATION BETWEEN C-MYB AND ESTROGEN-RECEPTOR EXPRESSION IN HUMAN BREAST-CANCER	ONCOGENE			English	Article									INST GUSTAVE ROUSSY,PHARMACOL CLIN & MOLEC LAB,F-94800 VILLEJUIF,FRANCE; INST GUSTAVE ROUSSY,DEPT STAT MED,F-94800 VILLEJUIF,FRANCE	UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy			ANDRIEU, Nadine/H-4255-2014					ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BARRETTLEE PJ, 1987, CANCER RES, V47, P6653; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; CHU AM, 1980, CANCER, V45, P2730, DOI 10.1002/1097-0142(19800601)45:11<2730::AID-CNCR2820451106>3.0.CO;2-C; CLARK GM, 1983, NEW ENGL J MED, V309, P1343, DOI 10.1056/NEJM198312013092240; CONTESSO G, 1987, J CLIN ONCOL, V5, P1378, DOI 10.1200/JCO.1987.5.9.1378; CRAIG RW, 1984, CANCER RES, V44, P442; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DELARUE JC, 1988, BREAST CANCER RES TR, V11, P173, DOI 10.1007/BF01805841; DICKSON RB, 1988, BREAST CANCER CELLUL, P119; DUBIK D, 1987, CANCER RES, V47, P6517; GRIFFIN CA, 1985, CANCER RES, V45, P272; GUERIN M, 1985, CR ACAD SCI III-VIE, V301, P833; GUERIN M, 1988, CR ACAD SCI III-VIE, V307, P855; GUERIN M, 1989, INT J CANCER, V43, P201, DOI 10.1002/ijc.2910430205; GUERIN M, 1988, ONCOGENE RES, V3, P21; JAKOWLEW SB, 1984, NUCLEIC ACIDS RES, V12, P2861, DOI 10.1093/nar/12.6.2861; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Maniatis T., 1982, MOL CLONING; MODJTAHEDI N, 1985, CANCER RES, V45, P4372; MORISSET M, 1986, BIOCHEM BIOPH RES CO, V138, P102, DOI 10.1016/0006-291X(86)90252-4; MOURALI N, 1982, BRIT J CANCER, V45, P367, DOI 10.1038/bjc.1982.63; MULLER R, 1988, CELLULAR ONCOGENE AC, P1; MURPHY C, 1988, BAILLIERES CLIN ONCO, V2, P117; RIO MC, 1987, P NATL ACAD SCI USA, V84, P9243, DOI 10.1073/pnas.84.24.9243; ROCHEFORT H, 1988, BREAST CANCER CELLUL, P207; ROUESSE J, 1986, J CLIN ONCOL, V4, P1765, DOI 10.1200/JCO.1986.4.12.1765; SAEZ RA, 1988, BAILLIERES CLIN ONCO, V2, P103; SAINSBURY JRC, 1985, LANCET, V1, P364; SLAMON DJ, 1986, SCIENCE, V233, P347, DOI 10.1126/science.3014652; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; THIELE CJ, 1988, MOL CELL BIOL, V8, P1677, DOI 10.1128/MCB.8.4.1677; THOMPSON CB, 1986, NATURE, V319, P374, DOI 10.1038/319374a0; TORELLI G, 1985, MOL CELL BIOL, V5, P2874, DOI 10.1128/MCB.5.10.2874; TORELLI G, 1987, CANCER RES, V47, P5266; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WALTER P, 1985, P NATL ACAD SCI USA, V82, P7889, DOI 10.1073/pnas.82.23.7889; WILDING G, 1988, CANCER RES, V48, P802	38	114	115	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					131	135						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181374				2022-12-28	WOS:A1990CM62000018
J	SANDGREN, EP; QUAIFE, CJ; PINKERT, CA; PALMITER, RD; BRINSTER, RL				SANDGREN, EP; QUAIFE, CJ; PINKERT, CA; PALMITER, RD; BRINSTER, RL			ONCOGENE-INDUCED LIVER NEOPLASIA IN TRANSGENIC MICE	ONCOGENE			English	Article									UNIV WASHINGTON, HOWARD HUGHES MED INST, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	SANDGREN, EP (corresponding author), UNIV PENN, SCH VET MED, REPROD PHYSIOL LAB, ROOM 100E, PHILADELPHIA, PA 19104 USA.			Pinkert, Carl/0000-0001-7460-3881; Brinster, Ralph/0000-0003-1408-7656	NCI NIH HHS [CA 38635] Funding Source: Medline; NICHD NIH HHS [HD 09172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD009172, R01HD009172] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA038635] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; BAETGE EE, 1988, P NATL ACAD SCI USA, V85, P3648, DOI 10.1073/pnas.85.10.3648; BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BEHRINGER RR, 1988, P NATL ACAD SCI USA, V85, P2648, DOI 10.1073/pnas.85.8.2648; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; BRINSTER RL, 1986, HARVEY LECT, V80, P1; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CHAMBERS PL, 1987, MOUSE LIVER TUMORS S, V10; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; DURNAM DM, 1983, ANAL BIOCHEM, V131, P385, DOI 10.1016/0003-2697(83)90188-4; EFRAT S, 1988, NEURON, V1, P605, DOI 10.1016/0896-6273(88)90110-9; FARBER E, 1987, LAB INVEST, V56, P4; FARBER E, 1986, CANCER SURV, V5, P695; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; FRITH CH, 1979, J ENVIRON PATHOL TOX, V3, P329; GUTIERREZ C, 1988, SCIENCE, V240, P1202, DOI 10.1126/science.3287614; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HELD WA, 1989, EMBO J, V8, P183, DOI 10.1002/j.1460-2075.1989.tb03363.x; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; KEW MC, 1986, CANCER SURV, V5, P719; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; KNUDSON AG, 1986, ANNU REV GENET, V20, P231; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MARONPOT RR, 1987, ARCH TOXICOL, P10; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; OBRIEN W, 1986, P NATL ACAD SCI USA, V83, P8659; ORNITZ DM, 1987, SCIENCE, V238, P188, DOI 10.1126/science.2821617; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; REYNOLDS SH, 1986, P NATL ACAD SCI USA, V83, P33, DOI 10.1073/pnas.83.1.33; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SONTAG JM, 1976, NCI CARCINOGENESIS T, V1; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; STUDZINSKI GP, 1988, SCIENCE, V240, P1202, DOI 10.1126/science.240.4856.1202-a; STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; TOOZE J, 1980, MOL BIOL TUMOR VIRUS; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; WEINSTEIN IB, 1987, J CELL BIOCHEM, V33, P213, DOI 10.1002/jcb.240330308; WISEMAN RW, 1986, P NATL ACAD SCI USA, V83, P5825, DOI 10.1073/pnas.83.16.5825; YUSPA SH, 1988, ADV CANCER RES, V50, P25, DOI 10.1016/S0065-230X(08)60434-0; [No title captured]	60	236	239	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1989	4	6					715	724						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543942				2022-12-28	WOS:A1989AA66000007
J	KAPPES, B; ZIEMIECKI, A; MULLER, RG; THEILEN, GH; BAUER, H; BARNEKOW, A				KAPPES, B; ZIEMIECKI, A; MULLER, RG; THEILEN, GH; BAUER, H; BARNEKOW, A			THE TP1 ISOLATE OF FELINE SARCOMA-VIRUS ENCODES A FGR-RELATED ONCOGENE LACKING GAMMA-ACTIN SEQUENCES	ONCOGENE			English	Article									UNIV GIESSEN,INST MED VIROL,FRANKFURTER STR 107,D-6300 GIESSEN,FED REP GER; UNIV BERN,TIEFENAU HOSP,INST CLIN & EXPTL CANC RES,CH-3004 BERN,SWITZERLAND; UNIV CALIF DAVIS,DEPT VET SURG,DAVIS,CA 95616; UNIV CALIF DAVIS,CTR COMPARAT CANC,DAVIS,CA 95616	Justus Liebig University Giessen; University of Bern; University of California System; University of California Davis; University of California System; University of California Davis								ADKINS B, 1982, J VIROL, V43, P448, DOI 10.1128/JVI.43.2.448-455.1982; BARBACID M, 1980, P NATL ACAD SCI-BIOL, V77, P5158, DOI 10.1073/pnas.77.9.5158; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BESMER P, 1983, NATURE, V303, P825, DOI 10.1038/303825a0; BESMER P, 1986, J VIROL, V60, P194, DOI 10.1128/JVI.60.1.194-203.1986; BESMER P, 1983, J VIROL, V46, P606, DOI 10.1128/JVI.46.2.606-613.1983; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; BRUGGE JS, 1981, CELL, V25, P363, DOI 10.1016/0092-8674(81)90055-6; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1988, IN PRESS PEPTIDES PR; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; DELORBE WJ, 1980, J VIROL, V36, P50, DOI 10.1128/JVI.36.1.50-61.1980; DONNER L, 1982, J VIROL, V41, P489, DOI 10.1128/JVI.41.2.489-500.1982; ELDER JH, 1983, J VIROL, V46, P871, DOI 10.1128/JVI.46.3.871-880.1983; FEDELE LA, 1981, P NATL ACAD SCI-BIOL, V78, P4036, DOI 10.1073/pnas.78.7.4036; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GARDNER MB, 1970, NATURE, V226, P807, DOI 10.1038/226807a0; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GUILHOT S, 1987, VIROLOGY, V161, P252, DOI 10.1016/0042-6822(87)90194-2; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAMPE A, 1982, CELL, V30, P775, DOI 10.1016/0092-8674(82)90282-3; HENDERSON IC, 1974, VIROLOGY, V60, P282, DOI 10.1016/0042-6822(74)90386-9; HOHN B, 1977, P NATL ACAD SCI USA, V74, P3259, DOI 10.1073/pnas.74.8.3259; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IKAWA S, 1986, MOL CELL BIOL, V6, P2420, DOI 10.1128/MCB.6.7.2420; IRGENS K, 1973, CR ACAD SCI D NAT, V276, P1783; JOVE R, 1986, J VIROL, V60, P840, DOI 10.1128/JVI.60.3.840-848.1986; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPREVOTTE I, 1984, J VIROL, V50, P884, DOI 10.1128/JVI.50.3.884-894.1984; LIPSICH LA, 1982, MOL CELL BIOL, V2, P875, DOI 10.1128/MCB.2.7.875; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MARTINZANCA D, 1989, IN PRESS MOL CELL BI; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; MCDONOUGH SK, 1971, CANCER RES, V31, P953; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; NAHARRO G, 1983, J VIROL, V47, P611, DOI 10.1128/JVI.47.3.611-619.1983; NAHARRO G, 1983, VIROLOGY, V125, P502, DOI 10.1016/0042-6822(83)90223-4; NECKAMEYER WS, 1985, J VIROL, V53, P879, DOI 10.1128/JVI.53.3.879-884.1985; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; OPPERMANN H, 1981, VIROLOGY, V113, P736, DOI 10.1016/0042-6822(81)90202-6; OSKAM R, 1988, P NATL ACAD SCI USA, V85, P2964, DOI 10.1073/pnas.85.9.2964; OSKARSSON M, 1980, SCIENCE, V207, P1222, DOI 10.1126/science.6243788; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; RASHEED S, 1982, VIROLOGY, V117, P238, DOI 10.1016/0042-6822(82)90522-0; RAYMOND VW, 1987, VIROLOGY, V160, P400, DOI 10.1016/0042-6822(87)90011-0; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUH S, 1985, J BIOL CHEM, V260, P4292; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SEFTON BM, 1986, CURR TOP MICROBIOL, V123, P39; SHERR CJ, 1980, J VIROL, V34, P200, DOI 10.1128/JVI.34.1.200-212.1980; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHUNTARO I, 1986, JPN J CANCER RES, V77, P611; SNYDER HW, 1984, VIROLOGY, V132, P205, DOI 10.1016/0042-6822(84)90104-1; SNYDER SP, 1969, NATURE, V221, P1074, DOI 10.1038/2211074a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; TAKEYA T, 1982, J VIROL, V44, P12, DOI 10.1128/JVI.44.1.12-18.1982; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDEVEN WJM, 1980, VIROLOGY, V101, P185, DOI 10.1016/0042-6822(80)90495-X; VENNSTROM B, 1980, J VIROL, V36, P575; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; ZIEMIECKI A, 1984, VIROLOGY, V138, P324, DOI 10.1016/0042-6822(84)90355-6; ZIEMIECKI A, 1986, VIROLOGY, V151, P265, DOI 10.1016/0042-6822(86)90048-6; ZIEMIECKI A, 1986, BIOCHEM BIOPH RES CO, V138, P1298, DOI 10.1016/S0006-291X(86)80424-7	79	5	5	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					363	372						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2539576				2022-12-28	WOS:A1989U567600013
J	NOGUCHI, T; GALLAND, F; BATOZ, M; MATTEI, MG; BIRNBAUM, D				NOGUCHI, T; GALLAND, F; BATOZ, M; MATTEI, MG; BIRNBAUM, D			ACTIVATION OF A MCF 2 ONCOGENE BY DELETION OF AMINO-TERMINAL CODING SEQUENCES	ONCOGENE			English	Article									EUROPEAN MOLEC BIOL LAB, MEYERHOFSTR 1 POSTFACH 102209, D-6900 HEIDELBERG, GERMANY; INSERM, U119, F-13009 MARSEILLE, FRANCE	European Molecular Biology Laboratory (EMBL); Institut National de la Sante et de la Recherche Medicale (Inserm)				Birnbaum, Daniel/0000-0001-7920-9883				ANSON DS, 1988, EMBO J, V7, P2795, DOI 10.1002/j.1460-2075.1988.tb03134.x; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1987, ONCOGENE, V1, P355; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUKUI M, 1987, MOL CELL BIOL, V7, P1776, DOI 10.1128/MCB.7.5.1776; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; ISHIKAWA F, 1987, MOL CELL BIOL, V7, P1226, DOI 10.1128/MCB.7.3.1226; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; NGUYEN C, 1987, EMBO J, V6, P3285, DOI 10.1002/j.1460-2075.1987.tb02647.x; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; RABIN M, 1987, ONCOGENE RES, V1, P169; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SHIMIZU K, 1985, P NATL ACAD SCI USA, V82, P5641, DOI 10.1073/pnas.82.17.5641; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P291, DOI 10.1016/0165-4608(86)90011-7; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	28	22	23	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1988	3	6					709	715						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577874				2022-12-28	WOS:A1988R646000014
J	ACKRILL, AM; BLAIR, GE				ACKRILL, AM; BLAIR, GE			REGULATION OF MAJOR HISTOCOMPATIBILITY CLASS-I GENE-EXPRESSION AT THE LEVEL OF TRANSCRIPTION IN HIGHLY ONCOGENIC ADENOVIRUS TRANSFORMED RAT-CELLS	ONCOGENE			English	Article									UNIV LEEDS, DEPT BIOCHEM, LEEDS LS2 9JT, W YORKSHIRE, ENGLAND	University of Leeds			Blair, George Eric/A-5906-2008	Blair, George Eric/0000-0003-0440-1795				ANTONIOU M, 1986, HUMAN GENETIC DISEAS, P65; BERNARDS R, 1987, TRENDS GENET, V3, P298, DOI 10.1016/0168-9525(87)90272-1; BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; BRANTON PE, 1984, BIOCHIM BIOPHYS ACTA, V780, P67, DOI 10.1016/0304-419X(84)90007-6; BRICKELL PM, 1985, NATURE, V316, P162, DOI 10.1038/316162a0; COLLINS T, 1986, P NATL ACAD SCI USA, V83, P446, DOI 10.1073/pnas.83.2.446; EAGER KB, 1985, P NATL ACAD SCI USA, V82, P5525, DOI 10.1073/pnas.82.16.5525; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FRIEDMAN DJ, 1988, VIROLOGY, V165, P303, DOI 10.1016/0042-6822(88)90689-7; GOODENOW RS, 1985, SCIENCE, V230, P777, DOI 10.1126/science.2997918; GRAND RJA, 1987, INT J CANCER, V40, P213, DOI 10.1002/ijc.2910400215; HAMMERLING GJ, 1987, BIOCHIM BIOPHYS ACTA, V907, P245, DOI 10.1016/0304-419X(87)90008-4; HARWOOD LMJ, 1975, INT J CANCER, V16, P498, DOI 10.1002/ijc.2910160317; HAYASHI H, 1985, CELL, V43, P263, DOI 10.1016/0092-8674(85)90031-5; HOUWELING A, 1980, VIROLOGY, V105, P537, DOI 10.1016/0042-6822(80)90054-9; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; KUSHTAI G, 1988, ONCOGENE, V2, P119; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MANIATIS T, 1982, MOL CLONING LABORATO; Mellor A L, 1986, Oxf Surv Eukaryot Genes, V3, P95; MINTY AJ, 1983, J MOL BIOL, V167, P77, DOI 10.1016/S0022-2836(83)80035-7; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; RASKA K, 1980, INT J CANCER, V26, P79, DOI 10.1002/ijc.2910260113; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; Roeder R.G., 1976, RNA POLYMERASE, P285; ROSA IM, 1986, INTERFERON, V7, P47; SAWADA Y, 1985, VIROLOGY, V147, P413, DOI 10.1016/0042-6822(85)90143-6; SAWADA Y, 1986, J EXP MED, V163, P563, DOI 10.1084/jem.163.3.563; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; TANAKA K, 1986, P NATL ACAD SCI USA, V83, P8723, DOI 10.1073/pnas.83.22.8723; VAESSEN RTMJ, 1986, EMBO J, V5, P335, DOI 10.1002/j.1460-2075.1986.tb04217.x; VAESSEN RTMJ, 1987, SCIENCE, V235, P1486, DOI 10.1126/science.3823900; VANDERMEIDE PH, 1986, J GEN VIROL, V67, P1059, DOI 10.1099/0022-1317-67-6-1059; VASAVADA R, 1986, P NATL ACAD SCI USA, V83, P5257, DOI 10.1073/pnas.83.14.5257; VERSTEEG R, 1988, EMBO J, V7, P1023, DOI 10.1002/j.1460-2075.1988.tb02909.x; VOGEL J, 1986, MOL CELL BIOL, V6, P3550, DOI 10.1128/MCB.6.10.3550; WEISS E, 1983, EMBO J, V2, P453, DOI 10.1002/j.1460-2075.1983.tb01444.x; ZAIDELBLAIR ME, 1981, NUCLEIC ACIDS RES, V9, P4547, DOI 10.1093/nar/9.18.4547	39	77	78	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1988	3	4					483	487						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Q7739	2484015				2022-12-28	WOS:A1988Q773900019
J	NIELSCH, U; FOGNANI, C; BABISS, LE				NIELSCH, U; FOGNANI, C; BABISS, LE			ADENOVIRUS E1A-P105(RB) PROTEIN INTERACTIONS PLAY A DIRECT ROLE IN THE INITIATION BUT NOT THE MAINTENANCE OF THE RODENT CELL TRANSFORMED PHENOTYPE	ONCOGENE			English	Article							RETINOBLASTOMA SUSCEPTIBILITY GENE; REGION 1A PROTEINS; LARGE T-ANTIGEN; TYPE-5 ADENOVIRUS; E1A GENE; EXPRESSION; BINDING; PRODUCTS; DNA; POLYPEPTIDES	The morphological transformation of rodent fibroblast cells by adenovirus requires expression of the viral E1A and E1B genes. Recent studies have suggested that one function of the E1A proteins is to interact with and inactivate specific cellular proteins (anti-oncoproteins) that maintain regulated cell growth. One candidate cellular protein that may be influenced by its interaction with the E1A oncoproteins is the retinoblastoma (Rb) susceptibility gene product. In this report we show that over-expressing the human Rb protein in two rodent fibroblast cell lines leads to a significant reduction in the frequency of focus-formation following adenovirus infection. Therefore, Rb-E1A protein interactions play an important role in the initiation of cellular transformation by adenovirus. Using cell lines which are conditionally transformed by adenovirus mutants which fail to express the E1A 289R protein, we show that the process leading to a loss of the maintenance of the transformed cell phenotype is not associated with changes in the levels of E1A-Rb protein complexes. These observations suggest distinct roles of Rb-E1A interactions in initiating and maintaining the transformed cell phenotype. Finally, in contrast to results with the SV40 large T Ag, we find that E1A protein expression has no affect on cellular Rb gene expression in both virus-infected and virus-transformed cell lines.	ROCKEFELLER UNIV,MOLEC CELL BIOL LAB,BOX 279,1230 YORK AVE,NEW YORK,NY 10021	Rockefeller University	BABISS, LE (corresponding author), ROCKEFELLER UNIV,MOLEC CELL BIOL LAB,BOX 279,1230 YORK AVE,NEW YORK,NY 10021, USA.				NATIONAL CANCER INSTITUTE [R29CA048707] Funding Source: NIH RePORTER; NCI NIH HHS [CA48707-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMI GR, 1990, J VIROL, V64, P3427, DOI 10.1128/JVI.64.7.3427-3436.1990; BABISS LE, 1983, P NATL ACAD SCI-BIOL, V80, P1352, DOI 10.1073/pnas.80.5.1352; BABISS LE, 1986, P NATL ACAD SCI USA, V83, P2167, DOI 10.1073/pnas.83.7.2167; BERNARDS R, 1989, P NATL ACAD SCI USA, V86, P6474, DOI 10.1073/pnas.86.17.6474; COSTA RH, 1986, MOL CELL BIOL, V6, P4697, DOI 10.1128/MCB.6.12.4697; EGAN C, 1988, MOL CELL BIOL, V8, P3955, DOI 10.1128/MCB.8.9.3955; EGAN C, 1989, ONCOGENE, V4, P383; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; FISHER PB, 1982, P NATL ACAD SCI-BIOL, V79, P3527, DOI 10.1073/pnas.79.11.3527; FLINT J, 1989, ANNU REV GENET, V23, P141, DOI 10.1146/annurev.genet.23.1.141; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Ginsberg HS, 1984, ADENOVIRUSES; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HARRISON T, 1977, VIROLOGY, V77, P319, DOI 10.1016/0042-6822(77)90428-7; HEARING P, 1983, CELL, V33, P292; HERBST RS, 1988, J VIROL, V62, P4634, DOI 10.1128/JVI.62.12.4634-4643.1988; HO YS, 1982, VIROLOGY, V122, P109, DOI 10.1016/0042-6822(82)90381-6; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MONTELL C, 1984, CELL, V36, P951, DOI 10.1016/0092-8674(84)90045-X; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MORITSUKA T, 1989, ONCOGENE RES, V5, P155; WEINBERG RA, 1990, TRENDS BIOCHEM SCI, V15, P199, DOI 10.1016/0968-0004(90)90162-5; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEE SP, 1985, VIROLOGY, V147, P142, DOI 10.1016/0042-6822(85)90234-X	30	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					1031	1036						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067843				2022-12-28	WOS:A1991GU62200019
J	PIM, D; BANKS, L				PIM, D; BANKS, L			LOSS OF HPV-16 E7 DEPENDENCE IN CELLS TRANSFORMED BY HPV-16 E7 PLUS EJ-RAS CORRELATES WITH INCREASED C-MYC EXPRESSION	ONCOGENE			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; RETINOBLASTOMA GENE-PRODUCT; CERVICAL-CARCINOMA; ADENOVIRUS E1A; ACTIVATED RAS; MOUSE CELLS; DNA; PROTEIN; ONCOGENE; SEQUENCES	We have previously shown that continued expression of the HPV-16 E7 gene was required to maintain the transformed phenotype of primary baby rat kidney cells transformed by HPV-16 E7 plus EJ-ras. In this study we aimed to investigate the possible mechanisms by which cells could overcome this continued requirement for E7 expression. Using an inducible system for expression of the E7 gene we were able to generate cell lines no longer dependent on continued E7 expression. All such lines were still fully transformed, maintained inducible E7 expression and showed increased proliferative activity in the presence of HPV-16 E7 gene product. Further analysis has demonstrated a marked increase in the presence of c-myc protein in these cell lines when compared with the parental cells, suggesting a possible mechanism by which E7 dependence can be overcome.	INT CTR GENET ENGN & BIOTECHNOL, PADRICIANO 99, I-34012 TRIESTE, ITALY	International Center for Genetic Engineering & Biotechnology (ICGEB)								ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; BANKS L, 1988, VIROLOGY, V165, P326, DOI 10.1016/0042-6822(88)90695-2; BANKS L, 1990, ONCOGENE, V5, P833; BANKS L, 1990, ONCOGENE, V5, P1383; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CROOK T, 1989, P NATL ACAD SCI USA, V86, P5713, DOI 10.1073/pnas.86.15.5713; CROOK T, 1989, EMBO J, V8, P513, DOI 10.1002/j.1460-2075.1989.tb03405.x; CROOK T, 1989, MOL CARCINOGEN, V2, P308, DOI 10.1002/mc.2940020605; CROOK T, 1988, P NATL ACAD SCI USA, V85, P8820, DOI 10.1073/pnas.85.23.8820; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EDMONDS C, 1989, J VIROL, V63, P2650, DOI 10.1128/JVI.63.6.2650-2656.1989; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; GISSMANN L, 1983, P NATL ACAD SCI-BIOL, V80, P560, DOI 10.1073/pnas.80.2.560; GLOSS B, 1987, EMBO J, V6, P3735, DOI 10.1002/j.1460-2075.1987.tb02708.x; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEES E, 1990, J GEN VIROL, V71, P183, DOI 10.1099/0022-1317-71-1-183; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; MUNGER K, 1989, J VIROL, V63, P4417; OCADIZ R, 1987, CANCER RES, V47, P4173; PATER MM, 1988, NATURE, V335, P832, DOI 10.1038/335832a0; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; RIOU G, 1987, LANCET, V1, P761; SCHNEIDERGADICKE A, 1986, EMBO J, V5, P2285, DOI 10.1002/j.1460-2075.1986.tb04496.x; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPENCE RP, 1988, CANCER RES, V48, P324; STOREY A, 1990, J GEN VIROL, V71, P965, DOI 10.1099/0022-1317-71-4-965; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; VOUSDEN KH, 1988, ONCOGENE RES, V3, P167; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0	34	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1991	6	4					589	594						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030911				2022-12-28	WOS:A1991FR93900013
J	AGUZZI, A; KLEIHUES, P; HECKL, K; WIESTLER, OD				AGUZZI, A; KLEIHUES, P; HECKL, K; WIESTLER, OD			CELL TYPE-SPECIFIC TUMOR-INDUCTION IN NEURAL TRANSPLANTS BY RETROVIRUS-MEDIATED ONCOGENE TRANSFER	ONCOGENE			English	Article							MIDDLE-T-ONCOGENE; EMBRYONAL CARCINOMA-CELLS; CENTRAL NERVOUS-SYSTEM; ROUS SARCOMA VIRUS; TRANSGENIC MICE; EXPRESSION; PP60C-SRC; PROTEIN; VECTOR; DIFFERENTIATION	Using a neural transplantation model which mimics structural and functional properties of the normal rat brain to a high extent, we have taken a novel approach to study the transforming potential of activated oncogenes in the developing brain. Single cell suspensions prepared from fetal rat brains were infected with replication-defective retroviral vectors encoding oncogenes and stereotaxically injected into the caudoputamen of adult F344 rats. Rats carrying transplants expressing the polyoma middle T antigen developed endothelial hemangiomas in the graft which in 70% of the recipient animals led to fatal cerebral hemorrhage within 13-50 days after transplantation. Expression of the v-src gene caused astrocytic and mesenchymal tumors with a 70% incidence after latency periods of 2-6 months, but no endothelial lesions. It was found by in situ hybridization that these oncogenes are expressed in all cell types present in the graft. This indicates that cell-type specific transformation is due to differential susceptibility of the respective target cell to the oncogenes, rather than selective integration or expression of the retroviral construct. The highly efficient gene transfer by retroviral vectors into fetal brain transplants provides a challenging experimental strategy to study differentiation and oncogenesis in the CNS.	UNIV ZURICH, DEPT PATHOL, NEUROPATHOL LAB, SCHMELZBERGSTR 12, CH-8091 ZURICH, SWITZERLAND	University of Zurich			Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				AGUZZI A, 1990, New Biologist, V2, P533; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BAUTCH VL, 1987, CELL, V51, P529, DOI 10.1016/0092-8674(87)90122-X; BIGNER DD, 1977, EXPT TUMORS CENTRAL; BOULTER CA, 1987, NUCLEIC ACIDS RES, V15, P7194, DOI 10.1093/nar/15.17.7194; BOULTER CA, 1988, ONCOGENE, V2, P207; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; BURGER PC, 1988, CANCER RES, V48, P2871; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CEPKO CL, 1989, ANNU REV NEUROSCI, V12, P47, DOI 10.1146/annurev.ne.12.030189.000403; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CLOYD MW, 1975, J NATL CANCER I, V54, P1479, DOI 10.1093/jnci/54.6.1479; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; EDWARDS PAW, 1988, ONCOGENE, V2, P407; GAGE FH, 1984, DEV NEUROSCI-BASEL, V6, P137, DOI 10.1159/000112341; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAGUENAU F, 1971, JNCI-J NATL CANCER I, V46, P539; IVANKOVIC S, 1968, Z KREBSFORSCH KLIN O, V71, P320, DOI 10.1007/BF00524414; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kleihues P, 1976, Int Rev Exp Pathol, V15, P153; KLEIHUES P, 1984, PROG EXP TUMOR RES, V27, P1; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; MONTESANO R, 1990, IN PRESS CELL; PERANTONI AO, 1987, P NATL ACAD SCI USA, V84, P6317, DOI 10.1073/pnas.84.17.6317; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; SMALL JA, 1986, P NATL ACAD SCI USA, V83, P8288, DOI 10.1073/pnas.83.21.8288; STOUT JT, 1985, NATURE, V317, P250, DOI 10.1038/317250a0; STUHLMANN H, 1984, P NATL ACAD SCI-BIOL, V81, P7151, DOI 10.1073/pnas.81.22.7151; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; VICK NA, 1971, J NEUROPATH EXP NEUR, V30, P354, DOI 10.1097/00005072-197107000-00004; WIESTLER OD, 1988, J IMMUNOL METHODS, V110, P153, DOI 10.1016/0022-1759(88)90098-1; WIESTLER OD, 1988, MOL CELL BIOL, V8, P502, DOI 10.1128/MCB.8.1.502; WIESTLER OD, 1988, EXP CELL BIOL, V56, P190; WILLIAMS RL, 1988, CELL, V52, P121; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	41	47	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					113	118						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992439				2022-12-28	WOS:A1991EY03900015
J	CASTELLAZZI, M; DANGY, JP; MECHTA, F; HIRAI, SI; YANIV, M; SAMARUT, J; LASSAILLY, A; BRUN, G				CASTELLAZZI, M; DANGY, JP; MECHTA, F; HIRAI, SI; YANIV, M; SAMARUT, J; LASSAILLY, A; BRUN, G			OVEREXPRESSION OF AVIAN OR MOUSE C-JUN IN PRIMARY CHICK-EMBRYO FIBROBLASTS CONFERS A PARTIALLY TRANSFORMED PHENOTYPE	ONCOGENE			English	Article									INST PASTEUR,DEPT BIOL MOLEC,UNITE VIRUS ONCOGENES,CNRS,URA 152,F-75724 PARIS 15,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	CASTELLAZZI, M (corresponding author), ECOLE NORM SUPER,BIOL MOLEC & CELLULAIRE LAB,CNRS,UMR 49,46 ALLEE ITALIE,F-69364 LYONS 07,FRANCE.		Samarut, Jacques/AAD-2587-2019; MECHTA-GRIGORIOU, Fatima/C-5253-2017; Lassailly, Anne/K-6975-2013	MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; 				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BRUN G, 1989, NUCLEIC ACIDS RES, V17, P6393, DOI 10.1093/nar/17.15.6393; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; FEO S, 1985, NATURE, V313, P493, DOI 10.1038/313493a0; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HANAFUSA H, 1969, P NATL ACAD SCI USA, V63, P318, DOI 10.1073/pnas.63.2.318; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MECHTA F, 1989, New Biologist, V1, P297; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MILLER AD, 1984, CELL, V36, P51; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NISHIMURA T, 1988, ONCOGENE, V3, P659; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SAVATIER P, 1989, J VIROL, V63, P513, DOI 10.1128/JVI.63.2.513-522.1989; SCHUTTE J, 1989, P NATL ACAD SCI USA, V86, P2257, DOI 10.1073/pnas.86.7.2257; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; VOGT PK, 1990, IN PRESS ADV CANCER; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	46	72	72	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1541	1547						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2123532				2022-12-28	WOS:A1990EK50200014
J	PROSSER, J; THOMPSON, AM; CRANSTON, G; EVANS, HJ				PROSSER, J; THOMPSON, AM; CRANSTON, G; EVANS, HJ			EVIDENCE THAT P53 BEHAVES AS A TUMOR SUPPRESSOR GENE IN SPORADIC BREAST-TUMORS	ONCOGENE			English	Article									ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND	Royal Infirmary of Edinburgh	PROSSER, J (corresponding author), WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ATKIN NB, 1989, CANCER GENET CYTOGEN, V37, P229, DOI 10.1016/0165-4608(89)90053-8; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BHATTACHARYYA A, 1989, J MOL BIOL, V209, P583, DOI 10.1016/0022-2836(89)90596-2; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CHUNG R, 1989, American Journal of Human Genetics, V45, pA17; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DEVILEE P, 1989, LANCET, V1, P154; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ELAZOUZI M, 1989, P NATL ACAD SCI USA, V86, P7186, DOI 10.1073/pnas.86.18.7186; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; GENDLER SJ, 1989, P INT ASS BREAST CAN; GENUARDI M, 1989, AM J HUM GENET, V45, P73; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HOYHEIM B, 1989, NUCLEIC ACIDS RES, V17, P8898, DOI 10.1093/nar/17.21.8898; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; JONG P, 1988, P NATL ACAD SCI USA, V85, P3499; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE J H, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P442; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MCCORMICK F, 1981, NATURE, V292, P63, DOI 10.1038/292063a0; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; ROVINSKI B, 1988, ONCOGENE, V2, P445; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SASAKI M, 1989, CANCER RES, V49, P4402; SOUSSI T, 1987, ONCOGENE, V1, P71; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; THOMAS R, 1983, VIROLOGY, V131, P502, DOI 10.1016/0042-6822(83)90516-0; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; TOGUCHIDA J, 1989, CANCER RES, V49, P6247; TSAI YC, 1990, CANCER RES, V50, P44; VARLEY JM, 1989, ONCOGENE, V4, P725; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; YANO T, 1989, J NATL CANCER I, V81, P518, DOI 10.1093/jnci/81.7.518; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	82	211	216	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1573	1579						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250913				2022-12-28	WOS:A1990EK50200018
J	LORD, KA; HOFFMANLIEBERMANN, B; LIEBERMANN, DA				LORD, KA; HOFFMANLIEBERMANN, B; LIEBERMANN, DA			NUCLEOTIDE-SEQUENCE AND EXPRESSION OF A CDNA-ENCODING MYD88, A NOVEL MYELOID DIFFERENTIATION PRIMARY RESPONSE GENE INDUCED BY IL6	ONCOGENE			English	Note									UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104	University of Pennsylvania					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007152] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA043618] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005415] Funding Source: NIH RePORTER; NCI NIH HHS [IROICA43618-01] Funding Source: Medline; NCRR NIH HHS [SO7-RR-05415-28] Funding Source: Medline; NICHD NIH HHS [5T32HD07152] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		FORANCE AJ, 1989, MOL CELL BIOL, V9, P4196; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEE F, 1989, ANN NY ACAD SCI, V5576, P215; LIEBERMANN D, 1980, DEV BIOL, V79, P46, DOI 10.1016/0012-1606(80)90072-X; LIEBERMANN DA, 1989, ONCOGENE, V4, P583; LORD K, 1989, IN PRESS ONCOGENE; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHABO Y, 1988, BLOOD, V72, P1543; VARNUM BC, 1989, ONCOGENE, V4, P119	11	212	233	0	17	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1095	1097						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2374694				2022-12-28	WOS:A1990DP41500024
J	KROLEWSKI, JJ; LEE, R; EDDY, R; SHOWS, TB; DALLAFAVERA, R				KROLEWSKI, JJ; LEE, R; EDDY, R; SHOWS, TB; DALLAFAVERA, R			IDENTIFICATION AND CHROMOSOMAL MAPPING OF NEW HUMAN TYROSINE KINASE GENES	ONCOGENE			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR CANC,NEW YORK,NY 10032; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	Columbia University; Columbia University; Roswell Park Cancer Institute					NCI NIH HHS [CA44029] Funding Source: Medline; NICHD NIH HHS [HD05196] Funding Source: Medline; NIGMS NIH HHS [GM20454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005196] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA044029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020454] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HAO QL, 1989, MOL CELL BIOL, V9, P1587, DOI 10.1128/MCB.9.4.1587; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KAMB A, 1989, P NATL ACAD SCI USA, V86, P4372, DOI 10.1073/pnas.86.12.4372; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LETWIN K, 1988, ONCOGENE, V3, P621; LINDBERG RA, 1988, ONCOGENE, V3, P629; Maniatis T., 1982, MOL CLONING; NISHIZAWA M, 1986, MOL CELL BIOL, V6, P511, DOI 10.1128/MCB.6.2.511; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PAWSON T, 1988, ONCOGENE, V3, P491; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; QUEEN C, 1984, NUCLEIC ACIDS RES, V12, P581, DOI 10.1093/nar/12.1Part2.581; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEREMETIS S, 1989, SCIENCE, V243, P660, DOI 10.1126/science.2536954; SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253; SHOWS TB, 1983, ISOZYMES-CURR T BIOL, V10, P323; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WOOLFORD J, 1985, MOL CELL BIOL, V5, P3458, DOI 10.1128/MCB.5.12.3458; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	38	82	93	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					277	282						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156206				2022-12-28	WOS:A1990CW41500004
J	MATIN, A; CHENG, KL; SUEN, TC; HUNG, MC				MATIN, A; CHENG, KL; SUEN, TC; HUNG, MC			EFFECT OF GLUCOCORTICOIDS ON ONCOGENE TRANSFORMED NIH3T3 CELLS	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center			Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	NATIONAL CANCER INSTITUTE [R01CA045265] Funding Source: NIH RePORTER; NCI NIH HHS [CA-45265] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALI IU, 1977, CELL, V11, P5; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; ENGVALL E, 1972, J IMMUNOL, V109, P129; FURCHT LT, 1979, NATURE, V277, P393, DOI 10.1038/277393a0; FURCHT LT, 1979, CANCER RES, V39, P2077; FURCHT LT, 1978, CELL, V13, P263, DOI 10.1016/0092-8674(78)90195-2; GOFF SP, 1982, J VIROL, V41, P271, DOI 10.1128/JVI.41.1.271-285.1982; HUNG MC, 1986, BIOCHEM BIOPH RES CO, V141, P1109, DOI 10.1016/S0006-291X(86)80158-9; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MAUTNER V, 1977, J CELL BIOL, V75, P743, DOI 10.1083/jcb.75.3.743; OLIVER N, 1983, CELL, V33, P287, DOI 10.1016/0092-8674(83)90357-4; OZANNE B, 1980, J CELL PHYSIOL, V105, P163, DOI 10.1002/jcp.1041050118; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; SHIELDS A, 1979, J VIROL, V31, P557, DOI 10.1128/JVI.31.2.557-567.1979; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; TOOZE J, 1973, MOL BIOL TUMOR VIRUS; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0; YAMADA KM, 1976, P NATL ACAD SCI USA, V73, P1217, DOI 10.1073/pnas.73.4.1217	27	26	26	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					111	116						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181373				2022-12-28	WOS:A1990CM62000015
J	MURAKAMI, Y; ASANO, M; SATAKE, M; ITO, Y				MURAKAMI, Y; ASANO, M; SATAKE, M; ITO, Y			A TUMOR PROMOTING PHORBOL ESTER, TPA, ENHANCES POLYOMAVIRUS DNA-REPLICATION BY ACTIVATING THE FUNCTION OF THE VIRAL ENHANCER	ONCOGENE			English	Article									KYOTO UNIV,DEPT VIRUS RES,SAKYO KU,KYOTO 606,JAPAN	Kyoto University			Murakami, Yota/F-8850-2012					ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAKER TA, 1988, CELL, V55, P113, DOI 10.1016/0092-8674(88)90014-1; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; DEPAMPHILIS ML, 1988, CELL, V52, P635, DOI 10.1016/0092-8674(88)90398-4; DEPAMPHILIS ML, 1986, PAPOVARIRIDAE, P1; DEVILLIERS J, 1984, NATURE, V312, P242, DOI 10.1038/312242a0; FROMENTAL C, 1988, CELL, V54, P943, DOI 10.1016/0092-8674(88)90109-2; Furth M., 1983, LAMBDA 2, P145; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HAI T, 1988, CELL, V54, P1034; HATTON KS, 1988, MOL CELL BIOL, V8, P2149, DOI 10.1128/MCB.8.5.2149; HEARING P, 1983, CELL, V33, P695, DOI 10.1016/0092-8674(83)90012-0; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; IMBRA RJ, 1987, MOL CELL BIOL, V7, P1358, DOI 10.1128/MCB.7.4.1358; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; ITO Y, 1979, VIROLOGY, V98, P261, DOI 10.1016/0042-6822(79)90545-2; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KIMMERLY W, 1988, EMBO J, V7, P2241, DOI 10.1002/j.1460-2075.1988.tb03064.x; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KRYSZKE MH, 1987, NATURE, V328, P254, DOI 10.1038/328254a0; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LUCIBELLO FC, 1988, ONCOGENE, V3, P43; MARINUS MG, 1973, J BACTERIOL, V114, P1143, DOI 10.1128/JB.114.3.1143-1150.1973; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MCMACKEN R, 1988, CANCER CELL, V6, P25; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER WJ, 1988, MOL CELL BIOL, V8, P5000, DOI 10.1128/MCB.8.11.5000; MULLER WJ, 1983, J VIROL, V47, P586, DOI 10.1128/JVI.47.3.586-599.1983; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; ONDEK B, 1988, NATURE, V333, P40, DOI 10.1038/333040a0; ONDEK B, 1987, EMBO J, V6, P1017, DOI 10.1002/j.1460-2075.1987.tb04854.x; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; ONEILL EA, 1988, J BIOL CHEM, V263, P931; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SATAKE M, 1988, ONCOGENE, V3, P69; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; TYNDALL C, 1981, NUCLEIC ACIDS RES, V9, P6231, DOI 10.1093/nar/9.23.6231; VELDMAN GM, 1985, MOL CELL BIOL, V5, P649, DOI 10.1128/MCB.5.4.649; WASYLYK B, 1988, P NATL ACAD SCI USA, V85, P7952, DOI 10.1073/pnas.85.21.7952; WASYLYK C, 1987, CELL, V48, P525, DOI 10.1016/0092-8674(87)90203-0; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; YAMAGUCHI Y, 1989, J VIROL, V63, P1040, DOI 10.1128/JVI.63.3.1040-1048.1989; ZHU Z, 1984, J VIROL, V51, P170, DOI 10.1128/JVI.51.1.170-180.1984	66	36	36	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					5	13						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157181				2022-12-28	WOS:A1990CM62000002
J	DE, BK; SRINIVASAN, A				DE, BK; SRINIVASAN, A			DETECTION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND HUMAN LYMPHOTROPIC VIRUS (HTLV) TYPE-I OR TYPE-II DUAL INFECTIONS BY POLYMERASE CHAIN-REACTION	ONCOGENE			English	Note									WISTAR INST,PHILADELPHIA,PA 19104	The Wistar Institute	DE, BK (corresponding author), CTR DIS CONTROL,RETROVIRUS DIS BRANCH,ATLANTA,GA 30333, USA.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BARTHOLOMEW C, 1987, JAMA-J AM MED ASSOC, V257, P2604, DOI 10.1001/jama.257.19.2604; BLASER MJ, 1986, REV INFECT DIS, V8, P21; CARMAN WF, 1989, J VIROL METHODS, V23, P272; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CURRAN JW, 1985, SCIENCE, V229, P1352, DOI 10.1126/science.2994217; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FOLKS T, 1986, SCIENCE, V231, P600, DOI 10.1126/science.3003906; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GAZDAR AF, 1980, BLOOD, V55, P409; GETCHELL JP, 1987, J INFECT DIS, V155, P612, DOI 10.1093/infdis/155.4.612; GOLDE DW, 1978, BLOOD, V52, P1068; HOXIE JA, 1985, SCIENCE, V229, P1400, DOI 10.1126/science.2994222; KALYANARAMAN VS, 1985, EMBO J, V4, P1455, DOI 10.1002/j.1460-2075.1985.tb03802.x; KANNER SB, 1987, J INFECT DIS, V155, P617, DOI 10.1093/infdis/155.4.617; KLATZMANN D, 1984, SCIENCE, V225, P59, DOI 10.1126/science.6328660; KOBAYASHI N, 1984, EMBO J, V3, P1339, DOI 10.1002/j.1460-2075.1984.tb01974.x; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; KWOK S, 1988, J INFECT DIS, V158, P1193, DOI 10.1093/infdis/158.6.1193; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; Maniatis T., 1982, MOL CLONING; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MOSCA JD, 1987, NATURE, V325, P67, DOI 10.1038/325067a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS G, 1988, HUMAN RETROVIRUSES A; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; RANDO RF, 1987, ONCOGENE, V1, P13; ROBERGUROFF M, 1987, JAMA-J AM MED ASSOC, V255, P3133; ROSENBLATT JD, 1988, SEMIN HEMATOL, V25, P230; SCHOCHETMAN G, 1988, J INFECT DIS, V158, P1154, DOI 10.1093/infdis/158.6.1154; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SRINIVASAN A, 1988, ARCH VIROL, V98, P135; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0	35	28	30	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1989	4	12					1533	1535						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2594369				2022-12-28	WOS:A1989CB65900019
J	CHALIFOUR, LE; GOMES, ML; MESMASSON, AM				CHALIFOUR, LE; GOMES, ML; MESMASSON, AM			MICROINJECTION OF METALLOTHIONEIN-ONCOMODULIN DNA INTO FERTILIZED MOUSE EMBRYOS IS CORRELATED WITH FETAL LETHALITY	ONCOGENE			English	Article									MCGILL UNIV,DEPT MICROBIOL & IMMUNOL,MONTREAL H3A 2B4,QUEBEC,CANADA	McGill University	CHALIFOUR, LE (corresponding author), NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,6100 ROYALMOUNT AVE,MONTREAL H4P 2R2,QUEBEC,CANADA.			Mes-Masson, Anne-Marie/0000-0002-6498-266X				ADAMS JM, 1987, CURRENT COMMUNICATIO, P212; ADAMSON ED, 1986, EXPT APPROACHES MAMM, P449; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; ANDREWS GK, 1984, DEV BIOL, V103, P294, DOI 10.1016/0012-1606(84)90317-8; ANDREWS GK, 1987, DEVELOPMENT, V100, P463; BEDDINGTON R, 1987, P43; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BREWER LM, 1987, PLACENTA, V8, P351, DOI 10.1016/0143-4004(87)90063-4; BREWER LM, 1985, DEV BIOL, V112, P49, DOI 10.1016/0012-1606(85)90117-4; BRINSTER RL, 1982, NATURE, V296, P39, DOI 10.1038/296039a0; CHALIFOUR LE, 1987, GENE DEV, V1, P1096, DOI 10.1101/gad.1.10.1096; CHALIFOUR LE, 1986, J VIROL, V59, P619, DOI 10.1128/JVI.59.3.619-627.1986; CHEN HY, 1986, MOL DEV BIOL, P149; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V13, P2633; COMPERE SJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P129, DOI 10.1016/0304-419X(88)90008-X; CORY S, 1988, ANNU REV IMMUNOL, V6, P25; DEPAMPHILIS ML, 1988, BIOTECHNIQUES, V6, P662; DURKIN JP, 1983, CANCER RES, V43, P5390; GILLEN MF, 1987, J BIOL CHEM, V262, P5308; HAMER DH, 1986, ANNU REV BIOCHEM, V55, P913, DOI 10.1146/annurev.biochem.55.1.913; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANAHAN D, 1986, ONCOGENES GROWTH CON, P349; HEIZMANN CW, 1987, METHOD ENZYMOL, V139, P207; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; KLEE CB, 1984, BIOCHEM BIOPH RES CO, V125, P420, DOI 10.1016/S0006-291X(84)80384-8; MACMANUS JP, 1982, ONCODEV BIOL MED, V3, P79; MACMANUS JP, 1979, CANCER RES, V39, P3000; MACMANUS JP, 1983, CALCIUM CELL FUNCTIO, V4, P411; MESMASSON AM, 1989, IN PRESS J CELL SCI; MULLER R, 1986, TRENDS BIOCHEM SCI, V11, P129, DOI 10.1016/0968-0004(86)90066-6; MUTUS B, 1985, BIOCHEM BIOPH RES CO, V131, P500, DOI 10.1016/0006-291X(85)91830-3; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PFYFFER GE, 1984, P NATL ACAD SCI-BIOL, V81, P6632, DOI 10.1073/pnas.81.21.6632; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; RUTHER U, 1988, CELL, V53, P847, DOI 10.1016/S0092-8674(88)90289-9; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; Shuster J, 1980, Prog Exp Tumor Res, V25, P89; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; WIRAK DO, 1985, MOL CELL BIOL, V5, P2924, DOI 10.1128/MCB.5.11.2924; ZAMCHEK N, 1983, ONCODEVELOPMENTAL MA, P335	44	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1241	1246						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2477784				2022-12-28	WOS:A1989AU50800012
J	GRAY, GM; MACARA, IG				GRAY, GM; MACARA, IG			SERUM-STIMULATED PHOSPHATIDYLINOSITOL TURNOVER IS ENHANCED IN 3T3 CELLS WITH ACTIVE PP60V-SRC	ONCOGENE			English	Article											GRAY, GM (corresponding author), UNIV ROCHESTER,MED CTR,CTR ENVIRONM HLTH SCI,DIV TOXICOL,ROCHESTER,NY 14642, USA.							ARZONIA R, 1984, J MEMBRANE BIOL, V82, P191; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BEDARD PA, 1987, P NATL ACAD SCI USA, V84, P6715, DOI 10.1073/pnas.84.19.6715; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BESTERMAN JM, 1986, J BIOL CHEM, V261, P723; DIRINGER H, 1977, CANCER RES, V37, P2979; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FRY MJ, 1985, EMBO J, V4, P3173, DOI 10.1002/j.1460-2075.1985.tb04061.x; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; GRAY GM, 1988, J BIOL CHEM, V263, P10714; HESLOP JP, 1986, CELL, V47, P703, DOI 10.1016/0092-8674(86)90513-1; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KATO M, 1987, J BIOL CHEM, V262, P5696; MACARA IG, 1985, AM J PHYSIOL, V248, pC3, DOI 10.1152/ajpcell.1985.248.1.C3; MACARA IG, 1984, P NATL ACAD SCI-BIOL, V81, P2728, DOI 10.1073/pnas.81.9.2728; PANET R, 1985, J BIOL CHEM, V260, P5752; PARRIES G, 1987, P NATL ACAD SCI USA, V84, P2648, DOI 10.1073/pnas.84.9.2648; SUGANO S, 1987, CELL, V49, P321, DOI 10.1016/0092-8674(87)90284-4; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0	20	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1213	1217						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2507998				2022-12-28	WOS:A1989AU50800008
J	PULLANO, TG; SINN, E; CARNEY, WP				PULLANO, TG; SINN, E; CARNEY, WP			CHARACTERIZATION OF MONOCLONAL-ANTIBODY R256, SPECIFIC FOR ACTIVATED RAS P21 WITH ARGININE AT 12, AND ANALYSIS OF BREAST-CARCINOMA OF V-HARVEY-RAS TRANSGENIC MOUSE	ONCOGENE			English	Article									HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Harvard University; Harvard Medical School	PULLANO, TG (corresponding author), DUPONT CO,ONCOGENE RES GRP,DEPT MED PROD,N BILLERICA,MA 01862, USA.							ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CARNEY WP, 1986, P NATL ACAD SCI USA, V83, P7485, DOI 10.1073/pnas.83.19.7485; CARNEY WP, 1988, HUMAN TUMOR ANTIGENS, P53; CLARK R, 1985, P NATL ACAD SCI USA, V82, P5280, DOI 10.1073/pnas.82.16.5280; Cooper G M, 1984, Biochim Biophys Acta, V738, P9, DOI 10.1016/0304-419X(84)90017-9; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DER CJ, 1983, CELL, V32, P201, DOI 10.1016/0092-8674(83)90510-X; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FEIG LA, 1987, MOL ENDOCRINOL, V1, P127, DOI 10.1210/mend-1-2-127; FINKEL T, 1984, CELL, V37, P151, DOI 10.1016/0092-8674(84)90310-6; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; GUERRERO I, 1984, P NATL ACAD SCI-BIOL, V81, P202, DOI 10.1073/pnas.81.1.202; KAGAN A, 1979, METHOD HORM RADIOIMM, P327; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; PAPAGEORGE AG, 1986, MOL CELL BIOL, V6, P1843, DOI 10.1128/MCB.6.5.1843; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RODENHUIS S, 1988, CANCER RES, V48, P5738; SANTOS E, 1984, SCIENCE, V223, P661, DOI 10.1126/science.6695174; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P38, DOI 10.1073/pnas.82.1.38; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	32	16	16	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1003	1008						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2474786				2022-12-28	WOS:A1989AJ29700009
J	LIEBERMANN, DA; HOFFMANLIEBERMANN, B				LIEBERMANN, DA; HOFFMANLIEBERMANN, B			PROTO-ONCOGENE EXPRESSION AND DISSECTION OF THE MYELOID GROWTH TO DIFFERENTIATION DEVELOPMENTAL CASCADE	ONCOGENE			English	Article											LIEBERMANN, DA (corresponding author), UNIV PENN,SCH MED,DEPT BIOCHEM & BIOPHYS,PHILADELPHIA,PA 19104, USA.							BARTOCCI A, 1987, P NATL ACAD SCI USA, V84, P6179, DOI 10.1073/pnas.84.17.6179; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BRADLEY TR, 1966, AUST J EXP BIOL MED, V44, P287, DOI 10.1038/icb.1966.28; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; COLLINS SJ, 1987, BLOOD, V70, P1233; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELDMAN RA, 1985, P NATL ACAD SCI USA, V82, P2379, DOI 10.1073/pnas.82.8.2379; FRANCHINI G, 1981, NATURE, V290, P154, DOI 10.1038/290154a0; GEARING DP, 1987, EMBO J, V6, P3995, DOI 10.1002/j.1460-2075.1987.tb02742.x; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GONDA TJ, 1985, EMBO J, V6, P3995; GOWDA SD, 1986, J CLIN INVEST, V77, P271, DOI 10.1172/JCI112287; GROSSO LE, 1985, CANCER RES, V45, P847; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HEARD JM, 1987, CELL, V51, P663, DOI 10.1016/0092-8674(87)90135-8; HEIDORN K, 1987, BLOOD, V70, P456; HOFFMANLIEBERMANN B, 1981, INT J CANCER, V28, P615, DOI 10.1002/ijc.2910280514; HOFFMANLIEBERMANN B, 1978, CELL, V14, P825, DOI 10.1016/0092-8674(78)90338-0; HOFFMANLIEBERMANN B, 1985, MOL CELL BIOL, V5, P991, DOI 10.1128/MCB.5.5.991; HOFFMANLIEBERMANN B, 1981, DEV BIOL, V81, P255, DOI 10.1016/0012-1606(81)90289-X; HOFFMANLIEBERMANN B, 1986, MOL CELL BIOL, V6, P3632, DOI 10.1128/MCB.6.11.3632; HORAK H, 1982, EXP HEMATOL, V10, P123; IHLE JN, 1982, J IMMUNOL, V129, P2431; JAFFE BD, 1988, ONCOGENE, V2, P167; LEE J, 1987, BLOOD, V69, P1542; LIEBERMANN D, 1978, CELL, V15, P823, DOI 10.1016/0092-8674(78)90267-2; LIEBERMANN D, 1982, INT J CANCER, V29, P159, DOI 10.1002/ijc.2910290208; LIEBERMANN D, 1986, MOL CELL BIOL, V6, P218, DOI 10.1128/MCB.6.1.218; LIEBERMANN D, 1980, DEV BIOL, V79, P46, DOI 10.1016/0012-1606(80)90072-X; LIEBERMANN D, 1983, NATURE, V306, P342, DOI 10.1038/306342a0; LIEBERMANN D, 1981, INT J CANCER, V28, P285, DOI 10.1002/ijc.2910280306; LIEBERMANN D, 1977, NATURE, V269, P173, DOI 10.1038/269173a0; LIEBERMANN D, 1979, P NATL ACAD SCI USA, V76, P3353, DOI 10.1073/pnas.76.7.3353; LIEBERMANN D, 1980, VIROLOGY, V107, P121, DOI 10.1016/0042-6822(80)90278-0; LOTEM J, 1988, INT J CANCER, V41, P101, DOI 10.1002/ijc.2910410119; LOTEM J, 1986, EMBO J, V5, P2163, DOI 10.1002/j.1460-2075.1986.tb04480.x; LOTEM J, 1981, INT J CANCER, V28, P375, DOI 10.1002/ijc.2910280318; METCALF D, 1985, CELL, V43, P5, DOI 10.1016/0092-8674(85)90004-2; MITCHELL RL, 1986, CELL, V45, P497, DOI 10.1016/0092-8674(86)90281-3; ONOZAKI K, 1988, J IMMUNOL, V140, P112; ORLOFSKY A, 1987, EMBO J, V6, P2947, DOI 10.1002/j.1460-2075.1987.tb02599.x; PERSSON H, 1984, SCIENCE, V225, P687, DOI 10.1126/science.6431612; PLUZNIK DH, 1965, J CELL COMPAR PHYSL, V66, P319, DOI 10.1002/jcp.1030660309; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; PRYSTOWSKY MB, 1983, EXP HEMATOL, V11, P931; REED JC, 1986, P NATL ACAD SCI USA, V83, P3982, DOI 10.1073/pnas.83.11.3982; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; RESNITZKY D, 1986, CELL, V46, P31, DOI 10.1016/0092-8674(86)90857-3; ROVERA G, 1980, NATURE, V284, P69, DOI 10.1038/284069a0; SACHS L, 1987, SCIENCE, V238, P1374, DOI 10.1126/science.3317831; SAMARUT J, 1985, MOL CELL BIOL, V5, P1067, DOI 10.1128/MCB.5.5.1067; SARBAN E, 1985, NATURE, V316, P64; SCHNEIDER MD, 1987, MOL CELL BIOL, V7, P1973, DOI 10.1128/MCB.7.5.1973; SHABO Y, 1988, INT J CANCER, V41, P622, DOI 10.1002/ijc.2910410424; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; TAKEDA K, 1986, NATURE, V323, P338, DOI 10.1038/323338a0; TRINCHIERI G, 1986, J EXP MED, V164, P1209; WIENSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010; WINTROBE MM, 1981, CLIN HEMATOLOGY, P35	66	92	92	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					583	592						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2471131				2022-12-28	WOS:A1989U768800008
J	KING, CR; BORRELLO, I; PORTER, L; COMOGLIO, P; SCHLESSINGER, J				KING, CR; BORRELLO, I; PORTER, L; COMOGLIO, P; SCHLESSINGER, J			LIGAND-INDEPENDENT TYROSINE PHOSPHORYLATION OF EGF RECEPTOR AND THE ERBB-2/NEU PROTO-ONCOGENE PRODUCT IS INDUCED BY HYPEROSMOTIC SHOCK	ONCOGENE			English	Article									RORER BIOTECHNOL,KING OF PRUSSIA,PA 19406; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL; UNIV TURIN,DIPARTIMENTO SCI BIOMED & ONCOL UMAMA,I-10126 TURIN,ITALY	Weizmann Institute of Science; University of Turin				Comoglio, Paolo/0000-0002-7056-5328; Porter, Laura/0000-0002-4068-1950				AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COCHET C, 1988, J BIOL CHEM, V263, P3290; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; EVELOFF JL, 1987, AM J PHYSIOL, V252, pF1, DOI 10.1152/ajprenal.1987.252.1.F1; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; GECK P, 1985, ANN NY ACAD SCI, V456, P166, DOI 10.1111/j.1749-6632.1985.tb14862.x; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KADOWAKI T, 1987, BIOCHEM BIOPH RES CO, V144, P699, DOI 10.1016/S0006-291X(87)80021-9; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; LALLEMAIN G, 1984, J BIOL CHEM, V259, P5809; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LIVNEH E, 1987, EMBO J, V6, P2669, DOI 10.1002/j.1460-2075.1987.tb02558.x; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2069; SCHULDINER S, 1982, P NATL ACAD SCI-BIOL, V79, P7778, DOI 10.1073/pnas.79.24.7778; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; TAL M, 1988, CANCER RES, V48, P1517; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; XU YH, 1984, NATURE, V309, P806, DOI 10.1038/309806a0; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1985, J BIOL CHEM, V260, P315; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; YOKOTA J, 1986, LANCET, V1, P765; ZIPPEL R, 1986, BIOCHIM BIOPHYS ACTA, V881, P54, DOI 10.1016/0304-4165(86)90096-6	35	38	44	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					13	18						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2464783				2022-12-28	WOS:A1989U567400002
J	ANDRES, AC; BCHINI, O; SCHUBAUR, B; DOLDER, B; LEMEUR, M; GERLINGER, P				ANDRES, AC; BCHINI, O; SCHUBAUR, B; DOLDER, B; LEMEUR, M; GERLINGER, P			H-RAS INDUCED TRANSFORMATION OF MAMMARY EPITHELIUM IS FAVORED BY INCREASED ONCOGENE EXPRESSION OR BY INHIBITION OF MAMMARY REGRESSION	ONCOGENE			English	Article							MILK PROTEIN GENE; HUMAN-BREAST CANCER; TRANSGENIC MICE; HYBRID GENE; MOUSE; PROMOTER; CELLS; ACTIVATION; INDUCTION; TUMORS	The promoter of the mammary specific murine whey acidic protein gene was used to direct Ha-ras expression in different lines of transgenic mice. We found that this promoter contains a tissue specific enhancer which directed expression in both orientations albeit to different levels. We used this feature to generate low and high ras expressing transgenic lines. The reversed orientation led to a weak expression in lines 3 and 58 and to a tumor frequency of 2%. In contrast, 72% of mice from line 25 showing high ras expression developed mammary tumors. Nulliparity is one risk factor for human breast cancer, suggesting a protective effect of post-lactational mammary regression. In order to investigate the effect of post-lactational regression, the low tumor frequency lines were crossed with mice expressing ubiquitously the human growth hormone gene, which induces permanent development of the mammary epithelium. Indeed, mammary tumors were observed in 76% of double transgenic females. Thus, the tumorigenic potential of the ras oncogene in mammary cells in vivo correlates with the level of its expression and with the developmental history of the mammary gland. Transformation coincides with the escape of oncogene expression from the regulation of the Wap promoter and the extinction of endogenous Wap gene expression.	FAC MED STRASBOURG, INST CHIM BIOL,INSERM,CNRS, GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN, F-67085 STRASBOURG, FRANCE; FAC MED STRASBOURG, INST CHIM BIOL, INSERM, UNITE 184 BIOL MOLEC & GENIE GENET, F-67085 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	GERLINGER, P (corresponding author), FAC MED STRASBOURG, INST CHIM BIOL,INSERM,CNRS, GENET MOLEC EUCARYOTES LAB, 11 RUE HUMANN, F-67085 STRASBOURG, FRANCE.							ADNANE J, 1989, ONCOGENE, V4, P1389; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; ASHLEY RL, 1980, CANCER RES, V40, P4232; BALL RK, 1988, MOL ENDOCRINOL, V2, P133, DOI 10.1210/mend-2-2-133; BARBACID M, 1986, CARCINOGENESIS, V7, P1037, DOI 10.1093/carcin/7.7.1037; BCHINI O, 1991, IN PRESS ENDOCRINOLO, V128; BOS JL, 1989, CANCER RES, V49, P4682; BOUKAMP P, 1990, CANCER RES, V50, P2840; BOYLE P, 1988, BAILLIERE CLIN ONCOL, P1; CALLAHAN R, 1989, JNCI-J NATL CANCER I, V81, P1780, DOI 10.1093/jnci/81.23.1780; CAMPBELL SM, 1984, NUCLEIC ACIDS RES, V12, P8685, DOI 10.1093/nar/12.22.8685; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CARDIFF RD, 1988, ONCOGENE, V3, P205; CHEN LH, 1989, CELL REGUL, V1, P45, DOI 10.1091/mbc.1.1.45; CHOWCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; CLAIR T, 1987, CANCER RES, V47, P5290; DANDEKAR S, 1986, MOL CELL BIOL, V6, P4104, DOI 10.1128/MCB.6.11.4104; DEMBINSKI TC, 1985, CANCER RES, V45, P3083; DENOTO FM, 1981, NUCLEIC ACIDS RES, V9, P3719, DOI 10.1093/nar/9.15.3719; DOPPLER W, 1989, P NATL ACAD SCI USA, V86, P104, DOI 10.1073/pnas.86.1.104; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; HOBBS AA, 1982, J BIOL CHEM, V17, P8389; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; Korenman S. G., 1981, Banbury Report, V8, P71; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; KUMAR R, 1990, SCIENCE, V248, P1101, DOI 10.1126/science.2188364; LATHE R, 1987, GENE, V57, P193, DOI 10.1016/0378-1119(87)90122-3; LIPSETT MB, 1960, CANCER RES, V20, P1172; LUBON H, 1987, NUCLEIC ACIDS RES, V15, P2103, DOI 10.1093/nar/15.5.2103; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MEDINA D, 1973, METHOD CANCER RES, V7, P353; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIYAMOTO S, 1990, CANCER RES, V50, P6010; MIYAMOTO S, 1990, MOL CELL BIOL, V10, P1593, DOI 10.1128/MCB.10.4.1593; PALMITER RD, 1982, CELL, V29, P701, DOI 10.1016/0092-8674(82)90186-6; PITTIUS CW, 1988, MOL ENDOCRINOL, V2, P1027, DOI 10.1210/mend-2-11-1027; REDMOND SMS, 1988, ONCOGENE, V2, P259; RUSSO J, 1989, DEV ONCOL, V58, P133; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHOENENBERGER CA, 1990, DEV BIOL, V139, P327, DOI 10.1016/0012-1606(90)90302-Y; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SCHUH AC, 1990, NATURE, V346, P756, DOI 10.1038/346756a0; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0; TANAKA T, 1986, CANCER RES, V46, P1465; Vonderhaar B K, 1988, Cancer Treat Res, V40, P251	48	31	32	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1991	6	5					771	779						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052356				2022-12-28	WOS:A1991GT82500013
J	ROSENBERG, CL; KIM, HG; SHOWS, TB; KRONENBERG, HM; ARNOLD, A				ROSENBERG, CL; KIM, HG; SHOWS, TB; KRONENBERG, HM; ARNOLD, A			REARRANGEMENT AND OVEREXPRESSION OF D11S287E, A CANDIDATE ONCOGENE ON CHROMOSOME 11Q13 IN BENIGN PARATHYROID TUMORS	ONCOGENE			English	Article							ENDOCRINE NEOPLASIA TYPE-1; B-CELL LYMPHOMAS; HORMONE GENE; MOLECULAR-CLONING; DNA POLYMORPHISMS; PROTO-ONCOGENE; BREAST-CANCER; AMPLIFICATION; INT-2; ABNORMALITIES	We report the detailed molecular characterization of a human parathyroid adenoma with a clonal parathyroid hormone gene rearrangement. This rearrangement is similar to one we characterized recently in an independent adenoma. In these two, plus a third partially characterized adenoma, one allele of the PTH gene, on 11p15, is rearranged with DNA from the D11S287 region on 11q13. This region contains a transcribed sequence, D11S287E, distinct from known 11q13 oncogenes, that is expressed in all parathyroid tissues examined, but is overexpressed dramatically in all three tumors with PTH gene-D11S287 rearrangements. These findings suggest that overexpression of D11S287E, perhaps driven by the misplaced PTH gene's regulatory elements, contributed to the development of these benign tumors. D11S287E is a new candidate oncogene with potential importance in parathyroid adenomas and perhaps other tumors with 11q13 abnormalities.	MASSACHUSETTS GEN HOSP,ENDOCRINE UNIT,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,HEMATOL ONCOL UNIT,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02115; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Roswell Park Cancer Institute					NIDDK NIH HHS [DK11794, DK07028] Funding Source: Medline; NIGMS NIH HHS [GM20454] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028, P01DK011794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020454] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADELAIDE J, 1988, ONCOGENE, V2, P413; ARNOLD A, 1989, J CLIN ENDOCR METAB, V69, P496, DOI 10.1210/jcem-69-3-496; ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ARNOLD A, 1983, NEW ENGL J MED, V309, P1593, DOI 10.1056/NEJM198312293092601; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BERENSON JR, 1989, ONCOGENE, V4, P1111; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CROCE CM, 1985, BLOOD, V65, P1; FANTL V, 1990, EUR J CANCER, V26, P423, DOI 10.1016/0277-5379(90)90009-I; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMAN E, 1990, J CLIN ENDOCR METAB, V71, P293, DOI 10.1210/jcem-71-2-293; FRIEDMAN E, 1989, NEW ENGL J MED, V321, P213, DOI 10.1056/NEJM198907273210402; FRIEND SH, 1988, NEW ENGL J MED, V318, P618; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; IGARASHI T, 1986, MOL CELL BIOL, V6, P1830, DOI 10.1128/MCB.6.5.1830; KIDD KK, 1989, CYTOGENET CELL GENET, V51, P622, DOI 10.1159/000132810; KODURU PRK, 1989, ONCOGENE, V4, P929; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; NAKAI H, 1986, CYTOGENET CELL GENET, V43, P215, DOI 10.1159/000132324; NAYLOR SL, 1983, J EXP MED, V57, P1020; RABBITTS PH, 1988, ONCOGENE, V3, P99; Sambrook J, 1989, MOL CLONING LABORATO; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SEIZINGER BR, 1986, NATURE, V322, P644, DOI 10.1038/322644a0; SEIZINGER BR, 1987, P NATL ACAD SCI USA, V84, P5419, DOI 10.1073/pnas.84.15.5419; SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253; SHOWS TB, 1982, ADV HUM GENET, V12, P341; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; THEILLET C, 1990, ONCOGENE, V5, P147; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; VASICEK TJ, 1983, P NATL ACAD SCI-BIOL, V80, P2127, DOI 10.1073/pnas.80.8.2127; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZABEL BU, 1985, CYTOGENET CELL GENET, V39, P200, DOI 10.1159/000132135	41	240	241	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					449	453						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011400				2022-12-28	WOS:A1991FT34400015
J	VENTER, DJ; BEVAN, KL; LUDWIG, RL; RILEY, TEW; JAT, PS; THOMAS, DGT; NOBLE, MD				VENTER, DJ; BEVAN, KL; LUDWIG, RL; RILEY, TEW; JAT, PS; THOMAS, DGT; NOBLE, MD			RETINOBLASTOMA GENE DELETIONS IN HUMAN GLIOBLASTOMAS	ONCOGENE			English	Article							GENOMIC ORGANIZATION; SUSCEPTIBILITY GENE; OSTEO-SARCOMA; HUMAN DNA; NEOPLASMS; TUMORS; CANCER	The retinoblastoma susceptibility gene, RB, is the best characterised of the tumour suppressor genes, or 'anti-oncogenes'. Abnormal function of the RB protein is thought to result in loss of an inhibitory effect on cell growth, and thus contribute towards the development of certain human cancers. One group of human cancers of particular interest in relationship to retinoblastoma gene function are the gliomas, which are central nervous system tumours thought to originate from the neuroectoderm, the embryological tissue which also gives rise to retinoblastomas. We have therefore examined a group of benign and malignant gliomas for evidence of structural alterations of the RB gene. Four out of nine (44%) glioblastomas, the most malignant gliomas, showed loss of heterozygosity of a locus within this gene. In addition, one of these hemizygous tumours showed deletion of part of the RB protein-coding region, and this abnormality was also present in cells cultured from the tumour. These findings suggest that RB gene abnormalities may contribute to the development of glioblastomas.	LUDWIG INST CANC RES,91 RIDING HOUSE ST,LONDON W1P 8BT,ENGLAND	Ludwig Institute for Cancer Research								ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; BIGNER SH, 1986, CANCER GENET CYTOGEN, V22, P121, DOI 10.1016/0165-4608(86)90172-X; BOOKSTEIN R, 1988, P NATL ACAD SCI USA, V85, P2210, DOI 10.1073/pnas.85.7.2210; CAVANEE WK, 1983, NATURE, V305, P779; DRAPER GJ, 1986, BRIT J CANCER, V53, P661, DOI 10.1038/bjc.1986.110; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HANSEN MF, 1985, P NATL ACAD SCI USA, V82, P6216, DOI 10.1073/pnas.82.18.6216; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; MEADOWS AT, 1985, J CLIN ONCOL, V3, P532, DOI 10.1200/JCO.1985.3.4.532; MIDDLETON PG, 1986, NUCLEIC ACIDS RES, V14, P1925, DOI 10.1093/nar/14.4.1925; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; REISSMANN PT, 1989, ONCOGENE, V4, P839; REY JA, 1987, CANCER GENET CYTOGEN, V29, P201, DOI 10.1016/0165-4608(87)90232-9; ROARTY JD, 1988, OPHTHALMOLOGY, V95, P1583; SEEMAYER TA, 1989, LAB INVEST, V60, P585; STRATTON MR, 1989, BRIT J CANCER, V60, P202, DOI 10.1038/bjc.1989.251; TANG A, 1989, ONCOGENE, V4, P401; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; WEINBERG RA, 1989, CANCER RES, V49, P3713; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	27	101	101	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					445	448						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011399				2022-12-28	WOS:A1991FT34400014
J	WERNER, S; VIEHWEGER, P; HOFSCHNEIDER, PH; ROTH, WK				WERNER, S; VIEHWEGER, P; HOFSCHNEIDER, PH; ROTH, WK			LOW MITOGENIC RESPONSE TO EGF AND TGF-ALPHA - A CHARACTERISTIC FEATURE OF CULTURED KAPOSIS-SARCOMA DERIVED CELLS	ONCOGENE			English	Article							EPIDERMAL GROWTH-FACTOR; LONG-TERM CULTURE; HUMAN-FIBROBLASTS; PREREPLICATIVE PHASE; BINDING; INVITRO; ACID	We have investigated the mitogenicity of Epidermal Growth Factor (EGF) and Transforming Growth Factor alpha (TGF-alpha) for cultured Kaposi's sarcoma derived cells (KS cells). In contrast to control fibroblasts from the same patients, KS cells revealed only a weak mitogenic response to these growth factors. Neither EGF nor TGF-alpha were able to substitute for Platelet-derived growth factor (PDGF) when KS cells were grown in PDGF-depleted Platelet-Poor-Plasma serum (PPPS)-supplemented medium. The low mitogenicity of EGF and TGF-alpha for KS cells is not based upon a reduced expression of EGF receptor mRNA and protein in KS cells. However, the binding of EGF to KS cells is about 50% lower than that to fibroblasts. This reduced binding is not due to an occupation of the receptors by TGF-alpha since the expression level of this mitogen in different KS cell lines does not correlate with their capacity to bind EGF. In contrast, the low EGF binding seems to be an intrinsic feature of the EGF receptors of KS cells. In spite of the low mitogenicity of EGF for the tumor cells, the expression of c-myc, PDGF-A and Fibroblast growth factor 5 (FGF-5) mRNA is equally induced by purified EGF in KS cells and fibroblasts. This shows that at least the signal transduction pathways which lead to the expression of these genes are functional in KS cells.	MAX PLANCK INST BIOCHEM,DEPT VIRUS RES,KLOPFERSPITZ 18A,W-8033 MARTINSRIED,GERMANY	Max Planck Society				Werner, Sabine/0000-0001-7397-8710				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BOVI PD, 1986, CANCER RES, V46, P6333; BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; CARPENTER G, 1990, GROWTH REGULATORY PE, P69; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DERYNCK R, 1985, CANCER CELL, V3, P79; GOTTLIEB GJ, 1982, HUM PATHOL, V13, P882, DOI 10.1016/S0046-8177(82)80047-6; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KATOH M, 1990, BIOCHEM BIOPH RES CO, V167, P1065, DOI 10.1016/0006-291X(90)90631-V; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NAKAMURA S, 1988, SCIENCE, V242, P426, DOI 10.1126/science.3262925; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; ROTHWK, 1989, ONCOGENE, V4, P483; SALAHUDDIN SZ, 1988, SCIENCE, V242, P430, DOI 10.1126/science.2459779; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SCHIRREN CG, 1990, BRIT J DERMATOL, V123, P373; SNOVER DC, 1985, CLIN BIOCH ANAL, V20, P181; WERNER S, 1990, EXP CELL RES, V187, P98, DOI 10.1016/0014-4827(90)90122-Q; WERNER S, 1989, INT J CANCER, V6, P1137; WESTERMARK B, 1985, J CELL PHYSIOL, V124, P43, DOI 10.1002/jcp.1041240108; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	25	6	6	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					59	64						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992446				2022-12-28	WOS:A1991EY03900008
J	RAZZAQUE, A				RAZZAQUE, A			ONCOGENIC POTENTIAL OF HUMAN HERPESVIRUS-6 DNA	ONCOGENE			English	Article											RAZZAQUE, A (corresponding author), US FDA,CBER,DIV VIROL,DNA VIRUS RES LAB,BETHESDA,MD 20892, USA.							ABLASHI DV, 1988, INT J CANCER, V42, P787, DOI 10.1002/ijc.2910420526; ABLASHI DV, 1988, J VIROL METHODS, V21, P29, DOI 10.1016/0166-0934(88)90050-X; ALBRECHT T, 1973, VIROLOGY, V55, P53, DOI 10.1016/S0042-6822(73)81007-4; CAMERON IR, 1985, J GEN VIROL, V66, P517, DOI 10.1099/0022-1317-66-3-517; DUFF R, 1971, NATURE-NEW BIOL, V233, P48, DOI 10.1038/newbio233048a0; DUFF R, 1973, J VIROL, V12, P209, DOI 10.1128/JVI.12.2.209-217.1973; EFSTATHIOU S, 1988, LANCET, V1, P8575; ELBEIK T, 1986, J VIROL, V60, P645, DOI 10.1128/JVI.60.2.645-652.1986; GALLOWAY DA, 1984, P NATL ACAD SCI-BIOL, V81, P4736, DOI 10.1073/pnas.81.15.4736; GALLOWAY DA, 1983, NATURE, V302, P21, DOI 10.1038/302021a0; GALLOWAY DA, 1981, J VIROL, V38, P749, DOI 10.1128/JVI.38.2.749-760.1981; GALLOWAY DA, 1986, CANCER CELL, V4, P355; GEDER L, 1976, SCIENCE, V192, P1134, DOI 10.1126/science.179143; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; JARRETT RF, 1988, LEUKEMIA, V2, P496; JOSEPHS SF, 1988, LEUKEMIA, V2, P132; JOSEPHS SF, 1986, SCIENCE, V234, P601, DOI 10.1126/science.3020691; JOSEPHS SF, 1988, J VIROL METHODS, V21, P179, DOI 10.1016/0166-0934(88)90064-X; KISHI M, 1988, J VIROL, V62, P4824, DOI 10.1128/JVI.62.12.4824-4827.1988; LOPEZ C, 1988, J INFECT DIS, V157, P1271, DOI 10.1093/infdis/157.6.1271; LUMBARDI L, 1987, CELL, V49, P161; LUSSO P, 1987, LANCET, V2, P743; LUSSO P, 1989, NATURE, V337, P370, DOI 10.1038/337370a0; MACNAB JCM, 1987, J GEN VIROL, V68, P2525, DOI 10.1099/0022-1317-68-10-2525; MILLER G, 1971, P SOC EXP BIOL MED, V137, P1459; NELSON JA, 1984, J VIROL, V49, P109, DOI 10.1128/JVI.49.1.109-115.1984; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; RAZZAQUE A, 1988, P NATL ACAD SCI USA, V85, P5709, DOI 10.1073/pnas.85.15.5709; SALAHUDDIN SZ, 1986, SCIENCE, V234, P596, DOI 10.1126/science.2876520; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPECTOR SA, 1985, CLIN CHEM, V31, P1514; TEDDER RS, 1987, LANCET, V2, P390; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; YAMANISHI K, 1988, LANCET, V1, P1065; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	36	77	80	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1365	1370						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2170897				2022-12-28	WOS:A1990EC24100013
J	DAVIS, JN; BARGMANN, W; BOSE, HR				DAVIS, JN; BARGMANN, W; BOSE, HR			IDENTIFICATION OF PROTEIN COMPLEXES CONTAINING THE C-REL PROTOONCOGENE PRODUCT IN AVIAN HEMATOPOIETIC-CELLS	ONCOGENE			English	Article									UNIV TEXAS,CELL RES INST,AUSTIN,TX 78712	University of Texas System; University of Texas Austin	DAVIS, JN (corresponding author), UNIV TEXAS,DEPT MICROBIOL,AUSTIN,TX 78712, USA.				NCI NIH HHS [CA 33192, CA 26169] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA026169, R01CA033192] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTH CF, 1988, J EXP MED, V167, P89, DOI 10.1084/jem.167.1.89; BEUG H, 1981, VIROLOGY, V115, P295, DOI 10.1016/0042-6822(81)90112-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAVIS N, 1990, J VIROL, V64, P584, DOI 10.1128/JVI.64.2.584-591.1990; FRANKLIN RB, 1974, INTERVIROLOGY, V3, P342, DOI 10.1159/000149771; GARSON K, 1986, BIOCHEM BIOPH RES CO, V134, P616; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; HERZOG NK, 1986, P NATL ACAD SCI USA, V83, P812, DOI 10.1073/pnas.83.3.812; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS RB, 1981, CELL, V25, P421, DOI 10.1016/0092-8674(81)90060-X; LIM MT, 1990, IN PRESS VIROLOGY; MOORE BE, 1989, ONCOGENE, V4, P845; MORRISON LE, 1989, ONCOGENE, V4, P677; RICE NR, 1986, VIROLOGY, V149, P217, DOI 10.1016/0042-6822(86)90123-6; SHIBUYA T, 1982, CANCER RES, V42, P2722; SIMEK S, 1988, ONCOGENE RES, V2, P103; SIMEK S, 1988, J VIROL, V62, P4730, DOI 10.1128/JVI.62.12.4730-4736.1988; SIMEK SL, 1986, J VIROL, V59, P120, DOI 10.1128/JVI.59.1.120-126.1986; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; TUNG HYL, 1988, P NATL ACAD SCI USA, V85, P2479, DOI 10.1073/pnas.85.8.2479; TUNG HYL, 1988, BIOCHEM BIOPH RES CO, V152, P441; WALRO DS, 1987, VIROLOGY, V160, P433, DOI 10.1016/0042-6822(87)90015-8; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984; WONG TC, 1981, VIROLOGY, V111, P289, DOI 10.1016/0042-6822(81)90674-7; ZHANG J, 1989, MOL CELL BIOL, V9, P4970, DOI 10.1128/MCB.9.11.4970; ZHANG J, 1990, UNPUB MOL CELL BIOL; ZHANG JY, 1989, J VIROL, V63, P1107, DOI 10.1128/JVI.63.3.1107-1115.1989	28	29	29	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1109	1115						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202947				2022-12-28	WOS:A1990DX36100001
J	MACGREGOR, PF; ABATE, C; CURRAN, T				MACGREGOR, PF; ABATE, C; CURRAN, T			DIRECT CLONING OF LEUCINE ZIPPER PROTEINS - JUN BINDS COOPERATIVELY TO THE CRE WITH CRE-BP1	ONCOGENE			English	Article									ROCHE INST MOLEC BIOL,ROCHE RES CTR,DEPT MOLEC ONCOL & VIROL,NUTLEY,NJ 07110	Roche Holding			Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008; Curran, Tom/F-5234-2018; Curran, Tom/D-7515-2011; Abate-Shen, Cory/O-2520-2014	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Abate-Shen, Cory/0000-0002-5021-0570				ABATE C, 1990, IN PRESS SEMINARS CA; ABATE C, 1990, IN PRESS P NATL ACAD; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1989, ONCOGENE, V4, P123; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; COHEN D R, 1989, Critical Reviews in Oncogenesis, V1, P65; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COHEN DR, 1990, UNPUB; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1984, CELL, V36, P259; Curran T, 1988, ONCOGENE HDB, P307; CURRAN T, 1985, MOL CELL BIOL, V5, P157; FRANZA BR, 1987, ONCOGENE, V1, P213; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GENTZ R, 1989, P NATL ACAD SCI USA, V86, P821, DOI 10.1073/pnas.86.3.821; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HUYNH TV, 1985, DNA CLONING PRACTICA, V1; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEE WMF, 1988, MOL CELL BIOL, V8, P5521, DOI 10.1128/MCB.8.12.5521; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maniatis T., 1982, MOL CLONING; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REDDY EPA, 1988, ONCOGENE HDB; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; SONNENBERG JL, 1989, J NEUROSCI RES, V24, P72, DOI 10.1002/jnr.490240111; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	46	256	263	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					451	458						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2139203				2022-12-28	WOS:A1990DB85300001
J	CAMPO, MS; MCCAFFERY, RE; DOHERTY, I; KENNEDY, IM; JARRETT, WFH				CAMPO, MS; MCCAFFERY, RE; DOHERTY, I; KENNEDY, IM; JARRETT, WFH			THE HARVEY RAS-1 GENE IS ACTIVATED IN PAPILLOMAVIRUS-ASSOCIATED CARCINOMAS OF THE UPPER ALIMENTARY CANAL IN CATTLE	ONCOGENE			English	Article											CAMPO, MS (corresponding author), BEATSON INST CANC RES,GARSCUBE ESTATE,SWITCHBACK RD,GLASGOW G61 1BD,SCOTLAND.							ANDROPHY EJ, 1985, SCIENCE, V230, P442, DOI 10.1126/science.2996134; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BANKS L, 1987, J GEN VIROL, V68, P1351, DOI 10.1099/0022-1317-68-5-1351; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BROWN K, 1988, MOL CARCINOGEN, V1, P161, DOI 10.1002/mc.2940010304; CAMPO MS, 1985, EMBO J, V4, P1819, DOI 10.1002/j.1460-2075.1985.tb03856.x; CAMPO MS, 1980, NATURE, V286, P180, DOI 10.1038/286180a0; CAMPO MS, 1987, CANCER SURV, V6, P39; CAMPO MS, 1986, CIBA F SYMP, V120, P117; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DURST M, 1987, P NATL ACAD SCI USA, V84, P1070, DOI 10.1073/pnas.84.4.1070; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; EVANS IA, 1982, P ROY SOC EDINB B, V81, P65, DOI 10.1017/S0269727000003249; EVANS WC, 1982, P ROY SOC EDINB B, V81, P29, DOI 10.1017/S0269727000003237; FUJITA J, 1988, J NATL CANCER I, V80, P37, DOI 10.1093/jnci/80.1.37; HUNTER T, 1984, JNCI-J NATL CANCER I, V73, P773; Jarrett W. F. H., 1985, Advances in Viral Oncology, V5, P83; JARRETT WFH, 1978, NATURE, V274, P215, DOI 10.1038/274215a0; MATLASHEWSKI G, 1987, EMBO J, V6, P1741, DOI 10.1002/j.1460-2075.1987.tb02426.x; MCCAFFERY RE, 1989, ONCOGENE, V4, P1441; PARADA LF, 1982, NATURE, V297, P474, DOI 10.1038/297474a0; POPESCU NC, 1987, J VIROL, V51, P1682; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RIOU G, 1984, CR ACAD SCI III-VIE, V299, P575; RIOU G, 1988, ONCOGENE, V3, P329; SATO H, 1989, VIROLOGY, V168, P195, DOI 10.1016/0042-6822(89)90423-6; SEERDOF K, 1987, EMBO J, V6, P139; SMITH KT, 1989, ONCOGENE, V4, P409; SMITH KT, 1988, VIROLOGY, V164, P39, DOI 10.1016/0042-6822(88)90617-4; SMITH KT, 1989, IN PRESS UCLA S PAPI; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPANDIDOS DA, 1984, TRANSCRIPTION TRANSL, P1; SUKUMAR S, 1983, NATURE, V306, P658, DOI 10.1038/306658a0	38	28	28	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					303	308						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156207				2022-12-28	WOS:A1990CW41500007
J	THEURING, F; GOTZ, W; BALLING, R; KORF, HW; SCHULZE, F; HERKEN, R; GRUSS, P				THEURING, F; GOTZ, W; BALLING, R; KORF, HW; SCHULZE, F; HERKEN, R; GRUSS, P			TUMORIGENESIS AND EYE ABNORMALITIES IN TRANSGENIC MICE EXPRESSING MSV-SV40 LARGE T-ANTIGEN	ONCOGENE			English	Article									UNIV GOTTINGEN, ZENTRUM ANAT, HISTOL ABT, W-3400 GOTTINGEN, GERMANY; UNIV GIESSEN, ANAT & ZYTOBIOL ABT, W-6300 GIESSEN, GERMANY	University of Gottingen; Justus Liebig University Giessen	THEURING, F (corresponding author), MAX PLANCK INST BIOPHYS CHEM, MOLEK ZELLBIOL ABT, W-3400 GOTTINGEN, GERMANY.		Korf, Horst/ACX-9860-2022; Balling, Rudi/E-9680-2010	Korf, Horst/0000-0002-5051-0303; Balling, Rudi/0000-0003-2902-5650				BECKER LE, 1983, HUM PATHOL, V14, P538, DOI 10.1016/S0046-8177(83)80006-9; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BURGER PC, 1987, ACTA NEUROPATHOL, V73, P115, DOI 10.1007/BF00693776; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cruickshank AH, 1986, PATHOLOGY PANCREAS; CUTHBERTSON RA, 1988, LAB INVEST, V58, P484; FUJITA T, 1979, TRENDS NEUROSCI, V2, P27, DOI 10.1016/0166-2236(79)90013-4; Gabe M, 1976, HISTOLOGICAL TECHNIQ; GELATT KN, 1984, CURR EYE RES, V3, P765, DOI 10.3109/02713688409065600; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HOGAN B, 1986, MAINPULATING MOUSE E; KHILLAN JS, 1987, GENE DEV, V1, P1327, DOI 10.1101/gad.1.10.1327; KHILLAN JS, 1988, NUCLEIC ACIDS RES, V16, P1423, DOI 10.1093/nar/16.4.1423; KLOPPEL G, 1981, SPEZIELLE PATHOLOGIS, V14, P523; LAHAV M, 1973, AM J OPHTHALMOL, V75, P648, DOI 10.1016/0002-9394(73)90817-9; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; LAIMINS LA, 1984, J VIROL, V49, P183, DOI 10.1128/JVI.49.1.183-189.1984; LANDEL CP, 1988, GENE DEV, V2, P1168, DOI 10.1101/gad.2.9.1168; LEVINSON BG, 1982, NATURE, V295, P658; MACKAY K, 1988, KIDNEY INT, V33, P677, DOI 10.1038/ki.1988.53; MACKAY K, 1987, KIDNEY INT, V32, P827, DOI 10.1038/ki.1987.283; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; MUGGLETONHARRIS AL, 1986, INT REV CYTOL, V104, P25, DOI 10.1016/S0074-7696(08)61922-1; MURPHY D, 1987, AM J PATHOL, V129, P552; NAUMANN GOH, 1980, SPEZIELLE PATHOLOGIS, V12, P501; PALMITER RD, 1985, NATURE, V316, P457, DOI 10.1038/316457a0; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PEARSE AGE, 1968, PROC R SOC SER B-BIO, V170, P71, DOI 10.1098/rspb.1968.0025; POCHEDLY C, 1982, NEUROBLASTOMA CLIN B; POULSOM R, 1988, GRAEF ARCH CLIN EXP, V226, P31, DOI 10.1007/BF02172713; POWER RF, 1987, GUT, V28, P121, DOI 10.1136/gut.28.Suppl.121; Romeis B., 1968, MIKROSKOPISCHE TECHN; SCHULZE F, 1985, DNA-J MOLEC CELL BIO, V4, P193, DOI 10.1089/dna.1985.4.193; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TABUCHI K, 1988, ATLAS BRAIN TUMORS L; VANDOORENMAALEN WJ, 1981, MOL CELLULAR BIOL EY, P415; WESTPHAL H, 1988, REGULATORY MECHANISM, P33	39	39	39	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1990	5	2					225	232						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2157185				2022-12-28	WOS:A1990CU02900009
J	ITO, E; SONNENBERG, JL; NARAYANAN, R				ITO, E; SONNENBERG, JL; NARAYANAN, R			NERVE GROWTH FACTOR-INDUCED DIFFERENTIATION IN PC-12 CELLS IS BLOCKED BY FOS ONCOGENE	ONCOGENE			English	Article									ROCHE INST MOLEC BIOL,DEPT MOLEC ONCOL,NUTLEY,NJ 07110		ITO, E (corresponding author), ROCHE RES CTR,DEPT MOLEC GENET,340 KINGSLAND ST,NUTLEY,NJ 07110, USA.			Narayanan, Ramaswamy/0000-0001-9346-9083; Ito, Etsuro/0000-0002-0168-2475				ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; BRAVO R, 1985, EMBO J, V4, P1193, DOI 10.1002/j.1460-2075.1985.tb03759.x; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1987, ONCOGENE, V2, P79; CURRAN T, 1984, CELL, V36, P259; Curran T, 1988, ONCOGENE HDB, P307; CURRAN T, 1987, UCLA S MOL CELLULAR, V58, P215; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; FINKEL MP, 1966, SCIENCE, V151, P698, DOI 10.1126/science.151.3711.698; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENE LA, 1978, NATURE, V276, P191, DOI 10.1038/276191a0; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; HEBY O, 1981, DIFFERENTIATION, V19, P1, DOI 10.1111/j.1432-0436.1981.tb01123.x; HICKOK NJ, 1986, P NATL ACAD SCI USA, V83, P594, DOI 10.1073/pnas.83.3.594; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE WMF, 1985, MOL CELL BIOL, V5, P3345, DOI 10.1128/MCB.5.12.3345; MARUYAMA K, 1987, ONCOGENE, V1, P361; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; Muller R, 1986, Biochim Biophys Acta, V823, P207, DOI 10.1016/0304-419X(86)90003-X; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; MULLER R, 1983, EMBO J, V2, P699; NARAYANAN R, 1988, EXP CELL RES, V174, P297, DOI 10.1016/0014-4827(88)90164-4; NARAYANAN R, 1986, BIOCHEM BIOPH RES CO, V141, P1018, DOI 10.1016/S0006-291X(86)80146-2; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REISS M, 1986, BIOCHEM BIOPH RES CO, V137, P244, DOI 10.1016/0006-291X(86)91202-7; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; RYDEL RE, 1987, J NEUROSCI, V7, P3639; SAFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795; SCHUBERT D, 1977, P NATL ACAD SCI USA, V74, P2579, DOI 10.1073/pnas.74.6.2579; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9	44	40	40	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1193	1199						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2552373				2022-12-28	WOS:A1989AU50800005
J	LUTTRELL, LM; LUTTRELL, DK; PARSONS, SJ; ROGOL, AD				LUTTRELL, LM; LUTTRELL, DK; PARSONS, SJ; ROGOL, AD			INSULIN AND PHORBOL ESTER INDUCE DISTINCT PHOSPHORYLATIONS OF PP60C-SRC IN THE BC3H-1 MURINE MYOCYTE CELL-LINE	ONCOGENE			English	Article									UNIV VIRGINIA,SCH MED,DEPT PEDIAT,BOX 386,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908	University of Virginia; University of Virginia; University of Virginia			Rogol, A.D./H-5871-2019	Rogol, A.D./0000-0002-7526-3142; Luttrell, Louis/0000-0003-2805-6949	NCI NIH HHS [CA 29243, CA 39438] Funding Source: Medline; NIADDK NIH HHS [AM 22125] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P60AM022125] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039438, R37CA029243, R01CA029243] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beavo J A, 1974, Methods Enzymol, V38, P299; BESTERMAN JM, 1986, J BIOL CHEM, V261, P723; BLACKSHEAR PJ, 1987, MOL ENDOCRINOL, V1, P44, DOI 10.1210/mend-1-1-44; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BLACKSHEAR PJ, 1986, MECHANISMS INSULIN A, P211; BOLEN JB, 1985, P NATL ACAD SCI USA, V82, P7275, DOI 10.1073/pnas.82.21.7275; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHAKALAPARAMPIL I, 1988, CELL, V52, P801; CHERQUI G, 1986, ENDOCRINOLOGY, V118, P1759, DOI 10.1210/endo-118-5-1759; CHU DTW, 1987, MOL ENDOCRINOL, V1, P53, DOI 10.1210/mend-1-1-53; CHU DTW, 1986, J BIOL CHEM, V261, P6848; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLETT MS, 1979, J VIROL, V29, P770, DOI 10.1128/JVI.29.2.770-781.1979; COLLETT MS, 1978, CELL, V15, P1363, DOI 10.1016/0092-8674(78)90061-2; COOPER DR, 1987, FEBS LETT, V214, P122, DOI 10.1016/0014-5793(87)80025-X; COOPER DR, 1987, J BIOL CHEM, V262, P3633; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; CROSS FR, 1983, CELL, V34, P597, DOI 10.1016/0092-8674(83)90392-6; FARESE RV, 1987, SCIENCE, V236, P586, DOI 10.1126/science.3107122; FARESE RV, 1985, ENDOCRINOLOGY, V116, P2650, DOI 10.1210/endo-116-6-2650; FARESE RV, 1985, BIOCHEM J, V231, P269, DOI 10.1042/bj2310269; FARESE RV, 1986, J BIOL CHEM, V261, P8589; FARESE RV, 1984, J BIOL CHEM, V259, P7094; FOX JA, 1987, P NATL ACAD SCI USA, V84, P2663, DOI 10.1073/pnas.84.9.2663; GENTRY LE, 1986, MOL CELL BIOL, V6, P735, DOI 10.1128/MCB.6.2.735; GESCHWENDT M, 1986, BIOCHEM BIOPH RES CO, V137, P766; GLYNN BP, 1986, BIOCHEM BIOPH RES CO, V135, P1119, DOI 10.1016/0006-291X(86)91044-2; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; GRANNER DK, 1986, MECHANISMS INSULIN A, P365; GRAVES CB, 1985, J BIOL CHEM, V260, P1286; HATHAWAY GM, 1983, METHOD ENZYMOL, V99, P317, DOI 10.1016/0076-6879(83)99067-5; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HERSHKO A, 1971, NATURE-NEW BIOL, V232, P206, DOI 10.1038/newbio232206a0; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KANNER SB, 1988, ONCOGENE, V2, P327; KIKKAWA U, 1986, BIOCHEM BIOPH RES CO, V135, P636, DOI 10.1016/0006-291X(86)90040-9; KURET J, 1985, EUR J BIOCHEM, V151, P39, DOI 10.1111/j.1432-1033.1985.tb09066.x; LALLEMAIN G, 1986, FEBS LETT, V197, P344, DOI 10.1016/0014-5793(86)80354-4; LARNER J, 1982, RECENT PROG HORM RES, V38, P511; LUTTRELL DK, 1988, MOL CELL BIOL, V8, P497, DOI 10.1128/MCB.8.1.497; LUTTRELL L, 1986, ENDOCRINOLOGY, V119, P331, DOI 10.1210/endo-119-1-331; LUTTRELL LM, 1988, J BIOL CHEM, V263, P6134; LUTTRELL LM, 1986, MOL PHARMACOL, V30, P624; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; PATSCHINSKY T, 1986, J VIROL, V59, P73, DOI 10.1128/JVI.59.1.73-81.1986; POTTER VR, 1984, IN VITRO CELL DEV B, V20, P723; RALSTON R, 1985, P NATL ACAD SCI USA, V82, P7845, DOI 10.1073/pnas.82.23.7845; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; ROZENGURT E, 1983, P NATL ACAD SCI USA, V81, P2975; SALTIEL AR, 1987, J BIOL CHEM, V262, P1116; SALTIEL AR, 1987, ENDOCRINOLOGY, V120, P967, DOI 10.1210/endo-120-3-967; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SPACH DH, 1986, J BIOL CHEM, V261, P2750; STANDAERT ML, 1988, J BIOL CHEM, V263, P8696; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TAKAYAMA S, 1984, P NATL ACAD SCI-BIOL, V81, P7797, DOI 10.1073/pnas.81.24.7797; TAMURA T, 1984, FEBS LETT, V177, P151, DOI 10.1016/0014-5793(84)81001-7; TAYLOR D, 1985, J BIOL CHEM, V260, P2011; TREVILLYAN JM, 1985, J BIOL CHEM, V260, P3041; WU VS, 1981, LIFE SCI, V29, P1855, DOI 10.1016/0024-3205(81)90516-6; YONEMOTO W, 1985, P NATL ACAD SCI USA, V82, P4568, DOI 10.1073/pnas.82.14.4568	68	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					317	324						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2468125				2022-12-28	WOS:A1989U567600007
J	FARR, CJ; MARSHALL, CJ; EASTY, DJ; WRIGHT, NA; POWELL, SC; PARASKEVA, C				FARR, CJ; MARSHALL, CJ; EASTY, DJ; WRIGHT, NA; POWELL, SC; PARASKEVA, C			A STUDY OF RAS GENE-MUTATIONS IN COLONIC ADENOMAS FROM FAMILIAL POLYPOSIS COLI PATIENTS	ONCOGENE			English	Article									INST CANC RES,CHESTER BEATTY LABS,CELL & MOLEC BIOL SECT,FULHAM RD,LONDON SW3 6JB,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOPATHOL,LONDON W12 0HS,ENGLAND; UNIV BRISTOL,SCH MED,DEPT PATHOL,BRISTOL BS8 1TD,AVON,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Imperial College London; University of Bristol			Wright, Nicholas/HHY-7227-2022	Farr, Christine/0000-0002-5357-5962; Wright, Nicholas/0000-0002-5525-3457				ALEXANDER RJ, 1986, GASTRENTEROLOGY, V91, P1510; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BALMAIN A, 1985, BRIT J CANCER, V51, P1, DOI 10.1038/bjc.1985.1; BERRY RD, 1988, CARCINOGENESIS, V9, P447, DOI 10.1093/carcin/9.3.447; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; BOS JL, 1988, REV GENET TOXICOL, V195, P255; BRATTAIN MG, 1982, J NATL CANCER I, V69, P767; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; BUSSEY HJR, 1982, RECENT RES CANCER, V83, P45; CAPON DJ, 1983, NATURE, V304, P507, DOI 10.1038/304507a0; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; GEISER AG, 1986, P NATL ACAD SCI USA, V83, P5209, DOI 10.1073/pnas.83.14.5209; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIEBOVITZ A, 1976, CANCER RES, V36, P4562; MONPEZAT JP, 1988, INT J CANCER, V41, P404, DOI 10.1002/ijc.2910410315; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; NAMBA M, 1983, INT J CANCER, V32, P697, DOI 10.1002/ijc.2910320608; OKAMOTO M, 1988, NATURE, V331, P273, DOI 10.1038/331273a0; PARASKEVA C, 1985, BRIT J CANCER, V51, P131, DOI 10.1038/bjc.1985.19; PARASKEVA C, 1988, INT J CANCER, V41, P908; PARASKEVA C, 1984, INT J CANCER, V34, P49, DOI 10.1002/ijc.2910340109; PELLING JC, 1988, CARCINOGENESIS, V9, P665, DOI 10.1093/carcin/9.4.665; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SOLOMON E, 1987, NATURE, V328, P616, DOI 10.1038/328616a0; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; YANEZ L, 1987, ONCOGENE, V1, P315; YUASA Y, 1986, JPN J CANCER RES, V77, P901; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0	42	72	73	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					673	678						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577869				2022-12-28	WOS:A1988R646000008
J	AVIVI, A; LAX, I; ULLRICH, A; SCHLESSINGER, J; GIVOL, D; MORSE, B				AVIVI, A; LAX, I; ULLRICH, A; SCHLESSINGER, J; GIVOL, D; MORSE, B			COMPARISON OF EGF RECEPTOR SEQUENCES AS A GUIDE TO STUDY THE LIGAND-BINDING SITE	ONCOGENE			English	Note							EPIDERMAL GROWTH-FACTOR; LOCALIZATION; EXPRESSION; CELLS	While murine and human EGF-receptor (EGF-R) bind mammalian EGF with high affinity their chicken counterpart has approximately 300 fold reduced binding affinity towards mammalian EGF. We now cloned and sequenced the extracellular ligand binding domain of murine EGF-R in order to define the amino-acids which comprise the binding site for EGF. Comparison of human, murine and chicken EGF-R allows the identification of amino acid substitutions which are conservative and would not affect EGF binding, substitutions which are responsible for the low affinity binding of EGF to chicken EGF-R and those responsible for the high affinity binding of EGF to mammalian EGF-R. This analysis will enable future design of point mutations in the EGF-R which will restore the high affinity binding for EGF typical of human or murine EGF-R.	NYU MED CTR,DEPT PHARMACOL,550 1ST AVE,NEW YORK,NY 10016; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL; RORER GRP INC,KING OF PRUSSIA,PA 19406; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	New York University; Weizmann Institute of Science; Max Planck Society								LAX I, 1988, MOL CELL BIOL, V8, P1970, DOI 10.1128/MCB.8.5.1970; LAX I, 1988, MOL CELL BIOL, V8, P1831, DOI 10.1128/MCB.8.4.1831; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; LAX I, 1991, UNPUB; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WU DG, 1989, J BIOL CHEM, V264, P17469	6	45	50	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					673	676						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030916				2022-12-28	WOS:A1991FR93900026
J	SOMERS, KD; CARTWRIGHT, SL; SCHECHTER, GL				SOMERS, KD; CARTWRIGHT, SL; SCHECHTER, GL			AMPLIFICATION OF THE INT-2 GENE IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS	ONCOGENE			English	Article									EASTERN VIRGINIA MED SCH, DEPT OTOLARYNGOL HEAD & NECK SURG, NORFOLK, VA 23501 USA; EASTERN VIRGINIA MED SCH, HEAD & NECK TUMOR BIOL PROGRAM, NORFOLK, VA 23501 USA	Eastern Virginia Medical School	SOMERS, KD (corresponding author), EASTERN VIRGINIA MED SCH, DEPT MICROBIOL & IMMUNOL, POB 1980, NORFOLK, VA 23501 USA.							ADELAIDE J, 1988, ONCOGENE, V2, P413; ALI IU, 1989, ONCOGENE, V4, P89; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BROOKES S, 1989, ONCOGENE, V4, P429; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DETAISNE C, 1984, NATURE, V310, P581, DOI 10.1038/310581a0; EISBRUCH A, 1987, CANCER RES, V47, P3603; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIELD JK, 1986, ANTICANCER RES, V6, P595; HOLLSTEIN MC, 1988, CANCER RES, V48, P5119; ISHITOYA J, 1989, BRIT J CANCER, V59, P559, DOI 10.1038/bjc.1989.113; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; KASID U, 1987, SCIENCE, V237, P1039, DOI 10.1126/science.3616625; KING CR, 1989, CANCER RES, V49, P4185; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LU SH, 1988, INT J CANCER, V42, P502, DOI 10.1002/ijc.2910420406; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; NGUYEN C, 1988, ONCOGENE, V3, P703; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; PATERNO GD, 1989, DEVELOPMENT, V106, P79; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; ROTHBERG PG, 1984, MOL CELL BIOL, V4, P1096, DOI 10.1128/MCB.4.6.1096; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; SARANATH D, 1989, JPN J CANCER RES, V80, P430, DOI 10.1111/j.1349-7006.1989.tb02332.x; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SILVERBERG E, 1989, CA-CANCER J CLIN, V39, P3; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPANDIDOS DA, 1985, ANTICANCER RES, V5, P221; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TADOKORO K, 1989, ONCOGENE, V4, P499; TAGGART RT, 1985, P NATL ACAD SCI USA, V82, P6240, DOI 10.1073/pnas.82.18.6240; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUTSUMI M, 1988, JPN J CANCER RES, V79, P428, DOI 10.1111/j.1349-7006.1988.tb01609.x; VARLEY JM, 1988, ONCOGENE, V3, P87; WADA A, 1988, BIOCHEM BIOPH RES CO, V157, P828, DOI 10.1016/S0006-291X(88)80324-3; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILLIAMS BP, 1988, ONCOGENE, V3, P345; WILLMAN CL, 1987, HUM PATHOL, V18, P895, DOI 10.1016/S0046-8177(87)80266-6; WRIGHT C, 1989, CANCER RES, V49, P2087; XU YH, 1984, NATURE, V309, P806, DOI 10.1038/309806a0; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487; ZHOU DJ, 1988, ONCOGENE, V2, P279	53	153	159	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1990	5	6					915	920						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2193294				2022-12-28	WOS:A1990DP55300019
J	BHAT, GV; TEMIN, HM				BHAT, GV; TEMIN, HM			MUTATIONAL ANALYSIS OF V-REL, THE ONCOGENE OF RETICULOENDOTHELIOSIS VIRUS STRAIN-T	ONCOGENE			English	Article									UNIV WISCONSIN,MCARDLE LAB CANC RES,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NCI NIH HHS [CA-22443, CA-07175] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA007175, P01CA022443] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEUG H, 1981, VIROLOGY, V115, P295, DOI 10.1016/0042-6822(81)90112-4; BISHOP JM, 1983, ANN REV BIOCH, V52, P501; BLAIR DG, 1981, SCIENCE, V212, P941, DOI 10.1126/science.7233190; CAPOBIANCO AJ, 1990, IN PRESS ONCOGENE; CHEN ISY, 1982, CELL, V31, P111, DOI 10.1016/0092-8674(82)90410-X; CHEN ISY, 1981, J VIROL, V40, P800, DOI 10.1128/JVI.40.3.800-811.1981; CHEN ISY, 1983, J VIROL, V45, P104, DOI 10.1128/JVI.45.1.104-113.1983; CICHUTEK K, 1986, P NATL ACAD SCI USA, V83, P2340, DOI 10.1073/pnas.83.8.2340; DOUGHERTY JP, 1986, MOL CELL BIOL, V6, P4387, DOI 10.1128/MCB.6.12.4387; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER DA, 1985, CELL, V42, P105, DOI 10.1016/S0092-8674(85)80106-9; FOSTER DA, 1983, J VIROL, V48, P744, DOI 10.1128/JVI.48.3.744-751.1983; FRANKLIN RB, 1974, INTERVIROLOGY, V3, P342, DOI 10.1159/000149771; GARSON K, 1986, BIOCHEM BIOPH RES CO, V134, P716, DOI 10.1016/S0006-291X(86)80479-X; GELINAS C, 1986, P NATL ACAD SCI USA, V83, P9211, DOI 10.1073/pnas.83.23.9211; GILMORE TD, 1988, J VIROL, V62, P703, DOI 10.1128/JVI.62.3.703-714.1988; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANNINK M, 1984, SCIENCE, V226, P1197, DOI 10.1126/science.6095451; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; HERZOG NK, 1986, J VIROL, V57, P371, DOI 10.1128/JVI.57.1.371-375.1986; HERZOG NK, 1986, P NATL ACAD SCI USA, V83, P812, DOI 10.1073/pnas.83.3.812; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOELZER JD, 1980, VIROLOGY, V100, P462, DOI 10.1016/0042-6822(80)90536-X; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LEWIS RB, 1981, CELL, V25, P421, DOI 10.1016/0092-8674(81)90060-X; Maniatis T., 1982, MOL CLONING; MILLER AD, 1984, CELL, V36, P51; MILLER CK, 1986, J VIROL, V58, P75, DOI 10.1128/JVI.58.1.75-80.1986; MOORE BE, 1988, VIROLOGY, V162, P377, DOI 10.1016/0042-6822(88)90478-3; PRYWES R, 1983, CELL, V34, P569, DOI 10.1016/0092-8674(83)90389-6; PULCIANI S, 1985, MOL CELL BIOL, V5, P2836, DOI 10.1128/MCB.5.10.2836; RICE NR, 1982, J VIROL, V42, P237, DOI 10.1128/JVI.42.1.237-252.1982; RICE NR, 1986, VIROLOGY, V149, P217, DOI 10.1016/0042-6822(86)90123-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBUYA T, 1982, CANCER RES, V42, P2722; SIMEK S, 1988, ONCOGENE RES, V2, P103; SIMEK SL, 1986, J VIROL, V59, P120, DOI 10.1128/JVI.59.1.120-126.1986; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEPHENS RM, 1983, P NATL ACAD SCI-BIOL, V80, P6229, DOI 10.1073/pnas.80.20.6229; SYLLA BS, 1986, MOL CELL BIOL, V6, P4709, DOI 10.1128/MCB.6.12.4709; TEMIN HM, 1984, CANCER SURV, V3, P229; TEMIN HM, 1974, J VIROL, V13, P291, DOI 10.1128/JVI.13.2.291-297.1974; THEILEN GH, 1966, J NATL CANCER I, V37, P731; VARMUS HE, 1984, ANNU REV GENET, V18, P553; WALRO DS, 1987, VIROLOGY, V160, P433, DOI 10.1016/0042-6822(87)90015-8; WILHELMSEN KC, 1984, J VIROL, V49, P521, DOI 10.1128/JVI.49.2.521-529.1984; WILHELMSEN KC, 1984, J VIROL, V52, P172, DOI 10.1128/JVI.52.1.172-182.1984	49	24	24	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					625	634						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189101				2022-12-28	WOS:A1990DG37400001
J	MARU, Y; HIRAI, H; TAKAKU, F				MARU, Y; HIRAI, H; TAKAKU, F			OVEREXPRESSION CONFERS AN ONCOGENIC POTENTIAL UPON THE EPH GENE	ONCOGENE			English	Note									UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo								BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COOPER CS, 1986, EMBO J, V5, P2623, DOI 10.1002/j.1460-2075.1986.tb04543.x; COULIER F, 1989, MOL CELL BIOL, V9, P15, DOI 10.1128/MCB.9.1.15; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8447; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MANSER T, 1984, P NATL ACAD SCI-BIOL, V81, P2470, DOI 10.1073/pnas.81.8.2470; MARGLIN A, 1970, ANNU REV BIOCHEM, V39, P841, DOI 10.1146/annurev.bi.39.070170.004205; MARU Y, 1988, MOL CELL BIOL, V8, P3770, DOI 10.1128/MCB.8.9.3770; PARK M, 1986, CELL, V45, P895, DOI 10.1016/0092-8674(86)90564-7; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; VARMUS HE, 1987, SCIENCE, V238, P1337, DOI 10.1126/science.2825348; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; WALTER G, 1980, P NATL ACAD SCI-BIOL, V77, P5197, DOI 10.1073/pnas.77.9.5197	27	88	98	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					445	447						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2314900				2022-12-28	WOS:A1990CW41500027
J	TARAKHOVSKY, AM; RESNIKOV, M; ZAICHUK, T; TUGUSHEVA, MV; BUTENKO, ZA; PRASSOLOV, VS				TARAKHOVSKY, AM; RESNIKOV, M; ZAICHUK, T; TUGUSHEVA, MV; BUTENKO, ZA; PRASSOLOV, VS			POLYMORPHIC CHANGES OF CELL PHENOTYPE CAUSED BY ELEVATED EXPRESSION OF AN EXOGENOUS NEU PROTOONCOGENE	ONCOGENE			English	Article									ACAD SCI USSR,INST MOLEC BIOL,MOSCOW V-71,USSR		TARAKHOVSKY, AM (corresponding author), ACAD SCI UKSSR,INST ONCOL PROBLEMS,DEPT LEUKEMIAGENESIS,VASILKOVSKAYA 45,KIEV 252022,UKRAINE,USSR.							ADAMSON ED, 1981, MOL CELL BIOCHEM, V34, P129, DOI 10.1007/BF02359619; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; Cowley GO, 1984, CANCER CELL, V1, P5; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FUKUSHIGE S, 1986, MOL CELL BIOL, V6, P955, DOI 10.1128/MCB.6.3.955; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GURROFF G, 1988, GROWTH MATURATION FA; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARTIN GS, 1971, P NATL ACAD SCI USA, V68, P2739, DOI 10.1073/pnas.68.11.2739; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; PERUCHO M, 1981, CELL, V27, P467, DOI 10.1016/0092-8674(81)90388-3; PRASOLOV VS, 1988, DOKL AKAD NAUK SSSR+, V300, P1498; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; ROGELJ S, 1988, NATURE, V331, P173, DOI 10.1038/331173a0; ROSENTHAL A, 1986, CELL, V46, P301, DOI 10.1016/0092-8674(86)90747-6; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, SCIENCE, V85, P6479; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SHIH C, 1979, P NATL ACAD SCI USA, V76, P5714, DOI 10.1073/pnas.76.11.5714; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SMITH JJ, 1987, P NATL ACAD SCI USA, V84, P7567, DOI 10.1073/pnas.84.21.7567; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YAMAZAKI H, 1988, MOL CELL BIOL, V8, P1816, DOI 10.1128/MCB.8.4.1816	38	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					405	410						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	1969137				2022-12-28	WOS:A1990CW41500019
J	STACHOWIAK, MK; SAR, M; TUOMINEN, RK; JIANG, HK; AN, S; IADAROLA, MJ; POISNER, AM; HONG, JS				STACHOWIAK, MK; SAR, M; TUOMINEN, RK; JIANG, HK; AN, S; IADAROLA, MJ; POISNER, AM; HONG, JS			STIMULATION OF ADRENAL-MEDULLARY CELLS INVIVO AND INVITRO INDUCES EXPRESSION OF C-FOS PROTO-ONCOGENE	ONCOGENE			English	Article									UNIV KANSAS, MED CTR, KANSAS CITY, KS 66103 USA; NIEHS, MOLEC & INTEGRAT NEUROSCI LAB, RES TRIANGLE PK, NC 27709 USA; UNIV N CAROLINA, DEPT CELL BIOL, CHAPEL HILL, NC 27599 USA; NIDR, NEUROBIOL & ANESTHESIOL BRANCH, BETHESDA, MD 20492 USA	University of Kansas; University of Kansas Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)			Poisner, Alan/Q-8226-2019; Hong, Jau-shyong/F-1920-2019; Poisner, Alan/AAC-8152-2022	Hong, Jau-shyong/0000-0002-3056-8401; Poisner, Alan/0000-0002-0161-8238	NINDS NIH HHS [NS-17479] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017479] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARKA T, 1987, ONCOGENE, V1, P439; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1987, ONCOGENE, V2, P79; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; DRAGUNOW M, 1987, EUR J PHARMACOL, V135, P113, DOI 10.1016/0014-2999(87)90767-9; DRAISCI G, 1989, IN PRESS MOL BRAIN R; EIDEN LE, 1984, NATURE, V312, P661, DOI 10.1038/312661a0; FAUSCHER FJ, 1988, CELL, V52, P471; Feldberg W, 1934, J PHYSIOL-LONDON, V81, P286, DOI 10.1113/jphysiol.1934.sp003136; FRANZA BR, 1987, ONCOGENE, V1, P213; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; GUBITS RM, 1988, MOL BRAIN RES, V3, P197, DOI 10.1016/0169-328X(88)90067-8; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; KANAMATSU T, 1986, P NATL ACAD SCI USA, V83, P9242; KAPLAN BB, 1979, BIOCHEM J, V183, P181, DOI 10.1042/bj1830181; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MILLER R, 1987, ONCOGENE RES, V2, P19; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; SAR M, 1984, SCIENCE, V223, P938, DOI 10.1126/science.6141639; SAR M, 1985, TECHNIQUES IMMUNOCYT, V3, P43; STACHOWIAK M, 1985, BRAIN RES, V359, P356, DOI 10.1016/0006-8993(85)91450-7; STACHOWIAK M, 1988, MOL BRAIN RES, V3, P193, DOI 10.1016/0169-328X(88)90066-6; STACHOWIAK MK, 1988, MOL BRAIN RES, V3, P275, DOI 10.1016/0169-328X(88)90050-2; STACHOWIAK MK, 1989, J CELL BIOL, pA506; WILSON SP, 1981, EXP CELL RES, V133, P159, DOI 10.1016/0014-4827(81)90366-9; ZIMLICHMAN R, 1987, CELL CALCIUM, V8, P315, DOI 10.1016/0143-4160(87)90006-6	31	54	54	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1990	5	1					69	73						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2108403				2022-12-28	WOS:A1990CM62000010
J	TAHIRA, T; ISHIZAKA, Y; ITOH, F; SUGIMURA, T; NAGAO, M				TAHIRA, T; ISHIZAKA, Y; ITOH, F; SUGIMURA, T; NAGAO, M			CHARACTERIZATION OF RET PROTO-ONCOGENE MESSENGER-RNAS ENCODING 2 ISOFORMS OF THE PROTEIN PRODUCT IN A HUMAN NEUROBLASTOMA CELL-LINE	ONCOGENE			English	Article											TAHIRA, T (corresponding author), NATL CANC CTR,RES INST,DIV CARCINOGENESIS,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN.							BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BIEDLER JL, 1973, CANCER RES, V33, P2643; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; ISHIKAWA S, 1979, ACTA PATHOL JAPON, V29, P289; ISHIZAKA Y, 1989, ONCOGENE, V4, P789; ISHIZAKA Y, 1988, ONCOGENE RES, V3, P193; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maniatis T., 1982, MOL CLONING; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1988, ONCOGENE, V3, P571; VELU TJ, 1989, MOL CELL BIOL, V9, P1772, DOI 10.1128/MCB.9.4.1772; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79; WICKENS M, 1984, SCIENCE, V226, P1045, DOI 10.1126/science.6208611; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	26	191	195	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					97	102						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181380				2022-12-28	WOS:A1990CM62000013
J	BERENSON, JR; YANG, J; MICKEL, RA				BERENSON, JR; YANG, J; MICKEL, RA			FREQUENT AMPLIFICATION OF THE BCL-1 LOCUS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS	ONCOGENE			English	Article									UNIV CALIF LOS ANGELES, SCH MED, DIV HEAD & NECK SURG, LOS ANGELES, CA 90024 USA; VET ADM WADSWORTH MED CTR, LOS ANGELES, CA 90073 USA; JONSSON CANC CTR, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	BERENSON, JR (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, 11-266 FACTOR BLDG, 10833 LE CONTE AVE, LOS ANGELES, CA 90024 USA.							ADELAIDE J, 1988, ONCOGENE, V2, P413; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BERENSON J, 1989, LEUKEMIA, V3, P133; BERENSON J, 1987, BLOOD, V70, P1550; BERGER MS, 1988, CANCER RES, V48, P1238; BONILLA M, 1988, J NATL CANCER I, V80, P665, DOI 10.1093/jnci/80.9.665; CALLAHAN R, 1989, J CELL BIOCH B, V13, P6; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; EISBRUCH A, 1987, CANCER RES, V47, P3603; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FIELD JK, 1986, ANTICANCER RES, V6, P595; HATADA I, 1988, ONCOGENE, V3, P537; INCE C, 1988, LEUKEMIA, V2, P343; KAOSHAN CS, 1987, CANCER RES, V47, P6278; KRAUSE CJ, 1981, ARCH OTOLARYNGOL, V107, P703; LESTER EP, 1988, P AM ASSOC CANC RES, V29, P28; MARIANICOSTANTINI R, 1988, CANCER RES, V48, P199; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MOORE C, 1971, J AMER MED ASSOC, V218, P553, DOI 10.1001/jama.218.4.553; MULERIS M, 1987, INT J CANCER, V39, P595, DOI 10.1002/ijc.2910390509; PULCIANI S, 1982, J CELL BIOCHEM, V20, P51, DOI 10.1002/jcb.240200106; RABBITTS PH, 1988, ONCOGENE, V3, P99; RECHAVI G, 1989, LEUKEMIA, V3, P57; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SELVANAYAGAM P, 1987, P AM ASSOC CANC RES, V28, P19; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TSUTSUMI M, 1988, JPN J CANCER RES, V79, P428, DOI 10.1111/j.1349-7006.1988.tb01609.x; VANDENBERGHE H, 1984, CANCER GENET CYTOGEN, V11, P381, DOI 10.1016/0165-4608(84)90017-7; VARLEY JM, 1988, ONCOGENE, V3, P87; WONG DTW, 1987, ONCOGENE, V2, P67; WUU KD, 1986, CANCER GENET CYTOGEN, V20, P279, DOI 10.1016/0165-4608(86)90084-1; YAMAMOTO T, 1986, CANCER RES, V46, P414; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898; YOKOTA J, 1986, LANCET, V1, P765; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V155, P1324, DOI 10.1016/S0006-291X(88)81286-5; YUNIS JJ, 1984, CANCER GENET CYTOGEN, V13, P17, DOI 10.1016/0165-4608(84)90084-0; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; ZHOU DJ, 1987, CANCER RES, V47, P6123; ZHOU DJ, 1988, ONCOGENE, V2, P279	48	211	212	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	1989	4	9					1111	1116						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AM531	2476705				2022-12-28	WOS:A1989AM53100009
J	LIPP, M; SCHILLING, R; BERNHARDT, G				LIPP, M; SCHILLING, R; BERNHARDT, G			TRANS-ACTIVATION OF HUMAN MYC - THE 2ND-PROMOTER IS TARGET FOR THE STIMULATION BY ADENOVIRUS E1A PROTEINS	ONCOGENE			English	Article											LIPP, M (corresponding author), UNIV MUNICH,INST BIOCHEM,KARLSTR 23,D-8000 MUNICH 2,FED REP GER.		Lipp, Martin/G-2235-2010; Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853				ALLAN M, 1984, CELL, V38, P399, DOI 10.1016/0092-8674(84)90495-1; ANTOINE G, 1982, EMBO J, V4, P453; ARMELIN HA, 1984, NATURE, V310, P655, DOI 10.1038/310655a0; BACCHETTI S, 1977, P NATL ACAD SCI USA, V74, P1590, DOI 10.1073/pnas.74.4.1590; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1979, CELL, V17, P935, DOI 10.1016/0092-8674(79)90333-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COLE MD, 1987, ANNU REV GENET, V13, P361; DUSSAIX E, 1982, VIROLOGY, V116, P641, DOI 10.1016/0042-6822(82)90156-8; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; GAYNOR RB, 1984, P NATL ACAD SCI-BIOL, V81, P1193, DOI 10.1073/pnas.81.4.1193; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREEN MR, 1983, CELL, V35, P137, DOI 10.1016/0092-8674(83)90216-7; HARLOW E, 1986, MOL CELL BIOL, V6, P1579, DOI 10.1128/MCB.6.5.1579; HARTL P, 1987, MOL CELL BIOL, V7, P2037, DOI 10.1128/MCB.7.6.2037; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KEATH EJ, 1984, CELL, V37, P521, DOI 10.1016/0092-8674(84)90382-9; KELEKAR A, 1987, MOL CELL BIOL, V7, P3899, DOI 10.1128/MCB.7.11.3899; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KLEIN G, 1985, NATURE, V315, P190, DOI 10.1038/315190a0; LALLY C, 1984, EMBO J, V3, P333, DOI 10.1002/j.1460-2075.1984.tb01807.x; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANGNER KD, 1986, P NATL ACAD SCI USA, V83, P1598, DOI 10.1073/pnas.83.6.1598; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; MCCORMACK JE, 1984, P NATL ACAD SCI-BIOL, V81, P5546, DOI 10.1073/pnas.81.17.5546; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; RULEY HE, 1984, CANCER CELL, V2, P481; SASSONECORSI P, 1987, P NATL ACAD SCI USA, V84, P6430, DOI 10.1073/pnas.84.18.6430; THALMEIER K, 1989, IN PRESS GENES DEV, V3; TREISMAN R, 1983, P NATL ACAD SCI-BIOL, V80, P7428, DOI 10.1073/pnas.80.24.7428; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x	42	36	36	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					535	541						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2471129				2022-12-28	WOS:A1989U768800002
J	HILLER, S; BREIT, S; WANG, ZQ; WAGNER, EF; SCHWAB, M				HILLER, S; BREIT, S; WANG, ZQ; WAGNER, EF; SCHWAB, M			LOCALIZATION OF REGULATORY ELEMENTS CONTROLLING HUMAN MYCN EXPRESSION	ONCOGENE			English	Article							HUMAN NEURO-BLASTOMA; AVIAN MYELOCYTOMATOSIS VIRUS; RNA POLYMERASE-II; C-MYC; N-MYC; NUCLEOTIDE-SEQUENCE; BURKITT-LYMPHOMA; GENE-EXPRESSION; PROMOTER REGION; PROTO-ONCOGENE	Expression of the cellular oncogene MYCN is restricted to few cell lineages and is highest during development both in mouse and in humans. In pursuit of elucidating the mechanisms underlying MYCN regulation we introduced a human MYCN clone (pNb-9) with approximately 2.5 kbp 5'- and 6 kbp 3'-flanking genomic sequences into different murine and human cell lines as well as into mice. In all cases we found a correlation between the expression of the exogenous and the endogenous MYCN. Among cell lines, only those expressing the endogenous gene also expressed the transfected gene. In the transgenic mice transcripts of the transgene were present in proportion to the transcripts of the endogenous MYCN gene with the highest level in the brain. Therefore, the genetic information necessary for regulated expression of MYCN appears to be contained in pNb-9. To localize the DNA-regions responsible for regulated expression, we generated MYCN/CAT hybrid genes with different portions of the putative MYCN promoter region linked to the reporter gene. Transient transfections into various murine and human cell lines identified three DNA regions apparently involved in the regulation of expression. One region about 200 bp upstream of the transcriptional start sites is responsible for a basal level of MYCN expression. A second region located about 800 bp further upstream appears to be involved in cell type-specific gene activation. The third regulatory element is located at the 3' end of the first exon and/or in the first intron and may mediate tissue-specific down regulation of gene expression.	INST MOLEK PATHOL,A-1030 VIENNA,AUSTRIA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	HILLER, S (corresponding author), DEUTSCH KREBSFORSCHUNGSZENTRUM,INST EXPTL PATHOL,NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY.			Wagner, Erwin F/0000-0001-7872-0196				AGHIB DF, 1990, ONCOGENE, V5, P707; ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; ALT FW, 1986, COLD SPRING HARB SYM, V51, P931, DOI 10.1101/SQB.1986.051.01.106; AMLER LC, 1989, MOL CELL BIOL, V9, P4903, DOI 10.1128/MCB.9.11.4903; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; ASKER C, 1989, ONCOGENE, V4, P1523; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BREIT S, 1989, J NEUROSCI RES, V24, P21, DOI 10.1002/jnr.490240105; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Cleveland J L, 1988, Oncogene Res, V3, P357; CLOSE TJ, 1982, GENE, V20, P305, DOI 10.1016/0378-1119(82)90048-8; COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FOUREL G, 1990, NATURE, V347, P294, DOI 10.1038/347294a0; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRADY EF, 1987, CANCER RES, V47, P2931; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRIGNANI F, 1990, EMBO J, V9, P3913, DOI 10.1002/j.1460-2075.1990.tb07612.x; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HOGAN B, 1986, MANIPULATING MOUSE E; IBSON JM, 1988, ONCOGENE, V2, P399; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; KADDURAHDAOUK R, 1987, GENE DEV, V1, P347, DOI 10.1101/gad.1.4.347; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAYE F, 1988, MOL CELL BIOL, V8, P186, DOI 10.1128/MCB.8.1.186; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KRYSTAL G, 1988, MOL CELL BIOL, V8, P3373, DOI 10.1128/MCB.8.8.3373; KUBOTA Y, 1989, BIOCHEM BIOPH RES CO, V162, P991, DOI 10.1016/0006-291X(89)90771-7; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCGROGAN M, 1985, J BIOL CHEM, V260, P2307; MELTON DW, 1986, CELL, V44, P319, DOI 10.1016/0092-8674(86)90766-X; NEPVEU A, 1987, ONCOGENE, V1, P243; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; SCHWAB M, 1988, ONCOGENE HDB, P381; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SPECTOR DL, 1987, ONCOGENE, V1, P5; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; STANTON LW, 1987, MOL CELL BIOL, V7, P4266, DOI 10.1128/MCB.7.12.4266; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; VANLOHUIZEN M, 1989, EMBO J, V8, P133, DOI 10.1002/j.1460-2075.1989.tb03357.x; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x; ZIMMERMAN K, 1990, MOL CELL BIOL, V10, P2096, DOI 10.1128/MCB.10.5.2096; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	64	35	36	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					969	977						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067849				2022-12-28	WOS:A1991GU62200011
J	COHN, SL; SALWEN, H; QUASNEY, MW; IKEGAKI, N; COWAN, JM; HERST, CV; KENNETT, RH; ROSEN, ST; DIGIUSEPPE, JA; BRODEUR, GM				COHN, SL; SALWEN, H; QUASNEY, MW; IKEGAKI, N; COWAN, JM; HERST, CV; KENNETT, RH; ROSEN, ST; DIGIUSEPPE, JA; BRODEUR, GM			PROLONGED N-MYC PROTEIN HALF-LIFE IN A NEUROBLASTOMA CELL-LINE LACKING N-MYC AMPLIFICATION	ONCOGENE			English	Article							HUMAN NEURO-BLASTOMA; ONCOGENE EXPRESSION; TUMORS; GENE; DNA; IDENTIFICATION; CHROMOSOME-1; DEFINITION	Genomic amplification of the oncogene N-myc is associated with rapid tumor progression and poor prognosis in patients with neuroblastoma (NB). However, 40% of NBs which lack N-myc amplification are also clinically aggressive. Factors other than N-myc copy number must therefore play a role in determining tumor progression in these NBs. We have established an unusual human NB cell line (NBL-S) from the primary tumor of a patient with rapidly progressive disease which lacks N-myc amplification. The doubling time in vitro (48 h) and the time from injection of 2 x 10(7) cells to detectable tumors in nude mice (46 days) is similar to NB cell lines with amplified N-myc. However, karyotype analysis reveals no evidence of double minutes (DMs), homogeneously staining regions (HSRs), or chromosome 1p deletions, features commonly seen in NB cell lines. The cells have the cell surface phenotype typical of N-myc amplified NB (HLA-A,B,C negative and HSAN 1.2 positive), and similar to other NB cell lines, N-myc RNA and protein are expressed. Interestingly, the half-life of the N-myc protein in NBL-S is prolonged (approximately 100 min) compared to the short N-myc protein half-life previously described in N-myc amplified NB cell lines (approximately 30 min). Because N-myc protein is thought to have a regulatory role, prolongation of the half-life of this protein may be an important factor in the regulation of growth in NBs which lack N-myc amplification and rapidly progress.	NORTHWESTERN UNIV,MED CTR,DEPT PEDIAT,CHICAGO,IL 60614; NORTHWESTERN UNIV,MED CTR,DEPT MED,CHICAGO,IL 60614; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; UNIV CHICAGO,MED CTR,DEPT RADIAT & CELLULAR ONCOL,CHICAGO,IL 60637; ONCORE ANALYT,HOUSTON,TX 77008; WASHINGTON UNIV,MED CTR,DEPT PEDIAT,ST LOUIS,MO 63110	Northwestern University; Northwestern University; University of Pennsylvania; University of Chicago; University of Chicago Medical Center; Washington University (WUSTL)			Cohn, Susan/AAB-6010-2021; DiGiuseppe, Joseph/AAD-1935-2019	Cohn, Susan/0000-0001-5749-7650	NCI NIH HHS [CA-01027, CA-39771] Funding Source: Medline; NCRR NIH HHS [RR-05730] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K04CA001027, R01CA039771] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTRAM CR, 1987, EUR J PEDIATR, V146, P162, DOI 10.1007/BF02343225; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; Brodeur G M, 1988, Prog Clin Biol Res, V271, P3; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1981, CANCER RES, V41, P4678; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CIECHANOVER A, 1990, IN PRESS P NATL ACAD; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COLLINS SJ, 1987, BLOOD, V70, P1233; COWAN JM, 1988, J NATL CANCER I, V80, P1159, DOI 10.1093/jnci/80.14.1159; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GILBERT F, 1984, CANCER RES, V44, P5444; GRADYLEOPARDI EF, 1986, CANCER RES, V46, P3196; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; IKEGAKI N, 1986, P NATL ACAD SCI USA, V83, P5929, DOI 10.1073/pnas.83.16.5929; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; MAKELA TP, 1989, MOL CELL BIOL, V9, P1545; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MICHITSCH RW, 1984, MOL CELL BIOL, V4, P2370, DOI 10.1128/MCB.4.11.2370; NISEN PD, 1988, J NATL CANCER I, V80, P1633, DOI 10.1093/jnci/80.20.1633; PARHAM P, 1979, J IMMUNOL, V123, P342; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; Reynolds C P, 1988, Prog Clin Biol Res, V271, P291; ROSS RA, 1983, J NATL CANCER I, V71, P741; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; Seeger R C, 1988, Prog Clin Biol Res, V271, P41; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; SLAVC I, 1990, CANCER RES, V50, P1459; SMITH RG, 1987, DIAGN CLIN IMMUNOL, V5, P209; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THIELE CJ, 1987, J CLIN INVEST, V80, P804, DOI 10.1172/JCI113137; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; VENNSTROM B, 1981, J VIROL, V39, P625; Wada R K, 1988, Prog Clin Biol Res, V271, P57; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; YOUNG JL, 1975, J PEDIATR-US, V86, P254, DOI 10.1016/S0022-3476(75)80484-7	43	96	96	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1821	1827						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284101				2022-12-28	WOS:A1990ET43600012
J	MORI, N; YOKOTA, J; AKIYAMA, T; SAMESHIMA, Y; OKAMOTO, A; MIZOGUCHI, H; TOYOSHIMA, K; SUGIMURA, T; TERADA, M				MORI, N; YOKOTA, J; AKIYAMA, T; SAMESHIMA, Y; OKAMOTO, A; MIZOGUCHI, H; TOYOSHIMA, K; SUGIMURA, T; TERADA, M			VARIABLE MUTATIONS OF THE RB GENE IN SMALL-CELL LUNG-CARCINOMA	ONCOGENE			English	Article									TOKYO WOMENS MED COLL,DEPT MED,SHINJUKU KU,TOKYO 162,JAPAN; UNIV TOKYO,INST MED SCI,DEPT ONCOL,MINATO KU,TOKYO 108,JAPAN	Tokyo Women's Medical University; University of Tokyo	YOKOTA, J (corresponding author), NATL CANC CTR,RES INST,STUDIES METASTASIS SECT,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN.							AKIYAMA T, 1990, ONCOGENE, V5, P179; BOOKSTEIN R, 1990, SCIENCE, V247, P712, DOI 10.1126/science.2300823; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; HONG FD, 1989, P NATL ACAD SCI USA, V86, P5502, DOI 10.1073/pnas.86.14.5502; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; MORI N, 1989, CANCER RES, V49, P5130; NAYLOR SL, 1987, NATURE, V329, P451, DOI 10.1038/329451a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WHANGPENG J, 1982, SCIENCE, V215, P181, DOI 10.1126/science.6274023; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YANDELL DW, 1989, NEW ENGL J MED, V321, P1659; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; YOKOTA J, 1988, ONCOGENE, V3, P471	24	115	116	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1713	1717						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2176283				2022-12-28	WOS:A1990EL40100015
J	FIRMBACHKRAFT, I; BYERS, M; SHOWS, T; DALLAFAVERA, R; KROLEWSKI, JJ				FIRMBACHKRAFT, I; BYERS, M; SHOWS, T; DALLAFAVERA, R; KROLEWSKI, JJ			TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES	ONCOGENE			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,CTR CANC,NEW YORK,NY 10032; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	Columbia University; Columbia University; Roswell Park Cancer Institute					NCI NIH HHS [CA44029] Funding Source: Medline; NICHD NIH HHS [HD05196] Funding Source: Medline; NIGMS NIH HHS [GM20454] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005196] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA044029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020454] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEARY ML, 1988, J EXP MED, V167, P682, DOI 10.1084/jem.167.2.682; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HALUSKA FG, 1987, ANNU REV GENET, V21, P321, DOI 10.1146/annurev.ge.21.120187.001541; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOFFMANN FM, 1983, CELL, V35, P393, DOI 10.1016/0092-8674(83)90172-1; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KROLEWSKI JJ, 1990, ONCOGENE, V5, P277; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maniatis T., 1982, MOL CLONING; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MELLENTIN JD, 1989, SCIENCE, V246, P379, DOI 10.1126/science.2799390; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; OPPERMANN H, 1981, VIROLOGY, V108, P47, DOI 10.1016/0042-6822(81)90526-2; PAWSON T, 1988, ONCOGENE, V3, P491; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; RUTA M, 1988, ONCOGENE, V3, P9; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SHAW AS, 1989, CELL, V59, P627, DOI 10.1016/0092-8674(89)90008-1; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; WILLIAMS DL, 1984, CELL, V36, P101, DOI 10.1016/0092-8674(84)90078-3; WOOLFORD J, 1985, MOL CELL BIOL, V5, P3458, DOI 10.1128/MCB.5.12.3458; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932	44	301	322	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1329	1336						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216457				2022-12-28	WOS:A1990EC24100008
J	ZHANG, XK; HUANG, DP; QIU, DK; CHIU, JF				ZHANG, XK; HUANG, DP; QIU, DK; CHIU, JF			THE EXPRESSION OF C-MYC AND C-N-RAS IN HUMAN CIRRHOTIC LIVERS, HEPATOCELLULAR CARCINOMAS AND LIVER-TISSUE SURROUNDING THE TUMORS	ONCOGENE			English	Article									UNIV VERMONT,COLL MED,DEPT BIOCHEM,BURLINGTON,VT 05405	University of Vermont					NATIONAL CANCER INSTITUTE [R01CA042969, R01CA025098] Funding Source: NIH RePORTER; NCI NIH HHS [CA42969, CA25098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANTHONY PP, 1976, CANCER RES, V36, P2579; BEER DG, 1986, CANCER RES, V46, P2435; BERMAN C, 1958, ADV CANCER RES, V5, P55, DOI 10.1016/S0065-230X(08)60409-1; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COOK JR, 1986, J BIOL CHEM, V261, P4463; CORCOS D, 1984, BIOCHEM BIOPH RES CO, V122, P259, DOI 10.1016/0006-291X(84)90468-6; COTE GJ, 1987, BIOCHEM BIOPH RES CO, V143, P624, DOI 10.1016/0006-291X(87)91399-4; COTE GJ, 1985, CANCER LETT, V26, P121, DOI 10.1016/0304-3835(85)90017-5; FAUSTO N, 1983, HEPATOLOGY, V3, P1016; HIRAI H, 1973, ALPHA FETOPROTEIN HE; HSIEH LL, 1988, CANCER RES, V48, P265; HSIEH LL, 1987, CANCER RES, V47, P3421; HSU TY, 1988, CELL, V55, P627, DOI 10.1016/0092-8674(88)90221-8; KLEIN G, 1986, CANCER RES, V46, P3211; KOSS B, 1982, CANCER RES, V42, P2146; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; MAKINO R, 1984, BIOCHEM BIOPH RES CO, V119, P1096, DOI 10.1016/0006-291X(84)90887-8; MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0; MANIATIS T, 1982, MOL CLONING LAB MANU, P221; MOROY T, 1986, NATURE, V324, P276, DOI 10.1038/324276a0; MURRAY MJ, 1983, CELL, V33, P749, DOI 10.1016/0092-8674(83)90017-X; NAGY P, 1988, CANCER RES, V48, P5522; NICOLSON GL, 1987, CANCER RES, V47, P1473; POPPER H, 1979, ENVIRON RES, V19, P482, DOI 10.1016/0013-9351(79)90072-0; REN GJ, 1986, J CELL PHYSIOL, V4, P13; ROGERS AE, 1965, LAB INVEST, V14, P1710; ROGERS AE, 1969, CANCER RES, V29, P1965; STRIVASTAVA A, 1985, J BIOL CHEM, V260, P6404; SU TS, 1985, BIOCHEM BIOPH RES CO, V32, P264; TANG ZY, 1985, SUBCLINICAL HEPATOCE, P54; TASHIRO F, 1986, BIOCHEM BIOPH RES CO, V138, P854; THOMPSON NL, 1986, CANCER RES, V46, P3111; YASWEN P, 1985, MOL CELL BIOL, V5, P780, DOI 10.1128/MCB.5.4.780; ZHANG XK, 1988, CANCER LETT, V41, P147, DOI 10.1016/0304-3835(88)90111-5; ZHANG XK, 1987, BIOCHEM BIOPH RES CO, V142, P923	36	73	79	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					909	914						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2163054				2022-12-28	WOS:A1990DP55300018
J	LEMOINE, NR; STADDON, S; DICKSON, C; BARNES, DM; GULLICK, WJ				LEMOINE, NR; STADDON, S; DICKSON, C; BARNES, DM; GULLICK, WJ			ABSENCE OF ACTIVATING TRANSMEMBRANE MUTATIONS IN THE C-ERBB-2 PROTOONCOGENE IN HUMAN BREAST-CANCER	ONCOGENE			English	Note									GUYS & ST THOMAS HOSP,IMPERIAL CANC RES FUND,CLIN ONCOL UNIT,LONDON SE1 9RT,ENGLAND; IMPERIAL CANC RES FUND,VIRAL CARCINOGENESIS LAB,LONDON WC2A 3PX,ENGLAND	Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; Cancer Research UK	LEMOINE, NR (corresponding author), HAMMERSMITH HOSP,MRC,IMPERIAL CANC RES FUND,MOLEC ONCOL GRP,CYCLOTRON BLDG,DUCANE RD,LONDON W12 0HS,ENGLAND.							BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; KUMAR R, 1988, ONCOGENE, V3, P647; KUMAR R, 1989, ONCOGENE RES, V1, P235; PROSPERI MT, 1987, ONCOGENE RES, V1, P121; SEGATTO O, 1988, MOL CELL BIOL, V8, P5570, DOI 10.1128/MCB.8.12.5570; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0	15	161	162	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1990	5	2					237	239						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CU029	2181382				2022-12-28	WOS:A1990CU02900011
J	GLINEUR, C; BAILLY, M; GHYSDAEL, J				GLINEUR, C; BAILLY, M; GHYSDAEL, J			THE C-ERBA ALPHA-ENCODED THYROID-HORMONE RECEPTOR IS PHOSPHORYLATED IN ITS AMINO TERMINAL DOMAIN BY CASEIN KINASE-II	ONCOGENE			English	Article											GLINEUR, C (corresponding author), INST PASTEUR,CNRS,UA 1160,INSERM,U186,1 RUE CALMETTE,F-59019 LILLE,FRANCE.		GHYSDAEL, Jacques/F-3377-2013					ACKERMAN P, 1985, P NATL ACAD SCI USA, V82, P3164, DOI 10.1073/pnas.82.10.3164; BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BREATHNACH R, 1983, NUCLEIC ACIDS RES, V11, P7110; DAHMUS ME, 1981, J BIOL CHEM, V256, P3332; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; DRAPEAU GR, 1980, J BIOL CHEM, V255, P839; DURBAN E, 1985, EMBO J, V4, P2921, DOI 10.1002/j.1460-2075.1985.tb04024.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GILMORE T, 1985, CELL, V40, P609, DOI 10.1016/0092-8674(85)90209-0; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOROWITZ ZD, 1989, MOL ENDOCRINOL, V3, P148, DOI 10.1210/mend-3-1-148; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JANSSON M, 1987, ONCOGENE, V1, P167; JANSSON M, 1983, EMBO J, V2, P561, DOI 10.1002/j.1460-2075.1983.tb01463.x; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LAZAR MA, 1988, MOL ENDOCRINOL, V2, P479, DOI 10.1210/mend-2-6-479; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MUNOZ A, 1988, EMBO J, V6, P375; NAKAI A, 1988, MOL ENDOCRINOL, V2, P1087, DOI 10.1210/mend-2-11-1087; NAKAI A, 1988, P NATL ACAD SCI USA, V85, P2781, DOI 10.1073/pnas.85.8.2781; PINNA LA, 1979, BIOCHEM BIOPH RES CO, V87, P114, DOI 10.1016/0006-291X(79)91654-1; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; SOMMERCORN J, 1987, J BIOL CHEM, V262, P3839; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; TUAZON PT, 1979, EUR J BIOCHEM, V94, P497, DOI 10.1111/j.1432-1033.1979.tb12918.x; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; WALTON GM, 1983, J BIOL CHEM, V258, P4440; WEINBERGER C, 1985, NATURE, V318, P670, DOI 10.1038/318670a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1	54	85	87	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1247	1254						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2552374				2022-12-28	WOS:A1989AU50800013
J	SUBRAMANIAN, T; LAREGINA, M; CHINNADURAI, G				SUBRAMANIAN, T; LAREGINA, M; CHINNADURAI, G			ENHANCED RAS ONCOGENE MEDIATED CELL-TRANSFORMATION AND TUMORIGENESIS BY ADENOVIRUS-2 MUTANTS LACKING THE C-TERMINAL REGION OF E1A PROTEIN	ONCOGENE			English	Article									ST LOUIS UNIV,MED CTR,INST MOLEC VIROL,3681 PK AVE,ST LOUIS,MO 63110; ST LOUIS UNIV,MED CTR,DEPT COMPARAT MED,ST LOUIS,MO 63104	Saint Louis University; Saint Louis University					NATIONAL CANCER INSTITUTE [R01CA033616, R01CA031719] Funding Source: NIH RePORTER; NCI NIH HHS [CA-33616, CA-31719] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERNARDS R, 1983, NATURE, V305, P776, DOI 10.1038/305776a0; CONE RD, 1988, MOL CELL BIOL, V8, P1036, DOI 10.1128/MCB.8.3.1036; COOK JL, 1986, P NATL ACAD SCI USA, V83, P6965, DOI 10.1073/pnas.83.18.6965; EAGER KB, 1985, P NATL ACAD SCI USA, V82, P5525, DOI 10.1073/pnas.82.16.5525; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HADDADA H, 1988, J VIROL, V62, P2755, DOI 10.1128/JVI.62.8.2755-2761.1988; HARLOW E, 1985, J VIROL, V55, P533, DOI 10.1128/JVI.55.3.533-546.1985; KIMELMAN D, 1985, J VIROL, V53, P399, DOI 10.1128/JVI.53.2.399-409.1985; KUPPUSWAMY M, 1988, ONCOGENE, V2, P567; KUPPUSWAMY M, 1988, ONCOGENE, V2, P613; KUPPUSWAMY MN, 1987, VIROLOGY, V159, P31, DOI 10.1016/0042-6822(87)90344-8; LATHE R, 1984, DNA-J MOLEC CELL BIO, V3, P173, DOI 10.1089/dna.1984.3.173; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LYONS RH, 1987, MOL CELL BIOL, V7, P2451, DOI 10.1128/MCB.7.7.2451; Maniatis T., 1982, MOL CLONING; MORAN E, 1988, NATURE, V334, P168, DOI 10.1038/334168a0; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; POZZATTI R, 1986, SCIENCE, V232, P223, DOI 10.1126/science.3456644; POZZATTI R, 1988, MOL CELL BIOL, V8, P2984, DOI 10.1128/MCB.8.7.2984; QUINLAN MP, 1988, MOL CELL BIOL, V8, P3191, DOI 10.1128/MCB.8.8.3191; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SCHNEIDER JF, 1987, EMBO J, V6, P2053, DOI 10.1002/j.1460-2075.1987.tb02470.x; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SUBRAMANIAN T, 1988, ONCOGENE, V2, P105; VANORMONDT H, 1980, GENE, V12, P63, DOI 10.1016/0378-1119(80)90016-5; VASAVADA R, 1986, P NATL ACAD SCI USA, V83, P5257, DOI 10.1073/pnas.83.14.5257; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WHYTE P, 1988, J VIROL, V62, P257, DOI 10.1128/JVI.62.1.257-265.1988; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887; [No title captured]	34	87	93	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					415	420						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2524023				2022-12-28	WOS:A1989U567700004
J	KANNER, SB; GILMER, TM; REYNOLDS, AB; PARSONS, JT				KANNER, SB; GILMER, TM; REYNOLDS, AB; PARSONS, JT			NOVEL TYROSINE PHOSPHORYLATIONS ACCOMPANY THE ACTIVATION OF PP60C-SRC DURING CHEMICAL CARCINOGENESIS	ONCOGENE			English	Article									UNIV VIRGINIA,SCH MED,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,SCH MED,CTR CANC,CHARLOTTESVILLE,VA 22908; NIEHS,MOLEC CARCINOGENESIS LAB,RES TRIANGLE PK,NC 27709	University of Virginia; University of Virginia; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)					NATIONAL CANCER INSTITUTE [P01CA040042, R01CA029243, R37CA029243, F32CA008316] Funding Source: NIH RePORTER; NCI NIH HHS [CA29243, CA08316, CA40042] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRETT JC, 1978, P NATL ACAD SCI USA, V75, P3761, DOI 10.1073/pnas.75.8.3761; BARRETT JC, 1979, CANCER RES, V39, P1504; BARRETT JC, 1980, CANCER RES, V40, P91; BARRETT JC, 1987, MECHANISMS ENV CARCI, V2; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER JA, 1983, METHODS ENZYMOLOGY; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; EKM B, 1984, J BIOL CHEM, V259, P11145; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; GILMER TM, 1987, CANCER RES, V47, P4663; GILMER TM, 1985, MOL CELL BIOL, V5, P1707, DOI 10.1128/MCB.5.7.1707; HAMAGUCHI M, 1988, MOL CELL BIOL, V8, P3035, DOI 10.1128/MCB.8.8.3035; HESTERBERG TW, 1984, CANCER RES, V44, P2170; IBA H, 1985, MOL CELL BIOL, V5, P1058, DOI 10.1128/MCB.5.5.1058; KAMPS MP, 1988, ONCOGENE, V2, P305; KANNER SB, 1988, ONCOGENE, V2, P327; KOI M, 1986, P NATL ACAD SCI USA, V83, P5992, DOI 10.1073/pnas.83.16.5992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDER ME, 1988, P NATL ACAD SCI USA, V85, P2608, DOI 10.1073/pnas.85.8.2608; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MARTINEZ R, 1982, MOL CELL BIOL, V2, P653, DOI 10.1128/MCB.2.6.653; MCLACHLAN JA, 1982, CANCER RES, V42, P3040; MORRISON DK, 1988, MOL CELL BIOL, V8, P176, DOI 10.1128/MCB.8.1.176; OHTSUKA M, 1984, INT J CANCER, V34, P855, DOI 10.1002/ijc.2910340618; OSHIMURA M, 1985, NATURE, V316, P636, DOI 10.1038/316636a0; OSHIMURA M, 1986, CANCER GENET CYTOGEN, V22, P225, DOI 10.1016/0165-4608(86)90159-7; PANG DT, 1985, ARCH BIOCHEM BIOPHYS, V242, P176, DOI 10.1016/0003-9861(85)90491-6; RESH MD, 1985, J CELL BIOL, V100, P409, DOI 10.1083/jcb.100.2.409; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; YOUNG JC, 1984, J VIROL, V52, P913, DOI 10.1128/JVI.52.3.913-918.1984	33	19	19	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					295	300						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2468123				2022-12-28	WOS:A1989U567600004
J	LARCHER, JC; VAYSSIERE, JL; LOSSOUARN, L; GROS, F; CROIZAT, B				LARCHER, JC; VAYSSIERE, JL; LOSSOUARN, L; GROS, F; CROIZAT, B			REGULATION OF C-MYC AND N-MYC EXPRESSION DURING INDUCED-DIFFERENTIATION OF MURINE NEUROBLASTOMA-CELLS	ONCOGENE			English	Article							NEURO-BLASTOMA CELLS; ACID-INDUCED DIFFERENTIATION; RNA; ONCOGENES; INDUCTION; MEMBRANE; GENES; DNA	Using clones N1E-115 and N1A-103 from mouse neuroblastoma C1300, a comparative analysis of c- and N-myc gene expression was undertaken both in proliferating cells and in cultures exposed to conditions which induce differentiation. Under the latter conditions, while N1E-115 cells extend abundant neurites and express many biochemical features of mature neurons, clone N1A-103 stops dividing and expresses certain neurospecific markers but is unable to differentiate morphologically. In both clones, chemical agents, i.e. 1-methyl cyclohexane carboxylic acid (CCA) or dimethyl sulfoxide (DMSO), induce a decrease in c-myc expression. Similar results were found for N-myc gene in N1E-115 cells, but in contrast, in clone N1A-103, N-myc expression is increased with CCA and not modified with DMSO. Globally, this study favours the hypothesis that changes in c-myc expression would correspond to cell division blockade and differentiation, while modulations in N-myc are more closely related to an early phase of terminal differentiation.			LARCHER, JC (corresponding author), COLL FRANCE, BIOCHIM CELLULAIRE LAB, 11 PL MARCELIN BERTHELOT, F-75231 PARIS 05, FRANCE.							AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; AUGUSTIT.G, 1969, P NATL ACAD SCI USA, V64, P311, DOI 10.1073/pnas.64.1.311; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BAUMGOLD J, 1987, J NEUROCHEM, V48, P1264, DOI 10.1111/j.1471-4159.1987.tb05656.x; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1984, BIOCHEM BIOPH RES CO, V122, P340, DOI 10.1016/0006-291X(84)90480-7; CROIZAT B, 1979, CR ACAD SCI D NAT, V289, P1283; CROIZAT B, 1977, EUR J BIOCHEM, V74, P405, DOI 10.1111/j.1432-1033.1977.tb11405.x; EDDE B, 1987, DEV BIOL, V123, P549, DOI 10.1016/0012-1606(87)90413-1; GRIEP AE, 1986, P NATL ACAD SCI USA, V83, P5539, DOI 10.1073/pnas.83.15.5539; HANLEY MR, 1988, NEURON, V1, P175, DOI 10.1016/0896-6273(88)90137-7; HELDIN CH, 1984, CELL, V37, P9, DOI 10.1016/0092-8674(84)90296-4; HENRIKSSON M, 1988, ONCOGENE, V3, P587; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; JALAVA AM, 1988, EXP CELL RES, V179, P10, DOI 10.1016/0014-4827(88)90343-6; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; KIMHI Y, 1976, P NATL ACAD SCI USA, V73, P462, DOI 10.1073/pnas.73.2.462; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LUCAS M, 1988, DEV NEUROSCI-BASEL, V10, P91, DOI 10.1159/000111960; Maniatis T., 1982, MOL CLONING; MAURO F, 1970, CANCER RES, V30, P1397; MCCACHREN SS, 1988, BIOCHEM BIOPH RES CO, V151, P574, DOI 10.1016/0006-291X(88)90633-X; PALFREY C, 1977, BIOCHEM BIOPH RES CO, V76, P937, DOI 10.1016/0006-291X(77)91592-3; PORTIER MM, 1982, FEBS LETT, V146, P283, DOI 10.1016/0014-5793(82)80935-6; SCHUBERT D, 1971, DEV BIOL, V25, P514, DOI 10.1016/0012-1606(71)90004-2; SEJERSEN T, 1987, EXP CELL RES, V172, P304, DOI 10.1016/0014-4827(87)90389-2; SERRANO L, 1989, EXP CELL RES, V181, P263, DOI 10.1016/0014-4827(89)90200-0; SHIMA H, 1989, P NATL ACAD SCI USA, V86, P7442, DOI 10.1073/pnas.86.19.7442; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; VAYSSIERE JL, 1987, BIOCHEM BIOPH RES CO, V145, P443, DOI 10.1016/0006-291X(87)91341-6; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; WHITE BA, 1982, J BIOL CHEM, V257, P8569; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0; ZISAPEL N, 1979, EUR J BIOCHEM, V95, P51, DOI 10.1111/j.1432-1033.1979.tb12938.x	36	19	19	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1991	6	4					633	638						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030913				2022-12-28	WOS:A1991FR93900019
J	LEE, JH; LI, YC; DOERRE, S; SISTA, P; BALLARD, DW; GREENE, WC; FRANZA, BR				LEE, JH; LI, YC; DOERRE, S; SISTA, P; BALLARD, DW; GREENE, WC; FRANZA, BR			A MEMBER OF THE SET OF KAPPA-B BINDING-PROTEINS, HIVEN86A, IS A PRODUCT OF THE HUMAN C-REL PROTOONCOGENE	ONCOGENE			English	Note							RECEPTOR-ALPHA-GENE; TRANSCRIPTION FACTOR; CELLULAR PROTEINS; T-CELLS; ENHANCER; NUCLEAR; EXPRESSION; TRANSACTIVATION; ACTIVATION; SEQUENCES	HIVEN86A is an inducible member of a set of cellular proteins that specifically bind to the kappa-B enhancer (Franza et al., 1987; Franza, 1988; Franza, 1990; Ballard et al., 1989; Bohnlein et al., 1988). This enhancer motif has been detected in numerous cellular and viral transcription control domains (Boshart et al., 1985; Sen & Baltimore, 1986; Nabel & Baltimore, 1987). Recently, cDNAs have been cloned (Kieran et al., 1990; Baldwin & Sharp, 1987) that encode the 50 kD DNA binding subunit of murine NF-kappa-B (for review: Leonardo & Baltimore, 1989) and the closely related human kappa binding factor (KBF-1) (Kimura et al., 1986; Baldwin & Sharp, 1987). A 350 amino acid domain at the N-terminus of these proteins was found to be homologous with the v-rel oncogene from the avian reticuloendotheliosis virus, strain T (REV-T), as well as a maternal effect gene, dorsal (Kieran et al., 1990; Ghosh et al., 1990). Dorsal is known to activate transcription of certain Drosophila genes (Rushlow et al., 1987). The v-Rel oncoprotein has been identified as a transcriptional activator (Gelinas & Temin, 1988; Hannink & Temin, 1989; Bull et al., 1990) in certain assay systems and shown to be induced by the tumor promoter, phorbol 12-myristate 13-acetate (PMA) in avian cells (for review: Rice & Gilden, 1988). HIVEN86A is also inducible by PMA (Franza et al., 1987; Franza, 1988; Franza, 1990). We now demonstrate that the protein product of the human c-rel proto-oncogene is structurally identical to HIVEN86A.	COLD SPRING HARBOR LAB,BUNGTOWN RD,POB 100,COLD SPRING HARBOR,NY 11724; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710	Cold Spring Harbor Laboratory; Duke University; Howard Hughes Medical Institute								BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALDWIN AS, 1987, MOL CELL BIOL, V7, P305, DOI 10.1128/MCB.7.1.305; BALLARD D W, 1989, New Biologist, V1, P83; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; BROWNELL E, 1989, ONCOGENE, V4, P935; BULL P, 1990, MOL CELL BIOL, V10, P5473, DOI 10.1128/MCB.10.10.5473; FRANZA BR, 1988, CONTROL OF HUMAN RETROVIRUS GENE EXPRESSION, P159; FRANZA BR, 1987, NATURE, V330, P391, DOI 10.1038/330391a0; FRANZA BR, 1990, HUMAN RETROVIRUSES, P181; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; GELINAS C, 1988, ONCOGENE, V3, P349; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HANNINK M, 1989, MOL CELL BIOL, V9, P4323, DOI 10.1128/MCB.9.10.4323; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KIMURA A, 1986, CELL, V44, P261, DOI 10.1016/0092-8674(86)90760-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonardo MJ, 1998, CELL, V58, P227; LISCHWE MA, 1977, J BIOL CHEM, V252, P4976; MOLITOR JA, 1990, P NATL ACAD SCI USA, V87, P10028, DOI 10.1073/pnas.87.24.10028; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; RICE NR, 1988, ONCOGENE HDB, P495; RUSHLOW CA, 1989, CELL, V59, P1165, DOI 10.1016/0092-8674(89)90772-1; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6	27	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					665	667						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030915				2022-12-28	WOS:A1991FR93900024
J	DRAGANI, TA; MANENTI, G; COLOMBO, BM; FALVELLA, FS; GARIBOLDI, M; PIEROTTI, MA; DELLAPORTA, G				DRAGANI, TA; MANENTI, G; COLOMBO, BM; FALVELLA, FS; GARIBOLDI, M; PIEROTTI, MA; DELLAPORTA, G			INCIDENCE OF MUTATIONS AT CODON-61 OF THE HA-RAS GENE IN LIVER-TUMORS OF MICE GENETICALLY SUSCEPTIBLE AND RESISTANT TO HEPATOCARCINOGENESIS	ONCOGENE			English	Article							TRANSGENIC MICE; B6C3F1 MOUSE; DIETHYLNITROSAMINE HEPATOCARCINOGENESIS; HEPATOCELLULAR-CARCINOMA; N-NITROSODIETHYLAMINE; ACTIVATED ONCOGENES; INFANT MOUSE; KI-RAS; EXPRESSION; LESIONS	By selective oligonucleotide hybridization of polymerase chain reaction (PCR) amplified tumor DNAs we have analysed the incidence of mutations at codon 61 of the Ha-ras gene in 42 liver tumors spontaneously developed in Balb/c, C3Hf and B6C3 male mice, and in 79 liver tumors induced by the chemical carcinogens diethylnitrosamine (NDEA) and urethan in B6C3 and B6C male and female mice. The incidence of Ha-ras gene mutations in both spontaneously developed and urethan-induced liver tumors was 50%-63% in mice genetically susceptible to hepatocarcinogenesis (C3Hf, B6C3) and 7%-9% in mice genetically resistant (Balb/c, B6C). Urethan-induced tumors showed about the same incidence of ras mutations in male and in female B6C3 mice. NDEA-induced tumors showed a low incidence of Ha-ras mutations in both the hybrid mice (3/18 and 1/13 in B6C3 and B6C male mice, respectively). The most frequently found mutations were a C --> A transversion at the 1st base of codon 61 in spontaneous tumors, and an A --> T transversion at the 2nd base in urethan-induced tumors. Our results indicate that liver tumors induced by NDEA or urethan or spontaneously arisen have a different pattern of Ha-ras mutations at codon 61 and that these mutations constitute a rare molecular alteration in the pathogenesis of liver tumors in genetically resistant mice.			DRAGANI, TA (corresponding author), IST NAZL TUMORI,DIV EXPTL ONCOL A,VIA G VENEZIAN 1,I-20133 MILAN,ITALY.		Manenti, Giacomo/J-3339-2017; Gariboldi, Manuela/K-4744-2016; Dragani, Tommaso A./K-4493-2016	Manenti, Giacomo/0000-0002-4887-4482; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X; Dragani, Tommaso A./0000-0001-5915-4598				ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECKER FF, 1982, CANCER RES, V42, P3918; BECKER FF, 1985, CANCER RES, V45, P768; BONHAM K, 1989, MOL CARCINOGEN, V2, P34, DOI 10.1002/mc.2940020106; BUCHMANN A, 1989, MOL CARCINOGEN, V2, P121, DOI 10.1002/mc.2940020303; DELLAPORTA G, 1978, TOXICOL APPL PHARM, V43, P293, DOI 10.1016/0041-008X(78)90009-1; DELLAPORTA G, 1990, TERATOGEN CARCIN MUT, V10, P137; DELLAPORTA G, 1984, J CANCER RES CLIN, V108, P308; DELLAPORTA G, 1982, CARCINOGENESIS, V3, P647; DIWAN BA, 1986, CARCINOGENESIS, V7, P215, DOI 10.1093/carcin/7.2.215; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; DRAGANI TA, 1987, J CANCER RES CLIN, V113, P223, DOI 10.1007/BF00396377; DRAGANI TA, 1986, CANCER RES, V46, P1915; DRAGANI TA, 1984, TUMORI J, V70, P485, DOI 10.1177/030089168407000603; DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701; FARBER E, 1984, CANCER RES, V44, P5463; FRITH CH, 1984, MOUSE LIVER NEOPLASI, P85; FRITH CH, 1980, J ENVIRON PATHOL TOX, V3, P329; GOLDFARB S, 1983, ENVIRON HEALTH PERSP, V50, P149, DOI 10.2307/3429545; GOLDFARB S, 1985, CANCER RES, V45, P909; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANIGAN MH, 1988, CARCINOGENESIS, V9, P885, DOI 10.1093/carcin/9.6.885; HELD WA, 1989, EMBO J, V8, P183, DOI 10.1002/j.1460-2075.1989.tb03363.x; ISHIKAWA F, 1985, JPN J CANCER RES, V76, P425; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; MARONPOT RR, 1987, ARCH TOXICOL S, V10, P10; MULDER MP, 1989, ONCOGENE, V4, P1345; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; SANDGREN EP, 1989, ONCOGENE, V4, P715; STOWERS SJ, 1988, CARCINOGENESIS, V9, P271, DOI 10.1093/carcin/9.2.271; TADA M, 1990, CANCER RES, V50, P1121; TAKADA S, 1989, ONCOGENE, V4, P189; TSUDA H, 1989, JPN J CANCER RES, V80, P196, DOI 10.1111/j.1349-7006.1989.tb02290.x; Vesselinovitch S D, 1982, Carcinog Compr Surv, V7, P127; VESSELINOVITCH SD, 1985, CANCER RES, V45, P910; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; WARD JM, 1979, J NATL CANCER I, V63, P849, DOI 10.1093/jnci/63.3.849; WISEMAN RW, 1986, P NATL ACAD SCI USA, V83, P5825, DOI 10.1073/pnas.83.16.5825; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070	43	66	66	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					333	338						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000226				2022-12-28	WOS:A1991FZ13400021
J	DEPPERT, W; BUSCHHAUSENDENKER, G; PATSCHINSKY, T; STEINMEYER, K				DEPPERT, W; BUSCHHAUSENDENKER, G; PATSCHINSKY, T; STEINMEYER, K			CELL-CYCLE CONTROL OF P53 IN NORMAL (3T3) AND CHEMICALLY TRANSFORMED (METH-A) MOUSE CELLS .2. REQUIREMENT FOR CELL-CYCLE PROGRESSION	ONCOGENE			English	Article									UNIV HAMBURG,HEINRICH PETTE INST EXPTL VIROL & IMMUNOL,W-2000 HAMBURG 13,GERMANY; UNIV HAMBURG,INST MOLEK BIOL,W-2000 HAMBURG 13,GERMANY	Heinrich Pette Institute; University of Hamburg; University of Hamburg								ARAI N, 1986, MOL CELL BIOL, V6, P323; BENCHIMOL S, 1989, NATO ASI SERIES H, V34, P409; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DEPPERT W, 1989, NATO ASI SERIES H, V34, P399; ELIYAHU D, 1988, ONCOGENE, V3, P313; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GRONOSTAJSKI RM, 1984, MOL CELL BIOL, V4, P442, DOI 10.1128/MCB.4.3.442; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; JENKINS JR, 1988, ONCOGENE HDB, P403; KACZMAREK L, 1986, EXP CELL RES, V132, P105; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1984, NATURE, V310, P143, DOI 10.1038/310143a0; PATSCHINSKY T, 1990, ONCOGENE, V5, P1071; PINHASI O, 1984, MOL CELL BIOL, V4, P2180, DOI 10.1128/MCB.4.10.2180; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; SHOHAT O, 1987, ONCOGENE, V1, P277; STEINMEYER K, 1990, ONCOGENE, V5, P1691; STEINMEYER K, 1988, ONCOGENE, V3, P501	25	104	105	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1701	1706						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267136				2022-12-28	WOS:A1990EL40100013
J	ECCLES, DM; CRANSTON, G; STEEL, CM; NAKAMURA, Y; LEONARD, RCF				ECCLES, DM; CRANSTON, G; STEEL, CM; NAKAMURA, Y; LEONARD, RCF			ALLELE LOSSES ON CHROMOSOME-17 IN HUMAN EPITHELIAL OVARIAN-CARCINOMA	ONCOGENE			English	Note									WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; JAPANESE FDN CANC RES,TOSHIMA KU,TOKYO 170,JAPAN; UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN ONCOL,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh; Japanese Foundation for Cancer Research; University of Edinburgh	ECCLES, DM (corresponding author), WESTERN GEN HOSP,IMPERIAL CANC RES FUND,EDINBURGH MED ONCOL UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		Eccles, Diana/K-6327-2019	Eccles, Diana/0000-0002-9935-3169				DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; EHLEN T, 1990, ONCOGENE, V5, P219; GREEN AR, 1988, BRIT J CANCER, V58, P115, DOI 10.1038/bjc.1988.176; LEE JH, 1989, CANCER RES, V49, P1220; LEE JH, 1989, CANCER GENET CYTOGEN, P243; MACKAY J, 1989, LANCET, V1, P154; Maniatis T., 1982, MOL CLONING; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	11	154	154	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1599	1601						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250917				2022-12-28	WOS:A1990EK50200023
J	CHEN, L; OBRYAN, JP; SMITH, HS; LIU, E				CHEN, L; OBRYAN, JP; SMITH, HS; LIU, E			OVEREXPRESSION OF MATRIX GLA PROTEIN MESSENGER-RNA IN MALIGNANT HUMAN BREAST CELLS - ISOLATION BY DIFFERENTIAL CDNA HYBRIDIZATION	ONCOGENE			English	Article									UNIV N CAROLINA, LINEBERGER CANC RES CTR, CB 7295, CHAPEL HILL, NC 27599 USA; PACIFIC MED CTR, GERALDINE BRUSH CANC RES INST, SAN FRANCISCO, CA 94115 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; California Pacific Medical Center; University of North Carolina; University of North Carolina Chapel Hill			Liu, Edison/C-4141-2008	O'Bryan, John/0000-0001-5386-1080	NATIONAL CANCER INSTITUTE [R01CA049240, P01CA044768] Funding Source: NIH RePORTER; NCI NIH HHS [P0I CA44768, R01-CA49240] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BENZ CC, 1989, JNCI-J NATL CANCER I, V81, P1704, DOI 10.1093/jnci/81.22.1704; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; DAIRKEE SH, 1987, BREAST CANCER RES TR, V10, P11, DOI 10.1007/BF01806130; DAIRKEE SH, 1988, J NATL CANCER I, V80, P691, DOI 10.1093/jnci/80.9.691; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVITA VT, 1982, CANCER PRINCIPLES PR, P914; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER JD, 1988, J BIOL CHEM, V263, P11033; GASIC GJ, 1984, CANCER METAST REV, V3, P99, DOI 10.1007/BF00047657; GORELIK E, 1987, CANCER RES, V47, P809; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALE JE, 1988, J BIOL CHEM, V263, P5820; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; KIEFER MC, 1988, NUCLEIC ACIDS RES, V16, P5213, DOI 10.1093/nar/16.11.5213; KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LIU E, 1988, ONCOGENE, V3, P323; MACKAY J, 1988, LANCET, V2, P1384; Maniatis T., 1982, MOL CLONING; MOLL R, 1984, J MOL BIOL, V179, P257; NEUBAUER BL, 1986, J UROLOGY, V135, P163, DOI 10.1016/S0022-5347(17)45554-6; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; POSER JW, 1979, J BIOL CHEM, V254, P431; PRICE PA, 1987, P NATL ACAD SCI USA, V84, P8335, DOI 10.1073/pnas.84.23.8335; PRICE PA, 1982, P NATL ACAD SCI-BIOL, V79, P7734, DOI 10.1073/pnas.79.24.7734; PRICE PA, 1985, J BIOL CHEM, V260, P4971; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWCHUK A, 1986, J PEDIATR SURG, V21, P1119, DOI 10.1016/0022-3468(86)90022-9; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SMITH HS, 1987, JNCI-J NATL CANCER I, V78, P611; SMITH HS, 1979, CANCER RES, V39, P4138; SMITH HS, 1983, BIOCHIM BIOPHYS ACTA, V738, P103, DOI 10.1016/0304-419X(84)90009-X; SMITH HS, 1984, BIOCHIM BIOPHYS ACTA, V41, P4637; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; TRASK D K, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P444	41	51	55	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP	1990	5	9					1391	1395						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216462				2022-12-28	WOS:A1990EC24100017
J	PATSCHINSKY, T; DEPPERT, W				PATSCHINSKY, T; DEPPERT, W			PHOSPHORYLATION OF P53 IN PRIMARY, IMMORTALIZED AND TRANSFORMED BALB/C MOUSE CELLS	ONCOGENE			English	Note											PATSCHINSKY, T (corresponding author), UNIV HAMBURG,HEINRICH PETTE INST EXPTL VIROL & IMMUNOL,MARTINISTR 52,W-2000 HAMBURG 20,GERMANY.							CHEN S, 1983, P NATL ACAD SCI-BIOL, V80, P5670, DOI 10.1073/pnas.80.18.5670; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DEPPERT W, 1989, ONCOGENE, V4, P1103; DEPPERT W, 1987, MOL CELL BIOL, V7, P4453, DOI 10.1128/MCB.7.12.4453; DEPPERT W, 1986, MOL CELL BIOL, V6, P223; DEPPERT W, 1989, NATO ASI SERIES H, V34, P399; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HALEVY O, 1989, MOL CELL BIOL, V9, P3385, DOI 10.1128/MCB.9.8.3385; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, ONCOGENE HDB, P403; KLEIN G, 1982, ADV VIRAL ONCOLOGY, V2; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; Maniatis T., 1982, MOL CLONING; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MORA PT, 1980, NATURE, V288, P722, DOI 10.1038/288722a0; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PATSCHINSKY T, 1988, ONCOGENE, V3, P357; PENNICA D, 1984, VIROLOGY, V134, P477, DOI 10.1016/0042-6822(84)90316-7; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROTTER V, 1985, ADV CANCER RES, V43, P113, DOI 10.1016/S0065-230X(08)60944-6; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; RUBIN H, 1989, P NATL ACAD SCI USA, V86, P1860, DOI 10.1073/pnas.86.6.1860; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SHOHAT O, 1987, ONCOGENE, V1, P277; STAUFENBIEL M, 1983, CELL, V33, P173, DOI 10.1016/0092-8674(83)90346-X; STEINMEYER K, 1988, ONCOGENE, V3, P501; STURZBECHER HW, 1987, VIROLOGY, V160, P445; VANROY F, 1981, J VIROL, V40, P28, DOI 10.1128/JVI.40.1.28-44.1981; ZANTEMA A, 1985, MOL CELL BIOL, V5, P3084, DOI 10.1128/MCB.5.11.3084	40	21	21	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1071	1076						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2142761				2022-12-28	WOS:A1990DP41500019
J	WU, JX; CARPENTER, PM; GRESENS, C; KEH, R; NIMAN, H; MORRIS, JWS; MERCOLA, D				WU, JX; CARPENTER, PM; GRESENS, C; KEH, R; NIMAN, H; MORRIS, JWS; MERCOLA, D			THE PROTOONCOGENE C-FOS IS OVER-EXPRESSED IN THE MAJORITY OF HUMAN OSTEOSARCOMAS	ONCOGENE			English	Article									UNIV CALIF SAN DIEGO,DEPT PATHOL,V-151,SAN DIEGO,CA 92161; MEM HOSP LONG BEACH,LONG BEACH,CA 90801; VET ADM MED CTR,SAN DIEGO,CA 92161; PROGENX INC,LA JOLLA,CA 92093	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)			mercola, dan/L-4182-2013	mercola, dan/0000-0002-0281-9840	NCI NIH HHS [R0-1 CA49963-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049963] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMSON ED, 1985, EMBO J, V4, P941, DOI 10.1002/j.1460-2075.1985.tb03722.x; ALLEN DC, 1987, J CLIN PATHOL, V40, P157, DOI 10.1136/jcp.40.2.157; BATTIFORA H, 1988, AM J SURG PATHOL, V12, P24; BETSHOLTZ C, 1984, CELL, V39, P447, DOI 10.1016/0092-8674(84)90452-5; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BOGENMANN E, 1987, CANCER RES, V47, P3808; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DETOGNI P, 1988, MOL CELL BIOL, V8, P2251, DOI 10.1128/MCB.8.5.2251; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FINKEL MP, 1966, SCIENCE, V151, P698, DOI 10.1126/science.151.3711.698; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOSH A, 1986, J CLIN PATHOL, V39, P428; GRAVES DT, 1983, CANCER RES, V43, P83; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HUANG JS, 1988, SCIENCE, V241, P1563; IBA H, 1988, ONCOGENE RES, V2, P121; IKEDA S, 1989, JPN J CANCER RES, V80, P6, DOI 10.1111/j.1349-7006.1989.tb02236.x; Marrack J, 1932, BRIT J EXP PATHOL, V13, P394; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MERCOLA D, 1988, GENE, V72, P253, DOI 10.1016/0378-1119(88)90151-5; MERCOLA D, 1987, BIOCHEM BIOPH RES CO, V147, P854; MERCOLA D, 1989, J CELL BIOL, V107, pA41; MILLER AD, 1984, CELL, V36, P51; MIZUKAMI Y, 1988, CANCER, V61, P873, DOI 10.1002/1097-0142(19880301)61:5<873::AID-CNCR2820610504>3.0.CO;2-W; MULLER R, 1983, NATURE, V454, P457; NARDEUX PC, 1987, BIOCHEM BIOPH RES CO, V146, P395, DOI 10.1016/0006-291X(87)90542-0; NIMAN HL, 1985, P NATL ACAD SCI USA, V82, P7924, DOI 10.1073/pnas.82.23.7924; NISTER M, 1988, CELL, V52, P791, DOI 10.1016/0092-8674(88)90421-7; NOWELL PC, 1986, CANCER RES, V46, P2203; Pauling L, 1944, J AM CHEM SOC, V66, P784, DOI 10.1021/ja01233a039; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHON A, 1986, INT J CANCER, V38, P67, DOI 10.1002/ijc.2910380112; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; STEINBERGER LA, 1986, IMMUNOCYTOCHEMISTRY, P211; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VARMA VA, 1989, ARCH PATHOL LAB MED, V113, P16; VIOLA M, 1986, NEW ENGL J MED, V6314, P133; WOMER R, 1987, J CELL PHYSL, V132, P66; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x	50	116	122	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					989	1000						12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2115647				2022-12-28	WOS:A1990DP41500006
J	POGNONEC, P; BOULUKOS, KE; BOSSELUT, R; BOYER, C; SCHMITTVERHULST, AM; GHYSDAEL, J				POGNONEC, P; BOULUKOS, KE; BOSSELUT, R; BOYER, C; SCHMITTVERHULST, AM; GHYSDAEL, J			IDENTIFICATION OF A ETS1 VARIANT PROTEIN UNAFFECTED IN ITS CHROMATIN AND INVITRO DNA-BINDING CAPACITIES BY T-CELL ANTIGEN RECEPTOR TRIGGERING AND INTRACELLULAR CALCIUM RISES	ONCOGENE			English	Article									INST PASTEUR,CNRS,UA 041160,INSERM,U186,1 RUE CALMETTE,F-59019 LILLE,FRANCE; CNRS,INSERM,CTR IMMUNOL,F-13288 MARSEILLE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			GHYSDAEL, Jacques/F-3377-2013	Schmitt-Verhulst, Anne-Marie/0000-0002-1296-2739				ALBERT F, 1982, IMMUNOGENETICS, V16, P533, DOI 10.1007/BF00372022; ALBERT F, 1984, IMMUNOGENETICS, V19, P279, DOI 10.1007/BF00345401; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BOULUKOS KE, 1988, EMBO J, V7, P697, DOI 10.1002/j.1460-2075.1988.tb02865.x; CHEN JH, 1985, MOL CELL BIOL, V5, P2993, DOI 10.1128/MCB.5.11.2993; CHEN JH, 1988, ONCOGENE RES, V2, P371; DUTERQUECOQUILLAUD M, 1988, ONCOGENE RES, V2, P335; FUJIWARA S, 1988, ONCOGENE, V2, P99; FUJIWARA S, 1988, MOL CELL BIOL, V8, P4700, DOI 10.1128/MCB.8.11.4700; GEGONNE A, 1987, VIROLOGY, V156, P177, DOI 10.1016/0042-6822(87)90450-8; GEGONNE A, 1987, MOL CELL BIOL, V7, P806, DOI 10.1128/MCB.7.2.806; GHYSDAEL J, 1986, EMBO J, V5, P2251, DOI 10.1002/j.1460-2075.1986.tb04492.x; GHYSDAEL J, 1986, P NATL ACAD SCI USA, V83, P1714, DOI 10.1073/pnas.83.6.1714; HUA C, 1986, J IMMUNOL, V136, P1927; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; LEPRINCE D, 1988, J VIROL, V62, P3233, DOI 10.1128/JVI.62.9.3233-3241.1988; PEARSON RB, 1985, J BIOL CHEM, V260, P4471; PINK JR, 1983, MOL IMMUNOL, V20, P491, DOI 10.1016/0161-5890(83)90030-5; POGNONEC P, 1988, ARCH INT PHYSIOL BIO, V96, pB51; POGNONEC P, 1989, ONCOGENE, V4, P691; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; RAO VN, 1987, SCIENCE, V237, P635, DOI 10.1126/science.3299708; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REDDY ESP, 1988, ONCOGENE RES, V3, P239; REDDY ESP, 1987, P NATL ACAD SCI USA, V84, P6131, DOI 10.1073/pnas.84.17.6131; SITKOVSKY MV, 1984, P NATL ACAD SCI-BIOL, V81, P1519, DOI 10.1073/pnas.81.5.1519; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2	30	38	38	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					603	610						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183162				2022-12-28	WOS:A1990DB85300022
J	VANLEEUWEN, F; VANDEVIJVER, MJ; LOMANS, J; VANDEEMTER, L; JENSTER, G; AKIYAMA, T; YAMAMOTO, T; NUSSE, R				VANLEEUWEN, F; VANDEVIJVER, MJ; LOMANS, J; VANDEEMTER, L; JENSTER, G; AKIYAMA, T; YAMAMOTO, T; NUSSE, R			MUTATION OF THE HUMAN NEU PROTEIN FACILITATES DOWN-MODULATION BY MONOCLONAL-ANTIBODIES	ONCOGENE			English	Article									NETHERLANDS CANC INST,DIV MOLEC BIOL,PLESMANLAAN 121,1066 CX AMSTERDAM,NETHERLANDS; UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN	Netherlands Cancer Institute; University of Tokyo			van Leeuwen, Frank/AAQ-6799-2020	van Leeuwen, Frank/0000-0003-1107-6513				AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; ALI IU, 1988, ONCOGENE RES, V3, P139; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BERGER MS, 1988, CANCER RES, V48, P1238; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; DREBIN JA, 1984, NATURE, V312, P545, DOI 10.1038/312545a0; DREBIN JA, 1988, ONCOGENE, V2, P387; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KING CR, 1985, NUCLEIC ACIDS RES, V13, P8477, DOI 10.1093/nar/13.23.8477; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SONNENBERG A, 1987, EMBO J, V6, P121, DOI 10.1002/j.1460-2075.1987.tb04728.x; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; TAL M, 1988, CANCER RES, V48, P1517; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VANDEVIJVER MJ, 1988, ONCOGENE, V2, P175; VARLEY JM, 1987, ONCOGENE, V1, P423; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YOKOTA J, 1988, ONCOGENE, V2, P283; YOKOTA J, 1986, LANCET, V1, P765; ZHOU DJ, 1987, CANCER RES, V47, P6123	47	26	26	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					497	503						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970152				2022-12-28	WOS:A1990DB85300007
J	CHRISTIANSEN, H; CHRISTIANSEN, NM; WAGNER, F; ALTMANNSBERGER, M; LAMPERT, F				CHRISTIANSEN, H; CHRISTIANSEN, NM; WAGNER, F; ALTMANNSBERGER, M; LAMPERT, F			NEUROBLASTOMA - INVERSE RELATIONSHIP BETWEEN EXPRESSION OF N-MYC AND NGF-R	ONCOGENE			English	Note									UNIV GIESSEN,KINDERKLIN,FEULGENSTR 12,W-6300 GIESSEN,GERMANY; UNIV GIESSEN,INST GENET,W-6300 GIESSEN,GERMANY; UNIV GIESSEN,INST PATHOL,W-6300 GIESSEN,GERMANY	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen								BERTHOLD F, 1986, MONOGR PAEDIATR, V18, P206; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1988, J CLIN ONCOL, V6, P1874, DOI 10.1200/JCO.1988.6.12.1874; BUCK CR, 1987, P NATL ACAD SCI USA, V84, P3060, DOI 10.1073/pnas.84.9.3060; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTIANSEN H, 1988, BRIT J CANCER, V57, P121, DOI 10.1038/bjc.1988.24; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; DANGIO GJ, 1971, LANCET, V1, P1046; DAVIES AM, 1988, TRENDS GENET, V4, P139, DOI 10.1016/0168-9525(88)90137-0; DAVIES AM, 1987, NATURE, V326, P353, DOI 10.1038/326353a0; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; GRADYLEOPARDI EF, 1986, CANCER RES, V46, P3196; HARMS D, 1979, KLIN PADIATR, V191, P228; HASKELL BE, 1987, CELL TISSUE RES, V247, P67, DOI 10.1007/BF00216548; HERLYN M, 1983, CANCER INVEST, V1, P215, DOI 10.3109/07357908309041361; HUGHES M, 1974, CANCER, V34, P1706, DOI 10.1002/1097-0142(197411)34:5<1706::AID-CNCR2820340519>3.0.CO;2-J; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; MOOS M, 1983, EMBO J, V2, P757, DOI 10.1002/j.1460-2075.1983.tb01496.x; NISEN PD, 1988, J NATL CANCER I, V80, P633; ROSS AH, 1984, P NATL ACAD SCI-BIOL, V81, P6681, DOI 10.1073/pnas.81.21.6681; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; THIELE CJ, 1988, EXP CELL BIOL, V56, P321	28	25	25	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					437	440						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2156211				2022-12-28	WOS:A1990CW41500025
J	FRISCH, SM; REICH, R; COLLIER, IE; GENRICH, LT; MARTIN, G; GOLDBERG, GI				FRISCH, SM; REICH, R; COLLIER, IE; GENRICH, LT; MARTIN, G; GOLDBERG, GI			ADENOVIRUS E1A REPRESSES PROTEASE GENE-EXPRESSION AND INHIBITS METASTASIS OF HUMAN TUMOR-CELLS	ONCOGENE			English	Article									NIDR, DEV BIOL & ANOMALIES LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	FRISCH, SM (corresponding author), WASHINGTON UNIV, SCH MED, DIV DERMATOL, ST LOUIS, MO 63110 USA.				NIADDK NIH HHS [TO-AM07284] Funding Source: Medline; NIAMS NIH HHS [AR 39472, AR 12129] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [T32AM007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039472, R01AR012129, R37AR012129] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBINI A, 1987, CANCER RES, V47, P3239; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ANGEL P, 1987, MOL CELL BIOL, V7, P256; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1978, CELL, V14, P695, DOI 10.1016/0092-8674(78)90252-0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; CALZONE FJ, 1988, GUIDE MOL CLONING TE, P611; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; COLLIER IE, 1988, J BIOL CHEM, V263, P10711; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DYNAN W, 1986, TRENDS GENET     AUG, P196; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FRISCH SM, 1985, MOL CELL BIOL, V5, P253, DOI 10.1128/MCB.5.1.253; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; GARBISA S, 1987, CANCER RES, V47, P1523; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GRANT GA, 1987, J BIOL CHEM, V262, P5886; GROSS JL, 1982, J CELL BIOL, V95, P974, DOI 10.1083/jcb.95.3.974; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; LAMPH W, 1988, NATURE, V34, P629; LATHANGUE NB, 1987, CELL, V49, P507, DOI 10.1016/0092-8674(87)90453-3; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LIOTTA LA, 1986, ANNU REV BIOCHEM, V55, P1037, DOI 10.1146/annurev.biochem.55.1.1037; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MARUYAMA K, 1987, ONCOGENE, V1, P361; MIGNATTI P, 1989, J CELL BIOL, V108, P671, DOI 10.1083/jcb.108.2.671; MISKIN R, 1981, ANAL BIOCHEM, V118, P252, DOI 10.1016/0003-2697(81)90187-1; POZZATTI R, 1988, MOL CELL BIOL, V8, P2984, DOI 10.1128/MCB.8.7.2984; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; REICH R, 1988, CANCER RES, V48, P3307; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; RULEY HE, 1984, CANCER CELLS, V2; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; STEIN RW, 1987, MOL CELL BIOL, V7, P1164, DOI 10.1128/MCB.7.3.1164; SUEMORI H, 1988, MOL CELL BIOL, V8, P3553, DOI 10.1128/MCB.8.8.3553; VELCICH A, 1985, CELL, V40, P705, DOI 10.1016/0092-8674(85)90219-3; WEBSTER KA, 1988, NATURE, V332, P553, DOI 10.1038/332553a0; WILHELM SM, 1989, J BIOL CHEM, V264, P17213	47	150	153	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					75	83						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157183				2022-12-28	WOS:A1990CM62000011
J	SALOME, N; VANHILLE, B; DUPONCHEL, N; MENEGUZZI, G; CUZIN, F; ROMMELAERE, J; CORNELIS, JJ				SALOME, N; VANHILLE, B; DUPONCHEL, N; MENEGUZZI, G; CUZIN, F; ROMMELAERE, J; CORNELIS, JJ			SENSITIZATION OF TRANSFORMED RAT-CELLS TO PARVOVIRUS MVMP IS RESTRICTED TO SPECIFIC ONCOGENES	ONCOGENE			English	Article									INST PASTEUR,CNRS,URA 0156,INSERM,U186,ONCOL MOLEC LAB,BP 245,F-59019 LILLE,FRANCE; UNIV NICE,CTR BIOCHIM,INSERM,U273,F-06034 NICE,FRANCE; UNIV LIBRE BRUXELLES,DEPT BIOL MOLEC,B-1640 RHODE ST GENESE,BELGIUM	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite Libre de Bruxelles			SALOME, NATHALIE/P-6408-2016	Meneguzzi, Guerrino/0000-0002-1609-6540; SALOME, NATHALIE/0000-0002-0349-0258				ANDERSON MJ, 1987, PROG MED VIROL, V34, P55; ASTELL CR, 1987, J GEN VIROL, V68, P885, DOI 10.1099/0022-1317-68-3-885; ASTELL CR, 1983, NUCLEIC ACIDS RES, V11, P999, DOI 10.1093/nar/11.4.999; BABISS LE, 1986, VIROLOGY, V154, P180, DOI 10.1016/0042-6822(86)90440-X; BANDO H, 1987, J VIROL, V61, P553, DOI 10.1128/JVI.61.2.553-560.1987; BERG L, 1986, CELL, V46, P753, DOI 10.1016/0092-8674(86)90351-X; BERGMAN P, 1988, ONCOGENE, V2, P453; BINETRUY B, 1987, CANCER CELL, V5, P223; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CHEN YQ, 1989, CARCINOGENESIS, V10, P163, DOI 10.1093/carcin/10.1.163; CHEN YQ, 1986, CANCER RES, V46, P3574; CORNELIS JJ, 1988, J VIROL, V62, P3438, DOI 10.1128/JVI.62.9.3438-3444.1988; CORNELIS JJ, 1988, J VIROL, V62, P1679, DOI 10.1128/JVI.62.5.1679-1686.1988; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; CUKOR G, 1983, BIOL ADENO ASS VIRUS, P33; DUPRESSOIR T, 1989, CANCER RES, V49, P3203; FAISST S, 1989, J VIROL, V63, P2152, DOI 10.1128/JVI.63.5.2152-2158.1989; GRISONI M, 1984, VIROLOGY, V135, P406, DOI 10.1016/0042-6822(84)90196-X; GUETTA E, 1986, J NATL CANCER I, V76, P1177; GUETTA E, 1989, IN PRESS J VIROL; HAUGEN TH, 1988, EMBO J, V7, P4245, DOI 10.1002/j.1460-2075.1988.tb03322.x; HOWLEY PM, 1987, PAPOVAVIRIDAE, V2, P141; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; KATZ E, 1986, CANCER RES, V46, P3023; LAMBERT PF, 1987, CELL, V50, P69, DOI 10.1016/0092-8674(87)90663-5; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; MARTIN P, 1986, EMBO J, V5, P1529, DOI 10.1002/j.1460-2075.1986.tb04393.x; MCKAY IA, 1986, MOL CELL BIOL, V6, P3382, DOI 10.1128/MCB.6.10.3382; MENEGUZZI G, 1984, EMBO J, V3, P365, DOI 10.1002/j.1460-2075.1984.tb01813.x; MERCHLINSKY MJ, 1983, J VIROL, V47, P227, DOI 10.1128/JVI.47.1.227-232.1983; MOUGNEAU E, 1984, P NATL ACAD SCI-BIOL, V81, P5758, DOI 10.1073/pnas.81.18.5758; MOUSSET S, 1982, NATURE, V300, P537, DOI 10.1038/300537a0; MOUSSET S, 1986, BIOCHIMIE, V68, P951, DOI 10.1016/S0300-9084(86)81058-6; OSTROVE JM, 1981, VIROLOGY, V113, P521, DOI 10.1016/0042-6822(81)90180-X; OZAWA K, 1988, J VIROL, V62, P2884, DOI 10.1128/JVI.62.8.2884-2889.1988; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; RHODE SL, 1987, J VIROL, V61, P1448, DOI 10.1128/JVI.61.5.1448-1456.1987; ROMMELAERE J, 1989, IN PRESS ONCOSUPPRES; SCHILLER JT, 1984, P NATL ACAD SCI-BIOL, V81, P7880, DOI 10.1073/pnas.81.24.7880; SIEGL G, 1983, BIOL PATHOGENICITY A, P297; TATTERSALL P, 1978, PARVOVIRUSES INTRO R, P3; THORNER L, 1988, J VIROL, V62, P2474, DOI 10.1128/JVI.62.7.2474-2482.1988; TOOLAN H, 1965, NATURE, V208, P812, DOI 10.1038/208812a0; TULLIS GE, 1988, J VIROL, V62, P2736, DOI 10.1128/JVI.62.8.2736-2744.1988; van der Eb A J, 1980, Methods Enzymol, V65, P826; VANHILLE B, 1989, IN PRESS VIROLOGY, V170; VENNSTROM B, 1984, EMBO J, V3, P3223, DOI 10.1002/j.1460-2075.1984.tb02282.x; WASYLYK C, 1988, EMBO J, V7, P2475, DOI 10.1002/j.1460-2075.1988.tb03094.x; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917	50	47	49	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					123	130						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157178				2022-12-28	WOS:A1990CM62000017
J	HEWLETT, IK; RUTA, M; CRISTIANO, K; HAWTHORNE, CA; EPSTEIN, JS				HEWLETT, IK; RUTA, M; CRISTIANO, K; HAWTHORNE, CA; EPSTEIN, JS			CO-AMPLIFICATION OF MULTIPLE REGIONS OF THE HIV-1 GENOME BY THE POLYMERASE CHAIN-REACTION - POTENTIAL USE IN MULTIPLE DIAGNOSIS	ONCOGENE			English	Article											HEWLETT, IK (corresponding author), US FDA,CTR BIOL EVALUAT & RES,DIV BLOOD & BLOOD PROD,RETROVIROL LAB,BETHESDA,MD 20892, USA.			Epstein, Jay/0000-0003-2293-9062				CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; HEWLETT IK, 1989, IN PRESS J CLIN IMMU; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; KWOK S, 1987, J VIROL, V61, P1690, DOI 10.1128/JVI.61.5.1690-1694.1987; KWOK S, 1989, IN PRESS; Maniatis T., 1984, MOL CLONING; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MURAKAWA GJ, 1988, DNA-J MOLEC CELL BIO, V7, P287, DOI 10.1089/dna.1988.7.287; OSTE C, 1988, BIOTECHNIQUES, V6, P162; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PETRICCIANI JC, 1985, ANN INTERN MED, V103, P726, DOI 10.7326/0003-4819-103-5-726; SAIKI RK, 1985, BIO-TECHNOL, V3, P1008, DOI 10.1038/nbt1185-1008; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SCHARF SJ, 1986, SCIENCE, V223, P1076; WOLINSKY S, 1988, 4TH INT AIDS M STOCK, P137	15	17	22	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1989	4	9					1149	1151						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AM531	2571115				2022-12-28	WOS:A1989AM53100016
J	ANDRE, C; DAURIOL, L; LACOMBE, C; GISSELBRECHT, S; GALIBERT, F				ANDRE, C; DAURIOL, L; LACOMBE, C; GISSELBRECHT, S; GALIBERT, F			C-KIT MESSENGER-RNA EXPRESSION IN HUMAN AND MURINE HEMATOPOIETIC-CELL LINES	ONCOGENE			English	Note									HOP COCHIN,CNRS,UA 628,INSERM,U152,F-75674 PARIS 14,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	ANDRE, C (corresponding author), HOP ST LOUIS,HEMATOL EXPTL LAB,CNRS,UPR RECOMBINAISONS GENET 41,F-75475 PARIS 10,FRANCE.							BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAURIOL L, 1988, HUM GENET, V78, P374, DOI 10.1007/BF00291740; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; LEBEAU MM, 1986, SCIENCE, V231, P984, DOI 10.1126/science.3484837; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAJUMDER S, 1988, MOL CELL BIOL, V8, P4896, DOI 10.1128/MCB.8.11.4896; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; RUSSELL ELIZABETH S., 1966, P351; SEIGNEURIN D, 1987, EXP HEMATOL, V15, P822; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SIEFF CA, 1987, J CLIN INVEST, V79, P1549, DOI 10.1172/JCI112988; SILINI G, 1967, J EMBRYOL EXP MORPH, V17, P303; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	21	79	81	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1047	1049						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2474787				2022-12-28	WOS:A1989AJ29700016
J	SHARP, NA; LUSCOMBE, MJ; CLEMENS, MJ				SHARP, NA; LUSCOMBE, MJ; CLEMENS, MJ			REGULATION OF C-FGR PROTO-ONCOGENE EXPRESSION IN BURKITTS-LYMPHOMA CELLS - EFFECT OF INTERFERON TREATMENT AND RELATIONSHIP TO EBV STATUS AND C-MYC MESSENGER-RNA LEVELS	ONCOGENE			English	Article									ST GEORGE HOSP,SCH MED,DEPT CELLULAR & MOLEC SCI,DIV BIOCHEM,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND	St Georges University London								ADAMS A, 1975, J GEN VIROL, V28, P207, DOI 10.1099/0022-1317-28-2-207; ALITALO K, 1987, BIOCHIM BIOPHYS ACTA, V907, P1, DOI 10.1016/0304-419X(87)90016-3; CHEAH MSC, 1986, NATURE, V319, P238, DOI 10.1038/319238a0; CLEMENS MJ, 1988, J CELL BIOCHEM, V38, P251, DOI 10.1002/jcb.240380404; DANI C, 1985, P NATL ACAD SCI USA, V82, P4896, DOI 10.1073/pnas.82.15.4896; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EXLEY R, 1987, P NATL ACAD SCI USA, V84, P6467, DOI 10.1073/pnas.84.18.6467; EXLEY R, 1987, INT J CANCER, V40, P53, DOI 10.1002/ijc.2910400110; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; HO YS, 1987, CANCER INVEST, V5, P101, DOI 10.3109/07357908709018463; INOUE K, 1987, ONCOGENE, V1, P301; JONAK GJ, 1984, P NATL ACAD SCI-BIOL, V81, P1747, DOI 10.1073/pnas.81.6.1747; KATAMINE S, 1988, MOL CELL BIOL, V8, P259, DOI 10.1128/MCB.8.1.259; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KLEIN C, 1988, INT J CANCER, V42, P29, DOI 10.1002/ijc.2910420107; KNIGHT E, 1985, P NATL ACAD SCI USA, V82, P1151, DOI 10.1073/pnas.82.4.1151; LEY TJ, 1989, MOL CELL BIOL, V9, P92, DOI 10.1128/MCB.9.1.92; Maniatis T., 1982, MOL CLONING; MCMAHON M, 1986, J VIROL, V57, P362, DOI 10.1128/JVI.57.1.362-366.1986; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; NISHIZAWA M, 1986, MOL CELL BIOL, V6, P511, DOI 10.1128/MCB.6.2.511; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; SILVERMAN RH, 1982, EUR J BIOCHEM, V126, P333; TRONICK SR, 1985, P NATL ACAD SCI USA, V82, P6595, DOI 10.1073/pnas.82.19.6595; WILLMAN CL, 1987, P NATL ACAD SCI USA, V84, P4480, DOI 10.1073/pnas.84.13.4480	27	20	21	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1043	1046						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2548145				2022-12-28	WOS:A1989AJ29700015
J	VELCICH, A; ZIFF, EB				VELCICH, A; ZIFF, EB			THE ADENOVIRUS-5 12S E1A PROTEIN, BUT NOT THE 13S INDUCES EXPRESSION OF THE ENDOA DIFFERENTIATION MARKER IN F9 CELLS	ONCOGENE			English	Article									NYU, DEPT BIOCHEM, NEW YORK, NY 10016 USA; NYU, KAPLAN CANC CTR, NEW YORK, NY 10016 USA	New York University; New York University				Ziff, Edward/0000-0001-7389-8649	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030760] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 30760] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMATI P, 1985, CELL, V43, P561, DOI 10.1016/0092-8674(85)90225-9; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BERK AJ, 1986, CANCER SURV, V5, P367; BOCCARA M, 1978, ANN INST PASTEUR MIC, VA129, P227; BORRELLI E, 1986, P NATL ACAD SCI USA, V83, P2846, DOI 10.1073/pnas.83.9.2846; BORRELLI E, 1984, NATURE, V312, P608, DOI 10.1038/312608a0; BRANTON PE, 1984, BIOCHIM BIOPHYS ACTA, V780, P67, DOI 10.1016/0304-419X(84)90007-6; BRULET P, 1982, P NATL ACAD SCI-BIOL, V79, P2328, DOI 10.1073/pnas.79.7.2328; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CREMISI C, 1987, NUCLEIC ACIDS RES, V15, P6105, DOI 10.1093/nar/15.15.6105; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; DUPREY P, 1985, P NATL ACAD SCI USA, V82, P8535, DOI 10.1073/pnas.82.24.8535; GORMAN CM, 1985, CELL, V42, P519, DOI 10.1016/0092-8674(85)90109-6; HEN R, 1985, SCIENCE, V230, P1391, DOI 10.1126/science.2999984; HEN R, 1986, NATURE, V321, P249, DOI 10.1038/321249a0; HOGAN BLM, 1981, NATURE, V291, P235, DOI 10.1038/291235a0; IMLER JL, 1987, MOL CELL BIOL, V7, P2558, DOI 10.1128/MCB.7.7.2558; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; KRYSZKE MH, 1987, NATURE, V328, P254, DOI 10.1038/328254a0; KURKINEN M, 1983, COLD SPRING HARBOR C, V10, P389; LATHANGUE NB, 1987, CELL, V49, P507, DOI 10.1016/0092-8674(87)90453-3; LILLIE JW, 1987, CELL, V50, P1091, DOI 10.1016/0092-8674(87)90175-9; LINNEY E, 1983, CELL, V35, P693, DOI 10.1016/0092-8674(83)90102-2; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MARUYAMA K, 1987, ONCOGENE, V1, P361; MONTANO X, 1987, MOL CELL BIOL, V7, P1782, DOI 10.1128/MCB.7.5.1782; MORAN E, 1987, CELL, V48, P177, DOI 10.1016/0092-8674(87)90418-1; MORAN E, 1986, MOL CELL BIOL, V6, P3470, DOI 10.1128/MCB.6.10.3470; MULLER R, 1986, TRENDS BIOCHEM SCI, V11, P129, DOI 10.1016/0968-0004(86)90066-6; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; PERRICAUDET M, 1979, NATURE, V281, P694, DOI 10.1038/281694a0; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SASSONECORSI P, 1987, P NATL ACAD SCI USA, V84, P6430, DOI 10.1073/pnas.84.18.6430; SERFLING E, 1985, TRENDS GENET, V1, P224, DOI 10.1016/0168-9525(85)90088-5; SLEIGH MJ, 1985, EMBO J, V4, P3831, DOI 10.1002/j.1460-2075.1985.tb04155.x; SMITH DH, 1985, MOL CELL BIOL, V5, P2684, DOI 10.1128/MCB.5.10.2684; STEIN RW, 1987, MOL CELL BIOL, V7, P1164, DOI 10.1128/MCB.7.3.1164; STRICKLAND S, 1980, CELL, V21, P347, DOI 10.1016/0092-8674(80)90471-7; STRICKLAND S, 1981, CELL, V24, P277, DOI 10.1016/0092-8674(81)90313-5; SUEMORI H, 1988, MOL CELL BIOL, V8, P3553, DOI 10.1128/MCB.8.8.3553; VELCICH A, 1986, MOL CELL BIOL, V6, P4019, DOI 10.1128/MCB.6.11.4019; VELCICH A, 1985, CELL, V40, P705, DOI 10.1016/0092-8674(85)90219-3; VELCICH A, 1988, MOL CELL BIOL, V8, P2177, DOI 10.1128/MCB.8.5.2177; VELCICH A, 1988, IN PRESS; WASYLYK B, 1988, P NATL ACAD SCI USA, V85, P7952, DOI 10.1073/pnas.85.21.7952; WEBSTER KA, 1988, NATURE, V332, P553, DOI 10.1038/332553a0; ZERLER B, 1987, MOL CELL BIOL, V7, P821, DOI 10.1128/MCB.7.2.821; ZERLER B, 1986, MOL CELL BIOL, V6, P887, DOI 10.1128/MCB.6.3.887; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	51	17	17	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1989	4	6					707	713						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543941				2022-12-28	WOS:A1989AA66000006
J	BROOKES, S; SMITH, R; CASEY, G; DICKSON, C; PETERS, G				BROOKES, S; SMITH, R; CASEY, G; DICKSON, C; PETERS, G			SEQUENCE ORGANIZATION OF THE HUMAN INT-2 GENE AND ITS EXPRESSION IN TERATOCARCINOMA CELLS	ONCOGENE			English	Article									IMPERIAL CANC RES FUND LABS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK	BROOKES, S (corresponding author), ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DOMIN HOUSE,LONDON EC1A 7BE,ENGLAND.							ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ADELAIDE J, 1988, ONCOGENE, V2, P413; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; FANTL V, 1988, CANCER CELLS, V7; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; GOSPODAROWICZ D, 1986, MOL CELL ENDOCRINOL, V46, P187, DOI 10.1016/0303-7207(86)90001-8; JAKOBOVITS A, 1986, P NATL ACAD SCI USA, V83, P7806, DOI 10.1073/pnas.83.20.7806; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; MANSOUR SL, 1988, EMBO J, V7, P2035, DOI 10.1002/j.1460-2075.1988.tb03043.x; MOORE R, 1986, EMBO J, V5, P919, DOI 10.1002/j.1460-2075.1986.tb04304.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NUSSE R, 1986, TRENDS GENET, V2, P244, DOI 10.1016/0168-9525(86)90247-7; NUSSE R, 1988, BREAST CANCER CELLUL, P283; PATTILLO RA, 1971, IN VITRO CELL DEV B, V6, P398; PERA MF, 1987, INT J CANCER, V40, P334, DOI 10.1002/ijc.2910400309; PETERS G, 1989, FRONTIERS MOL BIOL O; Peters G, 1987, CELLULAR MOL BIOL MA, P307; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; SMITH R, 1988, EMBO J, V7, P1013, DOI 10.1002/j.1460-2075.1988.tb02908.x; TAIRA M, 1987, P NATL ACAD SCI USA, V84, P2980, DOI 10.1073/pnas.84.9.2980; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P81, DOI 10.1016/0968-0004(86)90271-9; THOMPSON S, 1984, J CELL SCI, V72, P37; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; VARLEY JM, 1988, ONCOGENE, V3, P87; WANG N, 1980, CANCER RES, V40, P792; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILKINSON DG, 1988, EMBO J, V7, P691, DOI 10.1002/j.1460-2075.1988.tb02864.x; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487; ZHOU DJ, 1988, ONCOGENE, V2, P279	41	72	75	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					429	436						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2470007				2022-12-28	WOS:A1989U567700006
J	LI, WJ; DREAZEN, O; KLOETZER, W; GALE, RP; ARLINGHAUS, RB				LI, WJ; DREAZEN, O; KLOETZER, W; GALE, RP; ARLINGHAUS, RB			CHARACTERIZATION OF BCR GENE-PRODUCTS IN HEMATOPOIETIC-CELLS	ONCOGENE			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC PATHOL,1515 HOLCOMBE BLVD,HOUSTON,TX 77030; JOHNSON & JOHNSON BIOTECHNOL CTR,LA JOLLA,CA 92038; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024	University of Texas System; UTMD Anderson Cancer Center; Johnson & Johnson; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					NCI NIH HHS [CA16672, CA47372] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA047372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; CHAN LC, 1987, NATURE, V325, P635, DOI 10.1038/325635a0; CLARK SS, 1987, SCIENCE, V235, P85, DOI 10.1126/science.3541203; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLINS S, 1987, MOL CELL BIOL, V7, P2870, DOI 10.1128/MCB.7.8.2870; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CROCE CM, 1987, P NATL ACAD SCI USA, V84, P7174, DOI 10.1073/pnas.84.20.7174; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DREAZEN O, 1987, BRIT J HAEMATOL, V67, P319, DOI 10.1111/j.1365-2141.1987.tb02353.x; GALE RP, 1984, P NATL ACAD SCI-BIOL, V81, P5648, DOI 10.1073/pnas.81.18.5648; GIBSON W, 1974, VIROLOGY, V62, P319, DOI 10.1016/0042-6822(74)90395-X; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARIHARAN IK, 1987, EMBO J, V6, P115, DOI 10.1002/j.1460-2075.1987.tb04727.x; HERMANS A, 1987, CELL, V51, P33, DOI 10.1016/0092-8674(87)90007-9; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HUNTER T, 1986, ENZYMES, V17, P191; KLOETZER W, 1985, VIROLOGY, V140, P230, DOI 10.1016/0042-6822(85)90361-7; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; KONOPKA JB, 1985, MOL CELL BIOL, V5, P3116, DOI 10.1128/MCB.5.11.3116; KURZROCK R, 1987, NATURE, V325, P631, DOI 10.1038/325631a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI WJ, 1988, ONCOGENE, V2, P559; LIFSHITZ B, 1987, ONCOGENE, V2, P112; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAXWELL SA, 1987, CANCER RES, V47, P1731; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Smith Linda D., 1987, ADV LEUKEMIA LYMPHOM, P95; SMITH RG, 1981, J IMMUNOL, V126, P596; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; WALKER LC, 1987, NATURE, V329, P851, DOI 10.1038/329851a0	35	44	44	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					127	138						12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648252				2022-12-28	WOS:A1989U567500002
J	LINDBERG, RA; THOMPSON, DP; HUNTER, T				LINDBERG, RA; THOMPSON, DP; HUNTER, T			IDENTIFICATION OF CDNA CLONES THAT CODE FOR PROTEIN-TYROSINE KINASES BY SCREENING EXPRESSION LIBRARIES WITH ANTIBODIES AGAINST PHOSPHOTYROSINE	ONCOGENE			English	Article									UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093	University of California System; University of California San Diego	LINDBERG, RA (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92138, USA.				NATIONAL CANCER INSTITUTE [R35CA039780] Funding Source: NIH RePORTER; NCI NIH HHS [CA-39780] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; GILMER TM, 1981, NATURE, V294, P771, DOI 10.1038/294771a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HAYMAN MJ, 1985, P NATL ACAD SCI USA, V82, P8237, DOI 10.1073/pnas.82.23.8237; HIRAI H, 1987, SCIENCE, V238, P1717, DOI 10.1126/science.2825356; HOLTZMAN DA, 1987, P NATL ACAD SCI USA, V84, P8325, DOI 10.1073/pnas.84.23.8325; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; HUNTER T, 1988, IN PRESS COLD SPRING, V53; KAMPS MP, 1988, ONCOGENE, V2, P305; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KIPREOS ET, 1987, P NATL ACAD SCI USA, V84, P1345, DOI 10.1073/pnas.84.5.1345; LETWIN K, 1988, ONCOGENE, V3, P621; Maniatis T., 1982, MOL CLONING; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MCGRATH JP, 1982, NATURE, V295, P423, DOI 10.1038/295423a0; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RUTA M, 1988, ONCOGENE, V3, P9; SADOWSKI I, 1987, ONCOGENE, V1, P181; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; ULLRICH A, 1986, EMBO J, V5, P2503, DOI 10.1002/j.1460-2075.1986.tb04528.x; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WANG JYJ, 1982, J BIOL CHEM, V257, P13181; WANG JYJ, 1985, J BIOL CHEM, V260, P64; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	41	27	29	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					629	633						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2485256				2022-12-28	WOS:A1988R646000002
J	VARLEY, JM; BRAMMAR, WJ; LANE, DP; SWALLOW, JE; DOLAN, C; WALKER, RA				VARLEY, JM; BRAMMAR, WJ; LANE, DP; SWALLOW, JE; DOLAN, C; WALKER, RA			LOSS OF CHROMOSOME-17P13 SEQUENCES AND MUTATION OF P53 IN HUMAN BREAST CARCINOMAS	ONCOGENE			English	Article							CELLULAR TUMOR-ANTIGEN; RETINOBLASTOMA GENE-PRODUCT; MONOCLONAL-ANTIBODY; PROTO-ONCOGENE; ALLELE LOSS; SHORT ARM; SV40-TRANSFORMED CELLS; COLORECTAL CARCINOMAS; INCREASED EXPRESSION; TRANSFORMED-CELLS	DNAs from ninety seven primary breast carcinoma biopsies have been examined for loss of sequences on 17p13. In addition, immunohistochemical analysis has been carried out on the majority of these cases to determine whether p53 gene expression can be detected. Detection of p53 expression is taken to indicate mutation of p53 leading to stabilisation of the protein and thus detectable levels of p53 in the cell. In 86% of breast carcinoma samples where both allele loss and expression data were available, loss of sequences on 17p13 and/or expression of p53 was detected. Alterations to p53, whether loss of one allele or mutation, are therefore by far the most common changes so far detected in primary human breast tumours. In three cases where expression of p53 could be detected by immunohistochemistry, the precise mutation to p53 was identified. All three mutations fall within the regions which are highly conserved in p53, encoded by exons 5 to 8. Two are single base changes leading to missense mutations, and the third is a single base-pair deletion. The expression of the latter gene would result in production of a truncated protein which should lack normal biological activities.	UNIV LEICESTER,DEPT PATHOL,LEICESTER LE1 7RH,ENGLAND; IMPERIAL CANC RES FUND,CLARE HALL LABS,POTTERS BAR EN6 3LD,HERTS,ENGLAND	University of Leicester	VARLEY, JM (corresponding author), UNIV LEICESTER,ICI PLC UNIV JOINT LAB,LEICESTER LE1 7RH,ENGLAND.		Lane, David P/C-4920-2008	Lane, David/0000-0003-0551-3545				ADDISON C, 1990, ONCOGENE, V5, P423; AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; ALI IU, 1989, J NATL CANCER I, V81, P1815, DOI 10.1093/jnci/81.23.1815; ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; BARTEK J, 1990, ONCOGENE, V5, P893; BENCHIMOL S, 1985, SOMAT CELL MOLEC GEN, V11, P505, DOI 10.1007/BF01534845; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BENDAVID Y, 1988, ONCOGENE, V3, P179; CALLAHAN R, 1989, JNCI-J NATL CANCER I, V81, P1780, DOI 10.1093/jnci/81.23.1780; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; CHOW V, 1987, J VIROL, V61, P2777, DOI 10.1128/JVI.61.9.2777-2781.1987; Crawford L V, 1984, Mol Biol Med, V2, P261; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; DANG CV, 1989, J BIOL CHEM, V264, P18019; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FULTS D, 1989, CANCER RES, V49, P6572; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GUSTERSON BA, 1988, INT J CANCER, V42, P842, DOI 10.1002/ijc.2910420608; HICKS GG, 1988, J VIROL, V62, P4752, DOI 10.1128/JVI.62.12.4752-4755.1988; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; JAMES CD, 1989, P NATL ACAD SCI USA, V86, P2858, DOI 10.1073/pnas.86.8.2858; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, ONCOGENE HDB, P403; KOEFFLER HP, 1986, P NATL ACAD SCI USA, V83, P4035, DOI 10.1073/pnas.83.11.4035; LANE DP, 1985, PROC R SOC SER B-BIO, V226, P25, DOI 10.1098/rspb.1985.0077; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LIDEREAU R, 1988, ONCOGENE RES, V2, P285; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MACKAY J, 1988, LANCET, V2, P1384; MARSHAL R, 1990, BLOOD, V75, P180; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MEEK DW, 1988, MOL CELL BIOL, V8, P461, DOI 10.1128/MCB.8.1.461; MILLER C, 1986, NATURE, V319, P783, DOI 10.1038/319783a0; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; MUNROE DG, 1988, ONCOGENE, V2, P621; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROGERS J, 1983, NATURE, V305, P101, DOI 10.1038/305101a0; ROSEN PP, 1987, BREAST DISEASES; ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613; ROVINSKI B, 1987, MOL CELL BIOL, V7, P847, DOI 10.1128/MCB.7.2.847; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUSSI T, 1987, ONCOGENE, V1, P71; SOUSSI T, 1990, ONCOGENE, V5, P945; STURZBECHER HW, 1990, ONCOGENE, V5, P795; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; THOMAS R, 1983, VIROLOGY, V131, P502, DOI 10.1016/0042-6822(83)90516-0; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; TOGUCHIDA J, 1989, CANCER RES, V49, P6247; VANDENBERG FM, 1989, J PATHOL, V157, P193, DOI 10.1002/path.1711570304; VANDEVIJVER M, 1987, MOL CELL BIOL, V7, P2019, DOI 10.1128/MCB.7.5.2019; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; VARLEY JM, 1987, ONCOGENE, V1, P423; VARLEY JM, 1989, HORM RES, V32, P250, DOI 10.1159/000181357; VARLEY JM, 1988, ONCOGENE, V3, P87; VARLEY JM, 1989, ONCOGENE, V4, P725; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHITTAKER JL, 1986, INT J CANCER, V38, P651, DOI 10.1002/ijc.2910380506; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YEWDELL JW, 1986, J VIROL, V59, P444, DOI 10.1128/JVI.59.2.444-452.1986; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	83	262	262	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1991	6	3					413	421						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FT344	2011397				2022-12-28	WOS:A1991FT34400010
J	OROURKE, RW; MILLER, CW; KATO, GJ; SIMON, KJ; CHEN, DL; DANG, CV; KOEFFLER, HP				OROURKE, RW; MILLER, CW; KATO, GJ; SIMON, KJ; CHEN, DL; DANG, CV; KOEFFLER, HP			A POTENTIAL TRANSCRIPTIONAL ACTIVATION ELEMENT IN THE P53-PROTEIN	ONCOGENE			English	Article							TUMOR-ANTIGEN; GENE-PRODUCT; T-ANTIGEN; P53; TRANSFORMATION; PROTEIN; CELLS; EXPRESSION; MUTATIONS; ONCOGENE	The human p53 gene codes for a 393 amino acid nuclear phosphoprotein. p53 is most commonly described as a tumor suppressor, or anti-oncogene, although its role in vivo remains unclear. We report that GAL4-p53 fusion protein can activate transcription of a CAT reporter gene downstream of a GAL4-DNA binding site. We tested both the amino terminal 160 amino acids and the carboxy terminal 233 amino acids of the p53 protein and found that the transcriptional activating (TA) region was restricted to the amino terminal fragment. These results imply that p53 may be a transcriptional activating factor (TAF); furthermore, these data lend support to the hypothesis of p53 as a positive regulator of transcription which might mediate its tumor suppressor role by inducing expression of a set of genes with a negative effect on cellular growth.	UNIV CALIF LOS ANGELES,SCH MED,DIV HEMATOL ONCOL,11-240 FACTOR BLDG,10833 LE CONTE AVE,LOS ANGELES,CA 90024; JOHNS HOPKINS UNIV,JOHNS HOPKINS ONCOL CTR,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,JOHNS HOPKINS ONCOL CTR,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,JOHNS HOPKINS ONCOL CTR,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine			Kato, Gregory J/I-7615-2014; Dang, Chi/Y-3375-2019	Kato, Gregory J/0000-0003-4465-3217; O'Rourke, Robert/0000-0002-4038-4198; Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [CA 26038, CA 33936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA033936, R01CA026038] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CANN AJ, 1988, ONCOGENE, V3, P123; DICKSON D, 1978, NATURE, V273, P260, DOI 10.1038/273260a0; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; LANE DP, 1983, CELL BIOL INT REP, V7, P513, DOI 10.1016/0309-1651(83)90154-6; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LINZER D, 1979, CELL, V17, P143; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; ROTTER V, 1983, EMBO J, V2, P1041, DOI 10.1002/j.1460-2075.1983.tb01543.x; SADOWSKI I, 1988, NATURE, V335, P653; Sambrook J., 1989, MOL CLONING; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHMIDT MC, 1989, MOL CELL BIOL, V9, P3299, DOI 10.1128/MCB.9.8.3299; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAN TH, 1986, J VIROL, V59, P574, DOI 10.1128/JVI.59.3.574-583.1986; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WARNESS BA, 1990, SCIENCE, V248, P76; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; WHYTE P, 1989, CELL, V56, P67, DOI 10.1016/0092-8674(89)90984-7; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557	34	178	179	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1829	1832						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284102				2022-12-28	WOS:A1990ET43600013
J	SETH, A; PAPAS, TS				SETH, A; PAPAS, TS			THE C-ETS-1 PROTOONCOGENE HAS ONCOGENIC ACTIVITY AND IS POSITIVELY AUTOREGULATED	ONCOGENE			English	Article							AUTO-REGULATION; ETS GENES; MYC; EXPRESSION; ENHANCER; DAUGHTERLESS; SEQUENCE; PROTEINS; COMPLEX; BINDING	The proto-oncogene ets-1 is a member of the ets family of genes that share homology with the viral oncogene, v-ets, of the avian leukemia virus E26. By using expression vectors, we demonstrate that the ets-1 gene transforms NIH3T3 cells and the ets-1 transfected cells from colonies in soft agar and induce tumors in nude mice. We have also determined that the ets-1 protein contains homology with the helix-loop-helix motif of the HLH family proteins, but lacks the basic domain upstream of helix I. Transfection of the NIH3T3 cells with ets-1 vectors results in the activation of the endogenous ets-1 gene. Using hybridization probes that can distinguish between transcripts from endogenous and exogenous templates, we show that the endogenous ets-1 gene is activated by the expression of the transfected exogenous ets-1. In contrast, the expression of transfected ets-2 has no effect on the endogenous ets-1 gene expression. The results indicate that the ets-1 proto-oncogene is positively autoregulated by its product.			SETH, A (corresponding author), NCI,MOLEC ONCOL LAB,FREDERICK,MD 21702, USA.							ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BHAT NK, 1989, J IMMUNOL, V142, P672; BLAIR DG, 1980, P NATL ACAD SCI-BIOL, V77, P3504, DOI 10.1073/pnas.77.6.3504; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P773; FISHER RJ, 1990, ONCOGENESIS, P249; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GUNTHER CV, 1990, GENE DEV, V4, P667, DOI 10.1101/gad.4.4.667; KARPINSKI BA, 1989, MOL CELL BIOL, V9, P2588, DOI 10.1128/MCB.9.6.2588; KATZAV S, 1989, ONCOGENE, V4, P1129; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KOIZUMI S, 1990, ONCOGENE, V5, P675; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Maniatis T., 1982, MOL CLONING; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; PAVLAKIS GN, 1987, GENE TRANSFER VECTOR, P29; POGNONEC P, 1988, EMBO J, V7, P977, DOI 10.1002/j.1460-2075.1988.tb02904.x; POGNONEC P, 1990, ONCOGENE, V5, P603; REDDY ESP, 1987, P NATL ACAD SCI USA, V84, P6131, DOI 10.1073/pnas.84.17.6131; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SERFLING E, 1989, TRENDS GENET, V5, P131, DOI 10.1016/0168-9525(89)90049-8; SETH A, 1989, ONCOGENE RES, V5, P61; SETH A, 1989, P NATL ACAD SCI USA, V86, P7833, DOI 10.1073/pnas.86.20.7833; SETH A, 1989, ADV GENE TECHNOLOGY, P155; SETH A, 1990, ONCOGENESIS, P297; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WATSON D K, 1990, Critical Reviews in Oncogenesis, V1, P409; WATSON DK, 1988, VIROLOGY, V164, P99, DOI 10.1016/0042-6822(88)90624-1; WATSON DK, 1988, P NATL ACAD SCI USA, V85, P7862, DOI 10.1073/pnas.85.21.7862; WATSON DK, 1990, ONCOGENESIS, P221; YUAN CC, 1989, J VIROL, V63, P205, DOI 10.1128/JVI.63.1.205-215.1989; ZHAN X, 1987, ONCOGENE, V1, P369	38	163	165	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1761	1767						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284095				2022-12-28	WOS:A1990ET43600004
J	PAQUETTE, RL; BERENSON, J; LICHTENSTEIN, A; MCCORMICK, F; KOEFFLER, HP				PAQUETTE, RL; BERENSON, J; LICHTENSTEIN, A; MCCORMICK, F; KOEFFLER, HP			ONCOGENES IN MULTIPLE-MYELOMA - POINT MUTATION OF N-RAS	ONCOGENE			English	Article									VET ADM WADSWORTH MED CTR,DIV HEMATOL,LOS ANGELES,CA 90073; CETUS CORP,DEPT MOLEC BIOL,EMERYVILLE,CA 94608		PAQUETTE, RL (corresponding author), UNIV CALIF LOS ANGELES,DIV HEMATOL ONCOL,FACTOR BLDG 11-240,LOS ANGELES,CA 90024, USA.				NATIONAL CANCER INSTITUTE [R01CA026038, R01CA033936, P01CA032737] Funding Source: NIH RePORTER; NCI NIH HHS [CA 32737, CA 33936, CA 26038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; AHUJA HG, 1990, IN PRESS BLOOD; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BERENSON J, 1989, LEUKEMIA, V3, P133; BERENSON J, 1987, BLOOD, V70, P1550; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BROWETT PJ, 1989, ONCOGENE, V4, P1029; BROWETT PJ, 1988, LEUKEMIA RES, V12, P25, DOI 10.1016/S0145-2126(98)80005-2; CALIGARISCAPPIO F, 1985, J CLIN INVEST, V76, P1243, DOI 10.1172/JCI112080; CESARMAN E, 1987, SCIENCE, V238, P1272, DOI 10.1126/science.3685977; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DALLAFAVERA R, 1982, NATURE, V299, P61; DEWALD GW, 1985, BLOOD, V66, P380; ERNST TJ, 1988, BLOOD, V72, P1163; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; GROGAN TM, 1987, BLOOD, V70, P932; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; INCE C, 1988, LEUKEMIA, V2, P343; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; KUBAGAWA H, 1979, J EXP MED, V150, P792, DOI 10.1084/jem.150.4.792; LIANG W, 1979, CANCER, V44, P630; LUBBERT M, IN PRESS BLOOD; Marshall CJ, 1985, RNA TUMOR VIRUSES MO, P487; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MELTZER P, 1987, BLOOD, V70, pA985; NEEDLEMAN SW, 1986, BLOOD, V67, P753; NERI A, 1989, J EXP MED, V170, P1715, DOI 10.1084/jem.170.5.1715; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; PADUA RA, 1988, LEUKEMIA, V2, P503; PERRY RP, 1979, J CELL PHYSIOL, V98, P553, DOI 10.1002/jcp.1040980313; PULCIANI S, 1982, J CELL BIOCHEM, V20, P51, DOI 10.1002/jcb.240200106; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELVANAYAGAM P, 1987, P AM ASSOC CANC RES, V28, P19; SELVANAYAGAM P, 1988, BLOOD, V71, P30; SENN HP, 1988, INT J CANCER, V41, P59, DOI 10.1002/ijc.2910410112; SREMETIS S, 1989, SCIENCE, V243, P660; STEENVOORDEN ACM, 1988, LEUKEMIA, V2, P325; TSUCHIYA H, 1988, BLOOD, V72, P796; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529; YANAGI Y, 1984, NATURE, V308, P145, DOI 10.1038/308145a0	45	56	56	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1659	1663						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267133				2022-12-28	WOS:A1990EL40100007
J	ZAK, NB; SHILO, BZ				ZAK, NB; SHILO, BZ			BIOCHEMICAL-PROPERTIES OF THE DROSOPHILA EGF RECEPTOR HOMOLOG (DER) PROTEIN	ONCOGENE			English	Note									WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science				Shilo, Ben Zion/0000-0003-4903-8889	NIGMS NIH HHS [GM35998] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035998] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BRACHMANN R, 1989, CELL, V56, P691, DOI 10.1016/0092-8674(89)90591-6; CLIFFORD RJ, 1990, GENETICS, V123, P771; DECKER S, 1984, ARCH BIOCHEM BIOPHYS, V228, P621, DOI 10.1016/0003-9861(84)90031-6; DECKER SJ, 1984, MOL CELL BIOL, V4, P571, DOI 10.1128/MCB.4.4.571; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DERYNCK R, 1988, CELL, V54, P593, DOI 10.1016/S0092-8674(88)80001-1; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; FESSLER LI, 1987, J CELL BIOL, V105, P2383, DOI 10.1083/jcb.105.5.2383; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; KAMPS MP, 1988, ONCOGENE, V2, P305; LAUB O, 1983, J VIROL, V48, P271, DOI 10.1128/JVI.48.1.271-280.1983; LEE DC, 1985, NATURE, V313, P489, DOI 10.1038/313489a0; LEE F, 1981, NATURE, V294, P228, DOI 10.1038/294228a0; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PRICE JV, 1989, CELL, V56, P1085, DOI 10.1016/0092-8674(89)90641-7; SCHEJTER ED, 1989, CELL, V56, P1093, DOI 10.1016/0092-8674(89)90642-9; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SHILO BZ, 1987, TRENDS GENET, V3, P69, DOI 10.1016/0168-9525(87)90178-8; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WIDES RJ, 1990, EUR J BIOCHEM, V189, P637, DOI 10.1111/j.1432-1033.1990.tb15532.x; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZAK NB, 1990, DEVELOPMENT, V109, P865	34	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1589	1593						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250916				2022-12-28	WOS:A1990EK50200021
J	NOTARIO, V; CASTRO, R; FLESSATE, DM; DONIGER, J; DIPAOLO, JA				NOTARIO, V; CASTRO, R; FLESSATE, DM; DONIGER, J; DIPAOLO, JA			FREQUENT ACTIVATION OF NON-RAS TRANSFORMING SEQUENCES IN NEOPLASTIC SYRIAN-HAMSTER CELLS INITIATED WITH CHEMICAL CARCINOGENS	ONCOGENE			English	Note									GEORGETOWN UNIV,SCH MED,DEPT BIOCHEM,WASHINGTON,DC 20007; NCI,DIV CANC ETIOL,BIOL LAB,BETHESDA,MD 20892	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	NOTARIO, V (corresponding author), GEORGETOWN UNIV,SCH MED,VINCENT T LOMBARDI CANC RES CTR,DEPT RADIAT MED,WASHINGTON,DC 20007, USA.		/AFP-0764-2022; /AAB-6461-2022		NCI NIH HHS [CA49858] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA049858] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALMAIN A, 1988, ADV CANCER RES, V51, P147, DOI 10.1016/S0065-230X(08)60222-5; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARRETT JC, 1978, P NATL ACAD SCI USA, V75, P3761, DOI 10.1073/pnas.75.8.3761; BERWALD Y, 1965, J NATL CANCER I, V35, P641; BOREK C, 1987, P NATL ACAD SCI USA, V84, P794, DOI 10.1073/pnas.84.3.794; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; BUSS JE, 1989, SCIENCE, V243, P1600, DOI 10.1126/science.2648572; CICHUTEK K, 1986, P NATL ACAD SCI USA, V83, P2340, DOI 10.1073/pnas.83.8.2340; COHEN JB, 1988, NATURE, V334, P119, DOI 10.1038/334119a0; DIPAOLO JA, 1969, SCIENCE, V165, P917, DOI 10.1126/science.165.3896.917; DIPAOLO JA, 1973, CANCER RES, V33, P3250; DIPAOLO JA, 1971, CANCER RES, V31, P1118; DIPAOLO JA, 1969, J NATL CANCER I, V42, P867; DIPAOLO JA, 1989, ONCOGENE, V4, P395; DIPAOLO JA, 1981, CANCER LETT, V12, P203, DOI 10.1016/0304-3835(81)90069-0; DIPAOLO JA, 1971, NATURE-NEW BIOL, V230, P240, DOI 10.1038/newbio230240a0; DIPAOLO JA, 1972, NATURE, V235, P278, DOI 10.1038/235278a0; DIPAOLO JA, 1978, NATL CANCER I MONOGR, V48, P245; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GILMER TM, 1988, MOL CARCINOGEN, V1, P180, DOI 10.1002/mc.2940010306; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; HUBERMAN E, 1966, P NATL ACAD SCI USA, V56, P1123, DOI 10.1073/pnas.56.4.1123; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; MCCABE RP, 1983, ONCODEV BIOL MED, V4, P383; POPESCU NC, 1980, P NATL ACAD SCI-BIOL, V77, P7282, DOI 10.1073/pnas.77.12.7282; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SHIH C, 1979, P NATL ACAD SCI USA, V76, P5714, DOI 10.1073/pnas.76.11.5714; SLOAN SR, 1990, MOL CELL BIOL, V10, P405, DOI 10.1128/MCB.10.1.405; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SRIVASTAVA SK, 1985, P NATL ACAD SCI USA, V82, P38, DOI 10.1073/pnas.82.1.38; WEINSTEIN IB, 1984, CANCER CELL, V1, P229; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6	34	30	30	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1425	1430						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216466				2022-12-28	WOS:A1990EC24100024
J	BECKER, D; BEEBE, SJ; HERLYN, M				BECKER, D; BEEBE, SJ; HERLYN, M			DIFFERENTIAL EXPRESSION OF PROTEIN-KINASE-C AND CAMP-DEPENDENT PROTEIN-KINASE IN NORMAL HUMAN MELANOCYTES AND MALIGNANT MELANOMAS	ONCOGENE			English	Article									EASTERN VIRGINIA MED SCH,DEPT OBSTET & GYNECOL,NORFOLK,VA 23510; WISTAR INST,PHILADELPHIA,PA 19104	Eastern Virginia Medical School; The Wistar Institute	BECKER, D (corresponding author), UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,HOUSTON,TX 77030, USA.				NATIONAL CANCER INSTITUTE [P01CA025874] Funding Source: NIH RePORTER; NCI NIH HHS [CA 25874] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BECKER D, 1984, MOL CELL BIOL, V4, P2247, DOI 10.1128/MCB.4.11.2247; BECKER D, 1989, GENOMICS, V4, P97, DOI 10.1016/0888-7543(89)90320-0; BECKER D, 1989, EMBO J, V8, P3685, DOI 10.1002/j.1460-2075.1989.tb08543.x; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CLARK WH, 1988, ARCH DERMATOL, V124, P1207, DOI 10.1001/archderm.124.8.1207; CLARK WH, 1986, HUM PATHOL, V17, P443, DOI 10.1016/S0046-8177(86)80032-6; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018; FEIGE JJ, 1989, P NATL ACAD SCI USA, V86, P3174, DOI 10.1073/pnas.86.9.3174; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIALLONGO A, 1986, P NATL ACAD SCI USA, V83, P6741, DOI 10.1073/pnas.83.18.6741; GORDON PR, 1986, J INVEST DERMATOL, V87, P723, DOI 10.1111/1523-1747.ep12456842; HALABAN R, 1986, J INVEST DERMATOL, V87, P95, DOI 10.1111/1523-1747.ep12523594; HALABAN R, 1988, ONCOGENE RES, V3, P177; HERLYN M, 1988, EXP CELL RES, V179, P322, DOI 10.1016/0014-4827(88)90271-6; HERLYN M, 1987, CANCER RES, V47, P3057; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOUSEY GM, 1987, P NATL ACAD SCI USA, V84, P1065, DOI 10.1073/pnas.84.4.1065; KIKKAWA U, 1986, BIOCHEM BIOPH RES CO, V135, P636, DOI 10.1016/0006-291X(86)90040-9; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPEUCH CJ, 1983, P NATL ACAD SCI-BIOL, V80, P6858; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; LINNENBACH AJ, 1988, P NATL ACAD SCI USA, V85, P74, DOI 10.1073/pnas.85.1.74; MALDONADO F, 1988, NUCLEIC ACIDS RES, V16, P8189, DOI 10.1093/nar/16.16.8189; MELBER K, 1989, CANCER RES, V49, P3650; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NISHIZUKA Y, 1988, NATURE, V334, P662; OKEEFE E, 1974, P NATL ACAD SCI USA, V71, P2500, DOI 10.1073/pnas.71.6.2500; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; ONO Y, 1988, J BIOL CHEM, V263, P6927; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; PARKER PJ, 1985, EUR J BIOCHEM, V148, P579, DOI 10.1111/j.1432-1033.1985.tb08879.x; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PHILLIPS MA, 1983, J BIOL CHEM, V258, P2875; RODECK U, 1987, INT J CANCER, V40, P687, DOI 10.1002/ijc.2910400520; SALUSTRI A, 1985, BIOL REPROD, V33, P797, DOI 10.1095/biolreprod33.4.797; SANDBERG M, 1987, BIOCHEM BIOPH RES CO, V149, P939, DOI 10.1016/0006-291X(87)90499-2; SOLANKI V, 1981, P NATL ACAD SCI-BIOL, V78, P1722, DOI 10.1073/pnas.78.3.1722; TAYLOR SS, 1989, J BIOL CHEM, V264, P8443; ULLRICH A, 1986, COLD SPRING HARB SYM, V51, P713, DOI 10.1101/SQB.1986.051.01.084; WOODGETT JR, 1987, MOL CELL BIOL, V7, P85, DOI 10.1128/MCB.7.1.85; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; YOUNG S, 1988, EUR J BIOCHEM, V173, P247, DOI 10.1111/j.1432-1033.1988.tb13991.x; ZIEGLERHEITBROCK HWL, 1985, CANCER RES, V45, P1344	49	54	58	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1133	1139						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2392322				2022-12-28	WOS:A1990DX36100004
J	GILGENKRANTZ, S; CHERY, M; TEBOUL, M; MUJICA, P; LEOTARD, B; GREGOIRE, MJ; BOMAN, F; DUPREZ, A; HANAUER, A				GILGENKRANTZ, S; CHERY, M; TEBOUL, M; MUJICA, P; LEOTARD, B; GREGOIRE, MJ; BOMAN, F; DUPREZ, A; HANAUER, A			SUBLOCALIZATION OF THE X BREAKPOINT IN THE TRANSLOCATION (X-18)(P11.2-Q11.2) PRIMARY CHANGE IN SYNOVIAL SARCOMAS	ONCOGENE			English	Note									UNIV NANCY, F-54500 VANDOEUVRE LES NANCY, FRANCE; UNIV STRASBOURG 1, GENET MOLEC EUCARYOT LAB, F-67085 STRASBOURG, FRANCE	Universite de Lorraine; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	GILGENKRANTZ, S (corresponding author), UNIV NANCY, CTR REG TRANSFUS SANGUINE, F-54511 VANDOEUVRE LES NANCY, FRANCE.							BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; CANIZZARO LA, 1989, CYTOGENET CELL GENET, V51, P974; CORSON JM, 1984, HUM PATHOL, V15, P615, DOI 10.1016/S0046-8177(84)80284-1; DURFY SJ, 1986, NUCLEIC ACIDS RES, V14, P9226, DOI 10.1093/nar/14.22.9226; Enzinger RM., 2011, SOFT TISSUE TUMORS, P1178; FISHER C, 1986, HUM PATHOL, V17, P996, DOI 10.1016/S0046-8177(86)80083-1; FRASER N, 1987, CYTOGENET CELL GENET, V46, P615; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; GREGOIRE MJ, 1989, CANCER GENET CYTOGEN, V38, P160, DOI 10.1016/0165-4608(89)90548-7; GRIFFIN CA, 1987, CANCER GENET CYTOGEN, V26, P181, DOI 10.1016/0165-4608(87)90148-8; GUSTERSON B, 1985, INT J CANCER, V36, P689; HANAUER A, 1984, EMBO J, V3, P2627, DOI 10.1002/j.1460-2075.1984.tb02185.x; HENRY I, 1989, HUM GENET, V81, P273, DOI 10.1007/BF00279003; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HUEBNER K, 1986, AM J HUM GENET, V38, P819; KARAKOUSIS CP, 1987, ARCH SURG-CHICAGO, V122, P1257; KNIGHT JC, 1989, CYTOGENET CELL GENET, V51, P1023; KRUSE TA, 1986, NUCLEIC ACIDS RES, V14, P1921, DOI 10.1093/nar/14.4.1921; LIMON J, 1989, CANCER GENET CYTOGEN, V38, P215, DOI 10.1016/0165-4608(89)90662-6; LIMON J, 1986, CANCER GENET CYTOGEN, V23, P87, DOI 10.1016/0165-4608(86)90152-4; Mahtani MM, 1988, GENOMICS, V2, P294, DOI 10.1016/0888-7543(88)90017-1; MANDAHL N, 1988, CANCER GENET CYTOGEN, V30, P323, DOI 10.1016/0165-4608(88)90202-6; MIETTINEN M, 1983, VIRCHOWS ARCH B, V44, P187, DOI 10.1007/BF02890169; MULLER U, 1987, CYTOGENET CELL GENET, V45, P16, DOI 10.1159/000132418; NOGUERA R, 1988, CANCER GENET CYTOGEN, V33, P311, DOI 10.1016/0165-4608(88)90040-4; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; REEVES BR, 1989, ONCOGENE, V4, P373; RUDDLE FH, 1989, CYTOGENET CELL GENET, V51, P1, DOI 10.1159/000132773; SCHARDIN M, 1985, HUM GENET, V71, P281, DOI 10.1007/BF00388452; SHENG WW, 1987, CANCER GENET CYTOGEN, V29, P179, DOI 10.1016/0165-4608(87)90048-3; SMITH S, 1987, CANCER GENET CYTOGEN, V26, P179, DOI 10.1016/0165-4608(87)90147-6; SPURR NK, 1987, ANN HUM GENET, V51, P189, DOI 10.1111/j.1469-1809.1987.tb00870.x; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; TUCKER JD, 1984, EMBO J, V3, P2627; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P93, DOI 10.1016/0165-4608(86)90153-6; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; UEDA T, 1988, CANCER GENET CYTOGEN, V30, P183, DOI 10.1016/0165-4608(88)90111-2; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WILLARD HF, 1989, HUM GENET, V81, P234	41	26	26	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1990	5	7					1063	1066						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2165233				2022-12-28	WOS:A1990DP41500017
J	ZHU, QS; HEISTERKAMP, N; GROFFEN, J				ZHU, QS; HEISTERKAMP, N; GROFFEN, J			CHARACTERIZATION OF THE HUMAN ABL PROMOTER REGIONS	ONCOGENE			English	Article									CHILDRENS HOSP LOS ANGELES,DEPT PATHOL,MOLEC DIAG SECT,4650 SUNSET BLVD,LOS ANGELES,CA 90027	Children's Hospital Los Angeles			Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	NATIONAL CANCER INSTITUTE [R01CA047073, R55CA047456, R01CA047456] Funding Source: NIH RePORTER; NCI NIH HHS [CA 47073, CA 47456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARCOT SS, 1989, J BIOL CHEM, V264, P2343; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; BERNARDS A, 1988, ONCOGENE, V2, P297; BERNARDS A, 1987, MOL CELL BIOL, V7, P3231, DOI 10.1128/MCB.7.9.3231; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRUNKE KJ, 1984, MOL CELL BIOL, V4, P1115, DOI 10.1128/MCB.4.6.1115; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FROMM M, 1982, Journal of Molecular and Applied Genetics, V1, P457; GIDONI D, 1985, SCIENCE, V230, P511, DOI 10.1126/science.2996137; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P1432, DOI 10.1073/pnas.77.3.1432; HEISTERKAMP N, 1983, Journal of Molecular and Applied Genetics, V2, P57; HENTZE MW, 1986, P NATL ACAD SCI USA, V83, P7226, DOI 10.1073/pnas.83.19.7226; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAGEYAMA R, 1989, J BIOL CHEM, V264, P15508; KIM SJ, 1989, J BIOL CHEM, V264, P7041; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MELTON DW, 1986, CELL, V44, P319, DOI 10.1016/0092-8674(86)90766-X; MERRILL GF, 1984, J BIOL CHEM, V264, P1769; MYERS RM, 1981, CELL, V25, P373, DOI 10.1016/0092-8674(81)90056-8; NOWELL PC, 1960, SCIENCE, V132, P1497; RYFFEL GU, 1989, NUCLEIC ACIDS RES, V17, P939, DOI 10.1093/nar/17.3.939; SANCHEZPESCADOR R, 1985, SCIENCE, V227, P484, DOI 10.1126/science.2578227; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHNEIDER R, 1986, NUCLEIC ACIDS RES, V14, P1303, DOI 10.1093/nar/14.3.1303; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; STAM K, 1985, NEW ENGL J MED, V313, P1429, DOI 10.1056/NEJM198512053132301; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x	37	4	4	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					885	891						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2163052				2022-12-28	WOS:A1990DP55300015
J	STACEY, M; GALLIMORE, PH; MCCONVILLE, C; TAYLOR, AMR				STACEY, M; GALLIMORE, PH; MCCONVILLE, C; TAYLOR, AMR			REARRANGEMENT OF THE SAME CHROMOSOME REGIONS IN DIFFERENT SV40-TRANSFORMED HUMAN SKIN KERATINOCYTE LINES IS ASSOCIATED WITH TUMORIGENICITY	ONCOGENE			English	Article											STACEY, M (corresponding author), UNIV BIRMINGHAM, SCH MED, CANC RES CAMPAIGN LABS, DEPT CANC STUDIES, BIRMINGHAM B15 2TJ, W MIDLANDS, ENGLAND.			Stacey, Michael/0000-0002-3807-6233				ATKIN NB, 1985, CANCER GENET CYTOGEN, V15, P253, DOI 10.1016/0165-4608(85)90169-4; BADEN HP, 1987, IN VITRO CELL DEV B, V23, P205; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BANKSSCHLEGEL SP, 1983, J CELL BIOL, V96, P330, DOI 10.1083/jcb.96.2.330; BENEDICT WF, 1987, CANCER RES, V47, P4189; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROWN KW, 1987, BRIT J CANCER, V56, P545, DOI 10.1038/bjc.1987.240; CHANG SE, 1985, BIOCHIM BIOPHYS ACTA, V823, P161; DEBLOIS MC, 1986, CR ACAD SCI III-VIE, V302, P81; GLUZMAN Y, 1979, COLD SPRING HARB SYM, V44, P293; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HILL SM, 1987, CANCER GENET CYTOGEN, V24, P45, DOI 10.1016/0165-4608(87)90082-3; HOFFSCHIR F, 1988, CYTOGENET CELL GENET, V49, P264, DOI 10.1159/000132674; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JIN YS, 1988, CANCER GENET CYTOGEN, V33, P11, DOI 10.1016/0165-4608(88)90043-X; KOK K, 1987, NATURE, V330, P578, DOI 10.1038/330578a0; KOVACS G, 1988, P NATL ACAD SCI USA, V85, P1571, DOI 10.1073/pnas.85.5.1571; MULERIS M, 1987, INT J CANCER, V39, P595, DOI 10.1002/ijc.2910390509; PARASKEVA C, 1989, CANCER RES, V49, P1282; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHIM JS, 1986, SCIENCE, V232, P385, DOI 10.1126/science.2421406; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; SACKS PG, 1988, CANCER RES, V48, P2858; SASAKI M, 1989, CANCER RES, V49, P4402; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; STEINBERG ML, 1979, P NATL ACAD SCI USA, V76, P801, DOI 10.1073/pnas.76.2.801; TAYLORPAPADIMITRIOU J, 1982, CELL DIFFER DEV, V11, P169, DOI 10.1016/0045-6039(82)90008-2; TEYSSIER JR, 1987, CANCER GENET CYTOGEN, V25, P179, DOI 10.1016/0165-4608(87)90175-0; TEYSSIER JR, 1986, J NATL CANCER I, V77, P1187; TRENT J, 1985, CANCER GENET CYTOGEN, V16, P189, DOI 10.1016/0165-4608(85)90045-7; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WURSTERHILL DH, 1984, CANCER GENET CYTOGEN, V13, P303, DOI 10.1016/0165-4608(84)90075-X; YOKOTA J, 1989, CANCER RES, V49, P3598	35	26	27	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1990	5	5					727	739						13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2161098				2022-12-28	WOS:A1990DG37400014
J	WATERS, CM; HANCOCK, DC; EVAN, GI				WATERS, CM; HANCOCK, DC; EVAN, GI			IDENTIFICATION AND CHARACTERIZATION OF THE EGR-1 GENE-PRODUCT AS AN INDUCIBLE, SHORT-LIVED, NUCLEAR PHOSPHOPROTEIN	ONCOGENE			English	Article											WATERS, CM (corresponding author), IMPERIAL CANC RES FUND, DOMIN HOUSE, 59 BARTHOLOMEW CLOSE, LONDON EC1A 7BE, ENGLAND.							BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; GARCHON HJ, 1989, J CELL BIOL, V108, P779, DOI 10.1083/jcb.108.3.779; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; JANSSENTIMMEN U, 1989, GENE, V80, P325, DOI 10.1016/0378-1119(89)90296-5; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOORE JP, 1988, BIOCHIM BIOPHYS ACTA, V965, P60, DOI 10.1016/0304-4165(88)90151-1; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MORRIS CHT, 1988, NUCLEIC ACIDS RES, V16, P8835, DOI 10.1093/nar/16.18.8835; NAGAI K, 1988, NATURE, V332, P284, DOI 10.1038/332284a0; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; SEYFERT VL, 1989, MOL CELL BIOL, V9, P2083, DOI 10.1128/MCB.9.5.2083; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; VANSTRAATEN JP, 1987, ONCOGENE RES, V1, P221; VISVADER J, 1988, P NATL ACAD SCI USA, V85, P9474, DOI 10.1073/pnas.85.24.9474; VOSATKA RJ, 1989, J CELL PHYSIOL, V138, P493, DOI 10.1002/jcp.1041380308; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0	33	74	77	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1990	5	5					669	674						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189103				2022-12-28	WOS:A1990DG37400006
J	ROHRSCHNEIDER, LR; ROTHWELL, VM; NICOLA, NA				ROHRSCHNEIDER, LR; ROTHWELL, VM; NICOLA, NA			TRANSFORMATION OF MURINE FIBROBLASTS BY A RETROVIRUS ENCODING THE MURINE C-FMS PROTO-ONCOGENE	ONCOGENE			English	Article									ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA	Royal Melbourne Hospital; Walter & Eliza Hall Institute	ROHRSCHNEIDER, LR (corresponding author), FRED HUTCHINSON CANC RES CTR,DEPT CELL BIOL,1124 COLUMBIA ST,SEATTLE,WA 98104, USA.		Nicola, Nicos/D-2989-2011	Nicola, Nicos/0000-0003-1054-7889	NATIONAL CANCER INSTITUTE [R01CA040987, R01CA022556, R37CA022556, R01CA020551] Funding Source: NIH RePORTER; NCI NIH HHS [CA 20551, CA 40987, CA 22556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLAIN SB, 1988, ONCOGENE, V3, P129; BOWTELL DDL, 1988, J VIROL, V62, P2464, DOI 10.1128/JVI.62.7.2464-2473.1988; BYRNE PV, 1981, J CELL BIOL, V91, P848, DOI 10.1083/jcb.91.3.848; CALVO JC, 1983, BIOCHEM J, V212, P259, DOI 10.1042/bj2120259; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CLARKE MF, 1984, NATURE, V308, P464, DOI 10.1038/308464a0; COUSSENS L, 1986, NATURE, V320, P277, DOI 10.1038/320277a0; DELAMARTER JF, 1987, NUCLEIC ACIDS RES, V15, P2389, DOI 10.1093/nar/15.5.2389; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DOWNING JR, 1988, MOL CELL BIOL, V8, P1795, DOI 10.1128/MCB.8.4.1795; GAZIT A, 1984, CELL, V39, P89, DOI 10.1016/0092-8674(84)90194-6; GENTRY LE, 1983, J BIOL CHEM, V258, P1219; HUANG SS, 1988, J BIOL CHEM, V263, P12608; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; JAYE M, 1988, ONCOGENE, V3, P963; JOHNSON GR, 1989, EMBO J, V8, P441, DOI 10.1002/j.1460-2075.1989.tb03396.x; KACINSKI BM, 1988, IN PRESS AM J PATHOL; LANG RA, 1985, CELL, V43, P531, DOI 10.1016/0092-8674(85)90182-5; MANGER R, 1984, CELL, V39, P327, DOI 10.1016/0092-8674(84)90011-4; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MULLER R, 1983, MOL CELL BIOL, V3, P1062; MULLER R, 1983, NATURE, V304, P484; NICOLA NA, 1988, IN PRESS GROWTH FACT; RETTENMIER CW, 1985, SCIENCE, V228, P320, DOI 10.1126/science.2580348; ROGELJ S, 1988, NATURE, V331, P173, DOI 10.1038/331173a0; ROTHWELL VM, 1987, ONCOGENE RES, V1, P311; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; STANLEY ER, 1983, J CELL BIOCHEM, V21, P151, DOI 10.1002/jcb.240210206; STANLEY ER, 1981, J IMMUNOL METHODS, V42, P253, DOI 10.1016/0022-1759(81)90156-3; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; STEWART CC, 1978, J RETICULOENDOTH SOC, V23, P269; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; WOOLFORD J, 1988, CELL, V55, P965, DOI 10.1016/0092-8674(88)90242-5; WOOLFORD J, 1985, MOL CELL BIOL, V5, P3458, DOI 10.1128/MCB.5.12.3458	40	39	39	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1989	4	8					1015	1022						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AJ297	2548144				2022-12-28	WOS:A1989AJ29700011
J	SORRENTINO, V; BANDYOPADHYAY, S				SORRENTINO, V; BANDYOPADHYAY, S			TGF-BETA INHIBITS GO/S-PHASE TRANSITION IN PRIMARY FIBROBLASTS - LOSS OF RESPONSE TO THE ANTIGROWTH EFFECT OF TGF-BETA IS OBSERVED AFTER IMMORTALIZATION	ONCOGENE			English	Article											SORRENTINO, V (corresponding author), EUROPEAN MOLEC BIOL LAB, MEYERHOFSTR 1, D-6900 HEIDELBERG, GERMANY.		Sorrentino, Vincenzo/A-4793-2014	Sorrentino, Vincenzo/0000-0002-8573-8631				ANZANO MA, 1986, J CELL PHYSIOL, V126, P312, DOI 10.1002/jcp.1041260223; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CHAMBARD JC, 1988, J CELL PHYSIOL, V135, P101, DOI 10.1002/jcp.1041350114; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CRAIG RW, 1985, P NATL ACAD SCI USA, V82, P2062, DOI 10.1073/pnas.82.7.2062; EBSWORTH N, 1986, EXP CELL RES, V165, P255, DOI 10.1016/0014-4827(86)90549-5; EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0; EINAT M, 1985, P NATL ACAD SCI USA, V82, P7608, DOI 10.1073/pnas.82.22.7608; EINAT M, 1988, ONCOGENE, V2, P485; FANGER BO, 1986, BIOCHEMISTRY-US, V25, P3083, DOI 10.1021/bi00359a003; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HAMLIN JL, 1976, EXP CELL RES, V100, P265, DOI 10.1016/0014-4827(76)90147-6; HUME CR, 1988, ONCOGENE, V2, P223; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; KIMCHI A, 1988, SCIENCE, V240, P196, DOI 10.1126/science.2895499; KNABBE C, 1987, CELL, V48, P417, DOI 10.1016/0092-8674(87)90193-0; KOHASE M, 1986, CELL, V45, P659, DOI 10.1016/0092-8674(86)90780-4; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIN SL, 1986, SCIENCE, V233, P356, DOI 10.1126/science.3726533; LOO DT, 1987, SCIENCE, V236, P200, DOI 10.1126/science.3494308; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; MOUGNEAU E, 1988, ONCOGENE RES, V2, P177; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; PARDEE AB, 1987, J CELL PHYSIOL, P107; RIZZINO A, 1988, CANCER RES, V48, P4266; ROBERTS AB, 1985, NATURE, V315, P237, DOI 10.1038/315237a0; ROBERTS AB, 1983, BIOCHEMISTRY-US, V22, P5692, DOI 10.1021/bi00294a002; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SORRENTINO V, 1987, P NATL ACAD SCI USA, V84, P4131, DOI 10.1073/pnas.84.12.4131; SORRENTINO V, 1986, P NATL ACAD SCI USA, V83, P8167, DOI 10.1073/pnas.83.21.8167; SORRENTINO V, 1988, P NATL ACAD SCI USA, V85, P2191, DOI 10.1073/pnas.85.7.2191; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; TAINSKY MA, 1984, SCIENCE, V225, P643, DOI 10.1126/science.6740333; TAKEHARA K, 1987, CELL, V49, P415, DOI 10.1016/0092-8674(87)90294-7; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; TOMINAGA S, 1985, J BIOL CHEM, V260, P1975; ZERLIN M, 1987, ONCOGENE, V1, P19	45	54	54	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1989	4	5					569	574						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2498805				2022-12-28	WOS:A1989U768800006
J	KAWAKAMI, Y; FURUE, M; KAWAKAMI, T				KAWAKAMI, Y; FURUE, M; KAWAKAMI, T			IDENTIFICATION OF FYN-ENCODED PROTEINS IN NORMAL HUMAN-BLOOD CELLS	ONCOGENE			English	Note									NCI,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892; NCI,DERMATOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Kawakami, Toshiaki/O-1616-2015					AZARNIA R, 1988, SCIENCE, V239, P398, DOI 10.1126/science.2447651; BARNEKOW A, 1986, EMBO J, V5, P701, DOI 10.1002/j.1460-2075.1986.tb04270.x; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; GILMORE TD, 1986, CELL, V44, P791, DOI 10.1016/0092-8674(86)90845-7; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; JACOBS C, 1983, CANCER RES, V43, P1696; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KAWAKAMI T, 1988, P NATL ACAD SCI USA, V85, P3870, DOI 10.1073/pnas.85.11.3870; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; LEVY BT, 1984, DEV BIOL, V104, P9, DOI 10.1016/0012-1606(84)90031-9; Maniatis T., 1982, MOL CLONING; MARTH JD, 1988, NATURE, V332, P171, DOI 10.1038/332171a0; NAHARRO G, 1984, SCIENCE, V223, P63, DOI 10.1126/science.6318314; POPESCU NC, 1987, ONCOGENE, V1, P449; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	25	31	32	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					389	391						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2649850				2022-12-28	WOS:A1989U567600017
J	RICHON, VM; RAMSAY, RG; RIFKIND, RA; MARKS, PA				RICHON, VM; RAMSAY, RG; RIFKIND, RA; MARKS, PA			MODULATION OF THE C-MYB, C-MYC AND P53 MESSENGER-RNA AND PROTEIN-LEVELS DURING INDUCED MURINE ERYTHROLEUKEMIA CELL-DIFFERENTIATION	ONCOGENE			English	Article									CORNELL UNIV,GRAD SCH MED SCI,SLOAN KETTERING DIV,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,MEM SLOAN KETTERING CANC CTR,DEWITT WALLACE RES LAB,NEW YORK,NY 10021	Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center			Ramsay, Robert G/C-3291-2015	Ramsay, Robert G/0000-0001-5003-0433	NCI NIH HHS [CA-08748, CA 31768-07] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA031768] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENDER TP, 1987, J IMMUNOL, V139, P3822; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHEN ZX, 1982, P NATL ACAD SCI-BIOL, V79, P471, DOI 10.1073/pnas.79.2.471; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CRAIG RW, 1984, CANCER RES, V44, P442; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DONY C, 1985, NATURE, V317, P636, DOI 10.1038/317636a0; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; ENDO T, 1986, MOL CELL BIOL, V6, P1412, DOI 10.1128/MCB.6.5.1412; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIBACH E, 1977, CANCER RES, V37, P440; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; GUSELLA J, 1976, CELL, V9, P221, DOI 10.1016/0092-8674(76)90113-6; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; KHOCHBIN S, 1988, J MOL BIOL, V200, P55, DOI 10.1016/0022-2836(88)90333-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE J, 1987, BLOOD, V69, P1542; Maniatis T., 1982, MOL CLONING; MARKS PA, 1987, CANCER RES, V47, P659; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MILNER J, 1981, VIROLOGY, V112, P785, DOI 10.1016/0042-6822(81)90327-5; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; NUDEL U, 1977, CELL, V12, P463, DOI 10.1016/0092-8674(77)90122-2; OREN M, 1983, P NATL ACAD SCI-BIOL, V80, P56, DOI 10.1073/pnas.80.1.56; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; SHEFFERY M, 1984, J MOL BIOL, V172, P417, DOI 10.1016/S0022-2836(84)80015-7; SHEINESS D, 1984, MOL CELL BIOL, V4, P1206, DOI 10.1128/MCB.4.7.1206; SHEN DW, 1983, P NATL ACAD SCI-BIOL, V80, P5919, DOI 10.1073/pnas.80.19.5919; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; TODOKORO K, 1986, BIOCHEM BIOPH RES CO, V135, P1112, DOI 10.1016/0006-291X(86)91043-0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WINGROVE TG, 1988, J BIOL CHEM, V263, P8918; YENOFSKY R, 1983, MOL CELL BIOL, V3, P1197, DOI 10.1128/MCB.3.7.1197; ZAKUTHOURI R, 1983, NATURE, V306, P594, DOI 10.1038/306594a0	52	53	54	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					165	173						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2648254				2022-12-28	WOS:A1989U567500007
J	BOEHM, T; LAVENIR, I; FORSTER, A; WADEY, RB; COWELL, JK; HARBOTT, J; LAMPERT, F; WATERS, J; SHERRINGTON, P; COUILLIN, P; AZOULAY, M; JUNIEN, C; VANHEYNINGEN, V; PORTEOUS, DJ; HASTIE, ND; RABBITTS, TH				BOEHM, T; LAVENIR, I; FORSTER, A; WADEY, RB; COWELL, JK; HARBOTT, J; LAMPERT, F; WATERS, J; SHERRINGTON, P; COUILLIN, P; AZOULAY, M; JUNIEN, C; VANHEYNINGEN, V; PORTEOUS, DJ; HASTIE, ND; RABBITTS, TH			THE T-ALL SPECIFIC T(11-14)(P13-Q11) TRANSLOCATION BREAKPOINT CLUSTER REGION IS LOCATED NEAR TO THE WILMS TUMOR PREDISPOSITION LOCUS	ONCOGENE			English	Article									INST CHILD HLTH,DEPT HAEMATOL & ONCOL,ICRF,MOLEC GENET LAB,LONDON WC1N 1EH,ENGLAND; UNIV GIESSEN KLINIKUM,ZENTRUM KINDERHEILKUNDE,D-6300 GIESSEN,FED REP GER; ADDENBROOKES HOSP,DEPT CYTOGENET,CAMBRIDGE CB2 2QQ,ENGLAND; UNIV CAMBRIDGE,DEPT HAEMATOL MED,CAMBRIDGE CB2 2QH,ENGLAND; INSERM,U73,GENET & PATHOL FOETALE,F-75005 PARIS,FRANCE; WESTERN GEN HOSP,MRC,CLIN & POPULAT CYTOGENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of London; University College London; University Hospital of Giessen & Marburg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Edinburgh	BOEHM, T (corresponding author), MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND.		Porteous, David/AAA-3446-2021; van Heyningen, Veronica/B-8039-2008; VAN HEYNINGEN, Veronica/GYE-0531-2022; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; van Heyningen, Veronica/0000-0003-0359-0141; Porteous, David J/0000-0003-1249-6106; Cowell, John/0000-0002-2079-5950				BARKER PE, 1986, AM J HUM GENET, V39, P661; BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BOEHM T, 1988, EMBO J, V7, P2011, DOI 10.1002/j.1460-2075.1988.tb03040.x; BRESLOW NE, 1982, JNCI-J NATL CANCER I, V68, P429; COUILLIN P, 1988, UNPUB; COWELL JK, 1988, UNPUB; DAVIS LM, 1988, SCIENCE, V241, P840, DOI 10.1126/science.2841760; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; KORNELUK RG, 1984, J BIOL CHEM, V259, P3819; LAMPERT F, 1988, BLUT, V56, P117, DOI 10.1007/BF00320016; LEWIS WH, 1985, NATURE, V317, P544, DOI 10.1038/317544a0; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; RABBITTS TH, 1985, EMBO J, V4, P1461, DOI 10.1002/j.1460-2075.1985.tb03803.x; RICCARDI VM, 1978, PEDIATRICS, V61, P604; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; TUNNACLIFFE A, 1987, EMBO J, V6, P2953, DOI 10.1002/j.1460-2075.1987.tb02600.x; TURLEAU C, 1984, HUM GENET, V67, P455, DOI 10.1007/BF00291410; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205	19	29	29	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1988	3	6					691	695						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	R6460	2577871				2022-12-28	WOS:A1988R646000011
J	RAPP, UR				RAPP, UR			ROLE OF RAF-1 SERINE THREONINE PROTEIN-KINASE IN GROWTH-FACTOR SIGNAL TRANSDUCTION	ONCOGENE			English	Article							A-RAF; V-RAF; CARRYING RETROVIRUS; SRC FAMILY; C-FOS; ONCOGENE; PHOSPHORYLATION; ACTIVATION; CELLS; TRANSFORMATION				RAPP, UR (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702, USA.							AMBROSIO L, 1989, NATURE, V342, P288, DOI 10.1038/342288a0; APP H, 1991, MOL CELL BIOL, V11, P913, DOI 10.1128/MCB.11.2.913; BACCARINI M, 1990, EMBO J, V9, P3649, DOI 10.1002/j.1460-2075.1990.tb07576.x; BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BECK TW, 1991, IN PRESS BIOCH BIOPH; BLACKSHEAR PJ, 1990, J BIOL CHEM, V265, P12131; CARROLL MP, 1990, J BIOL CHEM, V265, P19812; CLEVELAND JL, 1989, MOL CELL BIOL, V9, P5685, DOI 10.1128/MCB.9.12.5685; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HEIDECKER G, 1989, GENES SIGNAL TRANSDU, P339; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; JAMAL S, 1990, NATURE, V344, P463, DOI 10.1038/344463a0; KAIBUCHI K, 1989, J BIOL CHEM, V264, P20855; KISS Z, 1988, FEBS LETT, V240, P221, DOI 10.1016/0014-5793(88)80372-7; KOLCH W, 1990, GROWTH REGULATION CA, V1, P279; KOVACINA KS, 1990, J BIOL CHEM, V265, P12115; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; MARK GE, 1984, SCIENCE, V224, P285, DOI 10.1126/science.6324342; MARK GE, 1987, MOL CELL BIOL, V7, P2134, DOI 10.1128/MCB.7.6.2134; MARK GE, 1984, J BIOL S8A, V63; MIHALY A, 1990, NEUROSCI LETT, V116, P45, DOI 10.1016/0304-3940(90)90384-L; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MORRISON DK, 1989, CELL, V58, P648; NISHIDA Y, 1988, EMBO J, V7, P775, DOI 10.1002/j.1460-2075.1988.tb02875.x; OLAH Z, 1990, IN PRESS EXP BRAIN R; PRINCIPATO M, 1990, MOL CELL BIOL, V10, P3562, DOI 10.1128/MCB.10.7.3562; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1987, CANCER REV, V9, P34; RAPP UR, 1988, HDB ONCOGENES, P213; RAPP UR, 1987, ONCOGENES CANCER, P55; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SIEGEL JN, 1990, IN PRESS J BIOL CHEM; SITHANANDAM G, 1990, ONCOGENE, V5, P1775; SMITH MR, 1990, MOL CELL BIOL, V10, P3828, DOI 10.1128/MCB.10.7.3828; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STORM S M, 1990, Critical Reviews in Oncogenesis, V2, P1; STORM SM, 1990, ONCOGENE, V5, P345; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TURNER B, 1990, IN PRESS P NATL ACAD; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WASYLYK C, 1989, MOL CELL BIOL, V9, P2247, DOI 10.1128/MCB.9.5.2247	43	266	272	0	5	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1991	6	4					495	500						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FR939	2030909				2022-12-28	WOS:A1991FR93900001
J	HIRVONEN, H; MAKELA, TP; SANDBERG, M; KALIMO, H; VUORIO, E; ALITALO, K				HIRVONEN, H; MAKELA, TP; SANDBERG, M; KALIMO, H; VUORIO, E; ALITALO, K			EXPRESSION OF THE MYC PROTOONCOGENES IN DEVELOPING HUMAN FETAL BRAIN	ONCOGENE			English	Article							HUMAN NEURO-BLASTOMA; CELL LUNG-CANCER; HUMAN N-MYC; EMBRYONAL CARCINOMA-CELLS; CENTRAL NERVOUS-SYSTEM; C-MYC; NUCLEOTIDE-SEQUENCE; MESSENGER-RNAS; PROTOONCOGENE EXPRESSION; INSITU HYBRIDIZATION	We have analysed c-myc, N-myc and L-myc gene expression in developing human fetal brain by Northern hybridization, RNAase protection and in situ hybridization. The unique zonal organization of the developing fetal brain allows a particularly good assessment of the coupling of myc gene expression to cell proliferation and differentiation in vivo. By Northern and in situ hybridization, L-myc as well as c-myc and N-myc transcripts in the brain were found in the post-mitotic cortical and intermediate layers, as well as in the mitotically active layers containing the neuroepithelial precursor cells. Consistent results were also obtained for L-myc using RNAase protection analysis. Both the 3.6 and 3.8 kb forms of the L-myc mRNA, resulting from alternative splicing of intron I, were detected in layers of neuroectodermal origin, but not in the meninges or choroid plexus. We also extended L-myc expression and splicing analyses to other developing human fetal tissues. L-myc mRNA was expressed in several other fetal tissues, particularly in fetal skin. Predominantly intron I containing L-myc mRNA was observed in fetal striated and cardiac muscle. Thus, L-myc is expressed in a wider spectrum of developing tissues than previously known. Our findings also, show that L-myc as well as N-myc and c-myc expression is uncoupled from cell division in developing brain.	UNIV TURKU,DEPT PATHOL,SF-20520 TURKU 52,FINLAND; UNIV HELSINKI,DEPT VIROL,CANC BIOL LAB,SF-00290 HELSINKI 29,FINLAND; UNIV HELSINKI,DEPT PATHOL,CANC BIOL LAB,SF-00290 HELSINKI 29,FINLAND	University of Turku; University of Helsinki; University of Helsinki	HIRVONEN, H (corresponding author), UNIV TURKU,DEPT MED BIOCHEM,KIINAMYLLYNKATU 10,SF-20520 TURKU 52,FINLAND.		makela, tomi/B-3734-2009; Alitalo, Kari K/J-5013-2014	makela, tomi/0000-0002-4869-8044; Alitalo, Kari K/0000-0002-7331-0902; Vuorio, Eero/0000-0003-3404-2439				ADAMSON ED, 1987, DEVELOPMENT, V99, P449; ALITALO K, 1987, BIOCHIM BIOPHYS ACTA, V907, P1, DOI 10.1016/0304-419X(87)90016-3; ALT FW, 1986, MOL BIOL HOMO SAPIEN, P931; AMATRUDA TT, 1985, BIOCHEM BIOPH RES CO, V126, P1189, DOI 10.1016/0006-291X(85)90311-0; BARTLETT PF, 1988, P NATL ACAD SCI USA, V85, P3255, DOI 10.1073/pnas.85.9.3255; BERNARD O, 1989, J NEUROSCI RES, V24, P9, DOI 10.1002/jnr.490240104; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DEGREVE J, 1988, MOL CELL BIOL, V8, P4381, DOI 10.1128/MCB.8.10.4381; DEPINHO R, 1990, IN PRESS ONCOGENES; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GRADY EF, 1987, CANCER RES, V47, P2931; HANLEY MR, 1988, NEURON, V1, P175, DOI 10.1016/0896-6273(88)90137-7; HERSCHKOWITZ N, 1988, BIOL NEONATE, V54, P1; HIRVONEN H, 1989, J CELL BIOL, V108, P1093, DOI 10.1083/jcb.108.3.1093; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; IKEGAKI N, 1986, P NATL ACAD SCI USA, V83, P5929, DOI 10.1073/pnas.83.16.5929; INGVARSSON S, 1988, MOL CELL BIOL, V8, P3168, DOI 10.1128/MCB.8.8.3168; JAKOBOVITS A, 1985, NATURE, V318, P188, DOI 10.1038/318188a0; JOHNSON BE, 1988, CANCER RES, V48, P5163; JOHNSTON JG, 1989, P NATL ACAD SCI USA, V86, P1066, DOI 10.1073/pnas.86.3.1066; KADURRAHDAOUK R, 1987, GENE DEV, V1, P347; KAYE F, 1988, MOL CELL BIOL, V8, P186, DOI 10.1128/MCB.8.1.186; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; KOHL NE, 1984, SCIENCE, V226, P1335, DOI 10.1126/science.6505694; KOHL NE, 1986, NATURE, V319, P73, DOI 10.1038/319073a0; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; LEE WH, 1984, NATURE, V309, P458, DOI 10.1038/309458a0; MAKELA TP, 1989, MOL CELL BIOL, V9, P1545; MAPLES JA, 1985, AM J CLIN PATHOL, V83, P356, DOI 10.1093/ajcp/83.3.356; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; MUGRAUER G, 1988, J CELL BIOL, V107, P1325, DOI 10.1083/jcb.107.4.1325; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MYERS MW, 1987, EMBO J, V6, P1617, DOI 10.1002/j.1460-2075.1987.tb02409.x; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NAU MM, 1986, P NATL ACAD SCI USA, V83, P1092, DOI 10.1073/pnas.83.4.1092; NOWAKOWSKI RS, 1981, J COMP NEUROL, V196, P129, DOI 10.1002/cne.901960110; OFVERSTEDT LG, 1984, BIOCHIM BIOPHYS ACTA, V782, P120, DOI 10.1016/0167-4781(84)90014-9; ONCLERCQ R, 1989, NUCLEIC ACIDS RES, V17, P735, DOI 10.1093/nar/17.2.735; ONCLERCQ R, 1988, J VIROL, V62, P4533, DOI 10.1128/JVI.62.12.4533-4537.1988; PERREAU J, 1988, GENE, V62, P7, DOI 10.1016/0378-1119(88)90575-6; PFEIFEROHLSSON S, 1985, P NATL ACAD SCI USA, V82, P5050, DOI 10.1073/pnas.82.15.5050; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAMSAY G, 1986, MOL CELL BIOL, V6, P4450, DOI 10.1128/MCB.6.12.4450; ROUAH E, 1989, CANCER RES, V49, P1797; RUPPERT C, 1986, EMBO J, V5, P1897, DOI 10.1002/j.1460-2075.1986.tb04442.x; SAKSELA K, 1989, INT J CANCER, V44, P182, DOI 10.1002/ijc.2910440132; SAKSELA K, 1987, ONCOGENE, V1, P291; SANDBERG M, 1987, J CELL BIOL, V104, P1077, DOI 10.1083/jcb.104.4.1077; SCHMID P, 1989, SCIENCE, V243, P226, DOI 10.1126/science.2911736; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; SCHWAB M, 1986, ONCOGENES GROWTH CON, P332; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SEMSEI I, 1989, ONCOGENE, V4, P465; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; SLAMON DJ, 1986, SCIENCE, V232, P768, DOI 10.1126/science.3008339; STANTON LW, 1986, P NATL ACAD SCI USA, V83, P1772, DOI 10.1073/pnas.83.6.1772; STANTON LW, 1987, MOL CELL BIOL, V7, P4266, DOI 10.1128/MCB.7.12.4266; STARNAUD R, 1988, ONCOGENE, V3, P553; SUDOL M, 1988, BRAIN RES REV, V13, P391, DOI 10.1016/0165-0173(88)90014-8; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; THIELE CJ, 1988, EXP CELL BIOL, V56, P321; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; ZIMMERMAN KA, 1986, NATURE, V319, P780, DOI 10.1038/319780a0	69	53	54	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1787	1797						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284098				2022-12-28	WOS:A1990ET43600008
J	BONNIEU, A; ROUX, P; MARTY, L; JEANTEUR, P; PIECHACZYK, M				BONNIEU, A; ROUX, P; MARTY, L; JEANTEUR, P; PIECHACZYK, M			AUUA MOTIFS ARE DISPENSABLE FOR RAPID DEGRADATION OF THE MOUSE C-MYC RNA	ONCOGENE			English	Note									UNIV MONTPELLIER 2,BIOL MOLEC LAB,CNRS,URA 1191,BIOL MOLEC LAB,F-34060 MONTPELLIER,FRANCE; CTR PAUL LAMARQUE,BIOCHIM LAB,F-34033 MONTPELLIER,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier			Bonnieu, Anne/ABA-7182-2020; PIECHACZYK, Marc/E-7896-2013; Roux, Pierre/D-8833-2017	PIECHACZYK, Marc/0000-0003-1367-2597; 				BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BONNIEU A, 1988, ONCOGENE RES, V3, P155; BONNIEU A, 1989, ONCOGENE, V4, P881; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1665; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; EICK D, 1985, EMBO J, V4, P3725; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GREENBERG JR, 1972, NATURE, V240, P102, DOI 10.1038/240102a0; HAYASHI K, 1987, NUCLEIC ACIDS RES, V15, P6419, DOI 10.1093/nar/15.16.6419; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; KRUYS V, 1989, SCIENCE, V245, P852, DOI 10.1126/science.2672333; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; NAKAMAYE K, 1985, NUCLEIC ACIDS RES, V13, P8764; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PIECHACZYK M, 1986, CURR TOP MICROBIOL, V132, P331; RAHMSDORF HJ, 1987, NUCLEIC ACIDS RES, V15, P1643, DOI 10.1093/nar/15.4.1643; RAYMOND V, 1989, ONCOGENE RES, V5, P1; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	27	45	47	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1585	1588						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2250915				2022-12-28	WOS:A1990EK50200020
J	MIOZZO, M; PIEROTTI, MA; SOZZI, G; RADICE, P; BONGARZONE, I; SPURR, NK; DELLAPORTA, G				MIOZZO, M; PIEROTTI, MA; SOZZI, G; RADICE, P; BONGARZONE, I; SPURR, NK; DELLAPORTA, G			HUMAN TRK PROTOONCOGENE MAPS TO CHROMOSOME 1Q32-Q41	ONCOGENE			English	Note									IST NAZL TUMORI,DIV EXPTL ONCOL A,VIA G VENEZIAN 1,I-20133 MILAN,ITALY; IMPERIAL CANC RES FUND,CLARE HALL LABS,S MIMMS EN6 3LID,HERTS,ENGLAND	Fondazione IRCCS Istituto Nazionale Tumori Milan			Bongarzone, Italia/B-9544-2017; Sozzi, Gabriella/G-8259-2011; Radice, Paolo/O-3119-2013	Bongarzone, Italia/0000-0003-2530-9170; Sozzi, Gabriella/0000-0001-9360-6914; Radice, Paolo/0000-0001-6298-4111; Miozzo, Monica/0000-0002-6523-4575; Pierotti, Marco Alessandro/0000-0002-7431-8332				AKAO Y, 1987, SOMAT CELL MOLEC GEN, V13, P273, DOI 10.1007/BF01535209; ANDREWS PW, 1985, ANN HUM GENET, V49, P31, DOI 10.1111/j.1469-1809.1985.tb01673.x; BONGARZONE I, 1989, ONCOGENE, V4, P1457; COULIER F, 1989, MOL CELL BIOL, V9, P15, DOI 10.1128/MCB.9.1.15; DONGHI R, 1989, ONCOGENE, V4, P521; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; ISHIZAKA Y, 1989, ONCOGENE, V4, P1519; JONES EA, 1976, SOMAT CELL GENET, V2, P483, DOI 10.1007/BF01542686; KATZAV S, 1989, ONCOGENE, V4, P1129; KIELTY CM, 1982, ANN HUM GENET, V46, P307, DOI 10.1111/j.1469-1809.1982.tb01582.x; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MAYALL BH, 1975, AUTOMATION CYTOGENET, P133; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; OLAH E, 1989, CANCER GENET CYTOGEN, V43, P179, DOI 10.1016/0165-4608(89)90029-0; PHILLIPS IR, 1985, ANN HUM GENET, V49, P267, DOI 10.1111/j.1469-1809.1985.tb01702.x; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; PULCIANI S, 1982, NATURE, V300, P539, DOI 10.1038/300539a0; SEWELL WA, 1988, IMMUNOGENETICS, V28, P278, DOI 10.1007/BF00345506; SOLOMON E, 1979, ANN HUM GENET, V42, P273, DOI 10.1111/j.1469-1809.1979.tb00661.x; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TONKS NK, 1988, BIOCHEMISTRY-US, V27, P8696; VANHEYNINGEN V, 1975, ANN HUM GENET, V38, P295; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021	29	48	48	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1411	1414						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2216464				2022-12-28	WOS:A1990EC24100021
J	GRANT, ML; BRUTON, RK; BYRD, PJ; GALLIMORE, PH; STEELE, JC; TAYLOR, AMR; GRAND, RJA				GRANT, ML; BRUTON, RK; BYRD, PJ; GALLIMORE, PH; STEELE, JC; TAYLOR, AMR; GRAND, RJA			SENSITIVITY TO IONIZING-RADIATION OF TRANSFORMED HUMAN-CELLS CONTAINING MUTANT RAS GENES	ONCOGENE			English	Article									UNIV BIRMINGHAM,SCH MED,DEPT CANC STUDIES,CANC RES CAMPAIGN LABS,POB 363,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND	University of Birmingham								ARLETT CF, 1988, INT J RADIAT BIOL, V54, P911, DOI 10.1080/09553008814552321; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; BURGOYNE RD, 1989, TRENDS BIOCHEM SCI, V14, P394, DOI 10.1016/0968-0004(89)90281-8; BYRD P, 1982, NATURE, V298, P69, DOI 10.1038/298069a0; BYRD PJ, 1988, ONCOGENE, V2, P477; CLARKE S, 1988, P NATL ACAD SCI USA, V85, P4643, DOI 10.1073/pnas.85.13.4643; COX R, 1980, INT J RADIAT BIOL, V38, P575, DOI 10.1080/09553008014551391; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; FITZGERALD TJ, 1985, AM J CLIN ONCOL-CANC, V8, P517, DOI 10.1097/00000421-198512000-00012; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GALLIMORE PH, 1986, ANTICANCER RES, V6, P499; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GLUZMAN Y, 1980, P NATL ACAD SCI-BIOL, V77, P3898, DOI 10.1073/pnas.77.7.3898; GRAND RJA, 1989, ONCOGENE, V4, P355; GRAND RJA, 1989, BIOCHEM J, V258, P625, DOI 10.1042/bj2580625; GRAND RJA, 1987, ONCOGENE, V1, P305; GRAND RJA, 1986, EMBO J, V5, P1253, DOI 10.1002/j.1460-2075.1986.tb04354.x; GUTIERREZ L, 1989, EMBO J, V8, P1098; HANCOCK JF, 1989, CELL, V57, P1166; HAND PH, 1987, BIOCHIM BIOPHYS ACTA, V908, P131, DOI 10.1016/0167-4781(87)90052-2; KASID UN, 1989, CANCER RES, V49, P3396; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; MASTERS SB, 1986, PROTEIN ENG, V1, P47, DOI 10.1093/protein/1.1.47; MCCKENNA WG, 1990, CANCER RES, V50, P97; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MEJBAUMKATZENELLENBOGEN W, 1959, CLIN CHIM ACTA, V4, P515, DOI 10.1016/0009-8981(59)90158-5; MURNANE JP, 1985, EXP CELL RES, V158, P119, DOI 10.1016/0014-4827(85)90437-9; NISHIMURA S, 1987, BIOCHEM J, V243, P313, DOI 10.1042/bj2430313; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; SIGNAL IS, 1986, P NATL ACAD SCI USA, V83, P4725; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; SMITH KJ, 1989, ONCOGENE, V4, P489; STACEY M, 1989, INT J RADIAT BIOL, V56, P45, DOI 10.1080/09553008914551171; TAYLOR AMR, 1987, J MED GENET, V24, P669, DOI 10.1136/jmg.24.11.669; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x	39	29	29	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1159	1164						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2168028				2022-12-28	WOS:A1990DX36100007
J	LAVECCHIO, JA; HAMER, PJ; NG, SC; TRIMPE, KL; CARNEY, WP				LAVECCHIO, JA; HAMER, PJ; NG, SC; TRIMPE, KL; CARNEY, WP			CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC TO THE ACTIVATED RAS P21 WITH ASPARTIC-ACID AT POSITION-13	ONCOGENE			English	Article											LAVECCHIO, JA (corresponding author), DUPONT CO,DEPT MED PROD,ONCOGENE RES GRP,N BILLERICA,MA 01862, USA.							ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BOS JL, 1985, NATURE, V315, P726, DOI 10.1038/315726a0; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1984, NUCLEIC ACIDS RES, V12, P9155, DOI 10.1093/nar/12.23.9155; CARNEY WP, 1986, P NATL ACAD SCI USA, V83, P7485, DOI 10.1073/pnas.83.19.7485; CARNEY WP, 1988, HUMAN TUMOR ANTIGENS, P53; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; DER CJ, 1983, CELL, V32, P201, DOI 10.1016/0092-8674(83)90510-X; DER CJ, 1986, CELL, V44, P167, DOI 10.1016/0092-8674(86)90495-2; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; GALFRE G, 1979, NATURE, V277, P131, DOI 10.1038/277131a0; GREENBERG PL, 1979, AM J MED, V66, P951, DOI 10.1016/0002-9343(79)90450-9; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; KAGAN A, 1979, METHOD HORM RADIOIMM, P327; KRAUS MH, 1984, P NATL ACAD SCI-BIOL, V81, P5384, DOI 10.1073/pnas.81.17.5384; LERNER EA, 1980, J EXP MED, V152, P1085, DOI 10.1084/jem.152.4.1085; LIU E, 1987, NATURE, V330, P186, DOI 10.1038/330186a0; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OHUCHI N, 1987, J NATL CANCER I, V79, P109; PADUA RA, 1988, LEUKEMIA, V2, P503; PAPAGEORGE AG, 1986, MOL CELL BIOL, V6, P1843, DOI 10.1128/MCB.6.5.1843; PULLANO TG, 1989, ONCOGENE, V4, P1003; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; RODENHUIS S, 1988, CANCER RES, V48, P5738; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TOKSOZ D, 1987, ONCOGENE, V1, P409; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UPDYKE TV, 1984, J IMMUNOL METHODS, V73, P83, DOI 10.1016/0022-1759(84)90034-6; VERLAANDEVRIES M, 1986, GENE, V50, P313, DOI 10.1016/0378-1119(86)90335-5; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YUASA Y, 1983, NATURE, V303, P775, DOI 10.1038/303775a0; YUNIS JJ, 1989, ONCOGENE, V4, P609	35	14	14	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1173	1178						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2202949				2022-12-28	WOS:A1990DX36100009
J	LEE, EB; HAYMAN, MJ				LEE, EB; HAYMAN, MJ			ANALYSIS OF THE ROLE OF THE EXTRACELLULAR DOMAIN OF THE NU-ERBB ONCOGENE IN CELLULAR-TRANSFORMATION	ONCOGENE			English	Article									SUNY STONY BROOK,DEPT MICROBIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NCI NIH HHS [CA 28146] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028146] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BASSIRI M, 1987, VIROLOGY, V159, P20, DOI 10.1016/0042-6822(87)90343-6; BASSIRI M, 1986, J VIROL, V59, P525, DOI 10.1128/JVI.59.2.525-530.1986; BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BEUG H, 1984, CELL, V36, P963, DOI 10.1016/0092-8674(84)90046-1; BEUG H, 1986, ONCOGENES GROWTH CON; CHOI OR, 1986, MOL CELL BIOL, V6, P1751, DOI 10.1128/MCB.6.5.1751; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; ENGELBRETH-HOLM J., 1935, Acta Pathologica et Microbiologica Scandinavica, V12, P352; GRAF T, 1973, VIROLOGY, V54, P398, DOI 10.1016/0042-6822(73)90152-9; HAYMAN MJ, 1978, VIROLOGY, V85, P241, DOI 10.1016/0042-6822(78)90428-2; HAYMAN MJ, 1984, NATURE, V309, P460, DOI 10.1038/309460a0; HAYMAN MJ, 1983, CELL, V32, P579, DOI 10.1016/0092-8674(83)90477-4; HAYMAN MJ, 1985, P NATL ACAD SCI USA, V82, P8237, DOI 10.1073/pnas.82.23.8237; HAYMAN MJ, 1986, TRENDS GENET, V2, P260, DOI 10.1016/0168-9525(86)90259-3; HAYMAN MJ, 1987, VIROLOGY, V85, P475; HIHARA H, 1983, J NATL CANCER I, V70, P891; HUNTER E, 1988, PROTEIN TRANSFER ORG, P109; JANSSON M, 1987, ONCOGENE, V1, P167; KAMPS MP, 1988, ONCOGENE, V2, P305; KAWAI S, 1987, J VIROL, V61, P1665, DOI 10.1128/JVI.61.5.1665-1669.1987; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KNIGHT J, 1988, ONCOGENE, V2, P317; KOWENZ E, 1987, MODERN TRENDS HUMAN, V4, P417; LIPSICK JS, 1986, J VIROL, V59, P267, DOI 10.1128/JVI.59.2.267-275.1986; MAIHLE N J, 1988, Biochimica et Biophysica Acta, V948, P287; MARTIN GS, 1986, CANCER SURV, V5, P199; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NG M, 1986, J VIROL, V58, P542, DOI 10.1128/JVI.58.2.542-553.1986; PELLEY RJ, 1989, P NATL ACAD SCI USA, V86, P7164, DOI 10.1073/pnas.86.18.7164; RAINES MA, 1988, J VIROL, V62, P2444, DOI 10.1128/JVI.62.7.2444-2452.1988; SCHMIDT JA, 1985, EMBO J, V4, P105, DOI 10.1002/j.1460-2075.1985.tb02323.x; SCOTTING P, 1987, ONCOGENE RES, V1, P265; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; YAMAMOTO T, 1983, CELL, V34, P225, DOI 10.1016/0092-8674(83)90153-8	34	10	10	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	AUG	1990	5	8					1165	1172						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX361	2168029				2022-12-28	WOS:A1990DX36100008
J	FAKTOR, O; SHAUL, Y				FAKTOR, O; SHAUL, Y			THE IDENTIFICATION OF HEPATITIS-B VIRUS X-GENE RESPONSIVE ELEMENTS REVEALS FUNCTIONAL SIMILARITY OF X-TAX AND HTLV-I-TAX	ONCOGENE			English	Article											FAKTOR, O (corresponding author), WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL.							ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALLARD DW, 1988, SCIENCE, V241, P1652, DOI 10.1126/science.2843985; Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209; BENLEVY R, 1989, MOL CELL BIOL, V9, P1804, DOI 10.1128/MCB.9.4.1804; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BRADY J, 1987, J VIROL, V61, P2175, DOI 10.1128/JVI.61.7.2175-2181.1987; CHEN ISY, 1983, P NATL ACAD SCI-BIOL, V80, P7006, DOI 10.1073/pnas.80.22.7006; FAKTOR O, 1990, IN PRESS J VIROL; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HONIGWACHS J, 1989, J VIROL, V63, P919, DOI 10.1128/JVI.63.2.919-924.1989; JEANG KT, 1988, P NATL ACAD SCI USA, V85, P8291, DOI 10.1073/pnas.85.21.8291; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LENARDO MJ, 1989, CELL, V57, P187; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; MILLER RH, 1986, P NATL ACAD SCI USA, V83, P2531, DOI 10.1073/pnas.83.8.2531; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; NYBORG JK, 1988, P NATL ACAD SCI USA, V85, P1457, DOI 10.1073/pnas.85.5.1457; ONDEK B, 1987, EMBO J, V6, P1017, DOI 10.1002/j.1460-2075.1987.tb04854.x; PARK RE, 1988, ONCOGENE, V3, P275; PASKALIS H, 1986, P NATL ACAD SCI USA, V83, P6558, DOI 10.1073/pnas.83.17.6558; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RADONOVICH M, 1989, J VIROL, V63, P2987, DOI 10.1128/JVI.63.7.2987-2994.1989; RUBEN S, 1988, SCIENCE, V241, P89, DOI 10.1126/science.2838905; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; SHAUL Y, 1985, EMBO J, V4, P427, DOI 10.1002/j.1460-2075.1985.tb03646.x; SHAUL Y, 1987, EMBO J, V6, P1913, DOI 10.1002/j.1460-2075.1987.tb02451.x; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SIDDIQUI A, 1989, VIROLOGY, V169, P479, DOI 10.1016/0042-6822(89)90177-3; SPANDAU DF, 1988, J VIROL, V62, P427, DOI 10.1128/JVI.62.2.427-434.1988; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; TAN TH, 1989, MOL CELL BIOL, V9, P1733, DOI 10.1128/MCB.9.4.1733; TREININ M, 1987, MOL CELL BIOL, V7, P545, DOI 10.1128/MCB.7.1.545; TWU JS, 1989, P NATL ACAD SCI USA, V86, P2046, DOI 10.1073/pnas.86.6.2046; TWU JS, 1989, J VIROL, V63, P2857, DOI 10.1128/JVI.63.6.2857-2860.1989; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; TWU JS, 1989, P NATL ACAD SCI USA, V86, P5168, DOI 10.1073/pnas.86.13.5168; VARMUS H, 1988, GENE DEV, V2, P1055, DOI 10.1101/gad.2.9.1055; WOLLERSHEIM M, 1988, ONCOGENE, V3, P545; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YAMAMOTO N, 1982, SCIENCE, V217, P737, DOI 10.1126/science.6980467; ZAHM P, 1988, ONCOGENE, V3, P169	44	68	85	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					867	872						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2359621				2022-12-28	WOS:A1990DP55300012
J	KOSKINEN, P; LEHVASLAIHO, H; MACDONALDBRAVO, H; ALITALO, K; BRAVO, R				KOSKINEN, P; LEHVASLAIHO, H; MACDONALDBRAVO, H; ALITALO, K; BRAVO, R			SIMILAR EARLY GENE RESPONSES TO LIGAND-ACTIVATED EGFR AND NEU TYROSINE KINASES IN NIH3T3 CELLS	ONCOGENE			English	Note									UNIV HELSINKI,DEPT PATHOL,SF-00290 HELSINKI 29,FINLAND; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY	University of Helsinki; European Molecular Biology Laboratory (EMBL)	KOSKINEN, P (corresponding author), UNIV HELSINKI,DEPT UROL,CANC BIOL LAB,HAARTMANINK 3,SF-00290 HELSINKI 29,FINLAND.		Koskinen, Päivi J/G-8939-2014; Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1988, ONCOGENE HDB, P107; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; Lehtola L, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000256; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LIN AH, 1988, MOL CELL BIOL, V8, P5052, DOI 10.1128/MCB.8.11.5052; PANDIELLA A, 1989, ONCOGENE, V4, P1299; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SISTONEN L, 1989, J CELL BIOL, V109, P1911, DOI 10.1083/jcb.109.5.1911; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	16	14	16	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					615	618						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970155				2022-12-28	WOS:A1990DB85300024
J	SASSONECORSI, P; RANSONE, LJ; VERMA, IM				SASSONECORSI, P; RANSONE, LJ; VERMA, IM			CROSS-TALK IN SIGNAL TRANSDUCTION - TPA-INDUCIBLE FACTOR JUN/AP-1 ACTIVATES CAMP-RESPONSIVE ENHANCER ELEMENTS	ONCOGENE			English	Note									SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,SAN DIEGO,CA 92138	Salk Institute	SASSONECORSI, P (corresponding author), CNRS,GENET MOLEC EUCARYOTES LAB,11 RUE HUMANN,F-67085 STRASBOURG,FRANCE.		Messier, Claude/A-2322-2008; Sassone-Corsi, Paolo/H-6182-2011	Messier, Claude/0000-0002-4791-1763; 				ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BELL JD, 1985, J BIOL CHEM, V260, P2625; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; CURRAN T, 1985, MOL CELL BIOL, V5, P162; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DELI E, 1988, FEBS LETT, V231, P407, DOI 10.1016/0014-5793(88)80860-3; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAI T, 1988, GENE DEV, V2, P1216, DOI 10.1101/gad.2.10.1216; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HOEFFLER JP, 1989, MOL ENDOCRINOL, V3, P868, DOI 10.1210/mend-3-5-868; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; QUANTIN B, 1988, NATURE, V334, P537; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RAUSCHER FJ, 1988, CELL, V52, P471, DOI 10.1016/S0092-8674(88)80039-4; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOEFFLER JP, 1988, SCIENCE, V242, P1430; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0	43	180	181	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1990	5	3					427	431						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CW415	2107494				2022-12-28	WOS:A1990CW41500023
J	SOBCZAK, J; MECHTI, N; TOURNIER, MF; BLANCHARD, JM; DUGUET, M				SOBCZAK, J; MECHTI, N; TOURNIER, MF; BLANCHARD, JM; DUGUET, M			C-MYC AND C-FOS GENE-REGULATION DURING MOUSE-LIVER REGENERATION	ONCOGENE			English	Article									CNRS, UA 1191, BIOCHIM PROT LAB, F-34060 MONTPELLIER, FRANCE; CNRS, UA 1191, BIOL MOLEC LAB, F-34060 MONTPELLIER, FRANCE	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	SOBCZAK, J (corresponding author), UNIV PARIS 06, ENZYMOL ACIDES NUCLEIQUES LAB, CNRS, URA 555, 96 BLVD RASPAIL, F-75006 PARIS, FRANCE.		Sobczak, Joelle/HHZ-5610-2022	Sobczak, Joelle/0000-0001-7180-2789				BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLANCHARD JM, 1988, BIOCHIMIE, V70, P877, DOI 10.1016/0300-9084(88)90228-3; BLANCHARD JM, 1988, LYMPHOCYTE ACTIVATIO, P339; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; BUCHER NLR, 1982, COLD SPRING HARBOR C, V9, P15; BUSCHER M, 1988, ONCOGENE, V3, P301; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FORT P, 1987, NUCLEIC ACIDS RES, V15, P5657, DOI 10.1093/nar/15.14.5657; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GOYETTE M, 1984, MOL CELL BIOL, V4, P1493, DOI 10.1128/MCB.4.8.1493; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; Higgins GM, 1931, ARCH PATHOL, V12, P186; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; KINDY MS, 1987, MOL CELL BIOL, V7, P2857, DOI 10.1128/MCB.7.8.2857; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KRUIJER W, 1986, J BIOL CHEM, V261, P7929; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1985, BIOCHIM BIOPHYS ACTA, V823, P207; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PIECHACZYK M, 1987, TRENDS GENET, V3, P47, DOI 10.1016/0168-9525(87)90166-1; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; SARIBAN E, 1988, MOL CELL BIOL, V8, P340, DOI 10.1128/MCB.8.1.340; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SOBCZAK J, 1989, EUR J BIOCHEM, V180, P49, DOI 10.1111/j.1432-1033.1989.tb14613.x; SOBCZAK J, 1986, BIOCHIMIE, V68, P957, DOI 10.1016/S0300-9084(86)80039-6; THOMPSON NL, 1986, CANCER RES, V46, P3111; TOURKINE N, 1989, ONCOGENE, V4, P973; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VERMA IM, 1986, TRENDS GENET, V2, P93, DOI 10.1016/0168-9525(86)90191-5; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WATSON RJ, 1988, MOL CELL BIOL, V8, P3938, DOI 10.1128/MCB.8.9.3938; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x	54	49	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC	1989	4	12					1503	1508						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB659	2512526				2022-12-28	WOS:A1989CB65900013
J	MILLIGAN, G; DAVIES, SA; HOUSLAY, MD; WAKELAM, MJO				MILLIGAN, G; DAVIES, SA; HOUSLAY, MD; WAKELAM, MJO			IDENTIFICATION OF THE PERTUSSIS AND CHOLERA-TOXIN SUBSTRATES IN NORMAL AND N-RAS TRANSFORMED NIH3T3 FIBROBLASTS AND AN ASSESSMENT OF THEIR INVOLVEMENT IN BOMBESIN-STIMULATION OF INOSITOL PHOSPHOLIPID-METABOLISM	ONCOGENE			English	Note									UNIV GLASGOW,DEPT BIOCHEM,MOLEC PHARMACOL GRP,GLASGOW G12 8QQ,SCOTLAND; UNIV GLASGOW,DEPT MED BIOCHEM,MOLEC PHARMACOL GRP,GLASGOW G12 8QQ,SCOTLAND	University of Glasgow; University of Glasgow			Houslay, Miles/AAM-5281-2020; Milligan, Graeme/F-9426-2011; Houslay, Miles D/A-6825-2011	Milligan, Graeme/0000-0002-6946-3519; Wakelam, Michael/0000-0003-4059-9276; Houslay, Miles/0000-0002-3826-8091				BACKLUND PS, 1988, BIOCHEMISTRY-US, V27, P2040, DOI 10.1021/bi00406a034; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; DOWNES CP, 1985, MOL ASPECTS CELL REG, V4, P2; FONG KHW, 1988, P NATL ACAD SCI USA, V85, P3066; GARDNER SD, 1989, IN PRESS BIOCH J; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; HANCOCK JF, 1988, ONCOGENE, V3, P187; JONES DT, 1987, J BIOL CHEM, V262, P14241; LITOSCH I, 1985, J BIOL CHEM, V260, P5464; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; MILLIGAN G, 1987, BIOCHEM J, V245, P501, DOI 10.1042/bj2450501; MILLIGAN G, 1988, BIOCHEM J, V254, P391, DOI 10.1042/bj2540391; MILLIGAN G, 1988, BIOCHEM J, V255, P1; MULLANEY I, 1988, BIOCHEM J, V256, P649, DOI 10.1042/bj2560649; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; WAKELAM MJO, 1988, FEBS LETT, V228, P182, DOI 10.1016/0014-5793(88)80613-6; WAKELAM MJO, 1986, NATURE, V323, P173, DOI 10.1038/323173a0	17	9	9	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					659	663						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2498808				2022-12-28	WOS:A1989U768800018
J	TROTTER, J; BOULTER, CA; SONTHEIMER, H; SCHACHNER, M; WAGNER, EF				TROTTER, J; BOULTER, CA; SONTHEIMER, H; SCHACHNER, M; WAGNER, EF			EXPRESSION OF V-SRC ARRESTS MURINE GLIAL-CELL DIFFERENTIATION	ONCOGENE			English	Article									EUROPEAN MOLEC BIOL LAB,D-6900 HEIDELBERG,FED REP GER	European Molecular Biology Laboratory (EMBL)	TROTTER, J (corresponding author), UNIV HEIDELBERG,DEPT NEUROBIOL,NEUENHEIMER FELD 364,D-6900 HEIDELBERG,FED REP GER.		Boulter, Catherine/A-6607-2010	Sontheimer, Harald/0000-0002-5843-9871; Wagner, Erwin F/0000-0001-7872-0196				ABNEY ER, 1983, DEV BIOL, V100, P166, DOI 10.1016/0012-1606(83)90207-5; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOULTER CA, 1988, ONCOGENE, V2, P207; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; COLLETT MS, 1978, P NATL ACAD SCI USA, V75, P2021, DOI 10.1073/pnas.75.4.2021; DUBOISDALCQ M, 1987, EMBO J, V6, P2587, DOI 10.1002/j.1460-2075.1987.tb02549.x; EDELMAN GM, 1985, ANNU REV BIOCHEM, V54, P135, DOI 10.1146/annurev.bi.54.070185.001031; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FAISSNER A, 1985, EMBO J, V4, P3105, DOI 10.1002/j.1460-2075.1985.tb04052.x; FAISSNER A, 1988, DIFFERENTIATION, V37, P104, DOI 10.1111/j.1432-0436.1988.tb00802.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GIOTTA GJ, 1982, DEV BRAIN RES, V4, P209, DOI 10.1016/0165-3806(82)90043-8; GIOTTA GJ, 1981, J CELL PHYSIOL, V107, P219, DOI 10.1002/jcp.1041070207; GIOTTA GJ, 1980, BRAIN RES, V202, P445, DOI 10.1016/0006-8993(80)90154-7; GREENBERG ME, 1984, P NATL ACAD SCI-BIOL, V81, P969, DOI 10.1073/pnas.81.3.969; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIRN M, 1981, BRAIN RES, V214, P433, DOI 10.1016/0006-8993(81)91208-7; KAHN P, 1986, ONCOGENES GROWTH CON; KEANE RW, 1984, DEV BIOL, V103, P38, DOI 10.1016/0012-1606(84)90005-8; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; KELLER G, 1987, COLD SPRING HARBOR S, V51; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; MANESS PF, 1988, P NATL ACAD SCI USA, V85, P5001, DOI 10.1073/pnas.85.14.5001; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MIRSKY R, 1978, BRAIN RES, V148, P251, DOI 10.1016/0006-8993(78)90399-2; NAGATA I, 1986, DEV BRAIN RES, V24, P217, DOI 10.1016/0165-3806(86)90190-2; NOWAK L, 1987, J NEUROSCI, V7, P101; PESSAC B, 1974, SCIENCE, V185, P709, DOI 10.1126/science.185.4152.709; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUTISCHAUSER U, 1986, TRENDS GENET, V22, P72; SCHACHNER M, 1981, DEV BIOL, V83, P328, DOI 10.1016/0012-1606(81)90478-4; SCHNITZER J, 1982, CELL TISSUE RES, V224, P625; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; SONTHEIMER GM, 1988, 16TH P GOTT NEUR C E; SONTHEIMER H, 1989, IN PRESS NEURON; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; TEMPLE S, 1985, NATURE, V313, P223, DOI 10.1038/313223a0; TROTTER J, 1989, IN PRESS DEV BRAIN R; TROTTER J, 1989, IN PRESS J NEUROSCI; WIESTLER OD, 1988, MOL CELL BIOL, V8, P502, DOI 10.1128/MCB.8.1.502	44	24	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					457	464						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2497422				2022-12-28	WOS:A1989U567700010
J	VEILLETTE, A; OSHAUGHNESSY, J; HORAK, ID; ISRAEL, MA; YEE, D; ROSEN, N; FUJITA, DJ; KUNG, HJ; BIEDLER, JL; BOLEN, JB				VEILLETTE, A; OSHAUGHNESSY, J; HORAK, ID; ISRAEL, MA; YEE, D; ROSEN, N; FUJITA, DJ; KUNG, HJ; BIEDLER, JL; BOLEN, JB			COORDINATE ALTERATION OF PP60C-SRC ABUNDANCE AND C-SRC RNA EXPRESSION IN HUMAN NEURO-BLASTOMA VARIANTS	ONCOGENE			English	Article									NCI,TUMOR VIRUS BIOL LAB,BLDG 41,ROOM D-824,BETHESDA,MD 20892; NCI,PEDIAT BRANCH,BETHESDA,MD 20892; NCI,MED BRANCH,BETHESDA,MD 20892; UNIV CALGARY,DEPT BIOCHEM,CALGARY T2N 4N1,ALBERTA,CANADA; CASE WESTERN RESERVE UNIV,DEPT MICROBIOL & MOLEC BIOL,CLEVELAND,OH 44106; MEM SLOAN KETTERING CANC CTR,CELLULAR & BIOCHEM GENET LAB,NEW YORK,NY 10021	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Calgary; Case Western Reserve University; Memorial Sloan Kettering Cancer Center			Rosen, Neal/ABF-2677-2020; Kung, Hsing-Jien/C-7651-2013					AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERNAL S, 1983, CANCER RES, V43, P1256; BIEDLER JL, 1976, J NATL CANCER I, V57, P683, DOI 10.1093/jnci/57.3.683; BIEDLER JL, 1973, CANCER RES, V33, P2643; BOLEN JB, 1985, P NATL ACAD SCI USA, V82, P7275, DOI 10.1073/pnas.82.21.7275; BOLEN JB, 1987, ONCOGENE RES, V1, P149; BRUGGE J, 1987, GENE DEV, V1, P287, DOI 10.1101/gad.1.3.287; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CARTWRIGHT CA, 1987, MOL CELL BIOL, V7, P1830, DOI 10.1128/MCB.7.5.1830; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157; FULTS DW, 1985, MOL CELL BIOL, V5, P27, DOI 10.1128/MCB.5.1.27; ISRAEL MA, 1986, AM J PEDIAT HEMATOL, V8, P163; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LEVY BT, 1984, DEV BIOL, V104, P9, DOI 10.1016/0012-1606(84)90031-9; LEVY JB, 1987, MOL CELL BIOL, V7, P4142, DOI 10.1128/MCB.7.11.4142; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MELLSTROM K, 1987, MOL CELL BIOL, V7, P4178, DOI 10.1128/MCB.7.12.4178; OSHAUGHNESSY J, 1987, ONCOGENE RES, V2, P1; RETTIG WJ, 1987, CANCER RES, V47, P1383; ROSEN N, 1986, J BIOL CHEM, V261, P3754; ROSS RA, 1983, J NATL CANCER I, V71, P741; ROSS RA, 1980, ADV NEUROBLASTOMA RE, P151; SCHARTL M, 1984, DEV BIOL, V105, P415, DOI 10.1016/0012-1606(84)90298-7; SEEGER RC, 1977, CANCER RES, V37, P1364; SEMBA K, 1986, P NATL ACAD SCI USA, V81, P4940; SORGE JP, 1985, AM J PATHOL, V119, P151; SORGE LK, 1984, CELL, V36, P249, DOI 10.1016/0092-8674(84)90218-6; STREBHARDT K, 1987, P NATL ACAD SCI USA, V84, P8778, DOI 10.1073/pnas.84.24.8778; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1987, ONCOGENE RES, V1, P357; WESTON JA, 1982, EMBRYONIC DEV B, P113; WIESTLER OD, 1988, MOL CELL BIOL, V8, P502, DOI 10.1128/MCB.8.1.502; YANG XM, 1988, ONCOGENE, V3, P237	38	12	12	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					421	427						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2470006				2022-12-28	WOS:A1989U567700005
J	LANG, JC; WILKIE, NM; CLARK, AM; CHUDLEIGH, A; TALBOT, S; WHITELAW, B; FRAME, MC				LANG, JC; WILKIE, NM; CLARK, AM; CHUDLEIGH, A; TALBOT, S; WHITELAW, B; FRAME, MC			REGULATORY DOMAINS WITHIN THE P0 PROMOTER OF HUMAN C-MYC	ONCOGENE			English	Article							IMMEDIATE EARLY GENE; TRANSCRIPTIONAL REGULATION; MODULATE EXPRESSION; BURKITT-LYMPHOMA; TRANS-ACTIVATION; THYMIDINE KINASE; PROTEIN-BINDING; MAMMALIAN-CELLS; DNA-BINDING; CCAAT BOX	Expression of P0 RNA in some Burkitt lymphoma cell lines varies independently of levels of RNA derived from P1 and P2. These data suggest the possibility that expression of P0 RNA may be capable of independent regulation. In order to investigate this possibility we have isolated putative regulatory domains flanking P0 RNA starts within the human c-myc gene and analysed both their ability to direct expression of control reporter genes and their ability to interact with specific transcription factors. Regulatory regions necessary for expression of P0 RNA have been located within 131 bp 5' of the first major P0 RNA start. DNAase 1 footprint analysis and gel retardation assays demonstrate binding of transcription factors Sp1, NF1 and CBP to this region. NF1 binds specifically to two consensus sequences. The more distal site overlaps with the binding site for CBP, and it is likely that concomitant binding of NF1 and CBP within the distal region of the P0 promoter is not possible. Previous work from our laboratory has described a negative regulatory domain within the 5' flanking region of c-myc. The P0 promoter resides within this domain and therefore may contain a negative regulator of c-myc gene expression.	BEATSON INST CANC RES, GLASGOW G61 1BD, SCOTLAND; AFRC, INST ANIM PHYSIOL & GENET RES, EDINBURGH EH9 3JQ, MIDLOTHIAN, SCOTLAND	Beatson Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute								ASSELIN C, 1989, ONCOGENE, V4, P549; BARBERIS A, 1987, CELL, V50, P347, DOI 10.1016/0092-8674(87)90489-2; BATLEY J, 1983, CELL, V34, P779; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, MOL CELL BIOL, V6, P3481, DOI 10.1128/MCB.6.10.3481; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BRUGGEMEIER U, 1990, EMBO J, V9, P2233, DOI 10.1002/j.1460-2075.1990.tb07393.x; CEREGHINI S, 1987, CELL, V50, P627, DOI 10.1016/0092-8674(87)90036-5; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COHEN RB, 1986, MOL CELL BIOL, V6, P821, DOI 10.1128/MCB.6.3.821; CONNELLY S, 1989, MOL CELL BIOL, V9, P5254, DOI 10.1128/MCB.9.11.5254; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; CORCORAN LM, 1984, CELL, V37, P113, DOI 10.1016/0092-8674(84)90306-4; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; EICK D, 1987, ONCOGENE, V2, P61; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; EICK D, 1990, ONCOGENE, V5, P1397; FRAME MC, 1991, ONCOGENE, V6, P205; GAFFNEY DF, 1985, NUCLEIC ACIDS RES, V13, P7847, DOI 10.1093/nar/13.21.7847; GAZIN C, 1984, EMBO J, V3, P383, DOI 10.1002/j.1460-2075.1984.tb01816.x; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HALL DJ, 1990, ONCOGENE, V5, P47; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KIT S, 1963, BIOCHEM BIOPH RES CO, V11, P55, DOI 10.1016/0006-291X(63)90027-5; LANG JC, 1983, J GEN VIROL, V64, P2679, DOI 10.1099/0022-1317-64-12-2679; LANG JC, 1988, BRIT J CANCER, V58, P62; LANG JC, 1984, EMBO J, V3, P389, DOI 10.1002/j.1460-2075.1984.tb01817.x; LEMAIGRE FP, 1990, MOL CELL BIOL, V10, P1811, DOI 10.1128/MCB.10.4.1811; LIPP M, 1989, ONCOGENE, V4, P535; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NEIL JC, 1984, NATURE, V308, P814, DOI 10.1038/308814a0; NEPVEU A, 1987, ONCOGENE, V1, P243; PARKIN N, 1988, MOL CELL BIOL, V8, P2875, DOI 10.1128/MCB.8.7.2875; PEI DQ, 1990, J VIROL, V64, P1517, DOI 10.1128/JVI.64.4.1517-1522.1990; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; RAY D, 1987, MOL CELL BIOL, V7, P940, DOI 10.1128/MCB.7.2.940; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROMAN D, 1990, New Biologist, V2, P642; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; SPANDIDOS DA, 1983, EMBO J, V2, P1193, DOI 10.1002/j.1460-2075.1983.tb01566.x; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; TOURKINE N, 1989, ONCOGENE, V4, P973; WEISINGER G, 1988, ONCOGENE, V3, P635; WHITELAW B, 1988, UCLA S MOL CELL BIOL, V58, P337; WRIGHT S, 1989, P NATL ACAD SCI USA, V86, P505, DOI 10.1073/pnas.86.2.505	62	15	15	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1991	6	11					2067	2075						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GX119	1945411				2022-12-28	WOS:A1991GX11900018
J	BISCHOFF, FZ; STRONG, LC; YIM, SO; PRATT, DR; SICILIANO, MJ; GIOVANELLA, BC; TAINSKY, MA				BISCHOFF, FZ; STRONG, LC; YIM, SO; PRATT, DR; SICILIANO, MJ; GIOVANELLA, BC; TAINSKY, MA			TUMORIGENIC TRANSFORMATION OF SPONTANEOUSLY IMMORTALIZED FIBROBLASTS FROM PATIENTS WITH A FAMILIAL CANCER SYNDROME	ONCOGENE			English	Article							DIPLOID HUMAN-FIBROBLASTS; ANCHORAGE-INDEPENDENT GROWTH; MALIGNANT TRANSFORMATION; SKIN FIBROBLASTS; MORPHOLOGICAL TRANSFORMATION; RAS ONCOGENE; HUMAN-CELLS; DNA; TRANSFECTION; EXPRESSION	Immortal cell lines arose spontaneously during in vitro culture of initially normal fibroblasts, MDAH041 and MDAH087, from patients with Li-Fraumeni familial cancer syndrome. Fibroblasts from a control donor, MDAH170, maintained a normal morphology and senesced at 31 population doublings. The immortal fibroblasts have several properties of transformed cells. In addition to having acquired an altered morphology and chromosomal anomalies, MDAH041 and MDAH087 have escaped from senescence, growing beyond 300 and 100 population doublings (pd), respectively. As early as 50 pd, these cells can be transformed by an activated H-ras oncogene to form tumors in nude mice. However, MDAH041 immortal cells were resistant to tumorigenic transformation by transfection with the v-abl oncogene.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PEDIAT,HOUSTON,TX 77030; ST JOSEPHS HOSP,STEHLIN FDN CANC RES,CANC RES LAB,HOUSTON,TX 77003; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center				Tainsky, Michael/0000-0002-0261-831X	NCI NIH HHS [CA 09299, CA 34936, CA 42810] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009299, P01CA034936, R01CA042810] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENEDICT WF, 1984, CANCER RES, V44, P3471; BERG P, 1982, MOL APPL GENET, V1, P327; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; CHEN S, 1989, P NATL ACAD SCI USA, V86, P2008, DOI 10.1073/pnas.86.6.2008; GUMERLOCK PH, 1989, ANAL BIOCHEM, V180, P158, DOI 10.1016/0003-2697(89)90105-X; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; HURLIN PJ, 1987, CANCER RES, V47, P5752; HUSCHTSCHA LI, 1986, PROC R SOC SER B-BIO, V229, P1, DOI 10.1098/rspb.1986.0070; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; LI FP, 1969, J NATL CANCER I, V43, P1365; LITTLE JB, 1987, CANCER RES, V47, P4229; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; MCCORMICK JJ, 1988, MUTAT RES, V199, P273; MORGAN TL, 1986, IN VITRO CELL DEV B, V22, P317, DOI 10.1007/BF02623404; RULEY HE, 1984, CANCER CELL, V2, P481; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SILINSKAS KC, 1981, CANCER RES, V41, P1620; SRINIVASAN A, 1981, P NATL ACAD SCI-BIOL, V78, P2077, DOI 10.1073/pnas.78.4.2077; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; SUTHERLAND BM, 1980, CANCER RES, V40, P1934; WILLIAMS WR, 1985, FAM CANCER, P151; WILSON DM, 1989, CARCINOGENESIS, V10, P635, DOI 10.1093/carcin/10.4.635; WILSON DM, 1990, CANCER RES, V50, P5587; ZIMMERMAN RJ, 1983, CANCER RES, V43, P2183	27	50	50	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					183	186						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000218				2022-12-28	WOS:A1991FZ13400001
J	SITHANANDAM, G; KOLCH, W; DUH, FM; RAPP, UR				SITHANANDAM, G; KOLCH, W; DUH, FM; RAPP, UR			COMPLETE CODING SEQUENCE OF A HUMAN B-RAF CDNA AND DETECTION OF B-RAF PROTEIN-KINASE WITH ISOZYME SPECIFIC ANTIBODIES	ONCOGENE			English	Article							SIGNAL TRANSDUCTION; BIOLOGICAL-ACTIVITY; FISSION YEAST; A-RAF; V-RAF; ONCOGENE; GENES; MIL; PHOSPHORYLATION; REQUIREMENT	A 2.2kb cDNA clone which presumably includes the complete human B-raf coding sequence was isolated from a human testes cDNA library. Sequence analysis showed the presence of all three conserved regions CR1, CR2 and CR3 previously identified in raf protein kinases. The cDNA was expressed in E. coli yielding a B-raf fusion protein which reacts with antibodies specific for B-raf raised against the C-terminal peptide as well as with monoclonal antibodies which map into the kinase domain.	NCI,FREDERICK CANC RES & DEV CTR,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702; NCI,FREDERICK CANC RES & DEV CTR,PROGRAM RESOURCES INC,FREDERICK,MD 21702	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick			Kolch, Walter/ABF-2102-2021	Kolch, Walter/0000-0001-5777-5016				BECK TW, 1987, NUCLEIC ACIDS RES, V15, P595, DOI 10.1093/nar/15.2.595; BECK TW, 1990, MOL CELL BIOL, V10, P3325, DOI 10.1128/MCB.10.7.3325; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOZIER C, 1988, MOL CELL BIOL, V8, P1835, DOI 10.1128/MCB.8.4.1835; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; HEIDECKER G, 1989, GENES SIGNAL TRANSDU, P339; HUEBNER K, 1986, P NATL ACAD SCI USA, V83, P3934, DOI 10.1073/pnas.83.11.3934; HULEIHEL M, 1986, MOL CELL BIOL, V6, P2655, DOI 10.1128/MCB.6.7.2655; IKAWA S, 1988, MOL CELL BIOL, V8, P2651, DOI 10.1128/MCB.8.6.2651; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KOLCH W, 1990, ONCOGENE, V5, P713; LEE M, 1988, TRENDS GENET, V4, P287, DOI 10.1016/0168-9525(88)90171-0; MALLER JL, 1989, J CELL SCI S, V12, P53; MIHALY A, 1990, NEUROSCI LETT, V116, P45, DOI 10.1016/0304-3940(90)90384-L; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; RAPP UR, 1988, COLD SPRING HARB SYM, V53, P173, DOI 10.1101/SQB.1988.053.01.023; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1988, HDB ONCOGENES, P213; SCHULTZ AM, 1988, ONCOGENE, V2, P187; SITHANANDAM G, 1989, ONCOGENE, V4, P451; SITHANANDAM G, 1989, MOL DIAGNOSTICS HUMA, P171; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STORM SM, 1990, ONCOGENE, V5, P345; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2	32	97	116	0	8	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1775	1780						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284096				2022-12-28	WOS:A1990ET43600006
J	SCHERDIN, U; STEFFEN, M; DIETEL, M; BOECKER, W; BREINDL, M; HOLZEL, F				SCHERDIN, U; STEFFEN, M; DIETEL, M; BOECKER, W; BREINDL, M; HOLZEL, F			ELEVATED EXPRESSION OF V-MOS IS CORRELATED WITH ALTERED DIFFERENTIATION OF CARCINOMA-CELLS	ONCOGENE			English	Article									UNIV HOSP EPPENDORF, DEPT INTERNAL MED, EPPENDORF, GERMANY; UNIV HOSP EPPENDORF, DEPT OBSTET, EPPENDORF, GERMANY; UNIV KIEL, INST PATHOL, W-2300 KIEL 1, GERMANY; UNIV MUNSTER, INST PATHOL, W-4400 MUNSTER, GERMANY; HEINRICH PETTE INST EXPTL VIROL & IMMUNOL, W-2000 HAMBURG 20, GERMANY	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Kiel; University of Munster; Heinrich Pette Institute	HOLZEL, F (corresponding author), UNIV HOSP EPPENDORF, INST PHYSIOL CHEM, EPPENDORF, GERMANY.							ALEMA S, 1985, NATURE, V316, P557, DOI 10.1038/316557a0; BALL JK, 1973, VIROLOGY, V56, P268, DOI 10.1016/0042-6822(73)90305-X; BOETTIGER D, 1989, CURR TOP MICROBIOL, V147, P31; BRADBURY JM, 1988, INT J CANCER, V42, P923, DOI 10.1002/ijc.2910420623; BROWN AMC, 1986, CELL, V46, P1001, DOI 10.1016/0092-8674(86)90699-9; CHISWELL DJ, 1982, NUCLEIC ACIDS RES, V10, P3967, DOI 10.1093/nar/10.13.3967; CHISWELL DJ, 1982, VIROLOGY, V116, P428, DOI 10.1016/0042-6822(82)90137-4; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; COLLETTA G, 1983, MOL CELL BIOL, V3, P2099, DOI 10.1128/MCB.3.11.2099; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DENIS N, 1987, EXP CELL RES, V172, P212, DOI 10.1016/0014-4827(87)90107-8; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DONNER L, 1980, J VIROL, V35, P129, DOI 10.1128/JVI.35.1.129-140.1980; DOUGHERTY JP, 1988, J VIROL, V62, P2817, DOI 10.1128/JVI.62.8.2817-2822.1988; DULBECCO R, 1983, P NATL ACAD SCI-BIOL, V80, P1033, DOI 10.1073/pnas.80.4.1033; DULBECCO R, 1986, CANCER RES, V46, P5144; DURBAN EM, 1981, P NATL ACAD SCI-BIOL, V78, P3600, DOI 10.1073/pnas.78.6.3600; DYSON PJ, 1985, EMBO J, V4, P413, DOI 10.1002/j.1460-2075.1985.tb03644.x; FEINSTEIN SC, 1982, J MOL BIOL, V156, P549, DOI 10.1016/0022-2836(82)90266-2; FUSCO A, 1985, J VIROL, V56, P284, DOI 10.1128/JVI.56.1.284-292.1985; FUSCO A, 1982, CANCER RES, V42, P618; GREEN AR, 1988, CANCER SURV, V7, P335; GROFFEN J, 1983, VIROLOGY, V126, P213, DOI 10.1016/0042-6822(83)90473-7; GUTANKA RV, 1980, J VIROL, V43, P569; HOLZEL F, 1983, CELL BIOL INT REP, V7, P555, DOI 10.1016/0309-1651(83)90175-3; INOUE H, 1983, VIROLOGY, V125, P242, DOI 10.1016/0042-6822(83)90078-8; ITO E, 1989, ONCOGENE, V4, P1193; JAMIESON S, 1986, J NATL CANCER I, V76, P247; KAZIKA S, 1989, MOL CELL BIOL, V9, P5669; KELLER JR, 1990, ONCOGENE, V5, P549; KURATA N, 1989, EMBO J, V8, P457, DOI 10.1002/j.1460-2075.1989.tb03398.x; LEIBOVITCH MP, 1987, EXP CELL RES, V170, P80, DOI 10.1016/0014-4827(87)90118-2; LEIDER JM, 1988, J VIROL, V62, P3084, DOI 10.1128/JVI.62.9.3084-3091.1988; LEMISCHKA IR, 1981, J MOL BIOL, V151, P101, DOI 10.1016/0022-2836(81)90223-0; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; MARUYAMA K, 1987, ONCOGENE, V1, P361; MATHEYPREVOT B, 1984, J VIROL, V50, P325, DOI 10.1128/JVI.50.2.325-334.1984; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; NAGLE RB, 1986, J HISTOCHEM CYTOCHEM, V34, P869, DOI 10.1177/34.7.2423579; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; OGISO Y, 1986, BIOCHEM BIOPH RES CO, V140, P477, DOI 10.1016/0006-291X(86)90757-6; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; PAPKOFF J, 1982, CELL, V29, P417, DOI 10.1016/0092-8674(82)90158-1; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; PROPST F, 1985, NATURE, V315, P516, DOI 10.1038/315516a0; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; ROY LM, 1990, CELL, V61, P825, DOI 10.1016/0092-8674(90)90192-H; RUDLAND PS, 1987, CELLULAR MOL BIOL MA, P9; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SHTIVELMAN E, 1984, P NATL ACAD SCI-BIOL, V81, P294, DOI 10.1073/pnas.81.2.294; SINGH B, 1986, J VIROL, V60, P1148, DOI 10.1128/JVI.60.3.1148-1152.1986; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEFFEN M, 1988, CANCER RES, V48, P7212; TROTTER J, 1989, ONCOGENE, V4, P457; TUREK LP, 1980, J VIROL, V35, P466, DOI 10.1128/JVI.35.2.466-478.1980; VANDERHOORN FA, 1985, MOL CELL BIOL, V5, P2204, DOI 10.1128/MCB.5.9.2204; VIAC J, 1983, J INVEST DERMATOL, V81, P351, DOI 10.1111/1523-1747.ep12519941; VOGT M, 1979, VIROLOGY, V93, P226, DOI 10.1016/0042-6822(79)90290-3; WARBURTON MJ, 1987, J NATL CANCER I, V78, P1191; WEBER K, 1984, EMBO J, V3, P2707, DOI 10.1002/j.1460-2075.1984.tb02198.x; WEINBERG RA, 1981, J GEN VIROL, V54, P1, DOI 10.1099/0022-1317-54-1-1; WEISSMAN B, 1985, MOL CELL BIOL, V5, P3386, DOI 10.1128/MCB.5.12.3386; WOOD TG, 1983, J VIROL, V46, P726, DOI 10.1128/JVI.46.3.726-736.1983; YU G, 1989, J BIOL CHEM, V264, P10276; ZARBL H, 1987, CELL, V51, P357, DOI 10.1016/0092-8674(87)90632-5	70	4	4	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV	1990	5	11					1619	1627						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2148370				2022-12-28	WOS:A1990EL40100002
J	RASSOULZADEGAN, M; COURTNEIDGE, SA; LOUBIERE, R; ELBAZE, P; CUZIN, F				RASSOULZADEGAN, M; COURTNEIDGE, SA; LOUBIERE, R; ELBAZE, P; CUZIN, F			A VARIETY OF TUMORS INDUCED BY THE MIDDLE T-ANTIGEN OF POLYOMA-VIRUS IN A TRANSGENIC MOUSE FAMILY	ONCOGENE			English	Article									EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY; UNIV NICE,FAC MED,F-06034 NICE,FRANCE	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Universite Cote d'Azur	RASSOULZADEGAN, M (corresponding author), UNIV NICE,CTR BIOCHIM,INSERM,U273,F-06034 NICE,FRANCE.		Rassoulzadegan, Minoo/O-7939-2016					ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AGUZZI A, 1990, IN PRESS NEW BIOL; BAUTCH VL, 1987, CELL, V51, P529, DOI 10.1016/0092-8674(87)90122-X; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; CHENG SH, 1988, EMBO J, V7, P3845, DOI 10.1002/j.1460-2075.1988.tb03270.x; CHOI YW, 1988, MOL CELL BIOL, V8, P3382, DOI 10.1128/MCB.8.8.3382; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; COURTNEIDGE SA, 1985, EMBO J, V4, P1471, DOI 10.1002/j.1460-2075.1985.tb03805.x; COURTNEIDGE SA, 1983, NATURE, V303, P435, DOI 10.1038/303435a0; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; CUZIN F, 1984, BIOCHIM BIOPHYS ACTA, V781, P193, DOI 10.1016/0167-4781(84)90084-8; DAWE CJ, 1987, AM J PATHOL, V127, P243; DEVILLIERS J, 1984, NATURE, V312, P242, DOI 10.1038/312242a0; GERLINGER P, 1986, NUCLEIC ACIDS RES, V14, P6565, DOI 10.1093/nar/14.16.6565; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HOGAN B, 1986, MANIPULATING MOUSE E; JENSEN NA, 1989, IN PRESS MOL BIOL ME; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KORNBLUTH S, 1987, NATURE, V325, P171, DOI 10.1038/325171a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; Maniatis T., 1982, MOL CLONING; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; STEWART SARAH E., 1960, ADVANCES IN VIRUS RES, V7, P61; SUDA Y, 1987, EMBO J, V6, P4055, DOI 10.1002/j.1460-2075.1987.tb02751.x; TREISMAN R, 1981, NATURE, V292, P595, DOI 10.1038/292595a0; WILLIAMS RL, 1988, CELL, V52, P121; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	28	29	29	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1507	1510						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2123530				2022-12-28	WOS:A1990EK50200009
J	MATTEI, MG; SIMONCHAZOTTES, D; HIRAI, SI; RYSECK, RP; GALCHEVAGARGOVA, Z; GUENET, JL; MATTEI, JF; BRAVO, R; YANIV, M				MATTEI, MG; SIMONCHAZOTTES, D; HIRAI, SI; RYSECK, RP; GALCHEVAGARGOVA, Z; GUENET, JL; MATTEI, JF; BRAVO, R; YANIV, M			CHROMOSOMAL LOCALIZATION OF THE 3 MEMBERS OF THE JUN PROTO-ONCOGENE FAMILY IN MOUSE AND MAN	ONCOGENE			English	Note									INST PASTEUR,CNRS,URA 152,UNITE VIRUS ONCOGENES,F-75724 PARIS 15,FRANCE; HOP ENFANTS LA TIMONE,INSERM,U242,F-13385 MARSEILLE 4,FRANCE; INST PASTEUR,CNRS,URA 146,UNITE GENET MAMMIFERES,F-75724 PARIS 15,FRANCE; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; European Molecular Biology Laboratory (EMBL)								ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; EISTETTER HR, 1988, P NATL ACAD SCI USA, V85, P3489, DOI 10.1073/pnas.85.10.3489; GUENET JL, 1988, CURR TOP MICROBIOL, V137, P13; HALUSKA FG, 1988, P NATL ACAD SCI USA, V85, P2215, DOI 10.1073/pnas.85.7.2215; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; HIRAI SI, 1989, IN PRESS NEW BIOL; LALLEY PA, 1987, CYTOGENET CELL GENET, V46, P367, DOI 10.1159/000132486; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LYON MF, 1988, MOUSE NEWS LETT, V81, P20; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MATTEI MG, 1985, HUM GENET, V69, P268, DOI 10.1007/BF00293038; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; PIETTE J, 1988, P NATL ACAD SCI USA, V85, P3401, DOI 10.1073/pnas.85.10.3401; ROBERT B, 1985, NATURE, V314, P181, DOI 10.1038/314181a0; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; TRENT J M, 1988, Cytogenetics and Cell Genetics, V49, P236, DOI 10.1159/000132669; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316	27	44	45	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					151	156						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2108401				2022-12-28	WOS:A1990CM62000021
J	NATESAN, S; QUINN, EM; BENTLEY, MM				NATESAN, S; QUINN, EM; BENTLEY, MM			THE EXPRESSION OF SEQUENCES SIMILAR TO THE HUMAN C-ERB-A ONCOGENE ARE REGULATED IN A TISSUE AND STAGE SPECIFIC MANNER IN DROSOPHILA-MELANOGASTER	ONCOGENE			English	Article											NATESAN, S (corresponding author), UNIV CALGARY,DEPT BIOL SCI,CALGARY T2N 1N4,ALBERTA,CANADA.							ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BENDER W, 1987, CELL, V50, P519, DOI 10.1016/0092-8674(87)90023-7; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; KUMAR V, 1988, CELL, V51, P469; Maniatis T, 1982, MOL CLONING LABORATO, P194; MASCHAT F, 1986, EMBO J, V5, P583, DOI 10.1002/j.1460-2075.1986.tb04250.x; NAKANISHI Y, 1983, P NATL ACAD SCI-BIOL, V80, P2971, DOI 10.1073/pnas.80.10.2971; SHILO B, 1981, P NATL ACAD SCI USA, V74, P5463; SHILO BZ, 1987, TRENDS GENET, V3, P69, DOI 10.1016/0168-9525(87)90178-8; VENNSTROM B, 1982, CELL, V28, P135, DOI 10.1016/0092-8674(82)90383-X; WEINBERGER C, 1985, NATURE, V318, P670, DOI 10.1038/318670a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	20	5	5	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1397	1401						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2478942				2022-12-28	WOS:A1989AX65900018
J	ASSELIN, C; NEPVEU, A; MARCU, KB				ASSELIN, C; NEPVEU, A; MARCU, KB			MOLECULAR REQUIREMENTS FOR TRANSCRIPTIONAL INITIATION OF THE MURINE C-MYC GENE	ONCOGENE			English	Article									SUNY STONY BROOK,DEPT BIOCHEM,STONY BROOK,NY 11794; SUNY STONY BROOK,DEPT MICROBIOL & PATHOL,STONY BROOK,NY 11794; LUDWIG INST,MONTREAL H3A 1A1,QUEBEC,CANADA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook			/AAB-8315-2020		NCI NIH HHS [CA36246] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA036246] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DEAN M, 1986, J BIOL CHEM, V261, P9161; DEAN M, 1986, MOL CELL BIOL, V6, P518, DOI 10.1128/MCB.6.2.518; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; GREENBERG ME, 1984, NATURE, V311, P438; HALL DJ, 1987, J BIOL CHEM, V262, P15302; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HENTSCHEL CC, 1982, NATURE, V295, P714, DOI 10.1038/295714a0; HERNANDEZ N, 1988, EMBO J, V7, P3125, DOI 10.1002/j.1460-2075.1988.tb03179.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHIHAMA A, 1988, TRENDS GENET, V4, P282, DOI 10.1016/0168-9525(88)90170-9; ISHII S, 1986, SCIENCE, V232, P1410, DOI 10.1126/science.3012774; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KELLY K, 1986, ANNU REV IMMUNOL, V4, P317, DOI 10.1146/annurev.immunol.4.1.317; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; MACE HAF, 1983, NATURE, V304, P555, DOI 10.1038/304555a0; MARCU KB, 1987, BIOESSAYS, V6, P28, DOI 10.1002/bies.950060108; MARCU KB, 1987, NUCLEAR ONCOGENES, P165; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; MECHTI N, 1986, NUCLEIC ACIDS RES, V14, P9653, DOI 10.1093/nar/14.24.9653; MEDRANO EE, 1980, P NATL ACAD SCI-BIOL, V77, P4123, DOI 10.1073/pnas.77.7.4123; NEPVEU A, 1987, GENE DEV, V1, P938, DOI 10.1101/gad.1.9.938; NEPVEU A, 1987, ONCOGENE, V1, P243; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NISHIKURA K, 1986, MOL CELL BIOL, V6, P4093, DOI 10.1128/MCB.6.11.4093; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SCHLOKAT U, 1986, EMBO J, V5, P3251, DOI 10.1002/j.1460-2075.1986.tb04636.x; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; WATSON RJ, 1988, MOL CELL BIOL, V8, P938; YANG JQ, 1985, EMBO J, V4, P1441, DOI 10.1002/j.1460-2075.1985.tb03800.x; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108	60	99	99	1	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1989	4	5					549	558						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U7688	2471130				2022-12-28	WOS:A1989U768800004
J	KONIECZNY, SF; DROBES, BL; MENKE, SL; TAPAROWSKY, EJ				KONIECZNY, SF; DROBES, BL; MENKE, SL; TAPAROWSKY, EJ			INHIBITION OF MYOGENIC DIFFERENTIATION BY THE H-RAS ONCOGENE IS ASSOCIATED WITH THE DOWN REGULATION OF THE MYOD1 GENE	ONCOGENE			English	Article									PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NCI NIH HHS [CA 42835] Funding Source: Medline; NICHD NIH HHS [HD 24489] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD024489] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA042835, R23CA042835] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEMA S, 1987, ADV CANCER RES, V49, P1, DOI 10.1016/S0065-230X(08)60792-7; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DENIS N, 1987, EXP CELL RES, V172, P212, DOI 10.1016/0014-4827(87)90107-8; DEVLIN BH, 1983, DEV BIOL, V95, P176; ENDO T, 1987, CELL, V49, P515, DOI 10.1016/0092-8674(87)90454-5; FALCONE G, 1985, P NATL ACAD SCI USA, V82, P426, DOI 10.1073/pnas.82.2.426; FLORINI JR, 1986, J BIOL CHEM, V261, P6509; FREEMAN GJ, 1983, P NATL ACAD SCI-BIOL, V80, P4094, DOI 10.1073/pnas.80.13.4094; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOSSETT LA, 1988, J CELL BIOL, V106, P2127, DOI 10.1083/jcb.106.6.2127; HARRINGTON MA, 1988, BIOESSAYS, V8, P100, DOI 10.1002/bies.950080403; HARRINGTON MA, 1988, MOL CELL BIOL, V8, P4322, DOI 10.1128/MCB.8.10.4322; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; KONIECZNY SF, 1982, DEV BIOL, V91, P11, DOI 10.1016/0012-1606(82)90003-3; KONIECZNY SF, 1985, MOL CELL BIOL, V5, P2423, DOI 10.1128/MCB.5.9.2423; KONIECZNY SF, 1984, CELL, V38, P791, DOI 10.1016/0092-8674(84)90274-5; KONIECZNY SF, 1987, MOL CELL BIOL, V7, P3065, DOI 10.1128/MCB.7.9.3065; KONIECZNY SF, 1986, MOL BIOL MUSCLE DEV, P21; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; LATHROP B, 1985, J CELL BIOL, V100, P1540, DOI 10.1083/jcb.100.5.1540; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; LINKHART TA, 1980, J SUPRAMOL STR CELL, V14, P483, DOI 10.1002/jss.400140407; MACKALL J, 1979, ANAL BIOCHEM, V95, P270, DOI 10.1016/0003-2697(79)90216-1; Maniatis T., 1982, MOL CLONING; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MIWA T, 1987, P NATL ACAD SCI USA, V84, P6702, DOI 10.1073/pnas.84.19.6702; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; OLSON EN, 1987, MOL CELL BIOL, V7, P2104, DOI 10.1128/MCB.7.6.2104; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; PAYNE PA, 1987, P NATL ACAD SCI USA, V84, P8956, DOI 10.1073/pnas.84.24.8956; PINNEY DF, 1988, CELL, V53, P781, DOI 10.1016/0092-8674(88)90095-5; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAPAROWSKY E, 1982, NATURE, V300, P762, DOI 10.1038/300762a0; TAPAROWSKY EJ, 1987, CANCER RES, V47, P4125; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; WEBSTER KA, 1988, NATURE, V332, P553, DOI 10.1038/332553a0; WICE B, 1987, J BIOL CHEM, V262, P1810	49	129	130	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					473	481						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2654809				2022-12-28	WOS:A1989U567700012
J	MONTENARH, M; QUAISER, A				MONTENARH, M; QUAISER, A			2 DIFFERENT PROTEIN-PROTEIN INTERACTIONS IN OLIGOMERIC COMPLEXES OF SV40 LARGE T-ANTIGEN WITH THE CELLULAR ONCOPROTEIN-P53	ONCOGENE			English	Note											MONTENARH, M (corresponding author), UNIV ULM,DEPT BIOCHEM,POB 4066,D-7900 ULM,FED REP GER.		Montenarh, Mathias/AAB-6689-2020					BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; BENCHIMOL S, 1982, EMBO J, V1, P1055, DOI 10.1002/j.1460-2075.1982.tb01296.x; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BRADLEY MK, 1982, CELL, V28, P125, DOI 10.1016/0092-8674(82)90382-8; BUTEL JS, 1986, BIOCHIM BIOPHYS ACTA, V865, P171, DOI 10.1016/0304-419X(86)90027-2; CHEN S, 1983, P NATL ACAD SCI-BIOL, V80, P5670, DOI 10.1073/pnas.80.18.5670; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; CRAWFORD LV, 1983, INT REV EXP PATHOL, V35, P1; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FANNING E, 1981, J VIROL, V37, P92, DOI 10.1128/JVI.37.1.92-102.1981; Flint S. J, 1981, DNA TUMOR VIRUSES; GIDONI D, 1982, J VIROL, V42, P456, DOI 10.1128/JVI.42.2.456-466.1982; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; KRESS M, 1979, J VIROL, V31, P472, DOI 10.1128/JVI.31.2.472-483.1979; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; MCCORMICK F, 1980, J VIROL, V34, P213, DOI 10.1128/JVI.34.1.213-224.1980; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MICHALOVITZ D, 1986, MOL CELL BIOL, V6, P3531, DOI 10.1128/MCB.6.10.3531; MONTENARH M, 1987, FEBS LETT, V221, P199, DOI 10.1016/0014-5793(87)80925-0; MONTENARH M, 1987, J VIROL, V61, P940, DOI 10.1128/JVI.61.3.940-944.1987; MONTENARH M, 1984, J VIROL, V49, P658, DOI 10.1128/JVI.49.3.658-664.1984; MONTENARH M, 1985, EMBO J, V4, P2941, DOI 10.1002/j.1460-2075.1985.tb04027.x; MONTENARH M, 1983, J VIROL, V45, P531, DOI 10.1128/JVI.45.2.531-538.1983; MONTENARH M, 1986, J VIROL, V60, P761, DOI 10.1128/JVI.60.2.761-764.1986; MONTENARH M, 1986, FEBS LETT, V204, P51, DOI 10.1016/0014-5793(86)81386-2; MONTENARH M, 1983, J GEN VIROL, V64, P241, DOI 10.1099/0022-1317-64-1-241; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; Rigby P. W. J., 1983, ADV VIRAL ONCOL, V3, P31; SCHEIDTMANN KH, 1982, J VIROL, V44, P116, DOI 10.1128/JVI.44.1.116-133.1982; SCHURMANN C, 1985, VIROLOGY, V146, P1, DOI 10.1016/0042-6822(85)90047-9; TODARO GJ, 1966, SCIENCE, V153, P1252, DOI 10.1126/science.153.3741.1252; WACHTER M, 1985, J VIROL, V56, P520, DOI 10.1128/JVI.56.2.520-526.1985	37	9	10	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAR	1989	4	3					379	382						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5676	2495505				2022-12-28	WOS:A1989U567600015
J	WENDLER, PA; BOSCHELLI, F				WENDLER, PA; BOSCHELLI, F			SRC HOMOLOGY-2 DOMAIN DELETION MUTANTS OF P60V-SRC DO NOT PHOSPHORYLATE CELLULAR PROTEINS OF 120-150 KDA	ONCOGENE			English	Article									MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)					NCI NIH HHS [5RO1-CO-36928] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRYANT D, 1982, J VIROL, V44, P683, DOI 10.1128/JVI.44.2.683-691.1982; BURR JG, 1981, COLD SPRING HARBOR C, V8, P1217; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; CROSS FR, 1985, MOL CELL BIOL, V5, P2789, DOI 10.1128/MCB.5.10.2789; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HANAFUSA H, 1977, COMPREHENSIVE VIROLO, V10, P41; HARTMAN S, 1988, IN PRESS P NAT ACAD; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cellbio.3.1.31; KATZ RA, 1982, J VIROL, V42, P346, DOI 10.1128/JVI.42.1.346-351.1982; LAU AF, 1986, VIROLOGY, V151, P86, DOI 10.1016/0042-6822(86)90106-6; LAUDANO AP, 1986, P NATL ACAD SCI USA, V83, P892, DOI 10.1073/pnas.83.4.892; LEVY JB, 1986, P NATL ACAD SCI USA, V83, P4228, DOI 10.1073/pnas.83.12.4228; LINDER ME, 1988, P NATL ACAD SCI USA, V85, P2608, DOI 10.1073/pnas.85.8.2608; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LUSKY M, 1981, NATURE, V293, P79, DOI 10.1038/293079a0; MAYER BJ, 1986, J VIROL, V60, P858, DOI 10.1128/JVI.60.3.858-867.1986; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; PARSONS JT, 1984, CANCER CELL, V2, P37; PIWINICAWORMS H, 1987, CELL, V49, P75; RAYMOND VW, 1987, VIROLOGY, V160, P400, DOI 10.1016/0042-6822(87)90011-0; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SEFTON BM, 1982, J VIROL, V41, P813, DOI 10.1128/JVI.41.3.813-820.1982; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; WAYE MMY, 1983, EMBO J, V2, P1827, DOI 10.1002/j.1460-2075.1983.tb01665.x; WEBER MJ, 1979, CELL, V16, P25, DOI 10.1016/0092-8674(79)90184-3	29	23	24	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1989	4	2					231	236						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5675	2494631				2022-12-28	WOS:A1989U567500015
J	BADING, H; BEUTLER, C; MOELLING, K				BADING, H; BEUTLER, C; MOELLING, K			MAPPING OF A SMALL PHOSPHOPEPTIDE AT THE CARBOXYTERMINUS OF THE VIRAL MYB PROTEIN BY MONOCLONAL-ANTIBODIES	ONCOGENE			English	Article											BADING, H (corresponding author), MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,D-1000 BERLIN 33,FED REP GER.							BADING H, 1987, ONCOGENE, V1, P395; BADING H, 1988, ONCOGENE, V3, P257; BADING H, 1988, NUCLEIC ACIDS RES, V16, P5241, DOI 10.1093/nar/16.12.5241; BADING H, 1987, MODERN TRENDS HUMAN, V7, P488; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6349, DOI 10.1021/bi00344a005; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; DUESBERG PH, 1980, P NATL ACAD SCI-BIOL, V77, P5120, DOI 10.1073/pnas.77.9.5120; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; Maniatis T., 1982, MOL CLONING LAB MANU; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; Moscovici C, 1975, Curr Top Microbiol Immunol, V71, P79; NUNN MF, 1983, NATURE, V306, P391, DOI 10.1038/306391a0; REMAUT E, 1981, GENE, V15, P81, DOI 10.1016/0378-1119(81)90106-2; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SOUZA LM, 1980, P NATL ACAD SCI-BIOL, V77, P5177, DOI 10.1073/pnas.77.9.5177; SYMONDS G, 1984, MOL CELL BIOL, V4, P2587, DOI 10.1128/MCB.4.12.2587	28	19	19	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1989	4	1					33	38						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5674	2464784				2022-12-28	WOS:A1989U567400005
J	KRUEGER, J; ZHAO, YH; MURPHY, D; SUDOL, M				KRUEGER, J; ZHAO, YH; MURPHY, D; SUDOL, M			DIFFERENTIAL EXPRESSION OF P62C-YES IN NORMAL, HYPERPLASTIC AND NEOPLASTIC HUMAN EPIDERMIS	ONCOGENE			English	Article							AVIAN-SARCOMA VIRUS; YES PROTO-ONCOGENE; HUMAN KERATINOCYTES; TRANSFORMING GENE; CELLULAR-YES; C-YES; RECEPTOR; SRC; PRODUCT; KINASE	The protein product of the c-yes proto-oncogene, p62c-yes, is highly expressed in a variety of mammalian cell types, including neurons, spermatozoa, platelets, and epithelial cells. In order to understand the function of p62c-yes in epithelial cells, the expression and localization of p62c-yes was studied in cultured human epidermal keratinocytes and in normal, hyperplastic, and neoplastic human epidermis. Human keratinocytes in culture produce a single 4 kb c-yes mRNA and a 62 kd protein product, p62c-yes, which is active as a protein tyrosine kinase. Using affinity-purified antibodies generated to the aminoterminus of the human c-yes protein, the expression of p62c-yes was localized to keratinocytes in the basal epidermal layer of normal neonatal and adult epidermis. There was a marked reduction in expression of p62c-yes by suprabasal keratinocytes undergoing progressive differentiation. By immunofluorescence microscopy, p62c-yes was localized to the plasma membrane and to a perinuclear cytoplasmic area in cultured keratinocytes. The apparent association of p62c-yes with plasma membranes was particularly evident in suprabasal keratinocytes from hyperplastic epidermis. Neoplastic keratinocytes in basal cell carcinomas showed a marked reduction in p62c-yes expression compared to normal basal keratinocytes in epidermis or to proliferating cultured keratinocytes. Thus the expression of p62c-yes by one epithelial cell type, the keratinocyte, is altered by cellular differentiation and neoplastic transformation. Keratinocytes provide a normal epithelial cell model in which the biochemical function of p62c-yes can be studied.	ROCKEFELLER UNIV,MOLEC ONCOL LAB,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,NEW YORK,NY 10021	Rockefeller University; Cornell University	KRUEGER, J (corresponding author), ROCKEFELLER UNIV,INVESTIGAT DERMATOL LAB,1230 YORK AVE,NEW YORK,NY 10021, USA.				NCRR NIH HHS [M01-RR00102, RR07065-23] Funding Source: Medline; NIAMS NIH HHS [AR07525] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007525] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BASSETSEGUIN EC, 1990, J INVEST DERMATOL, V94, P4182; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAMM D, 1990, J INVEST DERMATOL, V94, P517; FILVAROFF E, 1990, MOL CELL BIOL, V10, P1164, DOI 10.1128/MCB.10.3.1164; GESSLER M, 1984, BIOSCIENCE REP, V4, P757, DOI 10.1007/BF01128817; GHYSDAEL J, 1981, P NATL ACAD SCI-BIOL, V78, P2611, DOI 10.1073/pnas.78.4.2611; GOTTLIEB AB, 1988, J EXP MED, V167, P670, DOI 10.1084/jem.167.2.670; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KAWAI S, 1980, P NATL ACAD SCI-BIOL, V77, P6199, DOI 10.1073/pnas.77.10.6199; KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0; KRUEGER JG, 1980, P NATL ACAD SCI-BIOL, V77, P4142, DOI 10.1073/pnas.77.7.4142; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lever W. F., 1990, HISTOPATHOLOGY SKIN; MAGUIRE HC, 1989, J INVEST DERMATOL, V92, P786, DOI 10.1111/1523-1747.ep12696796; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; MURPHY D, 1990, J INVEST DERMATOL, V94, P557; NANNEY LB, 1986, J INVEST DERMATOL, V86, P260, DOI 10.1111/1523-1747.ep12285389; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SHIBUYA M, 1982, J VIROL, V42, P143, DOI 10.1128/JVI.42.1.143-152.1982; SHIPLEY GD, 1987, ARCH DERMATOL, V123, P1541; SUDOL M, 1989, J NEUROSCI RES, V24, P1, DOI 10.1002/jnr.490240103; SUDOL M, 1988, ONCOGENE RES, V2, P345; SUDOL M, 1988, NUCLEIC ACIDS RES, V16, P9876, DOI 10.1093/nar/16.20.9876; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; SUN TT, 1985, ANN NY ACAD SCI, V455, P307, DOI 10.1111/j.1749-6632.1985.tb50419.x; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; YOSHIDA MC, 1985, JPN J CANCER RES, V76, P559; ZHANG X, 1989, ONCOGENE, V4, P99; ZHAO YH, 1990, ONCOGENE, V5, P1629	30	20	22	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1991	6	6					933	940						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GU622	2067846				2022-12-28	WOS:A1991GU62200007
J	LOBANENKOV, VV; NICOLAS, RH; ADLER, VV; PATERSON, H; KLENOVA, EM; POLOTSKAJA, AV; GOODWIN, GH				LOBANENKOV, VV; NICOLAS, RH; ADLER, VV; PATERSON, H; KLENOVA, EM; POLOTSKAJA, AV; GOODWIN, GH			A NOVEL SEQUENCE-SPECIFIC DNA-BINDING PROTEIN WHICH INTERACTS WITH 3 REGULARLY SPACED DIRECT REPEATS OF THE CCCTC-MOTIF IN THE 5'-FLANKING SEQUENCE OF THE CHICKEN C-MYC GENE	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SP1; BETA-GLOBIN GENE; MODULATE EXPRESSION; PROMOTER ELEMENTS; BURKITT-LYMPHOMA; HL60 CELLS; KINASE-C; REGION; UPSTREAM; PURIFICATION	The chicken c-myc 5'-flanking sequence has previously been shown to bind multiple proteins present in undifferentiated and differentiated red blood cells. In this report the protein binding to one specific region within a hypersensitive site approximately 200 base pairs upstream of the start of transcription has been analysed in detail. Using a combination of a modified agarose gel retardation assay with O-phenanthroline-copper foot-printing in situ, missing contact point and methylation interference techniques, two proteins were found to bind to overlapping sequences within 180-230 bp upstream of the start of transcription. One protein resembles the transcription factor Sp1, the other is a protein which binds to three regularly spaced repeats of the core sequence CCCTC. This CCCTC-binding factor was termed CTCF. It requires additional sequences outside the three recognition motifs for tight binding. CTCF was purified to near homogeneity by sequence-specific DNA chromatography. The approximate molecular weight of the CTCF was estimated to be 130 000. Removal of 110 bp sequence binding both CTCF and Sp1-like proteins leads to a 4 to 8-fold increase in transcription of stably transfected c-myc fusion constructs in chicken embryonic fibroblasts, suggesting that the CTCF is likely to be one of multiple nuclear factors involved in the transcriptional regulation of the chicken c-myc gene.	INST CANC RES,CHESTER BEATTY LABS,FULHAM RD,LONDON SW3 6JB,ENGLAND; ALL UNION CANC RES CTR,INST CARCINOGENESIS,MOSCOW 115478,USSR	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK			Lobanenkov, Victor V./AGQ-8903-2022; Lobanenkov, Victor/ABD-5710-2021	Lobanenkov, Victor/0000-0001-6665-3635				ASSELIN C, 1989, ONCOGENE, V4, P549; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BRUNELLE A, 1987, P NATL ACAD SCI USA, V84, P6673, DOI 10.1073/pnas.84.19.6673; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; DYNAN WS, 1986, NATURE, V319, P246, DOI 10.1038/319246a0; EMERSON BM, 1985, CELL, V41, P21, DOI 10.1016/0092-8674(85)90057-1; GOODWIN GH, 1988, J VIROL, V62, P2186, DOI 10.1128/JVI.62.6.2186-2190.1988; HALL DJ, 1987, J BIOL CHEM, V262, P15302; HALL DJ, 1990, ONCOGENE, V5, P47; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HIEBERT SW, 1989, P NATL ACAD SCI USA, V86, P3594, DOI 10.1073/pnas.86.10.3594; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAKKIS E, 1987, P NATL ACAD SCI USA, V84, P7031, DOI 10.1073/pnas.84.20.7031; KUWABARA MD, 1987, BIOCHEMISTRY-US, V26, P7234, DOI 10.1021/bi00397a006; LETOVSKY J, 1989, NUCLEIC ACIDS RES, V17, P2639, DOI 10.1093/nar/17.7.2639; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; LINIAL M, 1985, P NATL ACAD SCI USA, V82, P53, DOI 10.1073/pnas.82.1.53; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; LOBANENKOV VV, 1986, EUR J BIOCHEM, V159, P181, DOI 10.1111/j.1432-1033.1986.tb09850.x; LOBANENKOV VV, 1990, GENE REGULATION AIDS, P45; Maniatis T., 1982, MOL CLONING; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PERKINS ND, 1989, NUCLEIC ACIDS RES, V17, P1299, DOI 10.1093/nar/17.4.1299; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PIETENPOL JA, 1990, P NATL ACAD SCI USA, V87, P3758, DOI 10.1073/pnas.87.10.3758; Plumb M A, 1988, Methods Mol Biol, V4, P139, DOI 10.1385/0-89603-127-6:139; PLUMB MA, 1986, NUCLEIC ACIDS RES, V14, P7675, DOI 10.1093/nar/14.19.7675; POSTEL EH, 1989, MOL CELL BIOL, V9, P5123, DOI 10.1128/MCB.9.11.5123; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; SHIH CK, 1984, P NATL ACAD SCI-BIOL, V81, P4697, DOI 10.1073/pnas.81.15.4697; SIEBENLIST U, 1988, MOL CELL BIOL, V8, P867, DOI 10.1128/MCB.8.2.867; SIEBENLIST U, 1984, CELL, V37, P381, DOI 10.1016/0092-8674(84)90368-4; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; WANG J, 1987, NUCLEIC ACIDS RES, V15, P10105, DOI 10.1093/nar/15.24.10105; WEISINGER G, 1988, ONCOGENE, V3, P635; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x	50	301	315	0	25	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	DEC	1990	5	12					1743	1753						11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET436	2284094				2022-12-28	WOS:A1990ET43600002
J	HAILAT, N; STRAHLER, J; MELHEM, R; ZHU, XX; BRODEUR, G; SEEGER, RC; REYNOLDS, CP; HANASH, S				HAILAT, N; STRAHLER, J; MELHEM, R; ZHU, XX; BRODEUR, G; SEEGER, RC; REYNOLDS, CP; HANASH, S			N-MYC GENE AMPLIFICATION IN NEUROBLASTOMA IS ASSOCIATED WITH ALTERED PHOSPHORYLATION OF A PROLIFERATION RELATED POLYPEPTIDE (OP18)	ONCOGENE			English	Article									UNIV MICHIGAN,SCH MED,DEPT PEDIAT HEMATOL,ANN ARBOR,MI 48109; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; UNIV SO CALIF,SCH MED,DEPT PEDIAT HEMATOL,LOS ANGELES,CA 90029; CHILDRENS HOSP LOS ANGELES,DEPT PEDIAT HEMATOL,LOS ANGELES,CA 90027	University of Michigan System; University of Michigan; Washington University (WUSTL); University of Southern California; Children's Hospital Los Angeles				Zhu, Charles/0000-0003-2922-0042; Reynolds, C. Patrick/0000-0002-2827-8536	NCI NIH HHS [CA22794, CA32146, CA26803] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022794, R01CA032146, P01CA026803] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRODEUR GM, 1982, CANCER GENET CYTOGEN, V7, P137, DOI 10.1016/0165-4608(82)90010-3; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1981, CANCER RES, V41, P4678; CHRISTIANSEN H, 1990, ONCOGENE, V5, P437; DOYE V, 1989, J BIOL CHEM, V264, P12134; FERRARI AC, IN PRESS GENES CHROM; FEURSTEIN N, 1983, J BIOL CHEM, V258, P10786; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; HAILAT N, UNPUB; HANASH SM, 1988, J BIOL CHEM, V263, P12813; HASKELL BE, 1987, CELL TISSUE RES, V247, P67, DOI 10.1007/BF00216548; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; KOHL NE, 1983, CELL, V35, P359, DOI 10.1016/0092-8674(83)90169-1; KUICK RD, 1987, ELECTROPHORESIS, V8, P199, DOI 10.1002/elps.1150080405; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; NISEN PD, 1988, J NATL CANCER I, V80, P633; SCHUBART UK, 1989, DNA-J MOLEC CELL BIO, V8, P389, DOI 10.1089/dna.1.1989.8.389; SCHWAB M, 1984, NATURE, V308, P288, DOI 10.1038/308288a0; SEEGER RC, 1985, NEW ENGL J MED, V313, P111; SHILOH Y, 1985, P NATL ACAD SCI USA, V82, P3761, DOI 10.1073/pnas.82.11.3761; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; SOBEL A, 1989, J BIOL CHEM, V264, P3765; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; ZHU XX, 1989, J BIOL CHEM, V264, P14556	24	108	111	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1615	1618						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267130				2022-12-28	WOS:A1990EL40100001
J	MERCER, WE; AMIN, M; SAUVE, GJ; APPELLA, E; ULLRICH, SJ; ROMANO, JW				MERCER, WE; AMIN, M; SAUVE, GJ; APPELLA, E; ULLRICH, SJ; ROMANO, JW			WILD-TYPE HUMAN P53 IS ANTIPROLIFERATIVE IN SV40-TRANSFORMED HAMSTER-CELLS	ONCOGENE			English	Article									NCI,CELL BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	MERCER, WE (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT PATHOL,3400 N BROAD ST,PHILADELPHIA,PA 19140, USA.				NCI NIH HHS [CA 42866] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA042866] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CALABRETTA B, 1986, CANCER RES, V46, P5738; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V62, P156; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; Crawford L V, 1984, Mol Biol Med, V2, P261; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; EHRHART JC, 1988, ONCOGENE, V3, P595; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Gai X X, 1988, Oncogene Res, V3, P377; GANNON JV, 1987, NATURE, V329, P456, DOI 10.1038/329456a0; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HIRSCHHORN RR, 1984, VIROLOGY, V134, P220, DOI 10.1016/0042-6822(84)90287-3; JENKINS JR, 1985, NATURE, V317, P816, DOI 10.1038/317816a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; KACZMAREK L, 1986, EXP CELL RES, V162, P268, DOI 10.1016/0014-4827(86)90445-3; KACZMAREK L, 1986, J BIOL CHEM, V261, P802; KLESSIG DF, 1984, MOL CELL BIOL, V4, P1354, DOI 10.1128/MCB.4.7.1354; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; MARTINIS J, 1978, P NATL ACAD SCI USA, V75, P2320, DOI 10.1073/pnas.75.5.2320; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1989, EXP CELL RES, V181, P531, DOI 10.1016/0014-4827(89)90109-2; MERCER WE, 1985, EXP CELL RES, V160, P31, DOI 10.1016/0014-4827(85)90233-2; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MUNROE DG, 1988, ONCOGENE, V2, P621; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROMANO JW, 1989, ONCOGENE, V4, P1483; ROVINSKI B, 1988, ONCOGENE, V2, P445; SAMAD A, 1986, P NATL ACAD SCI USA, V83, P897, DOI 10.1073/pnas.83.4.897; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SHEN YM, 1982, MOL CELL BIOL, V2, P1145, DOI 10.1128/MCB.2.9.1145; SHOHAT O, 1987, ONCOGENE, V1, P277; STEINMEYER K, 1988, ONCOGENE, V3, P501; STURZBECHER HW, 1988, ONCOGENE, V3, P405; TACK LC, 1989, J VIROL, V63, P1310, DOI 10.1128/JVI.63.3.1310-1317.1989; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TUCK SP, 1989, ONCOGENE RES, V4, P81; WADEEVANS A, 1985, EMBO J, V4, P699, DOI 10.1002/j.1460-2075.1985.tb03686.x; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WOLF D, 1984, MOL CELL BIOL, V4, P1402, DOI 10.1128/MCB.4.7.1402; WOLF D, 1985, P NATL ACAD SCI USA, V82, P790, DOI 10.1073/pnas.82.3.790; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	62	123	125	0	5	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					973	980						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	2165234				2022-12-28	WOS:A1990DP41500004
J	KOCH, I; HOFSCHNEIDER, PH; LOTTSPEICH, F; ECKERSKORN, C; KOSHY, R				KOCH, I; HOFSCHNEIDER, PH; LOTTSPEICH, F; ECKERSKORN, C; KOSHY, R			TUMOR-RELATED EXPRESSION OF A TRANSLATION-ELONGATION FACTOR-LIKE PROTEIN	ONCOGENE			English	Article									MAX PLANCK INST BIOCHEM,DEPT VIRUS RES,W-8033 MARTINSRIED,GERMANY	Max Planck Society								ALEXANDER JJ, 1976, S AFR MED J, V50, P2124; BISHOP JM, 1985, CELL, V42, P23, DOI 10.1016/S0092-8674(85)80098-2; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; ECKERSKORN C, 1989, CHROMATOGRAPHIA, V28, P92, DOI 10.1007/BF02290390; ECKERSKORN C, 1988, EUR J BIOCHEM, V176, P509, DOI 10.1111/j.1432-1033.1988.tb14308.x; HARISIADIS L, 1978, NATURE, V274, P486, DOI 10.1038/274486a0; HOVEMANN B, 1988, NUCLEIC ACIDS RES, V16, P3175, DOI 10.1093/nar/16.8.3175; JONES MD, 1980, EUR J BIOCHEM, V108, P507, DOI 10.1111/j.1432-1033.1980.tb04748.x; Kodama HA., 1981, JPN J ORAL BIOL, V23, P899, DOI DOI 10.2330/JORALBIOSCI1965.23.899; LENSTRA JA, 1986, EUR J BIOCHEM, V155, P475, DOI 10.1111/j.1432-1033.1986.tb09514.x; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MONTANDON PE, 1983, NUCLEIC ACIDS RES, V11, P5877, DOI 10.1093/nar/11.17.5877; MOON RC, 1977, NATURE, V267, P620, DOI 10.1038/267620a0; NAGATA S, 1984, EMBO J, V3, P1825, DOI 10.1002/j.1460-2075.1984.tb02053.x; NAGATA S, 1983, P NATL ACAD SCI-BIOL, V80, P6192, DOI 10.1073/pnas.80.20.6192; NAKAMURA S, 1988, SCIENCE, V242, P426, DOI 10.1126/science.3262925; OCHIYA T, 1986, P NATL ACAD SCI USA, V83, P4993, DOI 10.1073/pnas.83.14.4993; RENNER I, 1988, THESIS U MUNICH; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; WERNER S, 1989, J CELL PHYSIOL, V141, P490, DOI 10.1002/jcp.1041410307	22	14	15	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					839	843						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2193292				2022-12-28	WOS:A1990DP55300009
J	LUO, K; SEFTON, BM				LUO, K; SEFTON, BM			ANALYSIS OF THE SITES IN P56LCK WHOSE PHOSPHORYLATION IS INDUCED BY TETRADECANOYL PHORBOL ACETATE	ONCOGENE			English	Article											LUO, K (corresponding author), SALK INST BIOL STUDIES,MOLEC BIOL & VIROL LAB,POB 85800,SAN DIEGO,CA 92138, USA.				NATIONAL CANCER INSTITUTE [P30CA014195, R01CA042350] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42350, CA-14195] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACRES RB, 1986, J BIOL CHEM, V261, P6210; AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; CASNELLIE JE, 1982, J BIOL CHEM, V257, P3877; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; GLYNN JP, 1964, CANCER RES, V24, P502; GOULD KL, 1985, CELL, V42, P849, DOI 10.1016/0092-8674(85)90281-8; HOXIE JA, 1988, J IMMUNOL, V140, P786; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HURLEY TR, 1989, ONCOGENE, V4, P265; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; KAMPS MP, 1988, ONCOGENE, V2, P305; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; LUO K, 1990, ONCOGENE, V5, P921; MARTH JD, 1987, EMBO J, V6, P2727, DOI 10.1002/j.1460-2075.1987.tb02566.x; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MORGAN DO, 1989, CELL, V57, P775, DOI 10.1016/0092-8674(89)90792-7; PATSCHINSKY T, 1982, P NATL ACAD SCI-BIOL, V79, P973, DOI 10.1073/pnas.79.4.973; PATSCHINSKY T, 1986, J VIROL, V59, P73, DOI 10.1128/JVI.59.1.73-81.1986; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; PURCHIO AF, 1985, SCIENCE, V229, P1393, DOI 10.1126/science.2994221; REYNOLDS AB, 1987, EMBO J, V6, P2359, DOI 10.1002/j.1460-2075.1987.tb02512.x; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SEFTON BM, 1982, CELL, V31, P465, DOI 10.1016/0092-8674(82)90139-8; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SMART JE, 1981, P NATL ACAD SCI-BIOL, V78, P6013, DOI 10.1073/pnas.78.10.6013; TREVILLYAN JM, 1986, BIOCHIM BIOPHYS ACTA, V888, P286, DOI 10.1016/0167-4889(86)90228-4; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VEILLETTE A, 1988, ONCOGENE RES, V2, P385; VEILLETTE A, 1989, MOL CELL BIOL, V9, P4441, DOI 10.1128/MCB.9.10.4441; VEILLETTE A, 1987, ONCOGENE RES, V1, P357; VORONOVA AF, 1984, MOL CELL BIOL, V4, P2705, DOI 10.1128/MCB.4.12.2705; WEYAND CM, 1987, J IMMUNOL, V138, P1351	41	45	45	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					803	808						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	2359619				2022-12-28	WOS:A1990DP55300004
J	CAMPBELL, ML; LI, WJ; ARLINGHAUS, RB				CAMPBELL, ML; LI, WJ; ARLINGHAUS, RB			P210 BCR-ABL IS COMPLEXED TO P160 BCR AND PH-P53 PROTEINS IN K562 CELLS	ONCOGENE			English	Note									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MOLEC PATHOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NCI NIH HHS [CA47372, CA16672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA047372, P30CA016672] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COLLINS S, 1987, MOL CELL BIOL, V7, P2870, DOI 10.1128/MCB.7.8.2870; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HARIHARAN IK, 1987, EMBO J, V6, P115, DOI 10.1002/j.1460-2075.1987.tb04727.x; KLOETZER W, 1985, VIROLOGY, V140, P230, DOI 10.1016/0042-6822(85)90361-7; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LI WJ, 1989, ONCOGENE, V4, P127; LI WJ, 1988, ONCOGENE, V2, P559; LIFSHITZ B, 1988, ONCOGENE, V2, P112; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAXWELL SA, 1987, CANCER RES, V47, P1731; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; YOUNG JC, 1988, MOL CELL BIOL, V8, P4079, DOI 10.1128/MCB.8.10.4079	19	35	36	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					773	776						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2140598				2022-12-28	WOS:A1990DG37400020
J	CATO, ACB; MINK, S; NIERLICH, B; PONTA, H; SCHAAP, D; SCHUURING, E; SONNENBERG, A				CATO, ACB; MINK, S; NIERLICH, B; PONTA, H; SCHAAP, D; SCHUURING, E; SONNENBERG, A			TRANSFORMING GROWTH FACTOR-BETA REPRESSES TRANSCRIPTION OF THE MOUSE MAMMARY-TUMOR VIRUS-DNA IN CULTURED MOUSE MAMMARY CELLS	ONCOGENE			English	Article									NETHERLANDS CANC INST,DEPT TUMOUR BIOL,1066 CX AMSTERDAM,NETHERLANDS	Netherlands Cancer Institute	CATO, ACB (corresponding author), KERNFORSCHUNGSZENTRUM KARLSRUHE GMBH,INST GENET & TOXIKOL,POSTFACH 3640,W-7500 KARLSRUHE 1,GERMANY.		Cato, Andrew C. B./H-2071-2013	Cato, Andrew C. B./0000-0001-8508-3834				AFFRAY C, 1980, EUR J BIOCHEM, V107, P303; ANZANO MA, 1985, MOL CELL BIOL, V5, P242, DOI 10.1128/MCB.5.1.242; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; CIARDIELLO F, 1988, MOL ENDOCRINOL, V2, P1202, DOI 10.1210/mend-2-12-1202; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DICKSON C, 1984, CELL, V37, P529, DOI 10.1016/0092-8674(84)90383-0; DICKSON RB, 1987, P NATL ACAD SCI USA, V84, P837, DOI 10.1073/pnas.84.3.837; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HYNES N, 1983, P NATL ACAD SCI-BIOL, V80, P3637, DOI 10.1073/pnas.80.12.3637; HYNES NE, 1984, ADV CANCER RES, V41, P155, DOI 10.1016/S0065-230X(08)60016-0; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; MASON AJ, 1985, NATURE, V318, P659, DOI 10.1038/318659a0; Morris D. W., 1987, ADV VIRAL ONCOL, V7, P123; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSE R, 1988, PROGR CANCER RES THE, V35, P97; OTT MO, 1984, EMBO J, V3, P2505, DOI 10.1002/j.1460-2075.1984.tb02164.x; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; PETERS G, 1986, NATURE, V320, P628, DOI 10.1038/320628a0; RIJSEWIJK F, 1987, EMBO J, V6, P127, DOI 10.1002/j.1460-2075.1987.tb04729.x; RINGOLD G, 1975, VIROLOGY, V65, P135, DOI 10.1016/0042-6822(75)90014-8; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOLOMON DS, 1984, CANCER RES, V44, P4069; SONNENBERG A, 1987, EMBO J, V6, P121, DOI 10.1002/j.1460-2075.1987.tb04728.x; SONNENBERG A, 1986, CANCER RES, V46, P5913; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SPORN MB, 1985, NATURE, V313, P745, DOI 10.1038/313745a0; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; ZWIEBEL JA, 1982, CANCER RES, V42, P5117	39	11	12	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					103	110						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2157176				2022-12-28	WOS:A1990CM62000014
J	GIORDANO, S; DIRENZO, MF; NARSIMHAN, RP; COOPER, CS; ROSA, C; COMOGLIO, PM				GIORDANO, S; DIRENZO, MF; NARSIMHAN, RP; COOPER, CS; ROSA, C; COMOGLIO, PM			BIOSYNTHESIS OF THE PROTEIN ENCODED BY THE C-MET PROTO-ONCOGENE	ONCOGENE			English	Article									UNIV TURIN,DEPT BIOMED SCI & ONCOL,C SO MASSIMO DAZEGLIO 52,I-10126 TURIN,ITALY; INST CANC RES,CHESTER BEATTY LABS,LONDON SW3 6JB,ENGLAND	University of Turin; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK			Giordano, Silvia/J-9858-2018; DI RENZO, Maria Flavia/B-6091-2012	Giordano, Silvia/0000-0003-1854-1086; DI RENZO, Maria Flavia/0000-0002-5093-3373; Comoglio, Paolo/0000-0002-7056-5328				BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHAN AML, 1987, ONCOGENE, V1, P229; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; DEAN M, 1987, MOL CELL BIOL, V7, P921, DOI 10.1128/MCB.7.2.921; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; DEUTSCH PJ, 1983, P NATL ACAD SCI-BIOL, V80, P133, DOI 10.1073/pnas.80.1.133; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; GIORDANO S, 1988, MOL CELL BIOL, V8, P3510, DOI 10.1128/MCB.8.8.3510; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; GOLDSTEIN BJ, 1988, J BIOL CHEM, V263, P12809; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; HEDO JA, 1983, J BIOL CHEM, V258, P20; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OLSON TS, 1987, J BIOL CHEM, V262, P6816; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; RONNETT GV, 1984, J BIOL CHEM, V259, P4566; TEMPEST PR, 1988, BRIT J CANCER, V58, P3, DOI 10.1038/bjc.1988.150; TEMPEST PR, 1986, FEBS LETT, V209, P357, DOI 10.1016/0014-5793(86)81142-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	23	234	244	1	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1383	1388						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554238				2022-12-28	WOS:A1989AX65900016
J	TSUCHIE, H; CHANG, CHW; YOSHIDA, M; VOGT, PK				TSUCHIE, H; CHANG, CHW; YOSHIDA, M; VOGT, PK			A NEWLY ISOLATED AVIAN-SARCOMA VIRUS, ASV-1, CARRIES THE CRK ONCOGENE	ONCOGENE			English	Article									UNIV SO CALIF,SCH MED,NORRIS CANC CTR,2011 ZONAL AVE,HMR 401,LOS ANGELES,CA 90033; NATL INST HLTH,AIDS RES CTR,DIV AIDS VIRUS,MUSASHI MURAYAMA,TOKYO 19012,JAPAN; UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033; JAPANESE FDN CANC RES,INST CANC,DEPT VIRAL ONCOL,TOKYO 170,JAPAN	University of Southern California; University of Southern California; Japanese Foundation for Cancer Research			Vogt, Peter K./R-7547-2019	Vogt, Peter K./0000-0002-4519-7500	NATIONAL CANCER INSTITUTE [R35CA042564] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42564] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BISTER K, 1977, VIROLOGY, V82, P431, DOI 10.1016/0042-6822(77)90017-4; Burk D, 1941, J NATL CANCER I, V2, P201; CAVALIERI F, 1985, VIROLOGY, V143, P680, DOI 10.1016/0042-6822(85)90412-X; CLAUDE A, 1947, CANCER RES, V7, P421; DELORBE WJ, 1980, J VIROL, V36, P50, DOI 10.1128/JVI.36.1.50-61.1980; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; Maniatis T., 1982, MOL CLONING; MAYER BJ, 1988, COLD SPRING HARB SYM, V53, P907, DOI 10.1101/SQB.1988.053.01.104; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; Murphy JB, 1931, SCIENCE, V74, P180, DOI 10.1126/science.74.1911.180; PALESE P, 1976, J VIROL, V17, P876, DOI 10.1128/JVI.17.3.876-884.1976; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHANK PR, 1978, J VIROL, V25, P104, DOI 10.1128/JVI.25.1.104-104.1978; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; VANBEVEREN C, 1985, RNA TUMOR VIRUSES; Vogt PK, 1969, FUNDAMENTAL TECHNIQU, P198	19	43	43	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1989	4	11					1281	1284						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AX659	2554234				2022-12-28	WOS:A1989AX65900002
J	COLLEDGE, WH; GEBHARDT, A; EDGE, MD; BELL, JC				COLLEDGE, WH; GEBHARDT, A; EDGE, MD; BELL, JC			ANALYSIS OF A-MULV TRANSFORMED FIBROBLAST LINES FOR AMPLIFICATION OF THE C-MYC, P53 AND C-FOS NUCLEAR PROTO-ONCOGENES	ONCOGENE			English	Article									NATL INST MED RES,EUKARYOT MOLEC GENET LAB,LONDON NW7 1AA,ENGLAND; ICI PHARMACEUT,DIV BIOTECHNOL,ALDERLEY PK SK10 5TG,CHESHIRE,ENGLAND; MCGILL UNIV,DEPT BIOCHEM,MONTREAL H36 1Y6,QUEBEC,CANADA	MRC National Institute for Medical Research; McGill University			Colledge, William/X-4976-2019	Colledge, William/0000-0002-9603-4429				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; GEBHARDT A, 1986, EMBO J, V5, P2191, DOI 10.1002/j.1460-2075.1986.tb04483.x; GOFF SP, 1982, J VIROL, V41, P271, DOI 10.1128/JVI.41.1.271-285.1982; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; HEIGHWAY J, 1986, BRIT J CANCER, V53, P285, DOI 10.1038/bjc.1986.47; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; MCKAY IA, 1986, MOL CELL BIOL, V6, P3382, DOI 10.1128/MCB.6.10.3382; NEPVEU A, 1985, NATURE, V317, P440, DOI 10.1038/317440a0; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; RABBITTS TH, 1983, NATURE, V306, P760, DOI 10.1038/306760a0; ROSENBERG N, 1980, J VIROL, V33, P340, DOI 10.1128/JVI.33.1.340-348.1980; ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980; SCHER CD, 1975, NATURE, V253, P729, DOI 10.1038/253729a0; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; ZIEGLER SF, 1981, CELL, V27, P477, DOI 10.1016/0092-8674(81)90389-5	31	4	4	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1989	4	6					753	757						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2543944				2022-12-28	WOS:A1989AA66000011
J	KLEMENZ, R; HOFFMANN, S; JAGGI, R; WERENSKIOLD, AK				KLEMENZ, R; HOFFMANN, S; JAGGI, R; WERENSKIOLD, AK			THE V-MOS AND C-HA-RAS ONCOPROTEINS EXERT SIMILAR EFFECTS ON THE PATTERN OF PROTEIN-SYNTHESIS	ONCOGENE			English	Article									LUDWIG INST CANC RES, CH-3010 BERN, SWITZERLAND	Ludwig Institute for Cancer Research								ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; HIROMI Y, 1985, EMBO J, V4, P1681, DOI 10.1002/j.1460-2075.1985.tb03837.x; HUANG AL, 1981, CELL, V27, P245, DOI 10.1016/0092-8674(81)90408-6; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; IVARIE RD, 1978, CELL, V13, P41, DOI 10.1016/0092-8674(78)90136-8; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; KARLIK CC, 1984, CELL, V38, P711, DOI 10.1016/0092-8674(84)90266-6; KINGSTON RE, 1984, NATURE, V312, P280, DOI 10.1038/312280a0; KLOETZER WS, 1983, P NATL ACAD SCI-BIOL, V80, P412, DOI 10.1073/pnas.80.2.412; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MASON PJ, 1984, MOL GEN GENET, V194, P73, DOI 10.1007/BF00383500; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MCKAY IA, 1986, EMBO J, V5, P2617, DOI 10.1002/j.1460-2075.1986.tb04542.x; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NEVINS JR, 1982, CELL, V29, P913, DOI 10.1016/0092-8674(82)90453-6; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OMAR RA, 1984, CANCER RES, V44, P3976; PAPKOFF J, 1983, CELL, V33, P161, DOI 10.1016/0092-8674(83)90345-8; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; SANTAREN JF, 1986, EMBO J, V5, P877, DOI 10.1002/j.1460-2075.1986.tb04298.x; SANTAREN JF, 1987, EXP CELL RES, V168, P494, DOI 10.1016/0014-4827(87)90022-X; SINGH B, 1986, VIROLOGY, V152, P502, DOI 10.1016/0042-6822(86)90156-X; SIROTKIN K, 1982, DEV BIOL, V89, P196, DOI 10.1016/0012-1606(82)90307-4; SIROTKIN K, 1982, HEAT SHOCK BACTERIA, P69; ZIMMERMAN JL, 1983, CELL, V32, P1161	36	19	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	1989	4	6					799	803						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AA660	2525241				2022-12-28	WOS:A1989AA66000017
J	KUSHTAI, G; BARZILAY, J; FELDMAN, M; EISENBACH, L				KUSHTAI, G; BARZILAY, J; FELDMAN, M; EISENBACH, L			THE C-FOS PROTO-ONCOGENE IN MURINE 3LL CARCINOMA CLONES CONTROLS THE EXPRESSION OF MHC GENES	ONCOGENE			English	Article									WEIZMANN INST SCI, DEPT CELL BIOL, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science				Eisenbach, Lea R/0000-0002-4816-1968	NATIONAL CANCER INSTITUTE [R01CA028139] Funding Source: NIH RePORTER; NCI NIH HHS [CA 28139] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARZILAY J, 1987, LEUKEMIA, V1, P198; BERNARDS R, 1986, CELL, V47, P667, DOI 10.1016/0092-8674(86)90509-X; BISHOP JM, 1985, TRENDS GENET, V1, P245, DOI 10.1016/0168-9525(85)90094-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COCHRAN BH, 1984, SCIENCE, V226, P1080, DOI 10.1126/science.6093261; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1983, MOL CELL BIOL, V3, P914, DOI 10.1128/MCB.3.5.914; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1985, MOL CELL BIOL, V5, P167, DOI 10.1128/MCB.5.1.167; DANIEL F, 1983, EMBO J, V2, P1061, DOI 10.1002/j.1460-2075.1983.tb01546.x; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; EISENBACH L, 1985, TRANSPLANT P, V17, P729; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; EISENBACH L, 1984, INT J CANCER, V34, P567, DOI 10.1002/ijc.2910340421; EISENBACH L, 1986, Cancer Reviews, V5, P1; EISENBACH L, 1986, BIOCH MOL GENETICS C, P167; EISENBACH L, 1986, EXPT MODALITIES CONT, P81; EISENBACH L, 1987, IN PRESS CANCER META; FELDMAN M, 1987, IN PRESS CANCER META; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HOLT JT, 1986, P NATL ACAD SCI USA, V83, P4794, DOI 10.1073/pnas.83.13.4794; ISAKOV N, 1983, J NATL CANCER I, V71, P139; KNOWLES BB, 1980, NATURE, V288, P615, DOI 10.1038/288615a0; KRESS M, 1983, NATURE, V306, P602, DOI 10.1038/306602a0; KRESS M, 1983, J BIOL CHEM, V258, P3929; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LALANNE JL, 1983, NUCLEIC ACIDS RES, V11, P1567, DOI 10.1093/nar/11.5.1567; LEW AM, 1986, P NATL ACAD SCI USA, V83, P6084, DOI 10.1073/pnas.83.16.6084; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; MASON I, 1985, DIFFERENTIATION, V30, P76, DOI 10.1111/j.1432-0436.1985.tb00516.x; MILBRANDT J, 1986, P NATL ACAD SCI USA, V83, P4789, DOI 10.1073/pnas.83.13.4789; MILLER AD, 1984, CELL, V36, P51; MITCHELL RL, 1986, CELL, V45, P497, DOI 10.1016/0092-8674(86)90281-3; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MULLER R, 1986, EMBO J, V5, P311, DOI 10.1002/j.1460-2075.1986.tb04214.x; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; MULLER R, 1984, NATURE, V311, P438, DOI 10.1038/311438a0; MULLER R, 1985, NATURE, V314, P546, DOI 10.1038/314546a0; MULLER R, 1985, BIOCHIM BIOPHYS ACTA, V823, P207; MULLER R, 1984, EMBO J, V3, P1887, DOI 10.1002/j.1460-2075.1984.tb02063.x; MULLER R, 1983, EMBO J, V2, P679, DOI 10.1002/j.1460-2075.1983.tb01484.x; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; OZATO K, 1981, J IMMUNOL, V126, P317; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; SETOYAMA C, 1986, P NATL ACAD SCI USA, V83, P3213, DOI 10.1073/pnas.83.10.3213; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; VERMA IM, 1986, TRENDS GENET, V2, P93, DOI 10.1016/0168-9525(86)90191-5; VERRIER B, 1986, EMBO J, V5, P913, DOI 10.1002/j.1460-2075.1986.tb04303.x; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WEINBERGER C, 1985, NATURE, V318, P670, DOI 10.1038/318670a0; WEISS EH, 1983, NATURE, V301, P671, DOI 10.1038/301671a0; ZULLO JN, 1985, CELL, V43, P793, DOI 10.1016/0092-8674(85)90252-1	62	33	36	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1988	2	2					119	127						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	M0860	2453011				2022-12-28	WOS:A1988M086000004
J	SAKAMOTO, KM; BARDELEBEN, C; YATES, KE; RAINES, MA; GOLDE, DW; GASSON, JC				SAKAMOTO, KM; BARDELEBEN, C; YATES, KE; RAINES, MA; GOLDE, DW; GASSON, JC			5' UPSTREAM SEQUENCE AND GENOMIC STRUCTURE OF THE HUMAN PRIMARY RESPONSE GENE, EGR-1 TIS8	ONCOGENE			English	Note							COLONY-STIMULATING FACTOR; ZINC FINGER PROTEIN; NERVE GROWTH-FACTOR; WILMS-TUMOR LOCUS; C-FOS; BINDING DOMAINS; CELLS; IDENTIFICATION; EXPRESSION; ENCODES	EGR-1/TIS8 is a primary response gene that encodes a zinc finger containing protein and is induced in a number of cell types by a variety of ligands. We have isolated and mapped the human EGR-1/TIS8 gene and sequenced the 5' upstream flanking region. A 'TATA' homology and several putative regulatory elements, including two Sp1 sites, five serum response-like elements, two cAMP response-like elements, an EGR-1 binding site (EBS), and a tetra-decanoyl phorbol acetate (TPA)-responsive element have been identified within 700 nucleotides of the upstream region. We demonstrated that a 500-base pair fragment, which includes several of these possible regulatory sequences, is functional and responsive to TPA in transient transfection assays. A further understanding of the regulation and function of human EGR-1/TIS8 gene expression may provide insight into the mechanisms that control normal and neoplastic proliferation of human cells.	CHILDRENS HOSP, DEPT HEMATOL ONCOL, LOS ANGELES, CA 90054 USA; JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA	Children's Hospital Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	SAKAMOTO, KM (corresponding author), UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, DIV HEMATOL ONCOL, LOS ANGELES, CA 90024 USA.				NCI NIH HHS [CA 32737, CA 40163] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040163, P01CA032737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABBOUD CN, 1981, BLOOD, V58, P1148; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; CHO KO, 1989, MOL CELL BIOL, V9, P135, DOI 10.1128/MCB.9.1.135; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; GORMAN CM, 1982, MOL CELL BIOL, V8, P1979; HERSCHMAN HR, 1989, TRENDS BIOCHEM SCI, V14, P455, DOI 10.1016/0968-0004(89)90105-9; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIM RW, 1987, ONCOGENE, V1, P263; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORRIS CHT, 1988, NUCLEIC ACIDS RES, V16, P8835, DOI 10.1093/nar/16.18.8835; NIMER SD, 1988, MOL CELL BIOL, V8, P1979, DOI 10.1128/MCB.8.5.1979; ORLOFSKY A, 1987, EMBO J, V6, P2947, DOI 10.1002/j.1460-2075.1987.tb02599.x; PETERLIN BM, 1986, P NATL ACAD SCI USA, V83, P9734, DOI 10.1073/pnas.83.24.9734; RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209; SUGGS SV, 1990, NUCLEIC ACIDS RES, V18, P4283, DOI 10.1093/nar/18.14.4283; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SVETMOLDAVSKY GJ, 1980, EXP HEMATOL S7, V8, P76; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; VERMA IM, 1987, ADV CANCER RES, V49, P29, DOI 10.1016/S0065-230X(08)60793-9; WATERS CM, 1990, ONCOGENE, V5, P669; WRIGHT JJ, 1990, SCIENCE, V248, P588, DOI 10.1126/science.2110381	34	107	112	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	1991	6	5					867	871						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GT825	2052361				2022-12-28	WOS:A1991GT82500025
J	GARCIA, A; LAMONTAGNE, K; REAVIS, D; STOBERGRASSER, U; LIPSICK, JS				GARCIA, A; LAMONTAGNE, K; REAVIS, D; STOBERGRASSER, U; LIPSICK, JS			DETERMINANTS OF SEQUENCE-SPECIFIC DNA-BINDING BY P48V-MYB	ONCOGENE			English	Article							V-MYB ONCOGENE; AVIAN-MYELOBLASTOSIS VIRUS; AMINO-TERMINAL REGION; ENCODED PROTEIN DETECT; C-MYB; NUCLEOTIDE-SEQUENCE; TRANS-ACTIVATION; GENE-EXPRESSION; LEUKEMIA-VIRUS; ZEA-MAYS	The v-myb oncogene of the avian myeloblastosis virus encodes a nuclear protein, p48v-myb, which binds to DNA in a sequence-specific manner. We have used wild type and mutant forms of this protein expressed in E. coli to study the protein and DNA determinants for sequence-specific DNA-binding. We have shown that only the highly conserved domain at the amino terminus of p48v-myb is required for sequence-specific DNA-binding. However, neither of the tandem 50 amino acid repeats present in this domain is alone sufficient for such binding. We have also demonstrated that p48v-myb can recognize a single consensus myb binding site and appears to interact with DNA as a protein monomer. In addition, we have shown that sequence-specific binding by p48v-myb requires nucleotides which flank the previously reported PyAAC(T)/(G)G consensus.	SUNY STONY BROOK,SCH MED,DEPT MICROBIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [P01CA028146, R01CA043592, K04CA001457] Funding Source: NIH RePORTER; NCI NIH HHS [K04 CA-01457, R01 CA-43592, P01 CA-28146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADING H, 1987, ONCOGENE, V1, P395; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1984, P NATL ACAD SCI-BIOL, V81, P4265, DOI 10.1073/pnas.81.14.4265; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DURBAN EM, 1981, J VIROL, V37, P488, DOI 10.1128/JVI.37.1.488-492.1981; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; GERONDAKIS S, 1986, MOL CELL BIOL, V6, P3677, DOI 10.1128/MCB.6.11.3677; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HOWE KM, 1990, EMBO J, V9, P161, DOI 10.1002/j.1460-2075.1990.tb08092.x; IBANEZ CE, 1988, J VIROL, V62, P1981, DOI 10.1128/JVI.62.6.1981-1988.1988; IBANEZ CE, 1988, J VIROL, V62, P4398, DOI 10.1128/JVI.62.11.4398-4402.1988; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; LANE T, 1990, MOL CELL BIOL, V10, P2591, DOI 10.1128/MCB.10.6.2591; Lipsick J S, 1986, Gene Amplif Anal, V4, P73; LIPSICK JS, 1986, J VIROL, V59, P267, DOI 10.1128/JVI.59.2.267-275.1986; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MAROCCO A, 1989, MOL GEN GENET, V216, P183, DOI 10.1007/BF00334354; MCMAHON J, 1988, ONCOGENE, V3, P717; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MOSCOVICI C, 1981, VIROLOGY, V113, P765, DOI 10.1016/0042-6822(81)90205-1; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; RALSTON R, 1983, NATURE, V306, P803, DOI 10.1038/306803a0; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; SLAMON DJ, 1986, SCIENCE, V233, P347, DOI 10.1126/science.3014652; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	43	46	47	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					265	273						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000220				2022-12-28	WOS:A1991FZ13400012
J	VISVADER, J; BEGLEY, CG; ADAMS, JM				VISVADER, J; BEGLEY, CG; ADAMS, JM			DIFFERENTIAL EXPRESSION OF THE LYL, SCL AND E2A HELIX-LOOP-HELIX GENES WITHIN THE HEMATOPOIETIC SYSTEM	ONCOGENE			English	Article							T-CELL LEUKEMIA; DNA-BINDING MOTIF; CHROMOSOMAL TRANSLOCATION; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTOR; HEMATOPOIETIC-CELLS; ENHANCER BINDING; MESSENGER-RNA; PROTEIN; MYC	The helix-loop-helix genes LYL, SCL and E2A are associated with chromosome translocations found in human lymphoid leukemias. To establish their hematopoietic expression patterns, we have isolated murine LYL and SCL cDNA clones and investigated the expression of all three genes by Northern blot analysis of 58 murine hemopoietic cell lines and tissues. The nucleotide sequences of LYL cDNA clones revealed alternative 5' untranslated sequences and differential splicing within the 5' portion of the coding region that may produce a LYL polypeptide lacking an N-terminal segment. The LYL gene was expressed in most myeloid, erythroid and B lymphocyte cell lines and displayed two alternative size classes of transcripts, the smaller size class (1.5-1.8 kb) being typical of the erythroid lineage and the larger class (2.0-2.3 kb) of the B cell lineage. These two size classes were found to differ in the 5' untranslated region. Thus, expression of the LYL gene appears to be differentially regulated in different hemopoietic cell types. In contrast, the E2A gene was expressed throughout the hemopoietic compartment as a single dominant transcript (3.5 kb). SCL expression was restricted to erythroid, mast and early myeloid cell lines, and the level of SCL transcripts (3.0 and 4.7 kb species) increased markedly during DMSO-induced differentiation of erythroleukemia cells. Hence the SCL gene product may be an important regulatory factor for the erythroid lineage. The low or undetectable expression of both SCL and LYL in most T lymphoid cell sources is consistent with the view that the translocations of these genes in human T cell leukemias alter their normal regulation and may thereby contribute to neoplasia.			VISVADER, J (corresponding author), ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3050, AUSTRALIA.		Adams, Jerry M/E-1199-2013	Adams, Jerry/0000-0002-4360-8628	NATIONAL CANCER INSTITUTE [R01CA012421] Funding Source: NIH RePORTER; NCI NIH HHS [CA12421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410; ANDRE C, 1989, ONCOGENE, V4, P1047; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BERNARD O, 1990, GENE CHROMOSOME CANC, V1, P194, DOI 10.1002/gcc.2870010303; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CULVENOR JG, 1981, J IMMUNOL, V126, P1974; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; HAMILTON JA, 1988, BLOOD, V71, P1574; HARRIS AW, 1988, CURR TOP MICROBIOL, V141, P82; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kelso A, 1989, GROWTH FACTORS, V1, P165, DOI 10.3109/08977198909029126; Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MELLENTIN JD, 1989, SCIENCE, V246, P379, DOI 10.1126/science.2799390; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PERKINS A, 1990, IN PRESS P NATL ACAD; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STRASSER A, 1990, IN PRESS NATURE; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8	41	158	160	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1991	6	2					187	194						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000219				2022-12-28	WOS:A1991FZ13400002
J	PUNYAMMALEE, B; CRABEEL, M; DELANNOY, C; PERBAL, B; GLANSDORFF, N				PUNYAMMALEE, B; CRABEEL, M; DELANNOY, C; PERBAL, B; GLANSDORFF, N			2 C-MYB PROTEINS DIFFERING BY THEIR AMINOTERMINI EXHIBIT DIFFERENT TRANSCRIPTIONAL TRANSACTIVATION ACTIVITIES - YEAST REPORTER-EFFECTOR SYSTEM	ONCOGENE			English	Article							AVIAN-MYELOBLASTOSIS VIRUS; DNA-BINDING ACTIVITY; GENE V-MYB; NUCLEOTIDE-SEQUENCE; PROTO-ONCOGENE; SACCHAROMYCES-CEREVISIAE; TRANSFORMING GENE; MESSENGER-RNA; CHICKEN DNA; PLASMACYTOID LYMPHOSARCOMAS	We assayed in the yeast S. cerevisiae the transcriptional transactivation activity of the c-myb products encoded by a normal thymus cDNA and of an aminoterminally truncated version of it (minus 58 amino acids) corresponding to the cDNAs isolated from lymphoma and leukemia cells from different origins. Both proto-oncogene products were expressed under the control of the galactose inducible GAL10 promoter. The reporter system used to monitor the transactivation potential of the myb products consisted of a CYCl-lacZ gene fusion in which the UAS(cyc) signals were replaced by one or multiple copies of the myb recognition element (mRE). As shown by Northern blot analyses and by primer extension experiments both c-myb products increase the level of beta-galactosidase transcription. Interestingly, the c-myb product corresponding to lymphoma cDNAs stimulates transcription four to five times more efficiently than does the normal thymic c-myb product.	VRIJE UNIV BRUSSELS,COOVI,CERIA,RES INST,1 E GRYSONLAAN,B-1070 BRUSSELS,BELGIUM; UNIV PARIS 06,F-75230 PARIS 05,FRANCE; CTR UNIV ORSAY,INST CURIE,F-91405 ORSAY,FRANCE	Vrije Universiteit Brussel; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay								BADING H, 1987, ONCOGENE, V1, P395; BALUDA MA, 1983, FOLIA BIOL-PRAGUE, V29, P18; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BERGMAN DG, 1980, J VIROL, V40, P450; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1985, MOL CELL BIOL, V5, P3017, DOI 10.1128/MCB.5.11.3017; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; Broach J. R., 1983, EXPT MANIPULATION GE, P83; CHEN JH, 1980, J VIROL, V36, P162, DOI 10.1128/JVI.36.1.162-170.1980; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; GERONDAKIS S, 1986, MOL CELL BIOL, V6, P3677, DOI 10.1128/MCB.6.11.3677; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1988, ONCOGENE, V2, P545; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; KRUYS VI, 1988, GENE, V72, P191, DOI 10.1016/0378-1119(88)90144-8; LAVU S, 1986, NUCLEIC ACIDS RES, V14, P5309, DOI 10.1093/nar/14.13.5309; MA J, 1987, CELL, V51, P13; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MCMAHON J, 1988, ONCOGENE, V3, P717; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; Miller J.H., 1972, EXPT MOL GENETICS; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; NAKAGOSHI H, 1989, NUCLEIC ACIDS RES, V17, P7315, DOI 10.1093/nar/17.18.7315; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; PELLICI PG, 1986, SCIENCE, V224, P1117; PERBAL B, 1983, J VIROL, V45, P925, DOI 10.1128/JVI.45.3.925-940.1983; PERBAL B, 1982, J VIROL, V44, P586, DOI 10.1128/JVI.44.2.586-594.1982; PERBAL B, 1982, J VIROL, V41, P250, DOI 10.1128/JVI.41.1.250-257.1982; Perbal B., 1988, PRACTICAL GUIDE MOL; RAMOS F, 1979, EUR J BIOCHEM, V94, P409, DOI 10.1111/j.1432-1033.1979.tb12908.x; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380; SPRAGUE J, 1983, J VIROL, V45, P773, DOI 10.1128/JVI.45.2.773-781.1983; SSAMBROOK J, 1988, MOL CLONING LABORATO; STRICKLAND S, 1988, SCIENCE, V241, P680, DOI 10.1126/science.2456615; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WEINSTEIN Y, 1987, J VIROL, V61, P2339, DOI 10.1128/JVI.61.7.2339-2343.1987; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	63	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					11	19						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992438				2022-12-28	WOS:A1991EY03900002
J	KUGOH, HM; HASHIBA, H; SHIMIZU, M; OSHIMURA, M				KUGOH, HM; HASHIBA, H; SHIMIZU, M; OSHIMURA, M			SUGGESTIVE EVIDENCE FOR FUNCTIONALLY DISTINCT, TUMOR-SUPPRESSOR GENES ON CHROMOSOME-1 AND CHROMOSOME-11 FOR A HUMAN FIBROSARCOMA CELL-LINE, HT1080	ONCOGENE			English	Article									TOTTORI UNIV,FAC MED,SCH LIFE SCI,DEPT MOLEC & CELL GENET,NISHIMACHI 86,YONAGO,TOTTORI 683,JAPAN; KANAGAWA CANC CTR,RES INST,CELL BIOL LAB,ASAHI KU,YOKOHAMA 241,JAPAN	Tottori University; Kanagawa Prefectural Cancer Center								ATKIN NB, 1979, CANCER, V44, P604, DOI 10.1002/1097-0142(197908)44:2<604::AID-CNCR2820440230>3.0.CO;2-G; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P279, DOI 10.1016/0165-4608(86)90206-2; BENEDICT WF, 1984, CANCER RES, V44, P3471; BRODEUR GM, 1981, CANCER RES, V41, P4678; COWELL JK, 1989, HUM GENET, V82, P123, DOI 10.1007/BF00284042; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; FOURNIER REK, 1977, P NATL ACAD SCI USA, V74, P319, DOI 10.1073/pnas.74.1.319; GENUARDI M, 1989, AM J HUM GENET, V45, P73; GODDARD AD, 1988, MOL CELL BIOL, V8, P2082, DOI 10.1128/MCB.8.5.2082; HARPER ME, 1981, P NATL ACAD SCI-BIOL, V78, P4458, DOI 10.1073/pnas.78.7.4458; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; KLEIN G, 1971, J CELL SCI, V8, P659; KOI M, 1989, JPN J CANCER RES, V80, P413, DOI 10.1111/j.1349-7006.1989.tb02329.x; KOI M, 1989, MOL CARCINOGEN, V2, P12, DOI 10.1002/mc.2940020103; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; KUGOH MH, 1989, CHROMOSOME INFORMATI, V46, P25; MATHEW CGP, 1987, NATURE, V328, P524, DOI 10.1038/328524a0; MITELMAN F, 1985, PROGR TOPICS CYTOGEN, V5; OSHIMURA M, 1988, CANCER RES, V48, P1623; OSHIMURA M, 1985, NATURE, V316, P636, DOI 10.1038/316636a0; OSHIMURA M, 1990, J CELL BIOCHEM, V42, P135, DOI 10.1002/jcb.240420304; PATERSON H, 1987, CELL, V51, P803, DOI 10.1016/0092-8674(87)90103-6; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; SANDBERG AA, 1988, CANCER RES, V48, P1049; SAXON PJ, 1986, EMBO J, V5, P3461, DOI 10.1002/j.1460-2075.1986.tb04670.x; SHIMIZU M, 1990, ONCOGENE, V5, P185; SRIVATSAN ES, 1986, CANCER RES, V46, P6174; STANBRIDGE EJ, 1981, SOMAT CELL GENET, V7, P699, DOI 10.1007/BF01538758; STANBRIDGE EJ, 1978, P NATL ACAD SCI USA, V75, P1466, DOI 10.1073/pnas.75.3.1466; STANBRIDGE EJ, 1976, NATURE, V260, P17, DOI 10.1038/260017a0; STOLER A, 1985, P NATL ACAD SCI USA, V82, P570, DOI 10.1073/pnas.82.2.570; SUGAWARA O, 1990, SCIENCE, V247, P707, DOI 10.1126/science.2300822; THAKKER RV, 1989, NEW ENGL J MED, V321, P218, DOI 10.1056/NEJM198907273210403; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WEISSMAN BE, 1987, SCIENCE, V236, P175, DOI 10.1126/science.3031816; YAMADA H, IN PRESS ONCOGENE; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	39	56	56	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1637	1644						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267132				2022-12-28	WOS:A1990EL40100004
J	STEINMEYER, K; MAACKE, H; DEPPERT, W				STEINMEYER, K; MAACKE, H; DEPPERT, W			CELL-CYCLE CONTROL BY P53 IN NORMAL (3T3) AND CHEMICALLY TRANSFORMED (METH-A) MOUSE CELLS .1. REGULATION OF P53 EXPRESSION	ONCOGENE			English	Article									UNIV HAMBURG,HEINRICH PETTE INST EXPTL VIROL & IMMUNOL,MARTINISTR 52,W-2000 HAMBURG 13,GERMANY	Heinrich Pette Institute; University of Hamburg								AARONSON SA, 1968, J CELL PHYSIOL, V72, P141, DOI 10.1002/jcp.1040720208; ARAI N, 1986, MOL CELL BIOL, V6, P3232, DOI 10.1128/MCB.6.9.3232; BASERGA R, 1985, BIOL CELL REPRODUCTI; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P159; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; COOPER JL, 1985, J CELL PHYSIOL, V124, P433, DOI 10.1002/jcp.1041240311; DELEO AB, 1977, J EXP MED, V146, P720, DOI 10.1084/jem.146.3.720; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DENHARDT DT, 1986, BIOCHIM BIOPHYS ACTA, V865, P83, DOI 10.1016/0304-419X(86)90024-7; DEPPERT W, 1986, MOL CELL BIOL, V6, P2233, DOI 10.1128/MCB.6.6.2233; ELIYAHU D, 1988, ONCOGENE, V3, P313; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; GRONOSTAJSKI RM, 1984, MOL CELL BIOL, V4, P442, DOI 10.1128/MCB.4.3.442; GURNEY EG, 1980, J VIROL, V34, P752, DOI 10.1128/JVI.34.3.752-763.1980; HOLLEY RW, 1975, NATURE, V258, P487, DOI 10.1038/258487a0; JENKINS JR, 1984, NUCLEIC ACIDS RES, V12, P5609, DOI 10.1093/nar/12.14.5609; JENKINS JR, 1988, ONCOGENE HDB, P403; KACZMAREK L, 1986, EXP CELL RES, V132, P105; KOHN A, 1975, EXP CELL RES, V94, P15, DOI 10.1016/0014-4827(75)90526-1; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERCER WE, 1985, EXP CELL RES, V160, P31, DOI 10.1016/0014-4827(85)90233-2; MERCER WE, 1982, P NATL ACAD SCI-BIOL, V79, P6309, DOI 10.1073/pnas.79.20.6309; MILNER J, 1981, VIROLOGY, V112, P785, DOI 10.1016/0042-6822(81)90327-5; NIKAIDO T, 1989, EXP CELL RES, V182, P284, DOI 10.1016/0014-4827(89)90299-1; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; OREN M, 1985, BIOCHIM BIOPHYS ACTA, V823, P67, DOI 10.1016/0304-419X(85)90015-0; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; PATSCHINSKY T, 1990, ONCOGENE, V5, P1071; PINHASIKIMHI O, 1986, NATURE, V320, P182, DOI 10.1038/320182a0; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROSS F, 1989, ANN REV CELL BIOL, V5, P341; SHOHAT O, 1987, ONCOGENE, V1, P277; SKINNER MK, 1983, BIOCHEM J, V209, P281, DOI 10.1042/bj2090281; STAUFENBIEL M, 1983, CELL, V33, P173, DOI 10.1016/0092-8674(83)90346-X; STEINMEYER K, 1988, ONCOGENE, V3, P501; Tobey R A, 1973, Methods Cell Biol, V6, P67, DOI 10.1016/S0091-679X(08)60048-5; TOBEY RA, 1970, J CELL BIOL, V46, P151, DOI 10.1083/jcb.46.1.151; WYNFORDTHOMAS D, 1985, EXP CELL RES, V159, P191, DOI 10.1016/S0014-4827(85)80048-3; YEN A, 1978, EXP CELL RES, V114, P389, DOI 10.1016/0014-4827(78)90497-4	44	64	64	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1691	1699						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	2267135				2022-12-28	WOS:A1990EL40100012
J	MANGUES, R; SEIDMAN, I; PELLICER, A; GORDON, JW				MANGUES, R; SEIDMAN, I; PELLICER, A; GORDON, JW			TUMORIGENESIS AND MALE-STERILITY IN TRANSGENIC MICE EXPRESSING A MMTV-N-RAS ONCOGENE	ONCOGENE			English	Article									NYU MED CTR, DEPT PATHOL, NEW YORK, NY 10016 USA; NYU MED CTR, KAPLAN CANC CTR, NEW YORK, NY 10016 USA; CUNY MT SINAI SCH MED, CTR MOLEC BIOL, DEPT GERIATR & ADULT DEV, NEW YORK, NY 10029 USA; CUNY MT SINAI SCH MED, DEPT OBSTET & GYNECOL & REPROD SCI, NEW YORK, NY 10029 USA	New York University; New York University; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai				Mangues, Ramon/0000-0003-2661-9525; Pellicer, Angel/0000-0002-5062-0692	NATIONAL CANCER INSTITUTE [R01CA042103, P01CA016239, R37CA036327, R01CA036327] Funding Source: NIH RePORTER; NCI NIH HHS [CA 36327, CA 16239, CA 42103] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARDIN CW, 1981, ANNU REV PHYSIOL, V43, P189; BOS JL, 1988, MUTAT RES, V195, P255, DOI 10.1016/0165-1110(88)90004-8; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOI YW, 1987, J VIROL, V61, P3013, DOI 10.1128/JVI.61.10.3013-3019.1987; DARBRE P, 1986, MOL CELL BIOL, V6, P2847, DOI 10.1128/MCB.6.8.2847; DEFEO D, 1981, P NATL ACAD SCI-BIOL, V78, P3328, DOI 10.1073/pnas.78.6.3328; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GORDON JW, 1986, MOL CELL BIOL, V6, P2158, DOI 10.1128/MCB.6.6.2158; GORDON JW, 1986, J EXP ZOOL, V239, P347, DOI 10.1002/jez.1402390306; GORDON JW, 1983, METHOD ENZYMOL, V101, P411; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; GUERRERO I, 1984, SCIENCE, V225, P1041, DOI 10.1126/science.6089339; GUERRERO I, 1988, BIOCHEM BIOPH RES CO, V150, P1185, DOI 10.1016/0006-291X(88)90754-1; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; OTTEN AD, 1988, MOL ENDOCRINOL, V2, P143, DOI 10.1210/mend-2-2-143; QUINN P, 1982, J REPROD FERTIL, V66, P161; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P383, DOI 10.1073/pnas.80.2.383; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; THADANI VM, 1982, J EXP ZOOL, V219, P277, DOI 10.1002/jez.1402190303; TREMBLAY PJ, 1989, MOL CELL BIOL, V9, P854, DOI 10.1128/MCB.9.2.854; Yanagimachi R., 1981, FERTILIZATION EMBRYO, P81	29	46	47	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT	1990	5	10					1491	1497						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	2174525				2022-12-28	WOS:A1990EK50200007
J	BERENSON, JR; KOGA, H; YANG, J; PEARL, J; HOLMES, EC; FIGLIN, R				BERENSON, JR; KOGA, H; YANG, J; PEARL, J; HOLMES, EC; FIGLIN, R			FREQUENT AMPLIFICATION OF THE BCL-1 LOCUS IN POORLY DIFFERENTIATED SQUAMOUS-CELL CARCINOMA OF THE LUNG	ONCOGENE			English	Article									UNIV CALIF LOS ANGELES,VET ADM MED CTR W LOS ANGELES,SCH MED,CTR HLTH SCI,DEPT SURG,LOS ANGELES,CA 90024; LATTER DAY ST HOSP,DEPT MED,SALT LAKE CITY,UT 84143	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	BERENSON, JR (corresponding author), UNIV CALIF LOS ANGELES,VET ADM MED CTR W LOS ANGELES,SCH MED,CTR HLTH SCI,DEPT MED,LOS ANGELES,CA 90024, USA.							ADELAIDE J, 1988, ONCOGENE, V2, P413; ADNANE J, 1989, ONCOGENE, V4, P1389; ALI IU, 1989, ONCOGENE, V4, P89; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; BERENSON J, 1989, LEUKEMIA, V3, P133; BERENSON J, 1989, J CELL BIOCH B, V13, P80; BERENSON JR, 1989, ONCOGENE, V4, P1111; BERGER MS, 1987, J PATHOL, V152, P297, DOI 10.1002/path.1711520408; BERGER MS, 1988, CANCER RES, V48, P1238; BIRRER MJ, 1988, SEMIN ONCOL, V15, P226; BOS JL, 1989, CANCER RES, V49, P4682; CALLAHAN R, 1989, J CELL BIOCH B, V13, P6; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; CLINE MJ, 1987, CANCER, V60, P2669, DOI 10.1002/1097-0142(19871201)60:11<2669::AID-CNCR2820601116>3.0.CO;2-4; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4834, DOI 10.1073/pnas.83.13.4834; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HATADA I, 1988, ONCOGENE, V3, P537; HEIGHWAY J, 1986, BRIT J CANCER, V53, P285, DOI 10.1038/bjc.1986.47; INCE C, 1988, LEUKEMIA, V2, P343; KAOSHAN CS, 1987, CANCER RES, V47, P6278; KOOP CE, 1986, DHHS CDC878398 US DE; LESTER EP, 1988, P AM ASSOC CANC RES, V29, P28; MARIANICOSTANTINI R, 1988, CANCER RES, V48, P199; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MIYAKI M, 1985, JPN J CANCER RES, V76, P260; MULERIS M, 1987, INT J CANCER, V39, P595, DOI 10.1002/ijc.2910390509; RABBITTS PH, 1988, ONCOGENE, V3, P99; RECHAVI G, 1989, LEUKEMIA, V3, P57; RODENHUIS S, 1988, CANCER RES, V48, P5738; SAKSELA K, 1986, J CELL BIOCHEM, V31, P297, DOI 10.1002/jcb.240310407; SATYAPRAKASH KL, 1981, CANCER GENET CYTOGEN, V3, P61, DOI 10.1016/0165-4608(81)90057-1; SCHNEIDER PM, 1989, CANCER RES, V49, P4968; SCHWAB M, 1990, GENE CHROMOSOME CANC, V1, P181, DOI 10.1002/gcc.2870010302; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SELVANAYAGAM P, 1987, P AM ASSOC CANC RES, V28, P19; SHIRAISHI M, 1987, JPN J CANCER RES, V78, P1302; SILVERBERG E, 1990, CA-CANCER J CLIN, V40, P9, DOI 10.3322/canjclin.40.1.9; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TEDDER TF, 1988, P NATL ACAD SCI USA, V85, P208, DOI 10.1073/pnas.85.1.208; TEDDER TF, 1989, J IMMUNOL, V142, P2555; TSUDA T, 1988, JPN J CANCER RES, V79, P584, DOI 10.1111/j.1349-7006.1988.tb00026.x; TSUDA T, 1989, CANCER RES, V49, P5505; TSUJIMOTO Y, 1984, SCIENCE, V224, P1403, DOI 10.1126/science.6610211; TSUJIMOTO Y, 1985, NATURE, V315, P340, DOI 10.1038/315340a0; TSUTSUMI M, 1988, JPN J CANCER RES, V79, P428, DOI 10.1111/j.1349-7006.1988.tb01609.x; VANDENBERGHE H, 1984, CANCER GENET CYTOGEN, V11, P381, DOI 10.1016/0165-4608(84)90017-7; VARLEY JM, 1988, ONCOGENE, V3, P87; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WUU KD, 1986, CANCER GENET CYTOGEN, V20, P2798; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898; YOKOTA J, 1988, ONCOGENE, V2, P607; YOSHIDA MC, 1988, P NATL ACAD SCI USA, V85, P4861, DOI 10.1073/pnas.85.13.4861; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YOSHIDA T, 1988, BIOCHEM BIOPH RES CO, V155, P1324, DOI 10.1016/S0006-291X(88)81286-5; YOSHIMOTO K, 1986, JPN J CANCER RES, V77, P731; YUNIS JJ, 1984, CANCER GENET CYTOGEN, V13, P17, DOI 10.1016/0165-4608(84)90084-0; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310; ZHOU DJ, 1987, CANCER RES, V47, P6123; ZHOU DJ, 1988, ONCOGENE, V2, P279	60	81	81	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1343	1348						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	2170896				2022-12-28	WOS:A1990EC24100010
J	SHIRSAT, NV; PIGNOLO, RJ; KREIDER, BL; ROVERA, G				SHIRSAT, NV; PIGNOLO, RJ; KREIDER, BL; ROVERA, G			A MEMBER OF THE RAS GENE SUPERFAMILY IS EXPRESSED SPECIFICALLY IN T-CELLS, B-CELLS AND MYELOID HEMATOPOIETIC-CELLS	ONCOGENE			English	Note									WISTAR INST,3601 SPRUCE ST,PHILADELPHIA,PA 19104	The Wistar Institute								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ANDERSON PS, 1987, MOL CELL BIOL, V7, P3620, DOI 10.1128/MCB.7.10.3620; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHARDIN P, 1986, EMBO J, V5, P2203, DOI 10.1002/j.1460-2075.1986.tb04485.x; CHARDIN P, 1988, NUCLEIC ACIDS RES, V16, P2717, DOI 10.1093/nar/16.6.2717; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; GARRETT MD, 1989, J BIOL CHEM, V264, P10; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; KRAUS M, 1981, J CANCER RES CLIN, V100, P149, DOI 10.1007/BF00403364; LOWE DG, 1987, CELL, V48, P137, DOI 10.1016/0092-8674(87)90364-3; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; MEYER WH, 1983, BLOOD, V62, P308; OLOFSSON B, 1988, ONCOGENE, V3, P231; PIZON V, 1988, ONCOGENE, V3, P201; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOUCHOT N, 1987, P NATL ACAD SCI USA, V84, P8210, DOI 10.1073/pnas.84.23.8210; VALTIERI M, 1987, J IMMUNOL, V138, P3829; WOODS D, 1984, FOCUS, V6, P1; YARAMIAN P, 1987, NUCLEIC ACIDS RES, V15, P1869; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; ZAHRAOUI A, 1988, NUCLEIC ACIDS RES, V16, P1204, DOI 10.1093/nar/16.3.1204	27	104	110	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	MAY	1990	5	5					769	772						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG374	2189110				2022-12-28	WOS:A1990DG37400019
J	WAGNER, HE; JOYCE, AD; BEATRICE, K; SUMMERHAYES, IC				WAGNER, HE; JOYCE, AD; BEATRICE, K; SUMMERHAYES, IC			RAS INDUCED LESIONS IN A HETEROTOPIC MOUSE BLADDER	ONCOGENE			English	Article									NEW ENGLAND DEACONESS HOSP, CANC BIOL LAB, 50 BINNEY ST, BOSTON, MA 02215 USA						NATIONAL CANCER INSTITUTE [R23CA042944, P01CA044704, R01CA042944] Funding Source: NIH RePORTER; NCI NIH HHS [CA42944, CA44704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ANDRES AC, 1987, P NATL ACAD SCI USA, V84, P1299, DOI 10.1073/pnas.84.5.1299; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOS JL, 1989, CANCER RES, V49, P4682; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; BURMER GC, 1989, P NATL ACAD SCI USA, V86, P2403, DOI 10.1073/pnas.86.7.2403; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; EDWARDS PAW, 1988, ONCOGENE, V2, P407; FARR CJ, 1988, P NATL ACAD SCI USA, V85, P1629, DOI 10.1073/pnas.85.5.1629; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; FUJITA J, 1985, P NATL ACAD SCI USA, V82, P3849, DOI 10.1073/pnas.82.11.3849; HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x; JOYCE AD, 1988, J UROLOGY, V140, P1067, DOI 10.1016/S0022-5347(17)41928-8; JOYCE AD, 1989, LAB INVEST, V61, P212; LEMOINE NR, 1989, ONCOGENE, V4, P159; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; LIU E, 1987, NATURE, V330, P186, DOI 10.1038/330186a0; NADAKAVUKAREN KK, 1984, DIFFERENTIATION, V27, P209, DOI 10.1111/j.1432-0436.1984.tb01431.x; OHTANI M, 1986, CANCER RES, V46, P2001; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; QUAIFE CJ, 1987, CELL, V48, P1023, DOI 10.1016/0092-8674(87)90710-0; RODENHUIS S, 1987, NEW ENGL J MED, V317, P929, DOI 10.1056/NEJM198710083171504; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STRICKLAND JE, 1988, CANCER RES, V48, P165; SUAREZ HG, 1988, ONCOGENE, V2, P403; SUMMERHAYES IC, 1988, J UROLOGY, V139, P405, DOI 10.1016/S0022-5347(17)42444-X; SUMMERHAYES IC, 1982, CANCER RES, V42, P4098; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; VISVANATHAN KV, 1988, ONCOGENE RES, V3, P77; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	32	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1990	5	4					557	563						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	2183157				2022-12-28	WOS:A1990DB85300015
J	HALL, DJ				HALL, DJ			REGULATION OF C-MYC TRANSCRIPTION INVITRO - DEPENDENCE ON THE GUANINE-RICH PROMOTER ELEMENT ME1A1	ONCOGENE			English	Article									HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School					NCI NIH HHS [CA22042] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022042] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASSELIN C, 1989, ONCOGENE, V4, P549; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BENTLEY D, 1986, NATURE, V231, P702; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BERNARD O, 1983, EMBO J, V2, P2375, DOI 10.1002/j.1460-2075.1983.tb01749.x; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CHUNG J, 1987, CELL, V51, P1001, DOI 10.1016/0092-8674(87)90586-1; CHUNG J, 1986, P NATL ACAD SCI USA, V83, P7918, DOI 10.1073/pnas.83.20.7918; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; DEPINHO RA, 1987, GENE DEV, V1, P1311, DOI 10.1101/gad.1.10.1311; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROSVELD GC, 1981, CELL, V25, P215, DOI 10.1016/0092-8674(81)90246-4; HALL DJ, 1987, J BIOL CHEM, V262, P15302; HALL DJ, 1989, MOL CELL BIOL, V9, P1705, DOI 10.1128/MCB.9.4.1705; HAWLEY DK, 1987, J BIOL CHEM, V262, P3452; HAY N, 1987, GENE DEV, V1, P659, DOI 10.1101/gad.1.7.659; HU SL, 1981, P NATL ACAD SCI-BIOL, V78, P820, DOI 10.1073/pnas.78.2.820; HUANG DH, 1988, MOL CELL BIOL, V8, P1906, DOI 10.1128/MCB.8.5.1906; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; LEE KAW, 1987, P NATL ACAD SCI USA, V84, P8355, DOI 10.1073/pnas.84.23.8355; LIPP M, 1987, MOL CELL BIOL, V7, P1393, DOI 10.1128/MCB.7.4.1393; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MANLEY JL, 1983, METHOD ENZYMOL, V101, P568; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; NISHIKURA K, 1986, MOL CELL BIOL, V6, P4093, DOI 10.1128/MCB.6.11.4093; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REMMERS EF, 1986, EMBO J, V5, P899, DOI 10.1002/j.1460-2075.1986.tb04301.x; SASSONECORSI P, 1981, NUCLEIC ACIDS RES, V9, P3941, DOI 10.1093/nar/9.16.3941; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; WEISINGER G, 1988, ONCOGENE, V3, P635; YANG JQ, 1986, EMBO J, V5, P3553, DOI 10.1002/j.1460-2075.1986.tb04682.x	39	46	46	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1990	5	1					47	54						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CM620	2181377				2022-12-28	WOS:A1990CM62000007
J	HALL, BS; HOFFBRAND, AV; WICKREMASINGHE, RG				HALL, BS; HOFFBRAND, AV; WICKREMASINGHE, RG			AN ENDOGENOUS INHIBITOR OF THE PROTEIN TYROSINE KINASE-ACTIVITY OF NORMAL AND MALIGNANT HUMAN LYMPHOID-CELLS	ONCOGENE			English	Article									ROYAL FREE HOSP,DEPT HAEMATOL,POND ST,LONDON NW3 2QG,ENGLAND; UNIV LONDON,LONDON NW3 2QG,ENGLAND	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London			Hall, Belinda/AGU-6214-2022	Hall, Belinda/0000-0002-3753-1978				AMREIN KE, 1988, P NATL ACAD SCI USA, V85, P4247, DOI 10.1073/pnas.85.12.4247; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; CHENG YSE, 1981, P NATL ACAD SCI-BIOL, V78, P2388, DOI 10.1073/pnas.78.4.2388; DEMAILLE JG, 1977, BIOCHEMISTRY-US, V16, P3080, DOI 10.1021/bi00633a006; ENDO T, 1981, J BIOL CHEM, V256, P2485; HAGIWARA M, 1988, J BIOL CHEM, V263, P6438; HALL BS, 1987, FEBS LETT, V223, P6, DOI 10.1016/0014-5793(87)80499-4; HARDIE G, 1988, NATURE, V335, P592, DOI 10.1038/335592a0; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KANAMORI M, 1982, BIOCHEM BIOPH RES CO, V108, P1447, DOI 10.1016/S0006-291X(82)80069-7; KATAN M, 1988, NATURE, V332, P203, DOI 10.1038/332203a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MIRE AR, 1986, FEBS LETT, V206, P53, DOI 10.1016/0014-5793(86)81339-4; PATEL MD, 1987, J BIOL CHEM, V262, P5831; PIGA A, 1985, EXP CELL RES, V159, P103, DOI 10.1016/S0014-4827(85)80041-0; SWARUP G, 1981, J BIOL CHEM, V256, P8197; THOMPSON ST, 1975, P NATL ACAD SCI USA, V72, P669, DOI 10.1073/pnas.72.2.669; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WICKREMASINGHE RG, 1985, LEUKEMIA RES, V9, P1443, DOI 10.1016/0145-2126(85)90034-7	23	2	2	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1989	4	10					1225	1231						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AU508	2529467				2022-12-28	WOS:A1989AU50800010
J	MITSUNOBU, F; FUKUI, M; ODA, T; YAMAMOTO, T; TOYOSHIMA, K				MITSUNOBU, F; FUKUI, M; ODA, T; YAMAMOTO, T; TOYOSHIMA, K			A MECHANISM OF C-RAF-1 ACTIVATION - FUSION OF THE LIPOCORTIN-II AMINO-TERMINAL SEQUENCE WITH THE C-RAF-1 KINASE DOMAIN	ONCOGENE			English	Article									UNIV TOKYO,INST MED SCI,4-6-1 SHIROKANEDAI,MINATO KU,TOKYO 108,JAPAN; OKAYAMA UNIV,SCH MED,OKAYAMA 700,JAPAN	University of Tokyo; Okayama University			MITSUNOBU, Fumihiro/B-1983-2011					BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P4743; COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125; DAVIS RW, 1982, ADV BACTERIAL GENET, P109; ERIKSON E, 1980, CELL, V21, P829, DOI 10.1016/0092-8674(80)90446-8; FUKUI M, 1985, P NATL ACAD SCI USA, V82, P5954, DOI 10.1073/pnas.82.17.5954; FUKUI M, 1987, MOL CELL BIOL, V7, P1776, DOI 10.1128/MCB.7.5.1776; GLENNEY J, 1986, P NATL ACAD SCI USA, V83, P4258, DOI 10.1073/pnas.83.12.4258; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GLENNEY JR, 1986, J BIOL CHEM, V261, P485; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HUANG KS, 1986, CELL, V46, P191, DOI 10.1016/0092-8674(86)90736-1; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; ISHIKAWA F, 1986, P NATL ACAD SCI USA, V83, P3209, DOI 10.1073/pnas.83.10.3209; JOHNSSON N, 1986, FEBS LETT, V198, P361, DOI 10.1016/0014-5793(86)80437-9; KAWAI S, 1980, J VIROL, V34, P772, DOI 10.1128/JVI.34.3.772-776.1980; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MANIATIS T, 1975, P NATL ACAD SCI USA, V72, P1184, DOI 10.1073/pnas.72.3.1184; MOLDERS H, 1985, EMBO J, V4, P693, DOI 10.1002/j.1460-2075.1985.tb03685.x; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; PEPINSKY RB, 1986, J BIOL CHEM, V261, P4239; RADKE K, 1980, CELL, V21, P821, DOI 10.1016/0092-8674(80)90445-6; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARIS CJM, 1986, CELL, V46, P201, DOI 10.1016/0092-8674(86)90737-3; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIMIZU K, 1985, P NATL ACAD SCI USA, V82, P5641, DOI 10.1073/pnas.82.17.5641; SUTRAVE P, 1984, NATURE, V309, P85, DOI 10.1038/309085a0; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	16	16	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1989	4	4					437	442						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2524024				2022-12-28	WOS:A1989U567700007
J	SMITH, KJ; GALLIMORE, PH; GRAND, RJA				SMITH, KJ; GALLIMORE, PH; GRAND, RJA			THE EXPRESSION OF AD12 E1B 19K PROTEIN ON THE SURFACE OF ADENOVIRUS TRANSFORMED AND INFECTED HUMAN-CELLS	ONCOGENE			English	Article									UNIV BIRMINGHAM, DEPT CANC STUDIES, CANC RES CAMPAIGN LABS, BIRMINGHAM B15 2TJ, W MIDLANDS, ENGLAND	University of Birmingham								BELLGRAU D, 1988, J VIROL, V62, P1513, DOI 10.1128/JVI.62.5.1513-1519.1988; BERK AJ, 1978, CELL, V14, P695, DOI 10.1016/0092-8674(78)90252-0; BOS JL, 1981, CELL, V27, P121, DOI 10.1016/0092-8674(81)90366-4; BUTEL JS, 1986, BIOCHIM BIOPHYS ACTA, V865, P171, DOI 10.1016/0304-419X(86)90027-2; BYRD P, 1982, NATURE, V298, P69, DOI 10.1038/298069a0; BYRD PJ, 1988, ONCOGENE, V2, P477; CHINNADURAI G, 1983, CELL, V33, P759, DOI 10.1016/0092-8674(83)90018-1; COOK JL, 1986, P NATL ACAD SCI USA, V83, P6965, DOI 10.1073/pnas.83.18.6965; DEPPERT W, 1982, VIROLOGY, V122, P56, DOI 10.1016/0042-6822(82)90377-4; DEPPERT W, 1976, P NATL ACAD SCI USA, V73, P2505, DOI 10.1073/pnas.73.7.2505; FATT RBL, 1982, J VIROL, V42, P969, DOI 10.1128/JVI.42.3.969-977.1982; FLINT SJ, 1976, VIROLOGY, V72, P456, DOI 10.1016/0042-6822(76)90174-4; FREEMAN AARON E., 1967, J VIROL, V1, P362; GALLIMORE PH, 1986, ANTICANCER RES, V6, P499; GALLIMORE PH, 1974, J MOL BIOL, V89, P49, DOI 10.1016/0022-2836(74)90162-4; GALLIMORE PH, 1985, CANCER RES, V45, P2670; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRAND RJA, 1985, FEBS LETT, V181, P229, DOI 10.1016/0014-5793(85)80265-9; GRAND RJA, 1987, INT J CANCER, V40, P213, DOI 10.1002/ijc.2910400215; GRAND RJA, 1987, ONCOGENE, V1, P305; GRAND RJA, 1984, J GEN VIROL, V65, P2149, DOI 10.1099/0022-1317-65-12-2149; GRAND RJA, 1986, EMBO J, V5, P1253, DOI 10.1002/j.1460-2075.1986.tb04354.x; GUISO N, 1984, EMBO J, V3, P1769, DOI 10.1002/j.1460-2075.1984.tb02044.x; HERRMANN CH, 1987, ONCOGENE, V2, P25; HUEBNER RJ, 1962, P NATL ACAD SCI USA, V48, P2051, DOI 10.1073/pnas.48.12.2051; JING S, 1987, EMBO J, V6, P327, DOI 10.1002/j.1460-2075.1987.tb04758.x; KLOCKMANN U, 1983, EMBO J, V2, P1151, DOI 10.1002/j.1460-2075.1983.tb01560.x; KOCH N, 1986, J BIOL CHEM, V261, P3434; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Logan J, 1984, CANCER CELL, V2, P527; MCGLADE CJ, 1987, J VIROL, V61, P3227, DOI 10.1128/JVI.61.10.3227-3234.1987; PARASKEVA C, 1982, J VIROL, V44, P759, DOI 10.1128/JVI.44.2.759-764.1982; PERSSON H, 1982, J VIROL, V42, P905, DOI 10.1128/JVI.42.3.905-917.1982; PILDER S, 1984, J VIROL, V52, P664, DOI 10.1128/JVI.52.2.664-671.1984; ROSE JK, 1984, P NATL ACAD SCI-BIOL, V81, P2050, DOI 10.1073/pnas.81.7.2050; ROWE DT, 1983, VIROLOGY, V129, P456, DOI 10.1016/0042-6822(83)90183-6; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAWADA Y, 1986, J EXP MED, V163, P563, DOI 10.1084/jem.163.3.563; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; SCHULTZ AM, 1988, IN PRESS ANN REV CEL, V4; SHIROKI K, 1979, COLD SPRING HARB SYM, V44, P533; SOLNICK D, 1982, J VIROL, V42, P106, DOI 10.1128/JVI.42.1.106-113.1982; SPECTOR DJ, 1978, J MOL BIOL, V126, P395, DOI 10.1016/0022-2836(78)90048-7; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; SUBRAMANIAN T, 1984, J BIOL CHEM, V259, P1777; TAKEMORI N, 1968, VIROLOGY, V36, P575, DOI 10.1016/0042-6822(68)90189-X; TEVETHIA SS, 1986, CONCEPTS VIRAL PATHO, V2, P182; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TRENTIN JJ, 1962, SCIENCE, V137, P835, DOI 10.1126/science.137.3533.835; VANDENELSEN P, 1983, VIROLOGY, V128, P377; WHITE E, 1984, J VIROL, V52, P410, DOI 10.1128/JVI.52.2.410-419.1984; WHITE E, 1986, MOL CELL BIOL, V6, P3763, DOI 10.1128/MCB.6.11.3763; WHITE E, 1984, MOL CELL BIOL, V4, P2865, DOI 10.1128/MCB.4.12.2865; WILLINGHAM MC, 1980, CELL, V19, P1005, DOI 10.1016/0092-8674(80)90091-4; WILSON MC, 1981, J MOL BIOL, V148, P231, DOI 10.1016/0022-2836(81)90537-4	55	10	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	1989	4	4					489	497						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	U5677	2541391				2022-12-28	WOS:A1989U567700014
